19145484	2009	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	21#39		Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	7421	LONGTERM|GENE|GT|DICTIONARY|GA	vitamin d receptor	vitamin D receptor	29#47		Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	7421	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	vdr	VDR	49#52	19145484-1-29-47	Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	3	57862	SYMBOL|DICTIONARY	apa1	Apa1	174#178		We conducted a meta-analysis of 21 case-control studies with Fok1 (eight studies with 5,284 cases and 7,500 controls), Bsm1 (14 studies with 5,498 cases and 7,943 controls), Apa1 (four studies with 1,138 cases and 7,943 controls), Taq1 (10 studies with 4,459 cases and 5,485 controls) polymorphisms.
19145484	2009	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	57862	SYMBOL|DICTIONARY	apa1	Apa1	60#64		No significant associations were observed between the Bsm1, Apa1 and Taq1 variants and breast cancer risk.
18701098	2009	Fertil. Steril.	1556-5653	TITLE	0	0	11132	LONGTERM|DICTIONARY	calpain 10	Calpain-10	21#31		111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	11132	SYMBOL|DICTIONARY	capn 10	CAPN-10	28#35		We investigated whether the CAPN-10 polymorphism UCSNP-43, -19, and -63 contribute, either individually or as haplotype/diplotype, to the susceptibility of polycystic ovary syndrome (PCOS) or related quantitative traits in Korean women.
18701098	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	11132	SYMBOL|GENE|GN|DICTIONARY	capn 10	CAPN-10	77#84		Our data showed that 111 haplotype and 111/121 and 111/111 diplotypes in the CAPN-10 gene were associated with a significantly increased risk of PCOS, and 112 haplotype and 121/121 and 112/122 diplotypes were associated with decreased risk of PCOS in the Korean population.
19117570	2009	Atherosclerosis	1879-1484	TITLE	0	0	5468	SYMBOL|GENE|GN|DICTIONARY	ppargamma	PPARgamma	0#9		PPARgamma promoter polymorphisms and acute coronary syndrome.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	1	5468	SYMBOL|DICTIONARY	ppargamma	PPARgamma	0#9		PPARgamma (PPARg) is a nuclear transcription factor involved in the control of lipid and glucose homeostasis.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	1	5468	SYMBOL|()|DICTIONARY|EXTRACTED	pparg	PPARg	11#16	19117570-1-0-9	PPARgamma (PPARg) is a nuclear transcription factor involved in the control of lipid and glucose homeostasis.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	2	5468	SYMBOL|DICTIONARY|EXTRACTED	pparg	PPARg	4#9	19117570-1-0-9	Two PPARg common polymorphisms, Pro12Ala and 161C>T, have been found to be associated with cardiovascular disease.
19117570	2009	Atherosclerosis	1879-1484	BACKGROUND	1	3	5468	SYMBOL|DICTIONARY|EXTRACTED	pparg	PPARg	30#35	19117570-1-0-9	In this study, in addition to PPARg coding region, we looked for genetic variations in promoters and their association with acute coronary syndrome (ACS).
19117570	2009	Atherosclerosis	1879-1484	RESULTS	3	5	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	61#66	19117570-1-0-9	We identified 7 new and 2 already published polymorphisms in PPARg promoters.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	48#53	19117570-1-0-9	The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19117570	2009	Atherosclerosis	1879-1484	CONCLUSIONS	4	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pparg	PPARg	84#89	19117570-1-0-9	The protective role of 93695C>T polymorphism in PPARg promoter in ACS suggests that PPARg genetic variants may affect the susceptibility to atherosclerotic diseases.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	1	840	SYMBOL|()|DICTIONARY	casp7	CASP7	10#15		Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	1	10491	SYMBOL|DICTIONARY	casp	CASP	35#39		Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
19058873	2009	Lung Cancer	1872-8332	BACKGROUND	1	2	840	SYMBOL|GENE|GN|DICTIONARY	casp7	CASP7	99#104		The purpose of this study is to comprehensively evaluate potential functional polymorphisms in the CASP7 gene in relation to the risk of lung cancer.
19058873	2009	Lung Cancer	1872-8332	METHODS	2	3	840	SYMBOL|GENE|GN|DICTIONARY	casp7	CASP7	129#134		We first captured seven single nucleotide polymorphisms (SNPs) in the regulating region, exons and exon-intron boundaries of the CASP7 gene using public database and then determined their frequencies in 27 healthy Korean individuals.
19058873	2009	Lung Cancer	1872-8332	CONCLUSION	4	8	840	SYMBOL|DICTIONARY	casp7	CASP7	31#36		These results suggest that the CASP7 polymorphisms contribute to the genetic susceptibility to lung cancer.
19058785	2009	Biol. Psychiatry	1873-2402	METHODS	2	4	476	SYMBOL|DICTIONARY	atp1a1	ATP1A1	182#188		To test our hypothesis, we undertook a comprehensive study of 13 tagged single nucleotide polymorphisms (SNPs) across the three genes of the brain alpha isoforms of Na+, K+- ATPase (ATP1A1, ATP1A2, and ATP1A3, which encode the three alpha isoforms, alpha1, alpha2, and alpha3, respectively) identified using HapMap data and the Haploview algorithm.
19058785	2009	Biol. Psychiatry	1873-2402	METHODS	2	4	477	SYMBOL|DICTIONARY	atp1a2	ATP1A2	190#196		To test our hypothesis, we undertook a comprehensive study of 13 tagged single nucleotide polymorphisms (SNPs) across the three genes of the brain alpha isoforms of Na+, K+- ATPase (ATP1A1, ATP1A2, and ATP1A3, which encode the three alpha isoforms, alpha1, alpha2, and alpha3, respectively) identified using HapMap data and the Haploview algorithm.
19058785	2009	Biol. Psychiatry	1873-2402	METHODS	2	4	478	SYMBOL|DICTIONARY	atp1a3	ATP1A3	202#208		To test our hypothesis, we undertook a comprehensive study of 13 tagged single nucleotide polymorphisms (SNPs) across the three genes of the brain alpha isoforms of Na+, K+- ATPase (ATP1A1, ATP1A2, and ATP1A3, which encode the three alpha isoforms, alpha1, alpha2, and alpha3, respectively) identified using HapMap data and the Haploview algorithm.
19058785	2009	Biol. Psychiatry	1873-2402	RESULTS	3	8	477	SYMBOL|GENE|GN|DICTIONARY	atp1a2	ATP1A2	42#48		Haplotype analysis of the alpha2 isoform (ATP1A2 gene) showed a significant association with two loci haplotypes with BD (rs2295623: rs2070704; global p value = .0198, following a permutation test).
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	30#63		Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) mediates endothelium-dependent vasodilatation and antithrombotic action.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	65#69	19111531-1-30-63	Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) mediates endothelium-dependent vasodilatation and antithrombotic action.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	2	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	51#55	19111531-1-30-63	Controversial results regarding the association of eNOS gene (NOS3) polymorphisms with hypertension have been reported.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	2	4846	SYMBOL|()|DICTIONARY|EXTRACTED	nos3	NOS3	62#66	19111531-2-51-55	Controversial results regarding the association of eNOS gene (NOS3) polymorphisms with hypertension have been reported.
19111531	2009	Clin. Biochem.	1873-2933	OBJECTIVES	1	3	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nos3	NOS3	126#130	19111531-2-51-55	In the present study, we examined a possible association between the 27-base pair (bp) repeat polymorphism in intron 4 of the NOS3 gene and hypertension in a sample of the Tunisian population.
19111531	2009	Clin. Biochem.	1873-2933	DESIGN AND METHODS	2	5	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nos3	NOS3	4#8	19111531-2-51-55	The NOS3 gene intron 4a4b variable number of tandem repeats polymorphism was analyzed by PCR.
18384775	2009	Fertil. Steril.	1556-5653	TITLE	0	0	2332	SYMBOL|GENE|GN|DICTIONARY	fmr1	FMR1	91#95		A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
18384775	2009	Fertil. Steril.	1556-5653	OBJECTIVE	1	1	2332	SYMBOL|DICTIONARY	fmr1	FMR1	60#64		To assess whether the number of triple CGG expansion of the FMR1 (fragile X) gene, known to correlate at premutation (55-200 repeats) and full mutation (>200 repeats) ranges with risk toward premature ovarian failure (POF), also correlates with milder forms of premature ovarian senescence.
18384775	2009	Fertil. Steril.	1556-5653	INTERVENTION(S)	5	5	2332	SYMBOL|GENE|GN|DICTIONARY	fmr1	FMR1	65#69		Determination of number of triple CGG repeats on both alleles of FMR1 gene and of FSH and anti-Müllerian hormone (AMH) levels as a reflection of ovarian reserve.
18384775	2009	Fertil. Steril.	1556-5653	INTERVENTION(S)	5	5	268	SYMBOL|()|DICTIONARY|EXTRACTED	amh	AMH	114#117	18384775-5-90-112	Determination of number of triple CGG repeats on both alleles of FMR1 gene and of FSH and anti-Müllerian hormone (AMH) levels as a reflection of ovarian reserve.
18384775	2009	Fertil. Steril.	1556-5653	MAIN OUTCOME MEASURE(S)	6	6	268	SYMBOL|DICTIONARY|EXTRACTED	amh	AMH	117#120	18384775-5-90-112	Statistical correlation of higher (allele-2) triple repeat counts with patients' clinical diagnoses and with FSH and AMH levels.
18384775	2009	Fertil. Steril.	1556-5653	RESULT(S)	7	9	268	SYMBOL|DICTIONARY|EXTRACTED	amh	AMH	3#6	18384775-5-90-112	An AMH level of <1.0 ng/mL statistically correlated to >32 triple repeats.
19052543	2009	Neuropsychopharmacology	1740-634X	TITLE	0	0	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	36#40		Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	1	1268	SYMBOL|()|DICTIONARY|EXTRACTED	cnr1	CNR1	120#124	19052543-1-91-113	We recently reported that, in a European-American (EA) sample, the interaction between two cannabinoid receptor 1 gene (CNR1) variants significantly increased risk for drug dependence (DD), including cocaine dependence (CD).
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	2	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	65#69	19052543-1-91-113	This study aimed to investigate directly the association between CNR1 and CD in four independent samples.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_1/3	1	3	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	31#35	19052543-1-91-113	Eight markers across the 45 kb CNR1 region and four large samples, ie, family-based European-American (EA) sample (n=734), case-control EA sample (n=862), family-based African-American (AA) sample (n=834) and case-control AA sample (n=619) were examined in the present study.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_2/3	2	5	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	40#44	19052543-1-91-113	The interaction between two independent CNR1 variants, ie, the G allele-containing genotypes of rs6454674 (SNP3(G+)), and the T/T genotype of rs806368 (SNP8(T)/T), significantly increased risk for CD in the EA family (P(GEE)=0.015) and EA case-control (P(regression)=0.003) samples.
19052543	2009	Neuropsychopharmacology	1740-634X	ALL_TEXT_3/3	3	10	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	33#37	19052543-1-91-113	We conclude that two independent CNR1 variants have significant interaction effects on risk for CD in EAs; they may also have effects on risk for CD in AAs.
18820912	2009	Ann. Hematol.	1432-0584	TITLE	0	0	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	9#16		Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
18820912	2009	Ann. Hematol.	1432-0584	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	29#32		Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	87#90		Most hereditary haemochromatosis patients are homozygous for the C282Y mutation of the HFE gene.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	3	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	73#80		The main objective of this work was to study the role of variants in the SLC40A1 gene in the severity of iron overload and his clinical consequences in 100 Spanish probands homozygous for the C282Y mutation of the HFE gene.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_1/3	1	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	214#217		The main objective of this work was to study the role of variants in the SLC40A1 gene in the severity of iron overload and his clinical consequences in 100 Spanish probands homozygous for the C282Y mutation of the HFE gene.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_2/3	2	4	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	96#103		We performed automated sequencing of the coding regions, including intron-exon junctions of the SLC40A1 gene.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_2/3	2	5	30061	SYMBOL|GENE|GN|DICTIONARY	slc40a1	SLC40A1	56#63		We studied the association between polymorphisms in the SLC40A1 gene and median values of iron removed, taking into account statistical corrections for multiple comparisons.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_2/3	2	6	30061	SYMBOL|DICTIONARY	slc40a1	SLC40A1	31#38		No pathogenic mutations in the SLC40A1 were detected.
18820912	2009	Ann. Hematol.	1432-0584	ALL_TEXT_3/3	3	11	3077	SYMBOL|DICTIONARY	hfe1	HFE1	98#102		IVS1-24 C>G on the ferroportin gene seems to be a genetic modifier for clinical aggressiveness of HFE1 haemochromatosis.
18555221	2009	Fertil. Steril.	1556-5653	TITLE	0	0	23305	LONGTERM|DICTIONARY	acyl coa synthetase long chain family member 6	Acyl-CoA synthetase long-chain family member 6	0#46		Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure.
18555221	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	23305	SYMBOL|()|GENE|GN|DICTIONARY	acsl6	ACSL6	59#64		The acyl-coenzyme A synthetase long-chain family member 6 (ACSL6) gene on chromosome 5q31 was associated with premature ovarian failure and identified disease-susceptibility haplotypes.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1621	SYMBOL|DICTIONARY	dbh	DBH	114#117		Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	119#123		Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_1/3	1	2	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	128#134		Based on the genotyping results of 53 variants across the ten genes in 270 MA cases and 272 controls, three genes-DBH, DRD2 and SLC6A3-were chosen to proceed to additional genotyping of 380 MA cases and 378 controls.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_2/3	2	4	1621	SYMBOL|DICTIONARY	dbh	DBH	34#37		Three of these SNPs [rs2097629 in DBH (uncorrected allelic P value = 0.0012, OR = 0.77), rs7131056 in DRD2 (uncorrected allelic P value = 0.0018, OR = 1.28) and rs40184 in SLC6A3 (uncorrected allelic P value = 0.0082, OR = 0.81)] remained significant after gene-wide correction for multiple testing by permutation analysis.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_2/3	2	4	1813	SYMBOL|DICTIONARY	drd2	DRD2	102#106		Three of these SNPs [rs2097629 in DBH (uncorrected allelic P value = 0.0012, OR = 0.77), rs7131056 in DRD2 (uncorrected allelic P value = 0.0018, OR = 1.28) and rs40184 in SLC6A3 (uncorrected allelic P value = 0.0082, OR = 0.81)] remained significant after gene-wide correction for multiple testing by permutation analysis.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_2/3	2	4	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	172#178		Three of these SNPs [rs2097629 in DBH (uncorrected allelic P value = 0.0012, OR = 0.77), rs7131056 in DRD2 (uncorrected allelic P value = 0.0018, OR = 1.28) and rs40184 in SLC6A3 (uncorrected allelic P value = 0.0082, OR = 0.81)] remained significant after gene-wide correction for multiple testing by permutation analysis.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	5	1813	SYMBOL|DICTIONARY	drd2	DRD2	122#126		Further consideration of imputed genotype data from 2,937 British control individuals did not affirm the association with DRD2, but supported the associations with DBH and SLC6A3.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	5	1621	SYMBOL|DICTIONARY	dbh	DBH	164#167		Further consideration of imputed genotype data from 2,937 British control individuals did not affirm the association with DRD2, but supported the associations with DBH and SLC6A3.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	5	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	172#178		Further consideration of imputed genotype data from 2,937 British control individuals did not affirm the association with DRD2, but supported the associations with DBH and SLC6A3.
19152006	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	6	1621	LONGTERM|DICTIONARY	dopamine beta hydroxylase	dopamine-beta hydroxylase	108#133		Our data provide new evidence for an involvement of components of the dopaminergic system-in particular the dopamine-beta hydroxylase and dopamine transporter genes-to the pathogenesis of migraine with aura.
19002671	2009	Psychopharmacology (Berl.)	1432-2072	TITLE	0	0	2166	SYMBOL|DICTIONARY|EXTRACTED	faah	FAAH	52#56		Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis.
19002671	2009	Psychopharmacology (Berl.)	1432-2072	RATIONALE	1	4	2166	SYMBOL|()|DICTIONARY|EXTRACTED	faah	FAAH	92#96	19002671-4-64-90	A single nucleotide polymorphism (SNP) in the gene encoding for fatty acid amide hydrolase (FAAH) has demonstrated association with substance use disorder diagnoses, but has not been studied with respect to these narrower phenotypes.
19002671	2009	Psychopharmacology (Berl.)	1432-2072	RATIONALE	1	5	2166	SYMBOL|DICTIONARY|EXTRACTED	faah	FAAH	0#4		FAAH is an enzyme that inactivates anandamide, an endogenous agonist for CB(1) receptors (to which Delta(9)-tetrahydrocannabinol binds).
19002671	2009	Psychopharmacology (Berl.)	1432-2072	OBJECTIVES	2	7	2166	SYMBOL|DICTIONARY|EXTRACTED	faah	FAAH	9#13	19002671-4-64-90	The SNP, FAAH C385A (rs324420), was examined to determine whether its variance was associated with changes in craving and withdrawal after marijuana abstinence, craving after cue exposure, or sensitivity to the acute effects of marijuana.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	1813	SYMBOL|DICTIONARY	drd2	DRD2	35#39		The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	44#50		The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	199#205		This study attempts to determine genetic influences on the relationship between the dopamine pathway and smoking cessation by examining associations with a variable number tandem repeat variation in SLC6A3 and the DRD2 variants TaqIA (A2 vs. A1), TaqIB (B2 vs. B1), C957T (C vs. T), and -141C Ins/Del (C vs. Del).
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	1813	SYMBOL|DICTIONARY	drd2	DRD2	214#218		This study attempts to determine genetic influences on the relationship between the dopamine pathway and smoking cessation by examining associations with a variable number tandem repeat variation in SLC6A3 and the DRD2 variants TaqIA (A2 vs. A1), TaqIB (B2 vs. B1), C957T (C vs. T), and -141C Ins/Del (C vs. Del).
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	7	1813	SYMBOL|DICTIONARY	drd2	DRD2	66#70		In a model containing the matching variables and other genotypes, DRD2 TaqIA was significantly associated with being abstinent at 1 year (P = 0.01).
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	9	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	46#52		The other dopamine receptor genotypes and the SLC6A3 genotype were not associated with smoking status at 1 year.
18563706	2009	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	10	1813	SYMBOL|DICTIONARY	drd2	DRD2	24#28		The association between DRD2 TaqIA and smoking cessation supports the hypothesis that genetic variation in the dopamine pathway influences smoking cessation.
19131637	2009	Clin. Chem.	1530-8561	TITLE	0	0	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	64#98		Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	1	19	SYMBOL|()|DICTIONARY	abca1	ABCA1	25#30		ATP-binding cassette A1 (ABCA1) and cholesteryl ester transfer protein (CETP) play important roles in the reverse cholesterol transport pathway.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	1	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	36#70		ATP-binding cassette A1 (ABCA1) and cholesteryl ester transfer protein (CETP) play important roles in the reverse cholesterol transport pathway.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	1	1071	SYMBOL|()|DICTIONARY|EXTRACTED	cetp	CETP	72#76	19131637-1-36-70	ATP-binding cassette A1 (ABCA1) and cholesteryl ester transfer protein (CETP) play important roles in the reverse cholesterol transport pathway.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	2	19	SYMBOL|DICTIONARY	abca1	ABCA1	20#25		The associations of ABCA1 and CETP polymorphisms with lipoprotein subclasses have not been extensively studied.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	2	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	30#34	19131637-1-36-70	The associations of ABCA1 and CETP polymorphisms with lipoprotein subclasses have not been extensively studied.
19131637	2009	Clin. Chem.	1530-8561	METHODS	2	3	19	SYMBOL|DICTIONARY	abca1	ABCA1	15#20		We genotyped 2 ABCA1 and 5 CETP polymorphisms in 999 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and studied their associations with HDL and LDL subclass particle concentrations, measured by nuclear magnetic resonance spectroscopy.
19131637	2009	Clin. Chem.	1530-8561	METHODS	2	3	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	27#31	19131637-1-36-70	We genotyped 2 ABCA1 and 5 CETP polymorphisms in 999 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and studied their associations with HDL and LDL subclass particle concentrations, measured by nuclear magnetic resonance spectroscopy.
19131637	2009	Clin. Chem.	1530-8561	RESULTS	3	4	19	SYMBOL|DICTIONARY	abca1	ABCA1	0#5		ABCA1 and CETP polymorphisms were associated with different and distinct changes in lipoprotein subclass concentrations.
19131637	2009	Clin. Chem.	1530-8561	RESULTS	3	4	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	10#14	19131637-1-36-70	ABCA1 and CETP polymorphisms were associated with different and distinct changes in lipoprotein subclass concentrations.
19131637	2009	Clin. Chem.	1530-8561	RESULTS	3	5	19	SYMBOL|NUMBER|DICTIONARY	abca1	ABCA1	4#9		The ABCA1 1051G/A AA genotype, previously found to be associated with cardioprotective effects in this cohort, was associated with a 5.5% higher concentration of small HDL particles (P = 0.024).
19131637	2009	Clin. Chem.	1530-8561	RESULTS	3	6	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	4#8	19131637-1-36-70	The CETP TaqIB B2B2, -2505C/A AA, and -629C/A AA genotypes, previously demonstrated to lack cardioprotective effects, were associated with 15.2%, 15.4%, and 11.7% higher HDL cholesterol concentrations, respectively, and 36.5%, 40.7%, and 25.4% higher large HDL particle concentrations (P < 0.0001).
19131637	2009	Clin. Chem.	1530-8561	CONCLUSIONS	4	8	19	SYMBOL|DICTIONARY	abca1	ABCA1	30#35		Our study of the influence of ABCA1 and CETP genetic variants on lipoprotein subclasses demonstrates the importance of interpreting lipoprotein subclasses within the context of the biochemical processes involved in the alterations.
19131637	2009	Clin. Chem.	1530-8561	CONCLUSIONS	4	8	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	40#44	19131637-1-36-70	Our study of the influence of ABCA1 and CETP genetic variants on lipoprotein subclasses demonstrates the importance of interpreting lipoprotein subclasses within the context of the biochemical processes involved in the alterations.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	TITLE	0	0	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	35#43		Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	2	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	125#133		One of the most frequently studied genetic polymorphisms in the background of psychological and psychiatric phenomena is the 5-HTTLPR polymorphism of the serotonin transporter gene which has earlier been found to be associated with neuroticism and neuroticism-related traits and disorders.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	INTRODUCTION	1	4	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	63#71		The aim of our study was to investigate the association of the 5-HTTLPR polymorphism with several smaller, distinct and better characterisable phenomena related to the neuroticism trait.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	METHODS	2	7	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	36#44		All subjects were genotyped for the 5-HTTLPR using PCR.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	308#316		Our study is the first that confirms that traits and characteristics related to neuroticism, such as increased anxiety, depression, hopelessness, somatization, feeling of guilt, hostility, aggression, lack of self-directedness and affective temperament are consistently and independently associated with the 5-HTTLPR polymorphism of the serotonin transporter gene.
18806915	2009	Eur Arch Psychiatry Clin Neurosci	1433-8491	CONCLUSIONS	4	12	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	60#68		Our results thus yield further insight into the role of the 5-HTTLPR in the background of neuroticism and neuroticism-related psychiatric disorders.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	TITLE	0	0	7248	SYMBOL|GENE|GN|DICTIONARY	tsc1	TSC1	26#30		Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_2/3	2	2	7248	SYMBOL|GENE|GN|DICTIONARY	tsc1	TSC1	49#53		The disease is caused by mutations in either the TSC1 gene on chromosome 9q34 or the TSC2 gene on chromosome 16p13.3.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_2/3	2	2	7249	SYMBOL|GENE|GN|DICTIONARY	tsc2	TSC2	85#89		The disease is caused by mutations in either the TSC1 gene on chromosome 9q34 or the TSC2 gene on chromosome 16p13.3.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	7248	SYMBOL|DICTIONARY	tsc1	TSC1	4#8		The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	7249	SYMBOL|GENE|GN|DICTIONARY	tsc2	TSC2	13#17		The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	7248	SYMBOL|DICTIONARY	tsc1	TSC1	33#37		The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	7249	SYMBOL|DICTIONARY	tsc2	TSC2	42#46		The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	2475	LONGTERM|DICTIONARY	mammalian target of rapamycin	mammalian target of rapamycin	152#181		The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED|()	mtor	mTOR	183#187	18830229-3-152-181	The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR).
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7248	SYMBOL|DICTIONARY	tsc1	TSC1	44#48		Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7248	SYMBOL|DICTIONARY	tsc1	TSC1	131#135		Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	4	7249	SYMBOL|DICTIONARY	tsc2	TSC2	136#140		Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	5	7248	SYMBOL|DICTIONARY	tsc1	TSC1	74#78		We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.
18830229	2009	Eur. J. Hum. Genet.	1476-5438	ALL_TEXT_3/3	3	5	7248	SYMBOL|DICTIONARY	tsc1	TSC1	109#113		We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.
19147210	2009	Gynecol. Oncol.	1095-6859	TITLE	0	0	2492	SYMBOL|DICTIONARY	fshr	FSHR	21#25		The haplotype of two FSHR polymorphisms in ovarian cancer--a potential role of ethnology in risk modification.
19147210	2009	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	8	2492	SYMBOL|DICTIONARY	fshr	FSHR	25#29		We could not confirm the FSHR Ala307-Ser680 haplotype as a risk factor for epithelial ovarian cancer in Caucasian women.
19141698	2009	J. Nutr.	1541-6100	TITLE	0	0	6934	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	51#57		Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	LONGTERM|DICTIONARY	transcription factor 7 like 2	transcription factor 7-like 2	4#33		The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	35#41	19141698-1-4-33	The transcription factor 7-like 2 (TCF7L2) has been recently associated with diabetes risk, and it may exert its effect through metabolic syndrome (MetS)-related traits and be subjected to modification by environmental factors.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_1/3	1	2	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	106#112	19141698-1-4-33	We investigated the effect of single nucleotide polymorphisms (SNP), rs7903146 and rs12255372, within the TCF7L2 locus on postprandial lipemia and other MetS-related traits and their modulation by dietary fat.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	155#161	19141698-1-4-33	In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	5290	SYMBOL|DICTIONARY	pi3k	PI3K	26#30		Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	5728	SYMBOL|DICTIONARY|EXTRACTED	pten	PTEN	31#35		Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
19164214	2009	J. Clin. Oncol.	1527-7755	PURPOSE	1	1	5295	SYMBOL|()|DICTIONARY	pi3k	PI3K	31#35		The phosphoinositide-3-kinase (PI3K), phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog (AKT), and mammalian target of rapamycin (mTOR) signaling pathway has been implicated in resistance to several chemotherapeutic agents.
19164214	2009	J. Clin. Oncol.	1527-7755	PURPOSE	1	1	5728	SYMBOL|()|DICTIONARY|EXTRACTED	pten	PTEN	70#74	19164214-1-38-68	The phosphoinositide-3-kinase (PI3K), phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog (AKT), and mammalian target of rapamycin (mTOR) signaling pathway has been implicated in resistance to several chemotherapeutic agents.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	5290	SYMBOL|DICTIONARY	pik3ca	PIK3CA	58#64		Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	5728	SYMBOL|DICTIONARY|EXTRACTED	pten	PTEN	66#70	19164214-1-38-68	Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	207	SYMBOL|DICTIONARY	akt1	AKT1	72#76		Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	208	SYMBOL|DICTIONARY	akt2	AKT2	78#82		Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	2475	SYMBOL|DICTIONARY	frap1	FRAP1	88#93		Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	104#108	19164214-1-132-161	Sixteen tagging single nucleotide polymorphisms (SNPs) in PIK3CA, PTEN, AKT1, AKT2, and FRAP1 (encoding mTOR) were genotyped in these patients and analyzed for associations with response to therapy, survival, and recurrence.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	4	207	SYMBOL|DICTIONARY	akt1	AKT1	68#72		We observed an increased recurrence risk with genetic variations in AKT1 and AKT2 (hazard ratio [HR], 2.21; 95% CI, 1.06 to 4.60; and HR, 3.30; 95% CI, 1.64 to 6.66, respectively).
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	4	208	SYMBOL|DICTIONARY	akt2	AKT2	77#81		We observed an increased recurrence risk with genetic variations in AKT1 and AKT2 (hazard ratio [HR], 2.21; 95% CI, 1.06 to 4.60; and HR, 3.30; 95% CI, 1.64 to 6.66, respectively).
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	6	5728	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pten	PTEN	48#52	19164214-1-38-68	In contrast, a predictable protective effect by PTEN genetic variants on recurrence was evident.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	8	207	SYMBOL|DICTIONARY	akt1	AKT1	22#26		Genetic variations in AKT1, AKT2, and FRAP1 were associated with survival.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	8	208	SYMBOL|DICTIONARY	akt2	AKT2	28#32		Genetic variations in AKT1, AKT2, and FRAP1 were associated with survival.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	8	2475	SYMBOL|DICTIONARY	frap1	FRAP1	38#43		Genetic variations in AKT1, AKT2, and FRAP1 were associated with survival.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	9	2475	SYMBOL|DICTIONARY	frap1	FRAP1	38#43		Patients homozygous for either of the FRAP1 SNPs assayed had a more than three-fold increased risk of death.
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	10	208	SYMBOL|DICTIONARY	akt2	AKT2	11#15		Two genes--AKT2 and FRAP1--were associated with a poor treatment response, while a better response was associated with heterozygosity for AKT1:rs3803304 (odds ratio, 0.50; 95% CI, 0.25 to 0.99).
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	10	2475	SYMBOL|DICTIONARY	frap1	FRAP1	20#25		Two genes--AKT2 and FRAP1--were associated with a poor treatment response, while a better response was associated with heterozygosity for AKT1:rs3803304 (odds ratio, 0.50; 95% CI, 0.25 to 0.99).
19164214	2009	J. Clin. Oncol.	1527-7755	RESULTS	3	10	207	SYMBOL|DICTIONARY	akt1	AKT1	138#142		Two genes--AKT2 and FRAP1--were associated with a poor treatment response, while a better response was associated with heterozygosity for AKT1:rs3803304 (odds ratio, 0.50; 95% CI, 0.25 to 0.99).
19141695	2009	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	glucose-dependent insulinotropic polypeptide	33#77		Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	LONGTERM|DICTIONARY	glucose dependent insulinotropic polypeptide	Glucose-dependent insulinotropic polypeptide	0#44		Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	2695	SYMBOL|()|DICTIONARY|EXTRACTED	gip	GIP	46#49	19141695-2-0-44	Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to adipocyte metabolism and obesity-related metabolic disorders, including NAFLD, induced by an excess of saturated fatty acids (SFAs), but its role in vivo, as well as underlying mechanisms, is unknown.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	3	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	29#32	19141695-2-0-44	We hypothesized that altered GIP secretion may contribute to the pathogenesis of NAFLD.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	4	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	12#15	19141695-2-0-44	We assessed GIP response to SFA ingestion and its effect on glucose and lipid metabolism and on liver injury in patients with nonalcoholic steatohepatitis (NASH).
19141695	2009	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	6	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	113#116	19141695-2-0-44	OGTT-derived indexes of glucose homeostasis were calculated; circulating lipoproteins, total antioxidant status, GIP, adiponectin, resistin, and cytokeratin-18 fragments (markers of hepatocyte apoptosis) after a high-fat meal were assessed.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	6	3875	LONGTERM|DICTIONARY	cytokeratin 18	cytokeratin-18	145#159		OGTT-derived indexes of glucose homeostasis were calculated; circulating lipoproteins, total antioxidant status, GIP, adiponectin, resistin, and cytokeratin-18 fragments (markers of hepatocyte apoptosis) after a high-fat meal were assessed.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	7	6934	LONGTERM|DICTIONARY	transcription factor 7 like 2	transcription factor 7-like 2	32#61		All subjects were genotyped for transcription factor 7-like 2 (TCF7L2) polymorphism.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	7	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	63#69	19141695-7-32-61	All subjects were genotyped for transcription factor 7-like 2 (TCF7L2) polymorphism.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	8	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	41#44	19141695-2-0-44	Patients with NASH exhibited a prolonged GIP elevation after fat ingestion.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	9	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	0#3		GIP response correlated directly with hepatic steatosis, postprandial resistin, and free fatty acid (FFA) increase and inversely with beta cell function and incretin effect.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	10	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	55#61	19141695-7-32-61	Dietary polyunsaturated:saturated fatty acid ratio and TCF7L2 polymorphism independently predicted postprandial GIP response.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	10	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	112#115	19141695-2-0-44	Dietary polyunsaturated:saturated fatty acid ratio and TCF7L2 polymorphism independently predicted postprandial GIP response.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	11	3875	LONGTERM|DICTIONARY	cytokeratin 18	Cytokeratin-18	0#14		Cytokeratin-18 fragments increased significantly postprandially in both groups but more consistently in patients with NASH; their increase was predicted by postprandial adiponectin and FFA responses.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	0#3		GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	12	2695	SYMBOL|DICTIONARY|EXTRACTED	gip	GIP	215#218	19141695-2-0-44	GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	LONGTERM|GENE|GN|DICTIONARY	myocyte enhancer factor 2a	myocyte enhancer factor 2A	25#51		Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
19161138	2009	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	4205	SYMBOL|()|DICTIONARY|EXTRACTED	mef2a	MEF2A	58#63	19161138-0-25-51	Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
18573495	2009	Atherosclerosis	1879-1484	TITLE	0	0	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	0#4		IL1B genetic variation and plasma C-reactive protein level among young adults: the CARDIA study.
18573495	2009	Atherosclerosis	1879-1484	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	34#52		IL1B genetic variation and plasma C-reactive protein level among young adults: the CARDIA study.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	1	3553	SYMBOL|()|DICTIONARY	il1b	IL1B	16#20		Interleukin-1B (IL1B) modulates C-reactive protein (CRP) expression.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	1	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	32#50		Interleukin-1B (IL1B) modulates C-reactive protein (CRP) expression.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	1	1401	SYMBOL|()|DICTIONARY|EXTRACTED	crp	CRP	52#55	18573495-1-32-50	Interleukin-1B (IL1B) modulates C-reactive protein (CRP) expression.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	2	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	17#21		However, whether IL1B genetic variation is associated with CRP level is unknown.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	59#62	18573495-1-32-50	However, whether IL1B genetic variation is associated with CRP level is unknown.
18573495	2009	Atherosclerosis	1879-1484	OBJECTIVE	1	3	3553	SYMBOL|DICTIONARY	il 1	IL-1	77#81		Further, obesity, a state of low-grade inflammation that influences cellular IL-1 functions may modify this association.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	4	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	60#63	18573495-1-32-50	Study participants (N=3289), 48% blacks and 52% whites, had CRP level measurements at year 7 and year 15 examinations as part of the CARDIA study.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	5	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	72#76		Ten tag single nucleotide polymorphisms (SNPs) that characterize common IL1B gene variation were genotyped.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	6	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	81#84	18573495-1-32-50	In SNP analysis, no significant associations with either level or change in time CRP were observed after multiple testing adjustments.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	7	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	84#87	18573495-1-32-50	However, global ILIB gene variation was associated with year 7 to year 15 change in CRP (global nominal p=0.004, multiple testing corrected p=0.048) among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	129#132	18573495-1-32-50	Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	289#292	18573495-1-32-50	Compared to the commonest haplotype, a common haplotype that includes the SNP rs1143642 was associated with greater increases in CRP from year 7 to year 15 among obese blacks and whites while another common haplotype that includes the SNP rs3917356 was associated with decreased change in CRP from year 7 to year 15 among obese blacks.
18573495	2009	Atherosclerosis	1879-1484	METHODS AND RESULTS	2	9	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	134#137	18573495-1-32-50	The rare alleles of ILIB SNPs, SNP 7114 (rs1143642) and SNP 3298 (rs3917356), were associated with greater increases and decreases in CRP from year 7 to year 15 among blacks, respectively, compared to their common variants.
18573495	2009	Atherosclerosis	1879-1484	CONCLUSION	3	10	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	0#4		IL1B genetic variation may have a role in CRP level regulation and this association may be modified by obesity.
18573495	2009	Atherosclerosis	1879-1484	CONCLUSION	3	10	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	42#45	18573495-1-32-50	IL1B genetic variation may have a role in CRP level regulation and this association may be modified by obesity.
19115972	2009	Clin. Infect. Dis.	1537-6591	TITLE	0	0	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	7#12		Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_2/3	2	2	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	30#35		However, the carriage rate of HLA-B*5701 has rarely been studied in Asians.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_3/3	3	3	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	68#73		In 534 Korean patients with human immunodeficiency virus infection, HLA-B*5701 status was determined by polymerase chain reaction with HLA-B*5701-specific primers.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_3/3	3	3	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	135#140		In 534 Korean patients with human immunodeficiency virus infection, HLA-B*5701 status was determined by polymerase chain reaction with HLA-B*5701-specific primers.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_3/3	3	4	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	20#25		No patients had the HLA-B*5701 allele (95% confidence interval, 0%-0.7%).
18281036	2009	Fertil. Steril.	1556-5653	TITLE	0	0	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	30#47		Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns.
18281036	2009	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	66#83		The results suggest that short CAG repeats with a relatively high androgen receptor function may constitute a susceptibility factor for the development of POF.
18786162	2009	Genes Brain Behav.	1601-183X	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	14#47		Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
18786162	2009	Genes Brain Behav.	1601-183X	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	43#47	18786162-1-25-41	Genetic factors, such as apolipoprotein E (ApoE) polymorphisms, are thought to play an important role in the etiology of Alzheimer's disease (AD).
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	2	627	LONGTERM|GENE|GT|DICTIONARY|GA	brain derived neurotrophic factor	brain-derived neurotrophic factor	80#113		Recent association studies have suggested that the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene could play a role in the development of AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	2	627	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	Recent association studies have suggested that the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene could play a role in the development of AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	37#41	18786162-2-80-113	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_1/3	1	3	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	ApoE	50#54	18786162-1-25-41	To identify genotypic effects of the BDNF and the ApoE genes on disease progression in preclinical AD, we assessed morphological changes using serial magnetic resonance imaging during the preclinical period of AD in 35 individuals.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	19#23	18786162-2-80-113	Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	115#119	18786162-2-80-113	Individuals of the BDNF Val/Val genotype showed progressive atrophy in the left medial temporal areas, whereas the BDNF Met allele carriers showed additional changes in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC) and the precuneus.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	6	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	27#31	18786162-2-80-113	An interaction between the BDNF genotype and progressive morphological changes was found in the PCC.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	7	348	SYMBOL|EXTRACTED	apoe	ApoE	24#28	18786162-1-25-41	The noncarriers for the ApoE epsilon4 allele showed progressive atrophy in the bilateral medial temporal areas.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	9	348	SYMBOL|EXTRACTED	apoe	ApoE	27#31	18786162-1-25-41	An interaction between the ApoE genotype and progressive morphological change was noted in the right medial temporal area.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	348	SYMBOL|EXTRACTED	apoe	ApoE	66#70	18786162-1-25-41	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	79#83	18786162-2-80-113	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18786162	2009	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	10	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	166#170	18786162-2-80-113	The present preliminary study indicates that polymorphisms of the ApoE and the BDNF genes could affect disease progression in preclinical AD and implies that the Met-BDNF polymorphism could be an additional risk factor for rapid disease progression in preclinical AD.
18996923	2009	Hum. Mol. Genet.	1460-2083	TITLE	0	0	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	24#29		Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	2	217	SYMBOL|DICTIONARY	aldh2	ALDH2	36#41		The role of two genetic variants in ALDH2 and ADH1B in AD risk has been extensively investigated.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	2	125	SYMBOL|DICTIONARY	adh1b	ADH1B	46#51		The role of two genetic variants in ALDH2 and ADH1B in AD risk has been extensively investigated.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	3	217	SYMBOL|DICTIONARY	aldh2	ALDH2	65#70		This study tested for associations between nine polymorphisms in ALDH2 and 41 in the seven ADH genes, and alcohol-related flushing, alcohol use and dependence symptom scores in 4597 Australian twins.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_2/3	2	5	125	SYMBOL|DICTIONARY	adh1b	ADH1B	72#77		There were study-wide significant associations (P<2.3 x 10(-4)) between ADH1B-Arg48His (rs1229984) and flushing and consumption, but only nominally significant associations (P<0.01) with dependence.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	125	SYMBOL|()|DICTIONARY	adh1b	ADH1B	92#97		After controlling for rs1229984, an independent association was observed between rs1042026 (ADH1B) and alcohol intake (P=4.7 x 10(-5)) and suggestive associations (P<0.001) between alcohol consumption phenotypes and rs1693482 (ADH1C), rs1230165 (ADH5) and rs3762894 (ADH4).
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	126	SYMBOL|()|DICTIONARY	adh1c	ADH1C	227#232		After controlling for rs1229984, an independent association was observed between rs1042026 (ADH1B) and alcohol intake (P=4.7 x 10(-5)) and suggestive associations (P<0.001) between alcohol consumption phenotypes and rs1693482 (ADH1C), rs1230165 (ADH5) and rs3762894 (ADH4).
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	128	SYMBOL|()|DICTIONARY	adh5	ADH5	246#250		After controlling for rs1229984, an independent association was observed between rs1042026 (ADH1B) and alcohol intake (P=4.7 x 10(-5)) and suggestive associations (P<0.001) between alcohol consumption phenotypes and rs1693482 (ADH1C), rs1230165 (ADH5) and rs3762894 (ADH4).
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	127	SYMBOL|()|DICTIONARY	adh4	ADH4	267#271		After controlling for rs1229984, an independent association was observed between rs1042026 (ADH1B) and alcohol intake (P=4.7 x 10(-5)) and suggestive associations (P<0.001) between alcohol consumption phenotypes and rs1693482 (ADH1C), rs1230165 (ADH5) and rs3762894 (ADH4).
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	8	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		ALDH2 variation was not associated with flushing or alcohol consumption, but was weakly associated with AD measures.
18996923	2009	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	9	125	SYMBOL|DICTIONARY	adh1b	ADH1B	110#115		These results bridge the gap between DNA sequence variation and alcohol-related behavior, confirming that the ADH1B-Arg48His polymorphism affects both alcohol-related flushing in Europeans and alcohol intake.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	INTRODUCTION	1	1	1956	LONGTERM|GENE|GT|DICTIONARY|GA	epidermal growth factor receptor	epidermal growth factor receptor	56#88		It has been reported that the R497K polymorphism of the epidermal growth factor receptor (EGFR) gene has attenuated functions in ligand binding, tyrosine kinase activation, and growth stimulation.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	INTRODUCTION	1	1	1956	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	egfr	EGFR	90#94	18726117-1-56-88	It has been reported that the R497K polymorphism of the epidermal growth factor receptor (EGFR) gene has attenuated functions in ligand binding, tyrosine kinase activation, and growth stimulation.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	INTRODUCTION	1	2	1956	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	egfr	EGFR	15#19	18726117-1-56-88	On other hand, EGFR gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or erlotinib.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	MATERIALS AND METHODS	2	3	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	20#24	18726117-1-56-88	We investigated the EGFR mutations and/or R497K polymorphism statuses in 225 surgically treated NSCLC cases.192 adenocarcinoma cases were included.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	MATERIALS AND METHODS	2	4	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	27#31	18726117-1-56-88	The presence or absence of EGFR polymorphism of exon 13 was analyzed by PCR-RFLP method.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	5	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		EGFR mutations at kinase domain were found from 95 of 225 lung cancer patients.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	7	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	37#41	18726117-1-56-88	No correlation existed between R497K EGFR genotype and clinico-pathological features, such as gender, smoking status, and pathological subtypes.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSIONS	4	8	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	0#4		EGFR mutation status was not correlated with R497KEGFR genotype of lung cancers.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSIONS	4	10	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	42#46	18726117-1-56-88	In node-positive patients, however, R497K EGFR was significantly associated with better overall survival.
18726117	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSIONS	4	12	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	90#94	18726117-1-56-88	In 46 total gefitinib treated NSCLC patients, the prognosis was not different between the EGFR wild type (GG) patients and AG+AA patients.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	26#32		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	TITLE	0	0	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	83#89		A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	1	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	0#6		YKL-40 is a chitinase-like protein involved in matrix remodelling and a non-invasive fibrosis marker.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	58#64		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	75#81		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	144#150		We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	3	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	4#10		The CHI3L1 -131G-->C promoter polymorphism was genotyped in two cohorts of HCV infected patients (n=440) by 5'-endonuclease assays.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	4	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	33#39		Histological fibrosis scores and YKL-40 serum levels (ELISA) were associated with CHI3L1 -131G-->C by quantitative and qualitative genetic analyses and corrected by multivariate analysis.
19070929	2009	J. Hepatol.	0168-8278	METHODS	2	4	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	82#88		Histological fibrosis scores and YKL-40 serum levels (ELISA) were associated with CHI3L1 -131G-->C by quantitative and qualitative genetic analyses and corrected by multivariate analysis.
19070929	2009	J. Hepatol.	0168-8278	RESULTS	3	5	1116	SYMBOL|DICTIONARY	chi3l1	CHI3L1	0#6		CHI3L1 -131G-->C genotype was strongly associated with the stage of liver fibrosis in the screening (n=265, P=0.001) and validation cohort (n=175, P=0.009).
19070929	2009	J. Hepatol.	0168-8278	RESULTS	3	8	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	71#77		Functionally, the G allele was associated with reduced serum levels of YKL-40 in HCV infected patients (P=0.002).
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	1116	SYMBOL|GENE|GN|DICTIONARY	chi3l1	CHI3L1	4#10		The CHI3L1 promoter polymorphism -131G-->C determines YKL-40 serum levels and is associated with the severity of HCV-induced liver fibrosis.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	54#60		The CHI3L1 promoter polymorphism -131G-->C determines YKL-40 serum levels and is associated with the severity of HCV-induced liver fibrosis.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	10	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	43#49		These results suggest a functional role of YKL-40 in liver fibrogenesis and should be taken into account when using YKL-40 as a non-invasive fibrosis marker.
19070929	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	10	1116	SYMBOL|DICTIONARY	ykl 40	YKL-40	116#122		These results suggest a functional role of YKL-40 in liver fibrogenesis and should be taken into account when using YKL-40 as a non-invasive fibrosis marker.
19122664	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	56244	SYMBOL|DICTIONARY	btnl2	BTNL2	102#107		In addition, combined genome-wide significant evidence for association was found in a region spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0 x 10(-16), combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 1.3 x 10(-8), combined OR = 0.56; rs10889677, combined P = 1.3 x 10(-8), combined OR = 1.29).
19122664	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	111#119		In addition, combined genome-wide significant evidence for association was found in a region spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0 x 10(-16), combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 1.3 x 10(-8), combined OR = 0.56; rs10889677, combined P = 1.3 x 10(-8), combined OR = 1.29).
19122664	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	149233	SYMBOL|DICTIONARY	il23r	IL23R	210#215		In addition, combined genome-wide significant evidence for association was found in a region spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0 x 10(-16), combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 1.3 x 10(-8), combined OR = 0.56; rs10889677, combined P = 1.3 x 10(-8), combined OR = 1.29).
19104460	2009	Neuroreport	1473-558X	TITLE	0	0	5444	SYMBOL|DICTIONARY	pon1	PON1	20#24		Interaction between PON1 and population density in amyotrophic lateral sclerosis.
19132772	2009	World J. Gastroenterol.	2219-2840	METHODS	2	3	3586	SYMBOL|DICTIONARY	il 10	IL-10	139#144		Human DNA obtained from biopsy specimens was used in the determination of polymorphisms of the genes coding for interleukin (IL)-1beta and IL-10 by PCR-RFLP, and IL-1RN by PCR.
19132772	2009	World J. Gastroenterol.	2219-2840	METHODS	2	3	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	162#168		Human DNA obtained from biopsy specimens was used in the determination of polymorphisms of the genes coding for interleukin (IL)-1beta and IL-10 by PCR-RFLP, and IL-1RN by PCR.
19132772	2009	World J. Gastroenterol.	2219-2840	RESULTS	3	8	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	37#43		IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4).
19132772	2009	World J. Gastroenterol.	2219-2840	RESULTS	3	8	3586	SYMBOL|NUMBER|DICTIONARY	il 10	IL-10	70#75		IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4).
19027848	2009	Biochim. Biophys. Acta	0006-3002	TITLE	0	0	4641	SYMBOL|DICTIONARY	myo1c	MYO1C	4#9		Are MYO1C and MYO1F associated with hearing loss?
19027848	2009	Biochim. Biophys. Acta	0006-3002	TITLE	0	0	4542	SYMBOL|DICTIONARY	myo1f	MYO1F	14#19		Are MYO1C and MYO1F associated with hearing loss?
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_2/3	2	2	4641	SYMBOL|DICTIONARY	myo1c	MYO1C	110#115		To better understand the role of this gene family we performed a mutational screening on two candidate genes, MYO1C and MYO1F, analyzing hundreds of patients, affected by bilateral sensorineural hearing loss and coming from different European countries.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_2/3	2	2	4542	SYMBOL|DICTIONARY	myo1f	MYO1F	120#125		To better understand the role of this gene family we performed a mutational screening on two candidate genes, MYO1C and MYO1F, analyzing hundreds of patients, affected by bilateral sensorineural hearing loss and coming from different European countries.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_3/3	3	3	4641	SYMBOL|DICTIONARY	myo1c	MYO1C	89#94		This research activity led to the identification of 6 heterozygous missense mutations in MYO1C and additional 5 heterozygous missense mutations in MYO1F.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_3/3	3	3	4542	SYMBOL|DICTIONARY	myo1f	MYO1F	147#152		This research activity led to the identification of 6 heterozygous missense mutations in MYO1C and additional 5 heterozygous missense mutations in MYO1F.
19027848	2009	Biochim. Biophys. Acta	0006-3002	ALL_TEXT_3/3	3	5	79784	SYMBOL|GENE|GN|DICTIONARY	myosin	myosin	50#56		This study suggests a role of the above mentioned myosin genes in the pathogenesis of hearing loss.
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	41#45		Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	734#738		Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	2	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	759#763		Here we show a clear association between DRB1*1501 carrier status and four domains of disease severity in an investigation of genotype-phenotype associations in 505 robust, clinically well characterized MS patients evaluated cross-sectionally: (i) a reduction in the N-acetyl-aspartate (NAA) concentration within normal appearing white matter (NAWM) via (1)HMR spectroscopy (P = 0.025), (ii) an increase in the volume of white matter (WM) lesions utilizing conventional anatomical MRI techniques (1,127 mm(3); P = 0.031), (iii) a reduction in normalized brain parenchymal volume (nBPV) (P = 0.023), and (iv) impairments in cognitive function as measured by the Paced Auditory Serial Addition Test (PASAT-3) performance (Mean Z Score: DRB1*1501+: 0.110 versus DRB1*1501-: 0.048; P = 0.004).
19022862	2009	Brain	1460-2156	ALL_TEXT_2/3	2	3	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	13#17		In addition, DRB1*1501+ patients had significantly more women (74% versus 63%; P = 0.009) and a younger mean age at disease onset (32.4 years versus 34.3 years; P = 0.025).
19022862	2009	Brain	1460-2156	ALL_TEXT_2/3	2	4	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	26#30		Our findings suggest that DRB1*1501 increases disease severity in MS by facilitating the development of more T2-foci, thereby increasing the potential for irreversible axonal compromise and subsequent neuronal degeneration, as suggested by the reduction of NAA concentrations in NAWM, ultimately leading to a decline in brain volume.
19022862	2009	Brain	1460-2156	ALL_TEXT_3/3	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	111#115		These structural aberrations may explain the significant differences in cognitive performance observed between DRB1*1501 groups.
19021638	2009	Clin. Genet.	1399-0004	TITLE	0	0	55636	SYMBOL|DICTIONARY	chd7	CHD7	0#4		CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	2	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	46#50		CHARGE syndrome is caused by mutations in the CHD7 gene.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	55636	SYMBOL|DICTIONARY	chd7	CHD7	25#29		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	3730	SYMBOL|DICTIONARY	kal1	KAL1	153#157		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	2260	SYMBOL|DICTIONARY	fgfr1	FGFR1	159#164		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	60675	SYMBOL|DICTIONARY	prok2	PROK2	166#171		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_1/3	1	3	128674	SYMBOL|GENE|GN|DICTIONARY	prokr2	PROKR2	176#182		We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	4	55636	SYMBOL|DICTIONARY	chd7	CHD7	54#58		Three of 56 KS/nIHH patients had de novo mutations in CHD7.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	5	55636	SYMBOL|DICTIONARY	chd7	CHD7	27#31		In retrospect, these three CHD7-positive patients showed additional features that are seen in CHARGE syndrome.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_2/3	2	6	55636	SYMBOL|DICTIONARY	chd7	CHD7	0#4		CHD7 mutations can be present in KS patients who have additional features that are part of the CHARGE syndrome phenotype.
19021638	2009	Clin. Genet.	1399-0004	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	126#130		If such features are present, particularly deafness, dysmorphic ears and/or hypoplasia or aplasia of the semicircular canals, CHD7 sequencing is recommended.
18499652	2009	Eur. Heart J.	1522-9645	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	0#18		C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study.
18499652	2009	Eur. Heart J.	1522-9645	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	57#75		C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study.
18499652	2009	Eur. Heart J.	1522-9645	AIMS	1	1	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	12#30		Circulating C-reactive protein is associated with future cardiovascular events.
18499652	2009	Eur. Heart J.	1522-9645	AIMS	1	2	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	19#37		The causal role of C-reactive protein in the development of atherosclerosis remains controversial.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	139#157		We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	3	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	209#227		We analysed the association between three genetic polymorphisms (PM) (-717C>T, rs2794521; +1059G>C, rs1800947; +1444C>T, rs1130864) at the C-reactive protein locus and related haplotypes with both circulating C-reactive protein and angiographic coronary artery disease (CAD).
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	21#39		The concentration of C-reactive protein was similar in patients with stable CAD and in controls, but increased in patients presenting with acute coronary syndromes.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	197#215		In models adjusting for the main confounding variables, the minor alleles of the +1059G>C (rs1800947) and the +1444C>T PM (rs1130864) were associated with decreased and increased concentrations of C-reactive protein, respectively.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	6	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	56#74		Haplotypes 1 and 4 decreased, and haplotype 2 increased C-reactive protein, whereas haplotype 3 had no appreciable effect.
18499652	2009	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	7	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	51#69		None of the genetic variants affecting circulating C-reactive protein was consistently associated with the prevalence of angiographic CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	17#35		A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	150#168		A causal role of C-reactive protein in the development of CAD would require that genetic PM resulting in long-term modulation of the concentration of C-reactive protein be themselves associated with CAD.
18499652	2009	Eur. Heart J.	1522-9645	CONCLUSION	3	9	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	143#161		We were not able to detect such a relationship, which can be attributed to either a very small genetic effect size or the relationship between C-reactive protein and cardiovascular events may reflect confounding and reverse causation.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	97#104		Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	1	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	143#150		In this pilot study, we attempted to determine the optimal dosage regimens of esomeprazole for treatment of GERD with minimal influence of the CYP2C19 polymorphism through a study of the pharmacokinetics and pharmacodynamics of esomeprazole given at 3 different dosage regimens with the same total daily dose.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	METHODS	2	2	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	27#34		Each of the 3 genotypes of CYP2C19, homozygous extensive metabolizers (homEMs), heterozygous EMS (hetEMs), and poor metabolizers (PMs) were recruited in this clinical trial.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	5	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	80#87		The pharmacokinetic parameters and dynamic characteristics differed among the 3 CYP2C19 genotype groups.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	7	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	112#119		It was confirmed that intragastric pH values and plasma esomeprazole concentrations potentially depended on the CYP2C19 genotype status for treatment with esomeprazole.
18751689	2009	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	8	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	130#137		Dosage regimens of divided doses of 20TD or 10Q4D esomeprazole yielded improved antisecretory effects with a minimal influence of CYP2C19 polymorphisms.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_2/3	2	6	2580	SYMBOL|DICTIONARY	gak	GAK	54#57		The strongest association result was with SNPs in the GAK/DGKQ region on chromosome 4 (additive model: p = 3.4 x 10(-6); OR = 1.69).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_2/3	2	6	1609	SYMBOL|DICTIONARY	dgkq	DGKQ	58#62		The strongest association result was with SNPs in the GAK/DGKQ region on chromosome 4 (additive model: p = 3.4 x 10(-6); OR = 1.69).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	7	6622	SYMBOL|DICTIONARY	snca	SNCA	91#95		Consistent evidence of association was also observed to the chromosomal regions containing SNCA (additive model: p = 5.5 x 10(-5); OR = 1.35) and MAPT (recessive model: p = 2.0 x 10(-5); OR = 0.56).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	7	4137	SYMBOL|DICTIONARY	mapt	MAPT	146#150		Consistent evidence of association was also observed to the chromosomal regions containing SNCA (additive model: p = 5.5 x 10(-5); OR = 1.35) and MAPT (recessive model: p = 2.0 x 10(-5); OR = 0.56).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	9	2580	SYMBOL|DICTIONARY	gak	GAK	135#138		Meta-analysis was performed using data from a previous case-control GWAS, and yielded improved p values for several regions, including GAK/DGKQ (additive model: p = 2.5 x 10(-7)) and the MAPT region (recessive model: p = 9.8 x 10(-6); additive model: p = 4.8 x 10(-5)).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	9	1609	SYMBOL|DICTIONARY	dgkq	DGKQ	139#143		Meta-analysis was performed using data from a previous case-control GWAS, and yielded improved p values for several regions, including GAK/DGKQ (additive model: p = 2.5 x 10(-7)) and the MAPT region (recessive model: p = 9.8 x 10(-6); additive model: p = 4.8 x 10(-5)).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	9	4137	SYMBOL|DICTIONARY	mapt	MAPT	187#191		Meta-analysis was performed using data from a previous case-control GWAS, and yielded improved p values for several regions, including GAK/DGKQ (additive model: p = 2.5 x 10(-7)) and the MAPT region (recessive model: p = 9.8 x 10(-6); additive model: p = 4.8 x 10(-5)).
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	2580	SYMBOL|DICTIONARY	gak	GAK	82#85		These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	1609	SYMBOL|DICTIONARY	dgkq	DGKQ	86#90		These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	6622	SYMBOL|DICTIONARY	snca	SNCA	148#152		These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
18985386	2009	Hum. Genet.	1432-1203	ALL_TEXT_3/3	3	10	4137	SYMBOL|DICTIONARY	mapt	MAPT	157#161		These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	79068	SYMBOL|DICTIONARY	fto	FTO	64#67		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4160	SYMBOL|DICTIONARY	mc4r	MC4R	69#73		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY	bdnf	BDNF	75#79		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19079260	2009	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	25970	SYMBOL|GENE|GN|DICTIONARY	sh2b1	SH2B1	84#89		This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.
19039244	2009	Neuroepidemiology	1423-0208	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	65#73		Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study.
19039244	2009	Neuroepidemiology	1423-0208	METHODS	2	4	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	60#68		Subjects were aged between 18 and 50 years and positive for HLA DQB1*0602.
19039244	2009	Neuroepidemiology	1423-0208	CONCLUSION	4	8	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	69#77		Passive smoking may be a risk factor for narcolepsy in subjects with HLA DQB1*0602.
19073975	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	79068	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fto	FTO	22#25		An obesity-associated FTO gene variant and increased energy intake in children.
19073975	2008	N. Engl. J. Med.	1533-4406	BACKGROUND	1	1	79068	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	fto	FTO	50#53	19073975-1-17-48	Variation in the fat mass and obesity-associated (FTO) gene has provided the most robust associations with common obesity to date.
19073975	2008	N. Engl. J. Med.	1533-4406	BACKGROUND	1	2	79068	SYMBOL|DICTIONARY|EXTRACTED	fto	FTO	21#24	19073975-1-17-48	However, the role of FTO variants in modulating specific components of energy balance is unknown.
19073975	2008	N. Engl. J. Med.	1533-4406	METHODS	2	3	79068	SYMBOL|DICTIONARY|EXTRACTED	fto	FTO	86#89	19073975-1-17-48	We studied 2726 Scottish children, 4 to 10 years of age, who underwent genotyping for FTO variant rs9939609 and were measured for height and weight.
19073975	2008	N. Engl. J. Med.	1533-4406	METHODS	2	4	79068	SYMBOL|DICTIONARY|EXTRACTED	fto	FTO	72#75	19073975-1-17-48	A subsample of 97 children was examined for possible association of the FTO variant with adiposity, energy expenditure, and food intake.
19073975	2008	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	10	79068	SYMBOL|DICTIONARY|EXTRACTED	fto	FTO	4#7	19073975-1-17-48	The FTO variant that confers a predisposition to obesity does not appear to be involved in the regulation of energy expenditure but may have a role in the control of food intake and food choice, suggesting a link to a hyperphagic phenotype or a preference for energy-dense foods.
19094875	2009	Med Clin (Barc)	0025-7753	BACKGROUND AND OBJECTIVE	1	4	1312	SYMBOL|GENE|GN|DICTIONARY	comt	COMT	86#90		Genetic variants in the P2 promoter have been suggested to cause alterations in brain COMT protein levels.
19061983	2009	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	23#30		A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42).
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	5	9197	SYMBOL|()|DICTIONARY	slc33a1	SLC33A1	124#131		Screening of candidate genes revealed that the HSP is caused by a missense mutation in the gene for acetyl-CoA transporter (SLC33A1).
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	9197	SYMBOL|DICTIONARY	slc33a1	Slc33a1	13#20		Knockdown of Slc33a1 in zebrafish caused a curve-shaped tail and defective axon outgrowth from the spinal cord.
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	29#36		Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes.
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	9197	SYMBOL|DICTIONARY	slc33a1	Slc33a1	80#87		Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes.
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	123#130		Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes.
19061983	2009	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	9197	SYMBOL|DICTIONARY	slc33a1	SLC33A1	189#196		Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes.
19064752	2009	Arch. Neurol.	1538-3687	TITLE	0	0	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	36#41		Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease.
19064752	2009	Arch. Neurol.	1538-3687	BACKGROUND	1	1	6653	SYMBOL|()|DICTIONARY|EXTRACTED	sorl1	SORL1	108#113	19064752-1-81-106	Single-nucleotide polymorphisms (SNPs) in 2 distinct regions of the gene for the sortilin-related receptor (SORL1) (bounded by consecutively numbered SNPs 8-10 and 22-25) were shown to be associated with Alzheimer disease (AD) in multiple ethnically diverse samples.
19064752	2009	Arch. Neurol.	1538-3687	OBJECTIVE	2	2	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	28#33	19064752-1-81-106	To test the hypothesis that SORL1 is associated with brain magnetic resonance imaging (MRI) measurements of atrophy and/or vascular disease.
19064752	2009	Arch. Neurol.	1538-3687	DESIGN, SETTING, AND PATIENTS	3	3	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	49#54	19064752-1-81-106	We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study.
19064752	2009	Arch. Neurol.	1538-3687	CONCLUSIONS	5	9	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	12#17	19064752-1-81-106	Variants of SORL1 previously associated with AD are also associated with MRI and neuropathological measures of neurodegenerative and cerebrovascular disease.
19064752	2009	Arch. Neurol.	1538-3687	CONCLUSIONS	5	10	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	70#75	19064752-1-81-106	These findings not only support the hypothesis that multiple areas in SORL1 are of functional importance but also raise the possibility that multiple SORL1 variants influence amyloid precursor protein or endothelial lipoprotein processing or both in different regions of the brain.
19064752	2009	Arch. Neurol.	1538-3687	CONCLUSIONS	5	10	6653	SYMBOL|DICTIONARY|EXTRACTED	sorl1	SORL1	150#155	19064752-1-81-106	These findings not only support the hypothesis that multiple areas in SORL1 are of functional importance but also raise the possibility that multiple SORL1 variants influence amyloid precursor protein or endothelial lipoprotein processing or both in different regions of the brain.
18798262	2008	Int. J. Cancer	1097-0215	TITLE	0	0	4851	SYMBOL|DICTIONARY	notch1	Notch1	0#6		Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	1	4851	SYMBOL|DICTIONARY	notch1	Notch1	11#17		Activating Notch1 mutations have been reported in human T-lineage acute lymphoblastic leukemia (T-ALL) and lymphomas from genetically modified mice.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	4851	SYMBOL|DICTIONARY	notch1	Notch1	15#21		We report that Notch1 is a prevalent and major mutational target in chemically induced mouse lymphoma.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_2/3	2	4	55294	SYMBOL|DICTIONARY	cdc4	CDC4	14#18		Another gene, CDC4, is also involved in Notch1 degradation and shows frequent mutations.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_2/3	2	4	4851	SYMBOL|DICTIONARY	notch1	Notch1	40#46		Another gene, CDC4, is also involved in Notch1 degradation and shows frequent mutations.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_2/3	2	5	4851	SYMBOL|DICTIONARY	notch1	Notch1	196#202		Mutations in the heterodimerization and the ligand-binding regions may cause ligand-independent signaling, whereas mutations preventing protein degradation result in accumulation of intracellular Notch1.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_2/3	2	6	4851	SYMBOL|GENE|GN|DICTIONARY	notch1	Notch1	70#76		We analyzed 103 chemical-induced mouse lymphomas for mutations in the Notch1 gene using single strand conformation analysis (SSCA) and DNA sequencing.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	7	4851	SYMBOL|DICTIONARY	notch1	Notch1	57#63		Genetic alterations resulting in premature truncation of Notch1 were identified in 28 tumors, whereas 8 revealed alterations in the heterodimerization and 16 harbored deletions in the ligand-binding region.
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	8	4851	SYMBOL|DICTIONARY	notch1	Notch1	69#75		Dideoxycytidine-induced lymphomas displayed the highest frequency of Notch1 mutations (49%), whereas in butadiene- and phenolphthalein-induced tumors showed lower frequencies (26 and 10%, respectively).
18798262	2008	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	10	4851	SYMBOL|DICTIONARY	notch1	Notch1	23#29		This report shows that Notch1 is a prevalent and major mutational target for 2',3'-dideoxycytidine and butadiene-induced lymphoma.
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	90#96		We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	5	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	11#17		Ht SNPs of CTLA-4 and TNFalpha genes were significantly associated with susceptibility to PBC.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ae2	AE2	155#158	18930330-6-136-153	The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	7	6522	SYMBOL|DICTIONARY	slc4a2	SLC4A2	97#103		A multivariate Cox regression analysis including clinical and biochemical parameters showed that SLC4A2/AE2 variant was an independent prognostic factor.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	7	6522	SYMBOL|EXTRACTED	ae2	AE2	104#107	18930330-6-136-153	A multivariate Cox regression analysis including clinical and biochemical parameters showed that SLC4A2/AE2 variant was an independent prognostic factor.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	6522	SYMBOL|DICTIONARY	slc4a2	SLC4A2	62#68		They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	6522	SYMBOL|EXTRACTED	ae2	AE2	69#72	18930330-6-136-153	They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
19035720	2009	J. Neurosurg.	0022-3085	TITLE	0	0	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	24#30		Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population.
19035720	2009	J. Neurosurg.	0022-3085	OBJECT	1	1	1278	SYMBOL|GENE|GN|DICTIONARY	col1a2	COL1A2	4#10		The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.
19035720	2009	J. Neurosurg.	0022-3085	OBJECT	1	2	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	115#121		In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in COL1A2 and the occurrence of sporadic IAs in Chinese patients.
19035720	2009	J. Neurosurg.	0022-3085	METHODS	2	3	1278	SYMBOL|GENE|GN|DICTIONARY	col1a2	COL1A2	32#38		The polymorphism rs42524 of the COL1A2 gene was identified by polymerase chain reaction-based restriction analysis in genomic DNA from 226 patients with sporadic IAs (mean age 51.49 +/- 11.47 years) and 326 control participants (mean age 52.33 +/- 10.50 years).
19035720	2009	J. Neurosurg.	0022-3085	CONCLUSIONS	4	6	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	28#34		The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.
19035720	2009	J. Neurosurg.	0022-3085	CONCLUSIONS	4	7	1278	SYMBOL|DICTIONARY	col1a2	COL1A2	59#65		This study is the first to confirm the association between COL1A2 and IAs.
18951054	2008	Mol. Genet. Metab.	1096-7206	TITLE	0	0	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	0#4		MTTP variants and body mass index, waist circumference and serum cholesterol level: Association analyses in 7582 participants of the KORA study cohort.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_1/3	1	1	4547	LONGTERM|GENE|GT|DICTIONARY	microsomal triglyceride transfer protein	microsomal triglyceride transfer protein	4#44		The microsomal triglyceride transfer protein (MTTP) is a key regulator in the assembly and secretion of chylomicrons and very low density lipoprotein (VLDL) in the intestine and in liver.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_1/3	1	1	4547	SYMBOL|()|DICTIONARY|EXTRACTED	mttp	MTTP	46#50	18951054-1-4-44	The microsomal triglyceride transfer protein (MTTP) is a key regulator in the assembly and secretion of chylomicrons and very low density lipoprotein (VLDL) in the intestine and in liver.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_1/3	1	2	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	21#25	18951054-1-4-44	Associations between MTTP variants and traits of the metabolic syndrome are carried out in relatively small cohorts and are not consistent.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_1/3	1	3	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	12#16	18951054-1-4-44	We analysed MTTP polymorphisms in 7582 participants of the KORA study cohort.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_2/3	2	4	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	43#47	18951054-1-4-44	Seven htSNPs covering a 52kb region of the MTTP locus and two cSNPs (I128T, H297Q) were selected.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_2/3	2	5	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	2#6	18951054-1-4-44	A MTTP haplotype containing the minor allele of H297Q showed a significant decrease of -0.636 (95% CI: -1.226, -0.046; p=0.035) BMI units in females but not in males.
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_2/3	2	6	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	67#71	18951054-1-4-44	In comparison to homozygous H-carriers for the major allele of the MTTP H297Q polymorphism, homozygous Q297Q carriers showed a significant decrease in BMI of -0.425B MI units (95% CI: -0.74, -0.12; p=0.007), in waist circumference of -0.990 cm (95% CI: 1.74, -0.24; p=0.01) and in total cholesterol of -0.039 mmol/l (95% CI: -0.07, 0; p=0.03).
18951054	2008	Mol. Genet. Metab.	1096-7206	ALL_TEXT_3/3	3	10	4547	SYMBOL|DICTIONARY|EXTRACTED	mttp	MTTP	113#117	18951054-1-4-44	Our association analysis in a large population based study cohort provides evidence that the minor allele of the MTTP H297Q polymorphism is associated with lower BMI, waist circumference and total cholesterol in females but not in males.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3557	SYMBOL|()|DICTIONARY	il 1ra	IL-1RA	242#248		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	251#267		The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	269#273	19066720-1-251-267	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	5173	SYMBOL|()|DICTIONARY|EXTRACTED	pdyn	PDYN	293#297	19066720-1-279-291	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	348	SYMBOL|EXTRACTED	apoe	ApoE	41#45	19066720-1-251-267	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3557	SYMBOL|GENE|GN|DICTIONARY	il 1ra	IL-1RA	61#67		We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	5173	SYMBOL|DICTIONARY|EXTRACTED	pdyn	PDYN	144#148	19066720-1-279-291	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	TITLE	0	0	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	48#56		[Analysis of the tandem-repeat polymorphisms in DC-SIGNR alleles among drug users population with or without HIV/HCV infection].
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	OBJECTIVE	1	1	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	37#45		To study the distribution of DC-SIGN/DC-SIGNR alleles among drug user (DUs) populations with or without HIV/HCV infection in Shenzhen, and to evaluate the role of these alleles in the construction of genetic resistance to HIV or HCV and screen out the anti-HIV/HCV gene in Shenzhen.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	METHODS	2	5	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	42#50		The neck domain repeat regions of DC-SIGN/DC-SIGNR were sequenced directly from the PCR products to confirm the amplification for some samples and all positive PCR products were analyzed by agarose gel electrophoresis.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|NUMBER|DICTIONARY	dc signr	DC-SIGNR	67#75		Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	RESULTS	3	8	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	302#310		Among HIV + DUs, there was a higher proportion of patient with the DC-SIGNR 5/6 and 5/8 (Fisher's exact, P = 0.043 and P = 0.034) with statistical significance; there was no statistically significant difference between HCV + and HCV-DUs and no significant difference between IDUs and other DUs for the DC-SIGNR polymorphism.
19141225	2009	Zhonghua Yu Fang Yi Xue Za Zhi	0253-9624	CONCLUSION	4	9	10332	SYMBOL|DICTIONARY	dc signr	DC-SIGNR	40#48		The results might indicate that DC-SIGN/DC-SIGNR polymorphism might not influence the susceptibility to HCV.
18804097	2009	Brain Res.	1872-6240	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	112#118		Population-based association study and contrasting linkage disequilibrium pattern reveal genetic association of SLC6A4 with autism in the Indian population from West Bengal.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_1/3	1	2	6532	SYMBOL|()|DICTIONARY	slc6a4	SLC6A4	28#34		Serotonin transporter gene (SLC6A4) that regulates synaptic serotonin level has been investigated as a candidate gene for autism, but consensus opinion on possible association is still lacking.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	193#199		Converging evidences of platelet-hyperserotoninemia in approximately 25% of the patients, betterment of ritualistic behavior on administration of SSRI and linkage to chromosome 17q11 harboring SLC6A4, supports the hypothesis that SLC6A4 polymorphisms may contribute towards autism pathology.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	230#236		Converging evidences of platelet-hyperserotoninemia in approximately 25% of the patients, betterment of ritualistic behavior on administration of SSRI and linkage to chromosome 17q11 harboring SLC6A4, supports the hypothesis that SLC6A4 polymorphisms may contribute towards autism pathology.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_2/3	2	4	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	90#96		Our recent report on 5-HTTLPR marker represents the first study on genetic association of SLC6A4 with autism in the Indian population.
18804097	2009	Brain Res.	1872-6240	ALL_TEXT_3/3	3	8	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	437#443		However, the interesting finding of strong linkage disequilibrium (LD) between the markers and significant disease-specific distortion in the distribution of HTT-3'UTR-SNP genotypes (T1chi(2)=5.19, P=0.02; OR=2.89, 95% CI=1.13-7.41) and the specific haplotypes of the two markers (LRS=11.85, p(c)=0.02), with higher frequencies of T/T genotype and 10-T haplotype in autistic cases suggests that either these markers or nearby markers of SLC6A4 that are in LD, may pose a risk towards autism in the Eastern Indian population.
18787519	2009	Am. J. Hypertens.	1941-7225	TITLE	0	0	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	19#25		A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men.
18787519	2009	Am. J. Hypertens.	1941-7225	BACKGROUND	1	1	8529	SYMBOL|DICTIONARY	cyp4f2	CYP4F2	0#6		CYP4F2, a member of the cytochrome P450 family, acts mainly as an enzyme and is involved not only in the metabolism of leukotriene B4, but also in that of arachidonic acid.
18787519	2009	Am. J. Hypertens.	1941-7225	BACKGROUND	1	3	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	70#76		The aim of this study was to assess the association between the human CYP4F2 gene and cerebral infarction (CI), using a haplotype-based case-control study with separate analyses of data from the gender groups.
18787519	2009	Am. J. Hypertens.	1941-7225	METHODS	2	4	8529	SYMBOL|GENE|GN|DICTIONARY	cyp4f2	CYP4F2	128#134		A total of 175 CI patients and 246 control subjects were genotyped for five single-nucleotide polymorphisms (SNPs) of the human CYP4F2 gene (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).
18407370	2009	Lung Cancer	0169-5002	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	0#5		XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	1	7515	SYMBOL|()|DICTIONARY	xrcc1	XRCC1	42#47		X-ray repair cross-complementing group 1 (XRCC1) is one of the major DNA repair proteins involved in the base excision repair (BER) and single-strand break repair (SSBR) pathway.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	42#47		Single nucleotide polymorphisms (SNPs) in XRCC1 may alter protein function and repair capacity, thus lead to genetic instability and carcinogenesis.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	65#70		To establish our understanding of possible relationships between XRCC1 polymorphisms (5'UTR -77T>C, Arg194Trp, Arg280His and Arg399Gln) and the susceptibility to lung cancer among women nonsmokers, we performed a hospital-based case-control study of 350 patients with newly diagnosed lung cancer and 350 cancer-free controls, frequency matched by age.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	5	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	28#33		Individuals with homozygous XRCC1 399Gln/Gln genotype (OR=1.75, 95% CI [1.02-3.01]) and XRCC1 -77 combined TC and CC genotype (OR=1.66, 95% CI [1.13-2.42]) showed a slightly higher risk for lung cancer overall.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	88#93		Individuals with homozygous XRCC1 399Gln/Gln genotype (OR=1.75, 95% CI [1.02-3.01]) and XRCC1 -77 combined TC and CC genotype (OR=1.66, 95% CI [1.13-2.42]) showed a slightly higher risk for lung cancer overall.
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	101#106		In the subgroup of adenocarcinoma cases, adjusted ORs were increased for individuals with homozygous XRCC1 399Gln/Gln genotype (OR=2.62, 95% CI [1.44-4.79]) and XRCC1 -77 combined TC and CC genotype (OR=1.85, 95% CI [1.19-2.86]).
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	161#166		In the subgroup of adenocarcinoma cases, adjusted ORs were increased for individuals with homozygous XRCC1 399Gln/Gln genotype (OR=2.62, 95% CI [1.44-4.79]) and XRCC1 -77 combined TC and CC genotype (OR=1.85, 95% CI [1.19-2.86]).
18407370	2009	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	15#20		In conclusion, XRCC1 Arg399Gln and T-77C polymorphisms may alter the risk of lung cancer in women nonsmokers in China.
18949411	2009	Oncol. Rep.	1021-335X	TITLE	0	0	2264	LONGTERM|DICTIONARY	fibroblast growth factor receptor 4	Fibroblast growth factor receptor 4	0#35		Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	20#25		We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	67#72		We investigated the FGFR4 mutation status at the kinase domain and FGFR4 single nucleotide polymorphism (SNP) at codon 388 in surgically treated non-small cell lung cancer (NSCLC) cases.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	2	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	27#32		The presence or absence of FGFR4 mutations of kinase domains was analyzed by direct sequences (n=147), and the presence of FGFR4 Arg388 allele was analyzed by genotyping assay using LightCycler hybridization probes (n=387).
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	2	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	123#128		The presence or absence of FGFR4 mutations of kinase domains was analyzed by direct sequences (n=147), and the presence of FGFR4 Arg388 allele was analyzed by genotyping assay using LightCycler hybridization probes (n=387).
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	3	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	0#5		FGFR4 mutations were not present in our lung cancer patients.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_2/3	2	5	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	35#40		No correlation existed between the FGFR4 genotype and clinicopathological features such as gender, smoking status and pathological subtypes.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_2/3	2	6	1956	SYMBOL|DICTIONARY	egfr	EGFR	0#4		EGFR mutation status was not correlated with the FGFR4 genotype of lung cancers.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_2/3	2	6	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	49#54		EGFR mutation status was not correlated with the FGFR4 genotype of lung cancers.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	7	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	31#36		In node-negative patients, the FGFR4 genotype was not correlated with disease outcome, while in the node-positive patients FGFR4 Arg388 was significantly associated with worse survival.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	7	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	123#128		In node-negative patients, the FGFR4 genotype was not correlated with disease outcome, while in the node-positive patients FGFR4 Arg388 was significantly associated with worse survival.
18949411	2009	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	9	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	23#28		Therefore, the role of FGFR4 polymorphism is a prognostic marker for advanced NSCLC in Japanese patients.
19018715	2009	Pharmacogenomics	1744-8042	TITLE	0	0	627	SYMBOL|DICTIONARY	bdnf	BDNF	27#31		Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
19018715	2009	Pharmacogenomics	1744-8042	TITLE	0	0	4915	SYMBOL|GENE|GN|DICTIONARY	ntrk2	NTRK2	40#45		Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_1/3	1	1	627	SYMBOL|DICTIONARY	bdnf	BDNF	70#74		The neuroplasticity hypothesis of bipolar disorder indicates that the BDNF/Trk signaling pathway is associated with the pathogenesis of this illness and treatment with mood stabilizers, such as lithium.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_2/3	2	2	627	SYMBOL|DICTIONARY	bdnf	BDNF	131#135		This paper describes a relationship between response to lithium prophylaxis and polymorphisms of two functionally connected genes: BDNF and NTRK2, in bipolar illness.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_2/3	2	2	4915	SYMBOL|DICTIONARY	ntrk2	NTRK2	140#145		This paper describes a relationship between response to lithium prophylaxis and polymorphisms of two functionally connected genes: BDNF and NTRK2, in bipolar illness.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	3	627	SYMBOL|GENE|GN|DICTIONARY	bdnf	BDNF	29#33		Analyses of four SNPs of the BDNF gene (rs2030324, rs988748, rs6265 [Val66Met]and rs2203877) and three of the NTRK2 gene (rs1187326, rs2289656, rs1187327) were performed in the 108 bipolar patients, classified as excellent responders (23%), partial responders (51%) and nonresponders (26%) to lithium.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	3	4915	SYMBOL|GENE|GN|DICTIONARY	ntrk2	NTRK2	110#115		Analyses of four SNPs of the BDNF gene (rs2030324, rs988748, rs6265 [Val66Met]and rs2203877) and three of the NTRK2 gene (rs1187326, rs2289656, rs1187327) were performed in the 108 bipolar patients, classified as excellent responders (23%), partial responders (51%) and nonresponders (26%) to lithium.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	4	627	SYMBOL|GENE|GN|DICTIONARY	bdnf	BDNF	71#75		An association of C/G (rs988748) and G/A (rs6265) polymorphisms of the BDNF gene with a degree of prophylactic lithium response were found.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	5	4915	SYMBOL|GENE|GN|DICTIONARY	ntrk2	NTRK2	75#80		No association with lithium response was revealed with the polymorphism of NTRK2 gene, neither with interaction of BDNF and NTRK2 genes.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY	bdnf	BDNF	115#119		No association with lithium response was revealed with the polymorphism of NTRK2 gene, neither with interaction of BDNF and NTRK2 genes.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_3/3	3	5	4915	SYMBOL|GENE|GN|DICTIONARY	ntrk2	NTRK2	124#129		No association with lithium response was revealed with the polymorphism of NTRK2 gene, neither with interaction of BDNF and NTRK2 genes.
18998014	2009	Saudi Med J	0379-5284	METHODS	2	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	88#92		We used the polymerase chain reaction with sequence specific primer method to study the DRB1* locus in 147 Syrian patients with positive sputum smear or sputum culture for Mycobacterium Tuberculosis strains, and 209 Syrian healthy matching individuals with negative tuberculin skin test.
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	30#34		A significant decrease of the DRB1*11 allele was observed in patients compared to controls (34.7% in patients versus 51% in control, odds ratio [OR]=0.51, p=0.003, corrected p=0.04), whereas the DRB1*04 allele was increased in patients (38.8% in patients versus 26.4% in controls, OR=1.77, p=0.01, corrected p>0.05).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	195#199		A significant decrease of the DRB1*11 allele was observed in patients compared to controls (34.7% in patients versus 51% in control, odds ratio [OR]=0.51, p=0.003, corrected p=0.04), whereas the DRB1*04 allele was increased in patients (38.8% in patients versus 26.4% in controls, OR=1.77, p=0.01, corrected p>0.05).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	59#63		This increase became significant when individuals with the DRB1*11 allele were removed from both patients and controls (33% in DRB1*11 negative patients versus 17% in DRB1*11 negative controls, OR=2.5, p=0.003, corrected p=0.03).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	127#131		This increase became significant when individuals with the DRB1*11 allele were removed from both patients and controls (33% in DRB1*11 negative patients versus 17% in DRB1*11 negative controls, OR=2.5, p=0.003, corrected p=0.03).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	167#171		This increase became significant when individuals with the DRB1*11 allele were removed from both patients and controls (33% in DRB1*11 negative patients versus 17% in DRB1*11 negative controls, OR=2.5, p=0.003, corrected p=0.03).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	69#73		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	128#132		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	151#155		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	191#195		In addition, pulmonary cavitation was significantly increased in the DRB1*04 positive patients compared to patients without the DRB1*04 allele (33% in DRB1*04 positive patients versus 16% in DRB1*04 negative patients, OR=2.7, p=0.04).
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	88#92		The DRB1*04 allele is associated with susceptibility to pulmonary tuberculosis, whereas DRB1*11 is associated with protection from pulmonary tuberculosis in the Syrian population.
18998014	2009	Saudi Med J	0379-5284	CONCLUSION	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	109#113		In addition, cavity formation in patients with pulmonary tuberculosis seems to be favored by presence of the DRB1*04 allele.
18937791	2009	Tissue Antigens	1399-0039	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	62#96		Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	16#50		Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	52#56	18937791-1-16-50	Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18937791	2009	Tissue Antigens	1399-0039	ALL_TEXT_1/3	1	1	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	73#77	18937791-1-16-50	Polymorphism of vascular endothelial growth factor (VEGF) influences the VEGF production and is subjected to genetic susceptibility of many diseases including psoriasis.
18854826	2008	Br. J. Cancer	1532-1827	TITLE	0	0	5727	SYMBOL|DICTIONARY	ptch	PTCH	0#4		PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_1/3	1	2	5727	SYMBOL|GENE|GN|DICTIONARY	ptch	PTCH	160#164		To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carcinomas (BCC); 39 from OTRs receiving azathioprine and 21 from individuals never exposed to azathioprine.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_2/3	2	3	5727	SYMBOL|DICTIONARY	ptch	PTCH	0#4		PTCH was mutated in 55% of all tumours, independent of azathioprine treatment.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_3/3	3	6	5727	SYMBOL|DICTIONARY	ptch	PTCH	127#131		These were exclusive to the azathioprine-exposed group and all in the same TGTC sequence context at different positions within PTCH.
18854826	2008	Br. J. Cancer	1532-1827	ALL_TEXT_3/3	3	8	5727	SYMBOL|DICTIONARY	ptch	PTCH	114#118		This study of post-transplant BCC provides the first indication that azathioprine exposure may be associated with PTCH mutations, particularly in tumours from non-sun-exposed skin.
18922928	2008	Cancer Res.	1538-7445	TITLE	0	0	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	52#56		A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	3	3845	SYMBOL|NUMBER|DICTIONARY	kras	KRAS	279#283		The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	9	3845	SYMBOL|DICTIONARY	kras	KRAS	44#48		Functionally, the variant allele results in KRAS overexpression in vitro.
18922928	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	10	3845	SYMBOL|DICTIONARY	kras	KRAS	29#33		The LCS6 variant allele in a KRAS miRANA complementary site is significantly associated with increased risk for NSCLC among moderate smokers and represents a new paradigm for let-7 miRNAs in lung cancer susceptibility.
18922923	2008	Cancer Res.	1538-7445	TITLE	0	0	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	74#90		Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	31#47		Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	49#54	18922923-1-31-47	Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	1	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	201#206	18922923-1-31-47	Because the mRNA expression of cyclooxygenase-2 (COX-2) is up-regulated by arecoline in human gingival fibroblasts, as shown in our previous study, we further investigated the mRNA expression level of COX-2 and its upstream effectors in three oral epithelial carcinoma cell lines (KB, SAS, and Ca9-22) by using areca nut extract (ANE) and saliva-reacted ANE (sANE).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_1/3	1	2	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	157#162	18922923-1-31-47	A case-control study of 377 oral squamous cell carcinoma (OSCC) patients and 442 controls was conducted to evaluate the gene-environment interaction between COX-2 promoter polymorphisms and substance use of alcohol, betel quid, and cigarettes (ABC) in risk of OSCC.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_2/3	2	3	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	59#64	18922923-1-31-47	The heterogeneous characteristics of the oral site and the COX-2 -1195G>A polymorphism in these cell lines showed diverse inflammatory response (KB>Ca9-22>SAS) after 24-hour ANE/sANE treatments, and the COX-2 up-regulation might be mostly elicited from alternative nuclear factor-kappaB activation.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_2/3	2	3	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	203#208	18922923-1-31-47	The heterogeneous characteristics of the oral site and the COX-2 -1195G>A polymorphism in these cell lines showed diverse inflammatory response (KB>Ca9-22>SAS) after 24-hour ANE/sANE treatments, and the COX-2 up-regulation might be mostly elicited from alternative nuclear factor-kappaB activation.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_2/3	2	4	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	200#205	18922923-1-31-47	In the case-control study, betel chewing [adjusted odds ratios (aOR), 42.2] posed a much higher risk of OSCC than alcohol drinking and cigarette smoking (aORs, 2.4 and 1.8, respectively), whereas the COX-2 -1195A/A homozygote presented a potential genetic risk (OR, 1.55).
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	7	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	92#97	18922923-1-31-47	Taken together, these findings illustrate a valuable insight into the potential role of the COX-2 promoter region in contributing to the development of betel-related OSCC, including ANE/sANE-induced transcriptional effects and enhanced joint effects of COX-2 -1195A allele with substance use of ABC.
18922923	2008	Cancer Res.	1538-7445	ALL_TEXT_3/3	3	7	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	253#258	18922923-1-31-47	Taken together, these findings illustrate a valuable insight into the potential role of the COX-2 promoter region in contributing to the development of betel-related OSCC, including ANE/sANE-induced transcriptional effects and enhanced joint effects of COX-2 -1195A allele with substance use of ABC.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	16#20		[Association of PAX1 gene polymorphisms with susceptibility to congenital scoliosis in Chinese Han population].
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	51#55		To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	151#155		To investigate the association of polymorphisms of PAX1 gene with congenital scoliosis (CS) in Chinese Han population and the relationship between the PAX1 gene polymorphisms and the clinical phenotypes of CS.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	9	6625	SYMBOL|DICTIONARY	snp1	SNP1	11#15		The sites: SNP1 (rs17861031) and SNP2 (rs6047590), of PAX1 gene were genotyped and both polymorphisms were distributed in line with the Hardy-Weinberg equilibrium in these 2 groups.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	9	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	54#58		The sites: SNP1 (rs17861031) and SNP2 (rs6047590), of PAX1 gene were genotyped and both polymorphisms were distributed in line with the Hardy-Weinberg equilibrium in these 2 groups.
19080705	2009	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	14	5075	SYMBOL|GENE|GN|DICTIONARY	pax1	PAX1	24#28		The genetic variants of PAX1 gene may not be associated with the susceptibility to CS and different clinical phenotypes of CS in Chinese Han population.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	TITLE	0	0	360	SYMBOL|DICTIONARY	aqp3	AQP3	32#36		Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	116#120		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	214#218		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	OBJECTIVE	1	2	360	SYMBOL|DICTIONARY	aqp3	AQP3	300#304		Based on the involvement of AQPs in angiogenesis and cell migration as well as our previous studies which show that AQP3 is involved in human skin fibroblasts cell migration, in this study, we investigated whether AQP3 is expressed in cultured human ovarian cancer cell line CaOV3 cells, and whether AQP3 expression in these cells enhances cell migration and metastatic potential.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	4	360	SYMBOL|DICTIONARY	aqp3	AQP3	35#39		In this study, we demonstrate that AQP3 is expressed in CaOV3 cells.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	5	360	SYMBOL|DICTIONARY	aqp3	AQP3	45#49		EGF induces CaOV3 migration and up-regulates AQP3 expression.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	6	360	SYMBOL|DICTIONARY	aqp3	AQP3	52#56		EGF-induced cell migration is inhibited by specific AQP3 siRNA knockdown or AQP3 water transport inhibitor CuSO4 and NiCl2.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	6	360	SYMBOL|DICTIONARY	aqp3	AQP3	76#80		EGF-induced cell migration is inhibited by specific AQP3 siRNA knockdown or AQP3 water transport inhibitor CuSO4 and NiCl2.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	360	SYMBOL|DICTIONARY	aqp3	AQP3	82#86		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	1956	SYMBOL|DICTIONARY	egfr	EGFR	224#228		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	RESULTS	3	7	207	SYMBOL|DICTIONARY	akt	AKT	244#247		We also find that curcumin, a well known anti-ovarian cancer drug, down-regulates AQP3 expression and reduces cell migration in CaOV3, and the effects of curcumin are mediated, at least in part, by its inhibitory effects on EGFR and downstream AKT/ERK activation.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	47#51		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	8	360	SYMBOL|DICTIONARY	aqp3	AQP3	127#131		Collectively, our results provide evidence for AQP3-facilitated ovarian cancer cell migration, suggesting a novel function for AQP3 expression in high-grade tumors.
18214481	2008	Cancer Chemother. Pharmacol.	0344-5704	CONCLUSIONS	4	9	360	SYMBOL|DICTIONARY	aqp3	AQP3	64#68		The results that curcumin inhibits EGF-induced up-regulation of AQP3 and cell migration, provide a new explanation for the anticancer potential of curcumin.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3459	SYMBOL|DICTIONARY|GENE|GA	ifn gamma receptor 1	IFN-gamma receptor 1	71#91		We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3459	SYMBOL|EXTRACTED|()|GENE|GN	ifnr1	IFNR1	93#98	18548239-2-71-91	We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	METHODS	2	3	3459	SYMBOL|EXTRACTED	ifnr1	IFNR1	114#119	18548239-2-71-91	A restriction endonuclease fragment length polymorphism (RFLP)-PCR analysis and sequencing were used to study the IFNR1 and IFN-gamma polymorphisms.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	9	3459	SYMBOL|EXTRACTED|GENE|GN	ifnr1	IFNR1	38#43	18548239-2-71-91	The frequency of G/A (Val/Met) in the IFNR1 gene in allergic patients was significantly less than that in the controls (P < 0.05).
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	12	3459	SYMBOL|EXTRACTED|GENE|GN	ifnr1	IFNR1	22#27	18548239-2-71-91	The Met/Val allele in IFNR1 gene may have a protective role in the non-penicillin allergic population.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSIONS	4	13	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	26#35		The allele 18CA repeat in IFN-gamma gene may be associated with urticaria.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	TITLE	0	0	2913	SYMBOL|DICTIONARY	grm3	GRM3	70#74		Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_2/3	2	3	2913	SYMBOL|DICTIONARY	grm3	GRM3	146#150		Thus, a recently published trial of the amino acid analogue LY2140023, which exerts its effects through the activation of the glutamate receptors GRM3/GRM2, showed an improvement of positive and negative symptoms comparable to treatment with olanzapine.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_2/3	2	3	2912	SYMBOL|DICTIONARY	grm2	GRM2	151#155		Thus, a recently published trial of the amino acid analogue LY2140023, which exerts its effects through the activation of the glutamate receptors GRM3/GRM2, showed an improvement of positive and negative symptoms comparable to treatment with olanzapine.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_2/3	2	4	2913	SYMBOL|DICTIONARY	grm3	GRM3	24#28		A functional variant of GRM3 has been described which modulates synaptic glutamate levels.
18614340	2009	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	8	2913	SYMBOL|DICTIONARY	grm3	GRM3	92#96		Our results provide further evidence for the potential importance of the glutamate receptor GRM3 in schizophrenia, and indicate that the novel antipsychotic LY2140023 may actually be targeting a pathogenic pathway of schizophrenia.
18508830	2009	Eur. Respir. J.	1399-3003	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	Angiotensinogen	0#15		Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensin ii	Angiotensin II	0#14		Angiotensin II is a growth factor that plays a key role in the physiopathology of idiopathic pulmonary fibrosis (IPF).
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	2	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	103#118		A nucleotide substitution of an adenine instead of a guanine (G-6A) in the proximal promoter region of angiotensinogen (AGT), the precursor of angiotensin II, has been associated with an increased gene transcription rate.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	2	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	120#123	18508830-2-103-118	A nucleotide substitution of an adenine instead of a guanine (G-6A) in the proximal promoter region of angiotensinogen (AGT), the precursor of angiotensin II, has been associated with an increased gene transcription rate.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	2	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	143#157		A nucleotide substitution of an adenine instead of a guanine (G-6A) in the proximal promoter region of angiotensinogen (AGT), the precursor of angiotensin II, has been associated with an increased gene transcription rate.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	61#64	18508830-2-103-118	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_2/3	2	5	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	29#32	18508830-2-103-118	The G-6A polymorphism of the AGT gene was not associated with disease severity at diagnosis.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_3/3	3	8	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	25#40		G-6A polymorphism of the angiotensinogen gene is associated with idiopathic pulmonary fibrosis progression but not with disease predisposition.
18803945	2008	Metab. Clin. Exp.	1532-8600	ALL_TEXT_1/3	1	1	19	SYMBOL|()|GENE|GN|DICTIONARY	abca1	ABCA1	71#76		Variants in the adenosine triphosphate-binding-cassette transporter 1 (ABCA1) gene are known to affect high-density lipoprotein cholesterol and plasma triglycerides and the development of atherosclerosis.
18803945	2008	Metab. Clin. Exp.	1532-8600	ALL_TEXT_1/3	1	2	19	SYMBOL|GENE|GN|DICTIONARY	abca1	ABCA1	69#74		We investigated the influence of the R219K and I883M variants in the ABCA1 gene on plasma lipids and carotid intima media thickness and plaque extent in 688 healthy men (40-60 years old).
18155481	2009	Nutr Metab Cardiovasc Dis	1590-3729	METHODS AND RESULTS	2	6	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	69#102		Plasma glyco-metabolic parameters, platelet nitric oxide production, endothelial nitric oxide synthase (eNOS) gene polymorphism were measured in all subjects enrolled.
18728667	2008	Br. J. Cancer	1532-1827	ALL_TEXT_2/3	2	8	2030	SYMBOL|EXTRACTED|()	hent1	hENT1	117#122	18728667-8-77-115	ATP-TCA results for gemcitabine correlated to the tissue expression of human equilibrative nucleoside transporter-1 (hENT1).
18728667	2008	Br. J. Cancer	1532-1827	ALL_TEXT_3/3	3	10	2030	SYMBOL|EXTRACTED	hent1	hENT1	76#81	18728667-8-77-115	Furthermore, time to relapse in gemcitabine-treated patients was related to hENT1 expression (P=0.0067).
18307574	2009	Allergy	1398-9995	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	1	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	18307574-1-0-9	Filaggrin (FLG) null mutations are important genetic predisposing factors for atopic asthma and have recently been shown to influence controller and reliever medication needs in asthmatic children.
18307574	2009	Allergy	1398-9995	BACKGROUND	1	2	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	39#42	18307574-1-0-9	Our objective was to study the role of FLG null alleles in asthma exacerbations.
18307574	2009	Allergy	1398-9995	METHODS	2	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	0#3		FLG mutations R501X and 2282del4 were assayed in 1135 individuals ranging from 3 to 22 years old with asthma from Tayside and Dumfries, Scotland.
18307574	2009	Allergy	1398-9995	RESULTS	3	5	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	4#7	18307574-1-0-9	The FLG mutations were significantly associated with greater risk of exacerbations in children with asthma.
18307574	2009	Allergy	1398-9995	RESULTS	3	7	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	17#20	18307574-1-0-9	Individuals with FLG null alleles were more likely to require oral steroids (31.4%vs 19.5%; OR = 1.89; P = 0.021) for their exacerbations.
18307574	2009	Allergy	1398-9995	RESULTS	3	8	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	145#148	18307574-1-0-9	There was also a 1.71-fold increased risk (42.6%vs 30%; P = 0.041) of school absence owing to asthma exacerbations in asthmatic individuals with FLG null mutation.
18307574	2009	Allergy	1398-9995	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	37#40	18307574-1-0-9	On sub-group analysis, the effect of FLG mutations on asthma exacerbations is significant (P = 0.045) only for participants with relatively mild asthma controlled on inhaled steroids, with inhaled albuterol according to need.
18307574	2009	Allergy	1398-9995	CONCLUSION	4	10	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	131#134	18307574-1-0-9	In addition to their effect on asthma medication requirements reported previously, there is an association between the presence of FLG null mutations and the risk of asthma exacerbations in asthmatic children and young adults.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	TITLE	0	0	4160	LONGTERM|GENE|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	19#42		Association of the melanocortin-4 receptor V103I polymorphism with dietary intake in severely obese persons.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	1	4160	LONGTERM|GENE|GT|DICTIONARY|GA	melanocortin 4 receptor	melanocortin-4 receptor	70#93		Several studies have reported that carriers of the 103I allele of the melanocortin-4 receptor (MC4R) gene had lower body weight than did persons with the wild-type genotype.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	1	4160	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mc4r	MC4R	95#99	18779298-1-70-93	Several studies have reported that carriers of the 103I allele of the melanocortin-4 receptor (MC4R) gene had lower body weight than did persons with the wild-type genotype.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	BACKGROUND	1	2	4160	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mc4r	MC4R	43#47	18779298-1-70-93	A recent study found an association of the MC4R 103I variant with carbohydrate intake, which may mediate some of the association of this variant with leanness.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	OBJECTIVE	2	3	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	72#76	18779298-1-70-93	The purpose of the study was to investigate the association between the MC4R V103I polymorphism and the dietary intake of persons with severe obesity, which was derived by using the Willett food-frequency questionnaire.
18779298	2008	Am. J. Clin. Nutr.	1938-3207	DESIGN	3	4	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	4#8	18779298-1-70-93	The MC4R V103I polymorphism was genotyped in a group of 1029 severely obese white subjects with an average body mass index (BMI; in kg/m(2)) of 46.0 (range: 33-92).
18779298	2008	Am. J. Clin. Nutr.	1938-3207	CONCLUSIONS	5	7	4160	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mc4r	MC4R	78#82	18779298-1-70-93	The higher dietary intake of carbohydrates in severely obese persons with the MC4R 103I variant is in line with previous findings.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	4#10		The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	Cytochrome P450 1B1	0#19		Cytochrome P450 1B1 (CYP1B1) is a major enzyme in the initial catabolic step of estradiol (E2) metabolism and belongs to the multitude of genes regulated by the estrogen receptor alpha (ERalpha).
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	21#27	17922187-1-0-19	Cytochrome P450 1B1 (CYP1B1) is a major enzyme in the initial catabolic step of estradiol (E2) metabolism and belongs to the multitude of genes regulated by the estrogen receptor alpha (ERalpha).
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	2	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	40#46	17922187-1-0-19	The common non-synonymous polymorphisms CYP1B1_1358_A>G and CYP1B1_1294_C>G increase CYP1B1 enzymatic activity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	2	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	60#66	17922187-1-0-19	The common non-synonymous polymorphisms CYP1B1_1358_A>G and CYP1B1_1294_C>G increase CYP1B1 enzymatic activity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	2	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	85#91	17922187-1-0-19	The common non-synonymous polymorphisms CYP1B1_1358_A>G and CYP1B1_1294_C>G increase CYP1B1 enzymatic activity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	29#35	17922187-1-0-19	Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	152#158	17922187-1-0-19	Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	5	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	69#75	17922187-1-0-19	We observed a significant association between the homozygous variant CYP1B1_1358_GG genotype and negative ERalpha status (P = 0.005; OR 2.82, 95% CI: 1.37-5.82) with a highly significant Ptrend for CYP1B1_1358_A>G and negative ERalpha status (P = 0.003).
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	5	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	198#204	17922187-1-0-19	We observed a significant association between the homozygous variant CYP1B1_1358_GG genotype and negative ERalpha status (P = 0.005; OR 2.82, 95% CI: 1.37-5.82) with a highly significant Ptrend for CYP1B1_1358_A>G and negative ERalpha status (P = 0.003).
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	35#41	17922187-1-0-19	We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	5241	SYMBOL|EXTRACTED	pr	PR	63#65	17922187-6-168-189	We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	139#145	17922187-1-0-19	We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	5241	LONGTERM|GENE|GT|DICTIONARY	progesterone receptor	progesterone receptor	168#189		We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	5241	SYMBOL|EXTRACTED|()	pr	PR	191#193	17922187-6-168-189	We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	21#27	17922187-1-0-19	We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	111#117	17922187-1-0-19	We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	158#164	17922187-1-0-19	We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
18562701	2009	Reprod Sci	1933-7205	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	22#37		Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women.
18562701	2009	Reprod Sci	1933-7205	TITLE	0	0	183	SYMBOL|DICTIONARY	agt	AGT	62#65		Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	24#39		Genetic variants of the angiotensinogen gene have been linked to both hypertension and preeclampsia.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	22#37		A polymorphism in the angiotensinogen basal promoter region of AGT -217 is more common in African Americans with hypertension.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	3	183	SYMBOL|DICTIONARY	agt	AGT	63#66		A polymorphism in the angiotensinogen basal promoter region of AGT -217 is more common in African Americans with hypertension.
18562701	2009	Reprod Sci	1933-7205	INTRODUCTION	1	4	183	SYMBOL|DICTIONARY	agt	AGT	52#55		The authors investigated the frequency of M235T and AGT -217 in Caucasian and African American women with and without preeclampsia.
18562701	2009	Reprod Sci	1933-7205	RESULTS	3	7	183	SYMBOL|DICTIONARY	agt	AGT	14#17		The M235T and AGT -217 polymorphisms were both more common in African American women; however, the variants were not more common in preeclampsia.
18562701	2009	Reprod Sci	1933-7205	CONCLUSION	4	8	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	17#32		The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia.
18562701	2009	Reprod Sci	1933-7205	CONCLUSION	4	8	183	SYMBOL|DICTIONARY	agt	AGT	57#60		The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia.
19115152	2009	Turk J Gastroenterol	2148-5607	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	57#61		Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	3	5243	LONGTERM|DICTIONARY	p glycoprotein	P-glycoprotein	55#69		It is suggested that expression levels and function of P-glycoprotein, encoded by the MDR1 gene, are important for protection of the gut against xenobiotics and bacterial toxins.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	3	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	86#90		It is suggested that expression levels and function of P-glycoprotein, encoded by the MDR1 gene, are important for protection of the gut against xenobiotics and bacterial toxins.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	4	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	32#36		Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease.
19115152	2009	Turk J Gastroenterol	2148-5607	BACKGROUND/AIMS	1	5	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	74#78		The aim of this study was to investigate the G2677T/A polymorphism in the MDR1 gene in Turkish patients with inflammatory bowel disease and a healthy control group.
19115152	2009	Turk J Gastroenterol	2148-5607	METHODS	2	7	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	174#178		In the patient and control groups, polymerase chain reaction restriction fragment length polymorphism analysis was performed for two polymorphisms (G2677T and G2677A) of the MDR1 gene.
19115152	2009	Turk J Gastroenterol	2148-5607	RESULTS	3	8	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	64#68		In this study, the frequency of alleles at position 2677 of the MDR1 gene, which has a triallelic polymorphism, was not found to be significantly different between the patient and the healthy control groups.
19115152	2009	Turk J Gastroenterol	2148-5607	CONCLUSIONS	4	10	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	57#61		In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.
19173862	2009	Zhonghua Liu Xing Bing Xue Za Zhi	0254-6450	TITLE	0	0	7507	SYMBOL|GENE|GN|DICTIONARY	xpa	XPA	52#55		[Study on the relationship between polymorphisms of XPA gene and susceptibility of esophageal cancer].
18650507	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	0#7		SLCO1B1 variants and statin-induced myopathy--a genomewide study.
18650507	2008	N. Engl. J. Med.	1533-4406	RESULTS	3	5	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	139#146		The genomewide scan yielded a single strong association of myopathy with the rs4363657 single-nucleotide polymorphism (SNP) located within SLCO1B1 on chromosome 12 (P=4x10(-9)).
18650507	2008	N. Engl. J. Med.	1533-4406	RESULTS	3	6	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	0#7		SLCO1B1 encodes the organic anion-transporting polypeptide OATP1B1, which has been shown to regulate the hepatic uptake of statins.
18650507	2008	N. Engl. J. Med.	1533-4406	RESULTS	3	6	10599	SYMBOL|DICTIONARY	oatp1b1	OATP1B1	59#66		SLCO1B1 encodes the organic anion-transporting polypeptide OATP1B1, which has been shown to regulate the hepatic uptake of statins.
18650507	2008	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	13	10599	SYMBOL|DICTIONARY	slco1b1	SLCO1B1	38#45		We have identified common variants in SLCO1B1 that are strongly associated with an increased risk of statin-induced myopathy.
18698679	2008	World J. Gastroenterol.	1007-9327	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	38#65		Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.
18698679	2008	World J. Gastroenterol.	1007-9327	AIM	1	1	7124	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	121#130	18698679-1-91-119	To investigate the role that single nucleotide polymorphisms (SNPs) in the promoter of the tumour necrosis factor-alpha (TNF-alpha) gene play in the risk of inflammatory bowel diseases (IBDs) in a New Zealand population, in the context of international studies.
18698679	2008	World J. Gastroenterol.	1007-9327	METHODS	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	229#238	18698679-1-91-119	DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-alpha receptor: -238 G-->A, -308 G-->A and -857C-->T, using a Taqman assay.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	7	30829	SYMBOL|DICTIONARY	ibd3	IBD3	118#122		TNF-alpha is a key cytokine known to play a role in inflammatory response, and the locus for the gene is found in the IBD3 region on chromosome 6p21, known to be associated with an increased risk for IBD.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	8	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	24#33	18698679-1-91-119	The -308 G/A SNP in the TNF-alpha promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	8	30829	SYMBOL|DICTIONARY	ibd3	IBD3	128#132		The -308 G/A SNP in the TNF-alpha promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	TITLE	0	0	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	Peroxisome proliferator-activated receptor gamma	0#48		Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	TITLE	0	0	958	SYMBOL|DICTIONARY	cd40	CD40	84#88		Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	2	958	SYMBOL|DICTIONARY	cd40	CD40	23#27		Ligation of microglial CD40 plays a role in the development of inflammatory responses in the central nervous system (CNS).
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_1/3	1	3	958	SYMBOL|DICTIONARY	cd40	CD40	45#49		Our study showed that there was an increased CD40 expression on activated microglia in the brain injury after lithium pilocarpine-induced status epilepticus (SE) in rats.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor gamma	6#54		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|()|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	56#65	18455351-4-6-54	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	209#218	18455351-4-6-54	Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	4	958	SYMBOL|DICTIONARY	cd40	CD40	264#268		Since peroxisome proliferator-activated receptor gamma (PPARgamma) acts as a regulator of CNS inflammation and a powerful pharmacological target for counteracting CNS diseases, we investigated the role of the PPARgamma agonist, rosiglitazone, in the modulation of CD40 expression and in the pathological processes of inflammation after SE.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	5	103694380	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	62#83		We found that rosiglitazone inhibited the expression of CD40, tumor necrosis factor (TNF-alpha), and microglial activation in different regions of hippocampus.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_2/3	2	5	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	85#94	18455351-5-62-83	We found that rosiglitazone inhibited the expression of CD40, tumor necrosis factor (TNF-alpha), and microglial activation in different regions of hippocampus.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	8	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	118#127	18455351-4-6-54	These protective effects were significantly reversed by the co-treatment with T0070907, a selective antagonist of the PPARgamma, which clearly demonstrated a PPARgamma-dependent mechanism.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	8	5468	SYMBOL|DICTIONARY|EXTRACTED	ppargamma	PPARgamma	158#167	18455351-4-6-54	These protective effects were significantly reversed by the co-treatment with T0070907, a selective antagonist of the PPARgamma, which clearly demonstrated a PPARgamma-dependent mechanism.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	9	958	SYMBOL|DICTIONARY	cd40	CD40	116#120		Our data provide evidence that rosiglitazone considerably attenuates inflammatory responses after SE by suppressing CD40 expression and microglial activation.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	TITLE	0	0	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	17#24		Association of a CYP4A11 variant and blood pressure in black men.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	1	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	0#7		CYP4A11 arachidonic acid monooxygenase oxidizes endogenous arachidonic acid to 20-hydroxyeicosatetraenoic acid, a renal vasoconstrictor and natriuretic.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	2	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	94#101		Cyp4a deficiency causes hypertension in male mice, and a loss-of-function variant (T8590C) of CYP4A11 is associated with hypertension in white individuals.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_1/3	1	3	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	146#153		Hypertension and hypertensive renal disease are more common among black than white individuals, but the relationship between genetic variation at CYP4A11 and hypertension in black individuals is not known.
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_2/3	2	4	1579	SYMBOL|DICTIONARY	cyp4a11	CYP4A11	42#49		This study tested the hypothesis that the CYP4A11 T8590C polymorphism is associated with higher BP or clinical outcomes in 732 black Americans with hypertensive renal disease participating in the African American Study of Kidney Disease (AASK).
18385420	2008	J. Am. Soc. Nephrol.	1533-3450	ALL_TEXT_3/3	3	8	1579	SYMBOL|NUMBER|DICTIONARY	cyp4a11	CYP4A11	16#23		In summary, the CYP4A11 8590CC genotype is associated with increased BP in black men with hypertensive nephrosclerosis and is associated with adverse clinical outcomes in those with baseline proteinuria.
18555606	2008	Neurosci. Lett.	0304-3940	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	91#95		CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	197#213		The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	4	348	SYMBOL|EXTRACTED|()	apoe	ApoE	215#219	18555606-4-197-213	The aim of the present work is to investigate the usefulness of cerebrospinal fluid (CSF) beta-amyloid protein (Abeta1-42) and total tau protein (t-tau) analyses in the diagnosis of AD and whether apolipoprotein E (ApoE) epsilon4 allele is a factor for AD affecting Tunisian people.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	9	348	SYMBOL|EXTRACTED	apoe	ApoE	4#8	18555606-4-197-213	The ApoE epsilon4 allele frequency (29.5%) was significantly higher in the AD patients than in the nAD patients (17.1%) or in the control groups (9.5%).
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	10	348	SYMBOL|EXTRACTED	apoe	ApoE	21#25	18555606-4-197-213	AD patients carrying ApoE epsilon4 allele had lower Abeta1-42 (p<0.001) levels than those without a epsilon4 allele.
18555606	2008	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	11	348	SYMBOL|EXTRACTED	apoe	ApoE	136#140	18555606-4-197-213	The combination of t-tau and Abeta1-42 is a robust and reliable assay that may be useful in discriminating cases at risk for AD such as ApoE epsilon4 allele carriers from nAD patients or from age-matched control subjects.
18368408	2008	Rheumatol. Int.	0172-8172	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	Catalase	0#8		Catalase -262C>T polymorphism in systemic lupus erythematosus in Poland.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	2	847	LONGTERM|DICTIONARY	catalase	Catalase	0#8		Catalase (CAT) -330C>T transition, known also as -262C>T, generates three genotypes.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	2	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	10#13	18368408-2-0-8	Catalase (CAT) -330C>T transition, known also as -262C>T, generates three genotypes.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	3	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	4#7	18368408-2-0-8	The CAT -330CC genotype is associated with a significantly lower CAT expression in comparison to -330CT and -330CT genotypes.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	3	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	65#68	18368408-2-0-8	The CAT -330CC genotype is associated with a significantly lower CAT expression in comparison to -330CT and -330CT genotypes.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	4	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	99#102	18368408-2-0-8	Therefore, using restriction length fragment polymorphism analysis, we compared the frequencies of CAT -330C>T polymorphic variants between SLE patients (n = 102) and controls (n = 199).
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	5	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	64#67	18368408-2-0-8	We did not observe significant differences in the prevalence of CAT -330C>T polymorphic variants in SLE patients and controls.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	27#30	18368408-2-0-8	However, we found that the CAT -330CC genotype (recessive model) showed a significant association with thrombocytopenia OR = 7.314 (1.977-27.057, P = 0.0017).
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	26#29	18368408-2-0-8	We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	7	57819	SYMBOL|DICTIONARY	snrnp	snRNP	207#212		We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients.
18368408	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	8	847	SYMBOL|DICTIONARY|EXTRACTED	cat	CAT	30#33	18368408-2-0-8	Our findings suggest that the CAT -330CC genotype may contribute to some clinical manifestations in patients with SLE.
18644122	2008	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6555	SYMBOL|()|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	163#170	18644122-3-112-156	Recently, an association of colorectal adenoma with two variants (c.507C>T;p.L169L and c.511G>T;p.A171S) of the ileal sodium dependent bile acid transporter gene (SLC10A2) has been reported.
18644122	2008	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	41#48	18644122-3-112-156	Here, we reconstructed haplotypes of the SLC10A2 gene locus and tested for association with non-syndromic familial and sporadic CRC compared to 'hyper-normal' controls who displayed no colorectal polyps on screening colonoscopy.
18644122	2008	BMC Med. Genet.	1471-2350	METHODS	2	6	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	18#25	18644122-3-112-156	Haplotype-tagging SLC10A2 gene variants were identified in the Hapmap database and genotyped using PCR-based 5' exonuclease assays with fluorescent dye-labelled probes.
18644122	2008	BMC Med. Genet.	1471-2350	RESULTS	3	9	6555	SYMBOL|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	32#39	18644122-3-112-156	Minor allele frequencies of all SLC10A2 polymorphisms are within previously reported ranges, and no deviations from Hardy-Weinberg equilibrium are observed.
18644122	2008	BMC Med. Genet.	1471-2350	RESULTS	3	10	6555	SYMBOL|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	49#56	18644122-3-112-156	However, we found no association with any of the SLC10A2 haplotypes with sporadic or familial CRC in our samples (all P values > 0.05).
18644122	2008	BMC Med. Genet.	1471-2350	CONCLUSION	4	11	6555	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	slc10a2	SLC10A2	23#30	18644122-3-112-156	Common variants of the SLC10A2 gene are not associated with sporadic or familial CRC.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	627	SYMBOL|DICTIONARY	bdnf	BDNF	69#73		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	1312	SYMBOL|DICTIONARY	comt	COMT	117#121		The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_2/3	2	2	627	SYMBOL|DICTIONARY	bdnf	BDNF	25#29		We hypothesized that the BDNF-COMT gene interaction would affect the symptoms and cognition in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_2/3	2	2	1312	SYMBOL|GENE|GN|DICTIONARY	comt	COMT	30#34		We hypothesized that the BDNF-COMT gene interaction would affect the symptoms and cognition in schizophrenia.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_3/3	3	4	627	SYMBOL|DICTIONARY	bdnf	BDNF	22#26		The patients who were BDNF met/met x COMT L carriers had the highest scores of delusion of Positive Symptoms and the Scale for Assessment of Negative Symptoms, word reading of the color word test, and trail-making test B time, compared with the other three genotype interactions.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_3/3	3	4	1312	SYMBOL|DICTIONARY	comt	COMT	37#41		The patients who were BDNF met/met x COMT L carriers had the highest scores of delusion of Positive Symptoms and the Scale for Assessment of Negative Symptoms, word reading of the color word test, and trail-making test B time, compared with the other three genotype interactions.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY	bdnf	BDNF	51#55		The current results suggest that patients with the BDNF met/met x COMT L allele had more delusional symptoms and poorer cognitive flexibility, compared with the other three genotype interactions.
18596619	2008	Neuroreport	0959-4965	ALL_TEXT_3/3	3	5	1312	SYMBOL|DICTIONARY	comt	COMT	66#70		The current results suggest that patients with the BDNF met/met x COMT L allele had more delusional symptoms and poorer cognitive flexibility, compared with the other three genotype interactions.
18272905	2008	N. Engl. J. Med.	1533-4406	TITLE	0	0	3575	SYMBOL|DICTIONARY	il7ra	IL7RA	0#5		IL7RA polymorphisms and susceptibility to multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	TITLE	0	0	3383	LONGTERM|GENE|GN|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	1	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		Intercellular adhesion molecule-1 (ICAM-1), an important molecule in leucocyte activation and migration, is expressed on the CNS endothelial cells of patients with multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	1	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	17868277-1-0-33	Intercellular adhesion molecule-1 (ICAM-1), an important molecule in leucocyte activation and migration, is expressed on the CNS endothelial cells of patients with multiple sclerosis.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_1/3	1	2	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	46#52	17868277-1-0-33	This study was conducted to determine whether ICAM-1 gene polymorphism influences the risk of developing multiple sclerosis in an Iranian population.
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_2/3	2	4	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	49#55	17868277-1-0-33	The patients and the controls were genotyped for ICAM-1 gene polymorphism at codons 241 (exon 4) and 469 (exon 6).
17868277	2008	Eur. J. Neurol.	1468-1331	ALL_TEXT_3/3	3	6	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	30#36	17868277-1-0-33	We concluded that role of the ICAM-1 gene polymorphisms in the pathogenesis of multiple sclerosis is still controversial and should be studied further.
18576360	2008	Arthritis Rheum.	0004-3591	TITLE	0	0	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	45#51		To determine whether genetic variants of the PTPN22 gene, including the R620W (1858C>T) missense single-nucleotide polymorphism (SNP), are associated with systemic sclerosis (SSc).
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	6#12		Since PTPN22 is involved in multiple autoimmune diseases, we also examined the occurrence of a concomitant autoimmune disease.
18576360	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	138#144		We then conducted a meta-analysis of the most recent studies of SSc in order to verify the association or lack of association between the PTPN22 1858C>T variant and SSc.
18576360	2008	Arthritis Rheum.	0004-3591	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	6#12		Seven PTPN22 SNPs were analyzed in a French Caucasian cohort of 659 SSc patients and 504 healthy controls.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	7	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	99#105		In 33 of the 416 patients (8%), the concomitant autoimmune disease was known to be associated with PTPN22 1858T; these patients were excluded prior to analysis.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	0#6		PTPN22 haplotype analysis identified a strong association between SSc and the presence of a risk haplotype carrying the 1858T allele (P = 1.52 x 10(-7)) and a protective haplotype carrying the 1858C allele (P = 2.20 x 10(-16)) in our French Caucasian population.
18576360	2008	Arthritis Rheum.	0004-3591	RESULTS	3	10	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	45#51		The meta-analysis provided evidence that the PTPN22 1858T allele is involved in the genetic susceptibility to SSc in Caucasian (P = 8.39 x 10(-3), OR 1.08 [95% CI 1.02-1.15]) and mixed (P = 3.11 x 10(-3), OR 1.09 [95% CI 1.04-1.16]) populations, particularly in the anti-topo I-positive subset.
18576360	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	26#32		Our results indicate that PTPN22, a shared genetic factor of multiple autoimmune diseases, also contributes to the genetic background of SSc.
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_1/3	1	1	4552	LONGTERM|DICTIONARY	methionine synthase reductase	methionine synthase reductase	135#164		Polymorphisms of the genes 5'-10'-methylenetetrahydrofolate reductase (MTHFR, 677CT and 1298AC), methionine synthase (MTR, 2756AC) and methionine synthase reductase (MTRR, 66AC) provoke variations in enzyme activity, which can lead to alterations in the metabolism of folates and in the synthesis of S-adenosyl-methionine (SAM), the most active methyl donor in the body.
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_1/3	1	1	4552	SYMBOL|NUMBER|DICTIONARY	mtrr	MTRR	166#170		Polymorphisms of the genes 5'-10'-methylenetetrahydrofolate reductase (MTHFR, 677CT and 1298AC), methionine synthase (MTR, 2756AC) and methionine synthase reductase (MTRR, 66AC) provoke variations in enzyme activity, which can lead to alterations in the metabolism of folates and in the synthesis of S-adenosyl-methionine (SAM), the most active methyl donor in the body.
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_1/3	1	3	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	66#101		In the present study, four polymorphisms were studied, two of the methylenetetrahydrofolate reductase gene, and the other two of methionine synthase and methionine synthase reductase.
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_1/3	1	3	4552	LONGTERM|DICTIONARY	methionine synthase reductase	methionine synthase reductase	153#182		In the present study, four polymorphisms were studied, two of the methylenetetrahydrofolate reductase gene, and the other two of methionine synthase and methionine synthase reductase.
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_3/3	3	8	4552	SYMBOL|NUMBER|DICTIONARY	mtrr	MTRR	139#143		No statistically significant differences were found between patients and controls with respect to the MTHFR 1298AC, the MTR 2756AC and the MTRR 66AC polymorphisms.
18383527	2008	Head Neck	1097-0347	TITLE	0	0	2052	LONGTERM|DICTIONARY	microsomal epoxide hydrolase	Microsomal epoxide hydrolase	0#28		Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer.
18383527	2008	Head Neck	1097-0347	BACKGROUND	1	1	2052	LONGTERM|DICTIONARY	microsomal epoxide hydrolase	Microsomal epoxide hydrolase	0#28		Microsomal epoxide hydrolase (mEH) is an enzyme involved in the metabolism of (pre)carcinogens in tobacco smoke.
18383527	2008	Head Neck	1097-0347	BACKGROUND	1	1	2052	SYMBOL|EXTRACTED|()	meh	mEH	30#33	18383527-1-0-28	Microsomal epoxide hydrolase (mEH) is an enzyme involved in the metabolism of (pre)carcinogens in tobacco smoke.
18383527	2008	Head Neck	1097-0347	BACKGROUND	1	2	2052	SYMBOL|EXTRACTED	meh	mEH	60#63	18383527-1-0-28	We investigated whether functional genetic polymorphisms in mEH may have a risk-modifying effect on head and neck carcinogenesis.
18383527	2008	Head Neck	1097-0347	METHODS	2	3	2052	SYMBOL|EXTRACTED	meh	mEH	117#120	18383527-1-0-28	Blood from 429 patients with oral, pharyngeal, and laryngeal carcinoma and 419 healthy subjects was investigated for mEH polymorphisms.
18383527	2008	Head Neck	1097-0347	RESULTS	3	4	2052	SYMBOL|EXTRACTED	meh	mEH	57#60	18383527-1-0-28	Logistic regression analysis did not show differences in mEH genotype distributions between patients and controls, when categorized according to predicted mEH enzyme activity.
18383527	2008	Head Neck	1097-0347	RESULTS	3	4	2052	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	meh	mEH	155#158	18383527-1-0-28	Logistic regression analysis did not show differences in mEH genotype distributions between patients and controls, when categorized according to predicted mEH enzyme activity.
18383527	2008	Head Neck	1097-0347	CONCLUSION	4	7	2052	SYMBOL|EXTRACTED	meh	mEH	109#112	18383527-1-0-28	In contrast to earlier reports, we could not demonstrate a risk-modifying effect of genetic polymorphisms in mEH on head and neck carcinogenesis, except for the predicted high activity variant in patients with hypopharyngeal carcinoma.
18753723	2008	Int Heart J	1349-2365	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	6#19		Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	19#32		An increased serum interleukin-6 (IL-6) level is associated with an increased risk of cardiovascular events in healthy subjects.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	34#38	18753723-1-19-32	An increased serum interleukin-6 (IL-6) level is associated with an increased risk of cardiovascular events in healthy subjects.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	50#54	18753723-1-19-32	However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	66#70	18753723-1-19-32	However, it is unknown whether the level of serum IL-6 or genetic IL-6 polymorphism is correlated with the complexity of coronary plaque in patients with stable coronary artery disease (CAD).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	4	3569	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	il 6	IL-6	0#4		IL-6-174G > C polymorphism and serum levels of IL-6 and C-reactive protein (CRP) were investigated.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	4	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	47#51	18753723-1-19-32	IL-6-174G > C polymorphism and serum levels of IL-6 and C-reactive protein (CRP) were investigated.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	56#74		IL-6-174G > C polymorphism and serum levels of IL-6 and C-reactive protein (CRP) were investigated.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	4	1401	SYMBOL|()|DICTIONARY|EXTRACTED	crp	CRP	76#79	18753723-4-56-74	IL-6-174G > C polymorphism and serum levels of IL-6 and C-reactive protein (CRP) were investigated.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	49#53	18753723-1-19-32	No significant difference in the distribution of IL-6 genotypes was found among the groups.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	91#95	18753723-1-19-32	The presence of complex coronary plaque was associated with higher serum concentrations of IL-6 (P = 0.026) and CRP (P < 0.0001).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_2/3	2	6	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	112#115	18753723-4-56-74	The presence of complex coronary plaque was associated with higher serum concentrations of IL-6 (P = 0.026) and CRP (P < 0.0001).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	7	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	44#48	18753723-1-19-32	To predict the presence of complex lesions, IL-6 > 5.8 ng/L and CRP > 2.6 mg/L had sensitivities of 86% and 74%, and specificities of 61% and 62%, respectively.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	26#30	18753723-1-19-32	By multivariate analysis, IL-6 > 5.8 ng/L and CRP > 2.6 mg/L were independently related to the presence of complex coronary plaque (P = 0.0002 and 0.004, respectively).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	9	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	0#4		IL-6 > 5.8 ng/L and CRP > 2.6 mg/L were associated with a 4.5-fold increase in the odds of having complex coronary plaque (P < 0.005).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	10	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	34#38	18753723-1-19-32	A simple measurement of the serum IL-6 level in patients with CAD can potentially identify subjects with complex coronary lesions and provide the option of aggressive medical strategies in a clinical setting.
18436884	2008	Stroke	1524-4628	TITLE	0	0	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	7#11		Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population.
18436884	2008	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	66#70		The main aim of this study was to examine potential effect of the CCR5-del32 mutation on systemic inflammation, intima-media thickness in carotid and femoral arteries, and on the indices of cardiovascular disease.
18436884	2008	Stroke	1524-4628	METHODS	2	4	1234	SYMBOL|()|DICTIONARY|EXTRACTED	ccr5	CCR5	138#142	18436884-4-118-136	In the present study, we have examined the association of a common functional 32-bp frameshift deletion mutation in a chemokine receptor (CCR5) in relation to inflammation and atherosclerosis.
18436884	2008	Stroke	1524-4628	METHODS	2	5	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	0#4		CCR5 is a G protein-coupled receptor involved in inflammatory response and regulation of leukocytes activation and migration.
18436884	2008	Stroke	1524-4628	RESULTS	3	8	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	63#81		The mutation was associated with significantly lower levels of C-reactive protein in a dose-dependent manner.
18436884	2008	Stroke	1524-4628	RESULTS	3	9	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	10#14	18436884-4-118-136	Moreover, CCR5-del32 was associated with a significantly lower carotid intima-media thickness in the common carotid artery (del32/del32, 837+/-8 microm; wt/del32, 909+/-21 microm; wt/wt, 958+/-8 microm; P=0.007 after multivariable adjustment).
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	12	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	87#105		The chemokine receptor CCR5-del32 frameshift mutation is associated with low levels of C-reactive protein, decreased intima-media thickness, and cardiovascular disease risk.
18588668	2008	BMC Gastroenterol	1471-230X	TITLE	0	0	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	20#28		Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
18588668	2008	BMC Gastroenterol	1471-230X	BACKGROUND	1	1	10891	SYMBOL|()|DICTIONARY	ppargc1a	PPARGC1A	246#254		Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1alpha polymorphism (PPARGC1A) and NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	AIMS	2	2	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	156#164		We recruited 115 patients with biopsy-proven NAFLD, 65 with NASH and 50 with simple steatosis, and 441 healthy control subjects and investigated 15 SNPs of PPARGC1A.
18588668	2008	BMC Gastroenterol	1471-230X	RESULTS	3	5	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	86#94		The results of the real-time RT-PCR study showed that intrahepatic mRNA expression of PPARGC1A was lower in the TT group than in the GG or GT group at SNP rs2290602 (p = 0.0454).
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	6	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	95#103		This is the first study to demonstrate a significant association between genetic variations in PPARGC1A and NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	7	10891	SYMBOL|DICTIONARY	ppargc1a	PPARGC1A	28#36		This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.
18588668	2008	BMC Gastroenterol	1471-230X	CONCLUSION	4	7	10891	SYMBOL|GFAM|FN|DICTIONARY	ppargc1a	PPARGC1A	74#82		This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to etiology of NAFLD.
18512809	2008	Arthritis Rheum.	0004-3591	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	40#54		Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	21#35		Expression levels of interleukin-10 (IL-10), a potent and pleiotropic cytokine, are largely determined by variations in the gene encoding the IL-10 precursor.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3586	SYMBOL|EXTRACTED|()	il 10	IL-10	37#42	18512809-3-21-35	Expression levels of interleukin-10 (IL-10), a potent and pleiotropic cytokine, are largely determined by variations in the gene encoding the IL-10 precursor.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	142#147	18512809-3-21-35	Expression levels of interleukin-10 (IL-10), a potent and pleiotropic cytokine, are largely determined by variations in the gene encoding the IL-10 precursor.
18512809	2008	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	3586	SYMBOL|DICTIONARY	il10	IL10	53#57		This study was undertaken to determine the impact of IL10 polymorphisms on the pathogenesis of both WG and CSS in large cohorts.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|GENE|GN|DICTIONARY	il10	IL10	84#88		Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	95#99		Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	107#111		Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	123#127		Three single-nucleotide polymorphisms (SNPs) tagging the promoter haplotypes of the IL10 gene (IL10 -3575, IL10 -1082, and IL10 -592) were analyzed in 403 patients with WG and 103 patients with CSS as well as 507 matched control subjects from Germany.
18512809	2008	Arthritis Rheum.	0004-3591	METHODS	2	6	3586	SYMBOL|DICTIONARY	il10	IL10	50#54		In addition, 3 informative SNPs in other parts of IL10 were genotyped.
18512809	2008	Arthritis Rheum.	0004-3591	RESULTS	3	8	3586	SYMBOL|DICTIONARY	il10	IL10	17#21		In contrast, the IL10 -3575/-1082/-592 TAC haplotype, part of the extended ancient haplotype IL10.2, was highly significantly associated with ANCA-negative CSS (chi2 = 19.14, P = 0.000012, corrected P = 0.0003, odds ratio 2.16, 95% confidence interval 1.52-3.06).
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	9	3586	SYMBOL|DICTIONARY	il10	IL10	56#60		These findings challenge those from previous studies of IL10 in WG and provide further evidence that CSS and WG have distinct genetic backgrounds.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY	il10	IL10	77#81		Because the IL10.2 haplotype has been correlated reproducibly with increased IL10 expression, the possible role of IL-10 in the pathogenesis of ANCA-negative CSS needs to be further elucidated.
18512809	2008	Arthritis Rheum.	0004-3591	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	115#120	18512809-3-21-35	Because the IL10.2 haplotype has been correlated reproducibly with increased IL10 expression, the possible role of IL-10 in the pathogenesis of ANCA-negative CSS needs to be further elucidated.
19034705	2009	Endocrine	1355-008X	TITLE	0	0	7038	LONGTERM|GENE|GN|DICTIONARY	thyroglobulin	thyroglobulin	19#32		Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population.
19034705	2009	Endocrine	1355-008X	OBJECTIVE	1	1	7038	LONGTERM|DICTIONARY|GENE|GA	thyroglobulin	thyroglobulin	73#86		This study was performed to identify the presence of previously reported thyroglobulin (Tg) gene single nucleotide polymorphisms (SNPs) in Han Chinese Asians, and to investigate their potential relation to autoimmune thyroid disease (AITD).
19034705	2009	Endocrine	1355-008X	OBJECTIVE	1	1	7038	SYMBOL|EXTRACTED|()|GENE|GN	tg	Tg	88#90	19034705-1-73-86	This study was performed to identify the presence of previously reported thyroglobulin (Tg) gene single nucleotide polymorphisms (SNPs) in Han Chinese Asians, and to investigate their potential relation to autoimmune thyroid disease (AITD).
19034705	2009	Endocrine	1355-008X	RESULTS	3	3	7038	SYMBOL|EXTRACTED|GENE|GN	tg	Tg	34#36	19034705-1-73-86	(1) The occurrence of four common Tg gene SNPs (E10SNP24 T/G and E10SNP158 T/C in exon 10, E12SNP A/G in exon 12, and E33SNP C/T in exon 33) was confirmed in this Chinese population.
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	182#184	19034705-1-73-86	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
19034705	2009	Endocrine	1355-008X	RESULTS	3	6	7038	SYMBOL|EXTRACTED	tg	Tg	195#197	19034705-1-73-86	(2) Haplotype analysis of these four SNPs revealed that the G-C-A-C haplotype was significantly associated with HT (P < 0.01, OR = 3.06, OR 95% CI [1.326-7.089]) and with serum anti-Tg antibody (Tg-Ab) positive AITD patients (P = 0.028, OR = 3.34).
19034705	2009	Endocrine	1355-008X	CONCLUSION	4	8	7038	SYMBOL|EXTRACTED	tg	Tg	72#74	19034705-1-73-86	In addition, the association of one SNP haplotype with HT suggests that Tg may be an AITD susceptibility gene.
18569231	2008	J Asthma	1532-4303	ALL_TEXT_1/3	1	1	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 adrenoceptor	beta(2)-adrenoceptor	95#115		The aim of this study was to determine the influence of single nucleotide polymorphisms in the beta(2)-adrenoceptor gene, on the response to inhaled beta(2)-agonists in children with acute asthma.
18568133	2008	J Gastrointestin Liver Dis	1841-8724	BACKGROUND AND AIMS	1	2	3938	SYMBOL|GENE|GN|DICTIONARY	lactase	lactase	123#130		Hydrogen breath test (BTH) and genotyping of a single nucleotide polymorphism (SNP) C >T 13,910 base pairs upstream of the lactase gene represent potential methods for diagnosis of this autosomal-recessive trait.
18496208	2008	Psychiatr. Genet.	1473-5873	TITLE	0	0	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	0#6		PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|DICTIONARY	lim	LIM	74#77		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	3670	SYMBOL|DICTIONARY	isl 1	Isl-1	87#92		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	1	10611	SYMBOL|()|GENE|GN|DICTIONARY	pdlim5	PDLIM5	115#121		The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples.
18496208	2008	Psychiatr. Genet.	1473-5873	OBJECTIVES	1	2	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	86#92		We performed a family-based association study to test the hypothesis that variants in PDLIM5 increase susceptibility to BP in European-Americans and a meta-analysis to clarify whether there is a single marker consistently contributing to risk for BP.
18496208	2008	Psychiatr. Genet.	1473-5873	METHODS	2	3	10611	SYMBOL|GENE|GN|DICTIONARY	pdlim5	PDLIM5	44#50		Five single nucleotide polymorphisms in the PDLIM5 gene were genotyped in 290 European-American BP families.
18496208	2008	Psychiatr. Genet.	1473-5873	CONCLUSION	4	9	10611	SYMBOL|DICTIONARY	pdlim5	PDLIM5	0#6		PDLIM5 may have a minor effect on susceptibility to BP in Caucasians.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	51#66		[Study on the association between polymorphisms in angiotensinogen gene and deep venous thrombosis].
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	50#65		To investigate the association of polymorphism of angiotensinogen (AGT) -6G/A, -20A/C and T174M with the development of deep venous thrombosis.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	67#70	18543221-1-50-65	To investigate the association of polymorphism of angiotensinogen (AGT) -6G/A, -20A/C and T174M with the development of deep venous thrombosis.
18543221	2009	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	METHODS	2	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	21#36		The polymorphisms of angiotensinogen -6G/A, -20A/C and T174M were detected by PCR-RFLP.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	60412	SYMBOL|DICTIONARY	exoc4	EXOC4	19#24		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
18498660	2008	BMC Med. Genet.	1471-2350	TITLE	0	0	136332	SYMBOL|DICTIONARY	lrguk	LRGUK	29#34		Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.
18498660	2008	BMC Med. Genet.	1471-2350	METHODS	2	4	6934	SYMBOL|DICTIONARY	tcf7l2	TCF7L2	66#72		Regression modeling, adjusting for BMI, age, sex, smoking and the TCF7L2 polymorphism, was used to evaluate the association of these polymorphisms with T2D and fasting glucoses levels.
18498660	2008	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	60412	SYMBOL|DICTIONARY	exoc4	EXOC4	25#30		The closest nearby gene, EXOC4, is involved in insulin-stimulated glucose transport and may be a candidate for this association.
18498660	2008	BMC Med. Genet.	1471-2350	CONCLUSION	4	11	60412	SYMBOL|DICTIONARY	exoc4	EXOC4	159#164		Further work is needed to determine if the deletion represents a functional variant or may be in linkage disequilibrium with a functional mutation influencing EXOC4 or another nearby gene.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	2#7		A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
18285546	2008	Blood	1528-0020	TITLE	0	0	5054	SYMBOL|()|DICTIONARY|EXTRACTED	serpine1	SERPINE1	9#17	18285546-0-2-7	A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	7298	SYMBOL|DICTIONARY	tyms	TYMS	17#21		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	23#28		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5243	SYMBOL|DICTIONARY	abcb1	ABCB1	30#35		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	632	SYMBOL|DICTIONARY	bglap	BGLAP	37#42		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	54	SYMBOL|DICTIONARY	acp5	ACP5	44#48		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	4041	SYMBOL|DICTIONARY	lrp5	LRP5	50#54		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	2099	SYMBOL|DICTIONARY	esr1	ESR1	56#60		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	62#67		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	7421	SYMBOL|DICTIONARY	vdr	VDR	69#72		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5741	SYMBOL|DICTIONARY	pth	PTH	74#77		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	4	5745	SYMBOL|DICTIONARY	pthr	PTHR	83#87		Candidate genes (TYMS, MTHFR, ABCB1, BGLAP, ACP5, LRP5, ESR1, PAI-1, VDR, PTH, and PTHR) were chosen based on putative mechanisms underlying osteonecrosis risk.
18285546	2008	Blood	1528-0020	ALL_TEXT_2/3	2	6	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	2#7		A PAI-1 polymorphism (rs6092) was associated with risk of osteonecrosis in univariate (P = .002; odds ratio = 2.79) and multivariate (P = .002; odds ratio = 2.89) analyses (adjusting for gender, age, and treatment arm).
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	7	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	40#45		Overall, 21 of 78 (26.9%) children with PAI-1 GA/AA genotypes, versus 25 of 214 (11.7%) children with GG genotype, developed osteonecrosis.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	8	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	0#5		PAI-1 polymorphisms and PAI-1 serum levels have previously been associated with thrombosis.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	8	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	24#29		PAI-1 polymorphisms and PAI-1 serum levels have previously been associated with thrombosis.
18285546	2008	Blood	1528-0020	ALL_TEXT_3/3	3	9	5054	SYMBOL|GENE|GN|DICTIONARY	pai 1	PAI-1	17#22		We conclude that PAI-1 genetic variation may contribute to risk of osteonecrosis.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	36#39		A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_1/3	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	59#62		We describe a novel heterozygous mutation in exon 3 of the HFE-gene that was co-inherited with Cys282Tyr in two unrelated Dutch men both presenting a classical form of hereditary hemochromatosis.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_2/3	2	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	106#109		This c.548T>C mutation converts a leucine to a proline residue at position 183 in the alpha2-helix of the HFE-protein (Leu183Pro).
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_2/3	2	4	3077	SYMBOL|DICTIONARY	hfe	HFE	82#85		Standard bioinformatics analysis shows that the mutation is likely to disturb the HFE interaction with TfR1.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_2/3	2	4	7037	SYMBOL|DICTIONARY	tfr1	TfR1	103#107		Standard bioinformatics analysis shows that the mutation is likely to disturb the HFE interaction with TfR1.
18042412	2008	Blood Cells Mol. Dis.	1096-0961	ALL_TEXT_3/3	3	7	3077	SYMBOL|DICTIONARY	hfe	HFE	41#44		These findings may have implications for HFE-testing of iron overloaded heterozygous Cys282Tyr-patients of Northern European origin and their relatives.
18393292	2008	Hepatology	1527-3350	TITLE	0	0	7832	SYMBOL|DICTIONARY	tis21	TIS21	0#5		TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
18393292	2008	Hepatology	1527-3350	TITLE	0	0	2305	LONGTERM|DICTIONARY	forkhead box m1	Forkhead box M1	75#90		TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	1	7832	SYMBOL|DICTIONARY	tis21	TIS21	44#49		A functional and biochemical interaction of TIS21(/BTG2/PC3) with Forkhead box M1 (FoxM1), essential transcription factor for hepatocyte regeneration and a master regulator of mitotic gene expression, was explored.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	1	7832	SYMBOL|DICTIONARY	btg2	BTG2	51#55		A functional and biochemical interaction of TIS21(/BTG2/PC3) with Forkhead box M1 (FoxM1), essential transcription factor for hepatocyte regeneration and a master regulator of mitotic gene expression, was explored.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	1	2305	LONGTERM|DICTIONARY	forkhead box m1	Forkhead box M1	66#81		A functional and biochemical interaction of TIS21(/BTG2/PC3) with Forkhead box M1 (FoxM1), essential transcription factor for hepatocyte regeneration and a master regulator of mitotic gene expression, was explored.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	1	2305	SYMBOL|()|DICTIONARY|EXTRACTED	foxm1	FoxM1	83#88	18393292-1-66-81	A functional and biochemical interaction of TIS21(/BTG2/PC3) with Forkhead box M1 (FoxM1), essential transcription factor for hepatocyte regeneration and a master regulator of mitotic gene expression, was explored.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	128#133		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	143#148		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	2	7832	SYMBOL|DICTIONARY	tis21	TIS21	218#223		Growth of hepatocellular carcinoma (HCC), developed by a single injection of diethylnitrosamine (DEN), was the same in both the TIS21(+/+) and TIS21(-/-) mice until 6 months, whereas it was significantly higher in the TIS21(-/-) mice at 9 months.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	3	7832	SYMBOL|DICTIONARY	tis21	TIS21	14#19		Expression of TIS21 was significantly lower in both human and murine HCCs than in the surrounding tissues.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	4	7832	SYMBOL|DICTIONARY	tis21	TIS21	21#26		Forced expression of TIS21 impaired growth, proliferation, and tumorigenic potential of Huh7 cells.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	5	7832	SYMBOL|DICTIONARY	tis21	TIS21	26#31		At the mechanistic level, TIS21 inhibited FoxM1 phosphorylation, a required modification for its activation, by reducing cyclin B1-cdk1 activity, examined by in vitro kinase assay and FoxM1 mutant analyses.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	5	2305	SYMBOL|DICTIONARY|EXTRACTED	foxm1	FoxM1	42#47	18393292-1-66-81	At the mechanistic level, TIS21 inhibited FoxM1 phosphorylation, a required modification for its activation, by reducing cyclin B1-cdk1 activity, examined by in vitro kinase assay and FoxM1 mutant analyses.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	5	891	LONGTERM|DICTIONARY	cyclin b1	cyclin B1	121#130		At the mechanistic level, TIS21 inhibited FoxM1 phosphorylation, a required modification for its activation, by reducing cyclin B1-cdk1 activity, examined by in vitro kinase assay and FoxM1 mutant analyses.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	5	983	SYMBOL|DICTIONARY	cdk1	cdk1	131#135		At the mechanistic level, TIS21 inhibited FoxM1 phosphorylation, a required modification for its activation, by reducing cyclin B1-cdk1 activity, examined by in vitro kinase assay and FoxM1 mutant analyses.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	5	2305	SYMBOL|DICTIONARY|EXTRACTED	foxm1	FoxM1	184#189	18393292-1-66-81	At the mechanistic level, TIS21 inhibited FoxM1 phosphorylation, a required modification for its activation, by reducing cyclin B1-cdk1 activity, examined by in vitro kinase assay and FoxM1 mutant analyses.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	6	7832	SYMBOL|DICTIONARY	tis21	TIS21	79#84		These observations were further confirmed in vivo by the reciprocal control of TIS21 expression and FoxM1 phosphorylation in the diethylnitrosamine-induced HCCs and TIS21(-/-) mouse embryonic fibroblast (MEF), in addition to increased expression of cyclin B1 and cdk1 activity.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	6	2305	SYMBOL|DICTIONARY|EXTRACTED	foxm1	FoxM1	100#105	18393292-1-66-81	These observations were further confirmed in vivo by the reciprocal control of TIS21 expression and FoxM1 phosphorylation in the diethylnitrosamine-induced HCCs and TIS21(-/-) mouse embryonic fibroblast (MEF), in addition to increased expression of cyclin B1 and cdk1 activity.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	6	7832	SYMBOL|DICTIONARY	tis21	TIS21	165#170		These observations were further confirmed in vivo by the reciprocal control of TIS21 expression and FoxM1 phosphorylation in the diethylnitrosamine-induced HCCs and TIS21(-/-) mouse embryonic fibroblast (MEF), in addition to increased expression of cyclin B1 and cdk1 activity.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	6	891	LONGTERM|DICTIONARY	cyclin b1	cyclin B1	249#258		These observations were further confirmed in vivo by the reciprocal control of TIS21 expression and FoxM1 phosphorylation in the diethylnitrosamine-induced HCCs and TIS21(-/-) mouse embryonic fibroblast (MEF), in addition to increased expression of cyclin B1 and cdk1 activity.
18393292	2008	Hepatology	1527-3350	UNLABELLED	1	6	983	SYMBOL|DICTIONARY	cdk1	cdk1	263#267		These observations were further confirmed in vivo by the reciprocal control of TIS21 expression and FoxM1 phosphorylation in the diethylnitrosamine-induced HCCs and TIS21(-/-) mouse embryonic fibroblast (MEF), in addition to increased expression of cyclin B1 and cdk1 activity.
18393292	2008	Hepatology	1527-3350	CONCLUSION	2	7	7832	SYMBOL|DICTIONARY	tis21	TIS21	0#5		TIS21 negatively regulated hepatocarcinogenesis in part by disruption of the FoxM1-cyclin B1 regulatory loop, thereby inhibiting proliferation of transformed cells developed in mouse and human livers.
18393292	2008	Hepatology	1527-3350	CONCLUSION	2	7	2305	SYMBOL|DICTIONARY|EXTRACTED	foxm1	FoxM1	77#82	18393292-1-66-81	TIS21 negatively regulated hepatocarcinogenesis in part by disruption of the FoxM1-cyclin B1 regulatory loop, thereby inhibiting proliferation of transformed cells developed in mouse and human livers.
18393292	2008	Hepatology	1527-3350	CONCLUSION	2	7	891	LONGTERM|DICTIONARY	cyclin b1	cyclin B1	83#92		TIS21 negatively regulated hepatocarcinogenesis in part by disruption of the FoxM1-cyclin B1 regulatory loop, thereby inhibiting proliferation of transformed cells developed in mouse and human livers.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	4292	SYMBOL|DICTIONARY	mlh1	MLH1	18#22		Evaluation of the MLH1 I219V alteration in DNA mismatch repair activity and ulcerative colitis.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	2	4292	SYMBOL|DICTIONARY	mlh1	MLH1	122#126		A linkage susceptibility region for these diseases (IBD9) lies on chromosome 3p and includes the DNA mismatch repair gene MLH1.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	8#12		Loss of MLH1 confers the characteristic microsatellite instability (MSI) phenotype which is also frequently found in the mucosa of IBD patients.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	4	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		A common germline alteration of MLH1 (655A>G) results in the amino acid exchange MLH1 I219V.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	4	4292	SYMBOL|DICTIONARY	mlh1	MLH1	81#85		A common germline alteration of MLH1 (655A>G) results in the amino acid exchange MLH1 I219V.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	METHODS	2	6	4292	SYMBOL|DICTIONARY	mlh1	MLH1	16#20		We analyzed the MLH1 I219V alteration using in silico and biochemical analyses and assessed its appearance in 67 well-classified UC patients in comparison to 40 healthy individuals.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	4292	SYMBOL|DICTIONARY	mlh1	MLH1	112#116		The analyses showed that I219 is a conserved, buried hydrophobic residue, and that I219V is unlikely to abolish MLH1 function but may modulate it.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	10	4292	SYMBOL|DICTIONARY	mlh1	MLH1	4#8		The MLH1 I219V alteration does not directly contribute to the etiology of UC through an impairment of mismatch repair.
18200512	2008	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	11	4292	SYMBOL|DICTIONARY	mlh1	MLH1	37#41		A putative linkage disequilibrium of MLH1 I219V with the causative gene(s) of the IBD9 locus is rather distant.
18178632	2008	J. Med. Genet.	1468-6244	TITLE	0	0	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	0#6		CDKN2A mutations and melanoma risk in the Icelandic population.
18178632	2008	J. Med. Genet.	1468-6244	BACKGROUND	1	1	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	9#15		Germline CDKN2A mutations have been observed in 20-40% of high risk, melanoma prone families; however, little is known about their prevalence in population based series of melanoma cases and controls.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|GENE|GN|DICTIONARY	cdkn2a	CDKN2A	19#25		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	METHODS	2	2	1029	SYMBOL|DICTIONARY	p14arf	p14ARF	46#52		We resequenced the CDKN2A gene, including the p14ARF variant and promoter regions, in approximately 703 registry ascertained melanoma cases and 691 population based controls from Iceland, a country in which the incidence of melanoma has increased rapidly.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	7	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	107#113		This population based study of Icelandic melanoma cases and controls showed a frequency of disease related CDKN2A mutant alleles ranging from 0.7% to 1.0%, thus expanding our knowledge about the frequency of CDKN2A mutations in different populations.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	7	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	208#214		This population based study of Icelandic melanoma cases and controls showed a frequency of disease related CDKN2A mutant alleles ranging from 0.7% to 1.0%, thus expanding our knowledge about the frequency of CDKN2A mutations in different populations.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	8	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	139#145		In contrast to North America and Australia where a broad spectrum of mutations was observed at a similar frequency, in Iceland, functional CDKN2A mutations consist of only one or two different variants.
18178632	2008	J. Med. Genet.	1468-6244	CONCLUSIONS	4	10	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	82#88		This study adds to the geographic regions for which population based estimates of CDKN2A mutation frequencies are available.
18442637	2008	Metab. Clin. Exp.	0026-0495	TITLE	0	0	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol O-methyltransferase	0#28		Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol O-methyltransferase	0#28		Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	1	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	30#34	18442637-1-0-28	Catechol O-methyltransferase (COMT) degrades catecholamines and estrogens, both of which are of known importance for cardiovascular risk factors such as obesity and hypertension.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	2	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	20#24	18442637-1-0-28	The gene coding for COMT contains a val158-met polymorphism that exerts a considerable influence on enzymatic activity.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	6	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	88#92	18442637-1-0-28	All measured variables were significantly correlated; however, the associations between COMT val158-met and cardiovascular variables, and the association between COMT val158-met and anthropometry, respectively, were partly independent of each other, as revealed by multiple linear regression.
18442637	2008	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	6	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	162#166	18442637-1-0-28	All measured variables were significantly correlated; however, the associations between COMT val158-met and cardiovascular variables, and the association between COMT val158-met and anthropometry, respectively, were partly independent of each other, as revealed by multiple linear regression.
18191917	2008	Pathol. Biol.	0369-8114	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	11#24		The common prion protein gene (PRNP) codon 129 polymorphism is a strong susceptibility factor for human prion diseases.
18449423	2008	Thromb. Haemost.	0340-6245	TITLE	0	0	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	59#74		The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
18449423	2008	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	61#76		Several small case-control studies have investigated whether factor V Leiden (FVL) is a risk factor for retinal vein occlusion (RVO) and generated conflicting data.
18416843	2008	BMC Neurol	1471-2377	BACKGROUND	1	3	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	apolipoprotein E	48#64		We have described the allele frequencies of the apolipoprotein E gene (APOE) in a large population of patients with AD compared to the frequencies in a cognitively-normal control group, and estimated the effect of the APOE epsilon4 allele on the risk and the age at onset of AD in this population.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	Alpha-synuclein	0#15		Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	17#32		Mutations of the alpha-synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	6622	SYMBOL|()|DICTIONARY|EXTRACTED	snca	SNCA	39#43	17918232-3-17-32	Mutations of the alpha-synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	4	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	105#120		We have performed a case control study to investigate whether genetic variability in the promoter of the alpha-synuclein gene could predispose to dementia in PD.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	6	1121	SYMBOL|DICTIONARY	rep1	Rep1	36#40		Six polymorphic loci (including the Rep1 microsatellite) in the promoter of the SNCA gene were examined.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	6	6622	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	snca	SNCA	80#84	17918232-3-17-32	Six polymorphic loci (including the Rep1 microsatellite) in the promoter of the SNCA gene were examined.
17918232	2008	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	8	6622	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	snca	SNCA	48#52	17918232-3-17-32	Our data suggest the lack of involvement of the SNCA promoter in the pathogenesis of dementia in PD.
18318767	2008	Br. J. Haematol.	1365-2141	TITLE	0	0	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	sar1a	61#66		Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_1/3	1	2	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	SAR1A	110#115		Our preliminary analysis indicated that HC inducibility is transcriptionally regulated by elements within the SAR1A promoter.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_2/3	2	3	56681	SYMBOL|GENE|GN|DICTIONARY	sar1a	SAR1A	56#61		This study aimed to assess whether polymorphisms in the SAR1A promoter are associated with differences Hb F levels or HC therapeutic responses among sickle cell disease (SCD) patients.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_3/3	3	7	56681	SYMBOL|DICTIONARY	sar1a	SAR1A	41#46		These data suggest that variation within SAR1A regulatory elements might contribute to inter-individual differences in regulation of HbF expression and patient responses to HC in SCD.
17904846	2008	Breast	0960-9776	TITLE	0	0	2099	SYMBOL|DICTIONARY	esr1	ESR1	75#79		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	2100	SYMBOL|DICTIONARY	esr2	ESR2	81#85		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	91#108		Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	TITLE	0	0	367	SYMBOL|EXTRACTED|()|GENE|GN	ar	AR	110#112	17904846-0-91-108	Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	SYMBOL|DICTIONARY	esr1	ESR1	67#71		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2099	LONGTERM|()|DICTIONARY|EXTRACTED	er alpha	ER-alpha	73#81	17904846-2-67-71	To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|DICTIONARY	esr2	ESR2	84#88		To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	2100	SYMBOL|EXTRACTED|()	er beta	ER-beta	90#97	17904846-2-84-88	To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	103#105	17904846-0-91-108	To determine the possible contribution of genetic variation in the ESR1 (ER-alpha), ESR2 (ER-beta) and AR genes in breast cancer risk the -1174(TA)(7-27), c. 1092+3607(CA)(10-26) and c. 172(CAG)(6-40) repeat variants were studied in a case-control study of 79 women with sporadic breast cancer and 155 controls.
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	3	2099	SYMBOL|GENE|GN|DICTIONARY	esr1	ESR1	95#99		No significant difference was observed in the frequency distribution of -1174(TA)(7-27) in the ESR1 gene between patients and controls, while a significant difference was observed for repeat polymorphisms c. 1092+3607(CA)(10-26) in the ESR2 gene and c. 172(CAG)(6-40) in the AR gene (p0.0001).
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	3	2100	SYMBOL|GENE|GN|DICTIONARY	esr2	ESR2	236#240		No significant difference was observed in the frequency distribution of -1174(TA)(7-27) in the ESR1 gene between patients and controls, while a significant difference was observed for repeat polymorphisms c. 1092+3607(CA)(10-26) in the ESR2 gene and c. 172(CAG)(6-40) in the AR gene (p0.0001).
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	3	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	275#277	17904846-0-91-108	No significant difference was observed in the frequency distribution of -1174(TA)(7-27) in the ESR1 gene between patients and controls, while a significant difference was observed for repeat polymorphisms c. 1092+3607(CA)(10-26) in the ESR2 gene and c. 172(CAG)(6-40) in the AR gene (p0.0001).
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	4	2100	SYMBOL|DICTIONARY	esr2	ESR2	141#145		A significantly decreased odds ratio (OR) for breast cancer risk was observed in individuals having the LL and the SL genotypes for both the ESR2 (OR=0.010, 95% CI 0.003-0.036, p<0.001; OR=0.013, 95% CI 0.004-0.040, p<0.0001, respectively) and the AR gene (OR=0.040, 95% CI 0.011-0.138, p<0.0001; OR=0.189, 95% CI 0.10-0.359, p<0.0001, respectively), compared to SS genotype.
17904846	2008	Breast	0960-9776	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	248#250	17904846-0-91-108	A significantly decreased odds ratio (OR) for breast cancer risk was observed in individuals having the LL and the SL genotypes for both the ESR2 (OR=0.010, 95% CI 0.003-0.036, p<0.001; OR=0.013, 95% CI 0.004-0.040, p<0.0001, respectively) and the AR gene (OR=0.040, 95% CI 0.011-0.138, p<0.0001; OR=0.189, 95% CI 0.10-0.359, p<0.0001, respectively), compared to SS genotype.
17904846	2008	Breast	0960-9776	ALL_TEXT_3/3	3	6	2100	SYMBOL|DICTIONARY	esr2	ESR2	111#115		In conclusion, an association for breast cancer risk between short (SS) alleles for the repeat variants of the ESR2 and AR genes was found in women of Greek descent.
17904846	2008	Breast	0960-9776	ALL_TEXT_3/3	3	6	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	120#122	17904846-0-91-108	In conclusion, an association for breast cancer risk between short (SS) alleles for the repeat variants of the ESR2 and AR genes was found in women of Greek descent.
18362425	2008	Circ. J.	1346-9843	BACKGROUND	1	1	2778	SYMBOL|()|DICTIONARY	gnas1	GNAS1	84#89		Mutation T/C inside codon 131 of the gene encoding the alpha subunit of Gs protein (GNAS1) causes the increased activation of adenyl cyclase, which plays an important role in cardiovascular regulation.
18362425	2008	Circ. J.	1346-9843	BACKGROUND	1	2	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	45#50		The aim of the present study was to evaluate GNAS1 T/C,Ile 131 mutation's manifestation in syncopal patients regarding head-up tilt test (HUTT) results.
18362425	2008	Circ. J.	1346-9843	METHODS AND RESULTS	2	3	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	97#102		In 137 syncopal patients (without any other diseases) the silent T/C,Ile 131 mutation within the GNAS1 codon on chromosome 20 q was identified.
18362425	2008	Circ. J.	1346-9843	CONCLUSIONS	3	8	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	76#81		An association between positive tilting and mutation C/T,Ile 131 within the GNAS1 codon was found.
18362425	2008	Circ. J.	1346-9843	CONCLUSIONS	3	9	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	72#77		The predisposition to vasovagal syncope seems to be associated with the GNAS1 FokI+ allele.
18162506	2008	Diabetes	1939-327X	RESULTS	3	9	3767	SYMBOL|DICTIONARY	kcnj11	KCNJ11	43#49		In 279 patients with PND, the frequency of KCNJ11, ABCC8, and INS gene mutations was 31, 10, and 12%, respectively.
18162506	2008	Diabetes	1939-327X	RESULTS	3	9	6833	SYMBOL|DICTIONARY	abcc8	ABCC8	51#56		In 279 patients with PND, the frequency of KCNJ11, ABCC8, and INS gene mutations was 31, 10, and 12%, respectively.
18327256	2008	Nat. Genet.	1546-1718	TITLE	0	0	56606	SYMBOL|DICTIONARY	slc2a9	SLC2A9	0#6		SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
18327256	2008	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	2	56606	SYMBOL|DICTIONARY	slc2a9	SLC2A9	221#227		In the genome-wide association study KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K (n = 1,644), the most significant SNPs associated with uric acid concentrations mapped within introns 4 and 6 of SLC2A9, a gene encoding a putative hexose transporter (effects: -0.23 to -0.36 mg/dl per copy of the minor allele).
18327256	2008	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	4	56606	SYMBOL|DICTIONARY	slc2a9	SLC2A9	132#138		Analysis of whole blood RNA expression profiles from a KORA F3 500K subgroup (n = 117) showed a significant association between the SLC2A9 isoform 2 and urate concentrations.
18327256	2008	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	56606	SYMBOL|DICTIONARY	slc2a9	SLC2A9	4#10		The SLC2A9 genotypes also showed significant association with self-reported gout.
18688140	2009	Neurol India	0028-3886	BACKGROUND AND OBJECTIVES	1	3	6532	SYMBOL|()|DICTIONARY	5 httlpr	5-HTTLPR	89#97		These are: the variable number of tandem repeats (VNTR) and 5'-flanking promoter region (5-HTTLPR).
18688140	2009	Neurol India	0028-3886	MATERIALS AND METHODS	2	4	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	9#17		VNTR and 5-HTTLPR polymorphisms were investigated in 126 CTTH patients and 138 healthy control subjects.
18688140	2009	Neurol India	0028-3886	RESULTS	3	7	6532	SYMBOL|GENE|GN|DICTIONARY	5 httlpr	5-HTTLPR	61#69		There were no statistically significant results based on the 5-HTTLPR gene alleles, however, STin 2.12/12 genotype and STin 2.12 allele were seen to predominate the control group.
18688140	2009	Neurol India	0028-3886	RESULTS	3	10	6532	SYMBOL|DICTIONARY	5 httlpr	5-HTTLPR	52#60		No significant differences were noticed between the 5-HTTLPR and VNTR haplotype groups and success in treatment.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	TITLE	0	0	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	57#92		Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_1/3	1	4	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	4#39		The methylenetetrahydrofolate reductase (MTHFR) is the key enzyme in remethylation of Hcy to methionine and supplies the required 5-methyltetrahydrofolate as the methyl donor for this reaction.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_1/3	1	4	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	41#46	18234410-4-4-39	The methylenetetrahydrofolate reductase (MTHFR) is the key enzyme in remethylation of Hcy to methionine and supplies the required 5-methyltetrahydrofolate as the methyl donor for this reaction.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_2/3	2	6	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	21#26	18234410-4-4-39	The C677T variant of MTHFR gene can also lead to hyperhomocysteinemia particularly when serum folate level is decreased.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_2/3	2	7	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	243#248	18234410-4-4-39	In this study, we investigated the levels of serum folate, vitamin B-12 and Hcy in epileptic patients receiving carbamazepine (CBZ) or valproic acid (VPA) as monotherapy, and we also evaluated the probable contribution of the C677T variant of MTHFR gene in hyperhomocysteinemia.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_3/3	3	13	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	41#46	18234410-4-4-39	We also determined the C677T variants of MTHFR gene (as normal, heterozygote or homozygote) in epileptic patients.
18234410	2008	Prog. Neuropsychopharmacol. Biol. Psychiatry	0278-5846	ALL_TEXT_3/3	3	15	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	33#38	18234410-4-4-39	In conclusion, C677T variants of MTHFR gene have no contribution in hyperhomocysteinemia in epileptic patients receiving CBZ or VPA.
18313024	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	10908	LONGTERM|GENE|GN|DICTIONARY	neuropathy target esterase	Neuropathy target esterase	0#26		Neuropathy target esterase gene mutations cause motor neuron disease.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase 1	125#138		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	LONGTERM|DICTIONARY	neuropathy target esterase	neuropathy target esterase	280#306		The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	1	10908	SYMBOL|()|DICTIONARY|EXTRACTED	nte	NTE	308#311	18313024-1-280-306	The possibility that organophosphorus (OP) compounds contribute to motor neuron disease (MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic lateral sclerosis (ALS) and the occurrence of MND in OP compound-induced delayed neuropathy (OPIDN), in which neuropathy target esterase (NTE) is inhibited by organophosphorylation.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|DICTIONARY	spg20	SPG20	83#88		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|GENE|GN|DICTIONARY	spartin	spartin	89#96		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	23111	SYMBOL|DICTIONARY	spg20	SPG20	144#149		Affected subjects resembled those with OPIDN and those with Troyer Syndrome due to SPG20/spartin gene mutation (excluded by genetic linkage and SPG20/spartin sequence analysis).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	4	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	152#155	18313024-1-280-306	Genome-wide analysis suggested linkage to a 22 cM homozygous locus (D19S565 to D19S884, maximum multipoint LOD score 3.28) on chromosome 19p13 to which NTE had been mapped (GenBank AJ004832).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	5	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	0#3		NTE was a candidate because of its role in OPIDN and the similarity of our patients to those with OPIDN.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	85#88	18313024-1-280-306	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	171#174	18313024-1-280-306	Affected subjects in the consanguineous kindred were homozygous for disease-specific NTE mutation c.3034A-->G that disrupted an interspecies conserved residue (M1012V) in NTE's catalytic domain.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	168#171	18313024-1-280-306	Affected subjects in the nonconsanguineous family were compound heterozygotes: one allele had c.2669G-->A mutation, which disrupts an interspecies conserved residue in NTE's catalytic domain (R890H), and the other allele had an insertion (c.2946_2947insCAGC) causing frameshift and protein truncation (p.S982fs1019).
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	31#34	18313024-1-280-306	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	81#84	18313024-1-280-306	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	159#162	18313024-1-280-306	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18313024	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	10908	SYMBOL|DICTIONARY|EXTRACTED	nte	NTE	249#252	18313024-1-280-306	Disease-specific, nonconserved NTE mutations in unrelated MND patients indicates NTE's importance in maintaining axonal integrity, raises the possibility that NTE pathway disturbances contribute to other MNDs including ALS, and supports the role of NTE abnormalities in axonopathy produced by neuropathic OP compounds.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	0#4		NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	33#37	18349284-1-0-31	Arylamine N-acetyltransferase-2 (NAT2) displays extensive genetic polymorphisms that affect the rates of acetylation of drugs and toxic compounds such as amine carcinogens.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	19#23	18349284-1-0-31	The association of NAT2 polymorphisms with adult brain tumors has been unclear.
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	27#31	18349284-1-0-31	To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nat2	NAT2	142#146	18349284-1-0-31	To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	153#157	18349284-1-0-31	To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	169#173	18349284-1-0-31	To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	189#193	18349284-1-0-31	To investigate whether the NAT2 genotype is a risk factor of brain tumors, we determined the frequencies of three common polymorphisms in the NAT2 gene, NAT2*5 (T341C), NAT2*6 (G590A), and NAT2*7(G857A), in brain tumor patients and in age- and gender-matched control subjects (n = 27 in each group).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	18#22	18349284-1-0-31	The odds ratio of NAT2*7 allele frequency was significantly higher in patients with brain tumor than in controls (odds ratio, 6.786; 95% confidence interval, 2.06-22.37; P = 0.003); in the mean time, NAT2*4/*7 genotype was significantly more common in the patient group than in controls (odds ratio, 6.19; 95% confidence interval, 1.68-22.79; P = 0.0039).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	200#204	18349284-1-0-31	The odds ratio of NAT2*7 allele frequency was significantly higher in patients with brain tumor than in controls (odds ratio, 6.786; 95% confidence interval, 2.06-22.37; P = 0.003); in the mean time, NAT2*4/*7 genotype was significantly more common in the patient group than in controls (odds ratio, 6.19; 95% confidence interval, 1.68-22.79; P = 0.0039).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	32#36	18349284-1-0-31	The tumors in the patients with NAT2*7 allele tended to be high-grade astrocytoma or glioblastoma multiforme (P = 0.016).
18349284	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	55#59	18349284-1-0-31	In conclusion, these data suggest that the presence of NAT2*7 allele might be a potential risk factor for the development of brain tumors in Taiwan.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_2/3	2	3	7253	LONGTERM|GENE|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	109#129		We also examined 48 euthyroid patients with GD who had been under treatment and were still positive for anti-thyrotropin receptor antibodies (intractable GD), 20 euthyroid patients with GD in remission and 45 healthy controls.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	7133	SYMBOL|DICTIONARY	tnfrsf1b	TNFRSF1B	30#38		Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	2214	SYMBOL|DICTIONARY	fcgr3a	FCGR3A	107#113		The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	7133	SYMBOL|GENE|GN|DICTIONARY	tnfrsf1b	TNFRSF1B	132#140		The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	CONCLUSION	4	8	7133	SYMBOL|DICTIONARY	tnfrsf1b	TNFRSF1B	80#88		This is the first report of a statistically significant association between the TNFRSF1B-M196R SNP and response to infliximab in a French cohort.
18396210	2008	Hum. Immunol.	0198-8859	TITLE	0	0	3553	SYMBOL|NUMBER|DICTIONARY	il 1 beta	IL-1 beta	47#56		Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
18396210	2008	Hum. Immunol.	0198-8859	TITLE	0	0	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	63#69		Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	81#90		Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	122#128		Therefore, we studied genetic association of biallelic (-511C>T) polymorphism of IL-1 beta and 86-bp VNTR polymorphism of IL-1RN in 159 patients with esophageal cancer (EC) and 194 age- and gender-matched healthy controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	4	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	19#28		The frequencies of IL-1 beta (-511C>T) and IL-1RN (variable number tandem repeat) genotypes, alleles, and haplotypes did not differ significantly between patients and controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	4	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	43#49		The frequencies of IL-1 beta (-511C>T) and IL-1RN (variable number tandem repeat) genotypes, alleles, and haplotypes did not differ significantly between patients and controls.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	9#18		However, IL-1 beta -511TT genotype and T1+ haplotype combination illustrated low risk for disease at the middle third location of the tumor (odds ratio [OR] = 0.27; 95% confidence interval [CI] = 0.11-0.62; p = 0.002; OR = 0.462; 95% CI = 0.253-0.845, p = 0.01).
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	29#38		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3553	SYMBOL|DICTIONARY	il 1 beta	IL-1 beta	58#67		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	3557	SYMBOL|NUMBER|DICTIONARY	il 1rn	IL-1RN	70#76		In conclusion, subjects with IL-1 beta -511TT genotype or IL-1 beta*T-IL-1RN*1 (T1) haplotype had lower risk for middle third tumor location of EC in a northern Indian population.
18074111	2008	Mol. Cell. Biochem.	0300-8177	OBJECTIVE	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY	mthfr	MTHFR	68#73		To determine the incidence of methylene tetrahydrofolate reductase (MTHFR) gene 677C-->T polymorphism and plasma homocysteine (Hcy) levels in a group of subjects who underwent coronary angiography, in an attempt to establish a correlation between these parameters and the severity of coronary artery disease (CAD) and to investigate the correlation between hyperhomocysteinemia (HHcy) and the presence of 677C-->T polymorphism.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	5	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	45#54		Additionally, pro-apoptotic proteins Bax and caspase-3 have been implemented in the oxidative modification of PtdSer resulting in subsequent asymmetric collapse, while anti-apoptotic protein Bcl-2 has been found to prevent this process.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	5	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	191#196		Additionally, pro-apoptotic proteins Bax and caspase-3 have been implemented in the oxidative modification of PtdSer resulting in subsequent asymmetric collapse, while anti-apoptotic protein Bcl-2 has been found to prevent this process.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	245#250		The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	261#270		The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18067970	2008	Ophthalmology	1549-4713	TITLE	0	0	3075	LONGTERM|DICTIONARY	complement factor h	complement factor H	58#77		Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration.
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	LONGTERM|DICTIONARY	complement factor h	complement factor H	82#101		To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
18067970	2008	Ophthalmology	1549-4713	OBJECTIVE	1	1	3075	SYMBOL|()|DICTIONARY|EXTRACTED	cfh	CFH	103#106	18067970-1-82-101	To examine phenotypes of age-related macular degeneration (AMD) patients with the complement factor H (CFH) variant (Y402H, C allele at rs1061170).
18067970	2008	Ophthalmology	1549-4713	METHODS	4	4	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	67#70	18067970-1-82-101	Age-related macular degeneration phenotypes of 796 carriers of the CFH Y402H variant were compared with the AMD phenotypes of 160 noncarriers.
18067970	2008	Ophthalmology	1549-4713	RESULTS	6	6	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	105#108	18067970-1-82-101	Of the 34 features analyzed, only peripheral reticular pigmentary change (PRPC) was associated with this CFH variant (P = 0.0006).
18067970	2008	Ophthalmology	1549-4713	RESULTS	6	7	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	68#71	18067970-1-82-101	The proportion of AMD cases with PRPC correlated with the number of CFH risk C alleles in a dose-response fashion.
18067970	2008	Ophthalmology	1549-4713	CONCLUSIONS	7	8	3075	SYMBOL|DICTIONARY|EXTRACTED	cfh	CFH	4#7	18067970-1-82-101	The CFH Y402H polymorphism is associated with PRPC, suggesting that AMD changes are not limited to the macula.
18194365	2008	Tissue Antigens	0001-2815	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	36#42		The functional R620W variant of the PTPN22 gene is associated with celiac disease.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	40#46		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	3	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	34#40		These results support the role of PTPN22 as a general autoimmunity locus involved in tolerance induction in the thymus.
18281670	2008	J. Clin. Oncol.	1527-7755	TITLE	0	0	7184	SYMBOL|DICTIONARY	gp96	gp96	81#85		Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
18281670	2008	J. Clin. Oncol.	1527-7755	PURPOSE	1	1	7184	SYMBOL|DICTIONARY	gp96	gp96	92#96		To assess the antitumor activity of vitespen (autologous, tumor- derived heat shock protein gp96 peptide complexes) by determining whether patients with stage IV melanoma treated with vitespen experienced longer overall survival than patients treated with physician's choice.
18281670	2008	J. Clin. Oncol.	1527-7755	PATIENTS AND METHODS	2	2	3558	LONGTERM|DICTIONARY	interleukin 2	interleukin-2	176#189		Patients (N = 322) were randomly assigned 2:1 to receive vitespen or physician's choice (PC) of a treatment containing one or more of the following: dacarbazine, temozolomide, interleukin-2, or complete tumor resection.
18163425	2008	Prostate	0270-4137	TITLE	0	0	8797	LONGTERM|DICTIONARY	death receptor 4	death receptor 4	59#75		The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	LONGTERM|DICTIONARY	death receptor 4	Death receptor 4	0#16		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	1	8797	SYMBOL|GENE|GN|DICTIONARY	tnfrsf10a	TNFRSF10A	33#42		Death receptor 4, encoded by the TNFRSF10A gene, is an important mediator of apoptosis and its dysfunction may be related to cancer development and distant tumor spread.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	2	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	36#45		A single nucleotide polymorphism in TNFRSF10A (Glu228Ala, rs20576) within a conserved region of the extracellular cysteine-rich domain of death receptor 4 has been associated with an increased risk for a variety of tumor entities.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	2	8797	LONGTERM|DICTIONARY	death receptor 4	death receptor 4	138#154		A single nucleotide polymorphism in TNFRSF10A (Glu228Ala, rs20576) within a conserved region of the extracellular cysteine-rich domain of death receptor 4 has been associated with an increased risk for a variety of tumor entities.
18163425	2008	Prostate	0270-4137	BACKGROUND	1	3	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	57#66		Aim of the present study was to evaluate the role of the TNFRSF10A polymorphism in metastatic progression of prostate cancer after radiation therapy.
18163425	2008	Prostate	0270-4137	METHODS	2	6	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	0#9		TNFRSF10A genotypes were determined by a 5'-nuclease assay (TaqMan).
18163425	2008	Prostate	0270-4137	RESULTS	3	9	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	0#9		TNFRSF10A genotypes were not associated with tumor stage, grade, risk group or age at diagnosis.
18163425	2008	Prostate	0270-4137	CONCLUSION	4	10	8797	SYMBOL|DICTIONARY	tnfrsf10a	TNFRSF10A	21#30		We conclude that the TNFRSF10A Glu228Ala polymorphism may be a novel independent risk factor for prostate cancer metastases after radiation therapy.
18268124	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4582	SYMBOL|DICTIONARY	muc1	MUC1	67#71		Studies suggest that underglycosylation of the cell membrane mucin MUC1 may be associated with epithelial ovarian cancer.
18268124	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	2589	SYMBOL|DICTIONARY	galnt1	GALNT1	9#15		A SNP in GALNT1 (rs17647532) was the only one that remained statistically significant after Bonferroni adjustment for multiple testing but was not statistically significant in Hardy-Weinberg equilibrium among controls.
18268124	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	11	2589	SYMBOL|DICTIONARY	galnt1	GALNT1	52#58		Haplotype analyses revealed a global association of GALNT1 with risk (P = 0.038, under a recessive genetic model), which largely reflected a decreased risk of one haplotype (0.10 frequency; odds ratio, 0.07; P = 0.01) compared with the most common haplotype (0.39 frequency).
18186798	2008	Int. J. Immunogenet.	1744-313X	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	12#46		Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		Vascular endothelial growth factor (VEGF) is a cytokine that promotes endothelial cell proliferation, leucocyte chemotaxis and expression of adhesion molecules and is a major mediator of vascular permeability.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	18186798-1-0-34	Vascular endothelial growth factor (VEGF) is a cytokine that promotes endothelial cell proliferation, leucocyte chemotaxis and expression of adhesion molecules and is a major mediator of vascular permeability.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	2	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	30#34	18186798-1-0-34	It has been demonstrated that VEGF directly activates neutrophils and it could promote acute recruitment of leucocytes.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_1/3	1	3	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	144#148	18186798-1-0-34	It is known that neutrophils are the major cell population involved in acute inflammation in familial Mediterranean fever (FMF) and the role of VEGF in these cells may be crucial.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	4	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	92#96	18186798-1-0-34	The aim of this study was to investigate whether the 936 C/T functional polymorphism of the VEGF gene is associated with susceptibility to FMF and its relationship with the main clinical features of the disease.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	131#135	18186798-1-0-34	Polymerase chain reaction-restriction fragment length polymorphism technique was used to determine 936 C/T polymorphism within the VEGF gene in 75 patients with FMF and 122 non-related healthy controls.
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	6	7422	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	vegf	VEGF	39#43	18186798-1-0-34	Genotype and allele frequencies of the VEGF 936 C/T polymorphism between patients with FMF and healthy control groups were not significantly different (OR = 0.74, 95% CI = 0.40-1.37, P = 0.335 for CT genotype; OR = 1.11, 95% CI = 0.67-1.83, P = 0.700, for T allele).
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	7	7422	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	vegf	VEGF	9#13	18186798-1-0-34	Although VEGF 936 TT genotype was found to be more frequent in patients with FMF than in healthy controls (6.7% vs. 1.6%, respectively), the difference was not significant (OR = 4.28, 95% CI = 0.81-22.67, P = 0.108).
18186798	2008	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	9	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	29#33	18186798-1-0-34	Present results suggest that VEGF gene 936 C/T polymorphism does not seem to be associated with susceptibility to FMF and its clinical manifestations.
18083240	2008	J. Neuroimmunol.	0165-5728	TITLE	0	0	7124	SYMBOL|DICTIONARY	tnf	TNF	0#3		TNF and sTNFR1/2 plasma levels in ALS patients.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7132	SYMBOL|DICTIONARY	tnf r1	TNF-R1	83#89		In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7133	SYMBOL|DICTIONARY	tnf r2	TNF-R2	94#100		In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	3	7132	SYMBOL|DICTIONARY	tnf r1	TNF-R1	56#62		The genetic analysis of the polymorphisms of TNF-alpha, TNF-R1 and TNF-R2 showed no statistically significant differences in alleles and genotype frequencies between patients and controls.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	3	7133	SYMBOL|DICTIONARY	tnf r2	TNF-R2	67#73		The genetic analysis of the polymorphisms of TNF-alpha, TNF-R1 and TNF-R2 showed no statistically significant differences in alleles and genotype frequencies between patients and controls.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	TITLE	0	0	1577	SYMBOL|GENE|GN|DICTIONARY	cyp3a5	CYP3A5	50#56		[Relationship between the genetic polymorphism of CYP3A5 gene and the clinical response to bicyclol in chronic hepatitis B].
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	OBJECTIVE	1	1	1577	SYMBOL|DICTIONARY	cyp3a5	CYP3A5	69#75		To investigate the relationship between the genetic polymorphisms of CYP3A5 and the clinical effectiveness of Bicyclol on patients with chronic hepatitis B to make individual medication possible.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	METHODS	2	4	1577	SYMBOL|DICTIONARY	cyp3a5	CYP3A5	6#12		Blood CYP3A5 genotyping of each patient was determined by the PCR-RFLP analysis.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	5	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	36#42		All subjects were genotyped for the CYP3A5*3 gene and divided into different group.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	6	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	35#41		The groups comprised subjects with CYP3A5*3 carriers (n=18) and CYP3A5*1 carriers (n=16) which include CYP3A5*1/*1 (n=2) and CYP3A5*1/*3 (n=14).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	6	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	64#70		The groups comprised subjects with CYP3A5*3 carriers (n=18) and CYP3A5*1 carriers (n=16) which include CYP3A5*1/*1 (n=2) and CYP3A5*1/*3 (n=14).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	6	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	103#109		The groups comprised subjects with CYP3A5*3 carriers (n=18) and CYP3A5*1 carriers (n=16) which include CYP3A5*1/*1 (n=2) and CYP3A5*1/*3 (n=14).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	6	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	125#131		The groups comprised subjects with CYP3A5*3 carriers (n=18) and CYP3A5*1 carriers (n=16) which include CYP3A5*1/*1 (n=2) and CYP3A5*1/*3 (n=14).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	8	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	102#108		The mean percentage reduction of serum ALT and AST levels were significantly greater in subjects with CYP3A5*3 carriers (79.73% and 74.76%) than in those with CYP3A5*1 carriers (65.90% and 49.63%; P < 0.05) The recovery rates of ALT and AST were significantly highter in CYP3A5*3 carriers than those in CYP3A5*1 carriers (P < 0.05).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	8	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	159#165		The mean percentage reduction of serum ALT and AST levels were significantly greater in subjects with CYP3A5*3 carriers (79.73% and 74.76%) than in those with CYP3A5*1 carriers (65.90% and 49.63%; P < 0.05) The recovery rates of ALT and AST were significantly highter in CYP3A5*3 carriers than those in CYP3A5*1 carriers (P < 0.05).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	8	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	271#277		The mean percentage reduction of serum ALT and AST levels were significantly greater in subjects with CYP3A5*3 carriers (79.73% and 74.76%) than in those with CYP3A5*1 carriers (65.90% and 49.63%; P < 0.05) The recovery rates of ALT and AST were significantly highter in CYP3A5*3 carriers than those in CYP3A5*1 carriers (P < 0.05).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	RESULTS	3	8	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	303#309		The mean percentage reduction of serum ALT and AST levels were significantly greater in subjects with CYP3A5*3 carriers (79.73% and 74.76%) than in those with CYP3A5*1 carriers (65.90% and 49.63%; P < 0.05) The recovery rates of ALT and AST were significantly highter in CYP3A5*3 carriers than those in CYP3A5*1 carriers (P < 0.05).
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	CONCLUSION	4	9	1577	SYMBOL|DICTIONARY	cyp3a5	CYP3A5	0#6		CYP3A5 genotype has an impact on the therapeutic effects of Bicyclol.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	CONCLUSION	4	10	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	18#24		The subjects with CYP3A5*3 carriers is more effective than the subjects with CYP3A5*1 carriers.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	CONCLUSION	4	10	1577	SYMBOL|NUMBER|DICTIONARY	cyp3a5	CYP3A5	77#83		The subjects with CYP3A5*3 carriers is more effective than the subjects with CYP3A5*1 carriers.
18414696	2009	Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi	1003-9279	CONCLUSION	4	11	1577	SYMBOL|DICTIONARY	cyp3a5	CYP3A5	0#6		CYP3A5 genotyping may be helpful in predicting therapeutic effects of Bicyclol especially in the terms of decreasing ALT and AST.
17956895	2008	Hum. Mol. Genet.	1460-2083	TITLE	0	0	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	0#6		CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	LONGTERM|GENE|GN|DICTIONARY	charged multivesicular body protein 2b	charged multivesicular body protein 2B	4#42		The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	1	25978	SYMBOL|()|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	49#55	17956895-1-4-42	The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_1/3	1	2	25978	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	126#132	17956895-1-4-42	In this family, a mutation in the acceptor splice site of exon 6 produced two aberrant transcripts predicting two C-truncated CHMP2B proteins due to a read through of intron 5 (p.Met178ValfsX2) and a cryptic splicing event within exon 6 (p.Met178LeufsX30).
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_2/3	2	3	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	31#37	17956895-1-4-42	Extensive mutation analysis of CHMP2B in Belgian patients (N = 146) identified one nonsense mutation in exon 5 (c.493C>T) in a familial FTLD patient, predicting a C-truncated protein p.Gln165X analogous to the Danish mutant proteins.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	5	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	60#66	17956895-1-4-42	Together, these data suggest that C-truncating mutations in CHMP2B might underlie the pathogenic mechanism in FTLD by disturbing endosome function.
17956895	2008	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	6	25978	SYMBOL|DICTIONARY|EXTRACTED	chmp2b	CHMP2B	50#56	17956895-1-4-42	We also describe a missense mutation in exon 5 of CHMP2B (p.Asn143Ser) in a familial patient with cortical basal degeneration.
18179891	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	13#18		Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.
18179891	2008	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	2103	LONGTERM|DICTIONARY	estrogen related receptor beta	estrogen-related receptor beta	28#58		Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	4	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	21#26		Mutation analysis of ESRRB, a candidate gene in the overlapping region, revealed a homozygous 7 bp duplication in exon 8 in all affected individuals.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	6	2103	SYMBOL|GENE|GN|DICTIONARY	esrrb	ESRRB	25#30		Sequence analysis of the ESRRB gene in the affected individuals of the original DFNB35 family and in three other DFNB35-linked consanguineous families from Pakistan revealed four missense mutations.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	0#5		ESRRB encodes the estrogen-related receptor beta protein, and one of the substitutions (p.A110V) is located in the DNA-binding domain of ESRRB, whereas the other three are substitutions (p.L320P, p.V342L, and p.L347P) located within the ligand-binding domain.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	2103	LONGTERM|GENE|GN|DICTIONARY	estrogen related receptor beta	estrogen-related receptor beta	18#48		ESRRB encodes the estrogen-related receptor beta protein, and one of the substitutions (p.A110V) is located in the DNA-binding domain of ESRRB, whereas the other three are substitutions (p.L320P, p.V342L, and p.L347P) located within the ligand-binding domain.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	137#142		ESRRB encodes the estrogen-related receptor beta protein, and one of the substitutions (p.A110V) is located in the DNA-binding domain of ESRRB, whereas the other three are substitutions (p.L320P, p.V342L, and p.L347P) located within the ligand-binding domain.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	9	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	146#151		RNA in situ hybridization in mice revealed that Esrrb is expressed during inner-ear development, whereas immunohistochemical analysis showed that ESRRB is present postnatally in the cochlea.
18179891	2008	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	10	2103	SYMBOL|DICTIONARY	esrrb	ESRRB	23#28		Our data indicate that ESRRB is essential for inner-ear development and function.
18074359	2008	Am. J. Med. Genet. A	1552-4833	TITLE	0	0	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	33#37		Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	1	55636	SYMBOL|GENE|GN|DICTIONARY	chd7	CHD7	86#90		CHARGE syndrome is an autosomal dominant condition that is caused by mutations in the CHD7 gene.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	3	55636	SYMBOL|DICTIONARY	chd7	CHD7	23#27		We here report on five CHD7 mutation positive families and comment on their clinical features.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_1/3	1	4	55636	SYMBOL|DICTIONARY	chd7	CHD7	97#101		We observed somatic and germline mosaicism as well as parent-to-child transmission of non-mosaic CHD7 mutations as causes of familial CHARGE syndrome.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_2/3	2	6	55636	SYMBOL|DICTIONARY	chd7	CHD7	37#41		This is the second report of somatic CHD7 mosaicism in an unaffected parent.
18074359	2008	Am. J. Med. Genet. A	1552-4833	ALL_TEXT_3/3	3	9	55636	SYMBOL|DICTIONARY	chd7	CHD7	28#32		We find that alterations in CHD7 can result in a very mild phenotype, characterized by only a few minor symptoms of the CHARGE syndrome clinical spectrum.
18997459	2009	Ann. Nutr. Metab.	1421-9697	AIMS	1	1	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	141#168		To evaluate the effect of atorvastatin on bone mass and markers of bone remodeling in patients with acute coronary syndrome depending on the tumor necrosis factor-alpha (TNFalpha)-308 G/A polymorphism.
18997459	2009	Ann. Nutr. Metab.	1421-9697	AIMS	1	1	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	170#178	18997459-1-141-168	To evaluate the effect of atorvastatin on bone mass and markers of bone remodeling in patients with acute coronary syndrome depending on the tumor necrosis factor-alpha (TNFalpha)-308 G/A polymorphism.
18997459	2009	Ann. Nutr. Metab.	1421-9697	METHODS	2	7	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	4#12	18997459-1-141-168	The TNFalpha-308 G/A polymorphism was determined by the polymerase chain reaction.
18997459	2009	Ann. Nutr. Metab.	1421-9697	CONCLUSION	4	12	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	130#138	18997459-1-141-168	In patients with acute coronary syndrome, atorvastatin increases lumbar spine BMD solely in patients with the G/G genotype of the TNFalpha-308 G/A polymorphism.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5644	SYMBOL|DICTIONARY	prss1	PRSS1	103#108		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5644	LONGTERM|DICTIONARY	cationic trypsinogen	cationic trypsinogen	119#139		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5645	SYMBOL|DICTIONARY	prss2	PRSS2	145#150		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	BACKGROUND &amp; AIMS	1	1	5645	LONGTERM|GENE|GN|DICTIONARY	anionic trypsinogen	anionic trypsinogen	161#180		We have recently reported that the triplication of a approximately 605 kilobase segment containing the PRSS1 (encoding cationic trypsinogen) and PRSS2 (encoding anionic trypsinogen) genes causes hereditary pancreatitis.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	CONCLUSIONS	4	9	5644	SYMBOL|DICTIONARY	prss1	PRSS1	152#157		Finally, a dividend of this study is that we have provided convincing evidence to show that all 5 previously described copy number variations involving PRSS1 or/and PRSS2 are artifacts.
18063422	2008	Clin. Gastroenterol. Hepatol.	1542-7714	CONCLUSIONS	4	9	5645	SYMBOL|DICTIONARY	prss2	PRSS2	165#170		Finally, a dividend of this study is that we have provided convincing evidence to show that all 5 previously described copy number variations involving PRSS1 or/and PRSS2 are artifacts.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	TITLE	0	0	29979	SYMBOL|DICTIONARY|EXTRACTED	ubqln1	UBQLN1	12#18		Analysis of UBQLN1 variants in a Polish Alzheimer's disease patient: control series.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_1/3	1	2	29979	LONGTERM|GENE|GN|DICTIONARY	ubiquilin 1	ubiquilin 1	41#52		Recently an intronic polymorphism in the ubiquilin 1 gene (UBQLN1) and a particular haplotype was reported to be associated with LOAD.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_1/3	1	2	29979	SYMBOL|()|DICTIONARY|EXTRACTED	ubqln1	UBQLN1	59#65	18340109-2-41-52	Recently an intronic polymorphism in the ubiquilin 1 gene (UBQLN1) and a particular haplotype was reported to be associated with LOAD.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_1/3	1	3	29979	SYMBOL|DICTIONARY|EXTRACTED	ubqln1	UBQLN1	36#42	18340109-2-41-52	We investigated whether variants in UBQLN1 confer a risk for the disease in 407 Polish LOAD patients and 407 controls.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_2/3	2	6	348	SYMBOL|DICTIONARY	apoe4	APOE4	61#66		This effect was stronger in a group of LOAD patients without APOE4 allele.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	89#94		Also, the specific haplotypes with the A allele that increase AD risk differ between the APOE4-positive and APOE4-negative pools.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	108#113		Also, the specific haplotypes with the A allele that increase AD risk differ between the APOE4-positive and APOE4-negative pools.
18340109	2008	Dement Geriatr Cogn Disord	1421-9824	ALL_TEXT_3/3	3	10	29979	SYMBOL|DICTIONARY|EXTRACTED	ubqln1	UBQLN1	88#94	18340109-2-41-52	Results suggest a need for additional association studies and in silico analysis of the UBQLN1 locus.
17955208	2008	Diabetologia	0012-186X	TITLE	0	0	7275	SYMBOL|DICTIONARY	tub	TUB	0#3		TUB is a candidate gene for late-onset obesity in women.
17955208	2008	Diabetologia	0012-186X	AIMS/HYPOTHESES	1	1	7275	SYMBOL|DICTIONARY	tub	TUB	68#71		We recently reported significant associations between BMI and three TUB single nucleotide polymorphisms (SNPs) in two Dutch cohorts enriched for type 2 diabetes.
17955208	2008	Diabetologia	0012-186X	METHODS	2	3	7275	SYMBOL|DICTIONARY	tub	TUB	4#7		Two TUB SNPs (rs2272382, rs2272383) and a third (rs1528133), 22 kb distal to RIC3, were genotyped in 2694 Europid women from the St Thomas' UK Adult Twin Registry (Twins UK) (mean age +/- SD: 47.6 +/- 12.7 years; 42.8% postmenopausal).
17955208	2008	Diabetologia	0012-186X	METHODS	2	3	79608	SYMBOL|DICTIONARY	ric3	RIC3	77#81		Two TUB SNPs (rs2272382, rs2272383) and a third (rs1528133), 22 kb distal to RIC3, were genotyped in 2694 Europid women from the St Thomas' UK Adult Twin Registry (Twins UK) (mean age +/- SD: 47.6 +/- 12.7 years; 42.8% postmenopausal).
17955208	2008	Diabetologia	0012-186X	METHODS	2	4	7275	SYMBOL|DICTIONARY	tub	TUB	32#35		We explored the hypothesis that TUB is a candidate gene for late-onset obesity in humans through testing the interaction of the SNPs by menopausal status.
17955208	2008	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	10	7275	SYMBOL|DICTIONARY	tub	TUB	35#38		We have replicated associations of TUB SNP rs2272382 with measures of general and central obesity in normal postmenopausal women.
17955208	2008	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	11	7275	SYMBOL|DICTIONARY	tub	TUB	23#26		These findings confirm TUB as a candidate gene for late-onset obesity in humans.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	TITLE	0	0	4318	SYMBOL|DICTIONARY|EXTRACTED	mmp 9	MMP-9	0#5		MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	BACKGROUND	1	1	4318	SYMBOL|()|DICTIONARY|EXTRACTED	mmp 9	MMP-9	60#65	18173548-1-46-58	Among other matrix metalloproteinases (MMPs), gelatinase B (MMP-9) is discussed to be associated with the pathogenesis of vascular diseases.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	BACKGROUND	1	2	4318	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 9	MMP-9	50#55	18173548-1-46-58	Two single nucleotide polymorphisms (SNPs) of the MMP-9 gene, C-1562T in the promoter region and a G/A transition in exon 6 (R + 279Q), have been addressed in previous association studies which, however, produced conflicting results.
18173548	2008	Eur. J. Clin. Invest.	1365-2362	CONCLUSIONS	4	7	4318	SYMBOL|DICTIONARY|EXTRACTED	mmp 9	MMP-9	52#57	18173548-1-46-58	In summary, our results demonstrate associations of MMP-9 genotypes with different stages of carotid atherosclerosis.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	0#6		CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	1	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	46#52		To evaluate the impact of the two most common CYP2C9 variant alleles (*2 and *3) on the maintenance dose of warfarin and on the quality of anticoagulation control in Brazilians.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	METHODS	2	5	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	0#6		CYP2C9 genotyping was obtained by PCR-RFLP.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	6	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	19#25		The frequencies of CYP2C9*2 and CYP2C9*3 were 0.097 and 0.073, respectively, with genotypic distribution fitting Hardy-Weinberg equilibrium.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	6	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	32#38		The frequencies of CYP2C9*2 and CYP2C9*3 were 0.097 and 0.073, respectively, with genotypic distribution fitting Hardy-Weinberg equilibrium.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	7	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	0#6		CYP2C9 genotype was the only clinical feature associated with the risk of severe bleeding (one-sided P = 0.019, Fisher exact method), with an odds ratio of 4.8 (95% confidence interval of 1.4-16.6) for any variant genotype as compared to CYP2C9*1*1.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	7	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	238#244		CYP2C9 genotype was the only clinical feature associated with the risk of severe bleeding (one-sided P = 0.019, Fisher exact method), with an odds ratio of 4.8 (95% confidence interval of 1.4-16.6) for any variant genotype as compared to CYP2C9*1*1.
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	8	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	21#27		Patients with either CYP2C9*2 or CYP2C9*3 were equally difficult to maintain in the INR target range, showing significantly (one-sided P = 0.038, Mann-Whitney U-test) reduced ratio of adequate INR measures (0.54 +/- 0.2), when compared to CYP2C9*1*1 patients (0.63 +/- 0.2).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	8	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	33#39		Patients with either CYP2C9*2 or CYP2C9*3 were equally difficult to maintain in the INR target range, showing significantly (one-sided P = 0.038, Mann-Whitney U-test) reduced ratio of adequate INR measures (0.54 +/- 0.2), when compared to CYP2C9*1*1 patients (0.63 +/- 0.2).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	8	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	239#245		Patients with either CYP2C9*2 or CYP2C9*3 were equally difficult to maintain in the INR target range, showing significantly (one-sided P = 0.038, Mann-Whitney U-test) reduced ratio of adequate INR measures (0.54 +/- 0.2), when compared to CYP2C9*1*1 patients (0.63 +/- 0.2).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	9	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	14#20		Patients with CYP2C9*3, but not CYP2C9*2, required significantly (one-sided P = 0.001, Mann-Whitney U-test) lower warfarin maintenance doses (3.1 +/- 1.8 mg) than CYP2C9*1*1 patients (5.3 +/- 2.1 mg).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	9	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	32#38		Patients with CYP2C9*3, but not CYP2C9*2, required significantly (one-sided P = 0.001, Mann-Whitney U-test) lower warfarin maintenance doses (3.1 +/- 1.8 mg) than CYP2C9*1*1 patients (5.3 +/- 2.1 mg).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	9	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	163#169		Patients with CYP2C9*3, but not CYP2C9*2, required significantly (one-sided P = 0.001, Mann-Whitney U-test) lower warfarin maintenance doses (3.1 +/- 1.8 mg) than CYP2C9*1*1 patients (5.3 +/- 2.1 mg).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSION	4	10	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	21#27		Patients with either CYP2C9*2 or CYP2C9*3 show higher risk of over-anticoagulation compared to CYP2C9*1*1 subjects and could benefit from a reduction in the initial warfarin standard dose (e.g., to 2.5 mg/day).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSION	4	10	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	33#39		Patients with either CYP2C9*2 or CYP2C9*3 show higher risk of over-anticoagulation compared to CYP2C9*1*1 subjects and could benefit from a reduction in the initial warfarin standard dose (e.g., to 2.5 mg/day).
17955230	2008	Eur. J. Clin. Pharmacol.	1432-1041	CONCLUSION	4	10	1559	SYMBOL|NUMBER|DICTIONARY	cyp2c9	CYP2C9	95#101		Patients with either CYP2C9*2 or CYP2C9*3 show higher risk of over-anticoagulation compared to CYP2C9*1*1 subjects and could benefit from a reduction in the initial warfarin standard dose (e.g., to 2.5 mg/day).
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	21#55		Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis of endometrial carcinomas.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	18714564-1-0-34	Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis of endometrial carcinomas.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	2	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	64#68	18714564-1-0-34	Several studies have demonstrated positive associations between VEGF gene polymorphisms and several carcinomas.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	OBJECTIVE	1	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	38#42	18714564-1-0-34	In this study we investigated whether VEGF gene polymorphisms are associated with endometrial carcinomas in a Japanese population.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	METHODS	2	4	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	53#57	18714564-1-0-34	The allele frequencies and genotype distributions of VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms were examined in 105 endometrial carcinomas and 179 controls using PCR-RFLP analysis.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	RESULTS	3	6	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	83#87	18714564-1-0-34	No significant differences in the allele frequencies and genotype distributions of VEGF -460 C/T (p = 0.54, 0.90), +405 G/C (p = 0.31, 0.17), and +936 C/T polymorphisms (p = 0.46, 0.24) were observed between endometrial carcinoma patients and controls.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	RESULTS	3	8	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	12#16	18714564-1-0-34	Futhermore, VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms were not associated with three-year disease-free survival of endometrial carcinoma patients.
18714564	2008	Eur. J. Gynaecol. Oncol.	0392-2936	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	82#86	18714564-1-0-34	Although limited by sample size, our study did not demonstrated any evidence that VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms are associated with an increased risk of endometrial carcinomas in Japanese women.
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	39#44		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
18080216	2009	Fam. Cancer	1389-9600	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	57#62		Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	15#20		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	142#147		Interestingly, GSTM1 deletion was found to be significantly associated only with familial breast cancer (OR = 2.0; 95%CI = 1.252-3.128) while GSTT1 was associated only with sporadic breast cancer (OR = 2.3; 95%CI = 1.336-3.970).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_2/3	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	0#5		GSTP1 Ile105Val polymorphism was associated neither with sporadic nor familial breast cancer susceptibility (P value > 0.05).
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		However, familial breast cancer patients with GSTM1 null genotype had a relative risk of 0.42 (95%CI = 0.18-0.97) for an advanced disease stage.
18064451	2008	Immunogenetics	0093-7711	TITLE	0	0	3565	SYMBOL|DICTIONARY	il4	IL4	0#3		IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	1	3565	SYMBOL|DICTIONARY	il4	IL4	0#3		IL4, the gene coding the prototypic Th2 cytokine, has been frequently studied in the context of several inflammatory conditions, but conclusive results have not been obtained.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3565	SYMBOL|DICTIONARY	il4	IL4	55#58		Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	3565	SYMBOL|DICTIONARY	il4	IL4	4#7		The IL4 single-nucleotide polymorphisms (SNPs) -590C/T (rs2243250) and the OCTN1 exonic SNP L503F (rs1050152) were analysed in all samples.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	6583	SYMBOL|DICTIONARY	octn1	OCTN1	75#80		The IL4 single-nucleotide polymorphisms (SNPs) -590C/T (rs2243250) and the OCTN1 exonic SNP L503F (rs1050152) were analysed in all samples.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	7	3565	SYMBOL|DICTIONARY	il4	IL4	12#15		The -590C/T IL4 SNP was not found associated with T1D or RA when individual analyses were performed.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3565	SYMBOL|GENE|GN|DICTIONARY	il4	IL4	20#23		The location of the IL4 gene in the complex 5q31-33 genetic region, which contains many genes involved in immunological responses and presents linkage disequilibrium extended along many kilobases, makes necessary to interpret cautiously the previous IL4-association studies.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3565	SYMBOL|DICTIONARY	il4	IL4	250#253		The location of the IL4 gene in the complex 5q31-33 genetic region, which contains many genes involved in immunological responses and presents linkage disequilibrium extended along many kilobases, makes necessary to interpret cautiously the previous IL4-association studies.
18368507	2009	Int Urol Nephrol	0301-1623	TITLE	0	0	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	65#72		Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	1	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	102#109		Sulfation is a key pathway in xenobiotic metabolism and chemical defense, and phenol sulfotransferase SULT1A1 plays a central role in this reaction.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|GENE|GN|DICTIONARY	sult1a1	SULT1A1	28#35		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	42#49		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_1/3	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	170#177		Genetic polymorphism of the SULT1A1 gene, SULT1A1, was reported to be associated with risks of several cancers; however, one study showed no significant relation between SULT1A1 genotype with prostate cancer risk.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_2/3	2	3	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	98#105		The present study was conducted to confirm the association of a G638A polymorphism, Arg213His, in SULT1A1 with familial prostate cancer risk in a Japanese population.
18368507	2009	Int Urol Nephrol	0301-1623	ALL_TEXT_3/3	3	8	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	54#61		These findings suggested that genetic polymorphism of SULT1A1 might not be involved in genetic susceptibility to prostate cancer.
18259684	2008	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	3	23101	SYMBOL|GENE|GN|DICTIONARY	mcf2l2	MCF2L2	20#26		For example, in the MCF2L2 gene on 3q, a significant association (a nominal P value of 0.00009) was observed when logistic regression analysis was performed for three associated SNPs (rs684846, rs35069869 and rs35368790) that belonged to different LD groups.
18259684	2008	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	121260	SYMBOL|GENE|GN|DICTIONARY	slc15a4	SLC15A4	13#20		Also, in the SLC15A4 gene on 12q, rs3765108 showed a marginally significant association with an overall estimated odds ratio of 0.79 (P=0.001).
18259684	2008	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	9370	SYMBOL|DICTIONARY	adipoq	ADIPOQ	82#88		No significant association was found for known candidate gene loci on 3q, such as ADIPOQ and IGF2BP2.
18259684	2008	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	10644	SYMBOL|DICTIONARY	igf2bp2	IGF2BP2	93#100		No significant association was found for known candidate gene loci on 3q, such as ADIPOQ and IGF2BP2.
18088253	2008	J. Intern. Med.	1365-2796	TITLE	0	0	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	39#45		Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis.
18088253	2008	J. Intern. Med.	1365-2796	OBJECTIVES	1	1	1493	SYMBOL|DICTIONARY|GENE|GA	cd152	CD152	58#63		The molecular mechanisms underlying the regulation of the CD152 (CTLA-4) gene are largely unknown.
18088253	2008	J. Intern. Med.	1365-2796	OBJECTIVES	1	1	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	65#71	18088253-1-58-63	The molecular mechanisms underlying the regulation of the CD152 (CTLA-4) gene are largely unknown.
18088253	2008	J. Intern. Med.	1365-2796	OBJECTIVES	1	4	1493	SYMBOL|DICTIONARY	cd152	CD152	82#87		Gene typing of two SNPs (T/C(-1772) and A/G(-1661)) and quantification of soluble CD152 were performed in the patients.
18088253	2008	J. Intern. Med.	1365-2796	RESULTS	2	6	1493	SYMBOL|GENE|GN|DICTIONARY	cd152	CD152	55#60		We present new genetic associations of two SNPs in the CD152 gene with human MG.
18088253	2008	J. Intern. Med.	1365-2796	CONCLUSIONS	3	9	1493	SYMBOL|DICTIONARY	cd152	CD152	134#139		The two SNPs in the promoter region are associated with MG and might cause abnormal alternative splicing and affect the expression of CD152, thereby contributing to the pathogenesis of MG.
18061279	2008	J. Neuroimmunol.	0165-5728	TITLE	0	0	627	SYMBOL|DICTIONARY	bdnf	BDNF	0#4		BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences.
18061279	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	1	627	SYMBOL|GENE|GN|DICTIONARY	bdnf	BDNF	49#53		Two single nucleotide polymorphisms of the human BDNF gene, G196A and C270T, and their impact on the susceptibility to MS and disease progression in the Polish population were investigated.
18061279	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	4	627	SYMBOL|DICTIONARY	bdnf	BDNF	38#42		Our results show that C270T and G196A BDNF polymorphisms may affect susceptibility to and onset of MS, but further verification is needed, with special attention to gender differences.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	TITLE	0	0	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	74#78		Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	TITLE	0	0	2064	SYMBOL|GENE|GN|DICTIONARY	her2	HER2	107#111		Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	33#37		Overexpression or dysfunction of EGFR and other ErbBs is known to be involved in many human cancers.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_1/3	1	3	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	19#23		In intron 1 of the EGFR gene, simple CA repeats (CA-SSR) have been found to be associated with the level of transcriptional modulation of the EGFR both in vitro and in vivo.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_1/3	1	3	1956	SYMBOL|DICTIONARY	egfr	EGFR	142#146		In intron 1 of the EGFR gene, simple CA repeats (CA-SSR) have been found to be associated with the level of transcriptional modulation of the EGFR both in vitro and in vivo.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_2/3	2	5	1956	SYMBOL|DICTIONARY	egfr	EGFR	60#64		Pairwise BLAST was used to identify paralogs to intron 1 of EGFR in the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_2/3	2	5	2064	SYMBOL|GENE|GN|DICTIONARY	her2	HER2	72#76		Pairwise BLAST was used to identify paralogs to intron 1 of EGFR in the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_3/3	3	8	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	53#57		We found that the nearest homolog to intron 1 in the EGFR gene is intron 4 of the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_3/3	3	8	2064	SYMBOL|GENE|GN|DICTIONARY	her2	HER2	82#86		We found that the nearest homolog to intron 1 in the EGFR gene is intron 4 of the HER2 gene.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_3/3	3	9	1956	SYMBOL|DICTIONARY	egfr	EGFR	121#125		The experimental validation of four predicted short tandem repeats (STRs) (three dinucleotide repeats in intron 1 of the EGFR and one in intron 4 of the HER2 gene) by genotyping of about 100 controls showed that these STRs are polymorphic.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_3/3	3	9	2064	SYMBOL|GENE|GN|DICTIONARY	her2	HER2	153#157		The experimental validation of four predicted short tandem repeats (STRs) (three dinucleotide repeats in intron 1 of the EGFR and one in intron 4 of the HER2 gene) by genotyping of about 100 controls showed that these STRs are polymorphic.
18946768	2009	J. Recept. Signal Transduct. Res.	1532-4281	ALL_TEXT_3/3	3	11	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	99#103		These results suggest that the role of transcriptional regulation of CA repeats in intron 1 of the EGFR gene might be conserved in other ErbB genes.
17907287	2007	World J. Gastroenterol.	1007-9327	TITLE	0	0	10392	SYMBOL|()|DICTIONARY	nod1	NOD1	52#56		Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
17907287	2007	World J. Gastroenterol.	1007-9327	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	75#79		Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
17907287	2007	World J. Gastroenterol.	1007-9327	AIM	1	1	10392	SYMBOL|()|DICTIONARY	nod1	NOD1	69#73		To examine genetic variation of nucleotide oligomerization domain 1 (NOD1) and NOD2, their respective influences on Crohn's disease phenotype and gene-gene interactions.
17907287	2007	World J. Gastroenterol.	1007-9327	AIM	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	79#83		To examine genetic variation of nucleotide oligomerization domain 1 (NOD1) and NOD2, their respective influences on Crohn's disease phenotype and gene-gene interactions.
17907287	2007	World J. Gastroenterol.	1007-9327	METHODS	2	2	10392	SYMBOL|DICTIONARY	nod1	NOD1	15#19		(ND(1)+32656*) NOD1 polymorphism and SNP8, SNP12 and SNP13 of NOD2 were analyzed in 97 patients and 50 controls.
17907287	2007	World J. Gastroenterol.	1007-9327	METHODS	2	2	64127	SYMBOL|DICTIONARY	nod2	NOD2	62#66		(ND(1)+32656*) NOD1 polymorphism and SNP8, SNP12 and SNP13 of NOD2 were analyzed in 97 patients and 50 controls.
17907287	2007	World J. Gastroenterol.	1007-9327	METHODS	2	3	64127	SYMBOL|DICTIONARY	nod2	NOD2	0#4		NOD2 variants were determined by reaction restriction fragment length polymorphism analysis.
17907287	2007	World J. Gastroenterol.	1007-9327	METHODS	2	4	10392	SYMBOL|DICTIONARY	nod1	NOD1	0#4		NOD1 genotyping and NOD2 variant confirmation were performed by specific amplification and sequencing.
17907287	2007	World J. Gastroenterol.	1007-9327	METHODS	2	4	64127	SYMBOL|DICTIONARY	nod2	NOD2	20#24		NOD1 genotyping and NOD2 variant confirmation were performed by specific amplification and sequencing.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	5	10392	SYMBOL|DICTIONARY	nod1	NOD1	20#24		The distribution of NOD1 polymorphism in patients was different from controls (P = 0.045) and not altered by existence of NOD2 mutations.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	5	64127	SYMBOL|DICTIONARY	nod2	NOD2	122#126		The distribution of NOD1 polymorphism in patients was different from controls (P = 0.045) and not altered by existence of NOD2 mutations.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	6	64127	SYMBOL|DICTIONARY	nod2	NOD2	69#73		In this cohort, 30.92% patients and 6% controls carried at least one NOD2 variant (P < 0.001) with R702W being the most frequent variant.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	25#29		Presence of at least one NOD2 mutation was inversely associated with colon involvement (9.09% with colon vs 36.4% with ileal or ileocolonic involvement, P = 0.04) and indicative of risk of penetrating disease (52.63% with penetrating vs 25.64% with non-penetrating or stricturing behavior, P = 0.02).
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	22#26		L1007finsC and double NOD2 mutation conferred the highest risk for severity of disease (26.3% with penetrating disease vs 3.8% with non-penetrating or stricturing behavior presented L1007finsC, P = 0.01 and 21.0% with penetrating disease vs 2.5% with non-penentrating or stricturing behavior carried double NOD2 mutation, P = 0.007).
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	307#311		L1007finsC and double NOD2 mutation conferred the highest risk for severity of disease (26.3% with penetrating disease vs 3.8% with non-penetrating or stricturing behavior presented L1007finsC, P = 0.01 and 21.0% with penetrating disease vs 2.5% with non-penentrating or stricturing behavior carried double NOD2 mutation, P = 0.007).
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	9	64127	SYMBOL|DICTIONARY	nod2	NOD2	27#31		Exclusion of patients with NOD2 mutations from phenotype/NOD1-genotype analysis revealed higher prevalence of *1*1 genotype in groups of younger age at onset and colonic location.
17907287	2007	World J. Gastroenterol.	1007-9327	RESULTS	3	9	10392	SYMBOL|DICTIONARY	nod1	NOD1	57#61		Exclusion of patients with NOD2 mutations from phenotype/NOD1-genotype analysis revealed higher prevalence of *1*1 genotype in groups of younger age at onset and colonic location.
17907287	2007	World J. Gastroenterol.	1007-9327	CONCLUSION	4	10	10392	SYMBOL|DICTIONARY	nod1	NOD1	70#74		This study suggests population differences in the inheritance of risk NOD1 polymorphism and NOD2 mutations.
17907287	2007	World J. Gastroenterol.	1007-9327	CONCLUSION	4	10	64127	SYMBOL|DICTIONARY	nod2	NOD2	92#96		This study suggests population differences in the inheritance of risk NOD1 polymorphism and NOD2 mutations.
17907287	2007	World J. Gastroenterol.	1007-9327	CONCLUSION	4	11	10392	SYMBOL|DICTIONARY	nod1	NOD1	32#36		Although no interaction between NOD1-NOD2 was noticed, a relationship between disease location and Nod-like receptor molecules was established.
17907287	2007	World J. Gastroenterol.	1007-9327	CONCLUSION	4	11	64127	SYMBOL|DICTIONARY	nod2	NOD2	37#41		Although no interaction between NOD1-NOD2 was noticed, a relationship between disease location and Nod-like receptor molecules was established.
18082567	2008	Hum. Immunol.	0198-8859	TITLE	0	0	4153	LONGTERM|DICTIONARY	mannose binding lectin	Mannose-binding lectin	0#22		Mannose-binding lectin genotypes and pre-eclampsia: a case-control study.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	4153	LONGTERM|DICTIONARY	mannose binding lectin	mannose-binding lectin	22#44		The complement factor mannose-binding lectin (MBL) is associated with adverse pregnancy outcomes and has been suggested to play a role in abnormal placentation.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	4153	SYMBOL|()|DICTIONARY|EXTRACTED	mbl	MBL	46#49	18082567-2-22-44	The complement factor mannose-binding lectin (MBL) is associated with adverse pregnancy outcomes and has been suggested to play a role in abnormal placentation.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	3	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	24#27	18082567-2-22-44	We investigated whether MBL genotypes are associated with the systemic maternal syndrome pre-eclampsia.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	4	4153	SYMBOL|GENE|GN|DICTIONARY	mbl2	MBL2	0#4		MBL2 gene polymorphisms were determined in a case-control study including 157 women with pre-eclampsia (case subjects) and 157 women with uncomplicated pregnancies (control subjects).
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	5	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	12#15	18082567-2-22-44	Considering MBL polymorphisms, case and control subjects were categorized in groups of high (A), intermediate (B), and low (C) MBL production.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	5	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	127#130	18082567-2-22-44	Considering MBL polymorphisms, case and control subjects were categorized in groups of high (A), intermediate (B), and low (C) MBL production.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	6	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	33#36	18082567-2-22-44	No association was found between MBL genotypes and pre-eclampsia; adjusted odds ratios and 95% confidence intervals (95% CI) for group B were 0.97 (95% CI = 0.46-2.07) and for group C were 1.44 (95% CI = 0.52-3.94).
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	7	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	26#29	18082567-2-22-44	A trend was found between MBL genotype groups B and C and severe pre-eclampsia or eclampsia.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	0#3		MBL genotypes were not found to be associated with pre-eclampsia; however low-MBL production genotypes might be considered as disease modifier.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	78#81	18082567-2-22-44	MBL genotypes were not found to be associated with pre-eclampsia; however low-MBL production genotypes might be considered as disease modifier.
18082567	2008	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	9	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	19#22	18082567-2-22-44	This suggests that MBL may play a role in modulating placental inflammation by facilitating clearance of apoptotic cells and cell debris.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	7097	SYMBOL|DICTIONARY	tlr2	TLR2	0#4		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	7099	SYMBOL|DICTIONARY	tlr4	TLR4	6#10		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	54106	SYMBOL|DICTIONARY	tlr9	TLR9	15#19		TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	7097	SYMBOL|DICTIONARY	tlr2	TLR2	95#99		Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	7099	SYMBOL|DICTIONARY	tlr4	TLR4	101#105		Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	2	54106	SYMBOL|GENE|GN|DICTIONARY	tlr9	TLR9	110#114		Here we examined the association between candidate disease-susceptibility polymorphisms in the TLR2, TLR4 and TLR9 genes and CD in a New Zealand Caucasian population.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	4	7097	SYMBOL|DICTIONARY	tlr2	TLR2	97#101		We could not detect any significant difference in the allele frequencies of polymorphisms in the TLR2 (R753Q, 0.029 vs 0.016, P = 0.25), TLR4 (D299G and T399I, 0.085 vs 0.071, P = 0.49; and 0.085 vs 0.082, P = 0.90), and TLR9 (-1237T/C, 0.154 vs 0.148, P = 0.82) genes between controls and patients, respectively.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	4	7099	SYMBOL|DICTIONARY	tlr4	TLR4	137#141		We could not detect any significant difference in the allele frequencies of polymorphisms in the TLR2 (R753Q, 0.029 vs 0.016, P = 0.25), TLR4 (D299G and T399I, 0.085 vs 0.071, P = 0.49; and 0.085 vs 0.082, P = 0.90), and TLR9 (-1237T/C, 0.154 vs 0.148, P = 0.82) genes between controls and patients, respectively.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	4	54106	SYMBOL|DICTIONARY	tlr9	TLR9	221#225		We could not detect any significant difference in the allele frequencies of polymorphisms in the TLR2 (R753Q, 0.029 vs 0.016, P = 0.25), TLR4 (D299G and T399I, 0.085 vs 0.071, P = 0.49; and 0.085 vs 0.082, P = 0.90), and TLR9 (-1237T/C, 0.154 vs 0.148, P = 0.82) genes between controls and patients, respectively.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	7099	SYMBOL|DICTIONARY	tlr4	TLR4	94#98		However, combination of the datasets of published studies with our dataset confirmed that the TLR4 polymorphism 299G (P = 0.0005; OR of 1.42 [95% CI 1.17-1.74]) and the TLR9 polymorphism -1237C (P = 0.0416; OR of 1.33 [95% CI 1.01-1.75]) are associated with CD.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	54106	SYMBOL|DICTIONARY	tlr9	TLR9	169#173		However, combination of the datasets of published studies with our dataset confirmed that the TLR4 polymorphism 299G (P = 0.0005; OR of 1.42 [95% CI 1.17-1.74]) and the TLR9 polymorphism -1237C (P = 0.0416; OR of 1.33 [95% CI 1.01-1.75]) are associated with CD.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	7097	SYMBOL|DICTIONARY	tlr2	TLR2	53#57		There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	7099	SYMBOL|DICTIONARY	tlr4	TLR4	59#63		There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	7	54106	SYMBOL|GENE|GN|DICTIONARY	tlr9	TLR9	68#72		There was no evidence that the above variants of the TLR2, TLR4 and TLR9 genes are major risk factors for CD or influence disease phenotype in our New Zealand case-control study.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	8	7099	SYMBOL|NUMBER|DICTIONARY	tlr4	TLR4	38#42		Nevertheless, the significance of the TLR4 299G and TLR9-1237C associations with CD worldwide was confirmed by a meta-analysis test using our datasets and datasets from previously published studies.
17914947	2008	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	8	54106	SYMBOL|NUMBER|DICTIONARY	tlr9	TLR9	52#56		Nevertheless, the significance of the TLR4 299G and TLR9-1237C associations with CD worldwide was confirmed by a meta-analysis test using our datasets and datasets from previously published studies.
18075470	2008	Pharmacogenet. Genomics	1744-6872	INTRODUCTION	1	1	1544	LONGTERM|DICTIONARY	cytochrome p450 1a2	Cytochrome P450 1A2	0#19		Cytochrome P450 1A2 (CYP 1A2) is responsible for more than 90% of caffeine clearance.
18075470	2008	Pharmacogenet. Genomics	1744-6872	INTRODUCTION	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	25#31		A polymorphic variant of CYP1A2 (-163C>A) (rs762551) is associated with high CYP1A2 inducibility.
18075470	2008	Pharmacogenet. Genomics	1744-6872	INTRODUCTION	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	77#83		A polymorphic variant of CYP1A2 (-163C>A) (rs762551) is associated with high CYP1A2 inducibility.
18075470	2008	Pharmacogenet. Genomics	1744-6872	METHODS	3	7	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	18#24		Genotyping of the CYP1A2 variant was carried out using the allelic discrimination method.
18075470	2008	Pharmacogenet. Genomics	1744-6872	RESULTS	4	9	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	55#61		No evidence existed to suggest any association between CYP1A2 and the onset of PD (P=0.08).
18075470	2008	Pharmacogenet. Genomics	1744-6872	RESULTS	4	11	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	87#93		Multivariate analysis revealed no evidence of any interaction effects of caffeine with CYP1A2 (P=0.956).
18034620	2008	Pharmacogenomics	1744-8042	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	19#24		677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
18034620	2008	Pharmacogenomics	1744-8042	INTRODUCTION	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	Methylenetetrahydrofolate reductase	0#35		Methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism and has been shown to be polymorphic, affecting the enzyme activity.
18034620	2008	Pharmacogenomics	1744-8042	INTRODUCTION	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	37#42	18034620-2-0-35	Methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism and has been shown to be polymorphic, affecting the enzyme activity.
18034620	2008	Pharmacogenomics	1744-8042	METHODS	2	3	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	54#59	18034620-2-0-35	To examine the association between 677C>T and 1298A>C MTHFR polymorphisms and MTX efficacy in the treatment of RA, a total of 174 RA patients, treated with MTX plus methylprednisone 4 mg and folic acid 5 mg were analyzed.
18034620	2008	Pharmacogenomics	1744-8042	RESULTS	3	4	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	45#50	18034620-2-0-35	In univariate regression analysis model, the MTHFR 677T allele was associated with significantly higher frequency of remission, whereas in the case of the 1298C allele, a tendency for higher remission rate was observed.
18034620	2008	Pharmacogenomics	1744-8042	CONCLUSION	4	6	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	42#47	18034620-2-0-35	The results of our study suggest that the MTHFR 677T and 1298C alleles may be associated with an increased rate of RA remission in patients treated with MTX receiving high doses of folic acid supplementation.
17986123	2008	Respirology	1323-7799	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	17#33		Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and pulmonary tuberculosis in Koreans.
17986123	2008	Respirology	1323-7799	TITLE	0	0	3459	LONGTERM|GENE|GN|DICTIONARY	interferon gamma receptor 1	interferon-gamma receptor 1	38#65		Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and pulmonary tuberculosis in Koreans.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	19#35		The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3458	SYMBOL|EXTRACTED|()	ifn gamma	IFN-gamma	37#46	17986123-2-19-35	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3459	SYMBOL|DICTIONARY|GENE|GA	ifn gamma receptor 1	IFN-gamma receptor 1	52#72		The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	2	3459	SYMBOL|EXTRACTED|()|GENE|GN	ifn gammar1	IFN-gammaR1	74#85	17986123-2-52-72	The association of interferon-gamma (IFN-gamma) and IFN-gamma receptor 1 (IFN-gammaR1) gene polymorphisms with pulmonary TB is controversial.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	3	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	44#53	17986123-2-19-35	This study examined the association between IFN-gamma and IFN-gammaR1 gene polymorphisms and pulmonary TB among Koreans.
17986123	2008	Respirology	1323-7799	BACKGROUND AND OBJECTIVE	1	3	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	58#69	17986123-2-52-72	This study examined the association between IFN-gamma and IFN-gammaR1 gene polymorphisms and pulmonary TB among Koreans.
17986123	2008	Respirology	1323-7799	METHODS	2	5	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	21#30	17986123-2-19-35	Polymorphisms of the IFN-gamma gene at position +874 were determined using the amplification refractory mutation system PCR assay, and the IFN-gammaR1 gene was genotyped at positions -611, -270, -56 and +95 employing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using genomic DNA.
17986123	2008	Respirology	1323-7799	METHODS	2	5	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	139#150	17986123-2-52-72	Polymorphisms of the IFN-gamma gene at position +874 were determined using the amplification refractory mutation system PCR assay, and the IFN-gammaR1 gene was genotyped at positions -611, -270, -56 and +95 employing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using genomic DNA.
17986123	2008	Respirology	1323-7799	RESULTS	3	6	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	43#52	17986123-2-19-35	The genotype and allele frequencies of the IFN-gamma and IFN-gammaR1 gene polymorphisms did not differ significantly between the patients with pulmonary TB and controls.
17986123	2008	Respirology	1323-7799	RESULTS	3	6	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	57#68	17986123-2-52-72	The genotype and allele frequencies of the IFN-gamma and IFN-gammaR1 gene polymorphisms did not differ significantly between the patients with pulmonary TB and controls.
17986123	2008	Respirology	1323-7799	CONCLUSIONS	4	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	4#13	17986123-2-19-35	The IFN-gamma and IFN-gammaR1 gene polymorphisms do not appear to be responsible for host susceptibility to pulmonary TB in the Korean population.
17986123	2008	Respirology	1323-7799	CONCLUSIONS	4	7	3459	SYMBOL|EXTRACTED|GENE|GN	ifn gammar1	IFN-gammaR1	18#29	17986123-2-52-72	The IFN-gamma and IFN-gammaR1 gene polymorphisms do not appear to be responsible for host susceptibility to pulmonary TB in the Korean population.
18273796	2008	Genet. Mol. Res.	1676-5680	TITLE	0	0	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	0#4		LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	TITLE	0	0	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	34#37		LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3952	LONGTERM|DICTIONARY	leptin	leptin	42#48		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3952	SYMBOL|()|DICTIONARY|EXTRACTED	lep	LEP	50#53	18273796-2-42-48	The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3953	LONGTERM|GENE|GT|DICTIONARY|GA	leptin receptor	leptin receptor	59#74		The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	3953	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lepr	LEPR	76#80	18273796-2-59-74	The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	4	155	SYMBOL|EXTRACTED	beta3 ar	beta3-AR	62#70	18273796-2-24-29	In the present study, we investigated the relationship of the beta3-AR p.W64R, LEP c.-2548G>A and LEPR p.Q223R gene variants with body mass index (BMI), in Brazilian subjects of different genetic backgrounds and ethnic origins.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	4	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	79#82	18273796-2-42-48	In the present study, we investigated the relationship of the beta3-AR p.W64R, LEP c.-2548G>A and LEPR p.Q223R gene variants with body mass index (BMI), in Brazilian subjects of different genetic backgrounds and ethnic origins.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	4	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	98#102	18273796-2-59-74	In the present study, we investigated the relationship of the beta3-AR p.W64R, LEP c.-2548G>A and LEPR p.Q223R gene variants with body mass index (BMI), in Brazilian subjects of different genetic backgrounds and ethnic origins.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	8	155	SYMBOL|EXTRACTED	beta3 ar	beta3-AR	69#77	18273796-2-24-29	There was no significant difference in the genotype frequency of the beta3-AR p.W64R and the LEP c.-2548G>A polymorphisms, between lean and obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	8	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	93#96	18273796-2-42-48	There was no significant difference in the genotype frequency of the beta3-AR p.W64R and the LEP c.-2548G>A polymorphisms, between lean and obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	9	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	52#56	18273796-2-59-74	However, the genotype and allele frequencies of the LEPR p.Q223R variant were significantly different between the normal weight and obese groups.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	10	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	94#97	18273796-2-42-48	Haplotype analysis has shown an association between the G/G allelic combination of c.-2548G>A LEP and c.668A>G LEPR, in obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	10	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	111#115	18273796-2-59-74	Haplotype analysis has shown an association between the G/G allelic combination of c.-2548G>A LEP and c.668A>G LEPR, in obese subjects.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	11	3953	LONGTERM|GENE|GT|DICTIONARY	leptin receptor	leptin receptor	52#67		Our results suggest that genetic variability in the leptin receptor is associated with body weight regulation, the LEPR p.Q223R variant being related to BMI increase.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	11	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	115#119	18273796-2-59-74	Our results suggest that genetic variability in the leptin receptor is associated with body weight regulation, the LEPR p.Q223R variant being related to BMI increase.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	12	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	29#32	18273796-2-42-48	The haplotype combination of LEP c.-2548G>A and LEPR p.Q223R variants was related to a 58% increase in obesity risk.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	12	3953	SYMBOL|DICTIONARY|EXTRACTED	lepr	LEPR	48#52	18273796-2-59-74	The haplotype combination of LEP c.-2548G>A and LEPR p.Q223R variants was related to a 58% increase in obesity risk.
17905396	2008	C. R. Biol.	1631-0691	TITLE	0	0	1806	LONGTERM|GENE|GN|DICTIONARY	dihydropyrimidine dehydrogenase	dihydropyrimidine dehydrogenase	23#54		Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10333	SYMBOL|DICTIONARY	tlr6	TLR6	53#57		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7096	SYMBOL|DICTIONARY	tlr1	TLR1	59#63		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	81793	SYMBOL|DICTIONARY	tlr10	TLR10	69#74		Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	3	10333	SYMBOL|DICTIONARY	tlr6	TLR6	0#4		TLR6, TLR1, and TLR10 are also involved in the pathogen-mediated inflammation pathway.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	3	7096	SYMBOL|DICTIONARY	tlr1	TLR1	6#10		TLR6, TLR1, and TLR10 are also involved in the pathogen-mediated inflammation pathway.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	3	81793	SYMBOL|DICTIONARY	tlr10	TLR10	16#21		TLR6, TLR1, and TLR10 are also involved in the pathogen-mediated inflammation pathway.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	10333	SYMBOL|DICTIONARY	tlr6	TLR6	71#75		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	7096	SYMBOL|DICTIONARY	tlr1	TLR1	76#80		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	BACKGROUND	1	4	81793	SYMBOL|GENE|GN|DICTIONARY	tlr10	TLR10	81#86		A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	10333	SYMBOL|DICTIONARY	tlr6	TLR6	117#121		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	7096	SYMBOL|DICTIONARY	tlr1	TLR1	123#127		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	METHODS	2	8	81793	SYMBOL|DICTIONARY	tlr10	TLR10	133#138		We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	RESULTS	3	10	10333	SYMBOL|NUMBER|DICTIONARY	tlr6	TLR6	112#116		No effect modification was observed for age, body mass index, or family history of prostate cancer, except that TLR6_3649 showed nominally significant interaction with family history at the P < 0.05 level.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	10333	SYMBOL|DICTIONARY	tlr6	TLR6	62#66		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	7096	SYMBOL|DICTIONARY	tlr1	TLR1	67#71		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
17932345	2008	Cancer Epidemiol. Biomarkers Prev.	1055-9965	CONCLUSION	4	11	81793	SYMBOL|DICTIONARY	tlr10	TLR10	72#77		Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_1/3	1	2	64135	SYMBOL|()|GENE|GN|DICTIONARY	ifih1	IFIH1	96#101		A recent study revealed that the A946T polymorphism (rs1990760) in interferon induced helicase (IFIH1) gene was a susceptible locus for GD.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	3	64135	SYMBOL|GENE|GN|DICTIONARY	ifih1	IFIH1	160#165		A case-control study in a Chinese population was undertaken, with 261 GD patients and 206 healthy subjects, to analyze the association of A946T polymorphism in IFIH1 gene with GD.
18026693	2008	Endocrine	1355-008X	ALL_TEXT_2/3	2	4	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	33#38		In addition, the distribution of IFIH1 genotypes was investigated in subgroups according to the onset age and the Graves' ophthalmopathy (GO).
18026693	2008	Endocrine	1355-008X	ALL_TEXT_3/3	3	7	64135	SYMBOL|GENE|GN|DICTIONARY	ifih1	IFIH1	78#83		Therefore we were unable to find the association of A946T polymorphism of the IFIH1 gene with the development of GD in a Chinese population.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	48#52		Generic typing showed a significant increase of DRB1*04 (p=0.002), DRB1*14 (p=0.003) and DQB1*03 (p=0.02) allele frequencies and significant decrease of DRB1*15 (p<0.0001) and DQB1*06 (p=0.01) allele frequencies.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	7	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	67#71		Generic typing showed a significant increase of DRB1*04 (p=0.002), DRB1*14 (p=0.003) and DQB1*03 (p=0.02) allele frequencies and significant decrease of DRB1*15 (p<0.0001) and DQB1*06 (p=0.01) allele frequencies.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	7	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	153#157		Generic typing showed a significant increase of DRB1*04 (p=0.002), DRB1*14 (p=0.003) and DQB1*03 (p=0.02) allele frequencies and significant decrease of DRB1*15 (p<0.0001) and DQB1*06 (p=0.01) allele frequencies.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	8	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1*15-DQB1*06 haplotype seems to confer a protective effect in our population while DRB1*04-DQB1*03 and DRB1*14-DQB1*05 haplotypes induced susceptibility to the disease.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	90#94		HLA-DRB1*15-DQB1*06 haplotype seems to confer a protective effect in our population while DRB1*04-DQB1*03 and DRB1*14-DQB1*05 haplotypes induced susceptibility to the disease.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	110#114		HLA-DRB1*15-DQB1*06 haplotype seems to confer a protective effect in our population while DRB1*04-DQB1*03 and DRB1*14-DQB1*05 haplotypes induced susceptibility to the disease.
17898867	2007	Neoplasia	1476-5586	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	29#60		The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	40#71		We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	73#76	17898867-1-40-71	We studied the putative significance of angiotensin I-converting enzyme (ACE) in colorectal cancer (CRC) biology.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	20#23	17898867-1-40-71	Local expression of ACE was investigated by quantitative reverse transcription-polymerase chain reaction and by immunohistochemistry in CRCs and adenomas.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_1/3	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		ACE insertion (I)/deletion (D) polymorphism was studied in 141 CRC patients and 189 controls.
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_2/3	2	4	1636	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	ace	ACE	0#3		ACE mRNA was upregulated in CRCs compared to corresponding nonlesional tissues (2.5-fold; P = .009).
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_2/3	2	5	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	0#3		ACE protein was more commonly expressed in adenomas [17 (81%)] and cancer epithelial cells [22 (100%)] than in corresponding non-neoplastic crypt and surface epithelium [2 (10%) and 2 (9%), respectively].
17898867	2007	Neoplasia	1476-5586	ALL_TEXT_3/3	3	11	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	21#24	17898867-1-40-71	Our study shows that ACE is differentially expressed in CRCs and that gene polymorphism is associated with gender-specific differences in primary tumor size and patient survival.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3990	SYMBOL|GENE|GN|DICTIONARY	hepatic lipase	hepatic lipase	44#58		[The linkage disequilibrium of four loci in hepatic lipase promoter gene of cerebral infarction patients in Shanghai].
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	7172	LONGTERM|DICTIONARY	thiopurine methyltransferase	thiopurine methyltransferase	52#80		To discuss the relationship between the genotype of thiopurine methyltransferase (TPMT) and azathioprine tolerance in the patients with rheumatic diseases.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	7172	SYMBOL|()|DICTIONARY|EXTRACTED	tpmt	TPMT	82#86	17919375-1-52-80	To discuss the relationship between the genotype of thiopurine methyltransferase (TPMT) and azathioprine tolerance in the patients with rheumatic diseases.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|DICTIONARY|EXTRACTED	tpmt	TPMT	32#36	17919375-1-52-80	Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	78#82	17919375-1-52-80	Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	94#98	17919375-1-52-80	Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	117#121	17919375-1-52-80	Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	134#138	17919375-1-52-80	Four common mutation alleles of TPMT in 200 patients with rheumatic diseases [TPMT*2 (G238C), TPMT*3A (A719G/G460A), TPMT*3B (G460A), TPMT*3C (A719G)] were detected by allele specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-PFLP).
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	72#76	17919375-1-52-80	In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	114#118	17919375-1-52-80	In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	122#126	17919375-1-52-80	In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	4	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	133#137	17919375-1-52-80	In the 200 patients with rheumatic diseases, 4 cases of heterozygote of TPMT*3C were detected, but no mutation of TPMT*2, TPMT*3B or TPMT*3A was found.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	83#87	17919375-1-52-80	The genotypic frequency of wild-type homozygote was 98%, and that of heterozygote (TPMT*1/TPMT*3C) was 2%.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	7172	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	tpmt	TPMT	90#94	17919375-1-52-80	The genotypic frequency of wild-type homozygote was 98%, and that of heterozygote (TPMT*1/TPMT*3C) was 2%.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	7	7172	SYMBOL|DICTIONARY|EXTRACTED	tpmt	TPMT	11#15	17919375-1-52-80	Average of TPMT activity of the 4 cases of heterozygote was (2.4 +/- 1.2) U/ml red blood cells, significantly lower than that of the 196 cases of homozygote which was (12.2 +/- 6.8) U/ml RBC.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	7172	SYMBOL|DICTIONARY|EXTRACTED	tpmt	TPMT	34#38	17919375-1-52-80	Patients with mutation alleles of TPMT are intolerant to azathioprine, and likely to have severe crisis of hematopoietic system.
17919375	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	11	7172	SYMBOL|DICTIONARY|EXTRACTED	tpmt	TPMT	14#18	17919375-1-52-80	To detect the TPMT genotype before using azathioprine is significant to improve the therapeutic safety.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	1815	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d4 receptor	dopamine D4 receptor	17#37		[Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	dopamine D4 receptor	10#30		The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	32#36	17879560-1-10-30	The human dopamine D4 receptor (DRD4) gene has been extensively studied as a candidate gene for attention deficit hyperactivity disorder (ADHD).
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	3	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	49#53	17879560-1-10-30	The most widely investigated polymorphism of the DRD4 gene is the 48 bp VNTR (Variable Number of Tandem Repeats) in the third exon.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	5	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	199#203	17879560-1-10-30	In this study we describe an association analysis of the 120 bp duplication and three sequence variations (SNPs, Single Nucleotide Polymorphism; -616 C/G, -615 A/G, -521 C/T) in the 5' region of the DRD4 gene is presented among children with ADHD.
17879560	2007	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_3/3	3	9	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	166#170	17879560-1-10-30	The different 120 bp duplication alleles (1-repeat, 2-repeat and the newly identified 4-repeat allele) was found to have an effect on transcriptional activity of the DRD4 gene in both neuroblastoma and retinoblastoma cell lines in a dose-dependent manner.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	LONGTERM|DICTIONARY	interleukin 8	interleukin-8	15#28		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	SYMBOL|DICTIONARY	il 8	IL-8	30#34		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3576	SYMBOL|DICTIONARY	cxcl8	CXCL8	38#43		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	TITLE	0	0	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	57#62		Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	il 8	IL-8	145#149		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	179#184		A case-control study involving 257 breast cancer patients with invasive ductal carcinoma and 233 healthy women was carried out to explore if the IL-8 -251T/A polymorphism and the CXCR2 +1208 C/T polymorphism have a role in breast cancer susceptibility.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_2/3	2	2	3576	SYMBOL|DICTIONARY	il 8	IL-8	66#70		Genotypic analysis showed an increased frequency of high producer IL-8 -251AA genotype (p=0.016) in the patient group as compared to controls while CXCR2 +1208 C/T polymorphism did not show any differences between studied groups.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_2/3	2	2	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	148#153		Genotypic analysis showed an increased frequency of high producer IL-8 -251AA genotype (p=0.016) in the patient group as compared to controls while CXCR2 +1208 C/T polymorphism did not show any differences between studied groups.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	3	3576	SYMBOL|DICTIONARY	il 8	IL-8	24#28		However, in contrast to IL-8 -251 polymorphism, the percentage of CXCR2 +1208 TT genotype was significantly lower in patients with NPI<or=3.4 compared to NPI>3.4 (2% and 12%, respectively; p=0.03).
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	3	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	66#71		However, in contrast to IL-8 -251 polymorphism, the percentage of CXCR2 +1208 TT genotype was significantly lower in patients with NPI<or=3.4 compared to NPI>3.4 (2% and 12%, respectively; p=0.03).
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	4	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	60#65		Also, ER- tumors showed an approximately significant higher CXCR2 +1208 TT genotype compared to ER+ tumors (18.6% and 7.1%, respectively; p=0.07).
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	15#19		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
17949231	2008	Neoplasma	0028-2685	ALL_TEXT_3/3	3	5	3579	SYMBOL|DICTIONARY	cxcr2	CXCR2	129#134		In conclusion, IL-8 -251T/A polymorphism is associated with development of invasive ductal carcinoma type of breast cancer while CXCR2 +1208C/T polymorphism may affect the disease progression.
18671953	2008	Brain Res.	0006-8993	TITLE	0	0	347	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein d	apolipoprotein D	41#57		Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease.
18671953	2008	Brain Res.	0006-8993	ALL_TEXT_1/3	1	1	347	LONGTERM|DICTIONARY	apolipoprotein d	Apolipoprotein D	0#16		Apolipoprotein D (apoD) is a lipoprotein-associated glycoprotein that is increased in the hippocampus and cerebrospinal fluid of patients with Alzheimer's disease (AD), which implies that apoD might be involved in the pathogenesis of AD.
18671953	2008	Brain Res.	0006-8993	ALL_TEXT_1/3	1	2	347	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apod	apoD	189#193	18671953-1-0-16	We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing techniques to screen all exons (1-5) and the flanking exon-intron boundaries of the apoD gene (APOD).
17540481	2009	Neurobiol. Aging	1558-1497	TITLE	0	0	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	0#18		C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe4	APOE4	87#92		C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	1	348	SYMBOL|DICTIONARY	apoe4	APOE4	29#34		Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	1	348	SYMBOL|()|DICTIONARY	apoe4	APOE4	43#48		Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	1	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	61#79		Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	1	1401	SYMBOL|()|DICTIONARY|EXTRACTED	crp	CRP	81#84	17540481-1-61-79	Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	1	348	SYMBOL|DICTIONARY	apoe4	APOE4	105#110		Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe4	APOE4	8#13		Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	BACKGROUND	1	2	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	38#41	17540481-1-61-79	Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	41#44	17540481-1-61-79	The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	METHODS	2	4	348	SYMBOL|DICTIONARY	apoe4	APOE4	110#115		The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	5	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	0#3		CRP was significantly lower among those with APOE4 than in those without.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	5	348	SYMBOL|DICTIONARY	apoe4	APOE4	45#50		CRP was significantly lower among those with APOE4 than in those without.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	6	348	SYMBOL|DICTIONARY	apoe4	APOE4	17#22		Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	6	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	24#27	17540481-1-61-79	Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model.
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe4	APOE4	20#25		Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33).
17540481	2009	Neurobiol. Aging	1558-1497	RESULTS	3	7	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	50#53	17540481-1-61-79	Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33).
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	8	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	6#9	17540481-1-61-79	Lower CRP in those with APOE4 may reflect immune effects of the APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	24#29		Lower CRP in those with APOE4 may reflect immune effects of the APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	64#69		Lower CRP in those with APOE4 may reflect immune effects of the APOE4 genotype.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	1401	SYMBOL|DICTIONARY|EXTRACTED	crp	CRP	7#10	17540481-1-61-79	Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
17540481	2009	Neurobiol. Aging	1558-1497	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	25#30		Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
17624340	2008	Fertil. Steril.	1556-5653	TITLE	0	0	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	20#26		Association between PTPN22 and endometriosis.
17624340	2008	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	0#6		PTPN22 is currently one of the few known shared-autoimmunity genes and is therefore a candidate marker for endometriosis.
17624340	2008	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	42#48		Our data show that female carriers of the PTPN22( *)T variant are significantly more susceptible to endometriosis than controls.
17471286	2008	Pharmacogenomics J.	1473-1150	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	15#42		Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		Tumor necrosis factor-alpha (TNF-alpha) is released from mast cells via an immunoglobulin E (IgE)-dependent mechanism.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	29#38	17471286-1-0-27	Tumor necrosis factor-alpha (TNF-alpha) is released from mast cells via an immunoglobulin E (IgE)-dependent mechanism.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_1/3	1	2	7124	SYMBOL|DICTIONARY	tnfa	TNFA	27#31		The variant G>A at -308 of TNFA is part of an extended haplotype HLA-A1-B8-DR3-DQ2 and influences the gene expression.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnfa	TNFA	0#4		TNFA GG genotype was a significant independent predictor of the primary risk of betalactam allergy, concurrently with total IgE level, with an age- and sex-adjusted odds ratio estimated at 2.45 (95% confidence interval: 1.18-5.08, P=0.0163).
17870204	2008	Lung Cancer	0169-5002	TITLE	0	0	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	17#22		Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	93#98		Defects in MMR genes have been involved in several types of sporadic and hereditary cancers. hMLH1 is considered one of central members of the MMR pathway.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	4292	SYMBOL|GENE|GN|DICTIONARY	hmlh1	hMLH1	105#110		We conducted a hospital-based case-control study to investigate associations of common variations in the hMLH1 gene and risk of lung cancer.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	4	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	71#76		A total of 500 cases and 517 controls were genotyped for seven SNPs in hMLH1.
17870204	2008	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	7	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	33#38		These findings indicate that the hMLH1 rs1799977 polymorphism may contribute to the etiology of early-onset lung cancer as well as some specific subtype of lung cancer.
17690944	2008	J Neural Transm (Vienna)	0300-9564	TITLE	0	0	6531	LONGTERM|GENE|GN|DICTIONARY	dopamine transporter	dopamine transporter	74#94		Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura.
17690944	2008	J Neural Transm (Vienna)	0300-9564	ALL_TEXT_1/3	1	2	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	44#64		We examined three VNTR polymorphisms in the dopamine transporter, the 5'UTR VNTR, the intron 8 VNTR and the intron 14 VNTR, in a sample of 205 family trios.
17690944	2008	J Neural Transm (Vienna)	0300-9564	ALL_TEXT_3/3	3	6	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	94#114		Finally we examined migraine with and without aura, and likewise found no association between dopamine transporter VNTRs or their haplotypes and either classification of the disease.
17690944	2008	J Neural Transm (Vienna)	0300-9564	ALL_TEXT_3/3	3	7	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	53#73		We conclude that functional genetic variation in the dopamine transporter does not act as a significant risk factor for migraine.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	Methylenetetrahydrofolate reductase	0#35		Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	37#42	17260091-0-0-35	Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	BACKGROUND	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	22#57		A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	BACKGROUND	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	59#64	17260091-0-0-35	A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	METHODS	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	196#201	17260091-0-0-35	A total of 46 breast cancer cases and 80 unaffected controls matched to treatment allocation, years from randomization (+/-2 years) and age at randomization (+/-5 years), underwent genotyping for MTHFR C677T polymorphism using real time PCR.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	RESULTS	3	5	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	4#9	17260091-0-0-35	The MTHFR 677 genotype frequencies for CC, CT, TT in breast cancer cases were 30%, 44% and 26%, respectively, and 35%, 51%, 14% in controls.
17260091	2008	Breast Cancer Res. Treat.	0167-6806	CONCLUSIONS	4	8	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	62#67	17260091-0-0-35	Our study lends support to a positive association between the MTHFR variant homozygous allele 677TT and breast cancer risk.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	1813	SYMBOL|DICTIONARY	drd2	DRD2	38#42		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	44#49		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	54970	SYMBOL|DICTIONARY	ttc12	TTC12	51#56		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	TITLE	0	0	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	61#66		Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	1813	SYMBOL|DICTIONARY	drd2	DRD2	75#79		There have been many conflicting reports concerning the association of the DRD2 locus with alcohol dependence (AD).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	95#99		To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	364#369		To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	54970	SYMBOL|DICTIONARY	ttc12	TTC12	371#376		To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	378#383		To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	1813	SYMBOL|DICTIONARY	drd2	DRD2	388#392		To investigate whether these findings could be reconciled by considering the genomic region of DRD2 in greater detail, we conducted two separate association studies of AD in 1220 European-American subjects using family-based (488 subjects) and case-control (318 cases and 414 controls) designs, and 43 single nucleotide polymorphisms mapped to the gene cluster of NCAM1, TTC12, ANKK1 and DRD2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	54970	SYMBOL|DICTIONARY	ttc12	TTC12	35#40		Haplotype associations centered on TTC12 exon 3 [rs1893699-rs723077; optimal individual haplotype simulated P-value (P(oihs)) = 0.00021] in both independent samples (family and case-control).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	52#57		Additional AD-associated haplotypes centered around NCAM1 exon 12 in the family sample (P(oihs) = 0.0032), and at exons 2 and 5 of ANKK1 in the case-control sample (P(oihs) = 0.00058).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	131#136		Additional AD-associated haplotypes centered around NCAM1 exon 12 in the family sample (P(oihs) = 0.0032), and at exons 2 and 5 of ANKK1 in the case-control sample (P(oihs) = 0.00058).
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	6	54970	SYMBOL|DICTIONARY	ttc12	TTC12	61#66		LD contrasts between cases and controls support selection at TTC12 exon 3 and ANKK1 exon 2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	6	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	78#83		LD contrasts between cases and controls support selection at TTC12 exon 3 and ANKK1 exon 2.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	7	54970	SYMBOL|DICTIONARY	ttc12	TTC12	40#45		The armadillo repeat domains encoded by TTC12 and dopamine interact in the Wnt pathway and may have effects on dopamine cell development in the ventral midbrain.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	54970	SYMBOL|DICTIONARY	ttc12	TTC12	112#117		We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	4684	SYMBOL|DICTIONARY	ncam1	NCAM1	139#144		We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
17761687	2008	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	255239	SYMBOL|DICTIONARY	ankk1	ANKK1	166#171		We conclude that risk for AD is attributable in part to variants in four regions within this cluster: exon 3 of TTC12, exon 12/intron13 of NCAM1 and exons 2 and 5 of ANKK1.
17186357	2008	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	35#40		The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.
17186357	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	4#9		The GNAS1 locus encodes the G(alpha)s protein which stimulates the formation of cyclic AMP (cAMP).
17186357	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	100#105		We have recently shown that genotypes of the single nucleotide polymorphism (SNP) T393C in the gene GNAS1 are associated with survival of patients suffering from bladder, renal cell and colorectal carcinoma.
17186357	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2778	SYMBOL|DICTIONARY	gnas1	GNAS1	29#34		Our results suggest that the GNAS1 T393C SNP is a novel genetic host factor for disease progression in patients with invasive breast carcinoma.
17714919	2008	J. Dermatol. Sci.	0923-1811	TITLE	0	0	3558	SYMBOL|DICTIONARY	il 2	IL-2	16#20		Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population.
17714919	2008	J. Dermatol. Sci.	0923-1811	TITLE	0	0	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	25#29		Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3558	SYMBOL|DICTIONARY	il 2	IL-2	37#41		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3565	SYMBOL|DICTIONARY	il 4	IL-4	48#52		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	59#63		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	80#85		We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	5	3558	SYMBOL|DICTIONARY	il 2	IL-2	0#4		IL-2 -330*G and IL-4 -590*C alleles significantly increased in psoriasis patients, especially late-onset group, compared to the control.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	5	3565	SYMBOL|DICTIONARY	il 4	IL-4	16#20		IL-2 -330*G and IL-4 -590*C alleles significantly increased in psoriasis patients, especially late-onset group, compared to the control.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3558	SYMBOL|DICTIONARY	il 2	IL-2	23#27		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3565	SYMBOL|DICTIONARY	il 4	IL-4	39#43		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3558	SYMBOL|DICTIONARY	il 2	IL-2	91#95		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	RESULTS	4	6	3565	SYMBOL|DICTIONARY	il 4	IL-4	107#111		The combined effect of IL-2 -330*G and IL-4 -590*C showed that the positive combination of IL-2 -330*G and IL-4 -590*C alleles were more significantly associated with the late-onset group of psoriasis patients than the controls.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3558	SYMBOL|DICTIONARY	il 2	IL-2	56#60		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17714919	2008	J. Dermatol. Sci.	0923-1811	CONCLUSIONS	5	7	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	65#69		These results suggest that the genetic polymorphisms of IL-2 and IL-4 genes can be susceptible to psoriasis in Korean, especially late-onset psoriasis group.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	54715	SYMBOL|DICTIONARY	fox1	FOX1	52#56		Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	54715	LONGTERM|DICTIONARY|GENE|GA	ataxin 2 binding protein 1	ataxin-2 binding protein-1	133#159		FISH analysis identified a cryptic deletion of approximately 160 kb at the boundary of the first exon and first intron of the 1.7 Mb ataxin-2 binding protein-1 (A2BP1) gene, also called FOX1.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	54715	SYMBOL|EXTRACTED|()|GENE|GN	a2bp1	A2BP1	161#166	17503474-3-133-159	FISH analysis identified a cryptic deletion of approximately 160 kb at the boundary of the first exon and first intron of the 1.7 Mb ataxin-2 binding protein-1 (A2BP1) gene, also called FOX1.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	54715	SYMBOL|DICTIONARY	fox1	FOX1	186#190		FISH analysis identified a cryptic deletion of approximately 160 kb at the boundary of the first exon and first intron of the 1.7 Mb ataxin-2 binding protein-1 (A2BP1) gene, also called FOX1.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	54715	SYMBOL|EXTRACTED|GENE|GN	a2bp1	A2BP1	107#112	17503474-3-133-159	Quantitative real time PCR (Q-PCR) analysis verified a deletion of exon 1 in the 5' promoter region of the A2BP1 gene.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	151#156	17503474-3-133-159	Because of emerging evidence in the role of RNA processing and gene regulation in pervasive developmental disorders, we performed further screening of A2BP1 in additional individuals with autism from the Autism Genetics Resource Exchange (AGRE) collection.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	8	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	40#45	17503474-3-133-159	Twenty-seven SNPs were genotyped across A2BP1 in 206 parent-child trios and two regions showed association at P < or = 0.008 level.
17503474	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	10	54715	SYMBOL|EXTRACTED	a2bp1	A2BP1	124#129	17503474-3-133-159	Although only nominal association was observed, and no obvious causal mutations were identified, these results suggest that A2BP1 may affect susceptibility or cause autism in a subset of patients.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1610	LONGTERM|DICTIONARY	d amino acid oxidase	D-amino acid oxidase	59#79		Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	60#63	17492767-1-4-24	This may be mediated through modulation of NMDA function by DAO, which is in turn activated by DAO activator (DAOA, formerly G72).Chumakov et al.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	95#98	17492767-1-4-24	This may be mediated through modulation of NMDA function by DAO, which is in turn activated by DAO activator (DAOA, formerly G72).Chumakov et al.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	1610	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dao	DAO	196#199	17492767-1-4-24	(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	83#86	17492767-1-4-24	In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	6	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	177#180	17492767-1-4-24	Corrected for the number of tests performed, we found evidence for association between markers at both genes and schizophrenia: DAOA/G30 (P = 0.005, OR = 1.34 (1.09, 1.65)) and DAO (P = 0.003, OR = 1.43 (1.12, 1.84).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	1610	SYMBOL|DICTIONARY|EXTRACTED	dao	DAO	50#53	17492767-1-4-24	The data suggest that evidence for association at DAO (marker rs2111902) is more consistent than previously realized, particularly in Caucasian schizophrenia populations.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	8	1610	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dao	DAO	89#92	17492767-1-4-24	We identified evidence for epistatic interaction between the associated SNPs at DAOA and DAO genes in contributing to schizophrenia risk (OR = 9.3 (1.4, 60.5).
17680820	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	2220	LONGTERM|DICTIONARY	l ficolin	L-ficolin	12#21		Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene.
17680820	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	2220	SYMBOL|GENE|GN|DICTIONARY	fcn2	FCN2	133#137		Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	2220	LONGTERM|DICTIONARY	l ficolin	L-ficolin	0#9		L-ficolin (also called ficolin-2, P35 or hucolin) is a soluble pattern recognition molecule of suspected importance in anti-microbial immunity.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	2220	SYMBOL|DICTIONARY	ficolin 2	ficolin-2	23#32		L-ficolin (also called ficolin-2, P35 or hucolin) is a soluble pattern recognition molecule of suspected importance in anti-microbial immunity.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	2220	SYMBOL|DICTIONARY	p35	P35	34#37		L-ficolin (also called ficolin-2, P35 or hucolin) is a soluble pattern recognition molecule of suspected importance in anti-microbial immunity.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	70#79		It activates the lectin pathway of complement and acts as an opsonin. l-ficolin, encoded by the FCN2 gene, recognizes microbial polysaccharides and glycoconjugates rich in GlcNAc or GalNAc.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	2220	SYMBOL|GENE|GN|DICTIONARY	fcn2	FCN2	96#100		It activates the lectin pathway of complement and acts as an opsonin. l-ficolin, encoded by the FCN2 gene, recognizes microbial polysaccharides and glycoconjugates rich in GlcNAc or GalNAc.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	3	2220	SYMBOL|GENE|GN|DICTIONARY	fcn2	FCN2	82#86		We report here data concerning four single nucleotide polymorphisms (SNPs) of the FCN2 gene and their relationship to l-ficolin serum concentrations.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	3	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	118#127		We report here data concerning four single nucleotide polymorphisms (SNPs) of the FCN2 gene and their relationship to l-ficolin serum concentrations.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	5	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	48#57		We selected groups possessing low or high serum l-ficolin concentrations (<or= 2.8 microg/ml or >or= 4.5 microg/ml, respectively) from Polish children suffering from recurrent respiratory infections (n = 146).
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	4#13		Low l-ficolin levels were associated with variant alleles for ss32469536 and rs7851696 and normal alleles for ss32469537 and ss32469544.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	7	2220	LONGTERM|DICTIONARY	l ficolin	l-ficolin	17#26		Conversely, high l-ficolin levels were associated with variant alleles of ss32469537 and ss32469544.
17680820	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	8	2220	SYMBOL|DICTIONARY	fcn2	FCN2	0#4		FCN2 genotyping should be a valuable additional tool for disease association studies.
17438526	2007	Oncogene	0950-9232	TITLE	0	0	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	75#81		Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_1/3	1	3	1381	LONGTERM|DICTIONARY	cellular retinoic acid binding protein 1	cellular retinoic acid binding protein 1	111#151		In the course of this program, we identified frequent CpG methylation-dependent silencing of the gene encoding cellular retinoic acid binding protein 1 (CRABP1) in our panel of ESCC cell lines.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_1/3	1	3	1381	SYMBOL|()|DICTIONARY|EXTRACTED	crabp1	CRABP1	153#159	17438526-3-111-151	In the course of this program, we identified frequent CpG methylation-dependent silencing of the gene encoding cellular retinoic acid binding protein 1 (CRABP1) in our panel of ESCC cell lines.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	1381	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	crabp1	CRABP1	14#20	17438526-3-111-151	Expression of CRABP1 mRNA was restored in gene-silenced ESCC cells after treatment with 5-aza 2'-deoxycytidine.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_2/3	2	5	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	34#40	17438526-3-111-151	The DNA methylation status of the CRABP1 CpG island with clear promoter activity correlated inversely with expression of this gene.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	19#25	17438526-3-111-151	CpG methylation of CRABP1 was frequently observed in primary ESCC tissues as well.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	15#21	17438526-3-111-151	Restoration of CRABP1 expression in ESCC cells lacking the protein reduced cell growth by inducing arrest at G(0)-G(1), whereas knockdown of the gene in cells expressing CRABP1 promoted cell growth.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	170#176	17438526-3-111-151	Restoration of CRABP1 expression in ESCC cells lacking the protein reduced cell growth by inducing arrest at G(0)-G(1), whereas knockdown of the gene in cells expressing CRABP1 promoted cell growth.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	8	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	61#67	17438526-3-111-151	Among 113 primary ESCC tumors, the absence of immunoreactive CRABP1 was significantly associated with de-differentiation of cancer cells and with distant lymph-node metastases in the patients.
17438526	2007	Oncogene	0950-9232	ALL_TEXT_3/3	3	9	1381	SYMBOL|DICTIONARY|EXTRACTED	crabp1	CRABP1	28#34	17438526-3-111-151	These results indicate that CRABP1 appears to have a tumor-suppressor function in esophageal epithelium, and its epigenetic silencing may play a pivotal role during esophageal carcinogenesis.
17846284	2007	Circulation	1524-4539	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	41#56		Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	Angiotensinogen	0#15		Angiotensinogen, a key protein in the renin-angiotensin system, plays an important role in cardiovascular hemostasis.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	1	5972	LONGTERM|DICTIONARY	renin	renin	38#43		Angiotensinogen, a key protein in the renin-angiotensin system, plays an important role in cardiovascular hemostasis.
17846284	2007	Circulation	1524-4539	BACKGROUND	1	2	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	72#87		Many studies have examined the association between polymorphisms in the angiotensinogen gene and risk of coronary heart disease (CHD), but the results have been inconsistent.
17846284	2007	Circulation	1524-4539	METHODS AND RESULTS	2	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	61#76		We performed a meta-analysis of 43 associations studies on 2 angiotensinogen polymorphisms (M235T and T174M) and risk of CHD published before March 2007, including a total of 13,478 CHD cases and 17,024 controls.
17846284	2007	Circulation	1524-4539	CONCLUSIONS	3	11	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	103#118		Additional very large-scale studies are warranted to provide conclusive evidence on the effects of the angiotensinogen gene and other genes within the renin-angiotensin system on risk of CHD.
17846284	2007	Circulation	1524-4539	CONCLUSIONS	3	11	5972	LONGTERM|DICTIONARY	renin	renin	151#156		Additional very large-scale studies are warranted to provide conclusive evidence on the effects of the angiotensinogen gene and other genes within the renin-angiotensin system on risk of CHD.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	OBJECTIVE	1	1	7422	LONGTERM|GENE|GT|DICTIONARY|GA	vascular endothelial growth factor	vascular endothelial growth factor	73#107		The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	OBJECTIVE	1	1	7422	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	109#113	17826416-1-73-107	The purpose of this study was to evaluate potential associations between vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	STUDY DESIGN	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	157#161	17826416-1-73-107	After peripheral blood was obtained from all women and the genomic DNA was isolated, we genotyped +936C/T polymorphisms in the 3'-untranslated region of the VEGF gene, using polymerase chain reaction and restriction fragment length polymorphism techniques.
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	6	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	32#36	17826416-1-73-107	Logistic regression analysis on VEGF genotype and clinical parameters such as age, educational status, body mass index, and neonatal gender showed carriage of the 936T allele to be significantly more frequent in preeclamptic patients than in control subjects (adjusted odds ratio, 2.23; 95% CI, 1.46-3.42).
17826416	2007	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	7	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	17826416-1-73-107	Carriage of the +936T allele of the VEGF gene may be associated with increased susceptibility to the development of preeclampsia and may be an independent risk factor for preeclampsia.
17768272	2007	Arch. Gen. Psychiatry	0003-990X	CONTEXT	1	1	4988	SYMBOL|()|DICTIONARY|EXTRACTED	oprm1	OPRM1	211#216	17768272-1-186-204	Clinical trials have suggested a modest effect of naltrexone as a pharmacotherapy for alcoholism, and a recent study has suggested that the effects may be moderated by variations in the mu-opioid receptor gene (OPRM1).
17768272	2007	Arch. Gen. Psychiatry	0003-990X	CONTEXT	1	2	4988	SYMBOL|DICTIONARY|EXTRACTED	oprm1	OPRM1	96#101	17768272-1-186-204	However, the mechanism by which naltrexone may be differentially effective as a function of the OPRM1 genotype is unclear.
17768272	2007	Arch. Gen. Psychiatry	0003-990X	OBJECTIVES	2	3	4988	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oprm1	OPRM1	108#113	17768272-1-186-204	(1) To replicate and expand on the association between the A118G single nucleotide polymorphism(SNP) of the OPRM1 gene and alcohol sensitivity, (2) to examine the effects of naltrexone on alcohol sensitivity, and (3) to test the A118G SNP of the OPRM1 gene as a moderator of the effects of naltrexone on alcohol sensitivity.
17768272	2007	Arch. Gen. Psychiatry	0003-990X	OBJECTIVES	2	3	4988	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oprm1	OPRM1	246#251	17768272-1-186-204	(1) To replicate and expand on the association between the A118G single nucleotide polymorphism(SNP) of the OPRM1 gene and alcohol sensitivity, (2) to examine the effects of naltrexone on alcohol sensitivity, and (3) to test the A118G SNP of the OPRM1 gene as a moderator of the effects of naltrexone on alcohol sensitivity.
17701750	2007	Biomarkers	1354-750X	TITLE	0	0	7517	SYMBOL|DICTIONARY	xrcc3	XRCC3	4#9		The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population.
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_1/3	1	1	7517	SYMBOL|()|DICTIONARY	xrcc3	XRCC3	51#56		The X-ray repair cross-complementing group 3 gene (XRCC3) belongs to a family of genes responsible for repairing DNA double-strand breaks caused by normal metabolic processes and exposure to ionizing radiation.
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_1/3	1	3	7517	SYMBOL|GENE|GN|DICTIONARY	xrcc3	XRCC3	46#51		We examined the role of a polymorphism in the XRCC3 gene (rs861529; codon 241: threonine to methionine change) in determining breast cancer risk in Thai women.
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_2/3	2	6	7517	SYMBOL|NUMBER|DICTIONARY	xrcc3	XRCC3	4#9		The XRCC3 241Met allele was found to be uncommon in the Thai population (frequency 0.07 among cases and 0.05 among controls).
17701750	2007	Biomarkers	1354-750X	ALL_TEXT_3/3	3	10	7517	SYMBOL|DICTIONARY	xrcc3	XRCC3	30#35		Our findings suggest that the XRCC3 Thr241Met polymorphism is likely to play a modifying role in the individual susceptibility to breast cancer among Thai women as already shown for women of European ancestry.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	13#48		Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	Methylenetetrahydrofolate reductase	0#35		Methylenetetrahydrofolate reductase plays a key role in folate metabolism.
17855693	2007	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	5	4524	LONGTERM|GENE|GN|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	85#120		We investigated the association of C677T and A1298C, two common polymorphisms in the methylenetetrahydrofolate reductase gene, with risk for early onset colorectal cancer in Lynch syndrome.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	202#208		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	210#215		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	220#225		To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens.
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	62#68		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	75#81		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	124#129		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	134#139		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17307802	2008	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	5	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	240#246		The risk of lung cancer was increased with the combination of CYP1A1*2B or CYP1A1*4 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137).
17785557	2007	Clin. Cancer Res.	1078-0432	TITLE	0	0	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	0#6		CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	14#20		The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	38#43		The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	2	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	36#42		A single nucleotide polymorphism of CXCL12 G801A has been described and is regarded as a target for cis-acting factor that has the ability to up-regulate CXCL12 expression.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	2	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	154#160		A single nucleotide polymorphism of CXCL12 G801A has been described and is regarded as a target for cis-acting factor that has the ability to up-regulate CXCL12 expression.
17785557	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	3	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	58#64		Currently, there are no reports investigating the role of CXCL12 G801A polymorphism in prostate cancer (PC).
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	4	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	13#19		We genotyped CXCL12 G801A and p53Arg72Pro in 167 PC patients and 167 age-matched healthy subjects.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	33#39		To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	62#68		To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	6	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	73#78		To investigate the effect of the CXCL12 G801A polymorphism on CXCL12 and CXCR4 expression, immunohistochemistry was done in genotyped PC tissues.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	7	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	54#60		A significant increase in the GA + AA genotype of the CXCL12 G801A polymorphism was observed in PC patients compared with healthy controls.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	17#23		The frequency of CXCL12 AA genotype was significantly higher in a group of patients with lymph node metastasis (23%) compared with those without metastasis (7%).
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	9	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	17#23		The frequency of CXCL12 expression in AA + GA genotype carriers was significantly higher than that in GG genotype carriers.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	10	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	24#30		Among the carriers with CXCL12 GA + AA genotypes, CXCR4 expression was also significantly higher compared with those with the GG genotype.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	10	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	50#55		Among the carriers with CXCL12 GA + AA genotypes, CXCR4 expression was also significantly higher compared with those with the GG genotype.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	11	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	37#43		Moreover, among the groups with both CXCL12- and CXCR4-positive staining, the frequency of the CXCL12 GA + AA genotype was high.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	11	7852	SYMBOL|DICTIONARY	cxcr4	CXCR4	49#54		Moreover, among the groups with both CXCL12- and CXCR4-positive staining, the frequency of the CXCL12 GA + AA genotype was high.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	11	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	95#101		Moreover, among the groups with both CXCL12- and CXCR4-positive staining, the frequency of the CXCL12 GA + AA genotype was high.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	111#114		Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	181#187		Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	12	7157	SYMBOL|NUMBER|DICTIONARY	p53	p53	213#216		Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	13	7157	SYMBOL|DICTIONARY	p53	p53	32#35		These results indicate that the p53 codon 72 polymorphism may interact with CXCL12 G801A.
17785557	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	13	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	76#82		These results indicate that the p53 codon 72 polymorphism may interact with CXCL12 G801A.
17785557	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	14	6387	SYMBOL|DICTIONARY	cxcl12	CXCL12	38#44		This is the first report showing that CXCL12 G801A polymorphism may be a risk factor for PC.
17666372	2008	Haematologica	1592-8721	RESULTS	3	7	4255	SYMBOL|DICTIONARY	mgmt	MGMT	11#15		Two SNP in MGMT (Ile143Val and Lys178Arg) were in complete linkage disequilibrium and associated with increased risk of NHL (Ile143Val, Ile/Val vs. Ile/Ile, OR: 1.26; 95% CI: 0.93-1.70; Val/Val vs. Ile/Ile, OR: 2.55; 95% CI: 0.98-6.63; p trend: 0.024).
17666372	2008	Haematologica	1592-8721	RESULTS	3	9	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	17#22		In addition, the XRCC1 Arg194Trp polymorphism was associated with decreased NHL risk (Arg/Trp vs. Arg/Arg, OR: 0.72; 95% CI: 0.49-1.07; Trp/Trp vs. Arg/Arg, OR: 0.45; 95% CI: 0.10-1.99; p trend: 0.059), mainly in diffuse large B-cell lymphoma.
17666372	2008	Haematologica	1592-8721	INTERPRETATION AND CONCLUSIONS	4	10	4255	SYMBOL|DICTIONARY	mgmt	MGMT	39#43		The association of genetic variants in MGMT with increased risk of NHL suggests that alkyl adducts may contribute to lymphomagenesis, and points to environmental and endogenous alkylating agents as possible risk factors for NHL.
17597242	2007	Neurosci. Res.	0168-0102	TITLE	0	0	7157	SYMBOL|DICTIONARY	trp53	Trp53	15#20		Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	7157	SYMBOL|DICTIONARY	trp53	Trp53	0#5		Trp53 (transformation related protein 53, also known as p53) is a tumor suppressor gene that activates the expression of genes involved in inducing growth arrest of cells in response to multiple forms of cellular stress and it plays a significant role in apoptotic cell death during the early development of the nervous system.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	7157	LONGTERM|DICTIONARY	transformation related protein 53	transformation related protein 53	7#40		Trp53 (transformation related protein 53, also known as p53) is a tumor suppressor gene that activates the expression of genes involved in inducing growth arrest of cells in response to multiple forms of cellular stress and it plays a significant role in apoptotic cell death during the early development of the nervous system.
17597242	2007	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	5	7157	SYMBOL|DICTIONARY	p53	p53	45#48		We observed that the Pro72/Pro72 genotype of p53 is much less represented in children with nonsyndromic mental retardation than in controls (6.5% versus 14.08%) (OR=0.42; 95% CI 0.21-0.83).
17404734	2008	Rheumatol. Int.	0172-8172	TITLE	0	0	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	74#81		Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	2	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	40#47		In this respect, we investigate whether SLC19A1 genetic variations could affect rheumatoid arthritis (RA) patient response to antifolate treatment.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	6	6573	SYMBOL|DICTIONARY	slc19a1	SLC19A1	80#87		Western blot analysis of RFC protein was performed in respect of the identified SLC19A1 genotypes.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	8	6573	SYMBOL|GENE|GN|DICTIONARY	slc19a1	SLC19A1	29#36		No mutation was found in the SLC19A1 gene, but three polymorphic variants: the -43T>C in the 5'-flanking sequence to the ATG-transcription start site; and the 80G>A (R27H) and 696C>T (P232P) in the coding gene sequence.
17713436	2007	Transplantation	0041-1337	BACKGROUND	1	1	7099	SYMBOL|DICTIONARY	tlr4	TLR4	119#123		Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4.
17713436	2007	Transplantation	0041-1337	METHODS	2	3	7097	SYMBOL|DICTIONARY	tlr2	TLR2	87#91		A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms.
17713436	2007	Transplantation	0041-1337	METHODS	2	3	7099	SYMBOL|DICTIONARY	tlr4	TLR4	106#110		A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms.
17713436	2007	Transplantation	0041-1337	RESULTS	3	7	7097	SYMBOL|DICTIONARY	tlr2	TLR2	26#30		Twelve (13%) patients had TLR2 Arg753Gln and 32 (35%) had TLR4 Asp299Gly and/or Thr399Ile polymorphism.
17713436	2007	Transplantation	0041-1337	RESULTS	3	7	7099	SYMBOL|DICTIONARY	tlr4	TLR4	58#62		Twelve (13%) patients had TLR2 Arg753Gln and 32 (35%) had TLR4 Asp299Gly and/or Thr399Ile polymorphism.
17713436	2007	Transplantation	0041-1337	RESULTS	3	8	7097	SYMBOL|DICTIONARY	tlr2	TLR2	149#153		During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007).
17713436	2007	Transplantation	0041-1337	RESULTS	3	8	7097	SYMBOL|DICTIONARY	tlr2	TLR2	214#218		During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007).
17713436	2007	Transplantation	0041-1337	RESULTS	3	8	7097	SYMBOL|DICTIONARY	tlr2	TLR2	281#285		During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007).
17713436	2007	Transplantation	0041-1337	RESULTS	3	9	7097	SYMBOL|DICTIONARY	tlr2	TLR2	75#79		Time-to-event analysis showed a significant association between homozygous TLR2 polymorphism and the primary outcome (P<0.0001).
17713436	2007	Transplantation	0041-1337	RESULTS	3	10	7097	SYMBOL|DICTIONARY	tlr2	TLR2	63#67		After adjusting for donor age and azathioprine use, homozygous TLR2 mutation (RR 5.20 [1.65-13.9]; P=0.007) remained associated with the primary outcome.
17713436	2007	Transplantation	0041-1337	RESULTS	3	11	7099	SYMBOL|DICTIONARY	tlr4	TLR4	0#4		TLR4 polymorphisms were not associated with primary outcome.
17713436	2007	Transplantation	0041-1337	CONCLUSION	4	12	7097	SYMBOL|DICTIONARY	tlr2	TLR2	11#15		Homozygous TLR2 Arg753Gln polymorphism is associated with allograft failure and mortality after liver transplantation for chronic HCV.
17609663	2007	Br. J. Cancer	0007-0920	TITLE	0	0	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox2	COX2	0#4		COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase 2	34#50		Collective evidence suggests that cyclooxygenase 2 (COX2) plays a role in prostate cancer risk.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox2	COX2	52#56	17609663-1-34-50	Collective evidence suggests that cyclooxygenase 2 (COX2) plays a role in prostate cancer risk.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	2	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	Cyclooxygenase 2	0#16		Cyclooxygenase 2 is the major enzyme that converts arachidonic acid to prostaglandins, which are potent mediators of inflammation.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	3	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	80#84	17609663-1-34-50	Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the enzymatic activity of COX2 and long-term use of NSAIDs appears to modestly lower the risk of prostate cancer.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	4	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	52#56	17609663-1-34-50	We investigated whether common genetic variation in COX2 influences the risk of advanced prostate cancer.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	47#51	17609663-1-34-50	Nine single-nucleotide polymorphisms (SNPs) in COX2 were genotyped among 1012 men in our case-control study of advanced prostate cancer.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	6	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	38#42	17609663-1-34-50	Gene-environment interactions between COX2 polymorphisms and NSAID use were also evaluated.
17609663	2007	Br. J. Cancer	0007-0920	ALL_TEXT_3/3	3	12	5743	SYMBOL|DICTIONARY|EXTRACTED	cox2	COX2	39#43	17609663-1-34-50	Our findings suggest that variation in COX2 is associated with prostate cancer risk.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	SYMBOL|()|DICTIONARY|EXTRACTED	esr1	ESR1	101#105	17419075-1-85-94	This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	METHODS	2	5	2099	SYMBOL|DICTIONARY|EXTRACTED	esr1	ESR1	4#8	17419075-1-85-94	The ESR1 polymorphisms at intron I (Pvu II for a T/C substitution and Xba I for an A/G substitution) were genotyped in the context of a multiplex polymerase chain reaction (PCR) amplification followed by allele-specific single nucleotide polymorphism (SNP) detection with immobilized oligonucleotide probes in linear arrays.
17419075	2007	Osteoarthr. Cartil.	1063-4584	CONCLUSIONS	4	13	2099	LONGTERM|DICTIONARY	er alpha	ER alpha	41#49		We conclude that the C/C genotype of the ER alpha Pvu II polymorphism was associated with a modestly reduced risk of prevalent and incident RHOA in elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	CONCLUSIONS	4	14	2099	SYMBOL|DICTIONARY|EXTRACTED	esr1	ESR1	59#63	17419075-1-85-94	Additional work is required to understand how the intron I ESR1 polymorphism may alter joint degeneration.
17640379	2007	BMC Cancer	1471-2407	TITLE	0	0	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	31#36		Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.
17640379	2007	BMC Cancer	1471-2407	BACKGROUND	1	1	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	4#9		The BRCA2-8765delAG mutation was firstly described in breast cancer families from French-Canadian and Jewish-Yemenite populations; it was then reported as a founder mutation in Sardinian families.
17640379	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	40#45		We evaluated both the prevalence of the BRCA2-8765delAG variant in Sardinia and the putative existence of a common ancestral origin through a haplotype analysis of breast cancer family members carrying such a mutation.
17640379	2007	BMC Cancer	1471-2407	METHODS	2	3	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	101#106		Eight polymorphic microsatellite markers (D13S1250, centromeric, to D13S267, telomeric) spanning the BRCA2 gene locus were used for the haplotype analysis.
17640379	2007	BMC Cancer	1471-2407	METHODS	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	81#86		Screening for the 8765delAG mutation was performed by PCR-based amplification of BRCA2-exon 20, followed by automated sequencing.
17640379	2007	BMC Cancer	1471-2407	RESULTS	3	5	675	SYMBOL|DICTIONARY	brca2	BRCA2	264#269		Among families with high recurrence of breast cancer (> or = 3 cases in first-degree relatives), those from North Sardinia shared the same haplotype whereas the families from French Canadian and Jewish-Yemenite populations presented distinct genetic assets at the BRCA2 locus.
17640379	2007	BMC Cancer	1471-2407	RESULTS	3	6	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	18#23		Screening for the BRCA2-8765delAG variant among unselected and consecutively-collected breast cancer patients originating from the entire Sardinia revealed that such a mutation is present in the northern part of the island only [9/648 (1.4%) among cases from North Sardinia versus 0/493 among cases from South Sardinia].
17640379	2007	BMC Cancer	1471-2407	CONCLUSION	4	7	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	4#9		The BRCA2-8765delAG has an independent origin in geographically and ethnically distinct populations, acting as a founder mutation in North but not in South Sardinia.
17640379	2007	BMC Cancer	1471-2407	CONCLUSION	4	8	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	6#11		Since BRCA2-8765delAG occurs within a triplet repeat sequence of AGAGAG, our study further confirmed the existence of a mutational hot-spot at this genomic position (additional genetic factors within each single population might be involved in generating such a mutation).
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_2/3	2	6	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	76#103		Increased secretion of proMMP-9 was associated with increased expression of tumor necrosis factor-alpha and interleukin-6.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_2/3	2	6	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	108#121		Increased secretion of proMMP-9 was associated with increased expression of tumor necrosis factor-alpha and interleukin-6.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_3/3	3	11	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	31#36		These findings furnish a novel MMP-9-mediated pathway and its inhibition via proinflammatory cytokines by famotidine in ethanol-induced gastric ulceration.
17405833	2007	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	Interferon-gamma	0#16		Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.
17405833	2007	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3565	LONGTERM|GENE|GN|DICTIONARY	interleukin 4	interleukin-4	21#34		Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	21#37		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3458	SYMBOL|EXTRACTED|()	ifn gamma	IFN-gamma	39#48	17405833-1-21-37	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	LONGTERM|DICTIONARY|GENE|GA	interleukin 4	interleukin-4	54#67		To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3565	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il 4	IL-4	69#73	17405833-1-54-67	To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs).
17405833	2007	Ann. Rheum. Dis.	0003-4967	METHODS	2	4	3565	SYMBOL|DICTIONARY|EXTRACTED	il 4	IL-4	74#78	17405833-1-54-67	Single-nucleotide polymorphisms (SNPs) within intronic regions coding for IL-4, IFN-gamma and a microsatellite marker within intron 1 of the IFN-gamma gene were typed.
17405833	2007	Ann. Rheum. Dis.	0003-4967	METHODS	2	4	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	80#89	17405833-1-21-37	Single-nucleotide polymorphisms (SNPs) within intronic regions coding for IL-4, IFN-gamma and a microsatellite marker within intron 1 of the IFN-gamma gene were typed.
17405833	2007	Ann. Rheum. Dis.	0003-4967	METHODS	2	4	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	141#150	17405833-1-21-37	Single-nucleotide polymorphisms (SNPs) within intronic regions coding for IL-4, IFN-gamma and a microsatellite marker within intron 1 of the IFN-gamma gene were typed.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	6	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	7#16	17405833-1-21-37	In the IFN-gamma gene, a weak allelic association was observed in PM versus controls at rs1861493 (odds ratio (OR) 1.6, 95% confidence interval (CI) 1.03 to 2.4).
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	19#28	17405833-1-21-37	The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
17405833	2007	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	8	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	23#32	17405833-1-21-37	Genetic markers in the IFN-gamma gene demonstrate significant allelic associations with the IIMs in a UK Caucasian population.
17405833	2007	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	9	3565	SYMBOL|DICTIONARY|EXTRACTED	il 4	IL-4	59#63	17405833-1-54-67	The SNPs tested in this study within the region coding for IL-4 fail to show significant associations with susceptibility to IIM disease.
17442289	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	15#21		Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
17442289	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	10	SYMBOL|GENE|GN|DICTIONARY	nat2	NAT2	26#30		Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
17442289	2007	Clin. Chim. Acta	0009-8981	METHODS	2	3	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	74#80		We conducted a case-control study to investigate total 9 polymorphisms of CYP2E1, CYP2D6 and NAT2 genes by PCR-RFLP.
17442289	2007	Clin. Chim. Acta	0009-8981	METHODS	2	3	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	82#88		We conducted a case-control study to investigate total 9 polymorphisms of CYP2E1, CYP2D6 and NAT2 genes by PCR-RFLP.
17442289	2007	Clin. Chim. Acta	0009-8981	METHODS	2	3	10	SYMBOL|GENE|GN|DICTIONARY	nat2	NAT2	93#97		We conducted a case-control study to investigate total 9 polymorphisms of CYP2E1, CYP2D6 and NAT2 genes by PCR-RFLP.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	4	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	52#58		The -1053C/T and -1293G/C promoter polymorphisms of CYP2E1 were found to be in complete linkage disequilibrium (LD) (D'=1.00, r(2)=1.0, p<0.0001), whereas -1293G/C and 7632T/A polymorphisms of the same gene were also in significant LD (D'=0.5183, r(2)=1.0, p=0.01) in patients.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	83#89		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	103#107		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	113#117		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	124#128		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	134#138		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	147#151		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	169#173		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	315#319		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	363#367		The patients over-represented the -1293GC+CC genotypes of -1293G/C polymorphism of CYP2E1 (p=0.03) and NAT2*4/7, NAT2()5/6, NAT2*5/7, NAT2*6/6 and NAT2*6/7 genotypes of NAT2 (p=0.01, p=0.039, p=0.01, p=0.032, p=0.006, respectively), resulting in to higher frequency of -1293C (OR=7.02, 95% CI=1.63-30.15, p=0.002), NAT2*6 (OR=1.90, 95% CI=1.27-2.83, p=0.001) and NAT2*7 (OR=2.91, 95% CI=1.65-5.12, p=0.0001) alleles.
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	6	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	41#47		The 7632T/A and 9893C/G polymorphisms of CYP2E1 and 1934G/A polymorphism of CYP2D6 did not associate with the disease (p>0.05).
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	6	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	76#82		The 7632T/A and 9893C/G polymorphisms of CYP2E1 and 1934G/A polymorphism of CYP2D6 did not associate with the disease (p>0.05).
17442289	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	7	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	177#183		The haplotypes -1293G:9893C and -1293G:7632T:9893C were under-represented (p<0.001), whereas haplotypes -1293C:7632T, -1293C:9893C, -1293C:9893G and -1293C:7632T:9893C of the 4 CYP2E1 polymorphisms were over-represented in patients (p<0.05).
17442289	2007	Clin. Chim. Acta	0009-8981	CONCLUSION	4	8	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	4#10		The CYP2E1 and NAT2 variants associated with COPD.
17442289	2007	Clin. Chim. Acta	0009-8981	CONCLUSION	4	8	10	SYMBOL|DICTIONARY	nat2	NAT2	15#19		The CYP2E1 and NAT2 variants associated with COPD.
17459075	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	70#76	17459075-0-48-66	Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	97#103	17459075-0-48-66	Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	3	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	0#6		CTLA-4 promoter (-318C/T) and exon 1 (+49 A/G) polymorphisms have been analysed in 43 Italian females with SSc and in 93 unrelated matched healthy controls by a newly designed tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) method.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	6899	SYMBOL|()|DICTIONARY|EXTRACTED	tga	TGA	345#348	17459075-4-330-343	No significant association has been found with either polymorphisms.Nevertheless, SSc patients without concomitant Hashimoto's thyroiditis (HT) were carrying both the -318T allele (P = 0.031) and the +49 G allele (P = 0.076) more frequently than SSc patients with HT [defined by positivity for anti-thyroperoxidase (TPO) and anti-thyroglobulin (TGA) autoantibodies] than controls.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1493	SYMBOL|DICTIONARY|EXTRACTED	ctla 4	CTLA-4	34#40	17459075-0-48-66	Thus, in Italian SSc patients the CTLA-4 -318C/T promoter polymorphism appears to be associated with the susceptibility to develop SSc without thyroid involvement.
17558308	2007	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	38#43		Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
17558308	2007	Pharmacogenet. Genomics	1744-6872	MAIN RESULTS	3	10	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	16#21		Carriers of the XRCC1_1196_AA genotype had a reduced risk for recurrence/death (odds ratio adjusted 0.19; 95% confidence interval: 0.06-0.61), which was observed in survival analyses of all patients (P=0.003) and patients treated with chemotherapy but not radiotherapy (P=0.006).
17558308	2007	Pharmacogenet. Genomics	1744-6872	MAIN RESULTS	3	11	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	32#37		Multivariate analysis confirmed XRCC1 as a potential treatment predictor (hazard ratio 0.62; 95% confidence interval: 0.43-0.89).
17558308	2007	Pharmacogenet. Genomics	1744-6872	CONCLUSION	4	14	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	22#27		The DNA repair enzyme XRCC1 is a potential treatment predictor for the outcome and survival of anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of invasive breast cancer.
17116328	2007	Placenta	0143-4004	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	55#70		Placental abruption is more frequent in women with the angiotensinogen Thr235 mutation.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	2	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	37#52		Previous studies have shown that the angiotensinogen (AGT) Thr235 mutation is associated with abnormal remodeling of the uterine spiral arteries and occurs at higher frequencies in preeclampsia.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	2	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	54#57	17116328-2-37-52	Previous studies have shown that the angiotensinogen (AGT) Thr235 mutation is associated with abnormal remodeling of the uterine spiral arteries and occurs at higher frequencies in preeclampsia.
17116328	2007	Placenta	0143-4004	OBJECTIVE	1	3	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	44#47	17116328-2-37-52	This study was done to evaluate whether the AGT Thr235 mutation increases the risk of placental abruption.
17116328	2007	Placenta	0143-4004	MATERIALS AND METHODS	2	6	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		AGT Met235Thr mutation status was determined by single fluoresceine labeled probe real-time PCR using a LightCycler system.
17116328	2007	Placenta	0143-4004	RESULT	3	7	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		AGT genotypes were divided into three groups: MM (homozygous wild), TT (homozygous mutant), and MT (heterozygous).
17116328	2007	Placenta	0143-4004	RESULT	3	8	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	25#28	17116328-2-37-52	The constituent ratio of AGT genotype in abrupted placentas (MM 14.5%, MT 43.5%, TT 41.9%) was significantly different from in control group (MM42.5%, MT 39.6%, TT 17.9%) (p<0.001).
17116328	2007	Placenta	0143-4004	RESULT	3	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		AGT mutant allele frequency in placental abruption (0.637) was significantly higher than in the control group (0.377) (p<0.001).
17116328	2007	Placenta	0143-4004	CONCLUSION	4	10	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	4#7	17116328-2-37-52	The AGT Thr235 mutation was observed more frequently in placental abruption.
17116328	2007	Placenta	0143-4004	CONCLUSION	4	11	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	0#3		AGT Thr235 mutation may be considered a risk factor for placental abruption.
17587429	2007	Respirology	1323-7799	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	17#31		Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis.
17587429	2007	Respirology	1323-7799	BACKGROUND AND OBJECTIVES	1	2	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	127#136	17587429-2-97-125	The present study investigated the relationship between susceptibility to tuberculosis and human tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 genes (IL-10).
17587429	2007	Respirology	1323-7799	BACKGROUND AND OBJECTIVES	1	2	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	142#156		The present study investigated the relationship between susceptibility to tuberculosis and human tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 genes (IL-10).
17587429	2007	Respirology	1323-7799	RESULTS	3	5	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	43#52	17587429-2-97-125	There was no significant difference in the TNF-alpha-308 G/A genotype between the TB patient groups and the controls.
17587429	2007	Respirology	1323-7799	CONCLUSION	4	7	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	122#131	17587429-2-97-125	The -1082A allele of the IL-10 gene may be important in determining susceptibility to TB, however, the -308 allele of the TNF-alpha gene does not affect differential TB susceptibility.
17656222	2007	Urology	1527-9995	TITLE	0	0	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	19#29		Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
17656222	2007	Urology	1527-9995	OBJECTIVES	1	1	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	34#44		To explore the significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
17656222	2007	Urology	1527-9995	METHODS	2	3	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	32#42		The -160C/A polymorphism in the E-cadherin gene promoter was genotyped by polymerase chain reaction-restriction fragment length analysis.
17656222	2007	Urology	1527-9995	CONCLUSIONS	4	7	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	64#74		The presence of the A allele of the -160C/A polymorphism in the E-cadherin gene may be a risk factor for prostate cancer in the Japanese population.
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	84#90		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	92#98		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	100#106		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	109#114		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	BACKGROUND	1	2	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	123#130		Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	5	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	71#77		The interaction odds ratio (COR) for the gene-gene interaction between CYP1B1 1294G and SULT1A1 638A allele was 2.68 (95% CI: 1.16-6.26).
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	5	6817	SYMBOL|NUMBER|DICTIONARY	sult1a1	SULT1A1	88#95		The interaction odds ratio (COR) for the gene-gene interaction between CYP1B1 1294G and SULT1A1 638A allele was 2.68 (95% CI: 1.16-6.26).
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	6	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	116#122		The results of the gene-environment analyses revealed that an interaction existed between cigarette smoking and the CYP1B1 1294G allele for CRC (COR = 2.62, 95%CI: 1.01-6.72), the COR for the interaction of CYP1B1 1294G and smoking history > 35 pack-years was 3.47 (95%CI: 1.12-10.80).
17603900	2007	BMC Cancer	1471-2407	RESULTS	3	6	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	207#213		The results of the gene-environment analyses revealed that an interaction existed between cigarette smoking and the CYP1B1 1294G allele for CRC (COR = 2.62, 95%CI: 1.01-6.72), the COR for the interaction of CYP1B1 1294G and smoking history > 35 pack-years was 3.47 (95%CI: 1.12-10.80).
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	8	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	65#71		Our results showed that the interaction between polymorphisms in CYP1B1 1294G and SULT1A1*2 may play a significant role on CRC in the Chinese population.
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	8	6817	SYMBOL|NUMBER|DICTIONARY	sult1a1	SULT1A1	82#89		Our results showed that the interaction between polymorphisms in CYP1B1 1294G and SULT1A1*2 may play a significant role on CRC in the Chinese population.
17603900	2007	BMC Cancer	1471-2407	CONCLUSION	4	9	1545	SYMBOL|NUMBER|DICTIONARY	cyp1b1	CYP1B1	108#114		Also, it is suggested that the association between cigarette smoking and CRC could be differentiated by the CYP1B1 1294G allele.
17223007	2007	Biomed. Pharmacother.	0753-3322	TITLE	0	0	4318	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 9	matrix metalloproteinase-9	28#54		Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.
17223007	2007	Biomed. Pharmacother.	0753-3322	ALL_TEXT_2/3	2	4	4318	SYMBOL|GENE|GN|DICTIONARY	mmp 9	MMP-9	121#126		We evaluated two different polymorphisms, a CA repeat and a cytosine to thymidine transition in the promoter sequence of MMP-9 gene for frequency in 146 patients with AAA.
17223007	2007	Biomed. Pharmacother.	0753-3322	ALL_TEXT_3/3	3	7	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	36#41		We therefore found no evidence that MMP-9 is a marker of susceptibility for AAA.
17151092	2007	Carcinogenesis	0143-3334	TITLE	0	0	11221	SYMBOL|DICTIONARY	map kinase phosphatase 5	MAP kinase phosphatase-5	94#118		Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	3	11221	LONGTERM|DICTIONARY	mitogen activated protein kinase phosphatase 5	mitogen-activated protein kinase phosphatase-5	41#87		In this study, we demonstrate a role for mitogen-activated protein kinase phosphatase-5 (MKP5) in mediating anti-inflammatory activities of the phytochemicals curcumin, resveratrol and [6]-gingerol.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	3	11221	SYMBOL|()|DICTIONARY|EXTRACTED	mkp5	MKP5	89#93	17151092-3-41-87	In this study, we demonstrate a role for mitogen-activated protein kinase phosphatase-5 (MKP5) in mediating anti-inflammatory activities of the phytochemicals curcumin, resveratrol and [6]-gingerol.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	26#53		We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	55#63	17151092-4-26-53	We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	204#220		We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	222#227	17151092-4-204-220	We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	3569	SYMBOL|DICTIONARY	il 6	IL-6	230#234		We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	3576	SYMBOL|DICTIONARY	il 8	IL-8	239#243		We utilized the cytokines tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-1beta to increase p38-dependent nuclear factor kappa-B (NFkappaB) activation and expression of pro-inflammatory genes cyclooxygenase-2 (COX-2), IL-6 and IL-8 in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	0#4		MKP5 over-expression decreased cytokine-induced NFkappaB activation, COX-2, IL-6 and IL-8 in normal prostatic epithelial cells, suggesting potent anti-inflammatory activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	69#74	17151092-4-204-220	MKP5 over-expression decreased cytokine-induced NFkappaB activation, COX-2, IL-6 and IL-8 in normal prostatic epithelial cells, suggesting potent anti-inflammatory activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il 6	IL-6	76#80		MKP5 over-expression decreased cytokine-induced NFkappaB activation, COX-2, IL-6 and IL-8 in normal prostatic epithelial cells, suggesting potent anti-inflammatory activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	85#89		MKP5 over-expression decreased cytokine-induced NFkappaB activation, COX-2, IL-6 and IL-8 in normal prostatic epithelial cells, suggesting potent anti-inflammatory activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	176#180	17151092-3-41-87	MKP5 over-expression decreased cytokine-induced NFkappaB activation, COX-2, IL-6 and IL-8 in normal prostatic epithelial cells, suggesting potent anti-inflammatory activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1432	SYMBOL|DICTIONARY	p38	p38	29#32		Pretreatment of cells with a p38 inhibitor mimicked the results observed with MKP5 over-expression, further implicating p38 inhibition as the main activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	78#82	17151092-3-41-87	Pretreatment of cells with a p38 inhibitor mimicked the results observed with MKP5 over-expression, further implicating p38 inhibition as the main activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1432	SYMBOL|DICTIONARY	p38	p38	120#123		Pretreatment of cells with a p38 inhibitor mimicked the results observed with MKP5 over-expression, further implicating p38 inhibition as the main activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	159#163	17151092-3-41-87	Pretreatment of cells with a p38 inhibitor mimicked the results observed with MKP5 over-expression, further implicating p38 inhibition as the main activity of MKP5.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	7	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	60#64	17151092-3-41-87	Curcumin, the phytochemical found in turmeric, up-regulated MKP5, subsequently decreasing cytokine-induced p38-dependent pro-inflammatory changes in normal prostatic epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	8	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	109#113	17151092-3-41-87	Resveratrol and [6]-gingerol, phytochemicals present in red wine and ginger, respectively, also up-regulated MKP5 in normal prostate epithelial cells.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	106#110	17151092-3-41-87	Moreover, we found that PCa cell lines DU 145, PC-3, LNCaP and LAPC-4 retained the ability to up-regulate MKP5 following curcumin, resveratrol and [6]-gingerol exposure, suggesting utility of these phytochemicals in PCa treatment.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	67#71	17151092-3-41-87	In summary, our findings show direct anti-inflammatory activity of MKP5 in prostate cells and suggest that up-regulation of MKP5 by phytochemicals may contribute to their chemopreventive actions by decreasing prostatic inflammation.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	11221	SYMBOL|DICTIONARY|EXTRACTED	mkp5	MKP5	124#128	17151092-3-41-87	In summary, our findings show direct anti-inflammatory activity of MKP5 in prostate cells and suggest that up-regulation of MKP5 by phytochemicals may contribute to their chemopreventive actions by decreasing prostatic inflammation.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	TITLE	0	0	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	32#36		Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	catechol-O-methyltransferase	4#32		The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_1/3	1	2	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	34#38	16734939-2-4-32	The catechol-O-methyltransferase (COMT), residing in the 22q11.2 microdeletion region, is a major candidate gene for genetic susceptibility to neuropsychiatric disorders in VCFS.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_2/3	2	3	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	104#108	16734939-2-4-32	Individuals with VCFS carrying the low-activity allele (COMTL) are expected to have the lowest possible COMT activity since they have only a single copy of the gene.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	comt	COMT	103#107	16734939-2-4-32	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	5	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	143#147	16734939-2-4-32	Fifty-five unrelated individuals with VCFS underwent psychiatric evaluation and were genotyped for the COMT 158Val/Met polymorphism coding for COMT high/low-activity alleles.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	55#59	16734939-2-4-32	The results of this study suggest that greatly reduced COMT activity, as expected in VCFS COMTL individuals may be a risk factor for psychiatric sequelae in this population.
16734939	2007	Int. J. Neuropsychopharmacol.	1461-1457	ALL_TEXT_3/3	3	8	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	51#55	16734939-2-4-32	Future longitudinal studies focusing on additional COMT polymorphic sites and other candidate genes from the deleted region will elucidate the molecular pathways leading to schizophrenia and other psychiatric disorders in VCFS.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	TITLE	0	0	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	13#17		Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	TITLE	0	0	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	26#40		Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	1	57158	LONGTERM|DICTIONARY	junctophilin 2	Junctophilin-2	0#14		Junctophilin-2 (JPH2) is a cardiac specific member of the junctophilins, a newly characterized family of junctional membrane complex proteins important in physically approximating the plasmalemmal L-type calcium channel and the sarcoplasmic reticulum ryanodine receptor for calcium-induced calcium release.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	1	57158	SYMBOL|()|DICTIONARY|EXTRACTED	jph2	JPH2	16#20	17509612-1-0-14	Junctophilin-2 (JPH2) is a cardiac specific member of the junctophilins, a newly characterized family of junctional membrane complex proteins important in physically approximating the plasmalemmal L-type calcium channel and the sarcoplasmic reticulum ryanodine receptor for calcium-induced calcium release.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	2	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	0#4		JPH2 knockout mice showed disrupted calcium transients, altered junctional membrane complex formation, cardiomyopathy, and embryonic lethality.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_1/3	1	3	57158	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	jph2	JPH2	13#17	17509612-1-0-14	Furthermore, JPH2 gene expression is down-regulated in murine cardiomyopathy models.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	4	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	25#29	17509612-1-0-14	To this end, we explored JPH2 as a novel candidate gene for the pathogenesis of hypertrophic cardiomyopathy (HCM) in humans.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	5	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	179#183	17509612-1-0-14	Using polymerase chain reaction, denaturing high performance liquid chromatography, and direct DNA sequencing, comprehensive open reading frame/splice site mutational analysis of JPH2 was performed on DNA obtained from 388 unrelated patients with HCM.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_2/3	2	6	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	15#19	17509612-1-0-14	HCM-associated JPH2 mutations were engineered and functionally characterized using immunocytochemistry, cell morphometry measurements, and live cell confocal calcium imaging.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	8	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	71#85		Functionally, each human mutation caused (i) protein reorganization of junctophilin-2, (ii) perturbations in intracellular calcium signaling, and (iii) marked cardiomyocyte hyperplasia.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	LONGTERM|DICTIONARY	junctophilin 2	junctophilin-2	59#73		The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	9	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	228#232	17509612-1-0-14	The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2.
17509612	2007	J. Mol. Cell. Cardiol.	0022-2828	ALL_TEXT_3/3	3	10	57158	SYMBOL|DICTIONARY|EXTRACTED	jph2	JPH2	116#120	17509612-1-0-14	Whether susceptibility for other cardiomyopathies, such as dilated cardiomyopathy, can be conferred by mutations in JPH2 warrants investigation.
17434869	2007	Science	1095-9203	TITLE	0	0	79068	SYMBOL|GENE|GN|DICTIONARY	fto	FTO	24#27		A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
17434869	2007	Science	1095-9203	ALL_TEXT_2/3	2	3	79068	SYMBOL|DICTIONARY	fto	FTO	97#100		A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI).
17514530	2007	Curr. Eye Res.	0271-3683	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione-S-transferase M1	0#28		Glutathione-S-transferase M1 and T1 genetic polymorphisms and the risk of cataract development: a study in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione-S-transferase M1	77#105		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	107#112	17514530-1-77-105	In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2952	SYMBOL|()|DICTIONARY	gstt1	GSTT1	148#153		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	51#56	17514530-1-77-105	Using a multiplex polymerase chain reaction (PCR), GSTM1 and GSTT1 gene polymorphisms were analyzed in 195 patients with age-related cataract (75 patients with cortical, 53 with nuclear, 37 with posterior subcapsular, and 30 with mixed type) and in 136 patients of an otherwise healthy control group of similar age.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	2	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	61#66		Using a multiplex polymerase chain reaction (PCR), GSTM1 and GSTT1 gene polymorphisms were analyzed in 195 patients with age-related cataract (75 patients with cortical, 53 with nuclear, 37 with posterior subcapsular, and 30 with mixed type) and in 136 patients of an otherwise healthy control group of similar age.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_2/3	2	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	0#5		GSTM1 null genotype had a significant association with the development of cataract in female subjects (p < 0.0029; OR, 2.98; 95% CI, 1.41-6.34).
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	82#87	17514530-1-77-105	There was also a statistically significant association between the combination of GSTM1-null and GSTT1-positive genotypes and the risk of cataract development in female subjects (p = 0.01; OR = 2.87; 95% CI = 1.25-6.69).
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	97#102		There was also a statistically significant association between the combination of GSTM1-null and GSTT1-positive genotypes and the risk of cataract development in female subjects (p = 0.01; OR = 2.87; 95% CI = 1.25-6.69).
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	0#5		GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	42#47	17514530-1-77-105	GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	57#62		GSTM1-null genotype or combination of the GSTM1-null and GSTT1-positive genotypes in females may be associated with increased risk of cataract development in the Turkish population.
17467628	2007	Heart Rhythm	1547-5271	RESULTS	4	7	3784	SYMBOL|DICTIONARY	kcnq1	KCNQ1	73#78		DNA samples were screened for the four common Finnish founder mutations (KCNQ1 G589D and IVS7-2A-->G, HERG L552S, and R176W), which are known to account for the majority of inherited LQTS in Finland.
17467628	2007	Heart Rhythm	1547-5271	RESULTS	4	7	3757	SYMBOL|DICTIONARY	herg	HERG	102#106		DNA samples were screened for the four common Finnish founder mutations (KCNQ1 G589D and IVS7-2A-->G, HERG L552S, and R176W), which are known to account for the majority of inherited LQTS in Finland.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	49#53		The significance of C3435T point mutation of the MDR1 gene in endometrial cancer.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	1	5243	LONGTERM|DICTIONARY	p glycoprotein	P-glycoprotein	4#18		The P-glycoprotein (P-gp) plays an important role in carcinogen distribution and is connected with cell differentiation and apoptotic processes leading to carcinogenesis.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	1	5243	SYMBOL|EXTRACTED|()	p gp	P-gp	20#24	17300681-1-4-18	The P-glycoprotein (P-gp) plays an important role in carcinogen distribution and is connected with cell differentiation and apoptotic processes leading to carcinogenesis.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	2	5243	SYMBOL|EXTRACTED	p gp	P-gp	31#35	17300681-1-4-18	Interindividual differences in P-gp activity could modulate susceptibility to cancer development.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	3	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	4#8		The MDR1 gene, coding for P-gp, is highly polymorphic and some mutations modulate P-gp activity.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	3	5243	SYMBOL|EXTRACTED	p gp	P-gp	26#30	17300681-1-4-18	The MDR1 gene, coding for P-gp, is highly polymorphic and some mutations modulate P-gp activity.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_1/3	1	3	5243	SYMBOL|EXTRACTED	p gp	P-gp	82#86	17300681-1-4-18	The MDR1 gene, coding for P-gp, is highly polymorphic and some mutations modulate P-gp activity.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_2/3	2	4	5243	SYMBOL|DICTIONARY	mdr1	MDR1	34#38		Recently, association between the MDR1 C3435T polymorphism and the cancer susceptibility was shown.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_2/3	2	5	5243	SYMBOL|DICTIONARY	mdr1	MDR1	26#30		We have hypothesized that MDR1 polymorphism could influence endometrial cancer susceptibility.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_3/3	3	8	5243	SYMBOL|DICTIONARY	mdr1	MDR1	4#8		The MDR1 C3435T polymorphism was tested by LightCycler assay.
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_3/3	3	9	5243	SYMBOL|NUMBER|DICTIONARY	mdr1	MDR1	20#24		The distribution of MDR1 3435 genotypes was significantly different between cases and controls (P = 0.006).
17300681	2007	Int. J. Gynecol. Cancer	1048-891X	ALL_TEXT_3/3	3	11	5243	SYMBOL|DICTIONARY	mdr1	MDR1	30#34		Our observation suggests that MDR1 C3435T polymorphism is correlated with endometrial cancer susceptibility.
17316890	2007	Lung Cancer	0169-5002	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	20#25		The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	1	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	42#47		To evaluate the effect of DNA repair gene XRCC1 polymorphisms on the risk of lung cancer in a northeastern Chinese population, we studied five cSNPs in the XRCC1 gene, three that lead to non-synonymous changes: Arg194Trp, Arg280 His and Arg399Gln and two that lead to synonymous changes: Pro206Pro and Gln632Gln.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	1	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	156#161		To evaluate the effect of DNA repair gene XRCC1 polymorphisms on the risk of lung cancer in a northeastern Chinese population, we studied five cSNPs in the XRCC1 gene, three that lead to non-synonymous changes: Arg194Trp, Arg280 His and Arg399Gln and two that lead to synonymous changes: Pro206Pro and Gln632Gln.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	7	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	29#34		Our results suggest that the XRCC1 Pro206Pro polymorphism or the haplotype encompassing the minor allele may contribute to genetic susceptibility for lung cancer in this northeastern Chinese population.
17316890	2007	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	44#49		To our knowledge, this is first report that XRCC1 Pro206Pro influences cancer risk.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_1/3	1	1	7442	SYMBOL|()|DICTIONARY	trpv1	TRPV1	91#96		We tested the hypothesis that activation of transient receptor potential vanilloid type-1 (TRPV1) by capsaicin prevents adipogenesis.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_1/3	1	2	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	0#5		TRPV1 channels in 3T3-L1-preadipocytes and visceral adipose tissue from mice and humans were detected by immunoblotting and quantitative real-time RT-PCR.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_1/3	1	3	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	14#19		The effect of TRPV1 on cytosolic calcium was determined fluorometrically in 3T3-L1-preadipocytes and in human visceral fat tissue.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_1/3	1	4	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor-gamma	153#201		Adipogenesis in stimulated 3T3-L1-preadipocytes was determined by oil red O-staining of intracellular lipid droplets, triglyceride levels, expression of peroxisome proliferator-activated receptor-gamma, and expression of fatty acid synthase.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_1/3	1	4	2194	LONGTERM|DICTIONARY	fatty acid synthase	fatty acid synthase	221#240		Adipogenesis in stimulated 3T3-L1-preadipocytes was determined by oil red O-staining of intracellular lipid droplets, triglyceride levels, expression of peroxisome proliferator-activated receptor-gamma, and expression of fatty acid synthase.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_2/3	2	5	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	68#73		Long-term feeding experiments were undertaken in wild-type mice and TRPV1 knockout mice.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_2/3	2	6	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	12#17		We detected TRPV1 channels in 3T3-L1-preadipocytes and visceral adipose tissue from mice and humans.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_2/3	2	7	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	14#19		In vitro, the TRPV1 agonist capsaicin dose-dependently induced calcium influx and prevented the adipogenesis in stimulated 3T3-L1-preadipocytes.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_2/3	2	8	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	30#35		RNA interference knockdown of TRPV1 in 3T3-L1-preadipocytes attenuated capsaicin-induced calcium influx, and adipogenesis in stimulated 3T3-L1-preadipocytes was no longer prevented.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	9	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	28#33		During regular adipogenesis TRPV1 channels were downregulated which was accompanied by a significant and time-dependent reduction of calcium influx.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	11	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	12#17		The reduced TRPV1 expression in visceral adipose tissue from obese humans was accompanied by reduced capsaicin-induced calcium influx.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	12	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	102#107		The oral administration of capsaicin for 120 days prevented obesity in male wild type mice but not in TRPV1 knockout mice assigned to high fat diet.
17347480	2007	Circ. Res.	1524-4571	ALL_TEXT_3/3	3	13	7442	SYMBOL|DICTIONARY	trpv1	TRPV1	35#40		We conclude that the activation of TRPV1 channels by capsaicin prevented adipogenesis and obesity.
17082176	2007	Carcinogenesis	0143-3334	TITLE	0	0	2052	SYMBOL|GENE|GN|DICTIONARY	ephx1	EPHX1	22#27		Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	SYMBOL|()|DICTIONARY|EXTRACTED	nqo1	NQO1	34#38	17082176-1-8-30	NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	74#79		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	1728	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nqo1	NQO1	4#8	17082176-1-8-30	The NQO1 609*T allele was positively associated with high-risk adenoma in this population [odds ratio (OR), 1.36; 95% confidence interval (CI), 1.02-1.83].
17470138	2007	Clin. Genet.	0009-9163	TITLE	0	0	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	15#21		Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
17470138	2007	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	6934	SYMBOL|()|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	61#67	17470138-1-25-54	Polymorphisms within the transcription factor 7-like 2 gene (TCF7L2) have been associated with type 2 diabetes (T2D) in several recent studies.
17470138	2007	Clin. Genet.	0009-9163	ALL_TEXT_2/3	2	4	6934	SYMBOL|DICTIONARY|EXTRACTED	tcf7l2	TCF7L2	153#159	17470138-1-25-54	In order to minimize potential confounding because of the presence of population stratification in the sample, we evaluated the association of the three TCF7L2 polymorphisms with T2D by using the program admixmap to fit a logistic regression model incorporating individual ancestry, sex, age, body mass index and education.
17203304	2007	Hum. Genet.	0340-6717	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	31#37		Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.
17203304	2007	Hum. Genet.	0340-6717	TITLE	0	0	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	42#47		Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	150#156		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3350	SYMBOL|DICTIONARY	htr1a	HTR1A	158#163		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3352	SYMBOL|DICTIONARY	htr1d	HTR1D	165#170		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	172#177		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3361	SYMBOL|DICTIONARY	htr5a	HTR5A	179#184		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	7166	SYMBOL|DICTIONARY	tph1	TPH1	186#190		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	3	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	195#200		The role in autism etiology of seven candidate genes in the serotonin metabolic and neurotransmission pathways and mapping to autism linkage regions (SLC6A4, HTR1A, HTR1D, HTR2A, HTR5A, TPH1 and ITGB3) was analyzed in a sample of 186 nuclear families.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3361	SYMBOL|GENE|GN|DICTIONARY	htr5a	HTR5A	43#48		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	163#168		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	6532	SYMBOL|GENE|GN|DICTIONARY	slc6a4	SLC6A4	173#179		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	6	3361	SYMBOL|DICTIONARY	htr5a	HTR5A	213#218		We report a significant main effect of the HTR5A gene in autism (P = 0.0088), and a significant three-locus model comprising a synergistic interaction between the ITGB3 and SLC6A4 genes with an additive effect of HTR5A (P < 0.0010).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	7	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	55#61		In addition to the previously reported contribution of SLC6A4, we found significant associations of ITGB3 haplotypes with serotonin level distribution (P = 0.0163).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	7	3690	SYMBOL|DICTIONARY	itgb3	ITGB3	100#105		In addition to the previously reported contribution of SLC6A4, we found significant associations of ITGB3 haplotypes with serotonin level distribution (P = 0.0163).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	8	7166	SYMBOL|DICTIONARY	tph1	TPH1	103#107		The most significant models contributing to serotonin distribution were found for interactions between TPH1 rs4537731 and SLC6A4 haplotypes (P = 0.002) and between HTR1D rs6300 and SLC6A4 haplotypes (P = 0.013).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	8	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	122#128		The most significant models contributing to serotonin distribution were found for interactions between TPH1 rs4537731 and SLC6A4 haplotypes (P = 0.002) and between HTR1D rs6300 and SLC6A4 haplotypes (P = 0.013).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	8	3352	SYMBOL|DICTIONARY	htr1d	HTR1D	164#169		The most significant models contributing to serotonin distribution were found for interactions between TPH1 rs4537731 and SLC6A4 haplotypes (P = 0.002) and between HTR1D rs6300 and SLC6A4 haplotypes (P = 0.013).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	8	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	181#187		The most significant models contributing to serotonin distribution were found for interactions between TPH1 rs4537731 and SLC6A4 haplotypes (P = 0.002) and between HTR1D rs6300 and SLC6A4 haplotypes (P = 0.013).
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	9	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	85#91		In addition to the significant independent effects, evidence for interaction between SLC6A4 and ITGB3 markers was also found.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	9	3690	SYMBOL|GENE|GN|DICTIONARY	itgb3	ITGB3	96#101		In addition to the significant independent effects, evidence for interaction between SLC6A4 and ITGB3 markers was also found.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	30#36		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17203304	2007	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	10	3690	SYMBOL|GENE|GN|DICTIONARY	itgb3	ITGB3	41#46		The overall results implicate SLC6A4 and ITGB3 gene interactions in autism etiology and in serotonin level determination, providing evidence for a common underlying genetic mechanism and a molecular explanation for the association of platelet hyperserotonemia with autism.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	37#41		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	80#84		The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.
17102945	2007	Rheumatol. Int.	0172-8172	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	27#31		To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.
17102945	2007	Rheumatol. Int.	0172-8172	METHODS	2	3	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	84#88		After recording the demographic and clinical data, the predominant mutations in the MEFV gene locus (M694V, M680I, V726A, M694I, and E148Q) were investigated by direct sequencing.
17102945	2007	Rheumatol. Int.	0172-8172	CONCLUSION	4	8	4210	SYMBOL|DICTIONARY	mefv	MEFV	26#30		Though the effects of the MEFV genotypes seem clear, there are definitely other modifying factors or genes on the development of amyloidosis and on the course of the disease.
17135225	2007	Rheumatology (Oxford)	1462-0324	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	23#29		The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population.
17135225	2007	Rheumatology (Oxford)	1462-0324	OBJECTIVES	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	27#33		A missense SNP, C1858T, in PTPN22 has been identified as a genetic risk factor for rheumatoid arthritis (RA).
17135225	2007	Rheumatology (Oxford)	1462-0324	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	66#72		A total of 667 RA patients and 286 controls were genotyped for 13 PTPN22 single nucleotide polymorphisms (SNPs) by allele-specific kinetic polymerase chain reaction. rs3789604 was genotyped in an additional 410 RA and 270 UA patients participating in the Leiden early arthritis inception cohort.
17135225	2007	Rheumatology (Oxford)	1462-0324	RESULTS	3	6	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	83#89		The sole haplotype strongly associated with RA in our Dutch population carries the PTPN22 1858T allele.
17135225	2007	Rheumatology (Oxford)	1462-0324	RESULTS	3	8	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	61#67		No significant association of the haplotype tagged by the 3' PTPN22 SNP, rs3789604, with RA susceptibility (P = 0.134) was observed in our sample set.
17135225	2007	Rheumatology (Oxford)	1462-0324	CONCLUSION	4	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	36#42		We conclude that C1858T is the sole PTPN22 variant predisposing to RA in our white Dutch sample set.
17352815	2007	BMC Med. Genet.	1471-2350	TITLE	0	0	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	20#24		Association between CFL1 gene polymorphisms and spina bifida risk in a California population.
17352815	2007	BMC Med. Genet.	1471-2350	BACKGROUND	1	1	1072	SYMBOL|DICTIONARY	cfl1	CFL1	0#4		CFL1 encodes human non-muscle cofilin (n-cofilin), which is an actin-depolymerizing factor and is essential in cytokinesis, endocytosis, and in the development of all embryonic tissues.
17352815	2007	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	1072	SYMBOL|DICTIONARY	cfl1	Cfl1	0#4		Cfl1 knockout mice exhibit failure of neural tube closure at E10.5 and die in utero.
17352815	2007	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	56#60		We hypothesized that genetic variation within the human CFL1 gene may alter the protein's function and result in defective actin depolymerizing and cellular activity during neural tube closure.
17352815	2007	BMC Med. Genet.	1471-2350	METHODS	2	5	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	30#34		Having re-sequenced the human CFL1 gene and identified five common single nucleotide polymorphisms (SNPs) in our target population, we investigated whether there existed a possible association between the genetic variations of the CFL1 gene and risk of spina bifida.
17352815	2007	BMC Med. Genet.	1471-2350	METHODS	2	5	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	231#235		Having re-sequenced the human CFL1 gene and identified five common single nucleotide polymorphisms (SNPs) in our target population, we investigated whether there existed a possible association between the genetic variations of the CFL1 gene and risk of spina bifida.
17352815	2007	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	1072	SYMBOL|GENE|GN|DICTIONARY	cfl1	CFL1	32#36		The sequence variation of human CFL1 gene is a genetic modifier for spina bifida risk in this California population.
17054105	2007	Hum. Mutat.	1098-1004	TITLE	0	0	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76		Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	3265	SYMBOL|()|DICTIONARY|EXTRACTED	hras	HRAS	76#80	17054105-1-24-74	Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS).
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	72#76	17054105-1-24-74	To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	23#27	17054105-1-24-74	A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes.
17054105	2007	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	3265	SYMBOL|DICTIONARY|EXTRACTED	hras	HRAS	45#49	17054105-1-24-74	By analyzing the genomic region flanking the HRAS mutations, we traced the parental origin of lesions in nine informative families and demonstrated that de novo mutations were inherited from the father in all cases.
17329413	2007	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	7	494513	SYMBOL|()|DICTIONARY	dfnb59	DFNB59	126#132		Previous studies have described two missense mutations in the human pejvakin gene that cause nonsyndromic recessive deafness (DFNB59) by affecting the function of auditory neurons.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the central nervous system (CNS), and performs many biological functions such as neural survival, differentiation, and plasticity.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	35#39	17196936-1-0-33	Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the central nervous system (CNS), and performs many biological functions such as neural survival, differentiation, and plasticity.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	627	LONGTERM|DICTIONARY	neurotrophin	neurotrophin	72#84		Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the central nervous system (CNS), and performs many biological functions such as neural survival, differentiation, and plasticity.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	53#57	17196936-1-0-33	Previous studies have suggested that variants in the BDNF gene increase the risk of schizophrenia.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	71#75	17196936-1-0-33	In single-locus analysis, no significant association was found between BDNF polymorphisms and schizophrenia in our subjects.
17196936	2007	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	32#36	17196936-1-0-33	Our data provides evidence that BDNF is a susceptibility gene for schizophrenia in Chinese subjects.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	5027	SYMBOL|GENE|GN|DICTIONARY	p2x7	P2X7	22#26		A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVE	2	4	5027	SYMBOL|DICTIONARY	p2x7	P2X7	33#37		To determine if polymorphisms in P2X7 are associated with increased risk of TB, the prevalence of four polymorphisms was assessed in individuals from Southeast Asia, where the majority of patients with TB in our study originate.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	METHODS	3	6	5027	SYMBOL|DICTIONARY	p2x7	P2X7	14#18		Genotyping of P2X7 polymorphisms was performed from subjects in a nested case-control study of a longitudinal refugee cohort and a separate case-control study.
17005168	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	0#5		GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	10#15		GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	94#122		The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	124#129	17005168-1-94-122	The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	1	2952	SYMBOL|()|DICTIONARY	gstt1	GSTT1	140#145		The association between head and neck squamous cell carcinoma (HNSCC) and allelic variants of glutathione S-transferase M1 (GSTM1) and -T1 (GSTT1) is currently controversial.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	50#55		The present study investigates the prevalences of GSTT1 and GSTM1 polymorphism in a cohort of 100 head and neck cancer patients, 100 healthy donors and 200 controls with non-neoplastic head and neck diseases from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	60#65	17005168-1-94-122	The present study investigates the prevalences of GSTT1 and GSTM1 polymorphism in a cohort of 100 head and neck cancer patients, 100 healthy donors and 200 controls with non-neoplastic head and neck diseases from Italian Lazio Region.
17005168	2007	Clin. Chim. Acta	0009-8981	METHODS	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	24#29		Molecular definition of GSTT1 and GSTM1 genotype has been performed by means of allele-specific PCR technique.
17005168	2007	Clin. Chim. Acta	0009-8981	METHODS	2	4	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	34#39	17005168-1-94-122	Molecular definition of GSTT1 and GSTM1 genotype has been performed by means of allele-specific PCR technique.
17005168	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	5	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	59#64	17005168-1-94-122	A significant association between head and neck cancer and GSTM1 null genotype was observed both considering benign disease controls (p=0.001, OR=2.613; 95% C.I.=1.48-4.62), and healthy donors (p=0.0003, OR=3.35; 95% C.I.
17005168	2007	Clin. Chim. Acta	0009-8981	RESULTS	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	59#64		1.69-6.67) while no significant association was found with GSTT1 null genotype (p>or=0.14).
17005168	2007	Clin. Chim. Acta	0009-8981	CONCLUSIONS	4	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	61#66	17005168-1-94-122	The present study confirms a role for genetic alterations of GSTM1 detoxifying enzyme as a risk factor for the development of HNSCC in patients from the Italian Lazio Region, independently of age, sex and other confounding variables.
17385326	2007	Genetika	0016-6758	TITLE	0	0	142	SYMBOL|GENE|GN|DICTIONARY	adprt1	ADPRT1	51#57		[Polymorphic markers Val762Ala and Leu54Phe of the ADPRT1 gene associated with chronic glomerulonephritis in Russian patients from the city of Moscow].
17385326	2007	Genetika	0016-6758	ALL_TEXT_1/3	1	1	142	SYMBOL|GENE|GN|DICTIONARY	adprt1	ADPRT1	109#115		A comparative analysis of allelic and genotype distribution of polymorphic markers Val762Ala and Leu54Phe of ADPRT1 gene encoding poly(ADP-ribose)polymerase I has been performed in chronic glomerulonephritis patients compared to normal controls.
17203290	2007	Immunogenetics	0093-7711	TITLE	0	0	3569	SYMBOL|DICTIONARY	il 6	IL-6	47#51		Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3558	SYMBOL|DICTIONARY	il 2	IL-2	16#20		Polymorphism in IL-2 (-330 T/G, polymerase chain reaction [PCR]-restriction fragment length polymorphism), IL-4 (intron-3, variable number of tandem repeat, variable number tandem repeats analysis), and IL-6 (-174 G/C, amplification refractory mutation system, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3565	SYMBOL|DICTIONARY	il 4	IL-4	107#111		Polymorphism in IL-2 (-330 T/G, polymerase chain reaction [PCR]-restriction fragment length polymorphism), IL-4 (intron-3, variable number of tandem repeat, variable number tandem repeats analysis), and IL-6 (-174 G/C, amplification refractory mutation system, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	3569	SYMBOL|DICTIONARY	il 6	IL-6	203#207		Polymorphism in IL-2 (-330 T/G, polymerase chain reaction [PCR]-restriction fragment length polymorphism), IL-4 (intron-3, variable number of tandem repeat, variable number tandem repeats analysis), and IL-6 (-174 G/C, amplification refractory mutation system, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	3565	SYMBOL|DICTIONARY	il 4	IL-4	63#67		Significant difference was observed in genotype frequencies of IL-4 and IL-6 between ESRD patients and control group (p<0.001 and p=0.032, respectively).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il 6	IL-6	72#76		Significant difference was observed in genotype frequencies of IL-4 and IL-6 between ESRD patients and control group (p<0.001 and p=0.032, respectively).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	6	3565	SYMBOL|()|DICTIONARY	il 4	IL-4	59#63		Patients had higher frequency of homozygous B2B2 genotype (IL-4) than controls (62.7% vs 46.7) and GG genotype of IL-6 (73.1% vs 60.6%).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	114#118		Patients had higher frequency of homozygous B2B2 genotype (IL-4) than controls (62.7% vs 46.7) and GG genotype of IL-6 (73.1% vs 60.6%).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	7	3558	SYMBOL|DICTIONARY	il 2	IL-2	29#33		The genotypic frequencies of IL-2 were comparable in patients and controls (p=0.102).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_2/3	2	8	3565	SYMBOL|DICTIONARY	il 4	IL-4	27#31		Significant association of IL-4 was also observed in patients with glomerulonephritis (p=0.001).
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3565	SYMBOL|DICTIONARY	il 4	IL-4	19#23		Combination of low IL-4 and high IL-6 genotypes were significantly associated with ESRD showing the highest risk, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	9	3569	SYMBOL|DICTIONARY	il 6	IL-6	33#37		Combination of low IL-4 and high IL-6 genotypes were significantly associated with ESRD showing the highest risk, i.e.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	10	3565	SYMBOL|DICTIONARY	il 4	IL-4	112#116		>threefolds risk (odds ratio=3.48, 95%CI=1.88-6.42; p < 0.001) among the four possible combinations taking high IL-4 and low IL-6 as reference.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	10	3569	SYMBOL|DICTIONARY	il 6	IL-6	125#129		>threefolds risk (odds ratio=3.48, 95%CI=1.88-6.42; p < 0.001) among the four possible combinations taking high IL-4 and low IL-6 as reference.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	11	3565	SYMBOL|DICTIONARY	il 4	IL-4	40#44		Our study suggests that polymorphism in IL-4 and IL-6 may be associated with susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	11	3569	SYMBOL|DICTIONARY	il 6	IL-6	49#53		Our study suggests that polymorphism in IL-4 and IL-6 may be associated with susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	12	3565	SYMBOL|DICTIONARY	il 4	IL-4	78#82		Further, combined analysis implicated a higher risk in ESRD patients with low IL-4 and high IL-6 producing genotypes.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_3/3	3	12	3569	SYMBOL|DICTIONARY	il 6	IL-6	92#96		Further, combined analysis implicated a higher risk in ESRD patients with low IL-4 and high IL-6 producing genotypes.
17309100	2007	Proteomics	1615-9853	TITLE	0	0	3569	SYMBOL|DICTIONARY	il6	IL6	91#94		Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il 6	IL-6	5#9		Both IL-6 and the IL6 -174G>C promoter polymorphism have been linked to various diseases associated with inflammation.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il6	IL6	18#21		Both IL-6 and the IL6 -174G>C promoter polymorphism have been linked to various diseases associated with inflammation.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_2/3	2	4	3569	SYMBOL|DICTIONARY	il6	IL6	73#76		We postulated that serum proteome analysis of individuals with different IL6 -174G>C genotypes would provide insight on genotype-phenotype associations of this polymorphism and its role in disease susceptibility.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il6	IL6	139#142		Serum from a random sample of control participants in an ongoing population-based case-control study of non-Hodgkin lymphoma was pooled by IL6 genotype and used to screen for the optimal SELDI-TOF MS arrays for analysis.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	7	341	LONGTERM|DICTIONARY	apolipoprotein c i	apolipoprotein C-I	75#93		In particular, we report an association of the -174C allele with increased apolipoprotein C-I (ApoC-I).
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	7	341	SYMBOL|()|DICTIONARY|EXTRACTED	apoc i	ApoC-I	95#101	17309100-7-75-93	In particular, we report an association of the -174C allele with increased apolipoprotein C-I (ApoC-I).
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY	il6	IL6	191#194		Additionally, we corroborate previous findings of an association of the -174C allele with lower autoantibodies to heat shock protein 60 and confirm the absence of any association between the IL6 -174G>C genotype and serum IL-6 levels.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	222#226		Additionally, we corroborate previous findings of an association of the -174C allele with lower autoantibodies to heat shock protein 60 and confirm the absence of any association between the IL6 -174G>C genotype and serum IL-6 levels.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	10	3569	SYMBOL|DICTIONARY	il6	IL6	69#72		Additional studies are needed to clarify the interaction between the IL6 -174G>C polymorphism and ApoC-I.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_3/3	3	10	341	SYMBOL|DICTIONARY|EXTRACTED	apoc i	ApoC-I	98#104	17309100-7-75-93	Additional studies are needed to clarify the interaction between the IL6 -174G>C polymorphism and ApoC-I.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	0#4		DRB1*04, DRB1*09, DRB1*12 and DRB1*15 were the most common genotypes in all the groups.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	9#13		DRB1*04, DRB1*09, DRB1*12 and DRB1*15 were the most common genotypes in all the groups.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	7	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	18#22		DRB1*04, DRB1*09, DRB1*12 and DRB1*15 were the most common genotypes in all the groups.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	7	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	30#34		DRB1*04, DRB1*09, DRB1*12 and DRB1*15 were the most common genotypes in all the groups.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	8	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	26#34		The allele frequencies of HLA-DRB1*03 [10.6% of HBV-infected patients vs 3.7% of spontaneously cleared controls, odds ratios (OR) = 3.10, Pc = 0.008, P < 0.05] and HLA-DRB1*07 (17.6% of HBV-infected patients vs 9.3% of spontaneously cleared controls, Pc = 0.016, OR = 2.09, P < 0.05) were markedly higher in the HBV-infected group.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	8	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	164#172		The allele frequencies of HLA-DRB1*03 [10.6% of HBV-infected patients vs 3.7% of spontaneously cleared controls, odds ratios (OR) = 3.10, Pc = 0.008, P < 0.05] and HLA-DRB1*07 (17.6% of HBV-infected patients vs 9.3% of spontaneously cleared controls, Pc = 0.016, OR = 2.09, P < 0.05) were markedly higher in the HBV-infected group.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	117#121		The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	11	3123	SYMBOL|DICTIONARY	drb1	DRB1	29#33		Similar results were got for DRB1*03 and 15 alleles between the HBV-infected patients (n = 108) and 46 HBV seronegative spouses of the HBV patients, who were high-risk group for HBV infection.
17197814	2007	AIDS	0269-9370	TITLE	0	0	3106	SYMBOL|DICTIONARY	hla b	HLA-B	0#5		HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples.
17197814	2007	AIDS	0269-9370	BACKGROUND	1	2	3106	SYMBOL|DICTIONARY	hla b	HLA-B	8#13		Because HLA-B alleles influence HIV-1 disease progression and viral levels, they might also influence HIV-1 transmission.
17197814	2007	AIDS	0269-9370	OBJECTIVE	2	3	3106	SYMBOL|DICTIONARY	hla b	HLA-B	34#39		To investigate if the presence of HLA-B alleles with the Bw4 epitope in HIV-1-infected men decreased the risk of transmission to their female sex partners.
17197814	2007	AIDS	0269-9370	RESULTS	4	9	3106	SYMBOL|DICTIONARY	hla b	HLA-B	53#58		HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	11	3106	SYMBOL|DICTIONARY	hla b	HLA-B	180#185		Transmission was higher among couples in which the man's ethnicity was other than White (OR, 2.60; 95% CI, 1.25-5.40; P = 0.01), but the association between HIV-1 transmission and HLA-B genotype was not confounded by race.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	627	LONGTERM|GENE|GN|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	39#72		Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		Brain-derived neurotrophic factor (BDNF) plays an important role in normal neuronal development.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	35#39	17044097-1-0-33	Brain-derived neurotrophic factor (BDNF) plays an important role in normal neuronal development.
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	55#59	17044097-1-0-33	Several lines of evidence implicate the involvement of BDNF in attention-deficit hyperactivity disorder (ADHD).
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	47#51	17044097-1-0-33	This study investigated the role of two common BDNF variants (Val66Met, C270T) in two samples of ADHD probands from the United Kingdom (n = 180) and Taiwan (n = 212).
17044097	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	61#65	17044097-1-0-33	This study provides evidence for the possible involvement of BDNF in susceptibility to ADHD.
17522430	2007	Cancer Biomark	1574-0153	TITLE	0	0	8743	SYMBOL|GENE|GN|DICTIONARY	trail	TRAIL	17#22		Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	1	8743	SYMBOL|DICTIONARY	trail	TRAIL	0#5		TRAIL is a potent inducer of apoptosis in malignant but not in normal cells.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	2	8743	SYMBOL|DICTIONARY	trail	TRAIL	0#5		TRAIL binds to the proapoptotic death receptor DR4 and DR5 as well as to the decoy receptors DcR1 and DcR2.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	2	8794	SYMBOL|DICTIONARY	dcr1	DcR1	93#97		TRAIL binds to the proapoptotic death receptor DR4 and DR5 as well as to the decoy receptors DcR1 and DcR2.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	2	8793	SYMBOL|DICTIONARY	dcr2	DcR2	102#106		TRAIL binds to the proapoptotic death receptor DR4 and DR5 as well as to the decoy receptors DcR1 and DcR2.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_2/3	2	3	8743	SYMBOL|GENE|GN|DICTIONARY	trail	TRAIL	31#36		To evaluate the involvement of TRAIL receptor genes in breast cancer, we carried out a case-control study of eight selected polymorphisms in a large sample of Spanish women.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_2/3	2	4	8793	SYMBOL|DICTIONARY	dcr2	DcR2	75#79		Three of the eight selected SNPs (626G/C and 1322G/A in DR4 and 2699A/G in DcR2) showed some evidence of different genotype distributions in a random selection of 535 cases and 480 controls and were therefore studied in our entire sample (1008 cases and 768 controls).
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	6	8793	SYMBOL|DICTIONARY	dcr2	DcR2	50#54		Interestingly, allele 2699G in the decoy receptor DcR2 appears associated with reduced breast cancer risk (P=0.05).
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	7	8793	SYMBOL|GFAM|FN|DICTIONARY	dcr2	DcR2	71#75		Given that it is located in the 3' UTR, its effect might be related to DcR2 mRNA instability, or linkage disequilibrium with a functional variant residing in either DcR2 or neighbouring genes.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	7	8793	SYMBOL|DICTIONARY	dcr2	DcR2	165#169		Given that it is located in the 3' UTR, its effect might be related to DcR2 mRNA instability, or linkage disequilibrium with a functional variant residing in either DcR2 or neighbouring genes.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	8	8793	SYMBOL|DICTIONARY	dcr2	DcR2	26#30		A decreased efficiency of DcR2 to work as decoy receptor for TRAIL, would facilitate the apoptotic pathway in cells at risk.
17522430	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	8	8743	SYMBOL|DICTIONARY	trail	TRAIL	61#66		A decreased efficiency of DcR2 to work as decoy receptor for TRAIL, would facilitate the apoptotic pathway in cells at risk.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	TITLE	0	0	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	25#30		A common polymorphism in SCN5A is associated with lone atrial fibrillation.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_1/3	1	1	6331	SYMBOL|()|DICTIONARY	scn5a	SCN5A	28#33		The cardiac sodium channel (SCN5A) is a target for the treatment of arrhythmias.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_1/3	1	2	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	103#108		We hypothesized that vulnerability to atrial fibrillation (AF) could be caused by genetic variation in SCN5A.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_2/3	2	4	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	0#5		SCN5A was subject to targeted genotyping of a common loss-of-function H558R polymorphism and comprehensive mutation scanning.
17185997	2007	Clin. Pharmacol. Ther.	0009-9236	ALL_TEXT_3/3	3	8	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	4#9		The SCN5A R558 allele, present in one-third of the population, thus constitutes a risk factor for lone AF and may increase susceptibility to sodium channel blocker-induced proarrhythmia.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6256	SYMBOL|DICTIONARY	rxra	RXRA	165#169		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	METHODS	2	2	6257	SYMBOL|GENE|GN|DICTIONARY	rxrb	RXRB	174#178		A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study focused on 3 polymorphisms in RXRA and RXRB gene associations.
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	3	6256	SYMBOL|DICTIONARY	rxra	RXRA	65#69		A marginally significant increase in AA allelic frequency of the RXRA A39526AA polymorphism in plaque psoriatic men compared to healthy men was proved.
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	4	6257	SYMBOL|NUMBER|DICTIONARY	rxrb	RXRB	80#84		In women with psoriasis guttata, the higher risk for genotypes AA and TT in the RXRB 3'+140A/T polymorphism compared to healthy women was identified (p(corr) = 0.01).
17341859	2007	Dermatology (Basel)	1018-8665	RESULTS	3	7	6257	SYMBOL|DICTIONARY	rxrb	RXRB	7#11		In the RXRB polymorphism, no genotype TT is observed in patients with psoriasis guttata with a positive personal history of repeated tonsillitis (p(corr) = 0.001).
17473385	2007	Dis. Markers	0278-0240	TITLE	0	0	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	Lipoprotein lipase	0#18		Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: meta-analysis.
17473385	2007	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	lipoprotein lipase	33#51		Our aim was to determine whether lipoprotein lipase gene PvuII polymorphism can be considered as an independent risk factor for coronary artery disease (CAD) by conducting a meta-analysis of all available published trials, including our own study.
17595907	2007	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	10	3091	SYMBOL|DICTIONARY	hif 1alpha	HIF- 1alpha	57#68		These results suggest that the C1772-->T polymorphism in HIF- 1alpha does not contribute to individual peculiarities of adaptation to IHT.
17241880	2007	Gastroenterology	0016-5085	TITLE	0	0	7036	LONGTERM|GENE|GN|DICTIONARY	transferrin receptor 2	transferrin receptor 2	35#57		Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	1	7036	LONGTERM|DICTIONARY	transferrin receptor 2	Transferrin receptor 2	0#22		Transferrin receptor 2 (TfR2) plays a key role in the regulation of iron metabolism.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	1	7036	SYMBOL|()|DICTIONARY|EXTRACTED	tfr2	TfR2	24#28	17241880-1-0-22	Transferrin receptor 2 (TfR2) plays a key role in the regulation of iron metabolism.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	2	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	13#17	17241880-1-0-22	Mutations of TfR2 in humans cause type 3 hereditary hemochromatosis.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	3	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	66#70	17241880-1-0-22	Although highly expressed in liver, several studies have reported TfR2 expression in other tissues.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	4	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	49#53	17241880-1-0-22	To determine the contribution of liver expressed TfR2 in iron homeostasis, we have generated and characterized a liver-specific TfR2-knockout (KO) mouse.
17241880	2007	Gastroenterology	0016-5085	BACKGROUND &amp; AIMS	1	4	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	128#132	17241880-1-0-22	To determine the contribution of liver expressed TfR2 in iron homeostasis, we have generated and characterized a liver-specific TfR2-knockout (KO) mouse.
17241880	2007	Gastroenterology	0016-5085	METHODS	2	5	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	15#19	17241880-1-0-22	Liver-specific TfR2-KO mice were generated by crossing TfR2-floxed mice with transgenic albumin-Cre mice.
17241880	2007	Gastroenterology	0016-5085	METHODS	2	5	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	55#59	17241880-1-0-22	Liver-specific TfR2-KO mice were generated by crossing TfR2-floxed mice with transgenic albumin-Cre mice.
17241880	2007	Gastroenterology	0016-5085	METHODS	2	6	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	33#37	17241880-1-0-22	Tissue and serum from homozygous TfR2-floxed mice with and without albumin-Cre were analyzed.
17241880	2007	Gastroenterology	0016-5085	METHODS	2	9	7037	SYMBOL|DICTIONARY	tfr1	TfR1	36#40		Levels of the iron-related proteins TfR1, TfR2, ferritin, and prohepcidin were analyzed by immunoblotting.
17241880	2007	Gastroenterology	0016-5085	METHODS	2	9	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	42#46	17241880-1-0-22	Levels of the iron-related proteins TfR1, TfR2, ferritin, and prohepcidin were analyzed by immunoblotting.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	10	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	15#19	17241880-1-0-22	Liver-specific TfR2-KO mice develop significant iron overload comparable to complete TfR2-KO mice.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	10	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	85#89	17241880-1-0-22	Liver-specific TfR2-KO mice develop significant iron overload comparable to complete TfR2-KO mice.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	12	7036	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	tfr2	TfR2	8#12	17241880-1-0-22	Hepatic TfR2 mRNA and protein were absent in the livers of liver-specific TfR2-KO mice, and TfR1 expression was reduced consistent with liver iron loading.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	12	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	74#78	17241880-1-0-22	Hepatic TfR2 mRNA and protein were absent in the livers of liver-specific TfR2-KO mice, and TfR1 expression was reduced consistent with liver iron loading.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	12	7037	SYMBOL|DICTIONARY	tfr1	TfR1	92#96		Hepatic TfR2 mRNA and protein were absent in the livers of liver-specific TfR2-KO mice, and TfR1 expression was reduced consistent with liver iron loading.
17241880	2007	Gastroenterology	0016-5085	RESULTS	3	13	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	92#96	17241880-1-0-22	At 5 weeks of age, hepcidin1 mRNA, and prohepcidin protein were decreased in liver-specific TfR2-KO compared to control mice.
17241880	2007	Gastroenterology	0016-5085	CONCLUSIONS	4	14	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	98#102	17241880-1-0-22	The significant iron loading and modulation of expression of iron-related genes in liver-specific TfR2-KO mice demonstrates that the liver is the primary site for TfR2 expression and activity and that liver-expressed TfR2 is required for the regulation of hepcidin1.
17241880	2007	Gastroenterology	0016-5085	CONCLUSIONS	4	14	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	163#167	17241880-1-0-22	The significant iron loading and modulation of expression of iron-related genes in liver-specific TfR2-KO mice demonstrates that the liver is the primary site for TfR2 expression and activity and that liver-expressed TfR2 is required for the regulation of hepcidin1.
17241880	2007	Gastroenterology	0016-5085	CONCLUSIONS	4	14	7036	SYMBOL|DICTIONARY|EXTRACTED	tfr2	TfR2	217#221	17241880-1-0-22	The significant iron loading and modulation of expression of iron-related genes in liver-specific TfR2-KO mice demonstrates that the liver is the primary site for TfR2 expression and activity and that liver-expressed TfR2 is required for the regulation of hepcidin1.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_2/3	2	7	1277	SYMBOL|DICTIONARY	col1a1	COL1A1	59#65		The most significant findings for association with PE were COL1A1 (p = 0.0011) and IL1A (p = 0.0014) for the maternal genotype, and PLAUR (p = 0.0008) for the offspring genotype.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_2/3	2	7	3552	SYMBOL|DICTIONARY	il1a	IL1A	83#87		The most significant findings for association with PE were COL1A1 (p = 0.0011) and IL1A (p = 0.0014) for the maternal genotype, and PLAUR (p = 0.0008) for the offspring genotype.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_2/3	2	7	5329	SYMBOL|DICTIONARY	plaur	PLAUR	132#137		The most significant findings for association with PE were COL1A1 (p = 0.0011) and IL1A (p = 0.0014) for the maternal genotype, and PLAUR (p = 0.0008) for the offspring genotype.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_2/3	2	8	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	41#46		Common candidate genes for PE, including MTHFR and NOS3, were not significantly associated with PE.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_2/3	2	8	4846	SYMBOL|DICTIONARY	nos3	NOS3	51#55		Common candidate genes for PE, including MTHFR and NOS3, were not significantly associated with PE.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_3/3	3	9	3479	SYMBOL|DICTIONARY	igf1	IGF1	39#43		For the interaction model, SNPs within IGF1 (p = 0.0035) and IL4R (p = 0.0036) gave the most significant results.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_3/3	3	9	3566	SYMBOL|DICTIONARY	il4r	IL4R	61#65		For the interaction model, SNPs within IGF1 (p = 0.0035) and IL4R (p = 0.0036) gave the most significant results.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_3/3	3	11	1277	SYMBOL|DICTIONARY	col1a1	COL1A1	295#301		Although we did not identify statistically significant evidence of association for any of the candidate loci evaluated here after adjusting for multiple testing using the false discovery rate, additional compelling evidence exists, including multiple SNPs with nominally significant p values in COL1A1 and the IL1A region, and previous reports of association for IL1A, to support continued interest in these genes as candidates for PE.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_3/3	3	11	3552	SYMBOL|DICTIONARY	il1a	IL1A	310#314		Although we did not identify statistically significant evidence of association for any of the candidate loci evaluated here after adjusting for multiple testing using the false discovery rate, additional compelling evidence exists, including multiple SNPs with nominally significant p values in COL1A1 and the IL1A region, and previous reports of association for IL1A, to support continued interest in these genes as candidates for PE.
17179726	2007	Hum. Hered.	0001-5652	ALL_TEXT_3/3	3	11	3552	SYMBOL|DICTIONARY	il1a	IL1A	363#367		Although we did not identify statistically significant evidence of association for any of the candidate loci evaluated here after adjusting for multiple testing using the false discovery rate, additional compelling evidence exists, including multiple SNPs with nominally significant p values in COL1A1 and the IL1A region, and previous reports of association for IL1A, to support continued interest in these genes as candidates for PE.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	4#9		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	69#74		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	101#106		The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	2950	SYMBOL|()|DICTIONARY	gstp1	GSTP1	30#35		Glutathione S-transferase P1 (GSTP1), the abundant isoform of glutathione S-transferases (GSTs) in lung epithelium, plays a key role in cellular protection against oxidative stress.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	4	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	36#41		Several studies have shown that the GSTP1 geneis involved in the pathogenesis of asthma and a gene-gene interaction may occur within the GST gene superfamily.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	58#63		We screened single-nucleotide polymorphisms (SNPs) at the GSTP1 locus and performed an association study in the Japanese population using two independent case-control groups (group 1: 391 pediatric patients with asthma, 462 adult patients with asthma, and 639 controls, and group 2: 115 pediatric patients with asthma and 184 controls).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	14#19		The effect of GSTM1 null/present genotype on the association between GSTP1 Ile105Val and asthma was also investigated.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	69#74		The effect of GSTM1 null/present genotype on the association between GSTP1 Ile105Val and asthma was also investigated.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	8	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	58#63		The association between the Ile105Val polymorphism in the GSTP1 gene and childhood asthma was significant in both groups (p = 0.047 in group 1, and p = 0.021 in group 2).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	55#60		This association was only significant in patients with GSTM1-positive genotype in both groups (group 1: GSTM1 present p = 0.013 and GSTM1 null p = 0.925, and group 2: GSTM1 present p = 0.015 and GSTM1 null p = 0.362).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	104#109		This association was only significant in patients with GSTM1-positive genotype in both groups (group 1: GSTM1 present p = 0.013 and GSTM1 null p = 0.925, and group 2: GSTM1 present p = 0.015 and GSTM1 null p = 0.362).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	132#137		This association was only significant in patients with GSTM1-positive genotype in both groups (group 1: GSTM1 present p = 0.013 and GSTM1 null p = 0.925, and group 2: GSTM1 present p = 0.015 and GSTM1 null p = 0.362).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	167#172		This association was only significant in patients with GSTM1-positive genotype in both groups (group 1: GSTM1 present p = 0.013 and GSTM1 null p = 0.925, and group 2: GSTM1 present p = 0.015 and GSTM1 null p = 0.362).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	195#200		This association was only significant in patients with GSTM1-positive genotype in both groups (group 1: GSTM1 present p = 0.013 and GSTM1 null p = 0.925, and group 2: GSTM1 present p = 0.015 and GSTM1 null p = 0.362).
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	32#37		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	91#96		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSIONS	4	10	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	124#129		These findings suggest that the GSTP1 gene is a childhood asthma susceptible gene, and the GSTM1 gene is a modifier gene of GSTP1 for the risk of childhood asthma in the Japanese population.
17627031	2007	Neuromolecular Med.	1535-1084	ALL_TEXT_3/3	3	7	1815	SYMBOL|DICTIONARY	drd4	DRD4	120#124		The quantitative transmission disequilibrium tests-based association analysis suggested that functional variants of the DRD4 and MAO-A genes modulate memory-related cognition.
17627031	2007	Neuromolecular Med.	1535-1084	ALL_TEXT_3/3	3	7	4128	SYMBOL|GENE|GN|DICTIONARY	mao a	MAO-A	129#134		The quantitative transmission disequilibrium tests-based association analysis suggested that functional variants of the DRD4 and MAO-A genes modulate memory-related cognition.
16757160	2007	Respir Med	0954-6111	BACKGROUND	1	1	3565	SYMBOL|GENE|GN|DICTIONARY	il 4	IL-4	0#4		IL-4 receptor alpha chain is crucial for the binding and signaling of IL-4, which mediates isotype switching and IgE production.
16757160	2007	Respir Med	0954-6111	BACKGROUND	1	1	3565	SYMBOL|DICTIONARY	il 4	IL-4	70#74		IL-4 receptor alpha chain is crucial for the binding and signaling of IL-4, which mediates isotype switching and IgE production.
16757160	2007	Respir Med	0954-6111	CONCLUSION	5	12	3566	SYMBOL|GENE|GN|DICTIONARY	il 4ra	IL-4RA	0#6		IL-4RA gene polymorphisms and its haplotypes showed ethnic variations.
16757160	2007	Respir Med	0954-6111	CONCLUSION	5	13	3566	SYMBOL|GENE|GN|DICTIONARY	il 4ra	IL-4RA	24#30		The association between IL-4RA gene polymorphisms, its haplotypes and asthma differed from ethnicities.
17179858	2007	Neuroreport	0959-4965	TITLE	0	0	120892	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	26#31		A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_1/3	1	2	120892	LONGTERM|DICTIONARY|GENE|GA	leucine rich repeat kinase 2	leucine-rich repeat kinase 2	22#50		The identification of leucine-rich repeat kinase 2 (LRRK2) gene mutations as a cause of Parkinson's disease has greatly expanded our knowledge of the genetic and molecular pathogenesis of this disorder.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_1/3	1	2	120892	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	52#57	17179858-2-22-50	The identification of leucine-rich repeat kinase 2 (LRRK2) gene mutations as a cause of Parkinson's disease has greatly expanded our knowledge of the genetic and molecular pathogenesis of this disorder.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_2/3	2	3	120892	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	221#226	17179858-2-22-50	By denaturing high-performance liquid chromatography and gene sequencing in patients and controls, we identified a novel frequent heterozygous 2264C-->T substitution, which causes a proline-to-leucine mutation (P755L) in LRRK2 gene.
17179858	2007	Neuroreport	0959-4965	ALL_TEXT_2/3	2	4	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	81#86	17179858-2-22-50	In our sample of 598 patients of Chinese Han ancestry, 12 cases carried the same LRRK2 mutation.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	dopamine D4 receptor	24#44		Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	46#50	16917940-0-24-44	Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY|GA	dopamine d4 receptor	Dopamine D4 receptor	0#20		Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	22#26	16917940-0-24-44	Dopamine D4 receptor (DRD4) gene is implicated in the pathogenesis of attention deficit hyperactivity disorder (ADHD).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	4	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	83#87	16917940-0-24-44	We therefore perform another study to investigate the association between ADHD and DRD4 gene polymorphism in Chinese children in Hong Kong.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	6	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	26#30	16917940-0-24-44	VNTR polymorphisms of the DRD4 gene were determined by standard PCR followed by agarose gel electrophoresis.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	9	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	83#87	16917940-0-24-44	Both family-based and case-control analyses showed no association between ADHD and DRD4 gene polymorphisms (transmission dysequilibrium test (TDT): P = 0.91 and P = 0.33 for the 7-repeat and 4-repeat alleles, respectively; OR for the 7-repeat allele = 2.01 (95% CI 0.07-60.4, P = 0.66), OR for the 4-repeat allele = 1.51 (95% CI 0.80-2.85, P = 0.2)).
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	11	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	84#88	16917940-0-24-44	We concluded that ADHD is not associated with a particular VNTR polymorphism of the DRD4 gene.
16917940	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	12	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	90#94	16917940-0-24-44	Further studies are needed to clarify the role of repeat length of the VNTR region of the DRD4 gene in the pathogenesis of ADHD.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5663	LONGTERM|DICTIONARY	presenilin 1	presenilin 1	39#51		Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5663	SYMBOL|()|DICTIONARY|EXTRACTED	psen1	PSEN1	53#58	17186461-5-39-51	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5664	LONGTERM|DICTIONARY	presenilin 2	presenilin 2	63#75		Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	5	5664	SYMBOL|()|DICTIONARY|EXTRACTED	psen2	PSEN2	77#82	17186461-5-63-75	Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	80#85	17186461-5-39-51	A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	90#95	17186461-5-63-75	A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	10	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	8#13	17186461-5-39-51	A novel PSEN1 missense mutation (Asp333Gly) was identified in one family, and a single PSEN2 missense mutation (Ser130Leu) was found in two other families.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	10	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	87#92	17186461-5-63-75	A novel PSEN1 missense mutation (Asp333Gly) was identified in one family, and a single PSEN2 missense mutation (Ser130Leu) was found in two other families.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	12	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	4#9	17186461-5-39-51	The PSEN1 mutation was associated with complete penetrance and progressive disease that resulted in the necessity of cardiac transplantation or in death.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	13	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	4#9	17186461-5-63-75	The PSEN2 mutation showed partial penetrance, milder disease, and a more favorable prognosis.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	14	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	64#69	17186461-5-39-51	Calcium signaling was altered in cultured skin fibroblasts from PSEN1 and PSEN2 mutation carriers.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	14	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	74#79	17186461-5-63-75	Calcium signaling was altered in cultured skin fibroblasts from PSEN1 and PSEN2 mutation carriers.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5663	SYMBOL|DICTIONARY|EXTRACTED	psen1	PSEN1	25#30	17186461-5-39-51	These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
17186461	2007	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	15	5664	SYMBOL|DICTIONARY|EXTRACTED	psen2	PSEN2	35#40	17186461-5-63-75	These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.
16636019	2007	Gut	0017-5749	METHODS	3	3	4292	SYMBOL|DICTIONARY	mlh1	MLH1	157#161		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	4436	SYMBOL|DICTIONARY	msh2	MSH2	163#167		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	3	2956	SYMBOL|DICTIONARY	msh6	MSH6	172#176		In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification.
16636019	2007	Gut	0017-5749	METHODS	3	4	4292	SYMBOL|DICTIONARY	mlh1	MLH1	70#74		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	4436	SYMBOL|DICTIONARY	msh2	MSH2	76#80		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	METHODS	3	4	2956	SYMBOL|DICTIONARY	msh6	MSH6	85#89		MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours.
16636019	2007	Gut	0017-5749	RESULTS	4	5	4292	SYMBOL|NUMBER|DICTIONARY	mlh1	MLH1	30#34		25 pathogenic mutations (8 in MLH1, 9 in MSH2 and 8 in MSH6) were found.
16636019	2007	Gut	0017-5749	RESULTS	4	5	4436	SYMBOL|DICTIONARY	msh2	MSH2	41#45		25 pathogenic mutations (8 in MLH1, 9 in MSH2 and 8 in MSH6) were found.
16636019	2007	Gut	0017-5749	RESULTS	4	5	2956	SYMBOL|DICTIONARY	msh6	MSH6	55#59		25 pathogenic mutations (8 in MLH1, 9 in MSH2 and 8 in MSH6) were found.
17199794	2007	Nephrology (Carlton)	1320-5358	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	Angiotensin converting enzyme	0#29		Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin i converting enzyme	angiotensin I converting enzyme	51#82		Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	84#87	17199794-1-51-82	Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.
17199794	2007	Nephrology (Carlton)	1320-5358	AIM	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	33#36	17199794-1-51-82	We investigated the frequency of ACE polymorphisms and their impact on the clinical course of INS in children in a Swiss hospital.
17199794	2007	Nephrology (Carlton)	1320-5358	METHODS	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	The ACE gene polymorphism (I, insertion; D, deletion) was assessed in 32 children - 22 with steroid-sensitive INS and 10 with steroid-resistant INS - with a median age at onset of INS of 2.9 years (range 1.1-15.0).
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	4#7	17199794-1-51-82	The ACE genotype was I/I, I/D and D/D in two, 12 and eight patients, respectively, with steroid-sensitive INS, and in one, eight and one patient, respectively, with steroid resistance.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	8	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	45#48	17199794-1-51-82	There was no significant correlation between ACE genotype and steroid responsiveness, histology or outcome.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	9	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		ACE genotype was I/I, I/D and D/D in none, 12 and five patients, respectively, with minimal change glomerulopathy, and in one, five and two patients, respectively, with focal segmental glomerulosclerosis.
17199794	2007	Nephrology (Carlton)	1320-5358	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	90#93	17199794-1-51-82	Six patients with steroid-resistant nephrotic syndrome went into end stage renal disease; ACE genotype was I/I in one and I/D in five, but none were D/D.
17199794	2007	Nephrology (Carlton)	1320-5358	CONCLUSION	4	11	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	33#36	17199794-1-51-82	In contrast to previous reports, ACE gene polymorphism is irrelevant for clinical outcome, steroid responsiveness or morphology in Swiss children with INS.
17036313	2007	Am. J. Med. Genet. A	1552-4825	TITLE	0	0	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	5#16		V37I connexin 26 allele in patients with sensorineural hearing loss: evidence of its pathogenicity.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	4	2706	SYMBOL|()|DICTIONARY|EXTRACTED	gjb2	GJB2	43#47	17036313-4-30-36	Mutations of the gap junction beta-2 gene (GJB2) emerge as a leading cause of autosomal recessive non-syndromic SNHL.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	6	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	33#44		The status of the V37I allele of connexin 26 (GJB2 amino acid product) with regards to its association with SNHL has been controversial.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_2/3	2	6	2706	SYMBOL|DICTIONARY|EXTRACTED	gjb2	GJB2	46#50	17036313-4-30-36	The status of the V37I allele of connexin 26 (GJB2 amino acid product) with regards to its association with SNHL has been controversial.
17036313	2007	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_3/3	3	10	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	253#264		These results indicate that (1) the V37I allele is common in individuals of Chinese descent but rarely present in individuals of Caucasian decent; and (2) the V37I allele is pathogenic, but produces milder hearing loss compared to nonsense mutations of connexin 26 such as the 35delG mutation.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	22#26		The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	OBJECTIVE	1	3	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	4#8		The MDR1 gene product, P-glycoprotein (P-gp), is probably one of the most important and best defined transporters for drug delivery in humans.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	OBJECTIVE	1	3	5243	LONGTERM|DICTIONARY	p glycoprotein	P-glycoprotein	23#37		The MDR1 gene product, P-glycoprotein (P-gp), is probably one of the most important and best defined transporters for drug delivery in humans.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	OBJECTIVE	1	3	5243	SYMBOL|EXTRACTED|()	p gp	P-gp	39#43	16932953-3-23-37	The MDR1 gene product, P-glycoprotein (P-gp), is probably one of the most important and best defined transporters for drug delivery in humans.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	OBJECTIVE	1	5	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	63#67		The aim of this study was to examine the effect of the 3435C>T MDR1 gene polymorphism on the efficacy of RA treatment with disease-modifying antirheumatic drugs, i.e.
16932953	2007	Eur. J. Clin. Pharmacol.	0031-6970	CONCLUSION	4	9	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	60#64		The results from the present study suggest that the 3435C>T MDR1 gene polymorphism may influence the efficacy of RA therapy with disease-modifying antirheumatic drugs.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|GENE|GN|DICTIONARY	sert	SERT	76#80		Polymorphisms in the promoter region of the serotonin reuptake transporter (SERT) gene may underlie the disturbance in gut function in patients with irritable bowel syndrome (IBS).
17040410	2006	Neurogastroenterol. Motil.	1350-1925	ALL_TEXT_3/3	3	10	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	136#140		A significant association was observed between the SERT polymorphism and IBS, especially diarrhoea-predominant IBS, suggesting that the SERT gene is a potential candidate gene involved in IBS in Korea.
16816977	2007	Neurogenetics	1364-6745	TITLE	0	0	1815	SYMBOL|NUMBER|DICTIONARY	drd4	DRD4	164#168		Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1812	SYMBOL|DICTIONARY	drd1	DRD1	249#253		We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1813	SYMBOL|DICTIONARY	drd2	DRD2	255#259		We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1814	SYMBOL|DICTIONARY	drd3	DRD3	261#265		We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	271#275		We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	281#301		We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets.
16816977	2007	Neurogenetics	1364-6745	ALL_TEXT_3/3	3	5	1815	SYMBOL|GENE|GN|DICTIONARY	drd4	DRD4	62#66		Of the several markers analyzed, 120 bp duplication marker of DRD4 gene showed promising results with PD in both of the sample sets.
17138064	2007	Transpl. Immunol.	0966-3274	UNLABELLED	1	3	3586	SYMBOL|DICTIONARY	il10	IL10	11#15		Effects of IL10, IL6 and IFNG gene polymorphisms, known to affect CMV infectivity, were investigated in 71 CMV seronegative recipients of grafts from CMV seropositive cadaver donors.
17138064	2007	Transpl. Immunol.	0966-3274	UNLABELLED	1	4	3586	SYMBOL|DICTIONARY	il10	IL10	6#10		Donor IL10(-1082 AA) genotype reduced the incidence of CMV infection (p=0.031) and CMV episodes in these patients tended to occur later (AA: median 83 days,
17138064	2007	Transpl. Immunol.	0966-3274	AG/GG	2	5	3586	SYMBOL|DICTIONARY	il10	IL10	91#95		median 45 days, p=0.072).In multivariate analysis, other explaining factors than the donor IL10(-1082 AA) genotype alone did not improve Cox hazard model (HR=0.3, 95% CI=0.09-0.96, p=0.043).
17138064	2007	Transpl. Immunol.	0966-3274	AG/GG	2	7	3586	SYMBOL|GENE|GN|DICTIONARY	il10	IL10	23#27		We conclude that donor IL10 gene polymorphisms may influence the likelihood of CMV infection in the high risk patients investigated.
16721725	2006	Int. J. Cancer	0020-7136	TITLE	0	0	10	SYMBOL|DICTIONARY	nat2	NAT2	17#21		Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	5241	LONGTERM|GENE|GT|DICTIONARY	progesterone receptor	progesterone receptor	68#89		We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	5241	SYMBOL|EXTRACTED|()	pr	PR	91#93	16721725-3-68-89	We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	3	10	SYMBOL|()|DICTIONARY	nat2	NAT2	198#202		We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype.
16721725	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	0#4		NAT2 slow vs. rapid/intermediate acetylation genotype was not related to breast cancer risk (0.99 (0.87-1.13)), and did not significantly modify the smoking relationships.
16882462	2007	Ann Epidemiol	1047-2797	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort.
16882462	2007	Ann Epidemiol	1047-2797	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	60#76		The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence.
16882462	2007	Ann Epidemiol	1047-2797	PURPOSE	1	1	348	SYMBOL|EXTRACTED|()	apoe	apoE	78#82	16882462-1-60-76	The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence.
16882462	2007	Ann Epidemiol	1047-2797	CONCLUSIONS	4	7	348	SYMBOL|EXTRACTED	apoe	apoE	68#72	16882462-1-60-76	These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites.
16855621	2007	Genes Immun.	1466-4879	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritis.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	107#111		In the current study, we aimed to provide much less expensive typing approach with high predictability for DRB1 genotype.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	322#326		We have used a panel of three microsatellite markers in the class II region (D6S2666, D6S2665 and D6S2446) for genotyping and haplotype reconstruction in a total of 1687 Caucasian (1313 RA patients and 374 controls) and 1364 Korean individuals (744 RA patients and 620 controls), all of whom were previously genotyped for DRB1.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3123	SYMBOL|DICTIONARY	drb1	DRB1	45#49		Interestingly, we found that the majority of DRB1*09 and DRB1*10 alleles share a common three-marker haplotype in both Caucasian and Asian populations.
16855621	2007	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	57#61		Interestingly, we found that the majority of DRB1*09 and DRB1*10 alleles share a common three-marker haplotype in both Caucasian and Asian populations.
17050201	2006	Int. J. Hematol.	0925-5710	TITLE	0	0	2322	SYMBOL|DICTIONARY	flt3	flt3	43#47		Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication.
17050201	2006	Int. J. Hematol.	0925-5710	TITLE	0	0	2322	SYMBOL|DICTIONARY	flt3	flt3	73#77		Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	0#4		Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	Flt3	34#38		Flt3 internal tandem duplication (Flt3-ITD) is a prevalent mutation in acute myeloid leukemia (AML).
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_1/3	1	2	2322	SYMBOL|DICTIONARY	flt3	Flt3	0#4		Flt3-ITD constitutively activates various signaling pathways, including a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_2/3	2	4	2322	SYMBOL|DICTIONARY	flt3	Flt3	51#55		In this study, we aimed to clarify whether ATO and Flt3 inhibition would be a more specific and efficient therapy for Flt3-ITD cells.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_2/3	2	4	2322	SYMBOL|DICTIONARY	flt3	Flt3	118#122		In this study, we aimed to clarify whether ATO and Flt3 inhibition would be a more specific and efficient therapy for Flt3-ITD cells.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	5	2322	SYMBOL|DICTIONARY	flt3	Flt3	50#54		We demonstrate that the combination of ATO and an Flt3 inhibitor, AG1296, profoundly inhibits the growth of Flt3-ITD cells and induces their apoptosis.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	5	2322	SYMBOL|DICTIONARY	flt3	Flt3	108#112		We demonstrate that the combination of ATO and an Flt3 inhibitor, AG1296, profoundly inhibits the growth of Flt3-ITD cells and induces their apoptosis.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	7	2322	SYMBOL|DICTIONARY	flt3	Flt3	114#118		Moreover, using the Chou-Talalay method, we observed a synergistic growth-inhibitory effect for ATO and AG1296 in Flt3-ITD cells (BaF3-Flt3-ITD, MV4-11, and PL-21 cells), but not in Flt3 wild-type cells (RS4-11 and NB4 cells), for almost all dose ranges tested.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	7	2322	SYMBOL|DICTIONARY	flt3	Flt3	135#139		Moreover, using the Chou-Talalay method, we observed a synergistic growth-inhibitory effect for ATO and AG1296 in Flt3-ITD cells (BaF3-Flt3-ITD, MV4-11, and PL-21 cells), but not in Flt3 wild-type cells (RS4-11 and NB4 cells), for almost all dose ranges tested.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	7	2322	SYMBOL|DICTIONARY	flt3	Flt3	182#186		Moreover, using the Chou-Talalay method, we observed a synergistic growth-inhibitory effect for ATO and AG1296 in Flt3-ITD cells (BaF3-Flt3-ITD, MV4-11, and PL-21 cells), but not in Flt3 wild-type cells (RS4-11 and NB4 cells), for almost all dose ranges tested.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	8	2322	SYMBOL|DICTIONARY	flt3	Flt3	83#87		Our results provide an experimental basis for a specific and efficient therapy for Flt3-ITD cells that involves combined treatment with Flt3 inhibitors and ATO.
17050201	2006	Int. J. Hematol.	0925-5710	ALL_TEXT_3/3	3	8	2322	SYMBOL|DICTIONARY	flt3	Flt3	136#140		Our results provide an experimental basis for a specific and efficient therapy for Flt3-ITD cells that involves combined treatment with Flt3 inhibitors and ATO.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7827	SYMBOL|DICTIONARY	nphs2	NPHS2	198#203		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	23607	SYMBOL|DICTIONARY	cd2ap	CD2AP	205#210		We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16911713	2006	Am. J. Reprod. Immunol.	1046-7408	ALL_TEXT_2/3	2	3	3554	LONGTERM|DICTIONARY|GENE|GA	interleukin 1 receptor type i	interleukin-1 receptor type I	60#89		Distributions of two single-base polymorphisms of the human interleukin-1 receptor type I (IL-1RI) gene were evaluated: PstI, due to a C-->T transition in exon 1B and BsrBI a C-->A transition at position 52 in exon 1C.
16911713	2006	Am. J. Reprod. Immunol.	1046-7408	ALL_TEXT_2/3	2	3	3554	SYMBOL|EXTRACTED|()|GENE|GN	il 1ri	IL-1RI	91#97	16911713-3-60-89	Distributions of two single-base polymorphisms of the human interleukin-1 receptor type I (IL-1RI) gene were evaluated: PstI, due to a C-->T transition in exon 1B and BsrBI a C-->A transition at position 52 in exon 1C.
17094469	2006	Anticancer Res.	0250-7005	TITLE	0	0	4193	SYMBOL|DICTIONARY	mdm2	MDM2	0#4		MDM2 T309G polymorphism is associated with bladder cancer.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	1	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	91#95		Recently, a functional T to G polymorphism at nucleotide 309 in the promoter region of the MDM2 gene (rs: 2279744, SNP 309) has been identified.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	57#61		This polymorphism has an impact on the expression of the MDM2 gene, which is a key negative regulator of the tumor suppressor molecule p53.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	p53	p53	135#138		This polymorphism has an impact on the expression of the MDM2 gene, which is a key negative regulator of the tumor suppressor molecule p53.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	3	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	40#44		The effect of T309G polymorphism of the MDM2 gene on bladder cancer susceptibility was investigated in a case-control study of 75 bladder cancer patients and 103 controls from Turkey.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	4193	SYMBOL|DICTIONARY	mdm2	MDM2	42#46		These results show an association between MDM2 T309G polymorphism and bladder cancer in our study group.
17094469	2006	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	4193	SYMBOL|DICTIONARY	mdm2	MDM2	69#73		To the best of our knowledge, this is the first study reporting that MDM2 T309G polymorphism may be a potential genetic susceptibility factor for bladder cancer.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	17#21		"Are carriers for MEFV mutations ""healthy""?"
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	45#49		We aimed to compare whether carriers for the MEFV mutations display an increase or decrease in certain features.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	4210	SYMBOL|DICTIONARY	mefv	MEFV	270#274		The presence of febrile episodes more than four per year, arthralgia, past diagnosis for acute rheumatic fever, rheumatoid arthritis and prophylaxis of penicillin, acute rheumatic fever, and rheumatoid arthritis were significantly higher in asymptomatic parents for the MEFV mutations compared to controls.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	20#24		We suggest that one MEFV mutation may indeed be conferring a heightened inflammation as suggested by the increased frequency in inflammatory symptoms.
17067442	2007	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	11	4210	SYMBOL|DICTIONARY	mefv	MEFV	23#27		"The carrier status for MEFV mutations seem to be unique, in that they cause an alteration in the state of ""health""."
16956834	2006	Haematologica	1592-8721	TITLE	0	0	4846	SYMBOL|GENE|GN|DICTIONARY	ecnos	ecNOS	9#14		ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin 1	19#31		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	1906	SYMBOL|EXTRACTED|()	et 1	ET-1	33#37	16956834-1-19-31	The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	1	4846	SYMBOL|()|GENE|GN|DICTIONARY	ecnos	ecNOS	91#96		The association of endothelin 1 (ET-1) and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms (G5665T and T8002C, VNTR and T-786C respectively) with the occurrence of acute chest syndrome and painful vaso-occlusive crises was evaluated in homozygous SS children.
16956834	2006	Haematologica	1592-8721	ALL_TEXT	1	2	1906	SYMBOL|EXTRACTED	et 1	ET-1	38#42	16956834-1-19-31	This retrospective study reveals that ET-1 T8002 and ecNOS C-786 alleles are associated with, respectively, an increased and a decreased risk of acute chest syndrome.
16945136	2006	BMC Cancer	1471-2407	TITLE	0	0	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	42#47		Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	37#42		Germ-line mutations in genes such as BRCA1, BRCA2, and ATM can cause a substantial increase in risk of breast cancer.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	44#49		Germ-line mutations in genes such as BRCA1, BRCA2, and ATM can cause a substantial increase in risk of breast cancer.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	6	2876	SYMBOL|()|GENE|GN|DICTIONARY	gpx 1	GPX-1	88#93		Polymorphisms in the manganese superoxide dismutase (MnSOD) and glutathione peroxidase (GPX-1) genes have been proposed as low penetrance alleles, and have not been clearly associated with breast cancer.
16945136	2006	BMC Cancer	1471-2407	METHODS	2	9	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	36#41		The MnSOD (Val16Ala, rs1799725) and GPX-1 (Pro198Leu, rs1050450) were genotyped via TaqMan assay.
16945136	2006	BMC Cancer	1471-2407	RESULTS	3	11	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	241#246		While neither allele alone shows any change in breast cancer risk, an increase in the risk of breast cancer (OR 1.87, 95% CI 1.09 - 3.19) is observed in individuals who carry both the Ala16Ala genotype of MnSOD and the Leu198Leu genotype of GPX-1.
16945136	2006	BMC Cancer	1471-2407	CONCLUSION	4	12	2876	SYMBOL|DICTIONARY	gpx 1	GPX-1	21#26		Polymorphisms in the GPX-1 and MnSOD genes are associated with an increased risk of breast cancer.
16945136	2006	BMC Cancer	1471-2407	CONCLUSION	4	12	6648	SYMBOL|GENE|GN|DICTIONARY	mnsod	MnSOD	31#36		Polymorphisms in the GPX-1 and MnSOD genes are associated with an increased risk of breast cancer.
16361275	2006	Ann. Rheum. Dis.	0003-4967	TITLE	0	0	3552	SYMBOL|GENE|GN|DICTIONARY	il1	IL1	30#33		Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese.
16361275	2006	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	1	1	3552	SYMBOL|()|GENE|GN|DICTIONARY	il1	IL1	42#45		To test the association of interleukin 1 (IL1) gene family members with ankylosing spondylitis (AS), previously reported in Europid subjects, in an ethnically remote population.
16361275	2006	Ann. Rheum. Dis.	0003-4967	METHODS	2	2	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	149#154		200 Taiwanese Chinese AS patients and 200 ethnically matched healthy controls were genotyped for five single nucleotide polymorphisms (SNPs) and the IL1RN.VNTR, markers previously associated with AS.
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	4	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	75#80		Association of alleles and genotypes of the markers IL1F10.3, IL1RN.4, and IL1RN.VNTR was observed with AS (p<0.05).
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	6	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	108#113		The strongest associations observed were with the marker IL1RN.4, and with the two-marker haplotype IL1RN.4-IL1RN.VNTR (both p = 0.004).
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	91#95		Strong linkage disequilibrium was observed between all marker pairs except those involving IL1B-511 (D' 0.4 to 0.9, p<0.01).
16361275	2006	Ann. Rheum. Dis.	0003-4967	CONCLUSIONS	4	8	3552	SYMBOL|GENE|GN|DICTIONARY	il1	IL1	4#7		The IL1 gene cluster is associated with AS in Taiwanese Chinese.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_1/3	1	3	256933	SYMBOL|DICTIONARY	npb	NPB	191#194		Autopsy findings of hepatosplenomegaly, lymphadenopathy and ceroid-rich foam cells raised the suspicion of the visceral form of acid sphingomyelinase deficiency (Niemann-Pick disease type B; NPB) or a much rarer disorder, variant adult visceral form of Niemann-Pick disease type C (NPC).
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	4	6609	SYMBOL|DICTIONARY	smpd1	SMPD1	42#47		To verify the histopathological findings, SMPD1, NPC1 and NPC2 genes were analysed.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	4	4864	SYMBOL|DICTIONARY	npc1	NPC1	49#53		To verify the histopathological findings, SMPD1, NPC1 and NPC2 genes were analysed.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	4	10577	SYMBOL|GENE|GN|DICTIONARY	npc2	NPC2	58#62		To verify the histopathological findings, SMPD1, NPC1 and NPC2 genes were analysed.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	5	4864	SYMBOL|GENE|GN|DICTIONARY	npc1	NPC1	90#94		Two novel sequence variants, c.1997G>A (S666N) and c.2882A>G (N961S) were detected in the NPC1 gene.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	6	6609	SYMBOL|GENE|GN|DICTIONARY	smpd1	SMPD1	57#62		No pathogenic sequence variants were found either in the SMPD1 gene mutated in NPB or in NPC2 gene.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	6	256933	SYMBOL|DICTIONARY	npb	NPB	79#82		No pathogenic sequence variants were found either in the SMPD1 gene mutated in NPB or in NPC2 gene.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_2/3	2	6	10577	SYMBOL|GENE|GN|DICTIONARY	npc2	NPC2	89#93		No pathogenic sequence variants were found either in the SMPD1 gene mutated in NPB or in NPC2 gene.
16802107	2007	J. Inherit. Metab. Dis.	1573-2665	ALL_TEXT_3/3	3	7	4864	SYMBOL|DICTIONARY	npc1	NPC1	26#30		The pathogenicity of both NPC1 variants was supported by their location in regions important for the protein function.
16630736	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	79158	SYMBOL|GENE|GN|DICTIONARY	gnpta	GNPTA	47#52		When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	2	79158	SYMBOL|GENE|GN|DICTIONARY	gnpta	GNPTA	39#44		The alpha/beta subunits encoded by the GNPTA gene is the catalytic subunit of the enzyme while the gamma recognition subunit is encoded by the GNPTAG gene.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	2	84572	SYMBOL|GENE|GN|DICTIONARY	gnptag	GNPTAG	143#149		The alpha/beta subunits encoded by the GNPTA gene is the catalytic subunit of the enzyme while the gamma recognition subunit is encoded by the GNPTAG gene.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	3	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	36#41		We report the molecular analysis of GNPTA in 21 families with ML II and 3 families with ML III.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	114#119		The 21 ML II patients were homozygous while the three ML III patients were compound heterozygous for mutations in GNPTA.
16630736	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	9	79158	SYMBOL|DICTIONARY	gnpta	GNPTA	49#54		We suggest that the diseases due to mutations in GNPTA represent a clinical continuum between ML III and ML II, and the classification of these diseases should be based on the age of onset, clinical symptoms, and severity.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	27#31		Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY|GA	brain derived neurotrophic factor	brain derived neurotrophic factor	52#85		Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	627	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	87#91	16741941-1-52-85	Recent reports have implicated polymorphisms in the brain derived neurotrophic factor (BDNF) gene region in the etiology of several psychiatric phenotypes, including bipolar disorder.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	125#129	16741941-1-52-85	Significant disease association has been reported for the G allele at SNP rs6265, which encodes for Valine at position 66 of BDNF (Val66Met), an apparently functional variant of this key BDNF.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	187#191	16741941-1-52-85	Significant disease association has been reported for the G allele at SNP rs6265, which encodes for Valine at position 66 of BDNF (Val66Met), an apparently functional variant of this key BDNF.
16741941	2006	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	74#78	16741941-1-52-85	These results are consistent with previous studies pointing to a role for BDNF in susceptibility to mood disorders.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	TITLE	0	0	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	21#27		Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	TITLE	0	0	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	32#38		Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	1	54578	SYMBOL|()|DICTIONARY	ugt1a6	UGT1A6	79#85		Variant genotypes of uridine diphosphate glucuronsyltransferase isoenzyme 1A6 (UGT1A6) associated with decreased metabolic activity have been associated with an enhanced protective effect of aspirin on the development of colorectal adenomas.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	2	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	30#36		However, interactions between UGT1A6 variants or variants of another enzyme that metabolizes nonsteroidal anti-inflammatory drugs (NSAIDs), cytochrome P4502C9 (CYP2C9), and NSAIDs in the prevention of colorectal cancer have not been studied extensively.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	BACKGROUND AND AIMS	1	2	1559	SYMBOL|()|DICTIONARY	cyp2c9	CYP2C9	160#166		However, interactions between UGT1A6 variants or variants of another enzyme that metabolizes nonsteroidal anti-inflammatory drugs (NSAIDs), cytochrome P4502C9 (CYP2C9), and NSAIDs in the prevention of colorectal cancer have not been studied extensively.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	METHODS	2	3	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	0#6		UGT1A6 and CYP2C9 genotypes were determined in 2295 individuals with colorectal cancer and 2903 controls.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	METHODS	2	3	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	11#17		UGT1A6 and CYP2C9 genotypes were determined in 2295 individuals with colorectal cancer and 2903 controls.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	5	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	8#14		Variant CYP2C9 genotypes enhanced the protective effect of ibuprofen on the prevention of colorectal cancer, and a dose-response relationship with respect to increasing numbers of variant alleles was seen (P interaction = .02).
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	6	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	0#6		CYP2C9 variants were more effective in individuals with wild-type rather than variant UGT1A6 (P interaction < .007).
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	6	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	86#92		CYP2C9 variants were more effective in individuals with wild-type rather than variant UGT1A6 (P interaction < .007).
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	7	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	8#14		Variant CYP2C9 genotypes showed no interaction with aspirin usage, and variant UGT1A6 genotypes showed no interaction with either NSAID with respect to colorectal cancer protection.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	RESULTS	3	7	54578	SYMBOL|DICTIONARY	ugt1a6	UGT1A6	79#85		Variant CYP2C9 genotypes showed no interaction with aspirin usage, and variant UGT1A6 genotypes showed no interaction with either NSAID with respect to colorectal cancer protection.
16797247	2006	Clin. Gastroenterol. Hepatol.	1542-3565	CONCLUSIONS	4	8	1559	SYMBOL|DICTIONARY	cyp2c9	CYP2C9	79#85		In this study, the major effect seen was an enhancement by slower-metabolizing CYP2C9 variants of the chemopreventive activity of ibuprofen against colorectal cancer.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	TITLE	0	0	3576	LONGTERM|GENE|GN|DICTIONARY	interleukin 8	Interleukin-8	0#13		Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	98#103		In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	3557	SYMBOL|DICTIONARY	il 1rn	IL-1RN	109#115		In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	7157	SYMBOL|GENE|GN|DICTIONARY	p53	p53	57#60		The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	10	3576	SYMBOL|DICTIONARY	il 8	IL-8	14#18		We found that IL-8 -251 T/T genotype was significantly associated with increased risk of MSI-H GC compared to MSI-L/MSS GC and controls.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	12	7157	SYMBOL|DICTIONARY	p53	p53	47#50		The percentage of smokers and the frequency of p53 mutations were significantly lower in MSI-H than MSI-L/MSS GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	CONCLUSIONS	4	14	3576	SYMBOL|NUMBER|DICTIONARY	il 8	IL-8	49#53		Our study shows that MSI-H GC is associated with IL-8-251 T/T (low expression genotype) and is inversely correlated with cigarette smoking.
16860143	2006	J. Pediatr.	0022-3476	TITLE	0	0	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	97#101		Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	1	5551	SYMBOL|()|DICTIONARY|EXTRACTED	prf1	PRF1	32#36	16860143-1-17-25	Mutations of the perforin gene (PRF1) are present in a proportion of patients with hemophagocytic lymphohistiocytosis (HLH).
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	2	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	106#110	16860143-1-17-25	We found that all identified infants with HLH of African descent (17 from USA, 4 from Europe) have 50delT-PRF1 (16 homozygotes, 5 compound heterozygotes), accounting for the most frequently observed PRF1 mutation.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_1/3	1	2	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	199#203	16860143-1-17-25	We found that all identified infants with HLH of African descent (17 from USA, 4 from Europe) have 50delT-PRF1 (16 homozygotes, 5 compound heterozygotes), accounting for the most frequently observed PRF1 mutation.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_2/3	2	4	5551	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prf1	PRF1	166#170	16860143-1-17-25	To test the hypothesis that this mutation represents a single haplotype, DNA from 23 patients with HLH and 30 African-American control subjects was sequenced for the PRF1 gene, including portions of the intron containing known single nucleotide polymorphisms (SNPs).
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_3/3	3	5	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	64#68	16860143-1-17-25	The same groups were genotyped at 3 microsatellites proximal to PRF1.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_3/3	3	6	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	41#45	16860143-1-17-25	The SNP profiles of patients with 50delT-PRF1 were identical, and 5 novel SNPs were identified among African-American control subjects.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_3/3	3	7	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	21#25	16860143-1-17-25	Patients with 50delT-PRF1 were also found to have had an earlier age of disease onset than patients with other PRF1 mutations.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_3/3	3	7	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	111#115	16860143-1-17-25	Patients with 50delT-PRF1 were also found to have had an earlier age of disease onset than patients with other PRF1 mutations.
16860143	2006	J. Pediatr.	0022-3476	ALL_TEXT_3/3	3	8	5551	SYMBOL|DICTIONARY|EXTRACTED	prf1	PRF1	80#84	16860143-1-17-25	Extent of haplotype sharing and variability of microsatellite alleles in 50delT-PRF1 chromosomes suggest that this mutation arose approximately 1000 to 4000 years ago and is restricted to patients of African descent.
16788379	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	4255	LONGTERM|DICTIONARY	o6 methylguanine dna methyltransferase	O6-methylguanine DNA methyltransferase	17#55		Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk.
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	1	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor	estrogen receptor	84#101		Endogenous and exogenous estrogens influence breast cancer risk by interacting with estrogen receptor (ER).
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	1	2099	SYMBOL|EXTRACTED|()	er	ER	103#105	16788379-1-84-101	Endogenous and exogenous estrogens influence breast cancer risk by interacting with estrogen receptor (ER).
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	2	4255	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mgmt	MGMT	43#47	16788379-2-6-41	The O-methylguanine DNA methyltransferase (MGMT) gene has a dual role in repairing alkylation damage and in inhibiting ER-mediated cell proliferation.
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	2	2099	SYMBOL|EXTRACTED	er	ER	119#121	16788379-1-84-101	The O-methylguanine DNA methyltransferase (MGMT) gene has a dual role in repairing alkylation damage and in inhibiting ER-mediated cell proliferation.
16788379	2006	Pharmacogenet. Genomics	1744-6872	RESULTS	3	7	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor	estrogen receptor	354#371		This positive association was magnified among postmenopausal women with body mass index>25 (OR, 3.01; 95% CI, 1.30-6.94), those in the highest tertile of pre-diagnostic plasma endogenous estradiol levels (Phe carriers versus non-carriers, OR, 2.42; 95% CI, 1.49-3.94), non-current postmenopausal hormone users (OR, 2.60; 95% CI, 1.19-5.64), and possibly estrogen receptor-positive cases (OR, 1.82; 95% CI, 0.99-3.35).
16788379	2006	Pharmacogenet. Genomics	1744-6872	CONCLUSIONS	4	10	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor	estrogen receptor	89#106		These data suggest that the Leu84Phe polymorphism affect the capacity of MGMT to inhibit estrogen receptor-mediated cell proliferation and is associated with breast cancer risk.
16774538	2006	Tissue Antigens	0001-2815	TITLE	0	0	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	0#5		MMP-1 promoter gene polymorphism and susceptibility to chronic periodontitis in a Chinese population.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	81#86		A single nucleotide polymorphism in the promoter region of -1607 bp of the human MMP-1 gene has been found to be associated with an increased risk of various inflammatory diseases and cancer metastasis.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	57#62		This study aimed to evaluate the association between the MMP-1 promoter gene polymorphism and chronic periodontitis susceptibility and/or severity in a Chinese population.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	4	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	0#5		MMP-1 promoter fragment was amplified by polymerase chain reaction, and the polymorphism was analyzed by restriction endonuclease cleavage.
16774538	2006	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	8	4312	SYMBOL|GENE|GN|DICTIONARY	mmp 1	MMP-1	65#70		This study suggests that a single nucleotide polymorphism in the MMP-1 promoter region of -1607 bp may be associated with severe chronic periodontitis in a Chinese population.
16796743	2006	BMC Med. Genet.	1471-2350	TITLE	0	0	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	36#43		Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
16796743	2006	BMC Med. Genet.	1471-2350	TITLE	0	0	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	48#55		Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	60#67		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	6584	SYMBOL|GENE|GN|DICTIONARY	slc22a5	SLC22A5	72#79		Polymorphisms in the carnitine transporters, encoded by the SLC22A4 and SLC22A5 genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6584	SYMBOL|GENE|GN|DICTIONARY	octn2	OCTN2	190#195		For these reasons, we investigated for the first time the association with T1D of six single nucleotide polymorphisms (SNPs) mapping to these candidate genes: slc2F2, slc2F11, T306I, L503F, OCTN2-promoter and OCTN2-intron.
16796743	2006	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	6584	SYMBOL|DICTIONARY	octn2	OCTN2	209#214		For these reasons, we investigated for the first time the association with T1D of six single nucleotide polymorphisms (SNPs) mapping to these candidate genes: slc2F2, slc2F11, T306I, L503F, OCTN2-promoter and OCTN2-intron.
16796743	2006	BMC Med. Genet.	1471-2350	RESULTS	3	7	6583	SYMBOL|GENE|GN|DICTIONARY	slc22a4	SLC22A4	68#75		When independently analyzed, one of the tested polymorphisms in the SLC22A4 gene at 1672 showed significant association with T1D in our Spanish cohort.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	8#14		Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	3654	SYMBOL|()|DICTIONARY	irak 1	IRAK-1	37#43		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	7097	SYMBOL|DICTIONARY	tlr2	TLR2	69#73		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	7099	SYMBOL|DICTIONARY	tlr4	TLR4	79#83		The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	2	3654	SYMBOL|GENE|GN|DICTIONARY	irak 1	IRAK-1	33#39		There are two haplotypes for the IRAK-1 gene in Caucasians, with the variant haplotype consisting of five intron single-nucleotide polymorphisms (SNPs) and three exon SNPs.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVES	2	3	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	46#52		To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappaB and affecting outcomes from sepsis.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	5	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	41#47		Twenty-one (14%) were homozygous for the IRAK-1 variant haplotype as determined by a SNP in which T is replaced with C at nucleotide 1,595 within exon 12 of the IRAK-1 gene.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	5	3654	SYMBOL|GENE|GN|DICTIONARY	irak 1	IRAK-1	161#167		Twenty-one (14%) were homozygous for the IRAK-1 variant haplotype as determined by a SNP in which T is replaced with C at nucleotide 1,595 within exon 12 of the IRAK-1 gene.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	4#10		The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	212#218		The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	7	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	305#311		There was an increased incidence of shock (p=0.047) (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1-7.7), greater requirement for more prolonged mechanical ventilator support (p=0.04) (OR, 2.7; 95% CI, 1.05-6.9), and higher 60-d mortality (p=0.05) (OR, 2.7; 95% CI, 1.0-6.8) in patients with the IRAK-1 variant haplotype compared with wild type.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	CONCLUSIONS	4	8	3654	SYMBOL|DICTIONARY	irak 1	IRAK-1	32#38		These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappaB, more severe organ dysfunction, and higher mortality.
16687442	2006	Hum. Mol. Genet.	0964-6906	TITLE	0	0	842	LONGTERM|GENE|GN|DICTIONARY	caspase 9	Caspase 9	0#9		Caspase 9 promoter polymorphisms and risk of primary lung cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	842	LONGTERM|DICTIONARY	caspase 9	Caspase-9	0#9		Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	842	SYMBOL|()|DICTIONARY|EXTRACTED	casp 9	CASP-9	11#17	16687442-1-0-9	Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	1523	SYMBOL|DICTIONARY	casp	CASP	35#39		Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	44#50	16687442-1-0-9	Polymorphisms in the promoter region of the CASP-9 gene may influence the promoter activity of this gene, thereby modulating susceptibility to lung cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	157#163	16687442-1-0-9	To test this hypothesis, we examined the association of four polymorphisms [-1263A>G, -905T>G, -712C>T and -293_-275delCGTGAGGTCAGTGCGGGGA (-293del)] in the CASP-9 promoter with the risk of lung cancer in a Korean population.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	842	SYMBOL|DICTIONARY|EXTRACTED	casp 9	CASP-9	4#10	16687442-1-0-9	The CASP-9 genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and gender.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	10	842	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	casp 9	CASP-9	27#33	16687442-1-0-9	These results suggest that CASP-9 promoter polymorphisms affect CASP-9 expression and contribute to genetic susceptibility to lung cancer.
16687442	2006	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	10	842	SYMBOL|DICTIONARY|EXTRACTED	casp 9	CASP-9	64#70	16687442-1-0-9	These results suggest that CASP-9 promoter polymorphisms affect CASP-9 expression and contribute to genetic susceptibility to lung cancer.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	5444	LONGTERM|GENE|GN|DICTIONARY	paraoxonase 1	paraoxonase 1	36#49		Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	Paraoxonase 1	0#13		Paraoxonase 1 (PON1) plays an important role in the high-density lipoprotein-mediated prevention of low-density lipoprotein oxidation and the metabolism of lipid-soluble radicals.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	5444	SYMBOL|()|DICTIONARY|EXTRACTED	pon1	PON1	15#19	16775186-1-0-13	Paraoxonase 1 (PON1) plays an important role in the high-density lipoprotein-mediated prevention of low-density lipoprotein oxidation and the metabolism of lipid-soluble radicals.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	97#101	16775186-1-0-13	In this study, we investigated the association of two common, nonsynonymous polymorphisms in the PON1 gene (Q192R and L55M) with breast cancer risk in postmenopausal women through a nested case-control study within the American Cancer Society Cancer Prevention Study II Nutrition Cohort.
16775186	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	48#52	16775186-1-0-13	These results suggest that genetic variation in PON1, particularly at the L55M SNP, may be associated with increased risk of breast cancer in postmenopausal women.
16511860	2006	Mov. Disord.	0885-3185	TITLE	0	0	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	15#20		Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY|GENE|GA	leucine rich repeat kinase 2	leucine-rich repeat kinase 2	17#45		Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16511860	2006	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrrk2	LRRK2	47#52	16511860-1-17-45	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD).
16699517	2006	Nat. Genet.	1061-4036	TITLE	0	0	64135	SYMBOL|()|DICTIONARY	ifih1	IFIH1	125#130		A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	ifih1	IFIH1	149#154		In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16699517	2006	Nat. Genet.	1061-4036	ALL_TEXT_1/3	1	1	64135	SYMBOL|DICTIONARY	mda 5	mda-5	170#175		In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3.
16517578	2006	Thorax	0040-6376	BACKGROUND	1	2	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	48#56	16517578-2-18-46	The gene encoding tumour necrosis factor alpha (TNFalpha) is one of several candidate loci for asthma pathogenesis and is highly polymorphic.
16517578	2006	Thorax	0040-6376	BACKGROUND	1	3	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	58#66	16517578-2-18-46	A number of studies have investigated the polymorphism of TNFalpha-308 gene promoter (substitution G-->A, designated as TNF1 and TNF2) in relation to asthma susceptibility in different populations.
16517578	2006	Thorax	0040-6376	METHODS	2	5	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	90#98	16517578-2-18-46	To address the inconsistent findings in studies of the association of the polymorphism of TNFalpha-308 gene promoter with susceptibility to asthma, a systematic review was undertaken of the published data and a meta-analysis was performed.
16517578	2006	Thorax	0040-6376	CONCLUSIONS	4	13	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	103#111	16517578-2-18-46	A large scale case-control study is needed to clarify the functional effect of the polymorphism of the TNFalpha gene in the pathogenesis of asthma.
16380991	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	55#60		"We also evaluated interaction between fruit intake and GSTM1, GSTT1, NAT2 and SULT1A1 amongst ""ever-smokers."""
16380991	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	62#67		"We also evaluated interaction between fruit intake and GSTM1, GSTT1, NAT2 and SULT1A1 amongst ""ever-smokers."""
16380991	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	10	SYMBOL|DICTIONARY	nat2	NAT2	69#73		"We also evaluated interaction between fruit intake and GSTM1, GSTT1, NAT2 and SULT1A1 amongst ""ever-smokers."""
16380991	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	6817	SYMBOL|DICTIONARY	sult1a1	SULT1A1	78#85		"We also evaluated interaction between fruit intake and GSTM1, GSTT1, NAT2 and SULT1A1 amongst ""ever-smokers."""
12824768	2003	Neuroreport	0959-4965	TITLE	0	0	23621	SYMBOL|GENE|GN|DICTIONARY	bace	BACE	20#24		Polymorphism in the BACE gene influences the risk for Alzheimer's disease.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_1/3	1	3	23621	SYMBOL|DICTIONARY	bace	BACE	0#4		BACE (beta-site APP cleaving enzyme) was identified as the beta-secretase.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_1/3	1	3	23621	LONGTERM|()|GENE|GT|DICTIONARY	beta site app cleaving enzyme	beta-site APP cleaving enzyme	6#35		BACE (beta-site APP cleaving enzyme) was identified as the beta-secretase.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	4	23621	SYMBOL|GENE|GN|DICTIONARY	bace	BACE	18#22		Variations of the BACE gene might influence activity and function of the protein and, thus, might influence the pathogenesis of AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	5	23621	SYMBOL|DICTIONARY	bace	BACE	59#63		Consequently, we investigated the association of different BACE polymorphisms with AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_2/3	2	6	23621	SYMBOL|DICTIONARY	bace	BACE	0#4		BACE exon 5 polymorphism influenced the risk of AD.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_3/3	3	8	23621	SYMBOL|DICTIONARY	bace	BACE	53#57		Furthermore, Abeta(42) CSF levels were influenced by BACE genotype.
12824768	2003	Neuroreport	0959-4965	ALL_TEXT_3/3	3	9	23621	SYMBOL|DICTIONARY	bace	BACE	16#20		It appears that BACE polymorphism plays a more important role in the development of AD than previously assumed, possibly by influencing Abeta(42) levels.
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	45#51		Association between genetic polymorphisms of CYP1A1 and familial prostate cancer risk was examined by a case-control study of 185 individuals.
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_2/3	2	2	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	57#63		Although the individual analysis of m1 or m2 genotype of CYP1A1 showed no significant association with prostate cancer risk, the presence of any mutated alleles significantly increased prostate cancer risk in comparison with wild-type genotypes by combination analysis (odds ratio [OR]=2.38; 95% confidence interval [CI]=1.72-3.29; P=0.0069).
12767526	2003	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	4	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	29#35		These finding suggested that CYP1A1 polymorphisms has an association with prostate cancer risk, especially with progression of prostate cancer.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	5243	SYMBOL|DICTIONARY	mdr1	MDR1	23#27		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	4363	SYMBOL|DICTIONARY	mrp1	MRP1	29#33		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	1244	SYMBOL|DICTIONARY	mrp2	MRP2	35#39		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	MATERIALS AND METHODS	2	3	4035	SYMBOL|DICTIONARY	lrp	LRP	44#47		SNPs were analyzed for MDR1, MRP1, MRP2 and LRP in 60 advanced ovarian cancer patients.
16821592	2006	Anticancer Res.	0250-7005	RESULTS	3	5	4363	SYMBOL|DICTIONARY	mrp1	MRP1	145#149		As a result of examining the relevance of SNP genotypes to the response to chemotherapy, a significant relevance (p=0.01) was observed regarding MRP1 exon-17 SNP (G2168A) involving amino acid substitution.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	4683	SYMBOL|()|GENE|GN|DICTIONARY	nbs1	NBS1	34#38		The Nijmegen breakage syndrome 1 (NBS1) gene, which participates in DNA double strand break repair, has been postulated to be a susceptibility factor for a number of cancers, including prostate cancer.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	4683	SYMBOL|DICTIONARY	nbs1	NBS1	43#47		Numerous mutations have been identified in NBS1, including the founder mutation 657del5.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	3	4683	SYMBOL|DICTIONARY	nbs1	NBS1	80#84		In this study, a number of analyses were done to determine whether mutations in NBS1 are associated with an increased risk for prostate cancer.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	8	4683	SYMBOL|GENE|GN|DICTIONARY	nbs1	NBS1	11#15		The entire NBS1 gene was also sequenced in 20 of the youngest affected individuals from the Finnish group of familial cases to identify the presence of possible mutations in this high-risk group.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	12	4683	SYMBOL|DICTIONARY	nbs1	NBS1	53#57		However, our data does suggest that mutations within NBS1, and in particular, 657del5, do not significantly contribute to the overall prostate cancer burden within our patient samples.
16517152	2006	Eur. J. Cancer	0959-8049	TITLE	0	0	4153	LONGTERM|DICTIONARY	mannose binding lectin	mannose-binding lectin	12#34		The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia.
16517152	2006	Eur. J. Cancer	0959-8049	TITLE	0	0	4153	SYMBOL|()|DICTIONARY|EXTRACTED	mbl	MBL	36#39	16517152-0-12-34	The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	4153	LONGTERM|DICTIONARY	mannose binding lectin	Mannose-binding lectin	0#22		Mannose-binding lectin (MBL) deficiency might increase infection susceptibility in these children.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	3	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	0#3		MBL genotype and phenotype were prospectively determined in 110 paediatric oncology patients.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	4	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	28#31	16517152-0-12-34	During febrile neutropenia, MBL concentrations were measured longitudinally in time.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	5	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	0#3		MBL genotype and phenotype were correlated to clinical and laboratory parameters.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	6	4153	SYMBOL|DICTIONARY	mbl2	MBL2	18#22		Structural exon-1 MBL2 mutations and the LX promoter polymorphism lead to deficient MBL concentrations.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	7	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	25#28	16517152-0-12-34	The capacity to increase MBL concentrations during febrile neutropenia was associated with MBL2 genotype.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	7	4153	SYMBOL|DICTIONARY	mbl2	MBL2	91#95		The capacity to increase MBL concentrations during febrile neutropenia was associated with MBL2 genotype.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	45#48	16517152-0-12-34	Infectious parameters did not differ between MBL-deficient and MBL-sufficient neutropenic children (n = 66).
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	8	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	63#66	16517152-0-12-34	Infectious parameters did not differ between MBL-deficient and MBL-sufficient neutropenic children (n = 66).
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	9	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	13#16	16517152-0-12-34	In contrast, MBL-sufficient patients had a greater risk of Intensive Care admittance (Relative Risk 1.6, 95% Confidence Interval 1.3-2.0, P = 0.04).
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	11	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	131#134	16517152-0-12-34	However, most patients (61%) were severely neutropenic (<100 cells/microL), compromising the opsonophagocytic effector function of MBL.
16517152	2006	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	12	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	0#3		MBL substitution might still be beneficial in patients with phagocytic activity.
16331614	2006	Int. J. Cancer	0020-7136	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	45#50		Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
16331614	2006	Int. J. Cancer	0020-7136	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	55#60		Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	34#39		Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80%, and following the first diagnosis the 10-year risk of contralateral breast cancer is approximately 30%.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	50#55		Furthermore, the relative degree of protection in BRCA1 and BRCA2 carriers has not been well evaluated.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	60#65		Furthermore, the relative degree of protection in BRCA1 and BRCA2 carriers has not been well evaluated.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	56#61		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	65#70		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	139#144		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	148#153		We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutation, and 751 control women with unilateral breast cancer and a BRCA1 or BRCA2 mutation in a matched case-control study.
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	115#120		The multivariate odds ratio for contralateral breast cancer associated with tamoxifen use was 0.50 for carriers of BRCA1 mutations (95% CI, 0.30-0.85) and was 0.42 for carriers of BRCA2 mutations (95% CI, 0.17-1.02).
16331614	2006	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	7	675	SYMBOL|DICTIONARY	brca2	BRCA2	180#185		The multivariate odds ratio for contralateral breast cancer associated with tamoxifen use was 0.50 for carriers of BRCA1 mutations (95% CI, 0.30-0.85) and was 0.42 for carriers of BRCA2 mutations (95% CI, 0.17-1.02).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	9#15		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	16#21		Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	1	1543	LONGTERM|DICTIONARY	cytochrome p450 1a1	cytochrome P450 1A1	50#69		Polycyclic aromatic hydrocarbons are activated by cytochrome P450 1A1 (CYP1A1) and inactivated by glutathione S-transferase mu (GSTM1).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	1	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	71#77	16416283-1-50-69	Polycyclic aromatic hydrocarbons are activated by cytochrome P450 1A1 (CYP1A1) and inactivated by glutathione S-transferase mu (GSTM1).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	1	2944	SYMBOL|()|DICTIONARY	gstm1	GSTM1	128#133		Polycyclic aromatic hydrocarbons are activated by cytochrome P450 1A1 (CYP1A1) and inactivated by glutathione S-transferase mu (GSTM1).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	59#65	16416283-1-50-69	Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	90#95		Therefore, it is expected that a combination of proficient CYP1A1 genotype with deficient GSTM1 variant would result in particularly elevated lung cancer (LC) risk, especially for squamous cell carcinoma (SCC).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	3	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	45#51	16416283-1-50-69	This study was aimed to validate whether the CYP1A1-C (3801) (CYP1A1*2) allele has an unfavorable significance alone and/or in combination with the GSTM1 deficiency.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	3	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	62#68	16416283-1-50-69	This study was aimed to validate whether the CYP1A1-C (3801) (CYP1A1*2) allele has an unfavorable significance alone and/or in combination with the GSTM1 deficiency.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	3	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	148#153		This study was aimed to validate whether the CYP1A1-C (3801) (CYP1A1*2) allele has an unfavorable significance alone and/or in combination with the GSTM1 deficiency.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	32#38	16416283-1-50-69	We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	43#48		We compared the distribution of CYP1A1 and GSTM1 genotypes in LC patients (n=141), healthy donors (HD, n=204), and elderly tumor-free smokers and non-smokers (ED, n=246).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	5	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		CYP1A1*2 allele carriers demonstrated a clear-cut association with SCC: the adjusted odds ratios (OR) were 2.22 (95% CI=1.06-4.63) and 2.27 (95% CI=1.14-4.52) when HD and ED were used as referents, respectively.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	1543	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	0#6		CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	12#17		CYP1A1*2(+)/GSTM1(-) combined genotypes were overrepresented in the SCC patients (14/70, 20.0%) and underrepresented in the ED (19/246, 7.7%) as compared to the intermediate prevalence in the HD (26/204, 12.7%); the adjusted OR for SCC versus ED reached 3.85 (95% CI=1.43-10.33).
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	7	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	82#88	16416283-1-50-69	In agreement with some literature data, our results support the concerted role of CYP1A1 and GSTM1 at-risk genotypes in SCC predisposition.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	93#98		In agreement with some literature data, our results support the concerted role of CYP1A1 and GSTM1 at-risk genotypes in SCC predisposition.
16645213	2006	J Mol Diagn	1525-1578	TITLE	0	0	4869	SYMBOL|DICTIONARY	npm1	NPM1	84#88		Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia.
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4869	SYMBOL|GENE|GN|DICTIONARY	npm1	NPM1	0#4		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5371	SYMBOL|DICTIONARY	pml	PML	181#184		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	5914	SYMBOL|DICTIONARY	rara	RARA	185#189		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	861	SYMBOL|DICTIONARY	aml1	AML1	191#195		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	862	SYMBOL|DICTIONARY	eto	ETO	196#199		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	865	SYMBOL|DICTIONARY	cbfb	CBFB	201#205		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	4629	SYMBOL|DICTIONARY	myh11	MYH11	206#211		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	7913	SYMBOL|DICTIONARY	dek	DEK	213#216		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_2/3	2	4	4869	SYMBOL|DICTIONARY	npm1	NPM1	105#109		Here, we designed and tested a denaturing high-performance liquid chromatography (DHPLC) assay to detect NPM1 mutated variants.
16606986	2006	Am. J. Trop. Med. Hyg.	0002-9637	TITLE	0	0	2212	SYMBOL|()|DICTIONARY	cd32	CD32	37#41		Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	32#36		To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	OBJECTIVE	2	3	6531	SYMBOL|DICTIONARY	dat1	DAT1	61#65		To test the hypothesis that the DRD4 seven-repeat allele and DAT1 ten-repeat allele would prove useful in identifying a subset of children with attention-deficit/hyperactivity disorder (ADHD) who have compromised intellectual functions.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	RESULTS	7	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	57#61		We present replicated evidence that polymorphisms in the DRD4 and DAT1 genes were associated with variation in intellectual functioning among children diagnosed as having ADHD, apart from severity of their symptoms.
16585476	2006	Arch. Gen. Psychiatry	0003-990X	RESULTS	7	8	6531	SYMBOL|GENE|GN|DICTIONARY	dat1	DAT1	66#70		We present replicated evidence that polymorphisms in the DRD4 and DAT1 genes were associated with variation in intellectual functioning among children diagnosed as having ADHD, apart from severity of their symptoms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	61#66		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	6352	SYMBOL|DICTIONARY	rantes	RANTES	68#74		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	80#84		Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	68#95		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	97#102		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	6352	SYMBOL|DICTIONARY	rantes	RANTES	192#198		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY	tnf a	TNF-A	86#91		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	8	6352	SYMBOL|DICTIONARY	rantes	RANTES	141#147		Among patients with pancreatic cancer, pancreatitis was significantly associated with TNF-A -308 GA + AA (OR, 3.1; 95% CI, 1.3-7.4) and with RANTES -403 GA + AA (OR, 2.3; 95% CI, 1.0-5.4).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	9	1234	SYMBOL|NUMBER|DICTIONARY	ccr5	CCR5	81#85		There was evidence for a possible interaction between current active smoking and CCR5-32del.
16344274	2006	Carcinogenesis	0143-3334	TITLE	0	0	126	SYMBOL|DICTIONARY	adh3	ADH3	0#4		ADH3 genotype, alcohol intake and breast cancer risk.
16344274	2006	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	3	126	SYMBOL|()|DICTIONARY	adh3	ADH3	71#75		Individuals differ in their ADH genotype, and one locus in particular (ADH3) is polymorphic in Caucasian populations.
16344274	2006	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	126	SYMBOL|NUMBER|DICTIONARY	adh3	ADH3	130#134		Using data from the Long Island Breast Cancer Study Project, we examined whether fast metabolizers of alcohol, as measured by the ADH3(1-1) genotype, have a higher risk of breast cancer from alcohol intake compared with those individuals who are slow metabolizers, but consume similar amounts of alcohol.
16344274	2006	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	7	126	SYMBOL|NUMBER|DICTIONARY	adh3	ADH3	169#173		In contrast, the increase in risk from a lifetime alcohol consumption of 15-30 g/day was less pronounced in the intermediate and slow metabolizing groups, respectively: ADH3(1-2) (OR=1.5, 95% CI 0.9-2.4) and ADH(3)2-2 (OR=1.3, 95% CI 0.5-3.5).
16538170	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	196	LONGTERM|()|GENE|GT|DICTIONARY	aryl hydrocarbon receptor	aryl hydrocarbon receptor	44#69		Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	75#81		Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	1	196	LONGTERM|GENE|GT|DICTIONARY	aryl hydrocarbon receptor	aryl hydrocarbon receptor	4#29		The aryl hydrocarbon receptor (AhR) is a key regulator of the transcriptional expression for the cytochrome P450 1 (CYP1) genes.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	1	196	SYMBOL|EXTRACTED|()	ahr	AhR	31#34	16538170-1-4-29	The aryl hydrocarbon receptor (AhR) is a key regulator of the transcriptional expression for the cytochrome P450 1 (CYP1) genes.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	1	1543	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cyp1	CYP1	116#120	16538170-1-108-112	The aryl hydrocarbon receptor (AhR) is a key regulator of the transcriptional expression for the cytochrome P450 1 (CYP1) genes.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	0#6		CYP1A2 is one of the major CYP1 enzymes that catalyse 2-hydroxylation of estrogen, a hormone that plays a critical role in the etiology of breast cancer.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	2	1543	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1	CYP1	27#31	16538170-1-108-112	CYP1A2 is one of the major CYP1 enzymes that catalyse 2-hydroxylation of estrogen, a hormone that plays a critical role in the etiology of breast cancer.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	84#90		In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	3	196	SYMBOL|EXTRACTED	ahr	AhR	98#101	16538170-1-4-29	In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with breast cancer risk in 1090 cases and 1183 controls, a subset of the population-based case-control study, the Shanghai Breast Cancer Study.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_2/3	2	4	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	136#142		Caffeine tests were performed in vivo in a subset of 236 study subjects to investigate the relationship of these two polymorphisms with CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_2/3	2	5	196	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ahr	AhR	8#11	16538170-1-4-29	For the AhR gene, the A (Lys) allele was associated with a decreased risk of breast cancer.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	45#51		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	99#105		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	7	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	149#155		However, no association was observed between CYP1A2 genotypes and breast cancer risk, although the CYP1A2*1F polymorphism was found to be related to CYP1A2 activity.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	196	SYMBOL|EXTRACTED	ahr	AhR	59#62	16538170-1-4-29	In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_3/3	3	9	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	152#158		In conclusion, the results from our study suggest that the AhR Lys554Arg polymorphism may be a genetic susceptibility factor for breast cancer, whereas CYP1A2*1F, which is a potentially functional single nucleotide polymorphism, may not be related to breast cancer risk.
16309832	2006	Neurosci. Lett.	0304-3940	TITLE	0	0	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase 2	4#20		The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	15#21		Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	TITLE	0	0	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	26#32		Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	47#53		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	AIM	1	1	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	86#92		To investigate the possible association of the CYP2D6 gene C100T polymorphism and the CYP1A2 gene C163A polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	METHODS	2	3	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	21#27		Polymorphisms of the CYP2D6 and CYP1A2 genes were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	METHODS	2	3	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	32#38		Polymorphisms of the CYP2D6 and CYP1A2 genes were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	5	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	59#65		No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	6	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	31#37		Moreover, the frequency of the CYP1A2 C allele in patients with TD was significantly higher than that in those without TD (Chi2=6.38, P<0.05).
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	34#40		An association between TD and the CYP2D6 100T and CYP1A2 163C alleles was observed.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	7	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	50#56		An association between TD and the CYP2D6 100T and CYP1A2 163C alleles was observed.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	9	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	185#191		The results of logistic regression analysis demonstrated that mean age and duration of illness were risk factors for TD, but not sex, cumulative exposure to neuroleptic drugs in years, CYP2D6 or CYP1A2 genotype.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	RESULTS	3	9	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	195#201		The results of logistic regression analysis demonstrated that mean age and duration of illness were risk factors for TD, but not sex, cumulative exposure to neuroleptic drugs in years, CYP2D6 or CYP1A2 genotype.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	30#36		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
16490169	2006	Acta Pharmacol. Sin.	1671-4083	CONCLUSION	4	10	1544	SYMBOL|GENE|GN|DICTIONARY	cyp1a2	CYP1A2	76#82		The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia.
16510718	2006	J. Neurosci.	1529-2401	TITLE	0	0	2332	LONGTERM|GENE|GT|DICTIONARY	fragile x mental retardation protein	Fragile X mental retardation protein	0#36		Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	LONGTERM|GENE|GT|DICTIONARY	fragile x mental retardation protein	Fragile X mental retardation protein	0#36		Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	SYMBOL|()|DICTIONARY|EXTRACTED	fmrp	FMRP	38#42	16510718-1-0-36	Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	1	2332	SYMBOL|GENE|GN|DICTIONARY	fmr1	FMR1	131#135		Fragile X mental retardation protein (FMRP), the lack of which causes fragile X syndrome, is an RNA-binding protein encoded by the FMR1 gene.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_1/3	1	2	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	0#4		FMRP accompanies mRNAs from the nucleus to dendritic regions and is thought to regulate their translation at synapses.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_2/3	2	3	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	23#27	16510718-1-0-36	It has been shown that FMRP moves into nontranslating stress granules (SGs) during heat stress of cultured fibroblasts (Mazroui et al., 2002).
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_2/3	2	4	7072	SYMBOL|DICTIONARY	tia 1	TIA-1	70#75		We used a novel method to isolate SGs from neurons by virtue of their TIA-1 (T-cell intracellular antigen 1) protein component, and found that FMRP moved out of polyribosomes and into SGs subsequent to oxidative stress.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_2/3	2	4	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	143#147	16510718-1-0-36	We used a novel method to isolate SGs from neurons by virtue of their TIA-1 (T-cell intracellular antigen 1) protein component, and found that FMRP moved out of polyribosomes and into SGs subsequent to oxidative stress.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	5	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	17#21	16510718-1-0-36	We then examined FMRP changes in subcellular localization resulting from mechanically induced neuronal injury by placement of electrodes into the dentate gyrus and the perforant path of the hippocampus in vivo.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	6	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	72#76	16510718-1-0-36	During the first 10 min after electrode insertion into one hippocampus, FMRP shifted into SGs and away from polyribosomes, in both hippocampi.
16510718	2006	J. Neurosci.	1529-2401	ALL_TEXT_3/3	3	7	2332	SYMBOL|DICTIONARY|EXTRACTED	fmrp	FMRP	52#56	16510718-1-0-36	Although the injury discharge subsided beyond 10 s, FMRP levels in polyribosomes and stress granules did not return to basal levels until 30 min after electrode penetration.
16507928	2007	Obstet Gynecol	1873-233X	TITLE	0	0	355	SYMBOL|()|GENE|GN|DICTIONARY	tnfrsf6	TNFRSF6	5#12		Fas (TNFRSF6) gene polymorphism in pregnant women with hemolysis, elevated liver enzymes, and low platelets and in their neonates.
16507928	2007	Obstet Gynecol	1873-233X	OBJECTIVE	1	1	355	SYMBOL|DICTIONARY	tnfrsf6	TNFRSF6	97#104		To estimate whether an A>G polymorphism at position -670 in the gene coding for Fas (gene symbol TNFRSF6) is associated with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome.
16507928	2007	Obstet Gynecol	1873-233X	METHODS	2	2	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	233#240		In a retrospective study, buccal swabs from 81 women with the complete form of HELLP syndrome and 83 normotensive control women with uncomplicated full-term pregnancy, and 110 of their neonates, were analyzed for the presence of the TNFRSF6-670 polymorphism.
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	4	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	36#43		Pregnant women heterozygous for the TNFRSF6-670 genotype were more likely than those homozygous for TNFRSF6-670*A allele to have HELLP syndrome (P = .01; odds ratio 2.7, 95% confidence interval 1.2-5.9).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	4	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	100#107		Pregnant women heterozygous for the TNFRSF6-670 genotype were more likely than those homozygous for TNFRSF6-670*A allele to have HELLP syndrome (P = .01; odds ratio 2.7, 95% confidence interval 1.2-5.9).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	5	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	51#58		Moreover, patients with homozygous carriage of the TNFRSF6-670*G allele were more likely than those homozygous for the wild type of the Fas gene (TNFRSF6-670*A/A) to have HELLP syndrome (P = .006; odds ratio 4.0, 95% confidence interval 1.7-9.8).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	5	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	146#153		Moreover, patients with homozygous carriage of the TNFRSF6-670*G allele were more likely than those homozygous for the wild type of the Fas gene (TNFRSF6-670*A/A) to have HELLP syndrome (P = .006; odds ratio 4.0, 95% confidence interval 1.7-9.8).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	6	355	SYMBOL|NUMBER|DICTIONARY	tnfrsf6	TNFRSF6	13#20		In contrast, TNFRSF6-670 genotype distribution of neonates born to mothers with HELLP syndrome was not statistically different from that found in neonates born to healthy pregnant women (P = .4).
16507928	2007	Obstet Gynecol	1873-233X	RESULTS	3	7	355	SYMBOL|DICTIONARY	tnfrsf6	TNFRSF6	56#63		In patients with HELLP syndrome, no association between TNFRSF6 genotype distribution and severity of hemolysis, platelet counts or liver enzymes levels was noted.
16507928	2007	Obstet Gynecol	1873-233X	CONCLUSION	4	8	355	SYMBOL|GENE|GN|DICTIONARY	tnfrsf6	TNFRSF6	87#94		A single A>G nucleotide substitution at position -670 in the maternal but not neonatal TNFRSF6 gene coding for Fas is associated with a higher risk for HELLP syndrome.
16495393	2006	N. Engl. J. Med.	1533-4406	RESULTS	3	7	2064	SYMBOL|DICTIONARY	her2	HER2	40#44		Within the subgroup of patients who had HER2/neu-positive cancer, those who received trastuzumab had better three-year recurrence-free survival than those who did not receive the antibody (89 percent vs. 78 percent; hazard ratio for recurrence or death, 0.42; 95 percent confidence interval, 0.21 to 0.83; P=0.01).
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_1/3	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	27#30		We compared the results of HFE genotype with tests for iron binding saturation (IBS) in 190 consecutive patients with liver disease using 2 IBS cutoff levels: 45% and 60%.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_2/3	2	3	3077	SYMBOL|DICTIONARY	hfe	HFE	50#53		The number of patients (10) with the highest-risk HFE genotype (C282Y homozygote) was higher than expected.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_3/3	3	6	3077	SYMBOL|DICTIONARY	hfe	HFE	92#95		There was poor correlation of elevated saturation with other genotypes containing 1 or more HFE variants.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_3/3	3	7	3077	SYMBOL|DICTIONARY	hfe	HFE	44#47		Patients with a wild-type genotype (lacking HFE variants) and elevated IBS were far more likely to have an iron binding capacity less than 250 microg/dL (<44.8 micromol/L) than those with saturation values less than 45%, suggesting that a significant percentage of elevated IBS test results in liver disease are false-positives associated with decreased synthetic capacity.
16393683	2006	Am. J. Clin. Pathol.	0002-9173	ALL_TEXT_3/3	3	8	3077	SYMBOL|DICTIONARY	hfe	HFE	194#197		Nevertheless, an appreciable number of patients with elevated IBS had normal iron binding capacity, indicating the complexity of relationships among iron absorption and binding, disease status, HFE genotype, and other potential modifying factors in liver disease.
16361298	2006	Br J Anaesth	0007-0912	ALL_TEXT_3/3	3	3	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	111#116		Because of this uncommon clinical presentation, we analysed the patient's DNA, and found a polymorphism in the MTHFR gene that is associated with the thermolabile isoform of the 5,10-methylenetetrahydrofolate reductase enzyme, which explained the myelopathy experienced by the patient after being exposed to nitrous oxide.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1*07 allele detected in 19 of the 65 (29.2%) PBC patients was subtyped as DRB1*0701, as well as in 13.9% of controls (PC<0.05, OR=2.55, 95%CI: 1.4-4.6).
16481299	2006	HBPD INT	1499-3872	RESULTS	3	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	81#85		HLA-DRB1*07 allele detected in 19 of the 65 (29.2%) PBC patients was subtyped as DRB1*0701, as well as in 13.9% of controls (PC<0.05, OR=2.55, 95%CI: 1.4-4.6).
16481299	2006	HBPD INT	1499-3872	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		An increased frequency of DRB1*03 (18.4% vs. 7.2% in healthy controls) and a decreased frequency of DRB1*12 (16.9% vs. 28.8%) in PBC patients were statistically significant.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	100#104		An increased frequency of DRB1*03 (18.4% vs. 7.2% in healthy controls) and a decreased frequency of DRB1*12 (16.9% vs. 28.8%) in PBC patients were statistically significant.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	30#38		There was no association with HLA-DRB1*08 reported.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	7	3105	SYMBOL|DICTIONARY	hla a	HLA-A	20#25		The frequencies for HLA-A, B and the other DRB1 alleles were similar between patients and healthy controls.
16481299	2006	HBPD INT	1499-3872	RESULTS	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	43#47		The frequencies for HLA-A, B and the other DRB1 alleles were similar between patients and healthy controls.
16481299	2006	HBPD INT	1499-3872	CONCLUSIONS	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	68#72		The susceptibility to PBC in Chinese individuals is associated with DRB1*0701 allele.
16352452	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	3074	SYMBOL|DICTIONARY	hexb	HEXB	7#11		Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	2	3073	SYMBOL|DICTIONARY	hexa	HEXA	128#132		Both their serum HexA and HexB enzymatic activities were below reference range, suggesting inheritance of mutations in both the HEXA (alpha-subunit) and HEXB (beta-subunit) genes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	3	3073	SYMBOL|NUMBER|DICTIONARY	hexa	HEXA	66#70		DNA sequencing revealed that both individuals, carried the common HEXA 1277_1278insTATC mutation, and two common HEXB polymorphisms: [619A>G (+) delTG].
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	3	3074	SYMBOL|DICTIONARY	hexb	HEXB	113#117		DNA sequencing revealed that both individuals, carried the common HEXA 1277_1278insTATC mutation, and two common HEXB polymorphisms: [619A>G (+) delTG].
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3074	SYMBOL|DICTIONARY	hexb	HEXB	22#26		To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3074	SYMBOL|DICTIONARY	hexb	HEXB	336#340		To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	TITLE	0	0	2261	LONGTERM|GENE|GN|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	58#93		Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth factor receptor 3 gene responsible for achondroplasia.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	LONGTERM|DICTIONARY|GFAM|FA	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	99#134		The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	SYMBOL|()|GFAM|FN|DICTIONARY|EXTRACTED	fgfr3	FGFR3	136#141	16434832-4-99-134	The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_2/3	2	4	2261	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr3	FGFR3	222#227	16434832-4-99-134	The vast majority of patients with achondroplasia have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_3/3	3	7	2261	SYMBOL|DICTIONARY|EXTRACTED	fgfr3	FGFR3	175#180	16434832-4-99-134	This study was designed to improve the molecular diagnosis based on the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques for the FGFR3 G1138A mutation.
16434832	2006	Tohoku J. Exp. Med.	0040-8727	ALL_TEXT_3/3	3	8	2261	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	fgfr3	FGFR3	86#91	16434832-4-99-134	The newly designed forward primer contains one mismatch (G at position 1136) from the FGFR3 cDNA sequence (A at position 1136), thereby creating a PstI site (CTGCAG at positions 1134 to 1139) in the amplified DNA from alleles containing the G1138A mutation.
16454982	2006	Chin. Med. J.	0366-6999	TITLE	0	0	668	SYMBOL|GENE|GN|DICTIONARY	foxl2	FOXL2	12#17		Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
17131847	2007	Ann Acad Med Stetin	1427-440X	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	31#34		[The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	LONGTERM|DICTIONARY	beta thromboglobulin	beta-thromboglobulin	140#160		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5473	SYMBOL|EXTRACTED|()	beta tg	beta-TG	162#169	17131847-1-140-160	1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	3	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	120#123		The assessment of haemostasis parameters levels and ACE activity in effect of treatment with perindopril in relation to ACE gene I/D polymorphism.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	7	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	28#31		These changes not depend on ACE gene I/D polymorphism.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	9	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	83#86		The treatment with perindopril decreases blood pressure effectively independent of ACE gene I/D genotype and left ventricular hypertrophy.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	10	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	56#59		Perindopril impairs RAS activity, most in patients with ACE gene II genotype.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	12	5327	SYMBOL|EXTRACTED	t pa	t-PA	55#59	17131847-1-52-80	The treatment makes fibrinolysis better mainly to high t-PA levels, independently of ACE gene I/D polymorphism.3.
17131847	2007	Ann Acad Med Stetin	1427-440X	CONCLUSION	3	12	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	85#88		The treatment makes fibrinolysis better mainly to high t-PA levels, independently of ACE gene I/D polymorphism.3.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	4	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	84#105		The aim of the present study was to analyze the effect of antimalarial treatment on tumor necrosis factor (TNF)alpha serum levels and evaluate the possible influence of TNFalpha and IL-10 functional genetic polymorphisms on the response to antimalarial drugs.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	182#187		The aim of the present study was to analyze the effect of antimalarial treatment on tumor necrosis factor (TNF)alpha serum levels and evaluate the possible influence of TNFalpha and IL-10 functional genetic polymorphisms on the response to antimalarial drugs.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	170#175		To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	10	3586	SYMBOL|DICTIONARY	il 10	IL-10	149#154		This suggests, however, that antimalarial-mediated inhibition of TNFalpha was only significant in patients who were genetically high TNFalpha or low IL-10 producers.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	3586	SYMBOL|DICTIONARY	il 10	IL-10	204#209		In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	3586	SYMBOL|DICTIONARY	il 10	IL-10	141#146		In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
17168855	2007	Curr. Med. Chem.	0929-8673	ALL_TEXT_3/3	3	9	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	96#110		The only proven effective prevention of RBV-induced anemia is the concomitant administration of erythropoietin.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	TITLE	0	0	627	LONGTERM|GENE|GN|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	Brain-derived neurotrophic factor	0#33		Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	35#39	16391475-1-0-33	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, may represent a candidate gene conferring susceptibility to Alzheimer's disease (AD).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	2	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	96#100	16391475-1-0-33	This is because it has an important role in neuronal survival, and a decreased central level of BDNF is observed in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_1/3	1	3	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	62#66	16391475-1-0-33	Some previous studies, though not all, have demonstrated that BDNF C270T polymorphisms might be associated with AD susceptibility.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	15#19	16391475-1-0-33	We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	348	SYMBOL|()|DICTIONARY	apoe4	APOE4	101#106		We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe	APOE	44#48		Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	71#76		Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	8	348	SYMBOL|DICTIONARY	apoe4	APOE4	280#285		Stratification of the data according to the APOE status showed that in APOE4 allele bearers there was no significant difference in the frequency of haplotype 66Val-270C between AD and controls (p = 0.125), although there was a significant difference between the two groups in non-APOE4 carriers (p = 0.002).
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	9	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	27#31	16391475-1-0-33	These results suggest that BDNF genetic variation may possibly affect the risk for AD, particularly in subjects who are negative for APOE4.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_3/3	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	133#138		These results suggest that BDNF genetic variation may possibly affect the risk for AD, particularly in subjects who are negative for APOE4.
17006606	2007	J. Hum. Genet.	1434-5161	TITLE	0	0	3553	SYMBOL|DICTIONARY	il1b	IL1B	45#49		A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	115#119		Proinflammatory cytokine gene polymorphisms have been demonstrated to associate with gastric cancer risk, of which IL1B-31T/C and -511C/T changes have been well investigated due to the possibility that they may alter the IL1B transcription.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	3553	SYMBOL|DICTIONARY	il1b	IL1B	221#225		Proinflammatory cytokine gene polymorphisms have been demonstrated to associate with gastric cancer risk, of which IL1B-31T/C and -511C/T changes have been well investigated due to the possibility that they may alter the IL1B transcription.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	3553	LONGTERM|DICTIONARY	interleukin 1 beta	interleukin 1 beta	36#54		The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	3553	SYMBOL|EXTRACTED|()	il1beta	IL1beta	56#63	17006606-2-36-54	The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	3553	SYMBOL|DICTIONARY	il1b	IL1B	206#210		Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	224#227	17006606-2-225-245	Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	5	3553	SYMBOL|DICTIONARY	il1b	IL1B	155#159		We observed strong linkage disequilibrium between the T allele at -511 and the C allele at -31 and between the C allele at -511 and the T allele at -31 in IL1B in both the cases and controls (R (2)=0.94).
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	8#12		Neither IL1B-31, -511 nor FAS-670 polymorphisms showed significantly different risks of gastric adenocarcinoma.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	26#29	17006606-2-225-245	Neither IL1B-31, -511 nor FAS-670 polymorphisms showed significantly different risks of gastric adenocarcinoma.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	355	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	fas	FAS	7#10	17006606-2-225-245	Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019).
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	102#106		Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019).
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	116#120		Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019).
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	8	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	90#94		In particular, subjects with stage IV had a two times higher probability of having either IL1B-31TT (or IL1B-511CC) genotype compared with stage I subjects.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	8	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	104#108		In particular, subjects with stage IV had a two times higher probability of having either IL1B-31TT (or IL1B-511CC) genotype compared with stage I subjects.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	32#36		These observations suggest that IL1B-31TT and IL1B-511CC are associated with disease progression.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	3553	SYMBOL|NUMBER|DICTIONARY	il1b	IL1B	46#50		These observations suggest that IL1B-31TT and IL1B-511CC are associated with disease progression.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	3257	SYMBOL|DICTIONARY	hps1	HPS1	91#95		Two HPS genes and mutations have been identified in PR, a 16-base pair (bp) duplication in HPS1 and a 3,904-bp deletion in HPS3.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	84343	SYMBOL|DICTIONARY	hps3	HPS3	123#127		Two HPS genes and mutations have been identified in PR, a 16-base pair (bp) duplication in HPS1 and a 3,904-bp deletion in HPS3.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	LONGTERM|DICTIONARY	tyrosinase	tyrosinase	72#82		In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	SYMBOL|()|DICTIONARY|EXTRACTED	tyr	TYR	84#87	16417222-4-72-82	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	LONGTERM|DICTIONARY|GENE|GA	tyrosinase	tyrosinase	96#106		In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	7299	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	oca1	OCA1	108#112	16417222-4-96-106	In Puerto Ricans with more typical OCA, the most common mutation of the tyrosinase (TYR) (human tyrosinase (OCA1) gene) gene was G47D.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	5	4948	SYMBOL|GENE|GN|DICTIONARY	oca2	OCA2	98#102		We describe screening 229 Puerto Rican OCA patients for these mutations, and for mutations in the OCA2 gene.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	6	3257	SYMBOL|DICTIONARY	hps1	HPS1	13#17		We found the HPS1 mutation in 42.8% of cases, the HPS3 deletion in 17%, the TYR G47D mutation in 3.0%, and a 2.4-kb deletion of the OCA2 gene in 1.3%.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	6	84343	SYMBOL|DICTIONARY	hps3	HPS3	50#54		We found the HPS1 mutation in 42.8% of cases, the HPS3 deletion in 17%, the TYR G47D mutation in 3.0%, and a 2.4-kb deletion of the OCA2 gene in 1.3%.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	6	7299	SYMBOL|DICTIONARY|EXTRACTED	tyr	TYR	76#79	16417222-4-72-82	We found the HPS1 mutation in 42.8% of cases, the HPS3 deletion in 17%, the TYR G47D mutation in 3.0%, and a 2.4-kb deletion of the OCA2 gene in 1.3%.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	6	4948	SYMBOL|GENE|GN|DICTIONARY	oca2	OCA2	132#136		We found the HPS1 mutation in 42.8% of cases, the HPS3 deletion in 17%, the TYR G47D mutation in 3.0%, and a 2.4-kb deletion of the OCA2 gene in 1.3%.
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	7	3257	SYMBOL|DICTIONARY	hps1	HPS1	50#54		Among Puerto Rican newborns, the frequency of the HPS1 mutation is highest in northwest PR (1:21; 4.8%) and lower in central PR (1:64; 1.6%).
16417222	2006	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	8	84343	SYMBOL|GENE|GN|DICTIONARY	hps3	HPS3	4#8		The HPS3 gene deletion is most frequent in central PR (1:32; 3.1%).
17039310	2007	Mod Rheumatol	1439-7595	TITLE	0	0	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	0#4		SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6288	SYMBOL|GENE|GN|DICTIONARY	saa1	SAA1	59#63		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
17039310	2007	Mod Rheumatol	1439-7595	ALL_TEXT_1/3	1	1	6287	SYMBOL|GENE|GN|DICTIONARY	saa	SAA	366#369		To investigate the precise modality of association between SAA1 gene polymorphisms and the development of AA amyloidosis in patients with rheumatoid arthritis (RA), Japanese patients with RA (n=153), among whom 29 were histologically diagnosed as having amyloidosis, were genotyped for three single nucleotide polymorphisms (SNPs), C-13T, C2995T, and C3010T, in the SAA gene.
16322490	2006	Stroke	1524-4628	TITLE	0	0	7124	LONGTERM|NUMBER|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations.
16322490	2006	Stroke	1524-4628	METHODS	2	4	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	63#76		We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6-174G>C; IL-6-572G>C) and tumor necrosis factor-alpha (TNF-alpha-238G>A; TNF-alpha-308G>A).
16322490	2006	Stroke	1524-4628	METHODS	2	4	3569	SYMBOL|NUMBER|DICTIONARY	il 6	IL-6	78#82		We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6-174G>C; IL-6-572G>C) and tumor necrosis factor-alpha (TNF-alpha-238G>A; TNF-alpha-308G>A).
16322490	2006	Stroke	1524-4628	METHODS	2	4	3569	SYMBOL|NUMBER|DICTIONARY	il 6	IL-6	91#95		We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6-174G>C; IL-6-572G>C) and tumor necrosis factor-alpha (TNF-alpha-238G>A; TNF-alpha-308G>A).
16320352	2006	Arthritis Rheum.	0004-3591	TITLE	0	0	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	150#156		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	319#325		Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders.
16320352	2006	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	64#70		This study therefore examined whether the functionally relevant PTPN22 polymorphism is associated with Wegener's granulomatosis (WG).
16320352	2006	Arthritis Rheum.	0004-3591	METHODS	2	3	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	47#53		A population-based study was performed for the PTPN22 polymorphism in 199 patients with WG and in 399 healthy individuals.
16320352	2006	Arthritis Rheum.	0004-3591	RESULTS	3	5	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		The PTPN22 620W allele frequency was significantly increased in antineutrophil cytoplasmic antibody (ANCA)-positive WG patients compared with healthy controls (P < 0.001).
16320352	2006	Arthritis Rheum.	0004-3591	CONCLUSION	4	7	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	4#10		The PTPN22 620W allele appears to be involved in the pathogenesis of WG, and ANCA positivity seems to be the hallmark.
16359492	2006	Congenit Anom (Kyoto)	0914-3505	TITLE	0	0	1387	LONGTERM|GENE|GN|GT|DICTIONARY	creb binding protein	CREB-binding protein	27#47		Comprehensive screening of CREB-binding protein gene mutations among patients with Rubinstein-Taybi syndrome using denaturing high-performance liquid chromatography.
16359492	2006	Congenit Anom (Kyoto)	0914-3505	ALL_TEXT_2/3	2	8	1387	SYMBOL|GENE|GN|DICTIONARY	crebbp	CREBBP	104#110		We then wrote a computer script to analyze all the PCR amplicons generated from various portions of the CREBBP gene in a serial manner at optimized conditions determined individually for each amplicon.
16690408	2006	Hum. Immunol.	0198-8859	TITLE	0	0	6890	LONGTERM|DICTIONARY	transporter associated with antigen processing	transporter associated with antigen processing	42#88		Pemphigus vulgaris is associated with the transporter associated with antigen processing (TAP) system.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	3	6890	LONGTERM|DICTIONARY|GENE|GA	transporter associated with antigen processing	transporter associated with antigen processing	83#129		One cluster includes the microsatellite marker TAP1CA, located in proximity to the transporter associated with antigen processing (TAP) genes.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	7	6891	SYMBOL|DICTIONARY	tap2	TAP2	41#45		Significant differences were detected in TAP2 amino acid residues (p=0.001).
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	7#11		Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	42#46		Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	8	6891	SYMBOL|DICTIONARY	tap2	TAP2	53#57		Two PV TAP2 risk alleles were identified (TAP2*C and TAP2*D), the frequency of which was estimated to be 37.8% in the patients and 5.3 % in the controls.
16690408	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	10	6891	SYMBOL|GENE|GN|DICTIONARY	tap2	TAP2	28#32		It is therefore likely that TAP2 genes are involved in susceptibility to development of PV.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	LONGTERM|DICTIONARY|GENE|GA	keratin 12	keratin 12	100#110		Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
16352477	2006	Ophthalmic Genet.	1381-6810	TITLE	0	0	3859	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	krt12	KRT12	112#117	16352477-0-100-110	Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (KRT12) gene.
16352477	2006	Ophthalmic Genet.	1381-6810	PURPOSE	1	2	3850	SYMBOL|DICTIONARY	krt3	KRT3	42#46		It is caused by heterozygous mutations in KRT3 or KRT12 gene.
16352477	2006	Ophthalmic Genet.	1381-6810	PURPOSE	1	2	3859	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	krt12	KRT12	50#55	16352477-0-100-110	It is caused by heterozygous mutations in KRT3 or KRT12 gene.
16352477	2006	Ophthalmic Genet.	1381-6810	PURPOSE	1	3	3850	SYMBOL|DICTIONARY	krt3	KRT3	48#52		Actually, 14 mutations have been reported, 1 in KRT3 and 13 in KRT12.
16352477	2006	Ophthalmic Genet.	1381-6810	PURPOSE	1	3	3859	SYMBOL|DICTIONARY|EXTRACTED	krt12	KRT12	63#68	16352477-0-100-110	Actually, 14 mutations have been reported, 1 in KRT3 and 13 in KRT12.
16352477	2006	Ophthalmic Genet.	1381-6810	METHODS	2	5	3850	SYMBOL|DICTIONARY	krt3	KRT3	55#59		Patients from 2 families were screened for mutation in KRT3 and KRT12.
16352477	2006	Ophthalmic Genet.	1381-6810	METHODS	2	5	3859	SYMBOL|DICTIONARY|EXTRACTED	krt12	KRT12	64#69	16352477-0-100-110	Patients from 2 families were screened for mutation in KRT3 and KRT12.
16352477	2006	Ophthalmic Genet.	1381-6810	RESULTS/CONCLUSIONS	3	8	3859	SYMBOL|DICTIONARY|EXTRACTED	krt12	KRT12	63#68	16352477-0-100-110	In one family, the M129T heterozygous mutation was observed in KRT12.
16352477	2006	Ophthalmic Genet.	1381-6810	RESULTS/CONCLUSIONS	3	9	3859	SYMBOL|DICTIONARY|EXTRACTED	krt12	KRT12	85#90	16352477-0-100-110	In the second family, we identified a novel I426S heterozygous mutation in exon 6 of KRT12.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	34#39		[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	33#38		To investigate the prevalence of BRCA1 and BRCA2 mutations among early-onset breast cancer patients in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	43#48		To investigate the prevalence of BRCA1 and BRCA2 mutations among early-onset breast cancer patients in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	22#27		Mutation screening of BRCA1 and BRCA2 was performed in the whole coding sequence through Denaturing High Performance Liquid Chromatography (DHPLC) and subsequent DNA direct sequencing.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	32#37		Mutation screening of BRCA1 and BRCA2 was performed in the whole coding sequence through Denaturing High Performance Liquid Chromatography (DHPLC) and subsequent DNA direct sequencing.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	157#162		Six deleterious mutations, including 2 novel frameshift mutations (3449insA, 5587-1del8) and 2 novel splice-site mutations (IVS17-1G > T, IVS21 + 1G > C) in BRCA1 were identified.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	6	675	SYMBOL|DICTIONARY	brca2	BRCA2	38#43		Two deleterious mutations detected in BRCA2, including one frameshift mutation (5950delCT) and one novel missense mutation (5911G > C), all occurring on exon 11 adjacently.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	119#124		Additional 12 novel sequence variants were also detected including one unclassified variant and 7 intronic variants in BRCA1, and 4 novel intronic variants in BRCA2, all causing no alteration of amino acid coding.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	7	675	SYMBOL|DICTIONARY	brca2	BRCA2	159#164		Additional 12 novel sequence variants were also detected including one unclassified variant and 7 intronic variants in BRCA1, and 4 novel intronic variants in BRCA2, all causing no alteration of amino acid coding.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	672	SYMBOL|DICTIONARY	brca1	BRCA1	18#23		The prevalence of BRCA1 and BRCA2 mutations in the patients with early-onset breast cancer was 12% and 4%, respectively.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	28#33		The prevalence of BRCA1 and BRCA2 mutations in the patients with early-onset breast cancer was 12% and 4%, respectively.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		Four novel mutations in BRCA1 and one novel mutation in BRCA2 may be mutations characterized of early-onset breast cancer in Chinese population.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	675	SYMBOL|DICTIONARY	brca2	BRCA2	56#61		Four novel mutations in BRCA1 and one novel mutation in BRCA2 may be mutations characterized of early-onset breast cancer in Chinese population.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	675	SYMBOL|DICTIONARY	brca2	BRCA2	22#27		Germline mutations in BRCA2 may contribute less than mutations in BRCA1 to early-onset breast cancer in Shanghai.
16324400	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	66#71		Germline mutations in BRCA2 may contribute less than mutations in BRCA1 to early-onset breast cancer in Shanghai.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	104#110	16318816-1-104-110	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	112#118	16318816-1-104-110	To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	131#136		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	METHODS	2	3	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	82#88	16318816-1-104-110	All DNA samples from peripheral blood were genotyped for genetic polymorphisms of CYP1A1 and GSTM1 genes by genechip technique.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	METHODS	2	3	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	93#98		All DNA samples from peripheral blood were genotyped for genetic polymorphisms of CYP1A1 and GSTM1 genes by genechip technique.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	55#60		There was a significant difference in the frequency of GSTM1 [null] genotype in PC cases (57.8%) compared to healthy controls (41.7%) (chi(2) = 4.99, P = 0.025).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		Individuals with the GSTM1 [null] genotype demonstrated increased risk (OR = 1.9, 95% CI = 1.10-1.34).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		The frequency of the GSTM1 [null] genotype was also higher in patients with advanced stage or high grade disease.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	RESULTS	3	7	1543	SYMBOL|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	84#90	16318816-1-104-110	There were no significant differences in the frequent distribution of two locate of CYP1A1 polymorphisms between prostate cancer patients and healthy controls (P > 0.05).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	CONCLUSIONS	4	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 [null] genotype may be linked to prostate cancer risk in Chinese population.
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	CONCLUSIONS	4	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 [null] genotype was also related to the stage and grade, which may be helpful in determining the risk of locally disease and advanced PC.
16358723	2006	Genetika	0016-6758	TITLE	0	0	1234	SYMBOL|GENE|GN|DICTIONARY	ccr5	CCR5	38#42		[Comparison CCR5de132 mutation in the CCR5 gene frequencies in Russians, Tuvinians, and in different groups of HIV-infected individuals].
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	47#51		The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	102#106		The 32-bp deletion (CCR5del32 mutation) in the CCR5 (chemokine (C-C motif) receptor 5) gene, encoding CCR5 chemokine receptor, is one of the factors determining natural resistance to human immunodeficiency virus (HIV-1) infection.
16358723	2006	Genetika	0016-6758	ALL_TEXT_1/3	1	2	1234	SYMBOL|GENE|GN|DICTIONARY	ccr5	CCR5	166#170		In the present study, the samples of Russians (n = 107), Tuvinians (n = 50), and HIV-infected individuals were examined for the presence of CCR5del32 mutation in the CCR5 gene.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	1	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	228#232		Major histocompatibility complex (MHC) class I chain-related A (MICA) molecules deliver activating signals through the NKG2D receptor expressed on the surface of natural killer (NK), CD8alphabeta and gammadelta T cells, and the MICA gene is polymorphic.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	2	22914	SYMBOL|DICTIONARY	nkg2d	NKG2D	110#115		The recently described MICA amino acid substitution at position 129 (MICA-129) seems to affect its binding to NKG2D.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	4	3106	SYMBOL|GENE|GN|DICTIONARY	hla b	HLA-B	80#85		DNA from 129 patients and 76 healthy individuals were analyzed to determine the HLA-B generic type as well as MICA-129 polymorphism.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	6	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	64#68		These data suggest a potential role for a functionally relevant MICA gene polymorphism in autoimmune/inflammatory disease susceptibility.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	TITLE	0	0	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	16299685-0-0-13	Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	117#121	16299685-0-0-13	A sustained inflammatory reaction is observed in the disease course, and cytokine levels such as interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha (TNF-alfa) are shown to increase during and between the attacks.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_1/3	1	2	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	126#153		A sustained inflammatory reaction is observed in the disease course, and cytokine levels such as interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha (TNF-alfa) are shown to increase during and between the attacks.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_2/3	2	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	70#74	16299685-0-0-13	In this study, we investigated the role of the functionally important IL-6 -174 G/C polymorphism in the clinical outcome of FMF and amyloidosis.
16299685	2006	J. Nephrol.	1121-8428	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	22#26	16299685-0-0-13	The results show that IL-6 -174 G/C polymorphism is not associated with FMF and amyloidosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	89#103		[The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	116#130		We do this investigation in order to reveal the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter, and end stage renal disease (ESRD) patients microinflammatory state and arteriosclerosis (AS).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	65#70		We used PCR-RFLP to measure the various kinds of distribution of IL-10 gene-1082A/G genotype and relevant indexes of microinflammatory state and AS of 870 ESRD patients and 1000 healthy persons of control group and to analyze the mechanism of its protection effect keeping ESRD patients away from microinflammation and arteriosclerosis.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	1401	SYMBOL|DICTIONARY	crp	CRP	33#36		Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	3586	SYMBOL|DICTIONARY	il 10	IL-10	59#64		Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	3586	SYMBOL|DICTIONARY	il 10	IL-10	183#188		Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	1401	SYMBOL|DICTIONARY	crp	CRP	10#13		Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	176#181		Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	6	3586	SYMBOL|DICTIONARY	il 10	IL-10	18#23		The production of IL-10 in serum from patients with IL-10A/A genotype was significantly lower than that of patients with G/G and G/A genotype (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	7	3586	SYMBOL|NUMBER|DICTIONARY	il 10	IL-10	42#47		The incidence rate of AS of patients with IL-10-1082A/A genotype was significantly higher than that of patients with G/G and G/A genotype (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	75#80		The raise of AS incidence rate was correspondent with the decline of serum IL-10 and raise of serum CRP and Fib.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	8	1401	SYMBOL|DICTIONARY	crp	CRP	100#103		The raise of AS incidence rate was correspondent with the decline of serum IL-10 and raise of serum CRP and Fib.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	3586	SYMBOL|DICTIONARY	il 10	IL-10	66#71		We use IL-10G/G genotype to modulate the high production of serum IL-10, to decline inflammatory reaction and to keep away from microinflammation and AS in ESRD patients.
16457697	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	23#28		A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	1	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	9#14		The gene XRCC1 (X-ray repair cross-complementing group 1) encodes a protein involved in DNA base excision repair.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	2	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	36#41		Two non-synonymous polymorphisms in XRCC1 (Arg194Trp and Arg399Gln) have been shown to alter DNA repair capacity in some studies in vitro.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	62#67		However, results of previous association studies of these two XRCC1 variants and breast cancer have been inconsistent.
16457697	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	4	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	53#58		We examined the association between polymorphisms in XRCC1 and breast cancer in the American Cancer Society Cancer Prevention Study II (CPS-II) Nutrition Cohort, a large prospective study of cancer incidence in the USA.
16457697	2006	Breast Cancer Res.	1465-542X	METHODS	2	8	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	134#139		We also examined whether factors associated with DNA damage, such as smoking and antioxidant intake, modified the association between XRCC1 polymorphisms and breast cancer.
16457697	2006	Breast Cancer Res.	1465-542X	RESULTS	3	12	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	58#63		No other factor examined modified the association between XRCC1 polymorphisms and breast cancer risk.
16457697	2006	Breast Cancer Res.	1465-542X	CONCLUSION	4	13	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	61#66		Our results support the hypothesis that genetic variation in XRCC1, particularly in Arg194Trp, may influence postmenopausal breast cancer risk.
16457697	2006	Breast Cancer Res.	1465-542X	CONCLUSION	4	14	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	35#40		In our study, genetic variation in XRCC1 Arg399Gln was associated with breast cancer risk only among women with a history of smoking cigarettes.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	0#6		CYP1A1 activates environmental procarcinogens and catalyzes oxidative metabolism of estrogens and is likely to play an important role in the etiology of prostate cancer.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_2/3	2	2	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	186#192		To evaluate this phenomenon, the association between two single nucleotide polymorphisms (A to G transition in exon7 leading to amino acid substitution Ile462Val and T3801C at 3'UTR) of CYP1A1 gene in prostate cancer were analyzed in a case-control study of 100 individuals in South Indian population.
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	3	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	99#105		The estimated relative risk was significantly high for individuals with w1/m1 genotype at 3'UTR of CYP1A1 gene (OR-4.64; 95%CI = 1.51-14.86; P < 0.01) whereas the CYP1A1 Ile/Val genotype (w2/m2) on exon 7 was found to be associated with a decreased risk for prostate cancer (OR-0.17; 95%CI = 0.02-0.89; P=0.03).
17192049	2007	Cancer Biomark	1574-0153	ALL_TEXT_3/3	3	3	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	163#169		The estimated relative risk was significantly high for individuals with w1/m1 genotype at 3'UTR of CYP1A1 gene (OR-4.64; 95%CI = 1.51-14.86; P < 0.01) whereas the CYP1A1 Ile/Val genotype (w2/m2) on exon 7 was found to be associated with a decreased risk for prostate cancer (OR-0.17; 95%CI = 0.02-0.89; P=0.03).
17287556	2007	Indian J. Med. Res.	0971-5916	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran.
17287556	2007	Indian J. Med. Res.	0971-5916	BACKGROUND &amp; OBJECTIVES	1	1	4846	SYMBOL|GENE|GN|DICTIONARY	nos3	NOS3	121#125		Endo-derived nitric oxide (NO) is synthesized from L-arginine by endothelium nitric oxide synthase (eNOS) encoded by the NOS3 gene on chromosome7.
17287556	2007	Indian J. Med. Res.	0971-5916	BACKGROUND &amp; OBJECTIVES	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos	NOS	112#115		Since reduced NO synthesis has been implicated in the development of coronary atherosclerosis; polymorphisms of NOS gene might be associated with increased susceptibility to this disorder and coronary artery disease (CAD).
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	73#106		We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	4	4846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	108#112	17287556-4-73-106	We studied the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unrelated CAD patients with positive coronary angiograms and 159 age matched control subjects without a history of symptomatic CAD.
17287556	2007	Indian J. Med. Res.	0971-5916	METHODS	2	5	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	4#8	17287556-4-73-106	The eNOS gene intron4a/b VNTR polymorphism was analyzed by polymerase chain reaction.
12800193	2003	Int. J. Cancer	0020-7136	TITLE	0	0	1499	SYMBOL|GENE|GN|DICTIONARY	beta catenin	beta-catenin	82#94		Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	3	1499	SYMBOL|()|DICTIONARY	ctnnb1	Ctnnb1	41#47		We found both a prototypic beta-catenin (Ctnnb1) mutation (Thr(41)Ile) and a ki-ras (G12D) mutation, providing unambiguous evidence for the constitutive activation of these pathways in CC531 cells.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	8	595	LONGTERM|DICTIONARY	cyclin d1	cyclin D1	43#52		We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras pathway.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	8	8061	SYMBOL|DICTIONARY	fosl1	Fosl1	71#76		We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras pathway.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	8	960	SYMBOL|DICTIONARY	cd44	Cd44	85#89		We found 7 differentially expressed genes, cyclin D1, cyclin E, c-myc, Fosl1, c-fos, Cd44 and follistatin, which are known targets of the beta-catenin and/or the ras pathway.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	LONGTERM|GENE|GT|DICTIONARY	beta amyloid precursor protein	beta-amyloid precursor protein	49#79		Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	351	SYMBOL|()|DICTIONARY|EXTRACTED	app	APP	81#84	12746438-4-49-79	Transgenic mice overexpressing a mutant gene for beta-amyloid precursor protein (APP) show behavioral and histopathological abnormalities resembling AD and, therefore, were used as an AD model.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	6	351	SYMBOL|DICTIONARY|EXTRACTED	app	APP	65#68	12746438-4-49-79	In contrast, carbachol failed to increase the sIPSC amplitude in APP transgenic mice, whereas the carbachol-induced increase of the sIPSC frequency was not significantly changed in these mutants.
12746438	2003	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	9	351	SYMBOL|DICTIONARY|EXTRACTED	app	APP	3#6	12746438-4-49-79	In APP transgenic mice, carbachol failed to activate PKC despite the apparently normal expression of mAChRs.
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	10841	SYMBOL|()|DICTIONARY|EXTRACTED	ftcd	FTCD	244#248	12815595-1-207-242	Glutamate formiminotransferase deficiency, an autosomal recessive disorder and the second most common inborn error of folate metabolism, is presumed to be due to defects in the bifunctional enzyme glutamate formiminotransferase-cyclodeaminase (FTCD).
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	10841	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ftcd	FTCD	32#36	12815595-1-207-242	We found mutations in the human FTCD gene in three patients with putative glutamate formiminotransferase deficiency.
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	10841	SYMBOL|DICTIONARY|EXTRACTED	ftcd	FTCD	23#27	12815595-1-207-242	Mutagenesis of porcine FTCD and expression in E. coli showed that the R135C mutation reduced formiminotransferase activity to 61% of wild-type, whereas the R299P mutation reduced this activity to 57% of wild-type.
12815595	2003	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	10841	SYMBOL|DICTIONARY|EXTRACTED	ftcd	FTCD	120#124	12815595-1-207-242	These mutations are the first identified in glutamate formiminotransferase deficiency and demonstrate that mutations in FTCD represent the molecular basis for the mild phenotype of this disease.
12771801	2003	J. Urol.	0022-5347	TITLE	0	0	6716	SYMBOL|DICTIONARY	srd5a2	SRD5A2	20#26		Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
12771801	2003	J. Urol.	0022-5347	PURPOSE	1	1	6716	SYMBOL|GENE|GN|DICTIONARY	srd5a2	SRD5A2	4#10		The SRD5A2 gene codes the steroid 5-reductase type II, a critical mediator of androgen action, and the V89L and A49T polymorphisms of this gene may be associated with a distinct enzyme activity.
12771801	2003	J. Urol.	0022-5347	CONCLUSIONS	4	11	6716	SYMBOL|GENE|GN|DICTIONARY	srd5a2	SRD5A2	45#51		The V allele of the V89L polymorphism in the SRD5A2 gene may dominantly increase the risk of prostate cancer.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	42#48		Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_1/3	1	2	1019	SYMBOL|DICTIONARY	cdk4	CDK4	53#57		Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	4157	SYMBOL|DICTIONARY	mc1r	MC1R	28#32		One such pigmentation gene, MC1R, has not only been found to be a low penetrance melanoma gene but has also been shown to act as a genetic modifier of melanoma risk in individuals carrying CDKN2A mutations.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	189#195		One such pigmentation gene, MC1R, has not only been found to be a low penetrance melanoma gene but has also been shown to act as a genetic modifier of melanoma risk in individuals carrying CDKN2A mutations.
12789280	2003	Oncogene	0950-9232	ALL_TEXT_3/3	3	5	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	122#128		Most recently, an environmental agent, ultraviolet radiation, has also been established as a modifier of melanoma risk in CDKN2A mutation carriers.
12684755	2004	J. Mol. Med.	0946-2716	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	45#78		Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences.
12802709	2003	Am J Perinatol	0735-1631	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	21#48		Relationship between tumor necrosis factor-alpha genotype and success of emergent cerclage.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY|GENE|GA	tumor necrosis factor alpha	tumor necrosis factor-alpha	64#91		The guanine to adenine substitution at the -308 position in the tumor necrosis factor-alpha (TNF-alpha) gene promoter region results in a 5-fold greater cytokine response to an inciting event.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_1/3	1	1	7124	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	93#102	12802709-1-64-91	The guanine to adenine substitution at the -308 position in the tumor necrosis factor-alpha (TNF-alpha) gene promoter region results in a 5-fold greater cytokine response to an inciting event.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	5	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	121#130	12802709-1-64-91	DNA extraction from peripheral blood and polymerase chain reaction (PCR) amplification of a 144-base pair segment of the TNF-alpha gene were performed with subsequent sequencing.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	7	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	33#42	12802709-1-64-91	There were no differences in the TNF-alpha polymorphism between women with cervical incompetence and controls or between women with cervical incompetence who delivered before versus after 28 weeks.
12802709	2003	Am J Perinatol	0735-1631	ALL_TEXT_3/3	3	8	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	4#13	12802709-1-64-91	The TNF-alpha polymorphism was not associated with cervical incompetence or with delivery prior to 28 weeks in women who received an emergent cerclage.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	TITLE	0	0	185	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin ii type 1 receptor	angiotensin-II type 1 receptor	95#125		Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	172#175		The objective of the present study was to analyse the potential synergistic influence of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene (I/D ACE) and the A1166C polymorphism of the angiotensin-II type 1 receptor gene polymorphisms (A1166C AT1R) on the left ventricular size and performance.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_1/3	1	1	185	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin ii type 1 receptor	angiotensin-II type 1 receptor	212#242		The objective of the present study was to analyse the potential synergistic influence of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene (I/D ACE) and the A1166C polymorphism of the angiotensin-II type 1 receptor gene polymorphisms (A1166C AT1R) on the left ventricular size and performance.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_1/3	1	1	185	SYMBOL|DICTIONARY	at1r	AT1R	270#274		The objective of the present study was to analyse the potential synergistic influence of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene (I/D ACE) and the A1166C polymorphism of the angiotensin-II type 1 receptor gene polymorphisms (A1166C AT1R) on the left ventricular size and performance.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	4	1636	SYMBOL|DICTIONARY	ace	ACE	22#25		Screening for the I/D ACE and A1166C AT1R genotypes was performed by polymerase chain reaction of genomic DNA, followed by restriction enzyme digestion and agarose gel electrophoresis.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	4	185	SYMBOL|DICTIONARY	at1r	AT1R	37#41		Screening for the I/D ACE and A1166C AT1R genotypes was performed by polymerase chain reaction of genomic DNA, followed by restriction enzyme digestion and agarose gel electrophoresis.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	5	1636	SYMBOL|DICTIONARY	ace	ACE	8#11		The I/D ACE and A1166C AT1R genotypes separately were not significantly associated with the left ventricular size and function parameters in CAD patients.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_2/3	2	5	185	SYMBOL|DICTIONARY	at1r	AT1R	23#27		The I/D ACE and A1166C AT1R genotypes separately were not significantly associated with the left ventricular size and function parameters in CAD patients.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_3/3	3	8	185	SYMBOL|DICTIONARY	at1r	AT1R	56#60		This study does not support the role of the ACE I/D and AT1R A1166C polymorphisms in the determination of the left ventricular size and performance in patients with significant coronary atherosclerosis.
12579522	2003	Cell Biochem. Funct.	0263-6484	TITLE	0	0	133	LONGTERM|DICTIONARY	adrenomedullin	adrenomedullin	44#58		Pathophysiological role of nitric oxide and adrenomedullin in autism.
12579522	2003	Cell Biochem. Funct.	0263-6484	ALL_TEXT_1/3	1	3	133	LONGTERM|DICTIONARY	adrenomedullin	Adrenomedullin	0#14		Adrenomedullin (AM), a recently discovered 52-amino acid peptide hormone, induces vasorelaxation by activating adenylate cyclase and also by stimulating NO release.
12618866	2003	Genes Immun.	1466-4879	TITLE	0	0	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	24#29		Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
12618866	2003	Genes Immun.	1466-4879	TITLE	0	0	5788	SYMBOL|()|DICTIONARY|EXTRACTED	cd45	CD45	31#35	12618866-0-24-29	Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	73#78		A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	5788	SYMBOL|()|DICTIONARY|EXTRACTED	cd45	CD45	80#84	12618866-0-24-29	A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	3	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	108#113		The mutation was found with significantly enhanced frequency in patients suffering from SSc suggesting that PTPRC could play a role as susceptibility gene not only in MS but also in other autoimmune diseases.
12618866	2003	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	4	5788	SYMBOL|DICTIONARY	ptprc	PTPRC	59#64		Further understanding of the mode of interaction of mutant PTPRC with other susceptibility genes may uncover mechanisms common in various autoimmune disorders.
12586300	2003	J. Hepatol.	0168-8278	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
12586300	2003	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	27#30		The impact of heterozygous HFE mutations on the course of chronic hepatitis C and iron indices was studied.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	0#3		HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	5	3077	SYMBOL|DICTIONARY	hfe	HFE	326#329		HFE heterozygous HCV patients had higher ferritin (349+/-37 vs. 193+/-15 microg/l; P<0.0005), TS (38+/-2 vs. 32+/-1%; P<0.0005), serum iron (144+/-6 vs. 121+/-3 microg/dl; P<0.0005), semiquantitative liver iron staining (0.26+/-0.07 vs. 0.09+/-0.03; P<0.006) and fibrosis scores (1.9+/-0.2 vs. 1.4+/-0.1; P<0.003) compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	6	3077	SYMBOL|DICTIONARY	hfe	HFE	210#213		By multivariate regression analysis odds ratios for liver cirrhosis were 5.9 (confidence interval (CI) 1.6-22.6; P<0.009) for C282Y heterozygotes and 2.9 (CI 1.0-8.4; P<0.05) for H63D heterozygotes compared to HFE wildtypes.
12586300	2003	J. Hepatol.	0168-8278	RESULTS	3	7	3077	SYMBOL|DICTIONARY	hfe	HFE	16#19		Considering all HFE heterozygous HCV patients, odds ratios of 3.6 (CI 1.4-9.3; P<0.009) for cirrhosis and 3.1 (CI 1.3-7.3; P<0.009) for fibrosis were calculated.
12586300	2003	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	3077	SYMBOL|DICTIONARY	hfe	HFE	14#17		Screening for HFE mutations should be considered in HCV infection.
12498973	2003	Neurobiol. Aging	0197-4580	TITLE	0	0	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		Intercellular adhesion molecule-1 K469E gene polymorphism and Alzheimer's disease.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	LONGTERM|DICTIONARY	intercellular adhesion molecule 1	Intercellular adhesion molecule-1	0#33		Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	2	3383	SYMBOL|()|DICTIONARY|EXTRACTED	icam 1	ICAM-1	35#41	12498973-2-0-33	Intercellular adhesion molecule-1 (ICAM-1) is an important mediator of inflammatory response and immune cell activation, is expressed on cerebrovascular endothelium and neuritic plaques in brain of AD patients, and seems to be implicated in the process of neuro-degeneration.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_2/3	2	3	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	29#35	12498973-2-0-33	A common polymorphism of the ICAM-1 gene (K469E) has been recently reported.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_2/3	2	4	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	94#100	12498973-2-0-33	In this case-control study, we evaluated the distribution of E/K alleles and genotypes of the ICAM-1 gene in 98 patients affected by sporadic AD and 115 age- and sex-matched controls.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|DICTIONARY|EXTRACTED	icam 1	ICAM-1	59#65	12498973-2-0-33	This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12498973	2003	Neurobiol. Aging	0197-4580	ALL_TEXT_3/3	3	7	3383	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	icam 1	ICAM-1	133#139	12498973-2-0-33	This study shows for the first time an association between ICAM-1 E/K gene polymorphism and AD, suggesting that polymorphisms of the ICAM-1 gene may be clinically important and confirming that inflammatory mechanisms may be crucial in the pathophysiology of neuro-degenerative diseases.
12728591	2003	Vnitr Lek	0042-773X	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	11#14		[Effect of ACE gene polymorphism on left ventricular function in patients with type 2 diabetes].
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_1/3	1	1	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	43#46		The authors evaluated the influence of the ACE gene polymorphism on left ventricular function in patients with diabetes type 2.
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_2/3	2	4	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	72#75		No association was found between insertion-deletion polymorphism of the ACE gene and observed echocardiographic parameters [left ventricular mass index (p = 0.43), EF (p = 0.46), wall motion index (p = 0.25), E wave (p = 0.14), A wave (p = 0.07), deceleration time of the E wave (p = 0.06), E/A (p = 0.07), flow propagation velocity (Vp) (p = 0.14) and E/Vp (p = 0.38)].
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	5	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	103#106		The presence of myocardial infarction, ischemic heart disease and hypertension had no association with ACE gene polymorphism (p = 0.53, p = 0.61 and p = 0.64).
12728591	2003	Vnitr Lek	0042-773X	ALL_TEXT_3/3	3	6	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	47#50		In conclusion, there is no association between ACE gene polymorphism and systolic and diastolic function of the left ventricle in this group of patients with diabetes type 2.
12582029	2003	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4968	SYMBOL|DICTIONARY	ogg1	OGG1	23#27		No association between OGG1 Ser326Cys polymorphism and breast cancer risk.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	10891	SYMBOL|DICTIONARY	ppargc1	PPARGC1	64#71		Peroxisome proliferator-activated receptor-gamma coactivator-1 (PPARGC1/PGC-1) is a transcriptional coactivator of nuclear hormone receptors implicated in blood pressure regulation.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	10891	SYMBOL|DICTIONARY	pgc 1	PGC-1	72#77		Peroxisome proliferator-activated receptor-gamma coactivator-1 (PPARGC1/PGC-1) is a transcriptional coactivator of nuclear hormone receptors implicated in blood pressure regulation.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	2	10891	SYMBOL|GENE|GN|DICTIONARY	ppargc1	PPARGC1	37#44		We therefore ascertained whether the PPARGC1 gene locus is associated with hypertension.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_1/3	1	3	10891	SYMBOL|DICTIONARY	ppargc1	PPARGC1	46#53		We studied associations of 3 polymorphisms in PPARGC1 transcripts with hypertension in 683 middle-aged men and 530 middle-aged women of a cross-sectional Austrian population.
12574109	2003	Hypertension	1524-4563	ALL_TEXT_3/3	3	9	10891	SYMBOL|DICTIONARY	ppargc1	PPARGC1	46#53		These results suggest, but do not prove, that PPARGC1 participates in blood pressure control, and sequence substitutions at its gene locus confer an increased risk of hypertension to a substantial proportion of men.
12631109	2004	Kidney Int.	0085-2538	TITLE	0	0	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	79#85		Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
12631109	2004	Kidney Int.	0085-2538	BACKGROUND	1	3	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	10#16		Using the COL4A3 -/- mouse, an animal model for human AS, we evaluated therapy with ramipril in mice.
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	7	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	10#16		Untreated COL4A3 -/- mice died from renal failure after 71 +/- 6 days.
12631109	2004	Kidney Int.	0085-2538	CONCLUSIONS	4	13	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	96#102		The results indicate an antiproteinuric and antifibrotic nephroprotective effect of ramipril in COL4A3 -/- mice is mediated by down-regulation of TGF-beta1.
12631109	2004	Kidney Int.	0085-2538	CONCLUSIONS	4	15	1285	SYMBOL|DICTIONARY	col4a3	COL4A3	12#18		The data in COL4A3 -/- mice as an animal-model for Alport syndrome suggest that ramipril might as well delay renal failure in humans with AS.
12714823	2003	Acta Haematol.	0001-5792	TITLE	0	0	3077	LONGTERM|GENE|GN|DICTIONARY	hemochromatosis	hemochromatosis	14#29		Prevalence of hemochromatosis gene (HFE) mutations in Greece.
12714823	2003	Acta Haematol.	0001-5792	ALL_TEXT_1/3	1	1	3077	LONGTERM|GENE|GN|DICTIONARY	hemochromatosis	hemochromatosis	34#49		The frequencies of the hereditary hemochromatosis gene (HFE) mutations C282Y and H63D vary between different populations.
12714823	2003	Acta Haematol.	0001-5792	ALL_TEXT_2/3	2	4	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	4#7	12714823-0-14-29	The HFE gene region of DNA samples extracted from peripheral leukocytes was amplified by the polymerase chain reaction.
12492589	2003	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	4	2214	LONGTERM|NUMBER|DICTIONARY	fcgammariiia	FcgammaRIIIa	138#150		The genotypic frequencies for two Fcgamma receptor single nucleotide polymorphisms, FcgammaRIIa-131 arginine (R) versus histidine (H) and FcgammaRIIIa-158 valine (V) versus phenylalanine (F) were examined in 98 children diagnosed with childhood ITP.
12492589	2003	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	7	2214	LONGTERM|NUMBER|DICTIONARY	fcgammariiia	FcgammaRIIIa	34#46		Both the FcgammaRIIa-131H and the FcgammaRIIIa-158V were significantly over-represented in children with ITP versus the control subjects (P-values 0.03).
12492589	2003	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	8	2214	LONGTERM|NUMBER|DICTIONARY	fcgammariiia	FcgammaRIIIa	81#93		The same statistical difference was noted with the combined FcgammaRIIa-131H and FcgammaRIIIa-158V allelic gene frequencies.
12793904	2003	Breast Cancer Res.	1465-542X	TITLE	0	0	4035	LONGTERM|DICTIONARY|GENE|GA	low density lipoprotein receptor related protein 1	low-density lipoprotein receptor-related protein 1	6#56		C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer.
12793904	2003	Breast Cancer Res.	1465-542X	TITLE	0	0	4035	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	58#62	12793904-0-6-56	C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	1	4035	LONGTERM|DICTIONARY	low density lipoprotein receptor related protein 1	Low-density lipoprotein receptor-related protein 1	0#50		Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor with an important role in regulating the activity of proteinases in extracellular matrix.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	1	4035	SYMBOL|()|DICTIONARY|EXTRACTED	lrp1	LRP1	52#56	12793904-0-6-56	Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor with an important role in regulating the activity of proteinases in extracellular matrix.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	3	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	47#51	12793904-0-6-56	Previous studies showed that the expression of LRP1 is related to invasiveness of cancer cells.
12793904	2003	Breast Cancer Res.	1465-542X	BACKGROUND	1	4	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	24#28	12793904-0-6-56	However, recent data on LRP1 suggest that this receptor can also be involved in tumor establishment and progression.
12793904	2003	Breast Cancer Res.	1465-542X	METHODS	2	5	4035	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	87#91	12793904-0-6-56	We investigated an association between the C766T polymorphism of the third exon of the LRP1 gene and breast cancer in a sample of women of Caucasian origin.
12793904	2003	Breast Cancer Res.	1465-542X	RESULTS	3	7	4035	SYMBOL|DICTIONARY|EXTRACTED	lrp1	LRP1	15#19	12793904-0-6-56	An increase in LRP1 T allele frequency in subjects with breast cancer was observed compared with controls (0.21 versus 0.15, P = 0.01963).
12793904	2003	Breast Cancer Res.	1465-542X	CONCLUSION	4	9	4035	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lrp1	LRP1	46#50	12793904-0-6-56	The T allele of the C766T polymorphism in the LRP1 gene is associated with an increased risk of breast cancer development in women of Caucasian origin.
12502508	2003	Diabetes	0012-1797	ALL_TEXT_3/3	3	6	836	LONGTERM|DICTIONARY	caspase 3	Caspase-3	0#9		Caspase-3 labeling was significantly increased at all three time points, indicating commitment to the efferent limb of the apoptotic pathway.
12728975	2003	J Chin Med Assoc	1726-4901	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	29#44		Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	41#70		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	78#93		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	95#98	12728975-1-78-93	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin ii type 1 receptor	angiotensin II type 1 receptor	104#134		This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	BACKGROUND	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	136#140	12728975-1-104-134	This study compared the polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) gene between type II diabetes with diabetic nephropathy (DN) in end-stage renal disease (ESRD) and those of the normal individuals in Taiwan.
12728975	2003	J Chin Med Assoc	1726-4901	METHODS	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	45#48	12728975-1-41-70	Polymerase chain reaction (PCR) specific for ACE gene was tested for insertion/deletion polymorphism.
12728975	2003	J Chin Med Assoc	1726-4901	METHODS	2	4	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	45#48	12728975-1-78-93	M235T and T174M variant polymorphisms of the AGT gene and the AT1R A1166C polymorphism were also tested according to previously described protocols.
12728975	2003	J Chin Med Assoc	1726-4901	METHODS	2	4	185	SYMBOL|DICTIONARY|EXTRACTED	at1r	AT1R	62#66	12728975-1-104-134	M235T and T174M variant polymorphisms of the AGT gene and the AT1R A1166C polymorphism were also tested according to previously described protocols.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	5	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	72#75	12728975-1-41-70	Between the two groups, frequencies of the alleles and the genotypes in ACE gene polymorphism were comparable.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	43#46	12728975-1-41-70	There was no significant difference of the ACE insertion and deletion polymorphism and AT1R gene polymorphism between the two groups.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	6	185	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	87#91	12728975-1-104-134	There was no significant difference of the ACE insertion and deletion polymorphism and AT1R gene polymorphism between the two groups.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	7	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	26#29	12728975-1-78-93	The allele frequencies of AGT point mutation at 235 (M235T) was significantly higher in DM nephropathy but the genotypic frequencies were not.
12728975	2003	J Chin Med Assoc	1726-4901	RESULTS	3	8	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	7#10	12728975-1-78-93	In the AGT point mutation at 174 (T174M), the frequencies of both of alleles and genotypes were significantly higher in the DM nephropathy patients.
12728975	2003	J Chin Med Assoc	1726-4901	CONCLUSIONS	4	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	87#90	12728975-1-78-93	In conclusion, there were significantly higher frequencies of alleles and genotypes in AGT point mutation at 174, which had never been reported before.
12728975	2003	J Chin Med Assoc	1726-4901	CONCLUSIONS	4	10	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	3#6	12728975-1-78-93	In AGT point mutation at 235, there were significantly higher frequencies of alleles, but not genotypes in diabetic nephropathy.
12728975	2003	J Chin Med Assoc	1726-4901	CONCLUSIONS	4	11	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	29#32	12728975-1-78-93	Our study suggested that the AGT gene plays an important role in diabetic nephropathy.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	57#61		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	2201	SYMBOL|DICTIONARY|EXTRACTED	fbn2	FBN2	63#67		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
12750963	2004	J. Hum. Genet.	1434-5161	TITLE	0	0	4015	SYMBOL|DICTIONARY	lox	LOX	73#76		Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2246	LONGTERM|DICTIONARY	fibroblast growth factor 1	fibroblast growth factor 1	69#95		In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2246	SYMBOL|()|DICTIONARY|EXTRACTED	fgf1	FGF1	97#101	12750963-2-69-95	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2201	LONGTERM|DICTIONARY	fibrillin 2	fibrillin 2	104#115		In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	2201	SYMBOL|()|DICTIONARY|EXTRACTED	fbn2	FBN2	117#121	12750963-2-104-115	In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4015	SYMBOL|DICTIONARY	lox	LOX	149#152		In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	113#117	12750963-2-69-95	Association analysis was performed with ten, five, and four single-nucleotide polymorphisms (SNPs) identified in FGF1, FBN2, and LOX, respectively.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	2201	SYMBOL|DICTIONARY|EXTRACTED	fbn2	FBN2	119#123	12750963-2-104-115	Association analysis was performed with ten, five, and four single-nucleotide polymorphisms (SNPs) identified in FGF1, FBN2, and LOX, respectively.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	4015	SYMBOL|DICTIONARY	lox	LOX	129#132		Association analysis was performed with ten, five, and four single-nucleotide polymorphisms (SNPs) identified in FGF1, FBN2, and LOX, respectively.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	79#83	12750963-2-69-95	A difference in allelic frequency was observed for only the SNP at intron 4 in FGF1 (chi(2)=4.44, df=1, P=0.035).
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	6	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	82#86	12750963-2-69-95	Although a haplotype association was observed with the combination of ten SNPs in FGF1 (chi(2)=16.04, df=1, P=0.00006), significant haplotype associations were not observed when haplotypes were constructed with the three, two, and four SNPs in FGF1 according to the linkage disequilibrium structure.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	6	2246	SYMBOL|DICTIONARY|EXTRACTED	fgf1	FGF1	244#248	12750963-2-69-95	Although a haplotype association was observed with the combination of ten SNPs in FGF1 (chi(2)=16.04, df=1, P=0.00006), significant haplotype associations were not observed when haplotypes were constructed with the three, two, and four SNPs in FGF1 according to the linkage disequilibrium structure.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	2201	SYMBOL|DICTIONARY|EXTRACTED	fbn2	FBN2	19#23	12750963-2-104-115	No associations of FBN2 and LOX with IA were detected in the present study.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	4015	SYMBOL|DICTIONARY	lox	LOX	28#31		No associations of FBN2 and LOX with IA were detected in the present study.
12525557	2003	J. Med. Genet.	1468-6244	TITLE	0	0	1545	SYMBOL|GENE|GN|DICTIONARY	cyp1b1	CYP1B1	0#6		CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients.
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY	apoe4	ApoE4	63#68		"Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect ""brain repair"" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality."
12656452	2003	J Natl Med Assoc	0027-9684	ALL_TEXT_2/3	2	4	348	SYMBOL|DICTIONARY	apoe4	ApoE4	18#23		We found that the ApoE4 and epsilon2 alleles are more frequent in Ugandans (U) than Caucasians (C) or Asians (A) with corresponding alleles showing significant elevations of epsilon2 (U 15.71%, C 8.40%, A 4.20%) and 14 (U 25%, C 13.70%, A 8.90%) (p < .001).
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	27#60		[The G894T mutation of the endothelial nitric oxide synthase gene is associated with coronary atherosclerotic heart disease in Chinese].
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	4846	LONGTERM|DICTIONARY|GENE|GA	endothelial nitric oxide synthase	endothelial nitric oxide synthase	38#71		To investigate the association of the endothelial nitric oxide synthase (eNOS) gene polymorphism with coronary atherosclerotic heart disease (CHD) in Chinese Han nationality.
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	METHODS	2	2	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	100#133		For 106 patients with CHD and 108 unrelated health individuals, the G894T mutation at exon 7 of the endothelial nitric oxide synthase gene was studied by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
12476417	2003	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	10	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	26#59		The G894T mutation of the endothelial nitric oxide synthase gene may be a marker for genetical predisposition of CHD in Chinese Han population.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_2/3	2	4	5327	SYMBOL|GENE|GN|DICTIONARY	t pa	t-PA	57#61		The distributions of the II, ID, and DD genotypes of the t-PA gene in hypertensive patients (0.15, 0.49, 0.36) were similar to those in control subjects (0.11, 0.51, 0.38; p = 0.626).
12394840	2002	Transplantation	0041-1337	TITLE	0	0	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
12394840	2002	Transplantation	0041-1337	BACKGROUND	1	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	51#67		One factor that may influence the lipid profile is apolipoprotein E (Apo E) genotype.
12394840	2002	Transplantation	0041-1337	CONCLUSIONS	4	11	348	SYMBOL|GENE|GN|DICTIONARY	apo e	Apo E	93#98		Thus, Apo E4 has a larger impact than Apo E2 on fasting-lipid profile in PTX candidates, and Apo E gene polymorphism does not worsen lipid dyslipidemia after PTX, despite introduction of immunosuppressant medications known to cause dyslipidemia.
12373604	2002	Br. J. Cancer	0007-0920	TITLE	0	0	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	0#5		BRCA2 gene mutations in families with aggregations of breast and stomach cancers.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_1/3	1	2	999	SYMBOL|GENE|GN|DICTIONARY	e cadherin	E-cadherin	142#152		It is estimated that 25% of families meeting the criteria for hereditary diffuse gastric carcinoma (HDCG) will have germline mutations in the E-cadherin gene.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	4	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	98#103		Recently, it has been reported that the incidence of stomach cancer is significantly increased in BRCA2 gene mutation carriers.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_2/3	2	5	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	37#42		We analysed by direct sequencing the BRCA2 gene in 29 breast cancer patients derived from 29 families with an aggregation of at least one female breast cancer diagnosed before the age of 50 years and one male stomach cancer diagnosed before the age of 55 years.
12373604	2002	Br. J. Cancer	0007-0920	ALL_TEXT_3/3	3	8	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	25#30		Our results confirm that BRCA2 gene mutations are also associated with familial aggregations of not only breast but also of stomach cancer.
12297989	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	56172	SYMBOL|DICTIONARY	ankh	ANKH	130#134		Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
12297989	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	56172	SYMBOL|GENE|GN|DICTIONARY	ankh	ANKH	37#41		We have identified a mutation in the ANKH gene that segregates with the disease in a family with this condition.
12297989	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	56172	SYMBOL|DICTIONARY	ankh	ANKH	0#4		ANKH encodes a putative transmembrane inorganic pyrophosphate (PPi) transport channel.
12297989	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	4	56172	SYMBOL|DICTIONARY	ankh	ANKH	38#42		We postulate that loss of function of ANKH causes elevated extracellular PPi levels, predisposing to CPPD crystal deposition.
12189593	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6309	LONGTERM|DICTIONARY	3beta hydroxysteroid delta5 desaturase	3beta-hydroxysteroid-delta5-desaturase	96#134		Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
12189593	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	6309	SYMBOL|()|DICTIONARY|EXTRACTED	sc5d	SC5D	58#62	12189593-5-37-56	The activity of 3beta-hydroxysteroid-Delta(5)-desaturase (SC5D), the enzyme involved in this reaction, was deficient in the patient's fibroblasts.
12189593	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	6	6309	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	sc5d	SC5D	25#29	12189593-5-37-56	Sequence analysis of the SC5D gene in the patient's DNA, showing the presence of two missense mutations (R29Q and G211D), confirmed that the patient is affected by a novel defect of cholesterol biosynthesis.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	LONGTERM|DICTIONARY|GENE|GA	connexin 32	connexin 32	112#123		X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx32	Cx32	125#129	12325071-1-112-123	X-linked Charcot-Marie-Tooth disease (CMTX) is a hereditary demyelinating neuropathy caused by mutations in the connexin 32 (Cx32) gene.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	2	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		Cx32 is widely expressed in brain and peripheral nerve, yet clinical manifestations of CMTX mainly arise from peripheral neuropathy.
12325071	2002	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	8	2705	SYMBOL|DICTIONARY|EXTRACTED	cx32	Cx32	0#4		Cx32 mutations may cause central nervous system dysfunction by reducing the number of functioning gap junctions between oligodendrocytes and astrocytes, making both cells more susceptible to abnormalities of intercellular exchange of ions and small molecules in situations of metabolic stress.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	49#55		Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|()|DICTIONARY|EXTRACTED	dap12	DAP12	57#62	12080485-2-49-55	Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	249#255		Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	54209	SYMBOL|DICTIONARY	trem2	TREM2	65#70		Here we complete the molecular pathology of PLOSL by identifying TREM2 as the second PLOSL gene.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	4	54209	SYMBOL|DICTIONARY	trem2	TREM2	0#5		TREM2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	4	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	46#52		TREM2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	154#160		Patients with PLOSL have no defects in cell-mediated immunity, suggesting a remarkable capacity of the human immune system to compensate for the inactive TYROBP-mediated activation pathway.
12080485	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	6	7305	SYMBOL|DICTIONARY	tyrobp	TYROBP	24#30		Our data imply that the TYROBP-mediated signaling pathway plays a significant role in human brain and bone tissue and provide an interesting example of how mutations in two different subunits of a multisubunit receptor complex result in an identical human disease phenotype.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	9#26		Abnormal androgen receptor (AR) structure or function has also been implicated in male infertility.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED|()	ar	AR	28#30	12220434-2-9-26	Abnormal androgen receptor (AR) structure or function has also been implicated in male infertility.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	3	367	SYMBOL|EXTRACTED	ar	AR	196#198	12220434-2-9-26	To assess the contribution of these genetic defects to male infertility, 61 Israeli men with severe oligo- (n = 15) or azoospermia (n = 46), were screened for Y chromosome microdeletions, and the AR-(CAG)n repeat length.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_2/3	2	6	367	SYMBOL|EXTRACTED	ar	AR	30#32	12220434-2-9-26	PCR with primers flanking the AR-(CAG)n region and subsequent size fractionation on gradient acrylamide gels were used to determine AR-(CAG)n length.
12220434	2003	Clin. Genet.	0009-9163	ALL_TEXT_2/3	2	6	367	SYMBOL|EXTRACTED	ar	AR	132#134	12220434-2-9-26	PCR with primers flanking the AR-(CAG)n region and subsequent size fractionation on gradient acrylamide gels were used to determine AR-(CAG)n length.
12358323	2003	Eur. Respir. J.	0903-1936	TITLE	0	0	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	0#5		BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	1	659	SYMBOL|()|GENE|GN|DICTIONARY	bmpr2	BMPR2	228#233		This study investigated whether patients developing pulmonary arterial hypertension (PAH) after exposure to the appetite suppressants fenfluramine and dexfenfluramine have mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene, as reported in primary pulmonary hypertension.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_1/3	1	2	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	0#5		BMPR2 was examined for mutations in 33 unrelated patients with sporadic PAH, and in two sisters with PAH, all of whom had taken fenfluramine derivatives, as well as in 130 normal controls.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_2/3	2	4	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	6#11		Three BMPR2 mutations predicting changes in the primary structure of the BMPR-II protein were found in three of the 33 unrelated patients (9%), and a fourth mutation was found in the two sisters.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_2/3	2	4	659	SYMBOL|GENE|GN|DICTIONARY	bmpr ii	BMPR-II	73#80		Three BMPR2 mutations predicting changes in the primary structure of the BMPR-II protein were found in three of the 33 unrelated patients (9%), and a fourth mutation was found in the two sisters.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_3/3	3	5	659	SYMBOL|DICTIONARY	bmpr2	BMPR2	3#8		No BMPR2 mutations were identified in the 130 normal controls.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	1	1019	SYMBOL|DICTIONARY	cdk4	CDK4	137#141		The INK4a-ARF locus, located on chromosome 9p21, encodes 2 cell cycle-regulatory proteins, p16(INKa) and p14(ARF), acting through the Rb-CDK4 and p53 pathways.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	p53	p53	146#149		The INK4a-ARF locus, located on chromosome 9p21, encodes 2 cell cycle-regulatory proteins, p16(INKa) and p14(ARF), acting through the Rb-CDK4 and p53 pathways.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	7157	SYMBOL|DICTIONARY	p53	p53	40#43		Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	7157	SYMBOL|DICTIONARY	p53	p53	202#205		Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	9	7157	SYMBOL|DICTIONARY	p53	p53	38#41		Alterations of the INK4a-ARF locus or p53 as were not established independent prognostic factors in these tumors.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	10	7157	SYMBOL|DICTIONARY	p53	p53	141#144		In conclusion, our data indicate that the INK4a-ARF locus is frequently inactivated in angiosarcoma of the liver and occurs independently of p53 mutations.
12167522	2002	J Affect Disord	0165-0327	TITLE	0	0	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	48#53		Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	76#81		There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	52#57		The current study investigated whether variation in HTR2A was associated with symptoms of childhood ADHD in adult women with SAD.
12167522	2002	J Affect Disord	0165-0327	CONCLUSION	5	10	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	78#83		These preliminary results suggest a possible association between variation in HTR2A, childhood ADHD, and the later development of SAD in women.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	TITLE	0	0	3458	SYMBOL|GENE|GN|DICTIONARY	ifng	IFNG	15#19		Association of IFNG gene polymorphism with asthma in the Indian population.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	ALL_TEXT_1/3	1	2	3458	SYMBOL|DICTIONARY	ifng	IFNG	16#20		We selected the IFNG locus on 12q21 as a candidate gene for asthma on the basis of its role in pathophysiology and positive linkage demonstrated in other populations.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	ALL_TEXT_3/3	3	7	3458	SYMBOL|GENE|GN|DICTIONARY	ifng	IFNG	48#52		We found that the CA-repeat polymorphism in the IFNG gene was significantly associated with total serum IgE levels (ANOVA, P < 10(-4) for control subjects and P =.0036 for patients).
12200750	2002	Metab. Clin. Exp.	0026-0495	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	107#123		The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apo e	Apo E	0#5		Apo E genotyping was performed in consecutive NIDDM hospitalized patients in order to recruite size-adjusted groups of each apo E genotype.
12058348	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	68#74		Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	178#184		We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple café au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	26#32		Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations.
12058348	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	105#111		Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	11178	SYMBOL|GENE|GN|DICTIONARY	lzts1	LZTS1	34#39		Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	1	10728	SYMBOL|DICTIONARY	p23	p23	17#20		The 8p22 through p23 region has been identified as a potential site for genes associated with prostate cancer.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	9#14		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	10728	SYMBOL|DICTIONARY	p23	p23	51#54		The gene LZTS1 has been mapped to the 8p22 through p23 region and identified as a potential tumor suppressor based on loss of heterozygosity studies using primary esophageal tumors.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	4	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	34#39		The most recent report associates LZTS1 function with stabilization of p34(cdc2) during the late S-G2/M stage of mitosis, affecting normal cell growth.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	4	983	SYMBOL|()|DICTIONARY	cdc2	cdc2	75#79		The most recent report associates LZTS1 function with stabilization of p34(cdc2) during the late S-G2/M stage of mitosis, affecting normal cell growth.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	5	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	51#56		In this study, a detailed DNA sequence analysis of LZTS1 was performed in a screening panel consisting of sporadic and hereditary prostate cancer (HPC) cases and unaffected controls.
12377406	2002	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	9	11178	SYMBOL|DICTIONARY	lzts1	LZTS1	48#53		These results add evidence supporting a role of LZTS1 in prostate cancer risk.
12104085	2002	Clin. Chim. Acta	0009-8981	TITLE	0	0	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	0#4		CETP gene mutation (D442G) increases low-density lipoprotein particle size in patients with coronary heart disease.
12104085	2002	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	Cholesteryl ester transfer protein	0#34		Cholesteryl ester transfer protein (CETP) plays an important role in the transfer and exchange of cholesteryl esters and triglycerides between the lipoprotein classes of human plasma.
12104085	2002	Clin. Chim. Acta	0009-8981	BACKGROUND	1	2	1071	SYMBOL|()|DICTIONARY|EXTRACTED	cetp	CETP	36#40	12104085-2-0-34	Cholesteryl ester transfer protein (CETP) plays an important role in the transfer and exchange of cholesteryl esters and triglycerides between the lipoprotein classes of human plasma.
12104085	2002	Clin. Chim. Acta	0009-8981	BACKGROUND	1	3	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	23#27	12104085-2-0-34	It has been shown that CETP can also change the particle size of high-density lipoprotein (HDL) and LDL subfractions in vitro.
12104085	2002	Clin. Chim. Acta	0009-8981	BACKGROUND	1	4	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	32#36	12104085-2-0-34	Previous clinical studies about CETP gene mutations mainly focused on abnormalities in HDL, few involved those in LDL.
12104085	2002	Clin. Chim. Acta	0009-8981	OBJECTIVES	2	5	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	55#59	12104085-2-0-34	To investigate the effect of the D442G mutation in the CETP gene on major peak size of LDL particles in patients with coronary heart diseases (CHD).
12104085	2002	Clin. Chim. Acta	0009-8981	METHODS	3	6	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	22#26	12104085-2-0-34	D442G mutation in the CETP gene was detected using the PCR-RFLP.
12104085	2002	Clin. Chim. Acta	0009-8981	METHODS	3	7	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	129#133	12104085-2-0-34	LDL particles sizes were analyzed by 2-16% nondenaturing polyacrylamide gradient gels in CHD patients with D442G mutation in the CETP gene.
12104085	2002	Clin. Chim. Acta	0009-8981	RESULTS	4	12	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	53#57	12104085-2-0-34	The patients with gene mutation had decreased plasma CETP concentration, while increased concentration of HDL-C and apolipoprotein A-I compared with controls.
12104085	2002	Clin. Chim. Acta	0009-8981	CONCLUSIONS	5	13	1071	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cetp	CETP	0#4		CETP gene mutation (D442G) increases LDL particle size.
12104085	2002	Clin. Chim. Acta	0009-8981	CONCLUSIONS	5	14	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	19#23	12104085-2-0-34	This suggests that CETP play an antiatherogenic role.
12140136	2003	Lung Cancer	0169-5002	TITLE	0	0	2948	SYMBOL|GENE|GN|DICTIONARY	gstm4	GSTM4	29#34		A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	65#70		While there are many contradicting reports on the association of GSTM1 polymorphisms and cancer development, no studies exist to date describing polymorphisms in GSTM4.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_1/3	1	2	2948	SYMBOL|DICTIONARY	gstm4	GSTM4	162#167		While there are many contradicting reports on the association of GSTM1 polymorphisms and cancer development, no studies exist to date describing polymorphisms in GSTM4.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_2/3	2	3	2948	SYMBOL|GENE|GN|DICTIONARY	gstm4	GSTM4	61#66		We have identified a new C-T polymorphism in intron 6 of the GSTM4 gene (T2517C, Genebank sequence accession number X68677) and termed the allele carrying T at this position allele *A and the allele carrying C, allele *B.
12140136	2003	Lung Cancer	0169-5002	ALL_TEXT_3/3	3	6	2948	SYMBOL|GENE|GN|DICTIONARY	gstm4	GSTM4	69#74		This is the first report on the implication of a polymorphism in the GSTM4 gene in lung cancer risk.
12165742	2003	Med. Sci. Monit.	1234-1010	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	48#69		Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk.
12165742	2003	Med. Sci. Monit.	1234-1010	BACKGROUND	1	1	10	SYMBOL|DICTIONARY	nat2	NAT2	6#10		Rapid NAT2 acetylation has been considered as a risk factor for developing colon cancer in a number of studies, however the overall results of such studies are inconsistent.
12165742	2003	Med. Sci. Monit.	1234-1010	BACKGROUND	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	28#32		To clarify the influence of NAT2 rapid acetylation status on colon cancer risk, we have performed a meta-analysis of 20 published case-control studies (4431 cases, 4547 controls).
12165742	2003	Med. Sci. Monit.	1234-1010	MATERIAL/METHODS	2	3	10	SYMBOL|DICTIONARY	nat2	NAT2	64#68		Odd ratio was employed to evaluate the risk of colon cancer and NAT2 rapid acetylation status.
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	68#72		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
12165742	2003	Med. Sci. Monit.	1234-1010	CONCLUSIONS	4	10	10	SYMBOL|DICTIONARY	nat2	NAT2	142#146		The results of our meta-analyses do not support the hypothesis that NAT2 alone is an important risk factor for colon cancer and suggests that NAT2 rapid acetylation status has no specific effect on the risk of developing colon cancer.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	54578	SYMBOL|()|DICTIONARY	ugt1f	UGT1F	69#74		To study the genetic polymorphisms of UDP-glucuronosyltransferase 1F(UGT1F) and the relationship between polymorphisms and susceptibility to hepatocellular carcinoma (HCC).
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	METHODS	2	2	54578	SYMBOL|DICTIONARY	ugt1f	UGT1F	21#26		The polymorphisms of UGT1F of 84 patients with HCC and 144 healthy controls were detected by PCR-denaturation gradient gel electrophoresis-sequencing or PCR-single strain conformation polymorphsim-sequencing.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	RESULTS	3	6	54578	SYMBOL|DICTIONARY	ugt1f	UGT1F	82#87		Both frequencies of genotype G/G(13.10%) and allele G (29.17%) of position 754 of UGT1F in cases were sig nificantly greater than those in controls (2.78% and 19.44% ) respectively.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	8	54578	SYMBOL|DICTIONARY	ugt1f	UGT1F	13#18		Exons 2-5 of UGT1F are highly conservative, but exon 1 emerges highly polymorphic.
12089173	2002	Clin. Chem.	0009-9147	METHODS	2	5	125	SYMBOL|DICTIONARY	adh2	ADH2	4#8		The ADH2 genotype was determined by PCR and subsequent digestion with MaeIII.
12089173	2002	Clin. Chem.	0009-9147	METHODS	2	6	217	SYMBOL|DICTIONARY	aldh2	ALDH2	4#9		The ALDH2 genotype was determined based on amplified product length polymorphisms.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	7	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	53#57		When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	7	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	67#71		When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	7	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	85#89		When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	7	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	211#215		When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	7	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	242#246		When the workers were divided into three groups: the ADH2(1)/2(1), ADH2(1)/2(2), and ADH2(2)/2(2) groups, the mean triglycerides and gamma-glutamyl transpeptidase concentrations were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	8	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	224#228		In addition, multiple logistic regression analysis showed that the frequencies of individuals whose systolic blood pressure, triglycerides, and uric acid values were in the highest one third were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	8	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	255#259		In addition, multiple logistic regression analysis showed that the frequencies of individuals whose systolic blood pressure, triglycerides, and uric acid values were in the highest one third were significantly higher in the ADH2(2)/2(2) group than in the ADH2(1)/2(1) group.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	9	217	SYMBOL|NUMBER|DICTIONARY	aldh2	ALDH2	52#57		In contrast, no difference was observed between the ALDH2(1)/2(1) and (ALDH2(1)/2(2) + ALDH2(2)/2(2)) groups with regard to the mean value of any variable and to the frequency of individuals with any variable value in the highest one third.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	9	217	SYMBOL|NUMBER|DICTIONARY	aldh2	ALDH2	71#76		In contrast, no difference was observed between the ALDH2(1)/2(1) and (ALDH2(1)/2(2) + ALDH2(2)/2(2)) groups with regard to the mean value of any variable and to the frequency of individuals with any variable value in the highest one third.
12089173	2002	Clin. Chem.	0009-9147	RESULTS	3	9	217	SYMBOL|NUMBER|DICTIONARY	aldh2	ALDH2	87#92		In contrast, no difference was observed between the ALDH2(1)/2(1) and (ALDH2(1)/2(2) + ALDH2(2)/2(2)) groups with regard to the mean value of any variable and to the frequency of individuals with any variable value in the highest one third.
12089173	2002	Clin. Chem.	0009-9147	CONCLUSION	4	10	125	SYMBOL|NUMBER|DICTIONARY	adh2	ADH2	21#25		Individuals with the ADH2(1)/2(1) genotype might suffer fewer negative effects of drinking.
12136242	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	93#97		German descendents were 11% heterozygous and l% Delta32/Delta32.Amerindians were exclusively CCR5/CCR5.
12136242	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	98#102		German descendents were 11% heterozygous and l% Delta32/Delta32.Amerindians were exclusively CCR5/CCR5.
12136242	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	5	1234	SYMBOL|DICTIONARY	ccr5	CCR5	15#19		HIV-1-positive CCR5/CCR5 had higher viral loads than did heterozygous cells.
12136242	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	5	1234	SYMBOL|DICTIONARY	ccr5	CCR5	20#24		HIV-1-positive CCR5/CCR5 had higher viral loads than did heterozygous cells.
12150336	2003	J. Endocrinol. Invest.	0391-4097	TITLE	0	0	846	LONGTERM|GENE|GN|GT|DICTIONARY	calcium sensing receptor	Calcium-sensing receptor	0#24		Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY	calcium sensing receptor	calcium-sensing receptor	4#28		The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	1	846	SYMBOL|EXTRACTED|()	car	CaR	30#33	12150336-1-4-28	The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT).
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	2	846	SYMBOL|EXTRACTED	car	CaR	88#91	12150336-1-4-28	The aim of the present study was to investigate the frequency of this and other 2 known CaR polymorphisms (R990G and Q1011 E) in patients with PHPT and their effect on its phenotype.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_2/3	2	4	846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	car	CaR	28#31	12150336-1-4-28	A fragment of exon 7 of the CaR gene, containing the 3 polymorphic loci of interest (A986S, R990G, and Q1011E), was amplified by PCR and sequenced.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_2/3	2	5	5741	SYMBOL|DICTIONARY	pth	PTH	18#21		Serum calcium and PTH levels, BMD and other biochemical and clinical parameters were evaluated.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_3/3	3	7	846	SYMBOL|EXTRACTED	car	CaR	50#53	12150336-1-4-28	There was no difference in the frequency of the 3 CaR polymorphisms in the 50 matched pairs of patients and controls.
12150336	2003	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_3/3	3	10	846	SYMBOL|EXTRACTED	car	CaR	10#13	12150336-1-4-28	The A986S CaR polymorphism is the most common in Italian PHPT patients and the allotype AS does not appear to play a relevant role in the pathogenesis of PHPT and its severity.
12081984	2002	Circulation	1524-4539	BACKGROUND	1	3	6532	SYMBOL|()|DICTIONARY	slc6a4	SLC6A4	49#55		The site of action is the serotonin transporter (SLC6A4), which is expressed in brain and blood cells.
12081984	2002	Circulation	1524-4539	BACKGROUND	1	4	6532	SYMBOL|GENE|GN|DICTIONARY	slc6a4	SLC6A4	56#62		A functional polymorphism in the promoter region of the SLC6A4 gene has been described.
12081984	2002	Circulation	1524-4539	METHODS AND RESULTS	2	6	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	4#10		The SLC6A4 polymorphism has been investigated by polymerase chain reaction in 671 male patients with MI and in 688 controls from the Etude Cas-Témoins de l'Infarctus du Myocarde (ECTIM) multicentric study.
12081984	2002	Circulation	1524-4539	CONCLUSIONS	3	10	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	23#29		The LL genotype of the SLC6A4 polymorphism is associated with a higher risk of MI.
12078789	2002	Ann. Thorac. Surg.	0003-4975	TITLE	0	0	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	74#95		Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes.
12078789	2002	Ann. Thorac. Surg.	0003-4975	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin 10	100#114		Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes.
12078789	2002	Ann. Thorac. Surg.	0003-4975	METHODS	2	5	4049	LONGTERM|DICTIONARY	tumor necrosis factor beta	tumor necrosis factor beta	76#102		Polymerase chain reaction-based techniques were used to examine carriage of tumor necrosis factor beta (TNF-beta), TNF G-308A, and interleukin 10 (IL-10) G-1082A alleles.
12078789	2002	Ann. Thorac. Surg.	0003-4975	METHODS	2	5	4049	LONGTERM|()|DICTIONARY|EXTRACTED	tnf beta	TNF-beta	104#112	12078789-5-76-102	Polymerase chain reaction-based techniques were used to examine carriage of tumor necrosis factor beta (TNF-beta), TNF G-308A, and interleukin 10 (IL-10) G-1082A alleles.
12078789	2002	Ann. Thorac. Surg.	0003-4975	METHODS	2	5	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin 10	131#145		Polymerase chain reaction-based techniques were used to examine carriage of tumor necrosis factor beta (TNF-beta), TNF G-308A, and interleukin 10 (IL-10) G-1082A alleles.
12078789	2002	Ann. Thorac. Surg.	0003-4975	METHODS	2	5	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il 10	IL-10	147#152	12078789-5-131-145	Polymerase chain reaction-based techniques were used to examine carriage of tumor necrosis factor beta (TNF-beta), TNF G-308A, and interleukin 10 (IL-10) G-1082A alleles.
12078789	2002	Ann. Thorac. Surg.	0003-4975	RESULTS	3	7	4049	LONGTERM|DICTIONARY|EXTRACTED	tnf beta	TNF-beta	93#101	12078789-5-76-102	Lactic acid levels after intensive care admission changed over time and were related to both TNF-beta and IL-10 G-1082A polymorphisms.
12078789	2002	Ann. Thorac. Surg.	0003-4975	RESULTS	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	106#111	12078789-5-131-145	Lactic acid levels after intensive care admission changed over time and were related to both TNF-beta and IL-10 G-1082A polymorphisms.
12078789	2002	Ann. Thorac. Surg.	0003-4975	RESULTS	3	8	3586	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	il 10	IL-10	62#67	12078789-5-131-145	All 4 study patients homozygous for TNF-beta1 and carrying an IL-10-1082A allele developed lactic acidosis (p = 0.02).
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	1	1589	SYMBOL|()|DICTIONARY	cyp21	CYP21	194#199		Congenital adrenal hyperplasia (CAH) is a frequent autosomal recessive disease, with a wide range of clinical manifestations, most commonly attributable to mutations in the 21-hydroxylase gene (CYP21).
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	2	1589	SYMBOL|DICTIONARY	cyp21	CYP21	104#109		Large gene deletions, large gene conversions, a small 8-basepair deletion, and eight point mutations in CYP21 account for approximately 95% of all enzyme deficiencies.
12028996	2002	Clin. Chem.	0009-9147	BACKGROUND	1	3	1589	SYMBOL|DICTIONARY	cyp21	CYP21	40#45		We developed a new strategy for a rapid CYP21 analysis.
12028996	2002	Clin. Chem.	0009-9147	METHODS	2	4	1589	SYMBOL|GENE|GN|DICTIONARY	cyp21	CYP21	146#151		DNA samples from 40 CAH patients previously genotyped by direct DNA sequencing were reanalyzed by allele-specific amplification of the functional CYP21 gene followed by a multiplex minisequencing reaction using 13 primers.
12028996	2002	Clin. Chem.	0009-9147	RESULTS	3	6	1590	SYMBOL|DICTIONARY	cyp21p	CYP21P	203#209		The assay detected the P453S mutation and nine of the most common mutations (P30L, intron 2 splice, Delta 8bp, I172N, exon 6 cluster, V281L, F306+t, Q318X, and R356W) caused by microconversions from the CYP21P pseudogene.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	5	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	84#100		Patients were grouped into non-epsilon4 carriers and epsilon4 carriers according to apolipoprotein E (ApoE) genotype.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	5	348	SYMBOL|EXTRACTED|()	apoe	ApoE	102#106	12007670-5-84-100	Patients were grouped into non-epsilon4 carriers and epsilon4 carriers according to apolipoprotein E (ApoE) genotype.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	6	348	SYMBOL|EXTRACTED	apoe	ApoE	105#109	12007670-5-84-100	At baseline, all patients showed low APPr levels and no significant difference was found between the two ApoE subgroups.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	ALL_TEXT_3/3	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	109#113	12007670-5-84-100	The present study provides evidence that donepezil influences APP metabolism in platelets, and suggests that ApoE genotype might be an important modulating factor for drug responsiveness in AD.
12010932	2002	Heart	1468-201X	TITLE	0	0	4846	LONGTERM|GENE|GN|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	52#85		Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease.
12010932	2002	Heart	1468-201X	BACKGROUND	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	20#53		Genetic variants of endothelial nitric oxide synthase (eNOS) could influence individual susceptibility to coronary artery disease.
12010932	2002	Heart	1468-201X	BACKGROUND	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	55#59	12010932-1-20-53	Genetic variants of endothelial nitric oxide synthase (eNOS) could influence individual susceptibility to coronary artery disease.
12010932	2002	Heart	1468-201X	OBJECTIVE	2	2	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	51#55	12010932-1-20-53	To assess whether Glu298-->Asp polymorphism of the eNOS gene is associated with the occurrence and severity of angiographically defined coronary artery disease in the Italian population.
12010932	2002	Heart	1468-201X	METHODS	3	3	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	127#131	12010932-1-20-53	Polymerase chain reaction/restriction fragment length polymorphism analysis was done to detect the Glu298-->Asp variant of the eNOS gene in 201 patients with coronary artery disease and 114 controls.
12010932	2002	Heart	1468-201X	RESULTS	4	5	4846	SYMBOL|EXTRACTED	enos	eNOS	23#27	12010932-1-20-53	The frequencies of the eNOS Glu/Glu, Glu/Asp, and Asp/Asp genotypes in the coronary artery disease group were significantly different from those of controls (45.3%, 38.8%, and 15.9% v 42.1%, 51.8%, and 6.1%, respectively; chi2 = 8.589, p = 0.0136).
12010932	2002	Heart	1468-201X	RESULTS	4	6	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	59#63	12010932-1-20-53	In comparison with subjects who had a Glu298 allele in the eNOS gene, the risk of coronary artery disease was increased among Asp/Asp carriers (odds ratio 2.9, 95% confidence interval 1.2 to 6.8, p = 0.01) and was independent of the other common risk factors (p = 0.04).
12010932	2002	Heart	1468-201X	RESULTS	4	7	4846	SYMBOL|EXTRACTED	enos	eNOS	48#52	12010932-1-20-53	There was a significant association between the eNOS Glu298-->Asp variant and both the number of stenosed vessels (mean (SEM), 2.3 (0.1) for Asp/Asp v 1.9 (0.1) and 1.8 (0.1) for Glu/Glu and Glu/Asp, respectively; p = 0.01) and the Duke score (56.1 (3.1) for Asp/Asp v 46.7 (2.0) and 46.1 (1.9) for Glu/Glu and Glu/Asp, respectively; p = 0.02).
12010932	2002	Heart	1468-201X	CONCLUSIONS	5	8	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	33#37	12010932-1-20-53	Glu298-->Asp polymorphism of the eNOS gene appears to be associated with the presence, extent, and severity of angiographically assessed coronary artery disease.
12059121	2002	Mayo Clin. Proc.	0025-6196	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	87#90		Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
12059121	2002	Mayo Clin. Proc.	0025-6196	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	87#90		To determine the prevalence of hemochromatosis-related symptoms in homozygotes for the HFE mutation C282Y compared with controls without HFE mutations identified through a large screening program of subjects attending a health appraisal center.
12059121	2002	Mayo Clin. Proc.	0025-6196	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	137#140		To determine the prevalence of hemochromatosis-related symptoms in homozygotes for the HFE mutation C282Y compared with controls without HFE mutations identified through a large screening program of subjects attending a health appraisal center.
12059121	2002	Mayo Clin. Proc.	0025-6196	SUBJECTS AND METHODS	2	2	3077	SYMBOL|DICTIONARY	hfe	HFE	157#160		Presence of symptoms commonly associated with clinical hemochromatosis was ascertained by self-report on a written questionnaire among C282Y homozygotes and HFE wild-type subjects of white or Hispanic ethnicity identified from screening 41,599 adult subjects between March 1999 and August 2001.
12059121	2002	Mayo Clin. Proc.	0025-6196	SUBJECTS AND METHODS	2	5	3077	SYMBOL|DICTIONARY	hfe	HFE	70#73		Symptoms among subjects with other combinations of the C282Y and H63D HFE mutations were also assessed by questionnaire.
12059121	2002	Mayo Clin. Proc.	0025-6196	RESULTS	3	8	3077	SYMBOL|DICTIONARY	hfe	HFE	35#38		Symptoms among subjects with other HFE genotypes were similar to symptoms of wild-type subjects.
12059121	2002	Mayo Clin. Proc.	0025-6196	CONCLUSIONS	4	9	3077	SYMBOL|DICTIONARY	hfe	HFE	106#109		Results of this study indicate that many of the symptoms associated with hemochromatosis are common among HFE wild types and that clinical penetrance of the C282Y/C282Y genotype in regard to these symptoms is low.
12034804	2002	Neurology	0028-3878	ALL_TEXT_1/3	1	1	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	42#47		Polymorphisms in the interleukin-1 genes, IL-1A and IL-1B, have been associated with AD, but not in all studies.
12034804	2002	Neurology	0028-3878	ALL_TEXT_1/3	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	52#57		Polymorphisms in the interleukin-1 genes, IL-1A and IL-1B, have been associated with AD, but not in all studies.
12034804	2002	Neurology	0028-3878	ALL_TEXT_2/3	2	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	26#31		The authors genotyped the IL-1A(-889) and IL-1B(-511) polymorphisms in large independent cohorts of 503 control individuals and 395 patients with AD, and a further 100 with brain Abeta load.
12034804	2002	Neurology	0028-3878	ALL_TEXT_2/3	2	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	42#47		The authors genotyped the IL-1A(-889) and IL-1B(-511) polymorphisms in large independent cohorts of 503 control individuals and 395 patients with AD, and a further 100 with brain Abeta load.
12034804	2002	Neurology	0028-3878	ALL_TEXT_3/3	3	4	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	22#27		However, an impact of IL-1B(-511) on Abeta(40) load (p < 0.05) was detected.
11992568	2002	Am. J. Med. Genet.	0148-7299	TITLE	0	0	1636	SYMBOL|DICTIONARY	dcp1	DCP1	23#27		No association between DCP1 genotype and late-onset Alzheimer disease.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	dcp1	DCP1	211#215		In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	235#264		In a study of 261 patients with Alzheimer disease (AD) and 306 cognitively normal control subjects from Germany, Switzerland, and Italy, we found no association between genotype counts or allelic frequencies of DCP1, the gene encoding angiotensin-converting enzyme.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	3	1636	SYMBOL|DICTIONARY	dcp1	DCP1	47#51		Critical review about all studies available on DCP1 genotyping and AD, age-associated cognitive decline, longevity, and other conditions revealed remarkable inconsistencies.
11992568	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	1636	SYMBOL|DICTIONARY	dcp1	DCP1	200#204		Deviations from HWE may limit the comparability of study results and require clarification before drawing conclusions with respect to disease risk, health conditions, or longevity in association with DCP1 genotype.
11992567	2002	Am. J. Med. Genet.	0148-7299	TITLE	0	0	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	10#14		Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	15#19	11992567-1-0-13	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	167#171	11992567-1-0-13	"Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the ""C allele of IL-6 variable number of tandem repeat polymorphism"" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se."
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	2	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	36#40	11992567-1-0-13	Another polymorphism, G/C allele of IL-6 gene promoter region (IL-6prom), is also a candidate because it has an influence on the regulation of plasma IL-6 concentration.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	150#154	11992567-1-0-13	Another polymorphism, G/C allele of IL-6 gene promoter region (IL-6prom), is also a candidate because it has an influence on the regulation of plasma IL-6 concentration.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	18#22	11992567-1-0-13	We examined these IL-6 polymorphisms in 128 Japanese AD cases and 83 control cases using a PCR-RFLP method.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	7#11	11992567-1-0-13	Plasma IL-6 concentration of the AD cases was also significantly higher than that of the control cases.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	86#90	11992567-1-0-13	Moreover, the IL-6prom G allele-positive AD patients showed a tendency to have higher IL-6 concentration in the AD group.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	7	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	74#78	11992567-1-0-13	These findings suggest that the IL-6prom G allele which may affect plasma IL-6 concentration might be a risk factor for sporadic AD in Japanese.
11951178	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	6647	SYMBOL|DICTIONARY|EXTRACTED	sod 1	SOD-1	68#73		Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	1270	SYMBOL|DICTIONARY	cntf	CNTF	104#108		Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	6647	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	53#58	11951178-1-29-51	Mutations in the copper/zinc superoxide dismutase 1 (SOD-1) gene are found in approximately 20% of patients with familial amyotrophic lateral sclerosis (FALS), or amyotrophic lateral sclerosis 1.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	6647	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	18#23	11951178-1-29-51	Sequencing of the SOD-1 gene revealed a heterozygous T-->G exchange at position 1513 within exon 5, coding for a V-->G substitution at position 148 of the mature protein.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	1270	SYMBOL|GENE|GN|DICTIONARY	cntf	CNTF	195#199		Screening for candidate modifier genes that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous mutation of the CNTF gene not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with CNTF(-/-) mice and were investigated with respect to disease onset and duration, to test the hypothesis that CNTF acts as a candidate modifier gene in FALS with mutations in the SOD-1 gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	1270	SYMBOL|DICTIONARY	cntf	CNTF	281#285		Screening for candidate modifier genes that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous mutation of the CNTF gene not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with CNTF(-/-) mice and were investigated with respect to disease onset and duration, to test the hypothesis that CNTF acts as a candidate modifier gene in FALS with mutations in the SOD-1 gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	1270	SYMBOL|DICTIONARY	cntf	CNTF	390#394		Screening for candidate modifier genes that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous mutation of the CNTF gene not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with CNTF(-/-) mice and were investigated with respect to disease onset and duration, to test the hypothesis that CNTF acts as a candidate modifier gene in FALS with mutations in the SOD-1 gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	6647	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	459#464	11951178-1-29-51	Screening for candidate modifier genes that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous mutation of the CNTF gene not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with CNTF(-/-) mice and were investigated with respect to disease onset and duration, to test the hypothesis that CNTF acts as a candidate modifier gene in FALS with mutations in the SOD-1 gene.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	1270	SYMBOL|DICTIONARY	cntf	CNTF	16#20		Such hSOD-1G93A/CNTF-deficient mice develop motoneuron disease at a significantly earlier stage than hSOD-1G93A/CNTF-wild-type mice.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	1270	SYMBOL|DICTIONARY	cntf	CNTF	112#116		Such hSOD-1G93A/CNTF-deficient mice develop motoneuron disease at a significantly earlier stage than hSOD-1G93A/CNTF-wild-type mice.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	7	6647	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	sod 1	SOD-1	35#40	11951178-1-29-51	Linkage analysis revealed that the SOD-1 gene was solely responsible for the disease.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	8	1270	SYMBOL|DICTIONARY	cntf	CNTF	96#100		However, disease onset as a quantitative trait was regulated by the allelic constitution at the CNTF locus.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	9	1270	SYMBOL|GENE|GN|DICTIONARY	cntf	CNTF	87#91		In addition, patients with sporadic amyotrophic lateral sclerosis who had a homozygous CNTF gene defect showed significantly earlier disease onset but did not show a significant difference in disease duration.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	10	1270	SYMBOL|DICTIONARY	cntf	CNTF	23#27		Thus, we conclude that CNTF acts as a modifier gene that leads to early onset of disease in patients with FALS who have SOD-1 mutations, in patients with sporadic amyotrophic lateral sclerosis, and in the hSOD-1G93A mouse model.
11951178	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	10	6647	SYMBOL|DICTIONARY|EXTRACTED	sod 1	SOD-1	120#125	11951178-1-29-51	Thus, we conclude that CNTF acts as a modifier gene that leads to early onset of disease in patients with FALS who have SOD-1 mutations, in patients with sporadic amyotrophic lateral sclerosis, and in the hSOD-1G93A mouse model.
11891618	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	11132	LONGTERM|DICTIONARY	calpain 10	calpain-10	95#105		Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	LONGTERM|DICTIONARY	calpain 10	calpain-10	69#79		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	11132	SYMBOL|()|DICTIONARY	capn10	CAPN10	87#93		Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	11132	SYMBOL|DICTIONARY	capn10	CAPN10	125#131		To inform the interpretation of the original mapping results and to look for evidence for the action of natural selection on CAPN10, we undertook a population-based genotyping survey of the candidate susceptibility variants.
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	4	11132	SYMBOL|DICTIONARY	capn10	CAPN10	90#96		We then examined the ancestral state of these sites by sequencing orthologous portions of CAPN10 in chimpanzee and orangutan (the identity of sites 43 and 19 was further investigated in a limited sample of other great apes and Old World and New World monkeys).
11891618	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	11132	SYMBOL|DICTIONARY	capn10	CAPN10	76#82		Our survey suggests larger-than-expected differences in the distribution of CAPN10 susceptibility variants between African and non-African populations, with common, derived haplotypes in European and Asian samples (including one of two proposed risk haplotypes) being rare or absent in African samples.
12168876	2002	Anticancer Res.	0250-7005	TITLE	0	0	354	LONGTERM|GENE|GN|DICTIONARY	prostate specific antigen	prostate-specific antigen	15#40		Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	2	354	SYMBOL|DICTIONARY|EXTRACTED	psa	PSA	79#82	12168876-1-50-75	Furthermore, we have found that A-AA occurred frequently in tumors with higher PSA expressions.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	4	354	SYMBOL|DICTIONARY|EXTRACTED	psa	PSA	40#43	12168876-1-50-75	To test this hypothesis, we assayed the PSA genotype for 101 breast cancer cases.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	57534	SYMBOL|DICTIONARY	mib 1	MIB-1	70#75		We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	7	354	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	psa	PSA	64#67	12168876-1-50-75	Our results suggest that the presence of the A-AA allele at the PSA promoter region is associated with less aggressive forms of breast cancer and could be looked on as a favorable prognostic factor.
12135317	2003	Hypertens. Res.	0916-9636	TITLE	0	0	7056	LONGTERM|GENE|GN|DICTIONARY	thrombomodulin	thrombomodulin	41#55		Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		Thrombomodulin (TM), a thrombin receptor expressed on the endothelial surface, is known to play an important role in the anti-thrombogenic system in vivo.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	1	7056	SYMBOL|EXTRACTED|()	tm	TM	16#18	12135317-1-0-14	Thrombomodulin (TM), a thrombin receptor expressed on the endothelial surface, is known to play an important role in the anti-thrombogenic system in vivo.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	7056	SYMBOL|EXTRACTED|GENE|GN	tm	TM	90#92	12135317-1-0-14	In this study, we examined the effects of 3 single-nucleotide polymorphisms (SNPs) in the TM gene (G-33A, C1418T and C1922T) on the development of myocardial infarction (MI) in Koreans.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	10	7056	SYMBOL|EXTRACTED|GENE|GN	tm	TM	72#74	12135317-1-0-14	A reporter gene assay showed that G-33A had a significant effect on the TM promoter activity.
12135317	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	11	7056	SYMBOL|EXTRACTED	tm	TM	51#53	12135317-1-0-14	These results indicated that G-33A polymorphism in TM might be a genetic risk factor for myocardial infarction.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	1	999	SYMBOL|()|GENE|GN|DICTIONARY	cdh1	CDH1	37#41		Somatic mutations in the E-cadherin (CDH1) gene have frequently been reported in cases with diffuse gastric and lobular breast cancers.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	4	999	SYMBOL|DICTIONARY	cdh1	CDH1	66#70		The aim of this study was to investigate if germline mutations in CDH1 could explain the risk for cancer in HPC families with an excess of gastric and breast cancer.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_2/3	2	5	999	SYMBOL|DICTIONARY	cdh1	CDH1	136#140		In total, 17 members from 13 HPC families and 3 members from 3 families with hereditary gastric cancer (HGC) were screened for germline CDH1 sequence alterations using PCR/Denaturing HPLC for initial screening of nucleotide variants followed by confirmatory direct sequencing analysis.
11948460	2002	Int. J. Cancer	0020-7136	ALL_TEXT_3/3	3	12	999	SYMBOL|GENE|GN|DICTIONARY	cdh1	CDH1	76#80		We found several germline mutations of unknown clinical significance in the CDH1 gene that probably do not explain the association of prostate, gastric and/or breast cancers in the HPC-families.
11939812	2002	Arch Dermatol	0003-987X	PATIENTS	4	5	9119	SYMBOL|GENE|GN|DICTIONARY	k6hf	K6HF	89#93		For 9 of them and their first-degree relatives, molecular analyses were performed in the K6HF gene with 50 appropriate controls.
11939812	2002	Arch Dermatol	0003-987X	MAIN OUTCOME MEASURES	6	7	9119	SYMBOL|GENE|GN|DICTIONARY	k6hf	K6HF	70#74		Clinical and follow-up features and determination of mutations in the K6HF gene.
11939812	2002	Arch Dermatol	0003-987X	RESULTS	7	13	9119	SYMBOL|DICTIONARY	k6hf	K6hf	107#111		Polymerase chain reaction analysis of the gene segments encoding the alpha-helical 1A and 2B subdomains of K6hf, the type II cytokeratin exclusively expressed in the companion layer, was performed in 9 families.
11939812	2002	Arch Dermatol	0003-987X	RESULTS	7	14	9119	SYMBOL|DICTIONARY	k6hf	K6HF	125#129		In 3 of these 9 families, a heterozygous glutamic acid and lysine mutation, E337K, was identified in the L2 linker region of K6HF.
11939812	2002	Arch Dermatol	0003-987X	CONCLUSIONS	8	16	9119	SYMBOL|DICTIONARY	k6hf	K6HF	29#33		A keratin mutation, E337K in K6HF, was possibly causative in 3 of the 9 families studied.
11939812	2002	Arch Dermatol	0003-987X	CONCLUSIONS	8	17	9119	SYMBOL|DICTIONARY	k6hf	K6hf	52#56		Another keratin, and possibly the type I partner of K6hf, could be responsible for loose anagen hair syndrome in other patients, or the gene involved may be a minor gene.
12102452	2003	Clin. Auton. Res.	0959-9851	AIMS	1	2	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	144#147	12102452-2-113-142	The primary objective of this study was to determine the effect of an insertion/deletion polymorphism within the angiotensin-converting enzyme (ACE) gene on HRV in the early stages after a myocardial infarction at a time when cardiac autonomic control is deranged.
12102452	2003	Clin. Auton. Res.	0959-9851	AIMS	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	110#113	12102452-2-113-142	The secondary objective was to determine whether this polymorphism affected the HRV response to inhibition of ACE.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	9	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	32#35	12102452-2-113-142	The I/D polymorphism within the ACE gene does not influence HRV after MI or the HRV response to ACE inhibitor therapy with ramipril.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	9	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	96#99	12102452-2-113-142	The I/D polymorphism within the ACE gene does not influence HRV after MI or the HRV response to ACE inhibitor therapy with ramipril.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	87#90	12102452-2-113-142	These findings may reflect the relative lack of importance of the I/D polymorphism and ACE activity in determining plasma and tissue angiotensin II concentration after a major stimulus to the renin-angiotensin system as occurs after myocardial infarction.
12102452	2003	Clin. Auton. Res.	0959-9851	PRINCIPAL CONCLUSIONS	3	10	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	133#147		These findings may reflect the relative lack of importance of the I/D polymorphism and ACE activity in determining plasma and tissue angiotensin II concentration after a major stimulus to the renin-angiotensin system as occurs after myocardial infarction.
11933203	2002	Hum. Mutat.	1098-1004	TITLE	0	0	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	3#14		An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus.
11933203	2002	Hum. Mutat.	1098-1004	TITLE	0	0	6696	SYMBOL|()|DICTIONARY|EXTRACTED	spp1	SPP1	16#20	11933203-0-3-14	An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	6696	LONGTERM|DICTIONARY	osteopontin	Osteopontin	0#11		Osteopontin (SPP1) is a soluble ligand with pleomorphic immunologic activities including activation of macrophage chemotaxis, promotion of Th1 responses, and activation of B1 B cells.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	6696	SYMBOL|()|DICTIONARY|EXTRACTED	spp1	SPP1	13#17	11933203-0-3-14	Osteopontin (SPP1) is a soluble ligand with pleomorphic immunologic activities including activation of macrophage chemotaxis, promotion of Th1 responses, and activation of B1 B cells.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	30#41		We examined a polymorphism of osteopontin for an association with lupus in humans in an effort to determine whether there is any evidence that a genetic predisposition to altered osteopontin expression might explain the overexpression seen in human SLE patients.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	179#190		We examined a polymorphism of osteopontin for an association with lupus in humans in an effort to determine whether there is any evidence that a genetic predisposition to altered osteopontin expression might explain the overexpression seen in human SLE patients.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	45#56		A silent polymorphism (707C>T, rs1126616) of osteopontin was significantly associated with SLE.
11933203	2002	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	6696	LONGTERM|DICTIONARY	osteopontin	osteopontin	71#82		This is the first phenotypic association with a polymorphic variant of osteopontin.
12006918	2002	J Cardiovasc Risk	1350-6277	TITLE	0	0	3990	SYMBOL|GENE|GN|DICTIONARY	hepatic lipase	Hepatic lipase	0#14		Hepatic lipase gene -514 C/T polymorphism and premature coronary heart disease.
11799476	2002	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	55997	SYMBOL|DICTIONARY	cfc1	CFC1	0#4		CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	55997	SYMBOL|DICTIONARY	cfc1	CFC1	46#50		Recent investigations identified heterozygous CFC1 mutations in subjects with heterotaxy syndrome, all of whom had congenital cardiac malformations, including malposition of the great arteries.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	55997	SYMBOL|DICTIONARY	cfc1	CFC1	225#229		We hypothesized that a subset of patients with similar types of congenital heart disease---namely, transposition of the great arteries and double-outlet right ventricle, in the absence of laterality defects---would also have CFC1 mutations.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	55997	SYMBOL|GENE|GN|DICTIONARY	cfc1	CFC1	20#24		Our analysis of the CFC1 gene in patients with these cardiac disorders identified two disease-related mutations in 86 patients.
11799476	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	55997	SYMBOL|DICTIONARY	cfc1	CFC1	76#80		In addition, these results demonstrate that the molecular pathway involving CFC1 plays a critical role in normal and abnormal cardiovascular development.
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	22#27		A polymorphism in the CYP17 gene and risk of prostate cancer.
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	1586	SYMBOL|DICTIONARY	cyp17	CYP17	17#22		One such gene is CYP17, which encodes the cytochrome P450c17a enzyme responsible for the biosynthesis of testosterone.
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	9	1586	SYMBOL|DICTIONARY	cyp17	CYP17	31#36		These results suggest that the CYP17 A2/A2 genotype predicts susceptibility to prostate cancer in white men with a family history of the disease.
11895872	2002	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	1586	SYMBOL|DICTIONARY	cyp17	CYP17	25#30		It is also possible that CYP17 interacts with other genes that influence risk of familial prostate cancer.
11935341	2002	Hum. Genet.	0340-6717	TITLE	0	0	23209	SYMBOL|DICTIONARY	mlc1	MLC1	37#41		Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts.
11935341	2002	Hum. Genet.	0340-6717	ALL_TEXT_2/3	2	3	23209	SYMBOL|GENE|GN|DICTIONARY	mlc1	MLC1	17#21		Mutations in the MLC1 gene, encoding a putative membrane protein, have been recently identified as a cause for MLC.
11935341	2002	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	23209	SYMBOL|GENE|GN|DICTIONARY	mlc1	MLC1	121#125		The role, suggested by others, of a mutation in the MLC1gene in catatonic schizophrenia and the possible function of the MLC1 protein as a cation channel are discussed.
12142547	2003	Mol. Med.	1076-1551	BACKGROUND	1	1	4157	SYMBOL|DICTIONARY	mc1r	MC1R	49#53		The melanocortin system includes five receptors (MC1R to MC5R), and mouse and human MC4R has been shown to be involved in the regulation of feeding, and mouse MC3R in body composition.
12142547	2003	Mol. Med.	1076-1551	BACKGROUND	1	1	4161	SYMBOL|DICTIONARY	mc5r	MC5R	57#61		The melanocortin system includes five receptors (MC1R to MC5R), and mouse and human MC4R has been shown to be involved in the regulation of feeding, and mouse MC3R in body composition.
12142547	2003	Mol. Med.	1076-1551	BACKGROUND	1	1	4160	SYMBOL|DICTIONARY	mc4r	MC4R	84#88		The melanocortin system includes five receptors (MC1R to MC5R), and mouse and human MC4R has been shown to be involved in the regulation of feeding, and mouse MC3R in body composition.
12142547	2003	Mol. Med.	1076-1551	BACKGROUND	1	1	4159	SYMBOL|DICTIONARY	mc3r	MC3R	159#163		The melanocortin system includes five receptors (MC1R to MC5R), and mouse and human MC4R has been shown to be involved in the regulation of feeding, and mouse MC3R in body composition.
12142547	2003	Mol. Med.	1076-1551	BACKGROUND	1	2	4159	SYMBOL|DICTIONARY	mc3r	MC3R	39#43		To verify a possible similar effect of MC3R in humans, we analyzed one insertion and one single nucleotide polymorphism by restriction fragment length polymorphisms (RFLP), and a microsatellite (D20S32e) in relation to body composition and glucose metabolism.
12142547	2003	Mol. Med.	1076-1551	METHODS	2	4	4159	SYMBOL|GFAM|FN|DICTIONARY	mc3r	MC3R	32#36		Southern Blot with the complete MC3R cDNA was used to detect a new +2138InsCAGACC variant by Pst1 restriction.
12142547	2003	Mol. Med.	1076-1551	METHODS	2	4	7903	SYMBOL|DICTIONARY	pst1	Pst1	93#97		Southern Blot with the complete MC3R cDNA was used to detect a new +2138InsCAGACC variant by Pst1 restriction.
12142547	2003	Mol. Med.	1076-1551	METHODS	2	6	4159	SYMBOL|DICTIONARY	mc3r	MC3R	129#133		PCR and automatic DNA sequencers were used for the analysis of the TG dinucleotide repeat D20S32e located between -1933/-1892 of MC3R.
12142547	2003	Mol. Med.	1076-1551	RESULTS	3	9	4159	SYMBOL|DICTIONARY	mc3r	MC3R	42#46		An association between the +2138InsCAGACC MC3R polymorphism was observed with fat mass (FM), percent body fat (%FAT), and total abdominal fat (ATF).
12142547	2003	Mol. Med.	1076-1551	CONCLUSION	4	16	4159	SYMBOL|DICTIONARY	mc3r	MC3R	21#25		A new 12138InsCAGACC MC3R polymorphism is associated with the level of adiposity and with body fat partitioning in interaction with corpulence in humans.
11976977	2002	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	2	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	32#47		We investigated the presence of factor V Leiden and the serum level of anticardiolipin antibodies (aCL) in a consecutive series of 70 migraine patients (47 women; mean age, 34.1 years).
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	1130	SYMBOL|GENE|GN|DICTIONARY	chs1	CHS1	67#71		Here, we describe the organization and genomic DNA sequence of the CHS1 gene and mutation analysis of 21 unrelated patients with the childhood, adolescent, and adult forms of CHS.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	78#82		In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
11857544	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	1130	SYMBOL|DICTIONARY	chs1	CHS1	212#216		In patients with severe childhood CHS, we found only functionally null mutant CHS1 alleles, whereas in patients with the adolescent and adult forms of CHS we also found missense mutant alleles that likely encode CHS1 polypeptides with partial function.
11843659	2002	Arch Dermatol	0003-987X	TITLE	0	0	1294	SYMBOL|DICTIONARY	col7a1	COL7A1	23#29		Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	6448	SYMBOL|()|DICTIONARY|EXTRACTED	sgsh	SGSH	127#131	11793481-2-114-125	MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and a-N-acetylglucosaminidase (NAGLU) deficient in MPS IIIB.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	4669	SYMBOL|DICTIONARY	mps iiib	MPS IIIB	212#220		MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and a-N-acetylglucosaminidase (NAGLU) deficient in MPS IIIB.
11793481	2002	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	6448	SYMBOL|DICTIONARY|EXTRACTED	sgsh	SGSH	31#35	11793481-2-114-125	In this study two mutations of SGSH were identified in MPS IIIA patients: R74C and the novel mutation P288S, and one polymorphism (IVS1+23 C>G).
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_1/3	1	1	6915	SYMBOL|()|DICTIONARY	tbxa2r	TBXA2R	33#39		Thromboxane A2 and its receptor (TBXA2R) are involved in the constriction of vascular and respiratory smooth muscles.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_1/3	1	2	6915	SYMBOL|GENE|GN|DICTIONARY	tbxa2r	TBXA2R	30#36		The T924C polymorphism in the TBXA2R gene was recently found to be associated with asthma in Japanese adults but not in children.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_2/3	2	5	6915	SYMBOL|DICTIONARY	tbxa2r	TBXA2R	113#119		Then, peripheral blood was analyzed for serum total and aeroallergen-specific immunoglobulin E (IgE) levels, and TBXA2R T924C genotypes were determined by restriction fragment length polymorphism (RFLP) analysis.
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_3/3	3	11	6915	SYMBOL|DICTIONARY	tbxa2r	TBXA2R	34#40		Among our asthmatic patients, the TBXA2R T924C polymorphism correlated with the concentration of cat-specific IgE in serum (p = 0.046).
12000493	2002	Pediatr Allergy Immunol	0905-6157	ALL_TEXT_3/3	3	13	6915	SYMBOL|GENE|GN|DICTIONARY	tbxa2r	TBXA2R	64#70		In conclusion, our results suggest that the T924C marker in the TBXA2R gene is associated, in Chinese children, with an increased susceptibility of developing atopic asthma.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	21#27		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	29#35		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	9	SYMBOL|DICTIONARY	nat1	NAT1	37#41		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	10	SYMBOL|DICTIONARY	nat2	NAT2	43#47		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	49#54		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	56#61		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	4	4968	SYMBOL|GENE|GN|DICTIONARY	hogg1	hOGG1	67#72		Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	5	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	88#94		The level of aromatic DNA adducts was significantly associated with polymorphism of the CYP1A1 gene.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	6	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	74#79		No significant correlation was found between the level of 8-OH-dG and the MnSOD, GSTM1, and hOGG1 polymorphisms.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	81#86		No significant correlation was found between the level of 8-OH-dG and the MnSOD, GSTM1, and hOGG1 polymorphisms.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_2/3	2	6	4968	SYMBOL|DICTIONARY	hogg1	hOGG1	92#97		No significant correlation was found between the level of 8-OH-dG and the MnSOD, GSTM1, and hOGG1 polymorphisms.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_3/3	3	7	4968	SYMBOL|GENE|GN|DICTIONARY	hogg1	hOGG1	48#53		However, one novel polymorphism/mutation of the hOGG1 gene was found in a pancreatic tumor.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	TITLE	0	0	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	65#69		Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	99#120		Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat1	NAT1	23#27	12355549-1-0-21	N-acetyltransferase-1 (NAT1) and N-acetyltransferase-2 (NAT2) are important in the metabolism of aromatic and heterocyclic amine carcinogens that induce prostate tumors in the rat.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	1	9	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	56#60	12355549-1-33-54	N-acetyltransferase-1 (NAT1) and N-acetyltransferase-2 (NAT2) are important in the metabolism of aromatic and heterocyclic amine carcinogens that induce prostate tumors in the rat.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	60#64	12355549-1-0-21	We investigated the association of genetic polymorphisms in NAT1 and NAT2, alone and in combination, with human prostate cancer.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	69#73	12355549-1-33-54	We investigated the association of genetic polymorphisms in NAT1 and NAT2, alone and in combination, with human prostate cancer.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_2/3	2	4	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	33#37	12355549-1-0-21	The frequency of slow acetylator NAT1 genotypes (NAT1*14, *15, *17) was 5.8% in controls but absent in cases.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_2/3	2	4	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	49#53	12355549-1-0-21	The frequency of slow acetylator NAT1 genotypes (NAT1*14, *15, *17) was 5.8% in controls but absent in cases.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	42#46	12355549-1-0-21	In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|DICTIONARY|EXTRACTED	nat1	NAT1	87#91	12355549-1-0-21	In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	102#106	12355549-1-0-21	In contrast, in comparison with all other NAT1 genotypes the putative rapid acetylator NAT1 genotype (NAT1*10) was significantly higher in prostate cancer cases than controls (OR, 2.17; 95% CI, 1.08-4.33; P = 0.03).
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	16#20	12355549-1-0-21	Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	29#33	12355549-1-33-54	Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	109#113	12355549-1-33-54	Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	136#140	12355549-1-33-54	Combinations of NAT1*10 with NAT2 slow acetylator genotypes (OR, 5.08; 95% CI, 1.56-16.5; P = 0.008) or with NAT2 very slow (homozygous NAT2*5) acetylator genotypes (OR, 7.50; 95% CI, 1.55-15.4; P = 0.016) further increased prostate cancer risk.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	7	9	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat1	NAT1	124#128	12355549-1-0-21	The results of this small pilot study suggest increased susceptibility to prostate cancer for subjects with combinations of NAT1*10 and slow (particularly very slow) NAT2 acetylator genotypes.
12355549	2002	Environ. Mol. Mutagen.	0893-6692	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	166#170	12355549-1-33-54	The results of this small pilot study suggest increased susceptibility to prostate cancer for subjects with combinations of NAT1*10 and slow (particularly very slow) NAT2 acetylator genotypes.
12409629	2003	J. Atheroscler. Thromb.	1340-3478	ALL_TEXT_1/3	1	2	1071	SYMBOL|GENE|GN|DICTIONARY	cetp	CETP	79#83		Patients were divided into three groups according to TaqIB polymorphism of the CETP gene.
12409629	2003	J. Atheroscler. Thromb.	1340-3478	ALL_TEXT_3/3	3	7	1071	SYMBOL|GENE|GN|DICTIONARY	cetp	CETP	29#33		The genetic variation in the CETP gene may be one important factor in designing better treatments.
12181642	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	12#30		The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	77#95		Antiproliferative effects of vitamin D require the expression of the nuclear vitamin D receptor (VDR).
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	7421	SYMBOL|()|DICTIONARY|EXTRACTED	vdr	VDR	97#100	12181642-2-77-95	Antiproliferative effects of vitamin D require the expression of the nuclear vitamin D receptor (VDR).
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	78#96		A three-fold increase in prostate cancer risk associated with the less active vitamin D receptor allele (the T allele from VDR TaqI polymorphism at codon 352) was reported.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	123#126	12181642-2-77-95	A three-fold increase in prostate cancer risk associated with the less active vitamin D receptor allele (the T allele from VDR TaqI polymorphism at codon 352) was reported.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	12#15	12181642-2-77-95	The role of VDR genotypes in the susceptibility to prostate cancer has not yet been studied in populations of southern Europe.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	5	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	36#39	12181642-2-77-95	In the present study, we determined VDR TaqI genotypes in Portuguese prostate cancer cases ( n = 163) and controls ( n = 211), a southern European population.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	6	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	67#70	12181642-2-77-95	When cases were compared with controls, we found an association of VDR T allele with prostate cancer risk (odds ratio [OR] = 1.87, 95% confidence interval [CI] 1.02-3.37; P = 0.035).
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	46#49	12181642-2-77-95	Our results indicate that the contribution of VDR genotypes to prostate cancer susceptibility might depend on the population studied and its geographic localization, and that VDR genotypes are important in the definition of the genetic risk profile of populations of southern Europe.
12181642	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	9	7421	SYMBOL|DICTIONARY|EXTRACTED	vdr	VDR	175#178	12181642-2-77-95	Our results indicate that the contribution of VDR genotypes to prostate cancer susceptibility might depend on the population studied and its geographic localization, and that VDR genotypes are important in the definition of the genetic risk profile of populations of southern Europe.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	LONGTERM|DICTIONARY	lamin a c	lamin A/C	18#27		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
12032588	2002	J. Hum. Genet.	1434-5161	TITLE	0	0	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	30#34		Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	17#21		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	4000	SYMBOL|DICTIONARY	cmd1a	CMD1A	319#324		Mutations in the LMNA gene encoding lamins A and C by alternative splicing have been found to cause at least four different kinds of genetic disorders: autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD2; MIM 181350); limb-girdle muscular dystrophy type 1B (LGMD1B; MIM 159001); dilated cardiomyopathy type 1A (CMD1A; MIM 115200); and familial partial lipodystrophy (FPLD; MIM 151660).
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	4	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	40#44		We performed a mutation analysis of the LMNA gene by direct sequencing and found two different missense mutations: R249Q and R377L, in the EDMD2 and LGMD1B patient, respectively.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	67#71		The R249Q mutation is located within the central rod domain of the LMNA gene, and has been described in at least five unrelated sporadic EDMD2 patients.
12032588	2002	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	4000	SYMBOL|GENE|GN|DICTIONARY	lmna	LMNA	46#50		To our knowledge, this is the first report of LMNA gene mutations in Korean patients with EDMD2 and LGMD1B.
11756990	2002	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	103#111		When the nonresponders and responders with HLA class II were compared, the nonresponder group had more HLA-DRB1*07-positive donors (13/32 vs. 6/41 responders; P=.016, Fisher's exact test) and fewer HLA-DQB1*0603-9/14-positive donors (2/32 vs. 14/41 responders; P=.0045).
11756990	2002	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	6	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	198#206		When the nonresponders and responders with HLA class II were compared, the nonresponder group had more HLA-DRB1*07-positive donors (13/32 vs. 6/41 responders; P=.016, Fisher's exact test) and fewer HLA-DQB1*0603-9/14-positive donors (2/32 vs. 14/41 responders; P=.0045).
11802810	2002	Jpn. J. Cancer Res.	0910-5050	TITLE	0	0	540	SYMBOL|()|DICTIONARY	atp7b	ATP7B	53#58		Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_1/3	1	1	540	SYMBOL|DICTIONARY	atp7b	ATP7B	93#98		This is the first report to show that a copper-transporting P-type adenosine triphosphatase, ATP7B, is expressed in certain breast carcinomas, and a priori knowledge of its expression is important for the choice of therapy.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	36#41		We investigated the hypothesis that ATP7B, which was shown to be associated with cisplatin resistance in vitro, is expressed in certain breast carcinomas.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	3	540	SYMBOL|DICTIONARY	atp7b	ATP7B	25#30		To test this hypothesis, ATP7B expression and protein level were examined in 41 breast carcinomas using RT-PCR and immunohistochemistry.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	4	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	0#5		ATP7B gene / protein could be detected in 22.0% (9 / 41) of breast carcinomas and ATP7B gene expression was correlated well with the protein expression.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_2/3	2	4	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	82#87		ATP7B gene / protein could be detected in 22.0% (9 / 41) of breast carcinomas and ATP7B gene expression was correlated well with the protein expression.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	8#13		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	5	540	SYMBOL|DICTIONARY	atp7b	ATP7B	100#105		In nine ATP7B-positive tumors, adjacent normal breast tissue was similarly analyzed, revealing that ATP7B is upregulated in breast carcinoma.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	6	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	0#5		ATP7B gene expression in poorly differentiated carcinoma was significantly higher than that in well- / moderately differentiated carcinoma (P = 0.012).
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	7	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	49#54		Furthermore, we found no association between the ATP7B gene / protein expression and that of MDR1, MRP1, LRP and BCRP.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	7	5243	SYMBOL|DICTIONARY	mdr1	MDR1	93#97		Furthermore, we found no association between the ATP7B gene / protein expression and that of MDR1, MRP1, LRP and BCRP.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	7	4363	SYMBOL|DICTIONARY	mrp1	MRP1	99#103		Furthermore, we found no association between the ATP7B gene / protein expression and that of MDR1, MRP1, LRP and BCRP.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	7	4035	SYMBOL|DICTIONARY	lrp	LRP	105#108		Furthermore, we found no association between the ATP7B gene / protein expression and that of MDR1, MRP1, LRP and BCRP.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	7	644079	SYMBOL|DICTIONARY	bcrp	BCRP	113#117		Furthermore, we found no association between the ATP7B gene / protein expression and that of MDR1, MRP1, LRP and BCRP.
11802810	2002	Jpn. J. Cancer Res.	0910-5050	ALL_TEXT_3/3	3	8	540	SYMBOL|GENE|GN|DICTIONARY	atp7b	ATP7B	30#35		These findings suggested that ATP7B gene expression might be a chemoresistance marker for cisplatin in patients with poorly differentiated breast carcinoma.
12140789	2003	Mol. Psychiatry	1359-4184	TITLE	0	0	4160	LONGTERM|GENE|GN|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	79#102		Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	3	4160	LONGTERM|GENE|GN|GT|DICTIONARY	melanocortin 4 receptor	melanocortin-4 receptor	56#79		In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	3	4160	SYMBOL|()|DICTIONARY|EXTRACTED	mc4r	MC4R	86#90	12140789-3-56-79	In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN.
12140789	2003	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	4160	SYMBOL|DICTIONARY|EXTRACTED	mc4r	MC4R	92#96	12140789-3-56-79	A single patient with both extreme obesity and BN had a haplo-insufficiency mutation in the MC4R.
11750770	2002	Psychoneuroendocrinology	0306-4530	ALL_TEXT_1/3	1	1	5443	LONGTERM|DICTIONARY	adrenocorticotropin	adrenocorticotropin	34#53		Cocaine stimulates the release of adrenocorticotropin hormone (ACTH) and cortisol in both clinical and preclinical studies, but the temporal sequence of cocaine-induced changes in other hormones and affective states is unclear.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	TITLE	0	0	3125	SYMBOL|DICTIONARY	hla drb3	HLA-DRB3	0#8		HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	16#24		Oligotyping for HLA-DRB1, DRB3, DQA1 and DQB1 alleles was performed using the polymerase chain reaction sequence specific oligonucleotide probe (PCR-SSOP) technique.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	5	3125	SYMBOL|DICTIONARY	hla drb3	HLA-DRB3	25#33		RESULTS The frequency of HLA-DRB3 *0101 was increased significantly in the patients compared to controls (38.7% vs. 19.2%; RR = 2.72; Pc < 0.015).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3123	SYMBOL|DICTIONARY	drb1	DRB1	48#52		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	100#104		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	DESIGN	3	6	3126	SYMBOL|DICTIONARY	drb4	DRB4	151#155		The protective alleles for Graves' disease were DRB1 *0901 (0.9% vs. 20.2%; RR = 0.04; Pc < 0.001), DRB1*1001 (0.0% vs. 11%; RR = 0.0%; Pc < 0.01) and DRB4 *0101 (0.0% vs. 12.5%; RR = 0.0; Pc < 0.05).
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3126	SYMBOL|DICTIONARY	drb4	DRB4	87#91		Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	148#152		Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
11774187	2002	Mol. Diagn.	1084-8592	TITLE	0	0	3077	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	17#20	11774187-0-0-15	Hemochromatosis (HFE) gene sequence analysis of formalin-fixed, paraffin-embedded liver biopsy specimens.
11774187	2002	Mol. Diagn.	1084-8592	BACKGROUND	1	1	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	100#103	11774187-0-0-15	Hereditary hemochromatosis (HH) is a common disease predominantly characterized by mutations of the HFE gene.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	2	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	31#34	11774187-0-0-15	We investigated the utility of HFE gene sequence analysis in the diagnosis of HH in 61 prospectively accrued formalin-fixed, paraffin-embedded liver biopsy specimens with clinical or histologic features suggestive of HH.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	3	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	37#40	11774187-0-0-15	Mutations in codons 63 or 282 of the HFE gene were identified by direct sequencing; in 21 of these samples, quantitative hepatic iron testing was also performed.
11774187	2002	Mol. Diagn.	1084-8592	METHODS AND RESULTS	2	4	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	96#99	11774187-0-0-15	Changes characteristic of HH were present in 16 (26%) of the cases, and 54% of the cases showed HFE gene mutations.
11774187	2002	Mol. Diagn.	1084-8592	CONCLUSION	3	9	3077	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	hfe	HFE	55#58	11774187-0-0-15	When HH is clinically and/or histologically suspected, HFE gene sequencing of formalin-fixed, paraffin-embedded liver biopsy specimens is a rapid and cost-effective approach to genotypic diagnosis of HH.
11746272	2002	Prostate	0270-4137	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	40#43		Association of codon 72 polymorphism of p53 with lower prostate cancer risk.
11746272	2002	Prostate	0270-4137	BACKGROUND	1	1	7157	SYMBOL|DICTIONARY	p53	p53	34#37		A common germline polymorphism of p53 produces a protein with an Arg to Pro change at codon 72.
11746272	2002	Prostate	0270-4137	CONCLUSIONS	4	9	7157	SYMBOL|DICTIONARY	p53	p53	13#16		Men with the p53 codon 72 Pro/Pro genotype appear to be at reduced risk of prostate cancer.
11709213	2002	J. Inorg. Biochem.	0162-0134	TITLE	0	0	5697	LONGTERM|DICTIONARY	peptide yy	peptide YY	16#26		Neuropeptide Y, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship?
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_1/3	1	1	5697	LONGTERM|DICTIONARY	peptide yy	peptide YY	25#35		Neuropeptide Y (NPY) and peptide YY (PYY) are members of the pancreatic polypeptide family which have a high degree of primary and tertiary structural homology.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_1/3	1	1	5697	SYMBOL|()|DICTIONARY|EXTRACTED	pyy	PYY	37#40	11709213-1-25-35	Neuropeptide Y (NPY) and peptide YY (PYY) are members of the pancreatic polypeptide family which have a high degree of primary and tertiary structural homology.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	29#32	11709213-1-0-14	During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	63#66	11709213-1-0-14	During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	3	5697	SYMBOL|DICTIONARY|EXTRACTED	pyy	PYY	67#70	11709213-1-25-35	During the last two decades, NPY body fluid concentrations and NPY/PYY brain receptor numbers have been demonstrated to be altered during the course of Alzheimer's disease.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	4	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	36#39	11709213-1-0-14	Recent research has shown that both NPY and PYY may be involved in aluminum metabolism in animal models.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_3/3	3	4	5697	SYMBOL|DICTIONARY|EXTRACTED	pyy	PYY	44#47	11709213-1-25-35	Recent research has shown that both NPY and PYY may be involved in aluminum metabolism in animal models.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY	gstm1	GSTM1	42#47		To study the glutathione-S-tranterase M1 (GSTM1) genotype in patients with hepatocellular carcinoma (HCC) with aflatoxin B1(AFB1) in a high risk region in Guangxi.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	METHODS	2	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	9#14		Specific GSTM1 primers and PCR technique were used for the detection of GSTM1 genotype using the peripheral leukocytes.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	METHODS	2	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	72#77		Specific GSTM1 primers and PCR technique were used for the detection of GSTM1 genotype using the peripheral leukocytes.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	RESULTS	3	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	17#22		The frequency of GSTM1-null genotype in HCC patients was 102/162(63%), in local residents it was 92/177(52%) and in young men from outside it was 13/40(33%), which were significantly different.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	CONCLUSION	4	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 is one of the pivotal phase II detoxicated enzymes for AFB1.
11859714	2002	Zhonghua Zhong Liu Za Zhi	0253-3766	CONCLUSION	4	6	2944	SYMBOL|GENE|GN|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 genetic deletion predisposes the individuals to HCC.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	56#72		To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	OBJECTIVE	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	74#78	11769724-1-56-72	To study the association of Alzheimer disease (AD) with apolipoprotein E (ApoE) epsilon 4 allele and to find the biological peripheral markers for the laboratory diagnosis of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	METHODS	2	3	348	SYMBOL|EXTRACTED	apoe	ApoE	127#131	11769724-1-56-72	DNA from patients and healthy individuals was extracted from peripheral blood samples with the phenol-chloroform procedure and ApoE was investigated with the methods of polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe4	ApoE4	7#12		AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|EXTRACTED	apoe	ApoE	34#38	11769724-1-56-72	AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	CONCLUSION	4	9	348	SYMBOL|DICTIONARY	apoe 4	ApoE 4	82#88		AD and ApoE4 were closely related.ApoE epsilon 4 was a dangerous factor of AD and ApoE 4 allele made contribution to the heterogenicity of AD.
11583755	2001	Lancet	0140-6736	TITLE	0	0	1493	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	21#26		MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ctla4	CTLA4	159#164	11583755-2-137-155	We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	2	3586	SYMBOL|DICTIONARY	il 10	IL-10	16#21		The promoter of IL-10 is polymorphic, with 3 known single base substitutions (G/A at -1082, C/T at -819, and C/A at -592), which form 3 haplotypes: GCC, ACC, and ATA.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	39#44		To examine the effect of haplotypes on IL-10 production, IL-10 plasma levels were measured in 50 newborns and 400 adults and were correlated with the IL-10 haplotype.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	57#62		To examine the effect of haplotypes on IL-10 production, IL-10 plasma levels were measured in 50 newborns and 400 adults and were correlated with the IL-10 haplotype.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	150#155		To examine the effect of haplotypes on IL-10 production, IL-10 plasma levels were measured in 50 newborns and 400 adults and were correlated with the IL-10 haplotype.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	6	3586	SYMBOL|DICTIONARY	il 10	IL-10	4#9		The IL-10 levels were significantly higher in the ATA carriers than in the noncarriers.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY	il 10	IL-10	28#33		These data suggest that the IL-10 ATA haplotype confers protection against primary EBV infection and that the effect is mediated by high IL-10 levels.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY	il 10	IL-10	137#142		These data suggest that the IL-10 ATA haplotype confers protection against primary EBV infection and that the effect is mediated by high IL-10 levels.
11579943	2002	Intern. Med.	0918-2918	TITLE	0	0	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	32#35		C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
11579943	2002	Intern. Med.	0918-2918	OBJECTIVE	1	1	3077	SYMBOL|DICTIONARY	hfe	HFE	141#144		The gene responsible for hereditary hemochromatosis close to the human leukocyte antigen A locus was previously identified and designated as HFE.
11579943	2002	Intern. Med.	0918-2918	OBJECTIVE	1	2	3077	SYMBOL|DICTIONARY	hfe	HFE	99#102		This study was performed to evaluate the clinical significance of two mutations, C282Y and H63D of HFE, in Japanese patients with hepatic iron overload.
11579943	2002	Intern. Med.	0918-2918	PATIENTS AND METHODS	2	4	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	4#7		The HFE gene region of DNA samples extracted from peripheral leukocytes was amplified by polymerase chain reaction.
11579943	2002	Intern. Med.	0918-2918	CONCLUSION	4	12	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		Our results suggested that neither C282Y nor H63D in HFE affect Japanese patients with hemochromatosis or chronic hepatitis C.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	ALL_TEXT_2/3	2	4	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	4#8		The TP53 gene region on the short arm of chromosome 17 was also examined in these tumors using 3 markers.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	ALL_TEXT_3/3	3	8	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	129#132	11556548-2-14-33	The high rate of NF1 allele loss in NF1-associated pilocytic astrocytomas suggests a tumor initiating or promoting action of the NF1 gene in these patients.
11553050	2001	Clin. Genet.	0009-9163	TITLE	0	0	5080	SYMBOL|DICTIONARY	pax6	PAX6	0#4		PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation.
11553050	2001	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	5080	SYMBOL|GENE|GN|DICTIONARY	pax6	PAX6	67#71		Congenital aniridia is due to deletions and point mutations in the PAX6 gene.
11553050	2001	Clin. Genet.	0009-9163	ALL_TEXT_3/3	3	3	5080	SYMBOL|DICTIONARY	pax6	PAX6	39#43		The possibility of deletion around the PAX6 locus was excluded by polymorphism studies and fluorescence in situ hybridization analysis.
11553050	2001	Clin. Genet.	0009-9163	ALL_TEXT_3/3	3	4	5080	SYMBOL|GENE|GN|DICTIONARY	pax6	PAX6	26#30		Mutation screening of the PAX6 gene revealed the presence of a transversion C719A, resulting in the substitution of arginine for serine at residue 119.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	LONGTERM|GENE|GT|DICTIONARY|GA	calcium sensing receptor	calcium-sensing receptor	26#50		Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_1/3	1	1	846	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	casr	CaSR	52#56	11762699-1-26-50	Missense mutations in the calcium-sensing receptor (CaSR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_2/3	2	3	846	SYMBOL|EXTRACTED	casr	CaSR	54#58	11762699-1-26-50	The family members were studied, and we found a novel CaSR missense mutation with polymerase chain reaction single-strand conformational polymorphism analysis.
11762699	2002	Endocrine	1355-008X	ALL_TEXT_3/3	3	5	846	SYMBOL|EXTRACTED	casr	CaSR	167#171	11762699-1-26-50	A heterozygous missense mutation in exon 6 that substitutes a glutamic acid for the glycine at codon 557 (Gly557Glu), which corresponds to the extracellular domain of CaSR, was identified and shown to cosegregate with the disease.
11462241	2001	Hum. Mutat.	1098-1004	TITLE	0	0	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	86#90		Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).
11462241	2001	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	95#99		The most frequent form of chronic granulomatous disease (CGD) is caused by inactivation of the CYBB gene, which encodes the gp91-phox subunit of phagocyte NADPH oxidase.
11462241	2001	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	1536	SYMBOL|GENE|GN|DICTIONARY	cybb	CYBB	28#32		A mutation was found in the CYBB gene of all 16 patients, and 11 of these mutations were novel.
11474225	2001	Nephron	1660-8151	TITLE	0	0	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	16#19		Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	51#80		There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
11474225	2001	Nephron	1660-8151	BACKGROUND	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	82#85	11474225-1-51-80	There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS).
11474225	2001	Nephron	1660-8151	METHODS	2	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	63#66	11474225-1-51-80	A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 +/- (SD) 5.0 years.
11474225	2001	Nephron	1660-8151	RESULTS	3	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	37#40	11474225-1-51-80	The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p < 0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively).
11474225	2001	Nephron	1660-8151	RESULTS	3	4	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	0#3		ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	81#84	11474225-1-51-80	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11474225	2001	Nephron	1660-8151	CONCLUSION	4	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	246#249	11474225-1-51-80	The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.
11323423	2001	J. Biol. Chem.	0021-9258	TITLE	0	0	6662	SYMBOL|DICTIONARY	sox9	SOX9	93#97		Compound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation.
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_1/3	1	1	6662	SYMBOL|DICTIONARY	sox9	SOX9	44#48		Human mutations in the transcription factor SOX9 cause campomelic dysplasia/autosomal sex reversal.
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_1/3	1	2	6662	SYMBOL|DICTIONARY	sox9	SOX9	210#214		"Here we identify and characterize two novel heterozygous mutations, F154L and A158T, that substitute conserved ""hydrophobic core"" amino acids of the high mobility group domain at positions thought to stabilize SOX9 conformation."
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	6662	SYMBOL|DICTIONARY	sox9	SOX9	76#80		In cultured cells, strictly nuclear localization was observed for wild type SOX9 and the F154L mutant; however, the A158T mutant showed a 2-fold reduction in nuclear import efficiency.
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	5	6662	SYMBOL|DICTIONARY	sox9	SOX9	82#86		Importin-beta was demonstrated to be the nuclear transport receptor recognized by SOX9, with both mutant proteins binding importin-beta with wild type affinity.
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	7	6662	SYMBOL|DICTIONARY	sox9	SOX9	177#181		Despite this large effect, transcriptional activation in cultured cells was only reduced to 26% in F154L and 62% in A158T of wild type activity, suggesting that a small loss of SOX9 transactivation activity could be sufficient to disrupt proper regulation of target genes during bone and testis formation.
11323423	2001	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	8	6662	SYMBOL|DICTIONARY	sox9	SOX9	39#43		Thus, clinically relevant mutations of SOX9 affect protein structure leading to compound effects of reduced nuclear import and reduced DNA binding, the net effect being loss of transcriptional activation.
11712802	2001	Anticancer Res.	0250-7005	ALL_TEXT_2/3	2	9	1440	SYMBOL|DICTIONARY	g csf	G-CSF	83#88		Five patients experienced febrile neutropenia, which was successfully treated with G-CSF and broad-spectrum antibiotics.
11472373	2001	Br. J. Haematol.	0007-1048	TITLE	0	0	540	SYMBOL|DICTIONARY	atp7b	ATP7B	78#83		Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319.
11463752	2001	Hypertension	1524-4563	TITLE	0	0	133	LONGTERM|GENE|GN|DICTIONARY	adrenomedullin	adrenomedullin	41#55		Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	133	LONGTERM|DICTIONARY	adrenomedullin	Adrenomedullin	0#14		Adrenomedullin (AM) is a hypotensive peptide widely produced in the cardiovascular organs and tissues.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	133	SYMBOL|EXTRACTED|()	am	AM	16#18	11463752-1-0-14	Adrenomedullin (AM) is a hypotensive peptide widely produced in the cardiovascular organs and tissues.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	2	133	SYMBOL|EXTRACTED|GENE|GN	am	AM	64#66	11463752-1-0-14	We have cloned and sequenced the genomic DNA encoding the human AM gene and have determined that the gene is located in the short arm of chromosome 11.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_1/3	1	4	133	SYMBOL|EXTRACTED|GENE|GN	am	AM	73#75	11463752-1-0-14	In this study, we investigated the association between DNA variations in AM gene and the predisposition to hypertension.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_3/3	3	11	133	SYMBOL|EXTRACTED	am	AM	14#16	11463752-1-0-14	In NT, plasma AM concentrations were not significantly different between the genotypes.
11463752	2001	Hypertension	1524-4563	ALL_TEXT_3/3	3	12	133	SYMBOL|EXTRACTED|GENE|GN	am	AM	50#52	11463752-1-0-14	In conclusion, microsatellite DNA polymorphism of AM gene may be associated with the genetic predisposition to EH, although the gene expression is not likely to be affected by the genotypes.
11425413	2001	Lancet	0140-6736	TITLE	0	0	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	42#46		Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
11425413	2001	Lancet	0140-6736	ALL_TEXT_1/3	1	3	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	24#28		The recently identified NOD2 gene is a good positional and functional candidate gene since it is located in the region of linkage on chromosome 16q12, and activates nuclear factor (NF) kappaB in response to bacterial lipopolysaccharides.
11425413	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	4	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	46#50		Methods We sequenced the coding region of the NOD2 gene and genotyped an insertion polymorphism affecting the leucine-rich region of the protein product in 512 individuals with IBD from 309 German or British families, 369 German trios (ie, German patients with sporadic IBD and their unaffected parents), and 272 normal controls.
11425413	2001	Lancet	0140-6736	ALL_TEXT_3/3	3	9	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	45#49		Interpretation The insertion mutation in the NOD2 gene confers a substantially increased susceptibility to Crohn's disease but not to ulcerative colitis.
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	23#31		Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	3115	SYMBOL|GFAM|FN|DICTIONARY	hla dpb1	HLA-DPB1	56#64		History of infectious illness, EBV antibody titers, and HLA-DPB1 type have been compared in EBV(+ve) and EBV(-ve) cases.
11401923	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	3115	SYMBOL|DICTIONARY	hla dpb1	HLA-DPB1	82#90		Higher proportions of EBV(+ve) (43%) than EBV(-ve) (31%) cases typed positive for HLA-DPB1*0301, but this was not statistically significant; the association of infectious mononucleosis with EBV(+ve) cases was stronger in this HLA subgroup (OR, 17.1; 95%CI, 1.06-1177) than in other cases (OR, 1.24; 95% CI, 0.02-15.4).
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	4843	SYMBOL|GENE|GN|DICTIONARY	nos2	NOS2	64#68		We performed a mutational scanning of all 27 exons of the human NOS2 gene and linkage transmission disequilibrium testing of identified NOS2 polymorphisms in a Danish nationwide type 1 diabetes mellitus (IDDM) family collection.
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	4843	SYMBOL|DICTIONARY	nos2	NOS2	136#140		We performed a mutational scanning of all 27 exons of the human NOS2 gene and linkage transmission disequilibrium testing of identified NOS2 polymorphisms in a Danish nationwide type 1 diabetes mellitus (IDDM) family collection.
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	8	4843	SYMBOL|GENE|GN|DICTIONARY	nos2	NOS2	36#40		In conclusion, linkage of the human NOS2 gene to IDDM in a subset of patients supports a pathogenic role of nitric oxide in human IDDM.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	9	LONGTERM|DICTIONARY	n acetyltransferase 1	N-acetyltransferase 1	41#62		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	9	SYMBOL|()|DICTIONARY|EXTRACTED	nat1	NAT1	64#68	11422615-2-41-62	The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	10	SYMBOL|DICTIONARY	nat2	NAT2	71#75		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1543	LONGTERM|DICTIONARY	cytochrome p450 1a1	cytochrome P450 1A1	77#96		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1543	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1a1	CYP1A1	98#104	11422615-2-77-96	The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	107#113		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	1571	SYMBOL|DICTIONARY	cyp2e1	CYP2E1	115#121		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	123#151		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	153#158	11422615-2-123-151	The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	161#166		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	171#187		The frequency of polymorphisms involving N-acetyltransferase 1 (NAT1), NAT2, cytochrome P450 1A1 (CYP1A1), CYP2D6, CYP2E1, glutathione S-transferase M1 (GSTM1), GSTT1 and apolipoprotein E were compared in 219 white adults with sporadic colorectal cancer and 200 white controls attending for blood donation at a blood bank.
11422615	2001	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	19#24		Inheritance of the GSTT1 null genotype conferred a twofold risk of cancer that was statistically significant with crude data (OR 2.18; 95% CI 1.38-3.43), but not after adjustment for age (OR 1.91; 95% CI 0.99-3.70).
11340230	2001	Stroke	1524-4628	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	15#31		Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study.
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		APOE genotype is the most important genetic determinant of susceptibility to Alzheimer's disease, and it is also shown to be associated with the outcome after traumatic brain injury.
11340230	2001	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	30#46		We studied the association of apolipoprotein E polymorphism with the outcome after aneurysmal SAH.
11340230	2001	Stroke	1524-4628	METHODS	2	7	348	SYMBOL|DICTIONARY	apoe	APOE	53#57		Outcome was assessed with the Glasgow Outcome SCALE: APOE genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism.
11340230	2001	Stroke	1524-4628	RESULTS	3	8	348	SYMBOL|DICTIONARY	apoe	APOE	75#79		126 patients had aneurysmatic SAH, and detailed information on outcome and APOE genotype was available for 108 patients (86%).
11340230	2001	Stroke	1524-4628	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe	APOE	34#38		Sixteen (40%) of 40 patients with APOE epsilon4 had an unfavorable outcome compared with 13 (19%) of 68 without the APOE epsilon4 allele (OR 2.8, 95% CI 1.18 to 6.77).
11340230	2001	Stroke	1524-4628	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe	APOE	116#120		Sixteen (40%) of 40 patients with APOE epsilon4 had an unfavorable outcome compared with 13 (19%) of 68 without the APOE epsilon4 allele (OR 2.8, 95% CI 1.18 to 6.77).
11340230	2001	Stroke	1524-4628	CONCLUSIONS	4	11	348	SYMBOL|DICTIONARY	apoe	APOE	55#59		Our findings show a significant genetic association of APOE polymorphism with outcome after spontaneous aneurysmal SAH.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	LONGTERM|DICTIONARY|GENE|GA	mevalonate kinase	mevalonate kinase	20#37		Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	4598	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	39#42	11313768-0-20-37	Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	LONGTERM|DICTIONARY	mevalonate kinase	mevalonate kinase	188#205		Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|EXTRACTED|()	mk	MK	207#209	11313768-1-188-205	Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	4598	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	252#255	11313768-0-20-37	Mevalonic aciduria (MA) and hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) are two autosomal recessive inherited disorders both caused by a deficient activity of the enzyme mevalonate kinase (MK) resulting from mutations in the encoding MVK gene.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	2	4598	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	mvk	MVK	74#77	11313768-0-20-37	Thus far, disease-causing mutations only could be detected by analysis of MVK cDNA.
11313768	2001	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_2/3	2	3	4598	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mvk	MVK	54#57	11313768-0-20-37	We now describe the genomic organization of the human MVK gene.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	5888	SYMBOL|GENE|GN|DICTIONARY	rad51	RAD51	40#45		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	75#80		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	89#94		A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		BRCA1 and BRCA2 carriers are at increased risk for both breast and ovarian cancer, but estimates of lifetime risk vary widely, suggesting their penetrance is modified by other genetic and/or environmental factors.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	10#15		BRCA1 and BRCA2 carriers are at increased risk for both breast and ovarian cancer, but estimates of lifetime risk vary widely, suggesting their penetrance is modified by other genetic and/or environmental factors.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	4#9		The BRCA1 and BRCA2 proteins function in DNA repair in conjunction with RAD51.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	14#19		The BRCA1 and BRCA2 proteins function in DNA repair in conjunction with RAD51.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	5888	SYMBOL|DICTIONARY	rad51	RAD51	72#77		The BRCA1 and BRCA2 proteins function in DNA repair in conjunction with RAD51.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	5888	SYMBOL|DICTIONARY	rad51	RAD51	102#107		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	149#154		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	159#164		A preliminary report suggested that a single nucleotide polymorphism in the 5' untranslated region of RAD51 (135C/G) increases breast cancer risk in BRCA1 and BRCA2 carriers.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	96#101		To investigate this effect we studied 257 female Ashkenazi Jewish carriers of one of the common BRCA1 (185delAG, 5382insC) or BRCA2 (6174delT) mutations.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	126#131		To investigate this effect we studied 257 female Ashkenazi Jewish carriers of one of the common BRCA1 (185delAG, 5382insC) or BRCA2 (6174delT) mutations.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	6	5888	SYMBOL|DICTIONARY	rad51	RAD51	0#5		RAD51 genotyping was performed on all subjects.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	6#11		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	22#27		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	7	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	234#239		Among BRCA1 carriers, RAD51-135C frequency was similar in healthy and affected women [6.1% (3 of 49) and 9.9% (12 of 121), respectively], and RAD-135C did not influence age of cancer diagnosis [Hazard ratio (HR) = 1.18 for disease in RAD51-135C heterozygotes, not significant].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	12#17		However, in BRCA2 carriers, RAD51-135C heterozygote frequency in affected women was 17.4% (8 of 46) compared with 4.9% (2 of 41) in unaffected women (P = 0.07).
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	8	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	28#33		However, in BRCA2 carriers, RAD51-135C heterozygote frequency in affected women was 17.4% (8 of 46) compared with 4.9% (2 of 41) in unaffected women (P = 0.07).
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	9	675	SYMBOL|DICTIONARY	brca2	BRCA2	21#26		Survival analysis in BRCA2 carriers showed RAD51-135C increased risk of breast and/or ovarian cancer with an HR of 4.0 [95% confidence interval 1.6-9.8, P = 0.003].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	9	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	43#48		Survival analysis in BRCA2 carriers showed RAD51-135C increased risk of breast and/or ovarian cancer with an HR of 4.0 [95% confidence interval 1.6-9.8, P = 0.003].
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	675	SYMBOL|DICTIONARY	brca2	BRCA2	144#149		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	10	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	168#173		This effect was largely due to increased breast cancer risk with an HR of 3.46 (95% confidence interval 1.3-9.2, P = 0.01) for breast cancer in BRCA2 carriers who were RAD51-135C heterozygotes.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	11	5888	SYMBOL|DICTIONARY	rad51	RAD51	0#5		RAD51 status did not affect ovarian cancer risk.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	12	5888	SYMBOL|NUMBER|DICTIONARY	rad51	RAD51	19#24		These results show RAD51-135C is a clinically significant modifier of BRCA2 penetrance, specifically in raising breast cancer risk at younger ages.
11248061	2001	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	12	675	SYMBOL|DICTIONARY	brca2	BRCA2	70#75		These results show RAD51-135C is a clinically significant modifier of BRCA2 penetrance, specifically in raising breast cancer risk at younger ages.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	141#149		Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	143#151		In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	4	3117	SYMBOL|DICTIONARY	hla dqa1	HLA-DQA1	78#86		As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	110#114		Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	119#123		Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	128#132		Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	141#145		Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12.
11263767	2001	Arthritis Rheum.	0004-3591	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	37#45		Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	36#44		It is not known whether SE-negative HLA-DRB1 alleles influence the development of RA.
11263767	2001	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		This study examined the influence of SE-negative HLA-DR alleles (DRB1*X) on the development of RA in 3 different French populations.
11263767	2001	Arthritis Rheum.	0004-3591	METHODS	2	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1 alleles were defined by polymerase chain reaction with sequence-specific oligonucleotide hybridization or sequence-specific primers.
11263767	2001	Arthritis Rheum.	0004-3591	METHODS	2	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1 alleles *0103, *0402, *07, *08, *11 (except *1107), *12, and *13 have a neutral or negative P4 charge and are called DRB1*XP4n.
11263767	2001	Arthritis Rheum.	0004-3591	METHODS	2	6	3123	SYMBOL|DICTIONARY	drb1	DRB1	126#130		HLA-DRB1 alleles *0103, *0402, *07, *08, *11 (except *1107), *12, and *13 have a neutral or negative P4 charge and are called DRB1*XP4n.
11263767	2001	Arthritis Rheum.	0004-3591	METHODS	2	7	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16 have a positive P4 charge and are called DRB1*XP4p.
11263767	2001	Arthritis Rheum.	0004-3591	METHODS	2	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	107#111		HLA-DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16 have a positive P4 charge and are called DRB1*XP4p.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	32#36		Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	59#63		Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	175#179		Among the SE-negative subjects, DRB1 genotypes with 1 or 2 DRB1*XP4n alleles were significantly overrepresented in the control subjects compared with the RA patients, whereas DRB1*XP4p/XP4p genotypes were equally represented in the patients and controls.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		The DRB1*X allele polymorphism influences susceptibility to RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	12	3123	SYMBOL|DICTIONARY	drb1	DRB1	76#80		Alleles that have a neutral or negative electric charge in their P4 pocket (DRB1*XP4n), such as DRB1*0103, *0402, *07, *08, *11 (except *1107), *12, and *13, protect against RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	12	3123	SYMBOL|DICTIONARY	drb1	DRB1	96#100		Alleles that have a neutral or negative electric charge in their P4 pocket (DRB1*XP4n), such as DRB1*0103, *0402, *07, *08, *11 (except *1107), *12, and *13, protect against RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	13	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		Alleles that have a positive electric charge in their P4 pocket (DRB1*XP4p), such as DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16, have no influence on the predisposition to RA.
11263767	2001	Arthritis Rheum.	0004-3591	CONCLUSION	4	13	3123	SYMBOL|DICTIONARY	drb1	DRB1	85#89		Alleles that have a positive electric charge in their P4 pocket (DRB1*XP4p), such as DRB1*03, *0403, *0406, *0407, *0901, *1107, *14, *15, and *16, have no influence on the predisposition to RA.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	373156	LONGTERM|DICTIONARY	glutathione s transferase	glutathione S-transferase	40#65		This study was undertaken to examine if glutathione S-transferase (GST) M1, M3, P1, and T1 genotypes affected breast cancer risk in Finnish women.
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	81#86		When the genes were studied separately, the only significant finding was between GSTM1 null genotype and postmenopausal breast cancer risk (OR, 1.49; 95% CI, 1.03-2.15).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2947	SYMBOL|DICTIONARY	gstm3	GSTM3	106#111		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	150#155		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	261#266		Although only a moderate risk of breast cancer was seen for premenopausal women concurrently carrying the GSTM3*B allele containing genotypes and the GSTP1 Ile/ Ile genotype (OR, 2.07; 95% CI, 1.02-4.18), the risk rose steeply if they simultaneously lacked the GSTT1 gene (OR, 9.93, 95% CI, 1.10-90.0).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	125#130		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	137#142		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11303592	2001	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	156#161		A borderline significant increase in the risk of breast cancer was also seen for premenopausal women with the combination of GSTM1 null, GSTP1 Ile/Ile, and GSTT1 null genotypes (OR, 3.96; 95% CI, 0.99-15.8).
11357375	2001	Genetika	0016-6758	TITLE	0	0	847	LONGTERM|DICTIONARY	catalase	catalase	17#25		[Polymorphism of catalase and glutathione peroxidase genes in macrovascular complications in patients with non-insulin-dependent diabetes mellitus and hypertension].
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	100#108		Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	847	SYMBOL|()|DICTIONARY|EXTRACTED	cat	CAT	110#113	11357375-1-100-108	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11354633	2001	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	0#4		CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	41#92		In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	94#98	11354633-1-41-92	In order to investigate the incidence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and unclassified variants in chronic pulmonary disease in children and adults, we studied 20 patients with asthma, 19 with disseminated bronchiectasis (DB) of unknown aetiology, and 12 patients with chronic obstructive pulmonary disease (COPD), and compared the results to 52 subjects from the general Greek population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	43#47	11354633-1-41-92	Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	2	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	119#123	11354633-1-41-92	Analysis of the whole coding region of the CFTR gene and its flanking intronic regions revealed that the proportion of CFTR mutations was 45% in asthma (P<0.05), 26.3% in DB (P>0.05), 16.7% in COPD (P>0.05), compared to 15.4% in the general population.
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	41#45	11354633-1-41-92	The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	6	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	78#82	11354633-1-41-92	The study of the TGmTnM470 V polyvariant CFTR allele revealed the presence of CFTR function-modulating haplotypes TG13/T5/M470, TG11/T5/M470, TG12/T5/V470 and TG12/T7, combined with M470 or V470, in six asthma patients, four DB patients (P<0.01), and two COPD patients (P<0.05).
11354633	2001	Hum. Genet.	0340-6717	ALL_TEXT_3/3	3	7	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	45#49	11354633-1-41-92	These results confirm the involvement of the CFTR gene in asthma, DB and possibly in COPD.
11245417	2001	Cancer Res.	0008-5472	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	53#74		Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	TITLE	0	0	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	76#80	11245417-0-53-74	Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	13#34		Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	10	SYMBOL|()|DICTIONARY|EXTRACTED	nat2	NAT2	36#40	11245417-0-53-74	Mutations in N-acetyltransferase 2 (NAT2), a highly polymorphic enzyme involved in the metabolism of xenobiotics and carcinogens, may affect risk for colorectal cancer (CRC), especially among individuals with germ-line mutations in DNA mismatch repair genes.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	18#22	11245417-0-53-74	We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	4292	SYMBOL|DICTIONARY	hmlh1	hMLH1	105#110		We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	4436	SYMBOL|DICTIONARY	hmsh2	hMSH2	112#117		We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	2	5378	SYMBOL|DICTIONARY	hpms1	hPMS1	122#127		We determined the NAT2 genotypes and allele frequencies for 86 individuals with CRC who had mutations in hMLH1, hMSH2, or hPMS1.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	71#75	11245417-0-53-74	No significant difference in time to onset was observed between rapid (NAT2*4) and slow (NAT2*5, NAT2*6, and NAT2*7) acetylators.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	89#93	11245417-0-53-74	No significant difference in time to onset was observed between rapid (NAT2*4) and slow (NAT2*5, NAT2*6, and NAT2*7) acetylators.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	97#101	11245417-0-53-74	No significant difference in time to onset was observed between rapid (NAT2*4) and slow (NAT2*5, NAT2*6, and NAT2*7) acetylators.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	3	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	109#113	11245417-0-53-74	No significant difference in time to onset was observed between rapid (NAT2*4) and slow (NAT2*5, NAT2*6, and NAT2*7) acetylators.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	56#60	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	75#79	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	83#87	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	95#99	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	152#156	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	184#188	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	201#205	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	212#216	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	4	10	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	nat2	NAT2	396#400	11245417-0-53-74	However, when individuals were stratified separately by NAT2 polymorphism (NAT2*5, NAT2*6, and NAT2*7), those who were heterozygous at the mutant locus NAT2*7 after adjustment for the NAT2 mutant loci NAT2*5 and NAT2*6 had a significantly higher risk of CRC (hazard ratio, 2.96; P = 0.012) and all of the cancers (hazard ratio, 3.37; P = 0.00004) than individuals homozygous for wild type at the NAT2*7 allele.
11245417	2001	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	28#32	11245417-0-53-74	These findings suggest that NAT2 genotype may be an important factor in tumorigenesis of CRC and cancers related to hereditary nonpolyposis CRC among individuals with mismatch repair defects.
11331106	2001	Alcohol	0741-8329	TITLE	0	0	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	30#36		Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_1/3	1	1	1571	SYMBOL|()|DICTIONARY	cyp2e1	CYP2E1	21#27		Cytochrome P450IIEI (CYP2E1) is an ethanol-inducible enzyme.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_1/3	1	2	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	45#51		Recently, several novel polymorphisms in the CYP2E1 gene have been identified.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_2/3	2	4	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	149#155		The aim of this study was to investigate if this and other polymorphisms, at position -1019 [C(-1019)T], 4808 [G(4808)A], and 7668 [T(7668)A] of the CYP2E1 gene are associated with alcoholic pancreatitis.
11331106	2001	Alcohol	0741-8329	ALL_TEXT_3/3	3	8	1571	SYMBOL|GENE|GN|DICTIONARY	cyp2e1	CYP2E1	86#92		Therefore, our study results suggest to us that the polymorphisms investigated in the CYP2E1 gene are unlikely to be involved in the susceptibility and pathogenesis of alcoholic pancreatitis.
11159940	2001	Hum. Mol. Genet.	0964-6906	TITLE	0	0	8626	SYMBOL|DICTIONARY	p63	p63	85#88		Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	5818	SYMBOL|DICTIONARY	clped1	CLPED1	373#379		This constellation of clinical signs is unique, but some overlap can be recognized with other ectodermal dysplasia syndromes, for example ectrodactyly--ectodermal dysplasia--cleft lip/palate (EEC; OMIM 604292), limb--mammary syndrome (LMS; OMIM 603543), acro-dermato-ungual-lacrimal-tooth syndrome (ADULT; OMIM 103285) and recessive cleft lip/palate--ectodermal dysplasia (CLPED1; OMIM 225060).
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	8626	SYMBOL|GENE|GN|DICTIONARY	p63	p63	65#68		We have recently demonstrated that heterozygous mutations in the p63 gene are the major cause of EEC syndrome.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8626	SYMBOL|GENE|GN|DICTIONARY	p63	p63	101#104		Linkage studies suggest that the related LMS and ADULT syndromes are also caused by mutations in the p63 gene.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	8626	SYMBOL|GENE|GN|DICTIONARY	p63	p63	22#25		Thus, it appears that p63 gene mutations have highly pleiotropic effects.
11159940	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	6	8626	SYMBOL|DICTIONARY	p63	p63	17#20		We have analysed p63 in AEC syndrome patients and identified missense mutations in eight families.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	TITLE	0	0	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	0#5		CYP19 gene polymorphism in endometrial cancer patients.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	METHODS	2	3	1588	SYMBOL|DICTIONARY|GENE|GA	cyp19	CYP19	18#23		Here, we compared CYP19 (aromatase) gene polymorphism in 85 endometrial cancer patients and in 110 non-affected women.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	RESULTS	3	4	1588	SYMBOL|DICTIONARY	cyp19	CYP19	60#65		The genotypes containing the longest alleles (A6 and A7) of CYP19 were found to be over-represented in patients as compared to controls.
11216915	2001	J. Cancer Res. Clin. Oncol.	0171-5216	CONCLUSIONS	4	6	1588	SYMBOL|DICTIONARY	cyp19	CYP19	6#11		Thus, CYP19 polymorphism might be one of the genetic risk factors for endometrial cancer development.
11467490	2001	J Craniomaxillofac Surg	1010-5182	TITLE	0	0	2261	LONGTERM|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	44#79		New Zealand Maori family with the pro250arg fibroblast growth factor receptor 3 mutation associated with craniosynostosis.
11467490	2001	J Craniomaxillofac Surg	1010-5182	BACKGROUND	1	2	2261	LONGTERM|DICTIONARY	fibroblast growth factor receptor 3	fibroblast growth factor receptor 3	99#134		The aim of the study is to determine whether the family has the pro250arg mutation in the gene for fibroblast growth factor receptor 3 (FGFR3), a mutation found in patients with various types of craniosynostosis.
11467490	2001	J Craniomaxillofac Surg	1010-5182	BACKGROUND	1	2	2261	SYMBOL|()|DICTIONARY|EXTRACTED	fgfr3	FGFR3	136#141	11467490-2-99-134	The aim of the study is to determine whether the family has the pro250arg mutation in the gene for fibroblast growth factor receptor 3 (FGFR3), a mutation found in patients with various types of craniosynostosis.
11467490	2001	J Craniomaxillofac Surg	1010-5182	METHODS	3	6	2261	SYMBOL|DICTIONARY|EXTRACTED	fgfr3	FGFR3	127#132	11467490-2-99-134	Polymerase chain reaction, restriction-enzyme digestion and DNA sequencing was performed to identify the pro250arg mutation in FGFR3.
11467490	2001	J Craniomaxillofac Surg	1010-5182	RESULTS	4	7	2261	SYMBOL|DICTIONARY|EXTRACTED	fgfr3	FGFR3	69#74	11467490-2-99-134	Seven family members were heterozygous for the pro250arg mutation in FGFR3.
11159742	2001	Carcinogenesis	0143-3334	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	2944	SYMBOL|()|GENE|GN|DICTIONARY	gstm1	GSTM1	69#74		The null genetic polymorphism in the gene encoding the GST class mu (GSTM1) enzyme has been reported to be significantly elevated in endometriosis patients and may represent an endometriosis susceptibility allele.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	35#40		In this study the frequency of the GSTM1 null genotype was investigated in 84 cases of endometriosis, 293 cases of ovarian cancer and 219 controls.
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		The frequency of the GSTM1 null allele was not over-represented in the endometriosis patients (47.6%) compared with the controls (48.9%) (P = 0.898).
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	32#37		In the ovarian cancer group the GSTM1 null genotype was significantly elevated compared with controls (59.0 versus 48.9%, P = 0.025).
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	76#81		When stratified according to histological subtype a significantly increased GSTM1 null genotype was only observed for the endometrioid (65.4%, P = 0.013) and the combined endometrioid/clear cell ovarian cancers (67.0%, P = 0.004).
11159742	2001	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	21#26		We conclude that the GSTM1 null allele is not an endometriosis susceptibility allele, however, it may predispose endometriotic lesions to malignant transformation to endometrioid and clear cell ovarian cancer.
11136712	2001	Hum. Mol. Genet.	0964-6906	TITLE	0	0	8820	SYMBOL|DICTIONARY	hesx1	HESX1	13#18		Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	HESX1	272#277		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	278#283		We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	8820	SYMBOL|DICTIONARY	hesx1	HESX1	98#103		However, as most SOD/congenital hypopituitarism occurs sporadically, the possible contribution of HESX1 mutations to the aetiology of these cases is presently unclear.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	Hesx1	63#68		Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	8820	SYMBOL|DICTIONARY	hesx1	HESX1	156#161		Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	8820	SYMBOL|DICTIONARY	hesx1	HESX1	37#42		Accordingly, we have now scanned for HESX1 mutations in 228 patients with a broad spectrum of congenital pituitary defects, ranging in severity from isolated growth hormone deficiency to SOD with panhypopituitarism.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	8820	SYMBOL|DICTIONARY	hesx1	HESX1	26#31		Gel shift analysis of the HESX1-S170L mutant protein, which is encoded by the C509T mutated allele, indicated that a significant reduction in relative DNA binding activity results from this mutation.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	7	8820	SYMBOL|DICTIONARY	hesx1	HESX1	72#77		Segregation analysis of a haplotype spanning 6.1 cM, which contains the HESX1 locus, indicated that only one HESX1 mutation was present in the families containing the C509T and A541G mutations.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	7	8820	SYMBOL|DICTIONARY	hesx1	HESX1	109#114		Segregation analysis of a haplotype spanning 6.1 cM, which contains the HESX1 locus, indicated that only one HESX1 mutation was present in the families containing the C509T and A541G mutations.
11136712	2001	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	8820	SYMBOL|GENE|GN|DICTIONARY	hesx1	HESX1	171#176		These results demonstrate that some sporadic cases of the more common mild forms of pituitary hypoplasia have a genetic basis, resulting from heterozygous mutation of the HESX1 gene.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	TITLE	0	0	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	27#46		Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	TITLE	0	0	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	48#52		Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	47#66		Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	SYMBOL|()|DICTIONARY|EXTRACTED	pomc	POMC	68#72	11244459-1-47-66	Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	BACKGROUND	1	1	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	157#161	11244459-1-47-66	Although linkage studies strongly suggest that proopiomelanocortin (POMC) alterations could play a role in the genetic predisposition to obesity, systematic POMC mutational analysis did not completely confirm this hypothesis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	OBJECTIVES	2	2	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	43#47	11244459-1-47-66	To verify the presence of mutations of the POMC coding region in Italian children with very early onset obesity.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	SUBJECTS AND METHODS	3	5	5443	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pomc	POMC	4#8	11244459-1-47-66	The POMC gene coding region was screened using single-strand conformation polymorphism (SSCP) analysis.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	RESULTS	4	9	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	129#133	11244459-1-47-66	They showed leptin levels adjusted for BMI, gender and pubertal stage significantly higher than obese subjects homozyous for the POMC wild-type allele.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	CONCLUSIONS	5	10	5443	LONGTERM|DICTIONARY	proopiomelanocortin	proopiomelanocortin	89#108		Mutations in codons 7 and 9 of the signal peptide may alter the translocation of the pre-proopiomelanocortin into the endoplasmic reticulum and, therefore, can be implicated in obesity.
11244459	2001	Int. J. Obes. Relat. Metab. Disord.	-	CONCLUSIONS	5	11	5443	SYMBOL|DICTIONARY|EXTRACTED	pomc	POMC	176#180	11244459-1-47-66	Although further studies are required, the polymorphism between position 6997 and 6998 may represent one of the genetic variations that explain the linkage between obesity and POMC.
11244489	2001	Mol. Psychiatry	1359-4184	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	27#54		Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	14#41		In particular tumor necrosis factor alpha (TNFalpha), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	4	7124	SYMBOL|EXTRACTED|()	tnfalpha	TNFalpha	43#51	11244489-4-14-41	In particular tumor necrosis factor alpha (TNFalpha), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	5	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	10#18	11244489-4-14-41	Moreover, TNFalpha gene is located on the small arm of chromosome 6 (6p21.1-21.3), a locus associated with genetic susceptibility to schizophrenia.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	6	7124	SYMBOL|EXTRACTED|GENE|GN	tnfalpha	TNFalpha	38#46	11244489-4-14-41	We studied the distribution of -G308A TNFalpha gene polymorphism in 84 schizophrenic patients and in 138 healthy volunteers.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	7	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	59#67	11244489-4-14-41	This biallelic base exchange polymorphism directly affects TNFalpha plasma levels.
11244489	2001	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	11	7124	SYMBOL|EXTRACTED	tnfalpha	TNFalpha	39#47	11244489-4-14-41	These data suggest a potential role of TNFalpha as a candidate gene for susceptibility to schizophrenia and suggest that immune dysregulation in schizophrenic patients could also have a genetic component.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA DRB1	0#8		HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11186891	2001	Am. J. Med. Genet.	0148-7299	TITLE	0	0	1080	LONGTERM|GENE|GN|DICTIONARY	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	66#117		Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	31#82		More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	84#88	11186891-1-31-82	More than 900 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been reported to the cystic fibrosis (CF) consortium.
11186891	2001	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	7	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	55#59	11186891-1-31-82	Five patients were compound heterozygotes for a second CFTR mutation: two cases (one family) were N1303K/S1235R and three unrelated cases were deltaF508/S1235R.
11117918	2000	Lancet	0140-6736	ALL_TEXT_1/3	1	1	847	LONGTERM|DICTIONARY	catalase	catalase	42#50		Partial or near-total lack of erythrocyte catalase activity is a rare condition, generally thought to be benign.
11044587	2000	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|DICTIONARY	5 htt	5-HTT	110#115		The role of the deletion/insertion polymorphism within the promoter region of the serotonin transporter gene (5-HTT) is under discussion as a potential genetic risk factor for Alzheimers's disease (AD).
11044587	2000	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	5	6532	SYMBOL|GENE|GN|DICTIONARY	5 htt	5-HTT	118#123		However, given the reported negative findings, we are presently trying to identify diagnostic subgroups for which the 5-HTT promoter polymorphism represents a susceptibility locus.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	55#59		Lung disease associated with the IVS8 5T allele of the CFTR gene.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY	cftr	CFTR	87#91		Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	65#69		The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	166#170		The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	5	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	120#124		One patient's genotype is 5T-TG12-M470V/5T-TG12-M470V, and the other is DeltaF508/5T-TG12-M470V; full sequencing of the CFTR gene revealed no other mutation on the same allele as the 5T variant.
11069835	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	9	1080	SYMBOL|GENE|GN|DICTIONARY	cftr	CFTR	159#163		These data suggest that the 5T polythymidine tract sequence on specific haplotype backgrounds (TG12 and M470V) may cause a low level of full-length functional CFTR protein and CF-like lung disease.
11079451	2001	J. Endocrinol. Invest.	0391-4097	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	Androgen receptor	0#17		Androgen receptor polymorphisms and mutations in male infertility.
11079451	2001	J. Endocrinol. Invest.	0391-4097	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	87#104		To determine the contribution of genetic aberrations to male infertility, the X-linked androgen receptor (AR) gene was examined for mutations and polymorphisms in a large cohort of infertile men.
10993992	2000	Neurology	0028-3878	TITLE	0	0	1471	LONGTERM|GENE|GN|DICTIONARY	cystatin c	cystatin C	22#32		A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease.
10993992	2000	Neurology	0028-3878	OBJECTIVE	1	1	1471	LONGTERM|GENE|GN|DICTIONARY	cystatin c	cystatin C	59#69		To investigate whether or not a coding polymorphism in the cystatin C gene (CST3) contributes risk for AD.
10993992	2000	Neurology	0028-3878	OBJECTIVE	1	1	1471	SYMBOL|()|DICTIONARY|EXTRACTED	cst3	CST3	76#80	10993992-1-59-69	To investigate whether or not a coding polymorphism in the cystatin C gene (CST3) contributes risk for AD.
10993992	2000	Neurology	0028-3878	RESULTS	3	3	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	69#73	10993992-1-59-69	The authors find a signficant interaction between the GG genotype of CST3 and age/age of onset on risk for AD, such that in the over-80 age group the GG genotype contributes two-fold increased risk for the disease.
10993992	2000	Neurology	0028-3878	RESULTS	3	4	348	SYMBOL|DICTIONARY	apoe	APOE	56#60		The authors also see a trend toward interaction between APOE epsilon4-carrying genotype and age/age of onset in this dataset, but in the case of APOE the risk decreases with age.
10993992	2000	Neurology	0028-3878	RESULTS	3	4	348	SYMBOL|DICTIONARY	apoe	APOE	145#149		The authors also see a trend toward interaction between APOE epsilon4-carrying genotype and age/age of onset in this dataset, but in the case of APOE the risk decreases with age.
10993992	2000	Neurology	0028-3878	RESULTS	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	111#115		Analysis of only the community-based cases versus controls reveals a significant three-way interaction between APOE, CST3 and age/age of onset.
10993992	2000	Neurology	0028-3878	RESULTS	3	5	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	117#121	10993992-1-59-69	Analysis of only the community-based cases versus controls reveals a significant three-way interaction between APOE, CST3 and age/age of onset.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	6	348	SYMBOL|DICTIONARY	apoe	APOE	47#51		The reduced or absent risk for AD conferred by APOE in older populations has been well reported in the literature, prompting the suggestion that additional genetic risk factors confer risk for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	348	SYMBOL|DICTIONARY	apoe	APOE	48#52		In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	57#61	10993992-1-59-69	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10993992	2000	Neurology	0028-3878	CONCLUSION	4	7	1471	SYMBOL|DICTIONARY|EXTRACTED	cst3	CST3	119#123	10993992-1-59-69	In the author's dataset the opposite effects of APOE and CST3 genotype on risk for AD with increasing age suggest that CST3 is one of the risk factors for later-onset AD.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	LONGTERM|DICTIONARY|GENE|GA	cytochrome p450 1a2	cytochrome P450 1A2	33#52		A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	TITLE	0	0	1544	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	54#60	10889552-0-33-52	A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	3	1544	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	35#41	10889552-0-33-52	Smoking is a potent inducer of the CYP1A2 enzyme, and is known to cause a significant decrease in plasma concentrations of some antipsychotics.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	4	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	57#63	10889552-0-33-52	Therefore, person-to-person differences in the extent of CYP1A2 induction by smoking may contribute to risk for the development of TD.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	5	1544	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	68#74	10889552-0-33-52	Recently, a (C-->A) genetic polymorphism in the first intron of the CYP1A2 gene was found to be associated with variation in CYP1A2 inducibility in healthy volunteer smokers.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	5	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	125#131	10889552-0-33-52	Recently, a (C-->A) genetic polymorphism in the first intron of the CYP1A2 gene was found to be associated with variation in CYP1A2 inducibility in healthy volunteer smokers.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	6	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	89#95	10889552-0-33-52	The aim of this study was to test the clinical importance of the (C-->A) polymorphism in CYP1A2 in relation to TD severity.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	7	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	190#196	10889552-0-33-52	A total of 85 patients with schizophrenia were assessed for TD severity using the Abnormal Involuntary Movement Scale (AIMS), and were subsequently genotyped for the (C-->A) polymorphism in CYP1A2.
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_2/3	2	8	1544	SYMBOL|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	81#87	10889552-0-33-52	The mean AIMS score in patients with the (C/C) genotype (associated with reduced CYP1A2 inducibility) was 2.7- and 3.4-fold greater than in those with the (A/C) or (A/A) genotype, respectively (F[2,82] = 7.4, P = 0.0007).
10889552	2000	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	12	1544	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1a2	CYP1A2	64#70	10889552-0-33-52	These data suggest that the (C-->A) genetic polymorphism in the CYP1A2 gene may serve as a genetic risk factor for the development of TD in patients with schizophrenia.
10835642	2000	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	6	368	SYMBOL|()|DICTIONARY	abcc6	ABCC6	204#209		Here we report the exclusion of five of these genes and the identification of the first mutations responsible for the development of PXE in a gene encoding a protein associated with multidrug resistance (ABCC6).
10800171	2000	Haematologica	0390-6078	DESIGN AND METHODS	2	4	2157	SYMBOL|DICTIONARY	fviii	FVIII	33#38		Following pedigree analysis, the FVIII inversion was first examined in severe hemophilia A patients by polymerase chain reaction (PCR) analysis.
10800171	2000	Haematologica	0390-6078	DESIGN AND METHODS	2	6	2157	SYMBOL|DICTIONARY	fviii	FVIII	53#58		In uninformative cases, we initiated analysis of the FVIII or FIX gene coding region by conformation sensitive gel electrophoresis and DNA sequencing to identify the mutation responsible for the disease.
10800171	2000	Haematologica	0390-6078	DESIGN AND METHODS	2	6	2158	SYMBOL|GENE|GN|DICTIONARY	fix	FIX	62#65		In uninformative cases, we initiated analysis of the FVIII or FIX gene coding region by conformation sensitive gel electrophoresis and DNA sequencing to identify the mutation responsible for the disease.
10800171	2000	Haematologica	0390-6078	RESULTS	3	7	2157	SYMBOL|GENE|GN|DICTIONARY	fviii	FVIII	4#9		The FVIII gene inversion was present in 16 of the 32 patients (50%) affected by severe hemophilia A and was informative for 44 females.
10822820	2000	Genetika	0016-6758	TITLE	0	0	3578	SYMBOL|GENE|GN|DICTIONARY	il 9	il-9	73#77		[Analysis of the association between the T113M polymorphism of the human il-9 gene and bronchial asthma].
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	LONGTERM|DICTIONARY|GENE|GA	interleukin 9	interleukin 9	83#96		The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
10822820	2000	Genetika	0016-6758	ALL_TEXT_1/3	1	1	3578	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il9	IL9	98#101	10822820-1-83-96	The T113M polymorphism resulting from the missense mutation in exon 5 of the human interleukin 9 (IL9) gene was tested for association with bronchial asthma (BA).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2130	SYMBOL|GENE|GN|DICTIONARY	ews	EWS	183#186		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	1	2313	SYMBOL|DICTIONARY	fli1	FLI1	257#261		The Ewing's sarcoma (ES) family of tumors, including peripheral neuroectodermal tumor (PNET), is defined genetically by specific chromosomal translocations resulting in fusion of the EWS gene with a member of the ETS family of transcription factors, either FLI1 (90-95%) or ERG (5-10%).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	2	2130	SYMBOL|DICTIONARY	ews	EWS	192#195		A second level of molecular genetic heterogeneity stems from the variation in the location of the translocation breakpoints, resulting in the inclusion of different combinations of exons from EWS and FLI1 (or ERG) in the fusion products.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	2	2313	SYMBOL|DICTIONARY	fli1	FLI1	200#204		A second level of molecular genetic heterogeneity stems from the variation in the location of the translocation breakpoints, resulting in the inclusion of different combinations of exons from EWS and FLI1 (or ERG) in the fusion products.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	38#41		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	102#105		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	57534	SYMBOL|DICTIONARY	mib1	MIB1	177#181		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	3480	SYMBOL|EXTRACTED	igf 1r	IGF-1R	240#246	10702401-4-228-256	In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	7	3480	SYMBOL|EXTRACTED	igf 1r	IGF-1R	122#128	10702401-4-228-256	Logistic regression analysis suggests that this association was secondary to the association of type 1 EWS-FLI1 and lower IGF-1R expression (P = 0.04).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	8	2130	SYMBOL|DICTIONARY	ews	EWS	22#25		Comparing EWS-FLI1 to EWS-ERG cases, Ki-67 proliferative index was higher in the latter (P = 0.01, Mann-Whitney test; P = 0.02, Fisher's exact test), but there was no significant difference in IGF-1R.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	8	3480	SYMBOL|EXTRACTED	igf 1r	IGF-1R	193#199	10702401-4-228-256	Comparing EWS-FLI1 to EWS-ERG cases, Ki-67 proliferative index was higher in the latter (P = 0.01, Mann-Whitney test; P = 0.02, Fisher's exact test), but there was no significant difference in IGF-1R.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	10	3480	SYMBOL|EXTRACTED	igf 1r	IGF-1R	204#210	10702401-4-228-256	Our results suggest that clinical and functional differences between alternative forms of EWS-FLI1 are paralleled by differences in proliferative rate, possibly mediated by differential regulation of the IGF-1R pathway.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	OBJECTIVE	1	1	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 ar	beta 2-AR	35#44		To analyze the association between beta 2-AR genetic polymorphism and asthma in the people of the Han nationality of northern China.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	METHODS	2	2	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 ar	beta 2-AR	86#95		Allele Specific-PCR techniques were used to determine 16, 27 and 164 locus alleles of beta 2-AR genetic polymorphisms in 58 unrelated patients with asthma and 89 healthy controls from the people of the Han nationality of northern China.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	3	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	43#52		(1) The distribution frequency of genotype beta 2-AR 16 loci: Arg/Arg genotype accounts for 13%, Arg/Gly 76% and Gly/Gly 11%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	4	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	4#13		The beta 2-AR 27 loci: Gln/Gln genotype accounts for 36%, Gln/Glu 55% and Glu/Glu 9%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	5	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	4#13		The beta 2-AR 164 loci: Thr/Thr genotype accounts for 30%, Thr/Ile 53% and Ile/Ile 17%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	6	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	30#39		(2) The frequency of genotype beta 2-AR 16 loci in asthmatics: Arg/Arg genotype accounts for 24%, Arg/Gly 45% and Gly/Gly 31%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	8	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	26#35		The frequency of genotype beta 2-AR 27 loci in asthmatics: Gln/Gln genotype accounts for 34%, Gln/Glu 56% and Glu/Glu 10%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	10	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	26#35		The frequency of genotype beta 2-AR 164 loci in asthmatics: Thr/Thr genotype accounts for 10%, Thr/Ile 83% and Ile/Ile 7%.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	RESULTS	3	12	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	36#45		In addition, our study reveals that beta 2-AR 16 locus genetic polymorphism is in association with asthmatic severity.
11778498	2002	Zhonghua Jie He He Hu Xi Za Zhi	1001-0939	CONCLUSIONS	4	13	154	SYMBOL|NUMBER|DICTIONARY	beta 2 ar	beta 2-AR	27#36		These results suggest that beta 2-AR 16 locus genetic polymorphism is correlated with asthma severity in the people of the Han nationality of northern China.
10680585	2000	Life Sci.	0024-3205	TITLE	0	0	5368	LONGTERM|DICTIONARY	orphanin fq	Orphanin FQ	0#11		Orphanin FQ/nociceptin inhibits morphine withdrawal.
10680585	2000	Life Sci.	0024-3205	TITLE	0	0	5368	LONGTERM|DICTIONARY	nociceptin	nociceptin	12#22		Orphanin FQ/nociceptin inhibits morphine withdrawal.
10680585	2000	Life Sci.	0024-3205	ALL_TEXT_1/3	1	1	5368	LONGTERM|DICTIONARY	orphanin fq	orphanin FQ	17#28		The influence of orphanin FQ/nociceptin (OFQ/N) on the morphine-withdrawal symptom was investigated.
10680585	2000	Life Sci.	0024-3205	ALL_TEXT_1/3	1	1	5368	LONGTERM|DICTIONARY	nociceptin	nociceptin	29#39		The influence of orphanin FQ/nociceptin (OFQ/N) on the morphine-withdrawal symptom was investigated.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	7356	SYMBOL|DICTIONARY	cc16	CC16	27#31		Association between plasma CC16 levels, the A38G polymorphism, and asthma.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	7356	SYMBOL|()|GENE|GN|DICTIONARY	cc16	CC16	69#73		The effect of the A38G polymorphism on Clara cell secretory protein (CC16) gene expression and asthma was investigated by measuring plasma CC16 levels in 100 asthmatic and nonasthmatic children.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	7356	SYMBOL|DICTIONARY	cc16	CC16	139#143		The effect of the A38G polymorphism on Clara cell secretory protein (CC16) gene expression and asthma was investigated by measuring plasma CC16 levels in 100 asthmatic and nonasthmatic children.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	7356	SYMBOL|DICTIONARY	cc16	CC16	62#66		Restriction digestion determined the A38G genotype and plasma CC16 levels were analyzed using a sensitive latex immunoassay.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	3	7356	SYMBOL|DICTIONARY	cc16	CC16	33#37		Asthmatics had lower mean plasma CC16 levels adjusted for age and gender (7.96 microg/L; 95% confidence interval [CI] = 6.79 to 9.31) than nonasthmatic subjects (9.98 microg/L; 95% CI = 8.83 to 11.26) (p = 0.006).
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	4	7356	SYMBOL|DICTIONARY	cc16	CC16	32#36		Similarly adjusted, mean plasma CC16 levels were also lower in 38A/38A (6.79 microg/L; 95% CI = 4.56 to 9.02) than 38G/38G subjects (10.01 microg/L; 95% CI = 7.90 to 12.12; p = 0.003).
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	6	7356	SYMBOL|DICTIONARY	cc16	CC16	53#57		However, this was reduced when corrected from plasma CC16 level, suggesting that the odds of asthma was largely mediated through altered plasma CC16 levels.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	6	7356	SYMBOL|DICTIONARY	cc16	CC16	144#148		However, this was reduced when corrected from plasma CC16 level, suggesting that the odds of asthma was largely mediated through altered plasma CC16 levels.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	7	7356	SYMBOL|DICTIONARY	cc16	CC16	52#56		The 38A sequence was associated with reduced plasma CC16 levels and individuals with lower plasma CC16 levels were more likely to have asthma.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	7	7356	SYMBOL|DICTIONARY	cc16	CC16	98#102		The 38A sequence was associated with reduced plasma CC16 levels and individuals with lower plasma CC16 levels were more likely to have asthma.
10619808	2000	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	8	7356	SYMBOL|GENE|GN|DICTIONARY	cc16	CC16	61#65		This provides further evidence for a significant role of the CC16 gene, 38A allele in the development of asthma.
11043512	2000	J. Hum. Genet.	1434-5161	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	87#116		Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene.
11043512	2000	J. Hum. Genet.	1434-5161	TITLE	0	0	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	118#121	11043512-0-87-116	Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	92#121		Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	123#126	11043512-0-87-116	Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-converting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	46#49	11043512-0-87-116	We investigated a possible association of the ACE polymorphism with essential hypertension in a total of 263 cases/controls from among the elderly (age, over 70 years) and middle-aged (age between 30 and 60 years) Japanese population.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	49#52	11043512-0-87-116	These data suggest that genetic variation at the ACE locus may be associated with some determinants for blood pressure in elderly persons, and imply the involvement of the ACE insertion/deletion polymorphism in the etiology of age-related essential hypertension in the Japanese population.
11043512	2000	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	172#175	11043512-0-87-116	These data suggest that genetic variation at the ACE locus may be associated with some determinants for blood pressure in elderly persons, and imply the involvement of the ACE insertion/deletion polymorphism in the etiology of age-related essential hypertension in the Japanese population.
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	185	SYMBOL|GENE|GN|DICTIONARY	at1r	AT1R	25#29		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
10670188	2000	Minerva Cardioangiol	0026-4725	TITLE	0	0	1636	SYMBOL|DICTIONARY	ace	ACE	51#54		[The C1166 allele of the AT1R gene associated with ACE DD phenotype increases the risk for deep venous thrombosis].
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	TITLE	0	0	5311	SYMBOL|GENE|GN|DICTIONARY	pkd2	PKD2	25#29		Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease.
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_1/3	1	1	5311	SYMBOL|DICTIONARY	pkd2	PKD2	127#131		It is estimated that approximately 15% of families with autosomal dominant polycystic kidney disease (ADPKD) have mutations in PKD2.
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_3/3	3	10	5311	SYMBOL|DICTIONARY	pkd2	PKD2	115#119		"The study also defined a novel intragenic polymorphism in exon 1 that will be useful in analyzing ""second hits"" in PKD2."
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_3/3	3	11	5311	SYMBOL|DICTIONARY	pkd2	PKD2	119#123		Finally, the study demonstrates that there are reduced levels of normal polycystin-2 protein in lymphoblast lines from PKD2-affected individuals and that truncated mutant polycystin-2 cannot be detected in patient lymphoblasts, suggesting that the latter may be unstable in at least some tissues.
10541293	1999	J. Am. Soc. Nephrol.	1046-6673	ALL_TEXT_3/3	3	12	5311	SYMBOL|DICTIONARY	pkd2	PKD2	89#93		The mutations described will serve as critical reagents for future functional studies in PKD2.
10532948	1999	Circ. Res.	1524-4571	ALL_TEXT_2/3	2	3	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	54#59		Our group recently linked the disease to mutations in SCN5A, the gene encoding for the alpha subunit of the cardiac sodium channel.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2	LONGTERM|DNA|NN|DICTIONARY	alpha 2 macroglobulin	alpha(2) macroglobulin	23#45		Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	LONGTERM|GENE|GN|DICTIONARY	alpha 2 macroglobulin	alpha(2) macroglobulin	83#105		An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
10527839	1999	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2	SYMBOL|EXTRACTED|()	a2m	A2M	112#115	10527839-1-83-105	An association between a five-base-pair deletion/insertion DNA polymorphism at the alpha(2) macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD) has been recently described.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_2/3	2	6	23418	SYMBOL|DICTIONARY	crb1	CRB1	92#96		This protein is homologous to the Drosophila melanogaster protein crumbs (CRB), and denoted CRB1 (crumbs homologue 1).
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	7	23418	SYMBOL|DICTIONARY	crb1	CRB1	206#210		In ten unrelated RP patients with preserved para-arteriolar RPE, we identified a homozygous AluY insertion disrupting the ORF, five homozygous missense mutations and four compound heterozygous mutations in CRB1.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	8	23418	SYMBOL|DICTIONARY	crb1	CRB1	42#46		The similarity to CRB suggests a role for CRB1 in cell-cell interaction and possibly in the maintenance of cell polarity in the retina.
10508521	1999	Nat. Genet.	1061-4036	ALL_TEXT_3/3	3	9	23418	SYMBOL|DICTIONARY	crb1	CRB1	70#74		The distinct RPE abnormalities observed in RP12 patients suggest that CRB1 mutations trigger a novel mechanism of photoreceptor degeneration.
10533957	1999	Cardiovasc. Pathol.	1054-8807	ALL_TEXT_2/3	2	10	4023	LONGTERM|DICTIONARY	lipoprotein lipase	lipoprotein lipase	82#100		Potentiation of lipolysis by intravenous injections of phospholipase A2 (PLA2) or lipoprotein lipase (LPL) to rats treated with ISO substantially augmented MN.
10533957	1999	Cardiovasc. Pathol.	1054-8807	ALL_TEXT_2/3	2	10	4023	SYMBOL|()|DICTIONARY|EXTRACTED	lpl	LPL	102#105	10533957-10-82-100	Potentiation of lipolysis by intravenous injections of phospholipase A2 (PLA2) or lipoprotein lipase (LPL) to rats treated with ISO substantially augmented MN.
10488956	1999	Atherosclerosis	0021-9150	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	29#64		The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I-converting enzyme	85#116		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	118#121	10488956-1-85-116	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	187#202		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY|GENE|GA	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	228#263		We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	265#270	10488956-1-228-263	We analyzed the evolution with age of the frequencies of the I/D polymorphism of the angiotensin I-converting enzyme (ACE), a1166c of the angiotensin II AT1 receptor (AT1R), M235T of the angiotensinogen (AGT) and A225V of their methylenetetrahydrofolate reductase (MTHFR) gene in a healthy (H) population and the subsequent comparison to age- and sex-matched groups of myocardial infarction (MI) subjects.
10488956	1999	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	3	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	72#77	10488956-1-228-263	The evolution with age showed that the AGT M allele (P < 0.001) and the MTHFR V allele (P < 0.05) frequency decreased with age in H men.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	20#23		Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_1/3	1	2	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	26#29	10459349-1-0-19	Genetic alteration of the NF1 gene on 17q11.2 is the disease.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	5	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	86#89	10459349-1-0-19	In this study, we examined 14 such tumors from 10 NF1-patients for allele loss of the NF1 gene (LOH: loss of heterozygosity) using four intragenic polymorphic markers.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	7	4763	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nf1	NF1	99#102	10459349-1-0-19	This finding suggests that loss of the second allele, and thus inactivation of both alleles of the NF1 gene, is associated with the development of plexiform neurofibromas.
10459349	1999	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	8	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	68#72		The 14 plexiform neufibromas were also examined for mutation in the TP53 gene by screening exons 5 through 8 using temperature gradient gel electrophoresis.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	66#69		Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	3	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	151#154		To study the role of the major known target of cannabinoids in the CNS, the CB1 cannabinoid receptor, we have produced a mouse strain with a disrupted CB1 gene.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	71#74		Thus, most, but not all, CNS effects of Delta9-THC are mediated by the CB1 receptor.
10213916	1999	Neuroimmunomodulation	1021-7401	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	1	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		Urocortin, a newly isolated 40-amino-acid mammalian peptide homologous to corticotropin-releasing hormone (CRH), activates both CRH type 1 and 2 receptors, but may be an endogenous ligand for CRH receptor type 2.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	1	1392	LONGTERM|DICTIONARY	corticotropin releasing hormone	corticotropin-releasing hormone	74#105		Urocortin, a newly isolated 40-amino-acid mammalian peptide homologous to corticotropin-releasing hormone (CRH), activates both CRH type 1 and 2 receptors, but may be an endogenous ligand for CRH receptor type 2.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	1	1392	SYMBOL|()|DICTIONARY|EXTRACTED	crh	CRH	107#110	10213916-1-74-105	Urocortin, a newly isolated 40-amino-acid mammalian peptide homologous to corticotropin-releasing hormone (CRH), activates both CRH type 1 and 2 receptors, but may be an endogenous ligand for CRH receptor type 2.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	1	1392	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	crh	CRH	128#131	10213916-1-74-105	Urocortin, a newly isolated 40-amino-acid mammalian peptide homologous to corticotropin-releasing hormone (CRH), activates both CRH type 1 and 2 receptors, but may be an endogenous ligand for CRH receptor type 2.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	1	1392	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	crh	CRH	192#195	10213916-1-74-105	Urocortin, a newly isolated 40-amino-acid mammalian peptide homologous to corticotropin-releasing hormone (CRH), activates both CRH type 1 and 2 receptors, but may be an endogenous ligand for CRH receptor type 2.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	2	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		Urocortin given systemically inhibited heat-induced paw edema in the rat, and was therefore ascribed anti-inflammatory properties.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	3	7349	LONGTERM|DICTIONARY	urocortin	urocortin	27#36		We examined the effects of urocortin in the carrageenin-induced subcutaneous inflammation model.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_1/3	1	4	7349	LONGTERM|NUMBER|DICTIONARY	urocortin	urocortin	23#32		Rats were treated with urocortin 200 (n = 6) or 20 nmol/kg (n = 6); inflammatory exudates were reduced by approximately 30% compared to controls (n = 7) at both doses.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	5	7349	LONGTERM|DICTIONARY	urocortin	urocortin	28#37		However, since subcutaneous urocortin has been shown to reduce arterial blood pressure, we tested the hypothesis that its antiedema and antiextravasatory effects were secondary to arterial hypotension.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	6	7349	LONGTERM|DICTIONARY	urocortin	urocortin	47#56		Therefore, we examined the parallel effects of urocortin- and hydralazine-induced hypotension on acute inflammation induced by carrageenin in the rat.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_2/3	2	7	7349	LONGTERM|DICTIONARY	urocortin	urocortin	96#105		Rats were treated with subcutaneous carrageenin and control injections (n = 8), carrageenin and urocortin (20 nmol/kg, n = 9), or carrageenin and intraperitoneal hydralazine (10 mg/kg, n = 8).
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	10	7349	LONGTERM|DICTIONARY	urocortin	urocortin	129#138		Mean exudate volumes were reduced from 4.8 +/- 0.5 ml (controls) to 2.4 +/- 0.3 ml (p = 0.004) and 2.9 +/- 0.6 ml (p = 0.007) in urocortin- and hydralazine-treated animals, respectively.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	11	7349	LONGTERM|DICTIONARY	urocortin	Urocortin	0#9		Urocortin and hydralazine both produced a significant fall in blood pressure compared to controls, with mean arterial pressure 2 h after carrageenin injection falling to 51.0 +/- 4.1 (p < 0.001) and 34.6 +/- 4.6 (p < 0.001) vs. 92.9 +/- 3.7 mm Hg in controls, respectively.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	13	7349	LONGTERM|DICTIONARY	urocortin	urocortin	24#33		As both hydralazine and urocortin lowered blood pressure and inflammatory exudate volume, we suggest that the anti-inflammatory effects of urocortin and related neuropeptides may be nonspecific, acting through hypotension rather than through direct anti-inflammatory mechanisms.
10213916	1999	Neuroimmunomodulation	1021-7401	ALL_TEXT_3/3	3	13	7349	LONGTERM|DICTIONARY	urocortin	urocortin	139#148		As both hydralazine and urocortin lowered blood pressure and inflammatory exudate volume, we suggest that the anti-inflammatory effects of urocortin and related neuropeptides may be nonspecific, acting through hypotension rather than through direct anti-inflammatory mechanisms.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	5080	SYMBOL|NUMBER|DICTIONARY	pax6	PAX6	23#27		Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5080	SYMBOL|DICTIONARY	pax6	PAX6	44#48		Mutations in the developmental control gene PAX6 have been shown to be the genetic cause of aniridia, which is a severe panocular eye disease characterised by iris hypoplasia.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	3	5080	SYMBOL|DICTIONARY	pax6	PAX6	117#121		Here we describe a mutational analysis of 27 Danish patients using a dideoxy fingerprinting method, which identified PAX6 mutations in 18 individuals with aniridia.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_3/3	3	8	5080	SYMBOL|DICTIONARY	pax6	PAX6	45#49		We also describe a third alternative spliced PAX6 isoform in which two of the four missense mutations would be spliced out.
10234503	1999	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_3/3	3	9	5080	SYMBOL|DICTIONARY	pax6	PAX6	58#62		Our observations support the concept of dosage effects of PAX6 mutations as well as presenting evidence for variable expressivity and gonadal mosaicism.
10091612	1999	Mov. Disord.	0885-3185	TITLE	0	0	4129	LONGTERM|DICTIONARY|GENE|GA	monoamine oxidase b	monoamine oxidase B	18#37		Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
10091612	1999	Mov. Disord.	0885-3185	TITLE	0	0	4129	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	39#43	10091612-0-18-37	Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	4129	LONGTERM|GENE|GN|DICTIONARY	monoamine oxidase b	monoamine oxidase B	4#23		The monoamine oxidase B gene (MAOB; Xp15.21-4) is a candidate gene for Parkinson's disease (PD) given its role in dopamine metabolism and its possible role in the activation of neurotoxins.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	3	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	125#129	10091612-0-18-37	Genomic DNA was extracted from venous blood and polymerase chain reaction was used to amplify the appropriate regions of the MAOB gene.
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	7	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	168#172	10091612-0-18-37	After statistical adjustment for potential confounders using a logistic regression analysis, the (GT) repeat alleles > or =188 base pairs in the intron 2 marker of the MAOB gene were significantly associated with PD (OR = 4.60; p<0.00005; 95% CI = 1.97-10.77).
10091612	1999	Mov. Disord.	0885-3185	ALL_TEXT_3/3	3	9	4129	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	maob	MAOB	33#37	10091612-0-18-37	The GT repeat in intron 2 of the MAOB gene is a powerful marker for PD in this large Australian cohort.
10094550	1999	Hum. Mutat.	1059-7794	TITLE	0	0	6103	SYMBOL|GENE|GN|DICTIONARY	rpgr	RPGR	51#55		Identification of a 5' splice site mutation in the RPGR gene in a family with X-linked retinitis pigmentosa (RP3).
10094550	1999	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	6103	SYMBOL|GENE|GN|DICTIONARY	rpgr	RPGR	27#31		We have identified a novel RPGR gene mutation in a large Dutch family with X-linked retinitis pigmentosa (RP3).
10094550	1999	Hum. Mutat.	1059-7794	ALL_TEXT_2/3	2	2	6103	SYMBOL|DICTIONARY	rpgr	RPGR	108#112		In affected members, a G-->T transversion was found at position +1 of the 5' splice site of intron 5 of the RPGR (retinitis pigmentosa GTPase regulator) gene.
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	13#22		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	5630	LONGTERM|DICTIONARY	peripherin	peripherin	27#37		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	TITLE	0	0	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	38#41		[Analysis of rhodopsin and peripherin/RDS genes in Chinese patients with retinitis pigmentosa].
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	28#37		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	5630	LONGTERM|DICTIONARY	peripherin	peripherin	42#52		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
12579739	2004	Yan Ke Xue Bao	1000-4432	PURPOSE	1	1	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	53#56		To disclose the mutation of rhodopsin and peripherin/RDS genes among Chinese patients with retinitis pigmentosa as there was no identified mutation through sequencing reported in Chinese.
12579739	2004	Yan Ke Xue Bao	1000-4432	METHODS	2	3	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	22#31		Gene fragments of the rhodopsin and peripherin/RDS genes were amplified by the polymerase chain reaction.
12579739	2004	Yan Ke Xue Bao	1000-4432	METHODS	2	3	5630	LONGTERM|DICTIONARY	peripherin	peripherin	36#46		Gene fragments of the rhodopsin and peripherin/RDS genes were amplified by the polymerase chain reaction.
12579739	2004	Yan Ke Xue Bao	1000-4432	METHODS	2	3	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	47#50		Gene fragments of the rhodopsin and peripherin/RDS genes were amplified by the polymerase chain reaction.
12579739	2004	Yan Ke Xue Bao	1000-4432	RESULTS	3	6	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	33#42		Three different mutations in the rhodopsin gene were found in 3 of the 83 patients with retinitis pigmentosa(Va1104Phe, Lys311Glu, Pro347Leu).
12579739	2004	Yan Ke Xue Bao	1000-4432	RESULTS	3	9	5630	LONGTERM|DICTIONARY	peripherin	peripherin	12#22		Mutation of peripherin/RDS gene was not found in the 83 patients.
12579739	2004	Yan Ke Xue Bao	1000-4432	RESULTS	3	9	5961	SYMBOL|GENE|GN|DICTIONARY	rds	RDS	23#26		Mutation of peripherin/RDS gene was not found in the 83 patients.
12579739	2004	Yan Ke Xue Bao	1000-4432	CONCLUSION	4	10	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	16#25		Mutation in the rhodopsin gene is the common cause in Chinese patients with retinitis pigmentosa, either autosomal dominant, recessive or sporadic.
10732801	2000	Neurogenetics	1364-6745	TITLE	0	0	7249	LONGTERM|DICTIONARY|GENE|GA	tuberous sclerosis 2	tuberous sclerosis 2	42#62		Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene.
10732801	2000	Neurogenetics	1364-6745	TITLE	0	0	7249	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tsc2	TSC2	64#68	10732801-0-42-62	Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene.
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_1/3	1	1	7248	SYMBOL|()|DICTIONARY	tsc1	TSC1	129#133		Tuberous sclerosis complex (TSC) is an autosomal dominant multi-system disorder with two known disease loci on chromosomes 9q34 (TSC1) and 16p13.3 (TSC2).
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_2/3	2	3	7249	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tsc2	TSC2	68#72	10732801-0-42-62	Our laboratory has undertaken the complete mutation analysis of the TSC2 gene in 42 TSC families using single-strand conformation polymorphism analysis and reverse transcription-polymerase chain reaction.
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_3/3	3	5	7249	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tsc2	TSC2	4#8	10732801-0-42-62	The TSC2 gene spans at least 45 kilobases of genomic DNA, has 41 known exons, and codes for a 5,474-base pair transcript.
10732801	2000	Neurogenetics	1364-6745	ALL_TEXT_3/3	3	8	7249	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tsc2	TSC2	58#62	10732801-0-42-62	We have also detected 15 polymorphisms which occur in the TSC2 gene.
12782962	2004	Psychiatr. Genet.	0955-8829	TITLE	0	0	2913	SYMBOL|()|DICTIONARY	grm3	GRM3	91#95		Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
12782962	2004	Psychiatr. Genet.	0955-8829	OBJECTIVES	1	3	2913	SYMBOL|()|DICTIONARY	grm3	GRM3	63#67		We focused on the metabotropic glutamate receptor type 3 gene (GRM3) as a candidate for schizophrenia susceptibility.
12782962	2004	Psychiatr. Genet.	0955-8829	METHODS	2	4	2913	SYMBOL|DICTIONARY	grm3	GRM3	128#132		We genotyped Japanese schizophrenics (n=100) and controls (n=100) for six single nucleotide polymorphisms (SNPs) located in the GRM3 region at intervals of approximately 50 kb.
12782962	2004	Psychiatr. Genet.	0955-8829	CONCLUSIONS	4	10	2913	SYMBOL|DICTIONARY	grm3	GRM3	115#119		Our data indicate that at least one susceptibility locus for schizophrenia is situated within or very close to the GRM3 region in the Japanese patients.
12694583	2004	Tissue Antigens	0001-2815	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	36#40		The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	53#57		The prevalence of HLA-A*0207, -B*2704, -B*4601, and -DRB1*0901 among patients with Graves' disease was found to be increased, with odds ratios (OR) of 2.21, 3.82, 1.76 and 1.62, respectively.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	191#195		However, after correction for multiple comparisons, the relative risk of HLA-A*0207 susceptibility to Graves' disease remained statistically significant and the haplotype HLA-A*3303 -B*5801 -DRB1*0301 had a significantly protective effect.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	6	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	9#17		Although HLA-DRB1*1405 showed an increased relative risk in patients with GO (Graves' opthalmopathy) (OR 4.61) when compared with patients without GO, the relative risk after adjusting for the number of comparisons was not significant.
11793483	2002	Hum. Mutat.	1098-1004	TITLE	0	0	5009	LONGTERM|DICTIONARY	ornithine transcarbamylase	ornithine transcarbamylase	154#180		Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
11793483	2002	Hum. Mutat.	1098-1004	TITLE	0	0	5009	SYMBOL|()|DICTIONARY|EXTRACTED	otc	OTC	182#185	11793483-0-154-180	Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
11793483	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	5009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	otc	OTC	54#57	11793483-0-154-180	"Point mutations and small deletions/insertions in the OTC gene are responsible for the majority of the cases and have a ""private"" character with little recurrence."
11793483	2002	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	5009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	otc	OTC	48#51	11793483-0-154-180	We report on eleven pathological changes in the OTC gene sequence detected in three males with mild clinical presentations, and in eight symptomatic females.All of these mutations are novel.
11793483	2002	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	5009	SYMBOL|DICTIONARY|EXTRACTED	otc	OTC	192#195	11793483-0-154-180	All other mutations were point changes causing the simple amino acid substitutions (M1I, I160S, L191F, M206I, L301F, P305H and L341P), although the mutation M1I may abolish translation of the OTC polypeptide.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	SYMBOL|()|DICTIONARY|EXTRACTED	tfr1	TfR1	69#73	16111806-1-45-65	In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	2	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	117#121	16111806-1-45-65	While the majority of carcinoma patients were anemic, no relationship between the level of colon tissue ferritin and TfR1 and the systemic parameters of iron metabolism was evident.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_2/3	2	4	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	50#54	16111806-1-45-65	However, a relationship between the expression of TfR1 and the grade of colorectal carcinoma was observed.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	5	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	32#36	16111806-1-45-65	In this case high expression of TfR1 was found in colorectal carcinoma samples of Dukes A or B grade, and well differentiated colorectal carcinoma cells.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_3/3	3	6	7037	SYMBOL|DICTIONARY|EXTRACTED	tfr1	TfR1	40#44	16111806-1-45-65	In comparison, weak or no expression of TfR1 was observed in carcinoma samples of Dukes C or D grade with poorly differentiated cells and in carcinoma samples that had lymph node infiltration and distant metastasis.
15993987	2006	Neurobiol. Aging	0197-4580	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	70#74		Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype.
15993987	2006	Neurobiol. Aging	0197-4580	ALL_TEXT_2/3	2	3	348	SYMBOL|DICTIONARY	apoe	APOE	72#76		Moreover, Fe(2+) induced lysosomal accumulation of endogenous Abeta and APOE in cultured cells, and Abeta deposition in vascular tunica media in organotypic cultures of brain vessels.
15993987	2006	Neurobiol. Aging	0197-4580	ALL_TEXT_2/3	2	4	348	SYMBOL|DICTIONARY	apoe	APOE	109#113		Here we demonstrated that Fe(2+) enhanced an uptake of exogenous Abeta 1-40 and its deposition together with APOE in lysosomes in myocytes.
16054149	2006	Atherosclerosis	0021-9150	TITLE	0	0	116519	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein a5	apolipoprotein A5	22#39		Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	116519	SYMBOL|GENE|GN|DICTIONARY	apoa5	APOA5	59#64		Recently, a T/C polymorphism of the promoter region of the APOA5 gene at position -1131 and a G/T polymorphism at position 553 were found to be associated with increased levels of plasma triglyceride.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	2	116519	SYMBOL|DICTIONARY	apoa5	APOA5	132#137		Triglyceride plays a role in coronary artery disease (CAD), so this case-control study tested for a possible link between these two APOA5 polymorphisms, their common haplotypes and the risk of CAD.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	9	116519	SYMBOL|DICTIONARY	apoa5	APOA5	54#59		Notably, haplotype analysis further verified that the APOA5 -1131C and c.553T bi-loci haplotype was significantly overpresented in CAD, as compared to the controls.
16054149	2006	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	10	116519	SYMBOL|GENE|GN|DICTIONARY	apoa5	APOA5	44#49		These results indicate that the variants of APOA5 gene modulate plasma triglyceride and may use them to predict CAD susceptibility in Taiwanese Chinese.
16014697	2006	J. Med. Genet.	1468-6244	TITLE	0	0	64093	SYMBOL|GENE|GN|DICTIONARY	oas	OAS	24#27		Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	1	4938	SYMBOL|DICTIONARY	oas1	OAS1	43#47		The 2',5'-oligoadenylate synthetase genes (OAS1, OAS2, and OAS3) map to human chromosome 12q24 and encode a family of enzymes pivotal to innate antiviral defence.
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	1	4939	SYMBOL|DICTIONARY	oas2	OAS2	49#53		The 2',5'-oligoadenylate synthetase genes (OAS1, OAS2, and OAS3) map to human chromosome 12q24 and encode a family of enzymes pivotal to innate antiviral defence.
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	1	4940	SYMBOL|DICTIONARY	oas3	OAS3	59#63		The 2',5'-oligoadenylate synthetase genes (OAS1, OAS2, and OAS3) map to human chromosome 12q24 and encode a family of enzymes pivotal to innate antiviral defence.
16014697	2006	J. Med. Genet.	1468-6244	BACKGROUND	1	2	4938	SYMBOL|DICTIONARY	oas1	OAS1	33#37		Recently, the minor allele of an OAS1 single nucleotide polymorphism (SNP) that alters splicing (rs10774671) was found to be associated with increased enzymatic activity and, in a case-sibling control study, with type 1 diabetes (T1D).
16014697	2006	J. Med. Genet.	1468-6244	METHODS	2	4	4938	SYMBOL|DICTIONARY	oas1	OAS1	50#54		However, because of linkage disequilibrium within OAS1 and with the other two OAS genes, functional attribution of the association to this SNP cannot be assumed.
16014697	2006	J. Med. Genet.	1468-6244	METHODS	2	4	64093	SYMBOL|GENE|GN|DICTIONARY	oas	OAS	78#81		However, because of linkage disequilibrium within OAS1 and with the other two OAS genes, functional attribution of the association to this SNP cannot be assumed.
16014697	2006	J. Med. Genet.	1468-6244	METHODS	2	5	4938	SYMBOL|DICTIONARY	oas1	OAS1	75#79		To help answer this question, we also genotyped two non-synonymous SNPs in OAS1 exons 3 and 7.
16014697	2006	J. Med. Genet.	1468-6244	CONCLUSIONS	4	10	4938	SYMBOL|DICTIONARY	oas1	OAS1	33#37		A serine/glycine substitution in OAS1 exon 3 is more likely a functional variant.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	TITLE	0	0	1080	SYMBOL|DICTIONARY	cftr	CFTR	24#28		Analysis of most common CFTR mutations in patients affected by nasal polyps.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	ALL_TEXT_1/3	1	2	1080	SYMBOL|DICTIONARY	cftr	CFTR	196#200		Forty-four patients affected by nasal polyps were admitted to the Department of Otolaryngology, Lublin University School of Medicine, Lublin, Poland, and screened for the most-commonly identified CFTR mutations [DeltaF508, G542X, N1303 K, 1717-1 (G to A), W1282X, G551D, R553X and DeltaI507] by applying the INNO-LIPA CF2 test strips.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	ALL_TEXT_2/3	2	4	1080	SYMBOL|DICTIONARY	cftr	CFTR	44#48		We detected 5 of 44 (11.4%) carriers of the CFTR mutations.
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4314	SYMBOL|DICTIONARY	mmp 3	MMP-3	129#134		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	136#141		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4321	SYMBOL|DICTIONARY	mmp 12	MMP-12	143#149		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	METHODS	2	3	4313	SYMBOL|DICTIONARY	mmp 2	MMP-2	131#136		They also provided a DNA sample for analysis of the -1306 C > T, -1171 5A > 6A, -1562 C > T, -82 A > G and -675 4G > 5G alleles of MMP-2, MMP-3, MMP-9, MMP-12 and PAI-1, respectively.
16082623	2005	Br J Surg	0007-1323	METHODS	2	3	4314	SYMBOL|DICTIONARY	mmp 3	MMP-3	138#143		They also provided a DNA sample for analysis of the -1306 C > T, -1171 5A > 6A, -1562 C > T, -82 A > G and -675 4G > 5G alleles of MMP-2, MMP-3, MMP-9, MMP-12 and PAI-1, respectively.
16082623	2005	Br J Surg	0007-1323	METHODS	2	3	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	145#150		They also provided a DNA sample for analysis of the -1306 C > T, -1171 5A > 6A, -1562 C > T, -82 A > G and -675 4G > 5G alleles of MMP-2, MMP-3, MMP-9, MMP-12 and PAI-1, respectively.
16082623	2005	Br J Surg	0007-1323	METHODS	2	3	4321	SYMBOL|DICTIONARY	mmp 12	MMP-12	152#158		They also provided a DNA sample for analysis of the -1306 C > T, -1171 5A > 6A, -1562 C > T, -82 A > G and -675 4G > 5G alleles of MMP-2, MMP-3, MMP-9, MMP-12 and PAI-1, respectively.
16082623	2005	Br J Surg	0007-1323	METHODS	2	3	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	163#168		They also provided a DNA sample for analysis of the -1306 C > T, -1171 5A > 6A, -1562 C > T, -82 A > G and -675 4G > 5G alleles of MMP-2, MMP-3, MMP-9, MMP-12 and PAI-1, respectively.
16082623	2005	Br J Surg	0007-1323	RESULTS	3	5	4313	SYMBOL|DICTIONARY	mmp 2	MMP-2	4#9		For MMP-2, MMP-9 and MMP-12 genotypes, growth rates were similar to the mean linear growth rate of 3.08 mm per year.
16082623	2005	Br J Surg	0007-1323	RESULTS	3	5	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	11#16		For MMP-2, MMP-9 and MMP-12 genotypes, growth rates were similar to the mean linear growth rate of 3.08 mm per year.
16082623	2005	Br J Surg	0007-1323	RESULTS	3	5	4321	SYMBOL|DICTIONARY	mmp 12	MMP-12	21#27		For MMP-2, MMP-9 and MMP-12 genotypes, growth rates were similar to the mean linear growth rate of 3.08 mm per year.
16082623	2005	Br J Surg	0007-1323	RESULTS	3	6	4314	SYMBOL|DICTIONARY	mmp 3	MMP-3	4#9		For MMP-3, growth rates were 3.05 (for 5A5A), 3.19 (for 5A6A) and 2.90 (for 6A6A) mm per year.
16082623	2005	Br J Surg	0007-1323	RESULTS	3	8	5054	SYMBOL|NUMBER|DICTIONARY	pai 1	PAI-1	44#49		The increased growth rate for patients with PAI-1 5G5G genotype was not statistically significant (P = 0.061), although these patients had the lowest plasma PAI-1 concentrations (P = 0.018).
16082623	2005	Br J Surg	0007-1323	RESULTS	3	8	5054	SYMBOL|DICTIONARY	pai 1	PAI-1	157#162		The increased growth rate for patients with PAI-1 5G5G genotype was not statistically significant (P = 0.061), although these patients had the lowest plasma PAI-1 concentrations (P = 0.018).
15956286	2005	Blood	0006-4971	TITLE	0	0	81027	SYMBOL|DICTIONARY	tubb1	TUBB1	4#9		The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	0#5		CXCR3 polymorphisms associated with risk of asthma.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	116#121	16043121-1-4-38	In an effort to discover polymorphisms have been implicated in asthma, we investigated the genetic polymorphisms in CXCR3 to evaluate it as a potential candidate gene for a host genetic study of asthma.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	43#48	16043121-1-4-38	Our findings suggest that polymorphisms in CXCR3 might be one of the genetic factors for the risk of asthma development, especially in male atopic subjects.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	6	2833	SYMBOL|DICTIONARY|EXTRACTED	cxcr3	CXCR3	0#5		CXCR3 variation/haplotype information identified in this study will provide valuable information and insight into strategies for the control of asthma and its subgroup, atopy.
16086317	2006	Hum. Mutat.	1098-1004	TITLE	0	0	368	SYMBOL|DICTIONARY	abcc6	ABCC6	83#88		Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	368	SYMBOL|GENE|GN|DICTIONARY	abcc6	ABCC6	157#162		Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder that affects the elastic tissue in the skin, eye, and cardiovascular system.Mutations in the ABCC6 gene cause PXE.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	368	SYMBOL|DICTIONARY	abcc6	ABCC6	34#39		We performed a mutation screen in ABCC6 using haplotype analysis in conjunction with direct sequencing to achieve a mutation detection rate of 97%.
16086317	2006	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	368	SYMBOL|DICTIONARY	abcc6	ABCC6	86#91		Chromosomal haplotyping with two proximal and two distal polymorphic markers flanking ABCC6 demonstrated that most chromosomes that carry these relatively frequent PXE mutations have related haplotypes specific for these mutations, which suggests that these chromosomes originate from single founder mutations.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	LONGTERM|DICTIONARY	protein tyrosine phosphatase receptor type j	protein tyrosine phosphatase receptor type J	4#48		The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	SYMBOL|()|DICTIONARY|EXTRACTED	ptprj	PTPRJ	50#55	16000320-3-4-48	The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	3	5795	SYMBOL|DICTIONARY	scc1	Scc1	122#126		The protein tyrosine phosphatase receptor type J (PTPRJ) has been recently identified as being the protein encoded by the Scc1 mouse gene (susceptibility to colon cancer-1).
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	5795	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptprj	PTPRJ	17#22	16000320-3-4-48	In addition, the PTPRJ gene has been shown to be somatically altered in several human cancer types such as colon, lung and breast cancers and to have the characteristics of a tumour-suppressor gene.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	5	5795	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptprj	PTPRJ	74#79	16000320-3-4-48	The purpose of this study was to determine whether common variants in the PTPRJ gene represent low penetrance breast cancer susceptibility alleles.
16000320	2005	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	5795	SYMBOL|DICTIONARY|EXTRACTED	ptprj	PTPRJ	26#31	16000320-3-4-48	Thus, carrying a specific PTPRJ haplotype confers a protective effect on the risk of breast cancer.
16128377	2006	Acta Cardiol	0001-5385	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	30#59		Cardiovascular effects of I/D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years.
16128377	2006	Acta Cardiol	0001-5385	BACKGROUND	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	91#120		An increasing number of studies with conflicting results regarding the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease has recently been published.
16128377	2006	Acta Cardiol	0001-5385	BACKGROUND	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	122#125	16128377-1-91-120	An increasing number of studies with conflicting results regarding the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease has recently been published.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	10	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	50#53	16128377-1-91-120	We obtained 3 genetically distinct groups: I) the ACE-DD group (n = 225, 80 F/ 145 M, mean age 43.4 +/- 7.6 years) with 42 hypertensive subjects (18.3%), 5 heart failure (HF) subjects and 6 subjects with acute coronary syndromes (ACS).
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	12	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	7#10	16128377-1-91-120	2) the ACE-ID group (n = 335, 116 F/2 19 M, mean age 43.6 +/- 7 years) with 16 hypertensive subjects (4.7%) and 3 subjects with ACS.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	89#92	16128377-1-91-120	The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	124#127	16128377-1-91-120	The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	103#106	16128377-1-91-120	The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	15	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	114#117	16128377-1-91-120	The higher incidence of hypertension was observed in the older age groups (36-45 and 46-55 years) with ACE-DD and ACE-ID genotypes.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	16	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	10#13	16128377-1-91-120	Moreover, ACE-DD significantly and early affected myocardial diastolic properties in the total group examined, also when stratified for age.
16128377	2006	Acta Cardiol	0001-5385	CONCLUSION	4	18	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	22#25	16128377-1-91-120	Our data suggest that ACE-DD polymorphism is associated with a higher incidence of hypertension in baseline healthy subjects, irrespective of other risk factors, and appears to affect the diastolic function.
16006970	2005	J. Urol.	0022-5347	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	2#15		: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	17#21	16006970-1-2-15	: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	84#88	16006970-1-2-15	: Interleukin-6 (IL-6) has an important role during prostate cancer progression and IL-6 levels in the serum of patients with hormone refractory and metastatic prostate cancer are significantly increased compared with those in patients with hormone sensitive and localized prostate cancer.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	2	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	61#65	16006970-1-2-15	The G>C polymorphism at position -174 in the promoter of the IL-6 gene has been associated with differences in IL-6 transcription in vitro and IL-6 protein levels in vivo.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	111#115	16006970-1-2-15	The G>C polymorphism at position -174 in the promoter of the IL-6 gene has been associated with differences in IL-6 transcription in vitro and IL-6 protein levels in vivo.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	2	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	143#147	16006970-1-2-15	The G>C polymorphism at position -174 in the promoter of the IL-6 gene has been associated with differences in IL-6 transcription in vitro and IL-6 protein levels in vivo.
16006970	2005	J. Urol.	0022-5347	PURPOSE	1	3	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	33#37	16006970-1-2-15	We determined the association of IL-6 polymorphism with prostate cancer progression.
16006970	2005	J. Urol.	0022-5347	MATERIALS AND METHODS	2	4	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	33#37	16006970-1-2-15	: We examined the association of IL-6 polymorphism with the risk of advanced disease in 95 patients with different stages of prostate cancer using the tetra-primer polymerase chain reaction genotyping method.
16006970	2005	J. Urol.	0022-5347	RESULTS	3	5	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	40#44	16006970-1-2-15	: We found that the -174G>C genotype of IL-6 gene was associated with an overall increased risk of advanced prostate cancer.
16006970	2005	J. Urol.	0022-5347	RESULTS	3	6	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	102#106	16006970-1-2-15	A strong association between this genotype and Gleason score was observed at the -174G>C locus of the IL-6 gene (p <0.001).
16006970	2005	J. Urol.	0022-5347	RESULTS	3	8	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	17#21	16006970-1-2-15	In addition, the IL-6 genotype was linked with vascular invasion (p = 0.024), seminal vesicle involvement (p = 0.006) and capsular invasion (p <0.001).
16006970	2005	J. Urol.	0022-5347	RESULTS	3	9	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	41#45	16006970-1-2-15	Furthermore, the -174G>C genotype of the IL-6 gene was significantly associated with increased serum prostate specific antigen (p = 0.004) and with recurrent prostate cancer compared with GG homozygotes (p = 0.027).
16006970	2005	J. Urol.	0022-5347	RESULTS	3	9	354	LONGTERM|DICTIONARY	prostate specific antigen	prostate specific antigen	101#126		Furthermore, the -174G>C genotype of the IL-6 gene was significantly associated with increased serum prostate specific antigen (p = 0.004) and with recurrent prostate cancer compared with GG homozygotes (p = 0.027).
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	16006970-1-2-15	: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16006970	2005	J. Urol.	0022-5347	CONCLUSIONS	4	10	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	225#229	16006970-1-2-15	: These data demonstrate a strong association of the -174G>C polymorphism of the IL-6 gene with the aggressiveness and recurrence of prostate cancer, suggesting that genetic predisposition of genetic differences in the human IL-6 gene could be linked to the risk of recurrent prostate cancer.
16012724	2005	Oncol. Rep.	1021-335X	TITLE	0	0	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	0#5		FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_1/3	1	1	2264	SYMBOL|GENE|GN|DICTIONARY	fgfr4	FGFR4	40#45		A functional Gly388Arg variation in the FGFR4 gene has been reported to be associated with breast and colorectal cancer prognostic parameters.
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	4	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	71#76		A pooled analysis of the present and published data on nodal status by FGFR4 genotypes revealed no association in either breast cancer [odds ratio (OR), 1.0; 95% confidence interval (CI), 0.7-1.4; 702 subjects] or colorectal cancer (OR, 1.4; 95% CI, 0.6-3.4; 260 cases).
16012724	2005	Oncol. Rep.	1021-335X	ALL_TEXT_3/3	3	5	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	10#15		Thus, the FGFR4 polymorphism may not be relevant in predicting nodal involvement of breast cancer or colon cancer patients.
15809232	2005	Alcohol Alcohol.	0735-0414	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	17#33		Polymorphisms of apolipoprotein E and angiotensin-converting enzyme genes and carotid atherosclerosis in heavy drinkers.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	32#48		To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	50#54	15809232-1-32-48	To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	AIMS	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	91#94	15809232-1-60-89	To investigate the influence of apolipoprotein E (APOE) and angiotensin-converting enzyme (ACE) gene polymorphisms on carotid artery atherosclerosis in alcoholism.
15809232	2005	Alcohol Alcohol.	0735-0414	RESULTS	3	5	348	SYMBOL|DICTIONARY	apo e	APO E	22#27		Subjects carrying the APO E epsilon4 allele were more liable to develop atherosclerotic changes in carotid arteries compared with subjects with the epsilon3/3 genotype, which showed statistical significance in patients under 50 years of age.
15809232	2005	Alcohol Alcohol.	0735-0414	CONCLUSIONS	4	7	348	SYMBOL|DICTIONARY	apo e	APO E	0#5		APO E polymorphism can increase the risk of carotid atherosclerosis development in an alcoholic subject.
15809232	2005	Alcohol Alcohol.	0735-0414	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY	apo e	APO E	23#28		The association of the APO E epsilon4 allele with carotid atherosclerosis was significant in younger patients.
15902656	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	13#19		Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal dystrophy.
15902656	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	2	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	123#129		Linkage analysis localized CFD to a 24-cM (18-Mb) interval of chromosome 2q35 flanked by D2S2289 and D2S126 and containing PIP5K3.
15902656	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	3	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	0#6		PIP5K3 is a member of the phosphoinositide 3-kinase family and regulates the sorting and traffic of peripheral endosomes that contain lysosomally directed fluid phase cargo, by controlling the morphogenesis and function of multivesicular bodies.
15902656	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	200576	SYMBOL|DICTIONARY	pip5k3	PIP5K3	110#116		The histological and clinical characteristics of patients with CFD are consistent with biochemical studies of PIP5K3 that indicate a role in endosomal sorting.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	1	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	292#296		Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	2	7369	SYMBOL|DICTIONARY	umod	UMOD	16#20		Of 34 different UMOD mutations described to date, 28 were located in exon 4.
15983957	2005	Am. J. Kidney Dis.	1523-6838	BACKGROUND	1	3	7369	SYMBOL|DICTIONARY	umod	UMOD	91#95		Based on such mutation clustering, some investigators have proposed that the sequencing of UMOD exon 4 might become a preliminary diagnostic test for patients with this phenotype.
15983957	2005	Am. J. Kidney Dis.	1523-6838	METHODS	2	4	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	83#87		We performed linkage analysis and sequencing of the entire codifying region of the UMOD gene in 4 Spanish families with MCKD/FJHN/GCKD.
15983957	2005	Am. J. Kidney Dis.	1523-6838	RESULTS	3	5	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	52#56		All families were shown to present mutations in the UMOD gene.
15983957	2005	Am. J. Kidney Dis.	1523-6838	CONCLUSION	4	9	7369	SYMBOL|DICTIONARY	umod	UMOD	42#46		Our data show a novel mutation pattern in UMOD , suggesting that exon 5 mutations can be more frequent in some populations.
15983957	2005	Am. J. Kidney Dis.	1523-6838	CONCLUSION	4	10	7369	SYMBOL|GENE|GN|DICTIONARY	umod	UMOD	43#47		Our results support that every exon of the UMOD gene must be included in molecular testing and provide additional evidence for the existence of a fourth calcium-binding epidermal growth factor-like domain in the structure of Tamm-Horsfall protein.
15983957	2005	Am. J. Kidney Dis.	1523-6838	CONCLUSION	4	11	7369	SYMBOL|DICTIONARY	umod	UMOD	101#105		A second family reported to date is described, confirming that the GCKD phenotype may be caused by a UMOD mutation.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	2	940	SYMBOL|DICTIONARY	cd28	CD28	48#52		Programmed death 1 (PD-1) is a member of the B7/CD28 superfamily of costimulatory molecules exerting inhibitory functions on T cells.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	3	5133	SYMBOL|GENE|GN|DICTIONARY	pd 1	PD-1	54#58		Recently, an intronic 7146G/A polymorphism within the PD-1 gene was described and suggested to be associated with autoimmunity.
15958759	2005	Ann. Rheum. Dis.	0003-4967	BACKGROUND	1	1	4210	SYMBOL|DICTIONARY	mefv	MEFV	86#90		Pyrin is a newly recognised intracellular regulator of inflammation, and mutations in MEFV, the gene encoding pyrin, are the cause of familial Mediterranean fever.
15958759	2005	Ann. Rheum. Dis.	0003-4967	OBJECTIVE	2	2	4210	SYMBOL|DICTIONARY	mefv	MEFV	35#39		To determine if known mutations of MEFV are associated with rheumatoid arthritis (RA) morbidity or can modify RA severity.
15958759	2005	Ann. Rheum. Dis.	0003-4967	METHODS	3	3	4210	SYMBOL|DICTIONARY	mefv	MEFV	39#43		The frequency of the three most common MEFV mutations: M694V, V726A, and E148Q, was determined in 98 Israeli patients with RA (74 women, 24 men) and compared with that in 100 healthy subjects matched for origin.
15958759	2005	Ann. Rheum. Dis.	0003-4967	RESULTS	4	6	4210	SYMBOL|DICTIONARY	mefv	MEFV	70#74		17/98 (17%) patients with RA (all women) were heterozygous for common MEFV mutations, predominantly E148Q (12 patients), and one patient was homozygous for the V726A mutation.
15958759	2005	Ann. Rheum. Dis.	0003-4967	CONCLUSION	5	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	0#4		MEFV, and particularly the E148Q mutation, is an independent modifier of the clinical manifestations of RA.
15958759	2005	Ann. Rheum. Dis.	0003-4967	CONCLUSION	5	11	4210	SYMBOL|DICTIONARY	mefv	MEFV	56#60		This is the second Th1-type autoimmune disease in which MEFV mutations have been shown to aggravate the clinical status.
15939053	2005	Atherosclerosis	0021-9150	TITLE	0	0	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	0#4		CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	LONGTERM|GENE|GT|DICTIONARY	cholesteryl ester transfer protein	cholesteryl ester transfer protein	33#67		To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_1/3	1	1	1071	SYMBOL|()|DICTIONARY|EXTRACTED	cetp	CETP	69#73	15939053-1-33-67	To better understand the role of cholesteryl ester transfer protein (CETP) in cardiovascular disease, nine polymorphisms spanning the gene from the upstream promoter region to beyond the 3'UTR were genotyped in 2553 individuals from multiple ethnic groups and with different cardiovascular disease profiles.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	7	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	30#34	15939053-1-33-67	The association of HDL-C with CETP genotype was found to be independent of smoking or alcohol consumption.
15939053	2005	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	1071	SYMBOL|DICTIONARY|EXTRACTED	cetp	CETP	149#153	15939053-1-33-67	These results replicate some earlier findings and also help to explain some of the apparent contradictions in the literature surrounding the role of CETP in modulating HDL-C and cardiovascular disease.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	TITLE	0	0	1041	LONGTERM|DICTIONARY|GENE|GA	corneodesmosin	Corneodesmosin	0#14		Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	TITLE	0	0	1041	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cdsn	CDSN	16#20	15953084-0-0-14	Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_1/3	1	1	3107	SYMBOL|DICTIONARY	psors1	PSORS1	0#6		PSORS1 on chromosome 6p21.3, which contains the MHC, is a major susceptibility locus for psoriasis vulgaris.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_1/3	1	2	1041	LONGTERM|DICTIONARY|GENE|GA	corneodesmosin	corneodesmosin	79#93		This region is characterized by strong linkage disequilibrium and contains the corneodesmosin (CSDN) gene, an attractive candidate for psoriasis susceptibility based on its putative biological function in keratinocyte adhesion, and HLA-Cw6, an established marker for psoriasis susceptibility.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_2/3	2	4	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	38#42	15953084-0-0-14	All individuals were investigated for CDSN polymorphism (+619, +1236, +1240 and +1243) and HLA-C association.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	5	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	54#58	15953084-0-0-14	Our data confirms strong association with HLA-Cw6 and CDSN allele 5 (+619T, +1240G, +1243C) in the Caucasian cohort (TDT, P = 5.4 x 10(-6)) and in addition defines this region further by identifying a high-risk CDSN haplotype (allele 5 and +1236T, P = 8.5 x 10(-8)).
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	5	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	211#215	15953084-0-0-14	Our data confirms strong association with HLA-Cw6 and CDSN allele 5 (+619T, +1240G, +1243C) in the Caucasian cohort (TDT, P = 5.4 x 10(-6)) and in addition defines this region further by identifying a high-risk CDSN haplotype (allele 5 and +1236T, P = 8.5 x 10(-8)).
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	6	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	80#84	15953084-0-0-14	In contrast no association was observed in the Japanese cohort for any HLA-C or CDSN alleles.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	7	1041	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cdsn	CDSN	34#38	15953084-0-0-14	This data supports a role for the CDSN gene in Caucasian populations with psoriasis.
15953084	2005	Clin. Exp. Dermatol.	0307-6938	ALL_TEXT_3/3	3	8	1041	SYMBOL|DICTIONARY|EXTRACTED	cdsn	CDSN	49#53	15953084-0-0-14	However the lack of association with HLA-Cw6 and CDSN alleles in Japanese psoriasis patients may be because Japanese patients exhibit a form of psoriasis similar to late onset or Type II psoriasis vulgaris in contrast to early onset or Type I disease characterizing our Caucasian population.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	7099	LONGTERM|DICTIONARY	toll like receptor 4	Toll-like receptor 4	12#32		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	64127	SYMBOL|DICTIONARY	card15	CARD15	75#81		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	82#86		The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	LONGTERM|DICTIONARY	toll like receptor 4	Toll-like receptor 4	42#62		We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	BACKGROUND	1	1	7099	SYMBOL|()|DICTIONARY|EXTRACTED	tlr4	TLR4	64#68	15973118-1-42-62	We investigated the influence of 2 common Toll-like receptor 4 (TLR4) polymorphisms on susceptibility and disease characteristics of Crohn's disease (CD).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	2	7099	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tlr4	TLR4	139#143	15973118-1-42-62	Genomic DNA from 204 patients with CD and 199 unrelated controls was analyzed for the presence of 2 single nucleotide polymorphisms in the TLR4 gene, resulting in the amino acid substitutions Asp299Gly and Thr399Ile.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	3	64127	SYMBOL|DICTIONARY	card15	CARD15	63#69		In addition, the carrier status for the 3 common CD-associated CARD15/NOD2 gene mutations, Arg702Trp, Gly908Arg, and 1007fs, was determined.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	METHODS	2	3	64127	SYMBOL|GENE|GN|DICTIONARY	nod2	NOD2	70#74		In addition, the carrier status for the 3 common CD-associated CARD15/NOD2 gene mutations, Arg702Trp, Gly908Arg, and 1007fs, was determined.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	5	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	50#54	15973118-1-42-62	An almost 2-fold increase in the frequency of the TLR4 Asp299Gly phenotype was observed in patients with CD (14.2%) compared with healthy controls (7.5%, P = 0.038, odds ratio = 2.03).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	6	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	94#98	15973118-1-42-62	The prevalence of a stricturing phenotype was increased in patients heterozygous for 1 of the TLR4 polymorphisms studied (Asp299Gly, 34.5%; Thr399Ile, 36.7%) compared with patients with wild-type TLR4 (17.1% and 16.7%; P = 0.04 and 0.02, respectively).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	6	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	196#200	15973118-1-42-62	The prevalence of a stricturing phenotype was increased in patients heterozygous for 1 of the TLR4 polymorphisms studied (Asp299Gly, 34.5%; Thr399Ile, 36.7%) compared with patients with wild-type TLR4 (17.1% and 16.7%; P = 0.04 and 0.02, respectively).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	card15	CARD15	61#67		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	68#72		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	214#218		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	276#280		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	328#332		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	7	64127	SYMBOL|DICTIONARY	nod2	NOD2	352#356		The presence of the Asp299Gly polymorphism in the absence of CARD15/NOD2 mutations was a particularly strong predictor of the stricturing disease phenotype that was present in 47.4% of the patients with Asp299Gly+/NOD2- compared with 10.1% of the patients with the Asp299Gly-/NOD2+ status (P = 0.0009; P = 0.0004 for Thr399Ile+/NOD2- versus Thr399Ile-/NOD2+).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	8	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	94#98	15973118-1-42-62	In contrast, there was a trend toward a higher prevalence of the penetrating phenotype in the TLR4-/NOD2+ group (71.6%) compared with the TLR4+/NOD2- group (47.4%, P = 0.059).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	100#104		In contrast, there was a trend toward a higher prevalence of the penetrating phenotype in the TLR4-/NOD2+ group (71.6%) compared with the TLR4+/NOD2- group (47.4%, P = 0.059).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	8	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	138#142	15973118-1-42-62	In contrast, there was a trend toward a higher prevalence of the penetrating phenotype in the TLR4-/NOD2+ group (71.6%) compared with the TLR4+/NOD2- group (47.4%, P = 0.059).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	144#148		In contrast, there was a trend toward a higher prevalence of the penetrating phenotype in the TLR4-/NOD2+ group (71.6%) compared with the TLR4+/NOD2- group (47.4%, P = 0.059).
15973118	2005	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	9	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	4#8	15973118-1-42-62	The TLR4 Asp299Gly polymorphism is a risk factor for CD.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	10	7099	SYMBOL|DICTIONARY|EXTRACTED	tlr4	TLR4	0#4		TLR4 and CARD15/NOD2 mutations may contribute to distinct disease phenotypes.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	10	64127	SYMBOL|DICTIONARY	card15	CARD15	9#15		TLR4 and CARD15/NOD2 mutations may contribute to distinct disease phenotypes.
15973118	2005	Inflamm. Bowel Dis.	1078-0998	CONCLUSIONS	4	10	64127	SYMBOL|DICTIONARY	nod2	NOD2	16#20		TLR4 and CARD15/NOD2 mutations may contribute to distinct disease phenotypes.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_2/3	2	5	5337	SYMBOL|DICTIONARY	pld1	PLD1	29#33		The mRNA expressions of both PLD1 and PLD2 determined by semiquantitative competitive RT-PCR were markedly enhanced after aortic banding.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_2/3	2	5	5338	SYMBOL|DICTIONARY	pld2	PLD2	38#42		The mRNA expressions of both PLD1 and PLD2 determined by semiquantitative competitive RT-PCR were markedly enhanced after aortic banding.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_2/3	2	6	5338	SYMBOL|GENE|GN|DICTIONARY	pld2	PLD2	43#47		In the caveolar fraction of the rat heart, PLD2 protein determined by Western blot analysis was upregulated in parallel with the expression of caveolin-3.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_2/3	2	6	859	LONGTERM|DICTIONARY	caveolin 3	caveolin-3	143#153		In the caveolar fraction of the rat heart, PLD2 protein determined by Western blot analysis was upregulated in parallel with the expression of caveolin-3.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_3/3	3	8	5337	SYMBOL|DICTIONARY	pld1	PLD1	15#19		In conclusion, PLD1 and PLD2 expressions were strongly enhanced both in rat and human heart hypertrophy, which may be responsible for the coincident potentiation of the PLD activation by alpha-adrenoceptor and protein kinase C stimulation.
15988127	2005	J. Pharmacol. Sci.	1347-8613	ALL_TEXT_3/3	3	8	5338	SYMBOL|DICTIONARY	pld2	PLD2	24#28		In conclusion, PLD1 and PLD2 expressions were strongly enhanced both in rat and human heart hypertrophy, which may be responsible for the coincident potentiation of the PLD activation by alpha-adrenoceptor and protein kinase C stimulation.
15956634	2005	JAMA	1538-3598	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E and progression of chronic kidney disease.
15956634	2005	JAMA	1538-3598	CONTEXT	1	1	348	LONGTERM|DICTIONARY|GENE|GA	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon2 allele increasing and the epsilon4 allele decreasing risk.
15956634	2005	JAMA	1538-3598	CONTEXT	1	1	348	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	18#22	15956634-1-0-16	Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon2 allele increasing and the epsilon4 allele decreasing risk.
15956634	2005	JAMA	1538-3598	CONTEXT	1	2	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		APOE allelic associations with chronic kidney disease beyond diabetic nephropathy are unknown, with no studies reported in high-risk African American populations.
15956634	2005	JAMA	1538-3598	OBJECTIVE	2	3	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	75#79	15956634-1-0-16	To quantify the risk of chronic kidney disease progression associated with APOE in a population-based study including white, African American, diabetic, and nondiabetic individuals.
15956634	2005	JAMA	1538-3598	MAIN OUTCOME MEASURES	4	5	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	204#208	15956634-1-0-16	Incident chronic kidney disease progression, defined as hospitalization or death with kidney disease or increase in serum creatinine level of 0.4 mg/dL (35 micromol/L) or more above baseline, examined by APOE genotypes and alleles.
15956634	2005	JAMA	1538-3598	RESULTS	5	12	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	80#84	15956634-1-0-16	Excess risk of chronic kidney disease in African Americans was not explained by APOE alleles.
15956634	2005	JAMA	1538-3598	CONCLUSIONS	6	13	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		APOE variation predicts chronic kidney disease progression, independent of diabetes, race, lipid, and nonlipid risk factors.
15956634	2005	JAMA	1538-3598	CONCLUSIONS	6	14	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	140#144	15956634-1-0-16	Our study suggests that nonlipid-mediated pathways, such as cellular mechanisms of kidney remodeling, may be involved in the association of APOE alleles and progression of chronic kidney disease.
15927975	2006	Circulation	1524-4539	TITLE	0	0	1910	LONGTERM|GENE|GT|DICTIONARY	endothelin b receptor	endothelin B receptor	76#97		Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	146#180		Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	3371	LONGTERM|DICTIONARY	tenascin c	tenascin-C	182#192		Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15927975	2006	Circulation	1524-4539	METHODS AND RESULTS	2	10	4318	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 9	matrix metalloproteinase-9	208#234		Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	TITLE	0	0	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	10#17		Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	BACKGROUND	1	1	1557	LONGTERM|DICTIONARY	cytochrome p450 2c19	cytochrome P450 2C19	23#43		The polymorphic enzyme cytochrome P450 2C19 affects omeprazole metabolism.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	BACKGROUND	1	2	2520	LONGTERM|DICTIONARY	gastrin	gastrin	48#55		This influence on metabolism might affect serum gastrin levels, and safety, during long-term treatment of reflux oesophagitis.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	AIM	2	3	1557	LONGTERM|DICTIONARY	cytochrome p450 2c19	cytochrome P450 2C19	36#56		To examine the relationship between cytochrome P450 2C19 genotype and the safety profile of long-term omeprazole treatment.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	METHODS	3	4	1557	LONGTERM|DICTIONARY	cytochrome p450 2c19	cytochrome P450 2C19	78#98		A total of 119 Japanese patients with recurrent reflux oesophagitis underwent cytochrome P450 2C19 genotyping prior to receiving daily omeprazole 10 mg or 20 mg for 6-12 months, during which adverse event frequency, serum gastrin levels and endoscopic findings were monitored.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	METHODS	3	4	2520	LONGTERM|DICTIONARY	gastrin	gastrin	222#229		A total of 119 Japanese patients with recurrent reflux oesophagitis underwent cytochrome P450 2C19 genotyping prior to receiving daily omeprazole 10 mg or 20 mg for 6-12 months, during which adverse event frequency, serum gastrin levels and endoscopic findings were monitored.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	RESULTS	4	6	2520	LONGTERM|DICTIONARY	gastrin	gastrin	30#37		In all genotype groups, serum gastrin increased during the first 3 months of dosing but stabilized thereafter.
15932363	2005	Aliment. Pharmacol. Ther.	0269-2813	CONCLUSIONS	5	8	1557	LONGTERM|DICTIONARY	cytochrome p450 2c19	cytochrome P450 2C19	99#119		Long-term treatment with omeprazole was well-tolerated in Japanese patients, irrespective of their cytochrome P450 2C19 metabolic genotype, indicating that dose adjustment depending on metabolic genotype is not required during treatment with omeprazole.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	TITLE	0	0	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	45#51		Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	6#12		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	86#92		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	1	6046	SYMBOL|GENE|GN|DICTIONARY	nat	NAT	97#100		Human CYP1A2 and arylamine N-acetyltransferases, which are encoded by the polymorphic CYP1A2 and NAT genes respectively, have been shown to have wide interindividual variations in metabolic capacity and may be potential modifiers of an individual's susceptibility to certain types of cancers.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	61#67		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	9	SYMBOL|DICTIONARY	nat1	NAT1	69#73		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		The present study aimed to evaluate the relationship between CYP1A2, NAT1 and NAT2 polymorphisms and cholangiocarcinoma (CCA), the most prevalent cancer in the north-east of Thailand.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	1544	SYMBOL|DICTIONARY	cyp1a2	CYP1A2	4#10		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	20#26		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	9	SYMBOL|DICTIONARY	nat1	NAT1	54#58		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	9	SYMBOL|NUMBER|DICTIONARY	nat1	NAT1	68#72		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	10	SYMBOL|DICTIONARY	nat2	NAT2	125#129		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	139#143		Two CYP1A2 alleles (CYP1A2*1A wild-type and *1F), six NAT1 alleles (NAT1*4 wild-type, *3, *10, *11, *14A and *14B) and seven NAT2 alleles (NAT2*4 wild-type, *5, *6A, *6B, *7A, *7B and *13), which are the major alleles found in most populations, were analysed.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	9#15		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	9	SYMBOL|NUMBER|DICTIONARY	nat1	NAT1	27#31		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	51#55		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	153#159		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	1544	SYMBOL|NUMBER|DICTIONARY	cyp1a2	CYP1A2	294#300		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	5	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	342#346		Although CYP1A2*1A allele, NAT1*10 allele, and the NAT2 slow acetylator alleles were not associated with CCA risk, among the male subjects, the genotype CYP1A2*1A/*1A conferred a decreased risk of the cancer (adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.08-0.94) compared with CYP1A2*1F/1*F. Frequency distributions of rapid NAT2*13 and two slow alleles (*6B and *7A), but not the other major alleles, were associated with lower CCA risk.
15901993	2005	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	29#33		This study suggests that the NAT2 polymorphism may be a modifier of individual risk to CCA.
15956353	2005	J. Mol. Endocrinol.	0952-5041	TITLE	0	0	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	19#26		A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	1	1594	SYMBOL|DICTIONARY	cyp27b1	CYP27B1	70#77		Previous studies have suggested an association between alleles of the CYP27B1 (1-alpha hydroxylase) gene and autoimmune conditions.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	2	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	116#123		We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5' region and promoter of the CYP27B1 gene for association in a cohort of Graves' disease and autoimmune Addison's disease subjects from the UK.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_1/3	1	3	1594	SYMBOL|DICTIONARY	cyp27b1	CYP27B1	210#217		Genomic DNA samples from white patients with autoimmune Addison's disease (n = 104) and healthy controls (n = 464) were genotyped by PCR-RFLP analysis for the SNPs at positions -1260 and -1077 5' of the coding CYP27B1 sequences.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_3/3	3	7	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	21#28		Alleles at the three CYP27B1 markers were in tight linkage disequilibrium with each other and all showed association with autoimmune Addison's disease.
15956353	2005	J. Mol. Endocrinol.	0952-5041	ALL_TEXT_3/3	3	11	1594	SYMBOL|GENE|GN|DICTIONARY	cyp27b1	CYP27B1	30#37		We are able to confirm that a CYP27B1 promoter allele is associated with autoimmune Addison's disease, and extend this finding to include an associated promoter haplotype.
15940757	2005	J. Rheumatol.	0315-162X	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		Glutathione S-transferase M1, T1, and P1 genotypes and rheumatoid arthritis.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	89#94		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2950	SYMBOL|DICTIONARY	gstp	GSTP	100#104		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	METHODS	2	4	3123	SYMBOL|DICTIONARY	hla drb 1	HLA-DRB 1	0#9		HLA-DRB 1 typing and further subtyping of all alleles was performed using sequence-specific oligonucleotide probe hybridization after PCR.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	31#36		The OR for risk of RA with the GSTM1-null genotype was 1.40 (95% CI 1.02- 1.92, p = 0.04), and 1.86 (95% CI 1.12- 3.09, p = 0.005) among individuals without the shared epitope (SE).
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	61#66		Among patients with RA, the OR for risk of severe RA for the GSTM1-null genotype was 2.45 (95% CI 1.04- 5.77, p = 0.02).
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	9	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	40#45		No association was observed between the GSTT1 or GSTP1 genotypes and either risk or severity of RA.
15940757	2005	J. Rheumatol.	0315-162X	RESULTS	3	9	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	49#54		No association was observed between the GSTT1 or GSTP1 genotypes and either risk or severity of RA.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	56#61		These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
15940757	2005	J. Rheumatol.	0315-162X	CONCLUSION	4	10	3123	SYMBOL|DICTIONARY	hla drb 1	HLA-DRB 1	173#182		These results suggest that the deletion polymorphism of GSTM1 is associated with increased susceptibility for RA, particularly among individuals who are not carriers of the HLA-DRB 1 SE.
16004559	2006	Pharmacogenomics	1462-2416	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	abcb1	ABCB1	34#39		Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.
16004559	2006	Pharmacogenomics	1462-2416	OBJECTIVES	1	1	5243	SYMBOL|()|GENE|GN|DICTIONARY	abcb1	ABCB1	140#145		The aim of this study was to investigate the association of the complex haplotype system of the adenosine triphosphate-binding cassette B1 (ABCB1) gene with the epilepsy treatment response.
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	44#47		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	81890	SYMBOL|DICTIONARY	tgt	TGT	53#56		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	58#61		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	62#65		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	81890	SYMBOL|DICTIONARY	tgt	TGT	70#73		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	74#77		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	165#168		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16004559	2006	Pharmacogenomics	1462-2416	METHODS AND RESULTS	2	6	7368	SYMBOL|DICTIONARY	cgt	CGT	169#172		In contrast, patients with the TTC/TTC, TTC/CGT, TTC/TGT, CGT/CGT and TGT/CGT haplotype combinations were more likely to be seizure-free (all p-values<0.0001 except CGT/CGT [p=0.0063]).
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	TITLE	0	0	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	15#23		Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3123	SYMBOL|DICTIONARY	drb 1	DRB 1	112#117		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	RESULTS	3	5	3119	SYMBOL|DICTIONARY	hla dqb 1	HLA DQB 1	10#19		Comparing HLA DQB 1 typings of SFN+ patients, SFN- patients and control individuals revealed a significant increase of the allele DQB 1 0602 in SFN+ patients compared to controls.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin converting enzyme	20#49		Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	54#89		Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_1/3	1	2	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	181#186		This study was conducted to determine whether the ACE I/D gene variant is involved in migraine risk and whether this variant might act in combination with the previously implicated MTHFR C677T genetic variant in 270 migraine cases and 270 matched controls.
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	55#60		Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	5	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	95#100		Multivariate analysis, including genotype data for the MTHFR C677T, provided evidence that the MTHFR (TT) and ACE (ID/DD) genotypes act in combination to increase migraine susceptibility (OR = 2.18, 95% CI: 1.15-4.16, P = 0.018).
15893594	2005	Brain Res. Mol. Brain Res.	0169-328X	ALL_TEXT_3/3	3	7	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	160#165		In Caucasians, the ACE D allele confers a weak independent risk to migraine susceptibility and also appears to act in combination with the C677T variant in the MTHFR gene to confer a stronger influence on the disease.
15776395	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	47#52		Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
15776395	2005	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	3559	SYMBOL|DICTIONARY|EXTRACTED	cd25	CD25	53#57		Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|DICTIONARY	il2ra	IL2RA	147#152		As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	3559	SYMBOL|()|DICTIONARY|EXTRACTED	cd25	CD25	154#158	15776395-1-147-152	As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex.
15776395	2005	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	4	3559	SYMBOL|DICTIONARY|EXTRACTED	cd25	CD25	106#110	15776395-1-147-152	We found strong statistical evidence in the case-control collection (P=6.5x10(-8)) for a T1D locus in the CD25 region of chromosome 10p15 and replicated the association in the family collection (P=7.3x10(-3); combined P=1.3x10(-10)).
15772682	2005	Genes Immun.	1466-4879	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	Interleukin-10	0#14		Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3586	LONGTERM|DICTIONARY	interleukin 10	Interleukin-10	0#14		Interleukin-10 (IL-10) is an anti-inflammatory cytokine that modulates collagen production and B-cell survival.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il 10	IL-10	16#21	15772682-2-0-14	Interleukin-10 (IL-10) is an anti-inflammatory cytokine that modulates collagen production and B-cell survival.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	24#29	15772682-2-0-14	To determine if certain IL-10 genotypes are risk factors for the development of SSc and influence disease-associated autoimmune responses, 248 Caucasian and 264 Japanese SSc patients and controls were genotyped for three loci: -3575, -2849, and -2763.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	11#16	15772682-2-0-14	Particular IL-10 genotypes were associated with SSc-related autoantibodies.
15772682	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	8	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	27#32	15772682-2-0-14	These results suggest that IL-10 genotypes contribute to the etiology of scleroderma.
15834927	2005	Hepatology	0270-9139	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	29#34		Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	47#82		Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	84#89	15834927-2-47-82	Hyperhomocysteinemia causes steatosis, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism induces hyperhomocysteinemia.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_1/3	1	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	161#166	15834927-2-47-82	One hundred sixteen CHC patients were evaluated for HAI, fibrosis and steatosis grades, body mass index, HCV genotypes, HCV RNA levels, homocysteinemia, and the MTHFR C677T polymorphism.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	5	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	60#65	15834927-2-47-82	Hyperhomocysteinemia was associated with the TT genotype of MTHFR (r = 0.367; P = .001).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	6	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	Median values of homocysteine in the CC, CT, and TT genotypes of the MTHFR gene were 9.3, 12.2, and 18.6 micromol/L, respectively (P = .006).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	30#35	15834927-2-47-82	Steatosis correlated with the MTHFR polymorphism, homocysteinemia, HAI and fibrosis.
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	12	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	69#74	15834927-2-47-82	On univariate analysis, fibrosis was associated with age, steatosis, MTHFR, homocysteinemia and HAI; however, on multivariate analysis, liver fibrosis was independently associated with age (P = .03), HAI (P = .0001), and steatosis (P = .007).
15834927	2005	Hepatology	0270-9139	ALL_TEXT_3/3	3	13	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	48#53	15834927-2-47-82	In conclusion, a genetic background such as the MTHFR C677T polymorphism responsible for hyperhomocysteinemia plays a role in the development of higher degree of steatosis, which in turn accelerates the progression of liver fibrosis in CHC.
15886814	2005	Thromb. Haemost.	0340-6245	TITLE	0	0	1524	SYMBOL|GENE|GN|DICTIONARY	cx3cr1	CX3CR1	20#26		Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	88#94		Several lines of evidence suggest that the chemokine fractalkine (FKN) and its receptor CX3CR1 contribute to the accumulation of leukocytes in the atherosclerotic plaque.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	3	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	32#38		The influence of V249I, another CX3CR1 polymorphism, is discussed controversially.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	4	1524	SYMBOL|DICTIONARY	cx3cr1	CX3CR1	64#70		We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS).
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_2/3	2	5	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	129#147		Additionally, we assessed their association with the soluble ligand FKN and inflammatory activation measured by high sensitivity C-reactive protein (hsCRP).
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_3/3	3	9	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	127#145		During ACS these patients (carrying only I249) had significantly higher circulating concentrations of FKN and high sensitivity C-reactive protein (1.9- and 1.6-fold).
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	36#41		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	TITLE	0	0	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	46#51		Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_1/3	1	1	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	57#62		To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study was conducted in Korea.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_1/3	1	1	2072	SYMBOL|GENE|GN|DICTIONARY	ercc4	ERCC4	67#72		To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study was conducted in Korea.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_2/3	2	4	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	0#5		ERCC2 Asp(312)Asn (G>A) was genotyped by single-base extension assay and ERCC4 Ser(835)Ser (T>C) by dynamic allele-specific hybridization system.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_2/3	2	4	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	73#78		ERCC2 Asp(312)Asn (G>A) was genotyped by single-base extension assay and ERCC4 Ser(835)Ser (T>C) by dynamic allele-specific hybridization system.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	130#135		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	150#155		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	290#295		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	303#308		Although no significant association was observed between the genetic polymorphisms and the risk of breast cancer, women with both ERCC2 A allele- and ERCC4 C allele-containing genotypes showed a 2.6-fold risk (95% CI: 1.02-6.48) of breast cancer compared to women concurrently carrying the ERCC2 GG and ERCC4 TT genotypes.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	45#50		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	7	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	118#123		Interactive effect was also observed between ERCC4 genotype and body mass idnex (BMI) for the breast cancer risk; the ERCC4 C allele containing genotypes posed a 1.7-fold (95% CI: 0.96-2.93) breast cancer risk in obese women (BMI>25 kg/m(2)) with a borderline significance.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	8	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	49#54		Our finding suggests that the combined effect of ERCC2 Asp(312)Asn and ERCC4 Ser(835)Ser genotypes might be associated with breast cancer risk in Korean women.
15886521	2005	Exp. Mol. Med.	1226-3613	ALL_TEXT_3/3	3	8	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	71#76		Our finding suggests that the combined effect of ERCC2 Asp(312)Asn and ERCC4 Ser(835)Ser genotypes might be associated with breast cancer risk in Korean women.
15837080	2005	Int. J. Cardiol.	0167-5273	TITLE	0	0	7056	LONGTERM|DICTIONARY	thrombomodulin	thrombomodulin	25#39		Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	7056	LONGTERM|DICTIONARY	thrombomodulin	Thrombomodulin	0#14		Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	13#30		The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	4#21		The androgen receptor (AR) gene encodes a transcription factor, which mediates androgen action in target tissues, including the prostate.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	367	SYMBOL|EXTRACTED|()|GENE|GN	ar	AR	23#25	15824176-1-4-21	The androgen receptor (AR) gene encodes a transcription factor, which mediates androgen action in target tissues, including the prostate.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	367	SYMBOL|EXTRACTED	ar	AR	51#53	15824176-1-4-21	Prostate cancer is androgen dependent, implicating AR in susceptibility to this male condition.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	79017	SYMBOL|DICTIONARY	ggc	GGC	12#15		The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	367	SYMBOL|EXTRACTED	ar	AR	150#152	15824176-1-4-21	The CAG and GGC repeats in the AR have been studied extensively as markers of prostate cancer susceptibility, with inconclusive findings, whereas the AR-E211 G>A polymorphism has been associated with androgenetic alopecia.
15824176	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	367	SYMBOL|EXTRACTED	ar	AR	31#33	15824176-1-4-21	These results suggest that the AR-E211 A allele, in linkage with the functional repeat sequences, is associated with a lower risk of metastatic prostate cancer and a lower risk of alopecia.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	472	LONGTERM|DICTIONARY	ataxia telangiectasia mutated	ataxia telangiectasia mutated	25#54		Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	472	LONGTERM|DICTIONARY	ataxia telangiectasia mutated	ataxia telangiectasia mutated	49#78		To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	472	SYMBOL|()|DICTIONARY|EXTRACTED	atm	ATM	80#83	15824150-1-49-78	To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	3	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	17#20	15824150-1-49-78	Genotypes of the ATM polymorphisms-5144A > T, IVS21 + 1049T > C, IVS33 - 55T > C, IVS34 + 60G > A, and 3393T > G were determined by the 5'-nuclease assay.
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	5	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	5#8	15824150-1-49-78	Five ATM alleles were found to be in strong linkage disequilibrium (D' > 0.82; P < 0.001).
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	4#7	15824150-1-49-78	The ATM IVS21 + 1049 TC or CC, IVS34 + 60 GA or AA, and 3393 TG or GG genotypes were associated with increased breast cancer risk, particularly in premenopausal women [odds ratios (OR), 1.51; 95% confidence interval (CI), 1.11-2.05; OR, 1.42; 95% CI, 1.08-1.88; and OR, 1.37; 95% CI, 1.04-1.80, respectively].
15824150	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	472	SYMBOL|DICTIONARY|EXTRACTED	atm	ATM	55#58	15824150-1-49-78	Our results thus suggest that genetic polymorphisms of ATM play an important role in the development of breast cancer in Korean women.
15738346	2005	Hypertension	1524-4563	TITLE	0	0	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	0#10		PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites.
15738346	2005	Hypertension	1524-4563	ALL_TEXT_1/3	1	1	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	0#10		PGC-1alpha is a coactivator of numerous transcription factors and is expressed in tissues with high energy demands and abundant in mitochondria.
15738346	2005	Hypertension	1524-4563	ALL_TEXT_1/3	1	3	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	37#47		The common Gly482Ser polymorphism of PGC-1alpha has previously shown association with arterial hypertension among Austrian men.
15738346	2005	Hypertension	1524-4563	ALL_TEXT_3/3	3	9	10891	SYMBOL|DICTIONARY	pgc 1alpha	PGC-1alpha	33#43		In conclusion, the Ser allele of PGC-1alpha Gly482Ser confers a significantly reduced risk of hypertension in whites.
15781196	2005	Mol. Genet. Metab.	1096-7192	TITLE	0	0	590	SYMBOL|GENE|GN|DICTIONARY	bche	BCHE	26#30		Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample.
15781196	2005	Mol. Genet. Metab.	1096-7192	TITLE	0	0	590	LONGTERM|DICTIONARY	butyrylcholinesterase	butyrylcholinesterase	45#66		Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample.
15781196	2005	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	590	LONGTERM|DICTIONARY	butyrylcholinesterase	butyrylcholinesterase	31#52		The genetic variation of human butyrylcholinesterase has been associated with height, body mass index, Alzheimer's disease, and response to xenobiotic agents.
15781196	2005	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	2	590	SYMBOL|GENE|GN|DICTIONARY	bche	BCHE	73#77		The present study reports four new mutations, found in the exon 2 of the BCHE gene, in a sample from 3001 Brazilian blood donors.
15781196	2005	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	5	590	LONGTERM|DICTIONARY	butyrylcholinesterase	butyrylcholinesterase	42#63		A table with the 58 non-usual variants of butyrylcholinesterase is also presented.
15718509	2005	Stroke	1524-4628	TITLE	0	0	12	SYMBOL|()|DICTIONARY	serpina3	SERPINA3	30#38		Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	1	12	SYMBOL|()|DICTIONARY	serpina3	SERPINA3	57#65		The member 3 of clade A of serine proteinase inhibitors (SERPINA3), known previously as the alpha1-antichymotrypsin, is an acute phase protein, the levels of which increase in acute and chronic inflammation.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	2	12	SYMBOL|GENE|GN|DICTIONARY	serpina3	SERPINA3	28#36		The A/T polymorphism of the SERPINA3 gene influences expression of SERPINA3 protein.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	2	12	SYMBOL|GENE|GN|DICTIONARY	serpina3	SERPINA3	67#75		The A/T polymorphism of the SERPINA3 gene influences expression of SERPINA3 protein.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	3	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	0#8		SERPINA3 can be related to aneurysmal subarachnoid hemorrhage (SAH) by influencing inflammation or by regulating cathepsin G activity.
15718509	2005	Stroke	1524-4628	BACKGROUND AND PURPOSE	1	4	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	31#39		We studied the significance of SERPINA3 A/T polymorphism in patients with aneurysmal SAH compared with healthy controls.
15718509	2005	Stroke	1524-4628	METHODS	2	5	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	92#100		A total of 180 patients with aneurysmal SAH and 263 healthy controls were genotyped for the SERPINA3 A/T polymorphism.
15718509	2005	Stroke	1524-4628	METHODS	2	7	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	0#8		SERPINA3 polymorphism was detected by polymerase chain reaction amplification and restriction enzyme digestion.
15718509	2005	Stroke	1524-4628	RESULTS	3	8	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	4#12		The SERPINA3 genotype distribution in patients with aneurysmal SAH (AA-29 16.1%; AT-108 60.0%; TT-43 23.9%) differed significantly from controls (AA-70 26.6%; AT-123 46.8%; TT-70 26.6%; P=0.009).
15718509	2005	Stroke	1524-4628	RESULTS	3	9	12	SYMBOL|DICTIONARY	serpina3	SERPINA3	205#213		A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.
15718509	2005	Stroke	1524-4628	CONCLUSIONS	4	10	12	SYMBOL|GENE|GN|DICTIONARY	serpina3	SERPINA3	24#32		The A/T polymorphism of SERPINA3 gene is associated with the risk factor for aneurysmal SAH.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	3	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	70#84		The development of myocyte hypertrophy has been largely attributed to angiotensin II, whose growth properties are antagonized by taurine.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	183	LONGTERM|GFAM|FN|DICTIONARY	angiotensin ii	angiotensin II	42#56		However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	108#122		However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	METHODS	2	13	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	76#81		To examine cardiomyocyte apoptosis index (CAI), mRNA and protein of AT2 and Bcl-2 in cardiomyocytes, methods of terminal-deoxynucltidyl transferase mediated nick end labeling (TUNEL), reversal transcription polymerase chain reaction (RT-PCR) and immunoblot (Western Blot) were used, respectively.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	RESULTS	3	18	596	SYMBOL|DICTIONARY	bcl 2	Bcl-2	11#16		Changes of Bcl-2 were opposed to those of AT2.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	CONCLUSIONS	4	19	186	SYMBOL|GENE|GN|DICTIONARY	at2	AT2	235#238		A high expression of AT2 may accelerate the apoptosis of cardiomyocytes in diabetic rats and play a role in precipitating diabetic cardiomyopathy; taurine may protect diabetic rats from developing cardiomyopathy also by downregulating AT2 receptors.
15788153	2005	Microbes Infect.	1286-4579	TITLE	0	0	4055	LONGTERM|GENE|GT|DICTIONARY	lymphotoxin beta receptor	lymphotoxin beta receptor	58#83		Testosterone responsiveness of spleen and liver in female lymphotoxin beta receptor-deficient mice resistant to blood-stage malaria.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	1	4055	LONGTERM|GENE|GT|DICTIONARY	lymphotoxin beta receptor	lymphotoxin beta receptor	28#53		Disrupted signaling through lymphotoxin beta receptor (LTbetaR) results in severe defects of the spleen and even loss of all other secondary lymphoid tissues, making mice susceptible to diverse infectious agents.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	1	4055	SYMBOL|EXTRACTED|()	ltbetar	LTbetaR	55#62	15788153-1-28-53	Disrupted signaling through lymphotoxin beta receptor (LTbetaR) results in severe defects of the spleen and even loss of all other secondary lymphoid tissues, making mice susceptible to diverse infectious agents.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	2	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	43#50	15788153-1-28-53	Surprisingly, however, we find that female LTbetaR-deficient mice are even more resistant to blood stages of Plasmodium chabaudi malaria than wild-type C57BL/6 mice.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_1/3	1	3	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	21#28	15788153-1-28-53	Higher resistance of LTbetaR-deficient mice correlates with an earlier onset of reticulocytosis, and the period of anemia is shorter.
15788153	2005	Microbes Infect.	1286-4579	ALL_TEXT_3/3	3	9	4055	SYMBOL|EXTRACTED	ltbetar	LTbetaR	191#198	15788153-1-28-53	Collectively, our data suggest that testosterone dysregulates the inflammatory response in spleen and liver during their differentiation to anti-malaria effectors in malaria-resistant female LTbetaR-deficient mice, thus contributing to the testosterone-induced lethal outcome of malaria.
15670652	2005	Neurosci. Lett.	0304-3940	TITLE	0	0	1121	SYMBOL|DICTIONARY	rep1	Rep1	73#77		Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|DICTIONARY	snca	SNCA	47#51		It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	1	6622	SYMBOL|GENE|GN|DICTIONARY	alpha synuclein	alpha-synuclein	57#72		It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD).
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	2	1121	SYMBOL|DICTIONARY	rep1	Rep1	44#48		The polymorphic mixed sequence repeat (NACP-Rep1) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicting results.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_1/3	1	2	6622	SYMBOL|DICTIONARY	snca	SNCA	76#80		The polymorphic mixed sequence repeat (NACP-Rep1) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicting results.
15670652	2005	Neurosci. Lett.	0304-3940	ALL_TEXT_3/3	3	5	1121	SYMBOL|DICTIONARY	rep1	Rep1	72#76		Combined analysis including all previously published ancestral European Rep1 data yielded a highly significant association between the 0 allele and a reduced risk for PD (OR=0.79, 95% CI 0.70-0.89, p=0.0001).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	51#64		Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	29#42		The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	44#48	15635591-1-29-42	The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	142#146	15635591-1-29-42	The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system and increased levels of IL-6 have been found in patients with Parkinson's disease (PD).
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	53#57	15635591-1-29-42	It is known that estrogen inhibits the production of IL-6, via action on estrogen receptors, thereby pointing to an important influence of estrogen on IL-6.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	151#155	15635591-1-29-42	It is known that estrogen inhibits the production of IL-6, via action on estrogen receptors, thereby pointing to an important influence of estrogen on IL-6.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	2100	SYMBOL|EXTRACTED|()	erbeta	ERbeta	163#169	15635591-3-139-161	In a previous study, we reported an association between a G/A single nucleotide polymorphism (SNP) at position 1730 in the gene coding for estrogen receptor beta (ERbeta) and age of onset of PD.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	81#85	15635591-1-29-42	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	4	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	141#147	15635591-3-139-161	To investigate the influence of a G/C SNP at position 174 in the promoter of the IL-6 gene, and the possible interaction of this SNP and the ERbeta G-1730A SNP on the risk for PD, the G-174C SNP was genotyped, by pyrosequencing, in 258 patients with PD and 308 controls.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	5	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	61#65	15635591-1-29-42	A significantly elevated frequency of the GG genotype of the IL-6 SNP was found in the patient group and this was most obvious among patients with an early age of onset (</=50 years) of PD.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	29#33	15635591-1-29-42	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	6	2100	SYMBOL|EXTRACTED	erbeta	ERbeta	38#44	15635591-3-139-161	When the GG genotypes of the IL-6 and ERbeta SNPs were combined, the combination was much more robustly associated with PD, and especially with PD with an early age of onset, than respective GG genotype when analyzed separately.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 6	IL-6	48#52	15635591-1-29-42	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15635591	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	2100	SYMBOL|EXTRACTED|GENE|GN	erbeta	ERbeta	223#229	15635591-3-139-161	Our results indicate that the G-174C SNP in the IL-6 promoter may influence the risk for developing PD, particularly regarding early age of onset PD, and that the effect is modified by interaction of the G-1730A SNP in the ERbeta gene.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	17#22		Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	7515	SYMBOL|()|DICTIONARY	xrcc1	XRCC1	42#47		X-ray repair cross complementing group 1 (XRCC1) is an important DNA base excision repair gene and exhibits polymorphic variation.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	3	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	169#174		Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg-->Trp and 399 Arg-->Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	85#90		We observed no significant increases in risk among all subjects who were carriers of XRCC1 194Trp or 399Gln alleles.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	10	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	38#43		In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (>/=35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, -0.49; 95% CI, -0.03 to -0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	11	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	64#69		These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	12	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	60#65		However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk.
15734955	2005	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	13	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	52#57		Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pathway are needed.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	4353	SYMBOL|DICTIONARY	mpo	MPO	52#55		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	57#62		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
15705913	2005	Cancer Res.	0008-5472	TITLE	0	0	847	SYMBOL|DICTIONARY	cat	CAT	64#67		Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	4353	LONGTERM|DICTIONARY	myeloperoxidase	myeloperoxidase	150#165		Because mitochondrial manganese superoxide dismutase catalyzes conversion of superoxide radicals to H(2)O(2), with catalase neutralizing H(2)O(2) and myeloperoxidase converting H(2)O(2) to highly reactive hypochlorous acid, we hypothesized that gene variants could impact the efficacy of treatment for breast cancer and improve survival.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	4	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	70#75		DNA was extracted from paraffin-embedded normal tissue (n = 279), and MnSOD, CAT, and MPO genotypes were determined using mass spectrometry.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	4	847	SYMBOL|DICTIONARY	cat	CAT	77#80		DNA was extracted from paraffin-embedded normal tissue (n = 279), and MnSOD, CAT, and MPO genotypes were determined using mass spectrometry.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	4	4353	SYMBOL|DICTIONARY	mpo	MPO	86#89		DNA was extracted from paraffin-embedded normal tissue (n = 279), and MnSOD, CAT, and MPO genotypes were determined using mass spectrometry.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	4353	SYMBOL|DICTIONARY	mpo	MPO	30#33		Women who were homozygous for MPO G alleles, associated with increased transcription, had better survival (hazard ratio, 0.60; 95% confidence interval, 0.38-0.95; P = 0.03) than those with common alleles.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	847	SYMBOL|DICTIONARY	cat	CAT	5#8		Both CAT TT and MnSOD CC genotypes were associated with nonsignificant reduced hazard of death.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	16#21		Both CAT TT and MnSOD CC genotypes were associated with nonsignificant reduced hazard of death.
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	88#93		When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	4353	SYMBOL|DICTIONARY	mpo	MPO	98#101		When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	6648	SYMBOL|DICTIONARY	mnsod	MnSOD	114#119		When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15705913	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	4353	SYMBOL|DICTIONARY	mpo	MPO	127#130		When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01).
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	58#63		Cytokine gene polymorphisms for IFN-gamma (+874A-->T) and IL-10 (-1082G-->A) were assessed.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	41#46		X-ray repair cross-complementing gene 1 (XRCC1; Arg399Gln), xeroderma pigmentosum complementary group D (XPD; Lys751Gln), and excision repair cross-complementing gene 1 (ERCC1; codon 118) DNA repair polymorphisms were also determined.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	5	2068	LONGTERM|DICTIONARY	xeroderma pigmentosum complementary group d	xeroderma pigmentosum complementary group D	60#103		X-ray repair cross-complementing gene 1 (XRCC1; Arg399Gln), xeroderma pigmentosum complementary group D (XPD; Lys751Gln), and excision repair cross-complementing gene 1 (ERCC1; codon 118) DNA repair polymorphisms were also determined.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	5	2067	SYMBOL|DICTIONARY	ercc1	ERCC1	170#175		X-ray repair cross-complementing gene 1 (XRCC1; Arg399Gln), xeroderma pigmentosum complementary group D (XPD; Lys751Gln), and excision repair cross-complementing gene 1 (ERCC1; codon 118) DNA repair polymorphisms were also determined.
15709194	2005	Clin. Cancer Res.	1078-0432	RESULTS	3	6	3586	SYMBOL|DICTIONARY	il 10	IL-10	196#201		IFN-gamma (+874A-->T) gene polymorphism was statistically significantly associated with response (P = 0.001), progression-free survival (P = 0.0012), and overall survival (P < 0.001), whereas the IL-10 polymorphism was marginally associated with response (P = 0.03) and overall survival (P = 0.065).
15709194	2005	Clin. Cancer Res.	1078-0432	RESULTS	3	8	2067	SYMBOL|DICTIONARY	ercc1	ERCC1	4#9		The ERCC1 polymorphism was weakly associated with overall survival (P = 0.045).
15709194	2005	Clin. Cancer Res.	1078-0432	RESULTS	3	9	3586	SYMBOL|DICTIONARY	il 10	IL-10	39#44		"Combining polymorphisms for IFN-gamma, IL-10, and ERCC1 stratified patients into four distinct groups with significantly different clinical outcome (P < 0.001), so that patients with more ""favorable"" polymorphisms had a better outcome."
15709194	2005	Clin. Cancer Res.	1078-0432	RESULTS	3	9	2067	SYMBOL|DICTIONARY	ercc1	ERCC1	50#55		"Combining polymorphisms for IFN-gamma, IL-10, and ERCC1 stratified patients into four distinct groups with significantly different clinical outcome (P < 0.001), so that patients with more ""favorable"" polymorphisms had a better outcome."
15659127	2005	Clin Transplant	0902-0063	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	Angiotensinogen	0#15		Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.
15659127	2005	Clin Transplant	0902-0063	TITLE	0	0	5054	LONGTERM|GENE|GN|DICTIONARY	plasminogen activator inhibitor 1	plasminogen activator inhibitor-1	20#53		Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor 1	plasminogen activator inhibitor-1	19#52		It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_1/3	1	3	5054	SYMBOL|()|DICTIONARY|EXTRACTED	pai 1	PAI-1	54#59	15659127-3-19-52	It is thought that plasminogen activator inhibitor-1 (PAI-1) functions in the RAS, in addition to involvement in thrombotic risk and fibrosis.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_2/3	2	4	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	47#62		This study investigated possible links between angiotensinogen (AGT) genotypes (M235T/MM, MT, TT) and PAI-1 genotypes (4G4G, 4G5G, 5G5G) and CAD assessments of both types of polymorphism were performed in 82 renal allograft recipients.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_2/3	2	4	183	SYMBOL|()|DICTIONARY|EXTRACTED	agt	AGT	64#67	15659127-4-47-62	This study investigated possible links between angiotensinogen (AGT) genotypes (M235T/MM, MT, TT) and PAI-1 genotypes (4G4G, 4G5G, 5G5G) and CAD assessments of both types of polymorphism were performed in 82 renal allograft recipients.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_2/3	2	4	5054	SYMBOL|DICTIONARY|EXTRACTED	pai 1	PAI-1	102#107	15659127-3-19-52	This study investigated possible links between angiotensinogen (AGT) genotypes (M235T/MM, MT, TT) and PAI-1 genotypes (4G4G, 4G5G, 5G5G) and CAD assessments of both types of polymorphism were performed in 82 renal allograft recipients.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_2/3	2	5	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	56#59	15659127-4-47-62	One hundred healthy subjects were also investigated for AGT polymorphism, and 80 healthy subjects for PAI-1 polymorphism.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_2/3	2	5	5054	SYMBOL|DICTIONARY|EXTRACTED	pai 1	PAI-1	102#107	15659127-3-19-52	One hundred healthy subjects were also investigated for AGT polymorphism, and 80 healthy subjects for PAI-1 polymorphism.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_3/3	3	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	17#20	15659127-4-47-62	Determination of AGT M235T and PAI-1 genotypes prior to transplantation may help identify patients who at risk for chronic renal transplant dysfunction.
15659127	2005	Clin Transplant	0902-0063	ALL_TEXT_3/3	3	9	5054	SYMBOL|DICTIONARY|EXTRACTED	pai 1	PAI-1	31#36	15659127-3-19-52	Determination of AGT M235T and PAI-1 genotypes prior to transplantation may help identify patients who at risk for chronic renal transplant dysfunction.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	TITLE	0	0	1080	SYMBOL|DICTIONARY	cftr	CFTR	83#87		Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	BACKGROUND	1	3	1080	SYMBOL|DICTIONARY	cftr	CFTR	83#87		We assessed the decline of pancreatic function in CF infants carrying class 1 or 2 CFTR mutations who were diagnosed in a neonatal screening program.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	MATERIALS AND METHODS	2	5	1990	LONGTERM|DICTIONARY	pancreatic elastase 1	pancreatic elastase-1	23#44		In all subjects, fecal pancreatic elastase-1 concentrations and fecal fat excretion were scheduled to be determined at diagnosis, at 6 months of age and subsequently at 6-month intervals.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	RESULTS	3	6	1990	LONGTERM|DICTIONARY	pancreatic elastase 1	pancreatic elastase-1	26#47		In all CF patients, fecal pancreatic elastase-1 concentrations of the first assay after diagnosis (3 to 4 months of age) were lower than the cut-off level for normals of <200 microg/g stool.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	RESULTS	3	8	1990	LONGTERM|DICTIONARY	pancreatic elastase 1	pancreatic elastase-1	59#80		At the age of 6 months, all screened CF subjects had fecal pancreatic elastase-1 concentrations <100 microg/g and at the age of 12 months all were pancreatic insufficient.
15699697	2005	J. Pediatr. Gastroenterol. Nutr.	0277-2116	CONCLUSION	4	11	1080	SYMBOL|DICTIONARY	cftr	CFTR	34#38		In patients carrying class 1 or 2 CFTR mutations, pancreatic insufficiency develops in the first months of life.
15649153	2005	Pigment Cell Res.	0893-5785	TITLE	0	0	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	0#5		CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_1/3	1	1	1493	SYMBOL|()|GENE|GN|DICTIONARY	ctla4	CTLA4	37#42		The cytotoxic T lymphocyte antigen4 (CTLA4) gene plays a critical role in the control of T cell activation.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	91#96		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	3	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	208#213		Several studies have disclosed an association between the previously known variants of the CTLA4 gene and autoimmune disorders, but no study has as yet found any definite association between vitiligo and the CTLA4 polymorphisms.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_2/3	2	4	1493	SYMBOL|DICTIONARY	ctla4	CTLA4	174#179		A recent study identified new candidate susceptibility polymorphisms in this region, associated with differential gene splicing and thereby the relative abundance of soluble CTLA4.
15649153	2005	Pigment Cell Res.	0893-5785	ALL_TEXT_3/3	3	7	1493	SYMBOL|GENE|GN|DICTIONARY	ctla4	CTLA4	51#56		The results indicate that the polymorphisms in the CTLA4 gene region confer susceptibility to vitiligo when occurring together with other autoimmune diseases, but not in patients with isolated vitiligo.
15987458	2006	Breast Cancer Res.	1465-542X	TITLE	0	0	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	0#5		CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
15987458	2006	Breast Cancer Res.	1465-542X	INTRODUCTION	1	1	1586	SYMBOL|DICTIONARY	cyp17	CYP17	8#13		Because CYP17 can influence the degree of exposure of breast tissues to oestrogen, the interaction between polymorphisms in this gene and hormonal risk factors is of particular interest.
15987458	2006	Breast Cancer Res.	1465-542X	METHODS	2	3	1586	SYMBOL|DICTIONARY	cyp17	CYP17	16#21		Risk factor and CYP17 genotyping data were derived from a large Australian population-based case-control-family study of 1,284 breast cancer cases and 679 controls.
15987458	2006	Breast Cancer Res.	1465-542X	RESULTS	3	5	1586	SYMBOL|DICTIONARY	cyp17	CYP17	37#42		We found no associations between the CYP17 genotype and breast cancer overall.
15987458	2006	Breast Cancer Res.	1465-542X	CONCLUSION	4	9	1586	SYMBOL|DICTIONARY	cyp17	CYP17	79#84		We observed no evidence of effect modification of reproductive risk factors by CYP17 genotype, although the experiment did not have sufficient statistical power to detect small main effects and modest effects in subgroups.
15624175	2005	Electrophoresis	0173-0835	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	76#91		Genotyping the -6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	1	183	LONGTERM|DICTIONARY|GENE|GA	angiotensinogen	Angiotensinogen	0#15		Angiotensinogen (AGT) gene has been regarded as one of the candidate genes for essential hypertension.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	1	183	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	17#20	15624175-1-0-15	Angiotensinogen (AGT) gene has been regarded as one of the candidate genes for essential hypertension.
15624175	2005	Electrophoresis	0173-0835	ALL_TEXT_1/3	1	2	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	26#29	15624175-1-0-15	In our study, the role of AGT gene as a putatively predisposing gene for hypertension was evaluated by genotyping a A (-6) G polymorphism in the core promoter region in 123 patients with essential hypertension and 103 healthy controls.
15876692	2005	J. Appl. Genet.	1234-1983	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY|GA	androgen receptor	androgen receptor	31#48		CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
15876692	2005	J. Appl. Genet.	1234-1983	TITLE	0	0	367	SYMBOL|EXTRACTED|()|GENE|GN	ar	AR	50#52	15876692-0-31-48	CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
15876692	2005	J. Appl. Genet.	1234-1983	ALL_TEXT_2/3	2	2	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	46#63		SBMA is caused by CAG repeat expansion in the androgen receptor gene.
15308589	2005	Carcinogenesis	0143-3334	TITLE	0	0	1548	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	14#20		Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1548	SYMBOL|()|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	77#83	15308589-1-56-75	We reported previously that subjects homozygous for the cytochrome P450 2A6 (CYP2A6) (*)4 have a lower risk of lung cancer.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	2	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	161#167	15308589-1-56-75	The purpose of this study was to clarify whether or not the alterations of smoking behavior and risk for lung cancer could be found in subjects possessing novel CYP2A6 variants discovered recently.
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	4	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	86#92	15308589-1-56-75	It was found that the amounts of daily cigarette consumption in subjects who harbored CYP2A6(*)4/(*)7, (*)4/(*)10, (*)7/(*)7, (*)7/(*)9 and (*)4/(*)4 genotypes were significantly less than those in subjects carrying the (*)1/(*)1 genotype (P < 0.01).
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	5	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	147#153	15308589-1-56-75	Even after adjustment with cigarette consumption, the adjusted odds ratios (ORs) for lung cancer were significantly lower in subjects who harbored CYP2A6(*)1/(*)4, (*)1/(*)7, (*)1/(*)9, (*)1/(*)10, (*)4/(*)4, (*)4/(*)7, (*)4/(*)9, (*)7/(*)7 and (*)7/(*)9 genotypes than those who possessed the (*)1/(*)1 genotype (P < 0.05).
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	68#74	15308589-1-56-75	When participants were classified into four groups according to the CYP2A6 genotypes, group 1 ((*)1/(*)1), group 2 (heterozygotes for the (*)1 and a variant allele), group 3 (heterozygotes and homozygotes for variant alleles except for (*)4/(*)4) and group 4 ((*)4/(*)4), lung cancer risk was found to be less in subjects with the variant of CYP2A6 alleles [group 2, OR of 0.59 [95% confidence interval (CI), 0.44-0.79]; group 3, OR of 0.52 (95% CI, 0.37-0.72); group 4, OR of 0.30 (95% CI, 0.16-0.57)].
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_2/3	2	6	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	342#348	15308589-1-56-75	When participants were classified into four groups according to the CYP2A6 genotypes, group 1 ((*)1/(*)1), group 2 (heterozygotes for the (*)1 and a variant allele), group 3 (heterozygotes and homozygotes for variant alleles except for (*)4/(*)4) and group 4 ((*)4/(*)4), lung cancer risk was found to be less in subjects with the variant of CYP2A6 alleles [group 2, OR of 0.59 [95% confidence interval (CI), 0.44-0.79]; group 3, OR of 0.52 (95% CI, 0.37-0.72); group 4, OR of 0.30 (95% CI, 0.16-0.57)].
15308589	2005	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	1548	SYMBOL|DICTIONARY|EXTRACTED	cyp2a6	CYP2A6	31#37	15308589-1-56-75	These results suggest that the CYP2A6 is one of the principal determinants affecting not only smoking behavior but also susceptibility to tobacco-related lung cancer.
15571962	2005	Eur. J. Cancer	0959-8049	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	0#5		BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
15571962	2005	Eur. J. Cancer	0959-8049	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	15#20		BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	21#26		The frequency of the BRCA1 G5193A and BRCA2 999del5 mutations in all ovarian cancer patients diagnosed over the period 1991-2000 was determined.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	38#43		The frequency of the BRCA1 G5193A and BRCA2 999del5 mutations in all ovarian cancer patients diagnosed over the period 1991-2000 was determined.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	19#24		In the carcinomas, BRCA1 and BRCA2 mutations were present in 1.2% and 6% of cases, respectively.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	5	675	SYMBOL|DICTIONARY	brca2	BRCA2	29#34		In the carcinomas, BRCA1 and BRCA2 mutations were present in 1.2% and 6% of cases, respectively.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	7	675	SYMBOL|DICTIONARY	brca2	BRCA2	59#64		Odds Ratio (OR) of developing ovarian cancer was 20.65 for BRCA2 carriers.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	63#68		Family history of breast/ovarian cancer was present for 70% of BRCA2 carriers and approximately 14% for non-carriers with carcinoma.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	9	675	SYMBOL|NUMBER|DICTIONARY	brca2	BRCA2	15#20		In conclusion, BRCA2 999del5 is present in 6% of ovarian cancer cases in Iceland and is associated with a 20-fold increase in the risk of the disease.
15571962	2005	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	4#9		The BRCA1 G5193A mutation is too rare to contribute significantly to ovarian cancer in Iceland.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	45#65		[Association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group].
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	71#78		[Association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group].
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	63#83		To investigate the association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated population.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	OBJECTIVE	1	1	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	89#96		To investigate the association of the T(-344)C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated population.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	METHODS	2	3	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	15#22		The segment of CYP11B2 was amplified from DNA by polymerase chain reaction(PCR).
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	RESULTS	3	6	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	19#26		The frequencies of CYP11B2 genotypes of CC, CT and TT were 0.20, 0.50 and 0.30 in hypertensives respectively, and 0.12, 0.61 and 0.27 in controls respectively.
15583997	2005	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	9	1585	SYMBOL|GENE|GN|DICTIONARY	cyp11b2	CYP11B2	56#63		The results suggested that the T(-344)C polymorphism of CYP11B2 gene may be associated with hypertension in female Kazakh population of Xinjiang Barlikun area.
15522251	2005	Biol. Psychiatry	0006-3223	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	112#116		Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
15522251	2005	Biol. Psychiatry	0006-3223	BACKGROUND	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	82#86		Numerous lines of evidence have also suggested that individuals with at least one APOE epsilon4 allele on chromosome 19 are at increased risk of developing AD.
15522251	2005	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	348	SYMBOL|DICTIONARY	apoe	APOE	131#135		We tested these CSF markers in groups of subjects with AD and healthy older control subjects, using the absence or presence of the APOE epsilon4 allele as a predictive variable in the search for possible prognostic biomarkers of AD.
15522251	2005	Biol. Psychiatry	0006-3223	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	57#61		When divided according to the absence or presence of the APOE epsilon4 allele, the control subjects with at least one epsilon4 allele had significantly lower CSF beta-amyloid(1-42) but not tau levels than control subjects without an APOE epsilon4 allele (p < .01).
15522251	2005	Biol. Psychiatry	0006-3223	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	233#237		When divided according to the absence or presence of the APOE epsilon4 allele, the control subjects with at least one epsilon4 allele had significantly lower CSF beta-amyloid(1-42) but not tau levels than control subjects without an APOE epsilon4 allele (p < .01).
15522251	2005	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		The association of APOE epsilon4 allele and lower, more AD-like levels of CSF beta-amyloid(1-42) in older control subjects is consistent with previous studies showing possible neuroimaging and cognitive abnormalities with epsilon4 carriers and suggests that CSF beta-amyloid(1-42) decreases might represent an early biomarker of AD.
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	1	4973	SYMBOL|()|DICTIONARY|EXTRACTED	lox 1	LOX-1	65#70	15562935-1-48-61	A lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1) is the major receptor of oxidized LDL in endothelial cells.
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	2	4973	SYMBOL|DICTIONARY|EXTRACTED	lox 1	LOX-1	18#23	15562935-1-48-61	The expression of LOX-1 was shown to be upregulated in atherosclerotic lesions.
15562935	2005	Clin Cardiol	0160-9289	BACKGROUND	1	3	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	10#15	15562935-1-48-61	Recently, LOX-1 gene polymorphism (G501C) was reported to be associated with myocardial infarction (MI).
15562935	2005	Clin Cardiol	0160-9289	METHODS	3	5	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	13#18	15562935-1-48-61	We evaluated LOX-1 gene polymorphism using Invader assay in 586 patients undergoing coronary angiography.
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	9	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX- 1	17#23		The frequency of LOX- 1 gene variants (C/C or C/G) was lower in patients with significant than in those with normal/minimal stenosis (36 vs. 49%, p < 0.01).
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	10	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	17#22	15562935-1-48-61	The frequency of LOX-1 gene variants did not differ between patients with and without MI (34 vs. 37%).
15562935	2005	Clin Cardiol	0160-9289	RESULTS	4	12	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	35#40	15562935-1-48-61	Multivariate analysis demonstrated LOX-1 gene variants to be inversely associated with the presence of significant stenosis (odds ratio = 0.61; 95% confidence interval = 0.41-0.92).
15562935	2005	Clin Cardiol	0160-9289	CONCLUSIONS	5	13	4973	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lox 1	LOX-1	4#9	15562935-1-48-61	The LOX-1 gene variants at 501 were found to be inversely associated with the severity of CAD.
15479186	2005	Clin. Genet.	0009-9163	TITLE	0	0	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	27#47		Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	TITLE	0	0	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	53#60		Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1585	LONGTERM|GENE|GN|DICTIONARY	aldosterone synthase	aldosterone synthase	87#107		The objective of this study was to investigate the association of polymorphisms in the aldosterone synthase gene CYP11B2 (-344T/C, Lys173/Arg, and an intronic conversion [IC]) with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1585	SYMBOL|DICTIONARY	cyp11b2	CYP11B2	113#120		The objective of this study was to investigate the association of polymorphisms in the aldosterone synthase gene CYP11B2 (-344T/C, Lys173/Arg, and an intronic conversion [IC]) with stage-2 hypertension in northern Han Chinese.
15479186	2005	Clin. Genet.	0009-9163	ALL_TEXT_3/3	3	7	1585	SYMBOL|GENE|GN|DICTIONARY	cyp11b2	CYP11B2	75#82		These results indicate that the Lys173 and the IC-conversion allele of the CYP11B2 gene confer an increased risk for stage-2 hypertension in northern Han Chinese women.
15476622	2004	Am. J. Cardiol.	0002-9149	TITLE	0	0	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	Matrix metalloproteinase-1	0#26		Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction.
15476622	2004	Am. J. Cardiol.	0002-9149	ALL_TEXT	1	1	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	matrix metalloproteinase-1	21#47		The relation between matrix metalloproteinase-1 promoter genotype and remodeling was studied in 42 patients after their first acute myocardial infarctions.
15459589	2005	Am. Heart J.	1097-6744	BACKGROUND	1	3	6404	SYMBOL|()|DICTIONARY	psgl 1	PSGL-1	154#160		Recently, we have demonstrated the functional relevance of a variable number of tandem repeats polymorphism affecting the P-selectin glycoprotein ligand (PSGL-1).
15459589	2005	Am. Heart J.	1097-6744	METHODS	2	8	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	16#22		The role of the PSGL-1 polymorphism was also evaluated according to the additional risk factors of age, sex, smoking history, hypertension, hypercholesterolemia, and diabetes.
15459589	2005	Am. Heart J.	1097-6744	CONCLUSIONS	4	12	6404	SYMBOL|DICTIONARY	psgl 1	PSGL-1	44#50		According to our results, the short B and C PSGL-1 alleles might protect against premature MI, probably because of their lesser adhesive capacity.
15466944	2005	J Am Coll Nutr	0731-5724	METHODS	2	7	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	42#47	15466944-7-5-40	5,10-methylenetetrahydrofolate reductase (MTHFR) enzyme polymorphism was analyzed by polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP).
15466944	2005	J Am Coll Nutr	0731-5724	RESULTS	3	9	4524	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	128#133	15466944-7-5-40	Increased plasma THCy level was found in 10 children and adolescents from 12 cases homozygous for the C677T polymorphism of the MTHFR gene.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	5468	LONGTERM|GENE|GN|DICTIONARY	peroxisome proliferator activated receptor gamma	peroxisome proliferator-activated receptor-gamma	31#79		Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	5468	LONGTERM|DICTIONARY	peroxisome proliferator activated receptor gamma	Peroxisome proliferator-activated receptor-gamma	0#48		Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) regulates the transcription of several adipocyte-specific genes.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	5468	SYMBOL|EXTRACTED|()	ppar gamma	PPAR-gamma	50#60	15472214-3-0-48	Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) regulates the transcription of several adipocyte-specific genes.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	71#81	15472214-3-0-48	The aim of this study was to investigate the putative influence of the PPAR-gamma gene Pro12Ala polymorphism on the adiponectin levels in PCOS and healthy women.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	6	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	24#34	15472214-3-0-48	The genetic analysis of PPAR-gamma gene Pro12Ala polymorphism was performed by restriction fragment of polymorphisms.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	8	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	54#64	15472214-3-0-48	No subject was homozygous for the Ala12 allele of the PPAR-gamma gene.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	5468	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ppar gamma	PPAR-gamma	133#143	15472214-3-0-48	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	TITLE	0	0	81793	LONGTERM|GENE|GN|DICTIONARY	toll like receptor 10	TOLL-like receptor 10	0#21		TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	81793	LONGTERM|DICTIONARY	toll like receptor 10	TOLL-like receptor 10	0#21		TOLL-like receptor 10 (TLR10) is the most recently identified human homolog of the Drosophila TOLL protein.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	81793	SYMBOL|()|DICTIONARY|EXTRACTED	tlr10	TLR10	23#28	15201134-1-0-21	TOLL-like receptor 10 (TLR10) is the most recently identified human homolog of the Drosophila TOLL protein.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	1	7099	SYMBOL|GENE|GN|DICTIONARY	toll	TOLL	94#98		TOLL-like receptor 10 (TLR10) is the most recently identified human homolog of the Drosophila TOLL protein.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_1/3	1	2	7099	SYMBOL|DICTIONARY	toll	TOLL	15#19		In humans, the TOLL-like receptors recognize pathogen-associated molecular patterns (PAMPs) as part of innate immune host defenses.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	3	81793	SYMBOL|DICTIONARY|EXTRACTED	tlr10	TLR10	68#73	15201134-1-0-21	Localized to chromosome 4p14, the specific ligands and functions of TLR10 are currently unknown, although it is expressed in lung and in B-lymphocytes.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_2/3	2	4	81793	SYMBOL|DICTIONARY|EXTRACTED	tlr10	TLR10	0#5		TLR10 is a potential asthma candidate gene because early life innate immune responses to ubiquitous inhaled allergens and PAMPs may influence asthma susceptibility.
15201134	2004	Am. J. Respir. Crit. Care Med.	1073-449X	ALL_TEXT_3/3	3	8	81793	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tlr10	TLR10	125#130	15201134-1-0-21	Consistent association in two independent samples and association with an intermediate phenotype provides strong support for TLR10 genetic variation contributing to asthma risk.
15375002	2004	Cancer Res.	0008-5472	TITLE	0	0	9628	SYMBOL|DICTIONARY	rgs6	RGS6	29#33		A functional polymorphism in RGS6 modulates the risk of bladder cancer.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	5308	SYMBOL|GENE|GN|DICTIONARY	rgs	RGS	0#3		RGS proteins negatively regulate heterotrimeric G protein signaling.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	5308	SYMBOL|GENE|GN|DICTIONARY	rgs	RGS	31#34		Recent reports have shown that RGS proteins modulate neuronal, cardiovascular, and lymphocytic activity, yet their role in carcinogenesis has not been explored.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	5997	SYMBOL|DICTIONARY	rgs2	RGS2	141#145		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	9628	SYMBOL|DICTIONARY	rgs6	RGS6	150#154		In an epidemiologic study of 477 bladder cancer patients and 446 matched controls, three noncoding single-nucleotide polymorphisms (SNPs) in RGS2 and RGS6 were each associated with a statistically significant reduction in bladder cancer risk.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	5	9628	SYMBOL|DICTIONARY	rgs6	RGS6	44#48		When the SNPs were analyzed separately, the RGS6-rs2074647 (C-->T) polymorphism conferred the greatest overall reduction in risk of bladder cancer (odds ratio, 0.66; 95% confidence interval, 0.46-0.95).
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	9628	SYMBOL|DICTIONARY	rgs6	RGS6	28#32		In transfection assays, the RGS6-rs2074647 (C-->T) polymorphism increased the activity of a luciferase-RGS fusion protein by 2.9-fold, suggesting that this SNP is functionally significant.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	5308	SYMBOL|DICTIONARY	rgs	RGS	103#106		In transfection assays, the RGS6-rs2074647 (C-->T) polymorphism increased the activity of a luciferase-RGS fusion protein by 2.9-fold, suggesting that this SNP is functionally significant.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	5997	SYMBOL|DICTIONARY	rgs2	RGS2	29#33		Finally, we demonstrate that RGS2 transcripts and several splice variants of RGS6 are expressed in bladder cancer cells.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	9628	SYMBOL|DICTIONARY	rgs6	RGS6	77#81		Finally, we demonstrate that RGS2 transcripts and several splice variants of RGS6 are expressed in bladder cancer cells.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	5308	SYMBOL|GENE|GN|DICTIONARY	rgs	RGS	43#46		These data provide the first evidence that RGS proteins may be important modulators of cancer risk and validate RGS6 as a target for further study.
15375002	2004	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	9628	SYMBOL|DICTIONARY	rgs6	RGS6	112#116		These data provide the first evidence that RGS proteins may be important modulators of cancer risk and validate RGS6 as a target for further study.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3554	SYMBOL|DICTIONARY	il1r1	IL1R1	54#59		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3552	SYMBOL|DICTIONARY	il1a	IL1A	60#64		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3553	SYMBOL|DICTIONARY	il1b	IL1B	65#69		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	TITLE	0	0	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	70#75		Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	61#66		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3552	SYMBOL|DICTIONARY	il1a	IL1A	90#94		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3553	SYMBOL|DICTIONARY	il1b	IL1B	95#99		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	100#105		We explored the linkage between nine polymorphic loci in the IL1R1 promoter, eight in the IL1A-IL1B-IL1RN gene complex, and their association with osteoarthritis (OA), a common complex disease associated with low-level inflammation.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	3	3554	SYMBOL|DICTIONARY	il1r1	IL1R1	75#80		Using 195 healthy controls, we identified eight novel polymorphisms in the IL1R1 exon 1A region.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3554	SYMBOL|DICTIONARY	il1r1	IL1R1	28#33		We found limited LD between IL1R1 and the IL1A-IL1B-IL1RN cluster, although LD within these two individual groups was high.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3552	SYMBOL|DICTIONARY	il1a	IL1A	42#46		We found limited LD between IL1R1 and the IL1A-IL1B-IL1RN cluster, although LD within these two individual groups was high.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3553	SYMBOL|DICTIONARY	il1b	IL1B	47#51		We found limited LD between IL1R1 and the IL1A-IL1B-IL1RN cluster, although LD within these two individual groups was high.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	52#57		We found limited LD between IL1R1 and the IL1A-IL1B-IL1RN cluster, although LD within these two individual groups was high.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	6	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	0#5		IL1R1 promoter haplotypes showed no association with disease.
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3552	SYMBOL|DICTIONARY	il1a	IL1A	20#24		However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3553	SYMBOL|DICTIONARY	il1b	IL1B	25#29		However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	30#35		However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3553	SYMBOL|DICTIONARY	il1b	IL1B	143#147		However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	7	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	148#153		However, within the IL1A-IL1B-IL1RN complex, we identified a common haplotype conferring a four-fold risk of OA (P=0.00043; Pc=0.0043) and one IL1B-IL1RN haplotype conferring a four-fold reduced risk (P=0.0036; Pc=0.029).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3552	SYMBOL|DICTIONARY	il1a	IL1A	61#65		Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	66#70		Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	71#76		Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3553	SYMBOL|DICTIONARY	il1b	IL1B	148#152		Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15190266	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	9	3557	SYMBOL|DICTIONARY	il1rn	IL1RN	153#158		Here, the effects of the haplotypes were confirmed: the risk IL1A-IL1B-IL1RN haplotype conferred a two-fold risk of OA (P=0.02), and the protective IL1B-IL1RN haplotype conferred a five-fold reduced risk of OA (P=0.0000008).
15292102	2005	J. Androl.	0196-3635	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	10#43		Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population.
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	Endothelial nitric oxide synthase	0#33		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	45#74		Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	76#79	15292102-2-45-74	Endothelial nitric oxide synthase (eNOS) and angiotensin-converting enzyme (ACE) polymorphisms have been associated with endothelial dysfunction, which is described as a cause of erectile dysfunction (ED).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_1/3	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	20#23	15292102-2-45-74	Endothelial NOS and ACE are both regulators of vascular and corporal smooth muscle tone, which are connected by interaction between the NO-cyclic guanosine monophosphate pathway and the renin-angiotensin system.
15318030	2005	Psychiatr. Genet.	0955-8829	TITLE	0	0	151056	LONGTERM|GENE|GN|DICTIONARY	phospholipase a2	phospholipase A2	32#48		Allelic association analysis of phospholipase A2 genes with schizophrenia.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	1	151056	LONGTERM|DICTIONARY	phospholipase a2	phospholipase A2	46#62		Several studies suggest increased activity of phospholipase A2 in schizophrenic patients.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	151056	LONGTERM|GENE|GN|DICTIONARY	phospholipase a2	phospholipase A2	56#72		In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	5320	SYMBOL|DICTIONARY	spla2	sPLA2	88#93		In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	5321	SYMBOL|DICTIONARY	cpla2	cPLA2	95#100		In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	8398	SYMBOL|DICTIONARY	ipla2	iPLA2	102#107		In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	2	7941	SYMBOL|DICTIONARY	pafah	PAFAH	112#117		In the present study, variants of four genes coding for phospholipase A2 enzyme groups (sPLA2, cPLA2, iPLA2 and PAFAH) were analysed in a case-control sample using 240 schizophrenic patients and 312 healthy controls.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_2/3	2	3	5321	SYMBOL|DICTIONARY	cpla2	cPLA2	72#77		No difference was observed on the allelic and genotypic distribution of cPLA2 and sPLA2 gene polymorphisms among the groups.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_2/3	2	3	5320	SYMBOL|GENE|GN|DICTIONARY	spla2	sPLA2	82#87		No difference was observed on the allelic and genotypic distribution of cPLA2 and sPLA2 gene polymorphisms among the groups.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_2/3	2	4	7941	SYMBOL|DICTIONARY	pafah	PAFAH	4#9		The PAFAH variant was very rare in our population and therefore not informative.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	5	8398	SYMBOL|GENE|GN|DICTIONARY	ipla2	iPLA2	151#156		A significant allelic (chi2=5.86, P=0.0085, odds ratio=1.38, 95% confidence interval, 1.08-1.77) and genotypic (chi2=5.4, P=0.02) association with the iPLA2 gene polymorphism was found.
15318030	2005	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	6	8398	SYMBOL|DICTIONARY	ipla2	iPLA2	39#44		In conclusion, our data suggested that iPLA2 may play a role as a susceptibility gene for schizophrenia in our sample; however, confirmatory studies in independent samples are needed.
15266614	2005	Am. J. Med. Genet. A	1552-4825	TITLE	0	0	3077	LONGTERM|GENE|GN|DICTIONARY	hemochromatosis	hemochromatosis	31#46		Does bilirubin protect against hemochromatosis gene (HFE) related mortality?
15266614	2005	Am. J. Med. Genet. A	1552-4825	ALL_TEXT_1/3	1	2	3077	LONGTERM|GENE|GN|DICTIONARY	hemochromatosis	hemochromatosis	177#192		We hypothesized that increased levels of serum bilirubin may play a protective role against oxidative stress induced by iron overload in carriers of mutations in the hereditary hemochromatosis gene (HFE).
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3062	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ox2r	OX2R	27#31	15274044-1-13-23	The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	1	3060	LONGTERM|DICTIONARY	prepro orexin	prepro-orexin	101#114		The orexin-2/hypocretin-2 (OX2R) receptor gene is mutated in canine narcolepsy and disruption of the prepro-orexin/hypocretin ligand gene results in both an animal model of narcolepsy and sporadic cases of the human disease.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3062	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ox2r	OX2R	49#53	15274044-1-13-23	This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3061	SYMBOL|GENE|GN|DICTIONARY	ox1r	OX1R	83#87		This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15274044	2005	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	3060	LONGTERM|DICTIONARY	prepro orexin	prepro-orexin	203#216		This evidence suggests that the structure of the OX2R gene, and its homologue, the OX1R gene, both members of the G protein-coupled receptor (GPCR) family, and the gene encoding the peptide ligands, the prepro-orexin/hypocretin gene, may be variables in the etiology of sleep disorders.
15253766	2005	Clin. Genet.	0009-9163	TITLE	0	0	2706	SYMBOL|DICTIONARY|GENE|GA	gjb2	GJB2	45#49		Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness.
15253766	2005	Clin. Genet.	0009-9163	TITLE	0	0	2706	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cx26	Cx26	51#55	15253766-0-45-49	Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	2706	SYMBOL|()|DICTIONARY	gjb2	GJB2	43#47		Mutations in the gene gap junction beta 2 (GJB2), the gene for the connexin 26, are the most common cause of pre-lingual deafness worldwide.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	2706	LONGTERM|DICTIONARY	connexin 26	connexin 26	67#78		Mutations in the gene gap junction beta 2 (GJB2), the gene for the connexin 26, are the most common cause of pre-lingual deafness worldwide.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	2	2706	SYMBOL|DICTIONARY	gjb2	GJB2	27#31		The mutation 35delG within GJB2 is prevalent in Europe.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	3	2706	SYMBOL|DICTIONARY	gjb2	GJB2	33#37		To date, there are no data about GJB2 mutation spectrum and frequencies from the Czech population.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	4	2706	SYMBOL|GENE|GN|DICTIONARY	gjb2	GJB2	81#85		We investigated and report here the spectrum and frequencies of mutations in the GJB2 gene among 156 unrelated, congenital deafness Czech patients.
15253766	2005	Clin. Genet.	0009-9163	ALL_TEXT_2/3	2	6	2706	SYMBOL|DICTIONARY	gjb2	GJB2	32#36		The entire coding region of the GJB2 was directly sequenced in all patients who were not homozygous for the 35delG.
15279649	2004	Eur. J. Oral Sci.	0909-8836	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	29#33		The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.
15279649	2004	Eur. J. Oral Sci.	0909-8836	TITLE	0	0	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	34#40		The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	29#33		The 3020insC mutation of the NOD2/CARD15 gene leads to impaired activation of nuclear factor-kappa B (NF-kappaB) in vitro.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	1	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	34#40		The 3020insC mutation of the NOD2/CARD15 gene leads to impaired activation of nuclear factor-kappa B (NF-kappaB) in vitro.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	64127	SYMBOL|DICTIONARY	nod2	NOD2	174#178		As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	179#185		As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	5	64127	SYMBOL|DICTIONARY	nod2	NOD2	47#51		The prevalence of the 3020insC mutation of the NOD2/CARD15 protein in patients with periodontitis was 1.9% (three of 160) and that for the control group was 2.0% (five of 244) (P = 0.942).
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	5	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	52#58		The prevalence of the 3020insC mutation of the NOD2/CARD15 protein in patients with periodontitis was 1.9% (three of 160) and that for the control group was 2.0% (five of 244) (P = 0.942).
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|DICTIONARY	nod2	NOD2	63#67		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_3/3	3	6	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	68#74		Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
15257748	2004	J. Clin. Periodontol.	0303-6979	TITLE	0	0	4312	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 1	matrix metalloproteinase-1	26#52		Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	1	4312	LONGTERM|DICTIONARY	matrix metalloproteinase 1	Matrix metalloproteinase-1	0#26		Matrix metalloproteinase-1 (MMP-1) is a potent enzyme degrading extracellular matrix that was implicated in the pathogenesis of chronic periodontitis.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	1	4312	SYMBOL|()|DICTIONARY|EXTRACTED	mmp 1	MMP-1	28#33	15257748-1-0-26	Matrix metalloproteinase-1 (MMP-1) is a potent enzyme degrading extracellular matrix that was implicated in the pathogenesis of chronic periodontitis.
15257748	2004	J. Clin. Periodontol.	0303-6979	OBJECTIVES	1	2	4312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 1	MMP-1	107#112	15257748-1-0-26	Therefore, the aim of our study was to examine the association between three promoter polymorphisms of the MMP-1 gene and chronic periodontitis susceptibility and/or severity in a Czech population.
15257748	2004	J. Clin. Periodontol.	0303-6979	MATERIALS AND METHODS	2	5	4312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 1	MMP-1	0#5		MMP-1 promoter polymorphisms (-1607 1G/2G, -519A/G, and -422A/T) were genotyped using standard polymerase chain reaction-restriction fragment length product methods.
15257748	2004	J. Clin. Periodontol.	0303-6979	RESULTS	3	10	4312	SYMBOL|DICTIONARY|EXTRACTED	mmp 1	MMP-1	65#70	15257748-1-0-26	On the contrary, the distribution of genotype frequencies of the MMP-1 -422A/T polymorphism was different between the patient and control smokers with respect to heterozygotes (73.91% versus 50.91%; p=0.017).
15257748	2004	J. Clin. Periodontol.	0303-6979	CONCLUSIONS	4	11	4312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mmp 1	MMP-1	54#59	15257748-1-0-26	Our results demonstrate that the polymorphisms in the MMP-1 promoter may have only a small effect on the etiopathogenesis of chronic periodontitis.
15286153	2004	J. Med. Genet.	1468-6244	TITLE	0	0	83715	SYMBOL|DICTIONARY	espn	ESPN	13#17		Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	83715	SYMBOL|DICTIONARY	dfnb36	DFNB36	33#39		We mapped a human deafness locus DFNB36 to chromosome 1p36.3 in two consanguineous families segregating recessively inherited deafness and vestibular areflexia.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_2/3	2	2	83715	SYMBOL|DICTIONARY	espn	ESPN	102#106		This phenotype co-segregates with either of two frameshift mutations, 1988delAGAG and 2469delGTCA, in ESPN, which encodes a calcium-insensitive actin-bundling protein called espin.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	3	83715	SYMBOL|DICTIONARY	espn	ESPN	24#28		A recessive mutation of ESPN is known to cause hearing loss and vestibular dysfunction in the jerker mouse.
15286153	2004	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	5	83715	SYMBOL|DICTIONARY	espn	ESPN	50#54		The abnormal vestibular phenotype associated with ESPN mutations will be a useful clinical marker for refining the differential diagnosis of non-syndromic deafness.
15287851	2005	Liver Int.	1478-3223	BACKGROUND	1	3	3077	SYMBOL|DICTIONARY	hfe	HFE	53#56		Therefore our aim was to assess associations between HFE mutations and hepatic inflammation and stage of fibrosis in German hepatitis C patients.
15287851	2005	Liver Int.	1478-3223	RESULTS	3	6	3077	SYMBOL|DICTIONARY	hfe	HFE	26#29		The frequencies of common HFE mutations C282Y and H63D are 4.2% and 21.3%, whereas the recently described S65C substitution and the Y250X mutation in the transferrin receptor 2 gene are very rare.
15287851	2005	Liver Int.	1478-3223	RESULTS	3	6	7036	LONGTERM|GENE|GN|DICTIONARY	transferrin receptor 2	transferrin receptor 2	154#176		The frequencies of common HFE mutations C282Y and H63D are 4.2% and 21.3%, whereas the recently described S65C substitution and the Y250X mutation in the transferrin receptor 2 gene are very rare.
15287851	2005	Liver Int.	1478-3223	CONCLUSIONS	4	11	3077	SYMBOL|DICTIONARY	hfe	HFE	31#34		Our findings support a role of HFE mutations as primary risk factors for fibrogenesis and disease progression in chronic hepatitis C.
15320482	2004	Orv Hetil	0030-6002	TITLE	0	0	64127	SYMBOL|DICTIONARY	nod2	NOD2	1#5		[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
15320482	2004	Orv Hetil	0030-6002	TITLE	0	0	64127	SYMBOL|DICTIONARY	card15	CARD15	6#12		[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|DICTIONARY	nod2	NOD2	26#30		Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	1	64127	SYMBOL|GENE|GN|DICTIONARY	card15	CARD15	31#37		Recently mutations of the NOD2/CARD15 gene were identified as genetic markers for Crohn's disease (CD).
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	3	64127	SYMBOL|DICTIONARY	nod2	NOD2	63#67		The aim of this study was to determine the frequency of common NOD2/CARD15 mutations in Hungarian Crohn's patients.
15320482	2004	Orv Hetil	0030-6002	UNLABELLED	1	3	64127	SYMBOL|DICTIONARY	card15	CARD15	68#74		The aim of this study was to determine the frequency of common NOD2/CARD15 mutations in Hungarian Crohn's patients.
15320482	2004	Orv Hetil	0030-6002	RESULTS	3	8	64127	SYMBOL|DICTIONARY	nod2	NOD2	13#17		Mutations of NOD2/CARD15 were significantly more frequent in patients (n = 42, 29.6%) than in controls (11.3%, p = 0.0007, OR = 3.3, 95% CI = 1.7-6.5).
15320482	2004	Orv Hetil	0030-6002	RESULTS	3	8	64127	SYMBOL|DICTIONARY	card15	CARD15	18#24		Mutations of NOD2/CARD15 were significantly more frequent in patients (n = 42, 29.6%) than in controls (11.3%, p = 0.0007, OR = 3.3, 95% CI = 1.7-6.5).
15320482	2004	Orv Hetil	0030-6002	CONCLUSIONS	4	16	64127	SYMBOL|DICTIONARY	nod2	NOD2	60#64		In concordance with European data we found a high number of NOD2/CARD15 R702W and 3020insC mutations in Hungarian patients with Crohn's disease.
15320482	2004	Orv Hetil	0030-6002	CONCLUSIONS	4	16	64127	SYMBOL|DICTIONARY	card15	CARD15	65#71		In concordance with European data we found a high number of NOD2/CARD15 R702W and 3020insC mutations in Hungarian patients with Crohn's disease.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	TITLE	0	0	1234	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ccr5	CCR5	82#86	15307921-0-60-78	Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	1	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	0#4		CCR5 is a major coreceptor for cellular entry of macrophage-tropic isolates of the human immunodeficiency virus (HIV).
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	2	1234	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ccr5	CCR5	31#35	15307921-0-60-78	A 32-base pair deletion of the CCR5 gene (CCR5Delta32) protects against HIV infection because the frame shift leads to a truncated protein not expressed on the cell surface.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_1/3	1	4	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	22#26	15307921-0-60-78	Available methods for CCR5 genotyping, however, are cost expensive and/or time consuming.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_2/3	2	5	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	11#15	15307921-0-60-78	To improve CCR5 genotyping we studied four primer sets flanking the CCR5Delta32 deletion site using real-time polymerase chain reaction (PCR) on a LightCycler device.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_3/3	3	9	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	94#98	15307921-0-60-78	Finally, the validity of the new method was checked by analyzing 100 blood samples with known CCR5 genotypes.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_3/3	3	11	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	13#17	15307921-0-60-78	"Furthermore, CCR5 genotyping was possible without initial DNA extraction and yielded optimal results at 1:400 to 1:600 dilution of the ""interphase"" leukocytes."
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_3/3	3	12	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	75#79	15307921-0-60-78	Results of the new LightCycler PCR protocol were identical to conventional CCR5 genotyping but required considerably less time and expenditures.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY|EXTRACTED	ccr5	CCR5	96#100	15307921-0-60-78	We have established a new real-time PCR protocol, which enables fast, cost-saving, and reliable CCR5 genotyping.
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF alpha	62#71		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	88#92		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF alpha	58#67		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	84#88		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
15191797	2004	Exp. Neurol.	0014-4886	TITLE	0	0	960	SYMBOL|DICTIONARY	cd44	CD44	22#26		Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice.
15191797	2004	Exp. Neurol.	0014-4886	TITLE	0	0	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	31#37		Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_1/3	1	2	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	105#111		The molecular events responsible for MFS are not well understood, although the growth-associated protein GAP-43 has been implicated in rats.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_1/3	1	3	960	SYMBOL|DICTIONARY	cd44	CD44	42#46		Here, we focus on the hyaluronan receptor CD44, which is involved in routing of retinal axons during development and is upregulated after injury in many tissues including brain.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	4	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	86#100		After pilocarpine-induced status epilepticus (SE) in mice most hilar neurons died and neuropeptide Y (NPY) immunoreactivity appeared in the dentate inner molecular layer (IML) after 10-31 days indicative of MFS.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	5	960	SYMBOL|DICTIONARY	cd44	CD44	7#11		Strong CD44 immunoreactivity appeared in the IML 3 days after pilocarpine, then declined over the next 4 weeks.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_2/3	2	6	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	12#18		Conversely, GAP-43 immunoreactivity was decreased in the IML at 3-10 days after pilocarpine-induced SE.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	7	960	SYMBOL|DICTIONARY	cd44	CD44	101#105		After SE induced by repeated kainate injections, mice did not show any hilar cell loss or changes in CD44 or GAP-43 expression in the IML, and MFS was absent at 20-35 days.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	7	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	109#115		After SE induced by repeated kainate injections, mice did not show any hilar cell loss or changes in CD44 or GAP-43 expression in the IML, and MFS was absent at 20-35 days.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	8	2596	SYMBOL|DICTIONARY	gap 43	GAP-43	38#44		Thus, after SE in mice, early loss of GAP-43 and strong CD44 induction in the IML correlated with hilar cell loss and subsequent MFS.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	8	960	SYMBOL|DICTIONARY	cd44	CD44	56#60		Thus, after SE in mice, early loss of GAP-43 and strong CD44 induction in the IML correlated with hilar cell loss and subsequent MFS.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	9	960	SYMBOL|DICTIONARY	cd44	CD44	0#4		CD44 is one of the earliest proteins upregulated in the IML and coincides with early sprouting of mossy fibers, although its function is still unknown.
15191797	2004	Exp. Neurol.	0014-4886	ALL_TEXT_3/3	3	10	960	SYMBOL|DICTIONARY	cd44	CD44	20#24		We hypothesize that CD44 is involved in the response to axon terminal degeneration and/or neuronal reorganization preceding MFS.
15300989	2004	Hum. Genet.	0340-6717	TITLE	0	0	3664	SYMBOL|DICTIONARY	irf6	IRF6	13#17		Gene symbol: IRF6. Disease: Van der Woude syndrome.
15123604	2004	J. Biol. Chem.	0021-9258	TITLE	0	0	387082	SYMBOL|()|DICTIONARY	sumo 4	SUMO-4	42#48		A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_1/3	1	2	387082	SYMBOL|DICTIONARY	sumo 4	SUMO-4	62#68		We report the identification of a novel intronless SUMO gene, SUMO-4, that encodes a 95-amino acid protein having an 86% amino acid homology with SUMO-2.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_1/3	1	2	6613	SYMBOL|DICTIONARY	sumo 2	SUMO-2	146#152		We report the identification of a novel intronless SUMO gene, SUMO-4, that encodes a 95-amino acid protein having an 86% amino acid homology with SUMO-2.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	3	6613	SYMBOL|DICTIONARY	sumo 2	SUMO-2	15#21		In contrast to SUMO-2, which is highly expressed in all of the tissues examined, SUMO-4 mRNA was detected mainly in the kidney.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	3	387082	SYMBOL|GFAM|FN|DICTIONARY	sumo 4	SUMO-4	81#87		In contrast to SUMO-2, which is highly expressed in all of the tissues examined, SUMO-4 mRNA was detected mainly in the kidney.
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_2/3	2	4	387082	SYMBOL|DICTIONARY	sumo 4	SUMO-4	49#55		A single nucleotide polymorphism was detected in SUMO-4, substituting a highly conserved methionine with a valine residue (M55V).
15123604	2004	J. Biol. Chem.	0021-9258	ALL_TEXT_3/3	3	5	387082	SYMBOL|DICTIONARY	sumo 4	SUMO-4	62#68		In HepG2 (liver carcinoma) cells transiently transfected with SUMO-4 expression vectors, Met-55 was associated with the elevated levels of activated heat shock factor transcription factors as compared with Val-55, whereas the levels of NF-kappaB were suppressed to an identical degree.
15124102	2004	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	1947	LONGTERM|GENE|GN|DICTIONARY	ephrin b1	ephrin-B1	17#26		Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	109#114		Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	1947	LONGTERM|DICTIONARY	ephrin b1	ephrin-B1	139#148		Recently, we have mapped a gene for CFNS in the pericentromeric region of the X chromosome that contains the EFNB1 gene, which encodes the ephrin-B1 ligand for Eph receptors.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|DICTIONARY	efnb1	Efnb1	6#11		Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	3	1947	SYMBOL|GENE|GN|DICTIONARY	efnb1	EFNB1	124#129		Since Efnb1 mutant mice display a spectrum of malformations and an unusual inheritance reminiscent of CFNS, we analyzed the EFNB1 gene in three families with CFNS.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	1947	SYMBOL|DICTIONARY	efnb1	EFNB1	49#54		In the two other families, missense mutations in EFNB1 were detected that lead to amino acid exchanges P54L and T111I.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	6	1947	LONGTERM|DICTIONARY	ephrin b1	ephrin-B1	95#104		Both mutations are located in multimerization and receptor-interaction motifs found within the ephrin-B1 extracellular domain.
15124102	2004	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	8	1947	SYMBOL|DICTIONARY	efnb1	EFNB1	30#35		We conclude that mutations in EFNB1 cause CFNS.
15386943	2004	Biomed. Environ. Sci.	0895-3988	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin converting enzyme	37#66		Interaction and relationship between angiotensin converting enzyme gene and environmental factors predisposing to essential hypertension in Mongolian population of China.
15386943	2004	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	59#62		To investigate the association of specific functional gene ACE (I/D) variants of the renin-angiotensin system with essential hypertension (EH) and interaction between ACE (I/D) gene and risk factors for EH in a genetically homogenous Mongolia rural population of China.
15386943	2004	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	167#170		To investigate the association of specific functional gene ACE (I/D) variants of the renin-angiotensin system with essential hypertension (EH) and interaction between ACE (I/D) gene and risk factors for EH in a genetically homogenous Mongolia rural population of China.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	3	1636	SYMBOL|DICTIONARY	ace	ACE	34#37		The association was found between ACE genotype DD plus ID and EH, with an interaction between ACE genotype DD plus ID and cigarette smoking in an additive model.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	3	1636	SYMBOL|DICTIONARY	ace	ACE	94#97		The association was found between ACE genotype DD plus ID and EH, with an interaction between ACE genotype DD plus ID and cigarette smoking in an additive model.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	4	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	28#31		Cigarette smoking index and ACE gene showed a low exposure-gene (LEG) effect on EH, with interaction indices from 7.10 to 1.16.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	5	1636	SYMBOL|DICTIONARY	ace	ACE	20#23		Interaction between ACE genotype DD plus ID and alcohol drinking on EH appeared an additive model.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	6	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	27#30		Alcohol drinking index and ACE gene showed a low exposure-gene (LEG) effect on EH, with interaction indices from 1.66 to 1.09.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	7	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	8#11		BMI and ACE gene showed a low exposure-gene (LEG) effect on EH, with interaction indices from 6.15 to 2.49.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	8	1636	SYMBOL|DICTIONARY	ace	ACE	21#24		Interactions between ACE genotype and WHR on EH showed a multiplicative model.
15386943	2004	Biomed. Environ. Sci.	0895-3988	RESULTS	3	9	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	44#47		In a short,there was an interaction between ACE gene and cigarette smoking, alcohol drinking and BMI on EH, especially in a low dose-exposure effect
15386943	2004	Biomed. Environ. Sci.	0895-3988	CONCLUSION	4	10	1636	SYMBOL|DICTIONARY	ace	ACE	42#45		It is important for individuals who carry ACE D allele gene to prevent EH, and furthermore, to prevent and control coronary heart disease, in a view of population-based prevention.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		Tumor necrosis factor (TNF)-alpha has been implicated in the pathophysiology of heart failure.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3586	SYMBOL|DICTIONARY	il 10	IL-10	74#79		We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	7	3569	SYMBOL|DICTIONARY	il 6	IL-6	11#15		TNF-alpha, IL-6, IL-10, TGF-beta1, and IFN-gamma plasma levels were measured by enzyme-linked immunosorbent assay.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	7	3586	SYMBOL|DICTIONARY	il 10	IL-10	17#22		TNF-alpha, IL-6, IL-10, TGF-beta1, and IFN-gamma plasma levels were measured by enzyme-linked immunosorbent assay.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	70#74		Polymorphisms of TNF-alpha within the promoter at position -308a-->g, IL-6 within the promoter at position -174c-->g, IL-10 within the promoter at position -1082a-->g/-819t-->c and -819t-->c/-592a-->c, TGF-beta1 at codon 10t-->c and codon 25c-->g, and IFN-gamma at intron 1 at position + 874t-->a were studied.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	118#123		Polymorphisms of TNF-alpha within the promoter at position -308a-->g, IL-6 within the promoter at position -174c-->g, IL-10 within the promoter at position -1082a-->g/-819t-->c and -819t-->c/-592a-->c, TGF-beta1 at codon 10t-->c and codon 25c-->g, and IFN-gamma at intron 1 at position + 874t-->a were studied.
15142050	2004	Clin Transplant	0902-0063	TITLE	0	0	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
15142050	2004	Clin Transplant	0902-0063	PATIENTS AND METHODS	2	6	348	SYMBOL|DICTIONARY	apo e	Apo E	0#5		Apo E genotyping was carried out on genomic DNA using polymerase chain reaction and restriction enzyme.
15142050	2004	Clin Transplant	0902-0063	RESULTS	3	12	338	SYMBOL|DICTIONARY	apo b 100	apo B 100	94#103		Total cholesterol, total triglyceride, low-density lipoprotein, very low-density lipoprotein, apo B 100 levels were found to be higher in apo E4 carriers.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	42#51	15071492-1-13-40	The cytokine tumor necrosis factor alpha (TNF-alpha) is important in generating an immune response against a hepatitis C virus (HCV) infection.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	17#26	15071492-1-13-40	The functions of TNF-alpha may be altered by single-nucleotide polymorphisms (SNPs) in its gene, TNF.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	7124	SYMBOL|DICTIONARY	tnf	TNF	97#100		The functions of TNF-alpha may be altered by single-nucleotide polymorphisms (SNPs) in its gene, TNF.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	3	7124	SYMBOL|DICTIONARY	tnf	TNF	29#32		We hypothesized that SNPs in TNF may be important in determining the outcome of an HCV infection.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnf	TNF	39#42		To test this hypothesis, we typed nine TNF SNPs in a cohort of individuals with well-defined HCV outcomes.
15071492	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	10	7124	SYMBOL|EXTRACTED	tnf alpha	TNF-alpha	108#117	15071492-1-13-40	Further study of this polymorphism and haplotype is needed to understand these associations and the role of TNF-alpha in determining outcomes of HCV infection.
15057267	2005	Genes Immun.	1466-4879	TITLE	0	0	3586	LONGTERM|DICTIONARY	interleukin 10	Interleukin-10	0#14		Interleukin-10 polymorphisms in Spanish type 1 diabetes patients.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	6#20		Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il 10	IL-10	22#27	15057267-3-6-20	Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	3	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	167#172	15057267-3-6-20	Since interleukin-10 (IL-10) modulates immune and inflammatory responses and has been implicated in many autoimmune diseases, it seemed interesting to examine whether IL-10 polymorphisms participate in diabetes predisposition.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_2/3	2	4	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL- 10	75#81		In fact, this is the first association study investigating the role of the IL- 10 polymorphisms in susceptibility to T1D in a Caucasian population.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	6	3586	SYMBOL|DICTIONARY|EXTRACTED	il 10	IL-10	34#39	15057267-3-6-20	Our results prove a minor role of IL-10 in the autoimmune diabetes risk, although we found the same association trend with IL-10G(*)12 allele as was previously observed for multiple sclerosis and rheumatoid arthritis.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	21#34		Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	TITLE	0	0	23627	SYMBOL|GENE|GN|DICTIONARY	doppel	doppel	51#57		Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	4#17		The prion protein gene (PRNP) plays a central role in the origin of Creutzfeldt-Jakob disease (CJD), but there is growing interest in other polymorphisms that may be involved in CJD.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	2	5621	LONGTERM|GENE|GT|DICTIONARY	prion protein	prion protein	53#66		Polymorphisms upstream of PRNP that may modulate the prion protein production as well as polymorphisms in the prion-like doppel gene (PRND) have been studied, with inconsistent findings.
14970845	2004	Eur. J. Hum. Genet.	1018-4813	ALL_TEXT_1/3	1	2	23627	SYMBOL|GENE|GN|DICTIONARY	doppel	doppel	121#127		Polymorphisms upstream of PRNP that may modulate the prion protein production as well as polymorphisms in the prion-like doppel gene (PRND) have been studied, with inconsistent findings.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	15#31		Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	PURPOSE	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	43#47	15111581-1-25-41	To examine the effect of apolipoprotein E (APOE) alleles on age-related macular degeneration (AMD) risk and on age at diagnosis of AMD in a large patient cohort recruited from a single center.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	17#21	15111581-1-25-41	The frequency of APOE alleles was analyzed in 632 unrelated AMD patients and 206 unrelated controls, all of whom were of white ancestry.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	4	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	21#25	15111581-1-25-41	The association with APOE was explored in the context of AMD subtypes, family history status, possible interaction with smoking, and distribution of age at diagnosis of AMD.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	7	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	140#144	15111581-1-25-41	In the cohort, AMD patients with a positive family history exhibited a significant 3.5 years earlier age at diagnosis (P = 0.001); however, APOE alleles did not appear to modulate the age at diagnosis of AMD.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	8	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	28#32	15111581-1-25-41	The association between the APOE-epsilon4 allele and a reduced risk of AMD was established in a large cohort with sufficient statistical power.
15111581	2004	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	13#17	15111581-1-25-41	How distinct APOE alleles affect AMD susceptibility warrants further investigation.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	1583	SYMBOL|GENE|GN|DICTIONARY	cyp11a	CYP11A	49#55		Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	cyp11a	CYP11A	0#6		CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	1583	SYMBOL|DICTIONARY	p450scc	p450scc	26#33		CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	1583	SYMBOL|DICTIONARY	cyp11a	CYP11A	54#60		Four of the five published studies that have examined CYP11A for evidence of linkage and/or association have reported significant relationships with polycystic ovary (PCO) status and/or serum testosterone levels.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	1583	SYMBOL|GENE|GN|DICTIONARY	cyp11a	CYP11A	10#16		A pair of CYP11A promoter microsatellites, including the pentanucleotide (D15S520) previously implicated in trait susceptibility, were genotyped in 371 PCOS patients of United Kingdom origin, using both case-control and family-based association methods, and in 1589 women from a population-based birth cohort from Finland characterized for PCO symptomatology and testosterone levels.
15126571	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	6	1583	SYMBOL|GENE|GN|DICTIONARY	cyp11a	CYP11A	95#101		These studies indicate that the strength of, and indeed the existence of, associations between CYP11A promoter variation and androgen-related phenotypes has been substantially overestimated in previous studies.
12879272	2004	Rheumatol. Int.	0172-8172	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	Glutathione S-transferase M1	0#28		Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	57#85		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	88#93		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	118#123		We assessed the contribution of genetic polymorphisms of glutathione S-transferase M1 ( GSTM1), T1 ( GSTT1), and P1 ( GSTP1, Ile105Val) to carotid atherosclerosis in 40 postmenopausal rheumatoid arthritic (RA) women without histories of smoking.
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	3	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	18#23		Subjects with the GSTT1-0 genotype had greater IMT ( P<0.05).
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	120#125		On univariate analysis, carotid IMT was positively associated with age, systolic BP, antihypertensive drug use, and the GSTT1-0 genotype ( P<0.05).
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	49#54		When compared to subjects with a double-positive GSTM1/T1 genotype, IMT in those with concurrent lack of the GSTM1 and GSTT1 genes was significantly increased ( P=0.008).
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	109#114		When compared to subjects with a double-positive GSTM1/T1 genotype, IMT in those with concurrent lack of the GSTM1 and GSTT1 genes was significantly increased ( P=0.008).
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	5	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	119#124		When compared to subjects with a double-positive GSTM1/T1 genotype, IMT in those with concurrent lack of the GSTM1 and GSTT1 genes was significantly increased ( P=0.008).
12879272	2004	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	6	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	29#34		This study suggests that the GSTT1-0 genotype might have an interaction with carotid atherosclerosis related to RA in Korean postmenopausal RA women without histories of smoking.
15059717	2004	Am. J. Ophthalmol.	0002-9394	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	49#65		To examine the relation among serum cholesterol, apolipoprotein E genotype (APOE), and the risk of early and late age-related macular degeneration (AMD).
15059717	2004	Am. J. Ophthalmol.	0002-9394	CONCLUSION	5	9	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E genotype does not explain this association but may be an effect modifier.
15048896	2004	Ann. Neurol.	0364-5134	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	77#81		"Accelerated evolution of brain atrophy and ""black holes"" in MS patients with APOE-epsilon 4."
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	1	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	18#22	15048896-1-0-16	Apolipoprotein E (APOE)-epsilon4 has been associated with an unfavorable course of multiple sclerosis (MS).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_1/3	1	3	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	40#44	15048896-1-0-16	Here, we have studied the impact of the APOE genotype on both the longitudinal evolution of focal (BH ratio) and global (brain volume change [BVC]) brain tissue damage.
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_2/3	2	5	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	3#7	15048896-1-0-16	In APOE-epsilon4 patients, the annual reduction in brain volume was fivefold higher (-0.65 +/- 0.61%) than in those without APOE-epsilon4 (-0.13 +/- 0.36%; p = 0.0001).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_2/3	2	5	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	124#128	15048896-1-0-16	In APOE-epsilon4 patients, the annual reduction in brain volume was fivefold higher (-0.65 +/- 0.61%) than in those without APOE-epsilon4 (-0.13 +/- 0.36%; p = 0.0001).
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	9	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	195#199	15048896-1-0-16	Accelerated brain tissue loss and a higher proportion of lesions evolving into BH therefore provide magnetic resonance imaging evidence for more pronounced tissue destruction in MS patients with APOE-epsilon4.
15082902	2004	J. Korean Med. Sci.	1011-8934	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	14#19		Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.
15082902	2004	J. Korean Med. Sci.	1011-8934	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	24#29		Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_2/3	2	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	57#62		Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_2/3	2	5	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	67#72		Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced.
15060116	2004	J. Med. Genet.	1468-6244	TITLE	0	0	6899	SYMBOL|GENE|GN|DICTIONARY	tbx1	TBX1	75#79		Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	57#62		Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	46#51		We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	58530	SYMBOL|DICTIONARY	megt1	MEGT1	189#194		We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	2	720	SYMBOL|DICTIONARY	c4a6	C4A6	199#203		We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	4	3308	SYMBOL|GENE|GN|DICTIONARY	hsp70	Hsp70	136#141		Haplotype mapping within patients with allelic markers of the 57.1 ancestral haplotype suggests a susceptibility locus within the 14-kb Hsp70 gene cluster.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	5	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	0#5		HLA-B*5701 was present in 94.4% of hypersensitive cases compared with 1.7% of controls (odds ratio, 960; P < 0.00001).
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	3305	SYMBOL|DICTIONARY	hsp70 hom	Hsp70-Hom	43#52		A haplotypic nonsynonymous polymorphism of Hsp70-Hom (HspA1L, resulting from the substitution of residue M493T in the peptide-binding subunit) was found in combination with HLA-B*5701 in 94.4% of hypersensitive cases and 0.4% of controls (odds ratio, 3,893; P < 0.00001).
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	3305	SYMBOL|DICTIONARY	hspa1l	HspA1L	54#60		A haplotypic nonsynonymous polymorphism of Hsp70-Hom (HspA1L, resulting from the substitution of residue M493T in the peptide-binding subunit) was found in combination with HLA-B*5701 in 94.4% of hypersensitive cases and 0.4% of controls (odds ratio, 3,893; P < 0.00001).
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	173#178		A haplotypic nonsynonymous polymorphism of Hsp70-Hom (HspA1L, resulting from the substitution of residue M493T in the peptide-binding subunit) was found in combination with HLA-B*5701 in 94.4% of hypersensitive cases and 0.4% of controls (odds ratio, 3,893; P < 0.00001).
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	44#49		These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3106	SYMBOL|NUMBER|DICTIONARY	hla b	HLA-B	183#188		These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
15007140	2004	Neurology	1526-632X	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	15#19		Association of APOE polymorphisms with disease severity in MS is limited to women.
15007140	2004	Neurology	1526-632X	ALL_TEXT_1/3	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	103#107		The authors studied the association of an exon 4 (E4*epsilon2/3/4) and three promoter polymorphisms of APOE with disease course and severity stratified by gender in 221 patients with multiple sclerosis from two overlapping population-based prevalence cohorts.
15022317	2004	Arthritis Rheum.	0004-3591	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	76#80		Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus.
15022317	2004	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	40#44		Many studies have implicated alleles of DRB1 that encode a shared epitope.
15022317	2004	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	63#67		In this study, we sought to investigate whether a separate non-DRB1 effect could be detected and to determine its likely location.
15022317	2004	Arthritis Rheum.	0004-3591	RESULTS	3	6	7919	LONGTERM|DICTIONARY|GENE|GA	hla b associated transcript 1	HLA-B-associated transcript 1	112#141		Unconditioned TDTs revealed overtransmission of shared epitope alleles (P = 2.12 x 10(-5)) and an allele of the HLA-B-associated transcript 1 (BAT1) gene in the telomeric class III region (P = 0.009).
15022317	2004	Arthritis Rheum.	0004-3591	RESULTS	3	6	7919	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	bat1	BAT1	143#147	15022317-6-112-141	Unconditioned TDTs revealed overtransmission of shared epitope alleles (P = 2.12 x 10(-5)) and an allele of the HLA-B-associated transcript 1 (BAT1) gene in the telomeric class III region (P = 0.009).
15022317	2004	Arthritis Rheum.	0004-3591	RESULTS	3	7	7919	SYMBOL|DICTIONARY|EXTRACTED	bat1	BAT1	171#175	15022317-6-112-141	Using a DRB1-conditioned TDT to assess whether an independent effect existed, we detected unequal transmission of alleles of lymphocyte-specific transcript 1 (P = 0.004), BAT1 (P = 0.003), and PG8 (P = 0.003).
15022317	2004	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	26#30		At least 1 additional non-DRB1 susceptibility locus for RA exists in an interval that encompasses the junction of the class III and I regions.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	46#50		Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	25#29		Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_1/3	1	2	348	SYMBOL|DICTIONARY	apoe	APOE	123#127		Apolipoprotein epsilon4 (APOE epsilon4) carrier status may increase risk of AD, yet there are no data on relations between APOE status and progression of sleep disturbance in AD.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_2/3	2	3	348	SYMBOL|DICTIONARY	apoe	APOE	114#118		The objective of this study was to determine if sleep parameters in AD patients change over time as a function of APOE carrier status.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_3/3	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	55#59		Their sleep/wake parameters were compared according to APOE status.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_3/3	3	6	348	SYMBOL|DICTIONARY	apoe	APOE	4#8		For APOE epsilon4 carriers, only wake after sleep onset (WASO) increased in association with lower cognitive function as indicated by the Mini-Mental State Examination (MMSE); for non-epsilon4 subjects, increases in WASO and declines in total sleep time, sleep efficiency, and the amplitude of the rest/activity circadian rhythm over time were associated with lower performance on the MMSE.
15018693	2004	J Geriatr Psychiatry Neurol	0891-9887	ALL_TEXT_3/3	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	15#19		In these data, APOE status was associated with the progression of sleep/wake disturbances in AD.
15091236	2004	Laryngoscope	0023-852X	TITLE	0	0	2706	LONGTERM|GENE|GN|DICTIONARY	connexin 26	connexin 26	37#48		Nonsyndromic 35 delG mutation of the connexin 26 gene associated with deafness in syndromic children: two case reports.
15091236	2004	Laryngoscope	0023-852X	METHODS	3	5	2706	LONGTERM|GENE|GN|DICTIONARY	connexin 26	Connexin 26	36#47		A homozygous 35delG mutation on the Connexin 26 gene was found in both children (DFNB1 phenotype).
15091236	2004	Laryngoscope	0023-852X	RESULTS	4	7	2706	LONGTERM|GENE|GN|DICTIONARY	connexin 26	Connexin 26	112#123		The authors found no evidence for a genetic link between Del(22q11) or Down syndrome and 35delG mutation on the Connexin 26 gene.
15091236	2004	Laryngoscope	0023-852X	CONCLUSION	5	8	2706	SYMBOL|DICTIONARY	dfnb1	DFNB1	59#64		The case reports reveal a coincidental association between DFNB1 and a multiple congenital anomaly syndrome.
15255109	2004	Ophthalmic Genet.	1381-6810	PURPOSE	1	1	1545	SYMBOL|()|DICTIONARY	cyp1b1	CYP1B1	45#51		To determine the role of cytochrome P450IBI (CYP1B1) mutations in causing primary congenital glaucoma (PCG) in a cohort of Native Americans from Quito, Ecuador.
15255109	2004	Ophthalmic Genet.	1381-6810	MATERIALS AND METHODS	2	4	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	60#66		Purified DNA was prepared from peripheral blood samples and CYP1B1 coding exons (exons 2 and 3) were amplified and sequenced.
15255109	2004	Ophthalmic Genet.	1381-6810	MATERIALS AND METHODS	2	5	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	91#97		Southern blot was performed only on those affected patients who showed no mutations in the CYP1B1 coding exons.
15255109	2004	Ophthalmic Genet.	1381-6810	RESULTS	3	6	1545	SYMBOL|DICTIONARY	cyp1b1	CYP1B1	143#149		The molecular basis of PCG in two families was determined: two novel mutations (a deletion and a point mutation) and one novel polymorphism in CYP1B1 were identified in addition to a previously described single amino acid substitution.
14563640	2004	Blood	0006-4971	TITLE	0	0	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	30#38		Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.
14563640	2004	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	38#46		We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families.
14563640	2004	Blood	0006-4971	ALL_TEXT_2/3	2	4	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	93#101		In expression experiments using HeLa cells, all mutants showed no or a marginal secretion of ADAMTS13.
14563640	2004	Blood	0006-4971	ALL_TEXT_3/3	3	5	11093	SYMBOL|GENE|GN|DICTIONARY	adamts13	ADAMTS13	246#254		Taken together with the findings in our recent report we determined the responsible mutations in a total of 7 Japanese patients with USS with a uniform clinical picture of severe neonatal hyperbilirubinemia, and in their family members, based on ADAMTS13 gene analysis.
14563640	2004	Blood	0006-4971	ALL_TEXT_3/3	3	8	7057	LONGTERM|DICTIONARY	thrombospondin 1	thrombospondin 1	57#73		Molecular models of the metalloprotease, fifth domain of thrombospondin 1 (Tsp1-5), and Tsp1-8 domains of ADAMTS13 suggest that the missense mutations could cause structural defects in the mutants.
14563640	2004	Blood	0006-4971	ALL_TEXT_3/3	3	8	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	106#114		Molecular models of the metalloprotease, fifth domain of thrombospondin 1 (Tsp1-5), and Tsp1-8 domains of ADAMTS13 suggest that the missense mutations could cause structural defects in the mutants.
14717782	2004	Br. J. Haematol.	0007-1048	TITLE	0	0	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	23#44		Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	4#25		The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	7450	SYMBOL|()|DICTIONARY|EXTRACTED	vwf	VWF	27#30	14717782-1-4-25	The von Willebrand factor (VWF) may be causally associated with coronary heart disease (CHD) or merely be a marker of endothelial damage.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	7450	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vwf	VWF	59#62	14717782-1-4-25	The G allele of the -1793 C/G promoter polymorphism in the VWF gene has been associated with higher plasma levels of VWF.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	117#120	14717782-1-4-25	The G allele of the -1793 C/G promoter polymorphism in the VWF gene has been associated with higher plasma levels of VWF.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	3	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	23#26	14717782-1-4-25	To investigate whether VWF has a causal role in CHD, we designed a case-cohort study, including 352 subjects with CHD and a random cohort (n = 736), and prospectively examined the association of the -1793 C/G polymorphism with CHD in subjects with and without advanced atherosclerosis.
14717782	2004	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	9	7450	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vwf	VWF	90#93	14717782-1-4-25	In conclusion, this study suggests that the G allele of the -1793 C/G polymorphism in the VWF gene is associated with an increased risk of CHD, but only in subjects with advanced atherosclerosis.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	TITLE	0	0	1029	SYMBOL|DICTIONARY	ink4a	INK4A	55#60		Estimating the relative risk of developing melanoma in INK4A carriers.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	ink4a	INK4A	73#78		In this pilot study using a novel study design, we evaluated the role of INK4A mutations in melanoma by comparing patients with multiple primary melanomas to those with single primaries.
15075790	2004	Eur. J. Cancer Prev.	0959-8278	ALL_TEXT_2/3	2	4	1029	SYMBOL|DICTIONARY	ink4a	INK4A	90#95		Subjects completed a questionnaire covering risk factors for melanoma and were tested for INK4A mutations.
14713779	2004	J. Urol.	0022-5347	TITLE	0	0	4953	LONGTERM|DICTIONARY	ornithine decarboxylase	ornithine decarboxylase	21#44		Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk.
14713779	2004	J. Urol.	0022-5347	TITLE	0	0	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	59#76		Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	LONGTERM|DICTIONARY|GENE|GA	ornithine decarboxylase	ornithine decarboxylase	79#102		A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	odc	ODC	104#107	14713779-1-79-102	A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	1	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	145#148	14713779-1-79-102	A single nucleotide substitution of guanine to adenine (A) at base +316 in the ornithine decarboxylase (ODC) gene may be associated with greater ODC expression and increased tumor growth.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	2	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	0#3		ODC is induced by androgens in human prostatic epithelial cells, presumably via transcriptional activation of androgen receptor (AR) and also by nicotine.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	2	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	110#127		ODC is induced by androgens in human prostatic epithelial cells, presumably via transcriptional activation of androgen receptor (AR) and also by nicotine.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	2	367	SYMBOL|EXTRACTED|()	ar	AR	129#131	14713779-2-110-127	ODC is induced by androgens in human prostatic epithelial cells, presumably via transcriptional activation of androgen receptor (AR) and also by nicotine.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	3	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	77#80	14713779-1-79-102	A nested case-control study was done to examine the association between this ODC genotype and prostate cancer risk, and whether it varies by AR gene CAG repeat length and smoking.
14713779	2004	J. Urol.	0022-5347	PURPOSE	1	3	367	SYMBOL|EXTRACTED|GENE|GN	ar	AR	141#143	14713779-2-110-127	A nested case-control study was done to examine the association between this ODC genotype and prostate cancer risk, and whether it varies by AR gene CAG repeat length and smoking.
14713779	2004	J. Urol.	0022-5347	MATERIALS AND METHODS	2	5	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	0#3		ODC and AR genotyping was performed using a TaqMan (PE Applied Biosystems, Foster City, California) based assay and automated fragment analysis, respectively.
14713779	2004	J. Urol.	0022-5347	MATERIALS AND METHODS	2	5	367	SYMBOL|EXTRACTED	ar	AR	8#10	14713779-2-110-127	ODC and AR genotyping was performed using a TaqMan (PE Applied Biosystems, Foster City, California) based assay and automated fragment analysis, respectively.
14713779	2004	J. Urol.	0022-5347	RESULTS	3	7	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	20#23	14713779-1-79-102	The presence of the ODC A allele was not significantly associated with an increased risk of prostate cancer (OR 1.33, 95% CI 0.90 to 1.96).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	38#41	14713779-1-79-102	However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	367	SYMBOL|EXTRACTED	ar	AR	69#71	14713779-2-110-127	However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	8	367	SYMBOL|EXTRACTED	ar	AR	187#189	14713779-2-110-127	However, men who inherited at least 1 ODC A alleles and less than 22 AR CAG repeats were at twice the risk of prostate cancer compared with those with 2 guanine alleles and 22 or greater AR CAG repeats (OR 2.09, 95% CI 1.23 to 3.57).
14713779	2004	J. Urol.	0022-5347	RESULTS	3	9	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	75#78	14713779-1-79-102	Smoking was associated with prostate cancer only in men carrying a least 1 ODC A allele (p interaction = 0.02).
14713779	2004	J. Urol.	0022-5347	CONCLUSIONS	4	10	4953	SYMBOL|DICTIONARY|EXTRACTED	odc	ODC	4#7	14713779-1-79-102	The ODC A allele was not associated with a statistically significant increased risk of prostate cancer.
14732601	2004	Biol. Psychiatry	0006-3223	TITLE	0	0	9145	LONGTERM|GENE|GN|DICTIONARY	synaptogyrin 1	synaptogyrin 1	27#41		A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia.
14732601	2004	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	9145	LONGTERM|DICTIONARY	synaptogyrin 1	Synaptogyrin 1	8#22		Because Synaptogyrin 1 (SYNGR1), associated with presynaptic vesicles in neuronal cells, lies within 1 million base pairs of this marker, it is a potential candidate gene for schizophrenia.
14732601	2004	Biol. Psychiatry	0006-3223	BACKGROUND	1	3	9145	SYMBOL|()|DICTIONARY|EXTRACTED	syngr1	SYNGR1	24#30	14732601-3-8-22	Because Synaptogyrin 1 (SYNGR1), associated with presynaptic vesicles in neuronal cells, lies within 1 million base pairs of this marker, it is a potential candidate gene for schizophrenia.
14732601	2004	Biol. Psychiatry	0006-3223	METHODS	2	4	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	64#70	14732601-3-8-22	We sequenced all six exons and flanking splice junctions of the SYNGR1 gene.
14732601	2004	Biol. Psychiatry	0006-3223	METHODS	2	5	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	135#141	14732601-3-8-22	We also carried out reverse transcriptase polymerase chain reaction and Northern blot analysis for exon 2 containing transcript of the SYNGR1 gene.
14732601	2004	Biol. Psychiatry	0006-3223	RESULTS	3	6	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	63#69	14732601-3-8-22	We found a novel nonsense mutation (Trp27Ter) in exon 2 of the SYNGR1 gene in a family multiply affected with schizophrenia.
14732601	2004	Biol. Psychiatry	0006-3223	CONCLUSIONS	4	8	9145	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	syngr1	SYNGR1	12#18	14732601-3-8-22	Because the SYNGR1 gene is involved in presynaptic pathways, reduced levels of this protein might play some role in the pathogenesis of schizophrenia.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	24#59		Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	TITLE	0	0	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	61#66	15207432-0-24-59	Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_1/3	1	2	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	Methylenetetrahydrofolate reductase	0#35		Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in homocysteine (Hcy) metabolism.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_1/3	1	2	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	37#42	15207432-0-24-59	Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in homocysteine (Hcy) metabolism.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_1/3	1	3	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	9#14	15207432-0-24-59	Both the MTHFR 677C-->T and the 1298A-->C polymorphisms are associated with mild hyperhomocysteinemia, particularly in conditions of low folate status.
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_2/3	2	4	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	24#29	15207432-0-24-59	The prevalence of these MTHFR polymorphisms and their relationships with plasma total Hcy (tHcy), serum folate and cognitive function was evaluated in 194 elderly Italian individuals: 122 healthy controls (73.8 +/- 7.1 years of age), 24 cognitively- impaired- not-demented individuals (78.6 +/- 9.3 years), and 48 subjects with Alzheimer dementia (AD = 26), vascular dementia (VD =22; 85.5 +/- 7.0 years).
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_3/3	3	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	44#49	15207432-0-24-59	Plasma tHcy did not differ significantly by MTHFR genotypes, but, subjects of all genotypes with low serum folate (<12 nmole/l) had higher plasma tHcy (p < 0.001), than subjects with high serum folate (>= 12 nmole/l).
15207432	2004	Arch Gerontol Geriatr Suppl	0924-7947	ALL_TEXT_3/3	3	9	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	59#64	15207432-0-24-59	The lack of association of age and cognitive function with MTHFR genotypes argues against a negative selection for these polymorphisms.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	15#23		To investigate ER-alpha gene polymorphisms for its associations with primary knee OA, we conducted a case-control association study in patients with primary knee OA (n = 151) and healthy individuals (n = 397) in the Korean population.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	3	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	95#103		Haplotyping analysis was used to determine the relationship between three polymorphisms in the ER-alpha gene (intron 1 T/C, intron 1 A/G and exon 8 G/A) and primary knee OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	4	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	17#25		Genotypes of the ER-alpha gene polymorphism were determined by PCR followed by restriction enzyme digestion (PvuII for intron 1 T/C, XbaI for intron 1 A/G, and BtgI for exon 8 G/A polymorphism).
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	79#87		Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
15380041	2005	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	2099	LONGTERM|GENE|GN|DICTIONARY	er alpha	ER-alpha	173#181		Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	TITLE	0	0	7157	SYMBOL|DICTIONARY	tp53	TP53	148#152		Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_2/3	2	8	2064	SYMBOL|DICTIONARY	her 2 neu	HER-2/neu	188#197		In addition, more profound chromosomal changes were consistently associated with the more advanced-stage tumors, and less expression of the estrogen and the progesterone receptors, and of HER-2/neu.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	9	7157	SYMBOL|DICTIONARY	tp53	TP53	51#55		About 19% of the breast cancers examined carried a TP53 mutation in exons 4-9.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	11	7157	SYMBOL|DICTIONARY	tp53	TP53	36#40		On average, patients carrying these TP53 mutations had 9.5 CGH lesions per case, compared to only 2.8 changes in samples that had no TP53 mutation.
14697642	2004	Cancer Genet. Cytogenet.	0165-4608	ALL_TEXT_3/3	3	11	7157	SYMBOL|DICTIONARY	tp53	TP53	133#137		On average, patients carrying these TP53 mutations had 9.5 CGH lesions per case, compared to only 2.8 changes in samples that had no TP53 mutation.
14720258	2004	Clin. Exp. Allergy	0954-7894	TITLE	0	0	80332	SYMBOL|DICTIONARY	adam33	ADAM33	61#67		Asthma is associated with single-nucleotide polymorphisms in ADAM33.
14720258	2004	Clin. Exp. Allergy	0954-7894	BACKGROUND	1	1	80332	SYMBOL|GENE|GN|DICTIONARY	adam33	ADAM33	4#10		The ADAM33 gene has recently been associated with asthma and bronchial hyper-reactivity.
14720258	2004	Clin. Exp. Allergy	0954-7894	OBJECTIVE	2	3	80332	SYMBOL|DICTIONARY	adam33	ADAM33	37#43		We examined whether polymorphisms in ADAM33 are associated with asthma and related traits in two German populations.
14720258	2004	Clin. Exp. Allergy	0954-7894	CONCLUSION	5	12	80332	SYMBOL|GENE|GN|DICTIONARY	adam33	ADAM33	76#82		This study replicates the recently published association between asthma and ADAM33 gene variants.
14720258	2004	Clin. Exp. Allergy	0954-7894	CONCLUSION	5	14	80332	SYMBOL|DICTIONARY	adam33	ADAM33	134#140		As linkage disequilibrium is high among the tested SNPs, and there is no known functional polymorphism, either not-tested variants in ADAM33, unknown regulatory elements or a gene in close proximity is responsible for this association.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	3458	LONGTERM|GENE|GN|DICTIONARY	interferon gamma	Interferon-gamma	0#16		Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	METHODS	2	4	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	133#142	15675129-2-112-128	Patients and controls were genotyped by molecular methods for the microsatellite dinucleotide (CA) repeat within the first intron of IFN-gamma gene.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3458	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifn gamma	IFN-gamma	66#75	15675129-2-112-128	No significant differences in the distribution of alleles for the IFN-gamma gene polymorphism between GCA and isolated PMR patients and controls were found.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	6	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	26#35	15675129-2-112-128	However, the frequency of IFN-gamma allele *4 (128 bp) was reduced in GCA patients (33.1%) compared with isolated PMR patients (46.2%).
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	102#111	15675129-2-112-128	Also, GCA patients with visual ischemic manifestations exhibited a significantly reduced frequency of IFN-gamma allele *4 compared with those without visual manifestations (17.9% versus 42.5%; p = 0.05 [OR: 0.36, 95% CI: 0.13-1.00]).
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	3458	SYMBOL|EXTRACTED	ifn gamma	IFN-gamma	8#17	15675129-2-112-128	In GCA, IFN-gamma functional polymorphisms are associated with clinical manifestations of severity rather than susceptibility to this vasculitis.
14676460	2004	Horm. Res.	0301-0163	METHODS	2	2	1589	SYMBOL|GENE|GN|DICTIONARY	cyp21	CYP21	32#37		All the exons of the functional CYP21 gene (CYP21A2) were analyzed by polymerase chain reaction (PCR) and PCR direct sequencing.
14676460	2004	Horm. Res.	0301-0163	METHODS	2	2	1589	SYMBOL|()|DICTIONARY|EXTRACTED	cyp21a2	CYP21A2	44#51	14676460-2-32-37	All the exons of the functional CYP21 gene (CYP21A2) were analyzed by polymerase chain reaction (PCR) and PCR direct sequencing.
14676460	2004	Horm. Res.	0301-0163	RESULTS	3	5	1589	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp21a2	CYP21A2	45#52	14676460-2-32-37	Sequence analysis of the complete functional CYP21A2 gene revealed three, not yet described mutations that represent a common pseudogene sequence.
14695540	2004	Hum. Mutat.	1098-1004	TITLE	0	0	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	26#30		Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy.
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	LONGTERM|DICTIONARY	fibrillin 1	fibrillin-1	105#116		Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	1	2200	SYMBOL|()|DICTIONARY|EXTRACTED	fbn1	FBN1	118#122	14695540-1-105-116	Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	5	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	25#29	14695540-1-105-116	We detected 49 different FBN1 mutations, 30 (62%) of which were novel.
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	70#74	14695540-1-105-116	Genotype-phenotype analysis revealed that patients with an identified FBN1 mutation were more likely to have ectopia lentis and cardiovascular complications compared to those without an identifiable mutation (relative risks of 4.6 and 1.9, respectively).
14695540	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	129#133	14695540-1-105-116	Further analysis of detailed clinical information and mutation data may help to anticipate the clinical consequences of specific FBN1 mutations.
14695532	2004	Hum. Mutat.	1098-1004	TITLE	0	0	2548	SYMBOL|()|DICTIONARY|EXTRACTED	gaa	GAA	68#71	14695532-0-34-61	Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.
14695532	2004	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	2548	SYMBOL|()|DICTIONARY|EXTRACTED	gaa	GAA	122#125	14695532-0-34-61	We have investigated 29 cases of GSDII and thereby identified 55 pathogenic mutations of the acid alpha-glucosidase gene (GAA) encoding acid maltase.
14695532	2004	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	2548	SYMBOL|DICTIONARY|EXTRACTED	gaa	GAA	146#149	14695532-0-34-61	The outcome of our analysis underscores the notion that the clinical phenotype of GSDII is largely dictated by the nature of the mutations in the GAA alleles.
15256764	2004	J. Atheroscler. Thromb.	1340-3478	ALL_TEXT_2/3	2	3	3949	LONGTERM|GENE|GT|DICTIONARY	low density lipoprotein receptor	low density lipoprotein receptor	52#84		Mutations in the following genes were investigated: low density lipoprotein receptor, lecithin: cholesteryl acyltransferase, lipoprotein lipase (LPL), hepatic lipase, apolipoproteins A-I, A-II, A-IV, B, C-II, C-III and E, microsomal triglyceride transfer protein, and cholesterol ester transfer protein (CETP).
15256764	2004	J. Atheroscler. Thromb.	1340-3478	ALL_TEXT_2/3	2	3	4023	LONGTERM|DICTIONARY	lipoprotein lipase	lipoprotein lipase	125#143		Mutations in the following genes were investigated: low density lipoprotein receptor, lecithin: cholesteryl acyltransferase, lipoprotein lipase (LPL), hepatic lipase, apolipoproteins A-I, A-II, A-IV, B, C-II, C-III and E, microsomal triglyceride transfer protein, and cholesterol ester transfer protein (CETP).
15256764	2004	J. Atheroscler. Thromb.	1340-3478	ALL_TEXT_2/3	2	3	4023	SYMBOL|()|DICTIONARY|EXTRACTED	lpl	LPL	145#148	15256764-3-125-143	Mutations in the following genes were investigated: low density lipoprotein receptor, lecithin: cholesteryl acyltransferase, lipoprotein lipase (LPL), hepatic lipase, apolipoproteins A-I, A-II, A-IV, B, C-II, C-III and E, microsomal triglyceride transfer protein, and cholesterol ester transfer protein (CETP).
14962090	2004	J. Invest. Dermatol.	0022-202X	TITLE	0	0	3660	SYMBOL|GENE|GN|DICTIONARY	irf 2	IRF-2	18#23		Evaluation of the IRF-2 gene as a candidate for PSORS3.
14962090	2004	J. Invest. Dermatol.	0022-202X	TITLE	0	0	7889	SYMBOL|DICTIONARY	psors3	PSORS3	48#54		Evaluation of the IRF-2 gene as a candidate for PSORS3.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	LONGTERM|DICTIONARY	interferon regulatory factor 2	interferon regulatory factor 2	132#162		Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	2	3660	SYMBOL|()|DICTIONARY|EXTRACTED	irf2	IRF2	164#168	14962090-2-132-162	Hypersensitivity to type 1 interferon signaling causes a psoriasis-like skin disease in mice deficient for the transcription factor interferon regulatory factor 2 (IRF2).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	3660	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	irf2	IRF2	10#14	14962090-2-132-162	The human IRF2 gene is located at a previously identified candidate psoriasis susceptibility locus on chromosome 4q (PSORS3 at D4S1535).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	3	7889	SYMBOL|DICTIONARY	psors3	PSORS3	117#123		The human IRF2 gene is located at a previously identified candidate psoriasis susceptibility locus on chromosome 4q (PSORS3 at D4S1535).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	4	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	51#55	14962090-2-132-162	Therefore, we tested association of psoriasis with IRF2.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_2/3	2	6	3660	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	irf2	IRF2	166#170	14962090-2-132-162	Five novel microsatellite markers were developed and typed, and complemented with three known markers to yield a set of eight markers spaced within 600 kb around the IRF2 gene, three of which are located in the gene.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	7	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	27#31	14962090-2-132-162	We detected association of IRF2 with type 1 psoriasis at two markers in the IRF2 gene.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	7	3660	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	irf2	IRF2	76#80	14962090-2-132-162	We detected association of IRF2 with type 1 psoriasis at two markers in the IRF2 gene.
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	8	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	52#56	14962090-2-132-162	Haplotype sharing analysis confirmed association of IRF2 with type 1 psoriasis (p=0.0017; pcorr=0.03).
14962090	2004	J. Invest. Dermatol.	0022-202X	ALL_TEXT_3/3	3	11	3660	SYMBOL|DICTIONARY|EXTRACTED	irf2	IRF2	18#22	14962090-2-132-162	Our data identify IRF2 as a potential susceptibility gene for psoriasis.
14717963	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	29#64		Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
14717963	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	4524	SYMBOL|()|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	66#71	14717963-0-29-64	Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	129#164		In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	1	4524	SYMBOL|()|DICTIONARY|EXTRACTED	mthfr	MTHFR	166#171	14717963-0-29-64	In young women data are limited about the association between myocardial infarction (MI) and hyperhomocysteinemia, low folate or methylenetetrahydrofolate reductase (MTHFR) genotypes.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_1/3	1	3	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	70#75	14717963-0-29-64	We assessed the association between hyperhomocysteinemia, low folate, MTHFR 677TT mutation and risk of MI, and we investigated the effect of OC use on homocysteine levels in controls.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	8#13	14717963-0-29-64	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_3/3	3	11	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	67#72	14717963-0-29-64	Low folate is a risk factor for MI, particularly in women with the MTHFR 677TT genotype.
15128052	2004	Pharmacogenetics	0960-314X	TITLE	0	0	5465	SYMBOL|DICTIONARY	pparalpha	PPARalpha	11#20		Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_1/3	1	2	5465	SYMBOL|DICTIONARY	ppar	PPAR	48#52		Our objectives were to determine the effects of PPAR haplotypes on biochemical, angiographic, clinical phenotypes and their responses to treatment with fluvastatin.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_1/3	1	3	5465	SYMBOL|DICTIONARY	pparalpha	PPARalpha	125#134		We genotyped 372 Lipoprotein and Coronary Atherosclerosis Study subjects for seven single nucleotide polymorphisms (SNPs) in PPARalpha (-35 089A>C, 484C>G), delta (-4401C>T, 294T>C) and gamma (34C>G, 25 506C>T, 161C>T) by restriction mapping or 5' exonuclease assay.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_2/3	2	5	5467	SYMBOL|DICTIONARY	ppard	PPARD	114#119		Linkage disequilibrium (LD) was calculated by D' and haplotype effects by permutation and regression analyses.The PPARD and PPARG SNPs were in LD.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_2/3	2	5	5468	SYMBOL|DICTIONARY	pparg	PPARG	124#129		Linkage disequilibrium (LD) was calculated by D' and haplotype effects by permutation and regression analyses.The PPARD and PPARG SNPs were in LD.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_2/3	2	6	5467	SYMBOL|DICTIONARY	ppard	PPARD	111#116		The baseline plasma triglyceride levels and their responses to treatment with fluvastatin were associated with PPARD haplotypes (P = 0.01).
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	8	5467	SYMBOL|DICTIONARY	ppard	PPARD	0#5		PPARD haplotype 3 was also an independent determinant of plasma apolipoprotein (apo)B (P = 0.021) and apoC-III (P = 0.001) levels, mean number of coronary lesions (P = 0.046) and changes in triglyceride (P = 0.01) and apoC-III (P = 0.047) levels in response to fluvastatin.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	8	345	SYMBOL|DICTIONARY	apoc iii	apoC-III	102#110		PPARD haplotype 3 was also an independent determinant of plasma apolipoprotein (apo)B (P = 0.021) and apoC-III (P = 0.001) levels, mean number of coronary lesions (P = 0.046) and changes in triglyceride (P = 0.01) and apoC-III (P = 0.047) levels in response to fluvastatin.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	8	345	SYMBOL|DICTIONARY	apoc iii	apoC-III	218#226		PPARD haplotype 3 was also an independent determinant of plasma apolipoprotein (apo)B (P = 0.021) and apoC-III (P = 0.001) levels, mean number of coronary lesions (P = 0.046) and changes in triglyceride (P = 0.01) and apoC-III (P = 0.047) levels in response to fluvastatin.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	9	5468	SYMBOL|DICTIONARY	pparg	PPARG	191#196		Plasma triglyceride levels (P = 0.044), the mean number of coronary lesions (P = 0.026) and changes in minimum lumen diameter in response to fluvastatin (P = 0.022) were also associated with PPARG haplotypes.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	10	5465	SYMBOL|DICTIONARY	ppara	PPARA	36#41		No significant associations between PPARA haplotypes and the phenotypes or significant interactions between PPAR haplotypes and the occurrence of new clinical events were detected.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	10	5465	SYMBOL|DICTIONARY	ppar	PPAR	108#112		No significant associations between PPARA haplotypes and the phenotypes or significant interactions between PPAR haplotypes and the occurrence of new clinical events were detected.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	11	5467	SYMBOL|DICTIONARY	ppard	PPARD	0#5		PPARD and PPARG haplotypes are independent determinants of plasma levels of lipids, severity of coronary atherosclerosis and its response to therapy.
15128052	2004	Pharmacogenetics	0960-314X	ALL_TEXT_3/3	3	11	5468	SYMBOL|DICTIONARY	pparg	PPARG	10#15		PPARD and PPARG haplotypes are independent determinants of plasma levels of lipids, severity of coronary atherosclerosis and its response to therapy.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	1	1234	SYMBOL|GENE|GN|DICTIONARY	ccr5	CCR5	31#35		A 32-base-pair deletion in the CCR5 gene was previously shown to influence the susceptibility for several infectious diseases.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	2	1234	SYMBOL|DICTIONARY	ccr5	CCR5	48#52		The present study compared the frequency of the CCR5-Delta32 mutation among subjects with periodontal disease and healthy control individuals.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_1/3	1	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	22#26		The prevalence of the CCR5-Delta32 mutation was determined in 81 patients with generalized periodontitis and 121 healthy controls.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_2/3	2	5	1234	SYMBOL|DICTIONARY	ccr5	CCR5	4#8		The CCR5-Delta32 mutation was identified by PCR amplification and subsequent agarose gel electrophoresis.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	7	1234	SYMBOL|DICTIONARY	ccr5	CCR5	21#25		The frequency of the CCR5-Delta32 allele was 9.9% (16/162) for periodontitis patients and 10.7% (26/216) for the healthy controls.
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	8	1234	SYMBOL|DICTIONARY	ccr5	CCR5	84#88		The allele frequencies between periodontitis patients and the control group for the CCR5-Delta32 mutation were not significantly different (P=0.801).
14697747	2004	Clin. Immunol.	1521-6616	ALL_TEXT_3/3	3	9	1234	SYMBOL|DICTIONARY	ccr5	CCR5	54#58		The present study revealed no association between the CCR5-Delta32 mutation and susceptibility to periodontal disease.
14630904	2004	J. Dent. Res.	0022-0345	TITLE	0	0	5308	SYMBOL|DICTIONARY	pitx2	PITX2	62#67		Novel identification of a four-base-pair deletion mutation in PITX2 in a Rieger syndrome family.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	5308	SYMBOL|DICTIONARY	pitx2	PITX2	17#22		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	2296	SYMBOL|DICTIONARY	foxc1	FOXC1	24#29		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_1/3	1	2	5080	SYMBOL|GENE|GN|DICTIONARY	pax6	PAX6	35#39		Mutations in the PITX2, FOXC1, and PAX6 genes have been associated with Rieger syndrome.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_2/3	2	4	5308	SYMBOL|GENE|GN|DICTIONARY	pitx2	PITX2	50#55		Mutational screening and sequence analysis of the PITX2 gene revealed a previously unidentified four-base-pair deletion of nucleotides 717-720 in exon 5 in all affected members.
14630904	2004	J. Dent. Res.	0022-0345	ALL_TEXT_3/3	3	7	5308	SYMBOL|DICTIONARY	pitx2	PITX2	131#136		Our novel discovery indicates that the oligodontia and other phenotypes of Rieger syndrome observed in this family are due to this PITX2 mutation, and these data further support the critical role of PIXT2 in tooth morphogenesis.
14691540	2006	PLoS Biol.	1545-7885	TITLE	0	0	2572	SYMBOL|DICTIONARY	gad2	GAD2	0#4		GAD2 on chromosome 10p12 is a candidate gene for human obesity.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|DICTIONARY	gad2	GAD2	9#13		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	1	2572	SYMBOL|()|DICTIONARY	gad65	GAD65	63#68		The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11-12, a susceptibility locus for morbid obesity in four independent ethnic populations.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	2	2572	SYMBOL|DICTIONARY	gad65	GAD65	0#5		GAD65 catalyzes the formation of gamma-aminobutyric acid (GABA), which interacts with neuropeptide Y in the paraventricular nucleus to contribute to stimulate food intake.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_1/3	1	3	2572	SYMBOL|DICTIONARY	gad2	GAD2	77#81		A case-control study (575 morbidly obese and 646 control subjects) analyzing GAD2 variants identified both a protective haplotype, including the most frequent alleles of single nucleotide polymorphisms (SNPs) +61450 C>A and +83897 T>A (OR = 0.81, 95% CI [0.681-0.972], p = 0.0049) and an at-risk SNP (-243 A>G) for morbid obesity (OR = 1.3, 95% CI [1.053-1.585], p = 0.014).
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_2/3	2	5	2572	SYMBOL|GENE|GN|DICTIONARY	gad2	GAD2	101#105		In the murine insulinoma cell line betaTC3, the G at-risk allele of SNP -243 A>G increased six times GAD2 promoter activity (p < 0.0001) and induced a 6-fold higher affinity for nuclear extracts.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_3/3	3	7	2572	SYMBOL|DICTIONARY	gad2	GAD2	3#7		As GAD2 is highly expressed in pancreatic beta cells, we analyzed GAD65 antibody level as a marker of beta-cell activity and of insulin secretion.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_3/3	3	7	2572	SYMBOL|DICTIONARY	gad65	GAD65	66#71		As GAD2 is highly expressed in pancreatic beta cells, we analyzed GAD65 antibody level as a marker of beta-cell activity and of insulin secretion.
14691540	2006	PLoS Biol.	1545-7885	ALL_TEXT_3/3	3	8	2572	SYMBOL|DICTIONARY	gad65	GAD65	91#96		In the control group, -243 A>G, +61450 C>A, and +83897 T>A SNPs were associated with lower GAD65 autoantibody levels (p values of 0.003, 0.047, and 0.006, respectively).
14623371	2004	Schizophr. Res.	0920-9964	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	18#45		No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor alpha	0#27		Tumor necrosis factor alpha (TNF-alpha), a potent immunomodulator and proinflammatory cytokine, has been implicated in schizophrenia pathogenesis and clozapine response.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tnf alpha	TNF-alpha	29#38	14623371-1-0-27	Tumor necrosis factor alpha (TNF-alpha), a potent immunomodulator and proinflammatory cytokine, has been implicated in schizophrenia pathogenesis and clozapine response.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_2/3	2	2	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	74#83	14623371-1-0-27	Two studies have established an association between schizophrenia and the TNF-alpha gene -308G/A polymorphism; however, both increased and decreased -308A allele frequency have been reported in two analogous investigations.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_3/3	3	3	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	51#60	14623371-1-0-27	The present study examined the hypothesis that the TNF-alpha gene -308G/A polymorphism confers susceptibility to schizophrenia in 205 patients with schizophrenia compared with 192 controls.
14623371	2004	Schizophr. Res.	0920-9964	ALL_TEXT_3/3	3	5	7124	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf alpha	TNF-alpha	53#62	14623371-1-0-27	The results of these investigations suggest that the TNF-alpha gene -308G/A variants do not play a major role in susceptibility to, clinical manifestations for, or clozapine response in, schizophrenia.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	TITLE	0	0	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	1869	SYMBOL|DICTIONARY	e2f1	E2F1	19#23		The expressions of E2F1 and retinoblastoma protein (pRB) were analyzed in 165 lymph node-positive breast cancers.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		E2F1 was expressed in 43.6% and pRB was expressed in 46.1%.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		E2F1 expression was significantly increased in pRB-expressing tumors and was associated with an S-phase fraction.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	5	1869	SYMBOL|DICTIONARY	e2f1	E2F1	33#37		By univariate survival analyses, E2F1 expression and ER were identified as significant prognostic factors for disease recurrence and patient survival.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	6	1869	SYMBOL|DICTIONARY	e2f1	E2F1	0#4		E2F1 was the only significant prognostic factor of patient outcome after FAC chemotherapy by multivariate analysis.
14602139	2004	Eur. J. Cancer	0959-8049	TITLE	0	0	1588	SYMBOL|DICTIONARY	cyp19	CYP19	40#45		Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
14602139	2004	Eur. J. Cancer	0959-8049	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	50#56		Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	1588	SYMBOL|()|DICTIONARY	cyp19	CYP19	93#98		Thus, the significance of genetic polymorphisms of genes involved in oestrogen biosynthesis (CYP19) and metabolism (CYP1A1) as a risk factor for ER-positive breast cancers was evaluated.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_1/3	1	2	1543	SYMBOL|()|DICTIONARY	cyp1a1	CYP1A1	116#122		Thus, the significance of genetic polymorphisms of genes involved in oestrogen biosynthesis (CYP19) and metabolism (CYP1A1) as a risk factor for ER-positive breast cancers was evaluated.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	4	1588	SYMBOL|DICTIONARY	cyp19	CYP19	19#24		Two polymorphisms, CYP19 (TTTA repeats) in intron 4 and CYP1A1 6235C/T in the 3' non-coding region, and their association with the breast cancer risk after adjustment for the other epidemiological risk factors were examined.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_2/3	2	4	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	56#62		Two polymorphisms, CYP19 (TTTA repeats) in intron 4 and CYP1A1 6235C/T in the 3' non-coding region, and their association with the breast cancer risk after adjustment for the other epidemiological risk factors were examined.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	5	1588	SYMBOL|DICTIONARY	cyp19	CYP19	0#5		CYP19 (TTTA)7(-3bp) allele carriers showed a significantly (P<0.05) increased risk of ER-positive breast cancers (Odds Ratio (OR)=1.72, 95% Confidence Interval (CI) 1.10-2.69), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	6	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	0#6		CYP1A1 6235C allele carriers showed a non-significant (P=0.06) trend towards a decreased risk of ER-positive breast cancers (OR=0.65, 95% CI 0.42-1.02), but not ER-negative breast cancers.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	7	1588	SYMBOL|DICTIONARY	cyp19	CYP19	164#169		The combination of these two polymorphisms was found to be more useful in the assessment of the ER-positive breast cancer risk (OR=3.00, 95% CI=1.56-5.74) than the CYP19 (TTTA)7(-3bp) polymorphism alone.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	1588	SYMBOL|DICTIONARY	cyp19	CYP19	19#24		The combination of CYP19 (TTTA)7(-3bp) and CYP1A1 6235C/T polymorphisms is associated with an ER-positive, but not ER-negative, breast cancer risk, and, thus, would be useful in the selection of candidates for chemoprevention with tamoxifen.
14602139	2004	Eur. J. Cancer	0959-8049	ALL_TEXT_3/3	3	8	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	43#49		The combination of CYP19 (TTTA)7(-3bp) and CYP1A1 6235C/T polymorphisms is associated with an ER-positive, but not ER-negative, breast cancer risk, and, thus, would be useful in the selection of candidates for chemoprevention with tamoxifen.
14661542	2004	Nippon Ganka Gakkai Zasshi	0029-0203	METHODS	2	2	25794	SYMBOL|()|GENE|GN|DICTIONARY	fscn 2	FSCN 2	149#155		Previously reported mutations for ADRP are summarized, and the results of screening for 120 Japanese patients with ADRP of the human retinal bascin (FSCN 2) gene are presented.
14661542	2004	Nippon Ganka Gakkai Zasshi	0029-0203	RESULTS AND CONCLUSION	3	4	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	48#57		The Pro 23 His and Pro 347 Leu mutations in the rhodopsin gene are representative mutations for ADRP in other countries, but the mutation in the rhodopsin gene is very rare in Japanese patients with ADRP.
14661542	2004	Nippon Ganka Gakkai Zasshi	0029-0203	RESULTS AND CONCLUSION	3	4	6010	LONGTERM|GENE|GN|DICTIONARY	rhodopsin	rhodopsin	145#154		The Pro 23 His and Pro 347 Leu mutations in the rhodopsin gene are representative mutations for ADRP in other countries, but the mutation in the rhodopsin gene is very rare in Japanese patients with ADRP.
14661542	2004	Nippon Ganka Gakkai Zasshi	0029-0203	RESULTS AND CONCLUSION	3	5	25794	SYMBOL|GENE|GN|DICTIONARY	fscn 2	FSCN 2	52#58		On the other hand, a novel 208 delG mutation in the FSCN 2 gene was identified in 14 patients from 4 Japanese families with ADRP.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	TITLE	0	0	57379	LONGTERM|GENE|GN|DICTIONARY	activation induced cytidine deaminase	activation-induced cytidine deaminase	21#58		[Correlation between activation-induced cytidine deaminase gene polymorphism and atopic asthma and plasma IgE in adult].
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	AIM	1	1	57379	LONGTERM|DICTIONARY	activation induced cytidine deaminase	activation-induced cytidine deaminase	23#60		To explore whether the activation-induced cytidine deaminase(AICDA) gene 8408 C/T polymorphism is related to adult atopic asthma and the level of plasma IgE.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	AIM	1	1	57379	SYMBOL|()|GENE|GN|DICTIONARY	aicda	AICDA	61#66		To explore whether the activation-induced cytidine deaminase(AICDA) gene 8408 C/T polymorphism is related to adult atopic asthma and the level of plasma IgE.
15182647	2004	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi	1007-8738	METHODS	2	2	57379	SYMBOL|GENE|GN|DICTIONARY	aicda	AICDA	20#25		The polymorphism of AICDA gene was detected by PCR and restriction fragment length polymorphism (PCR-RFLP).
14763782	2004	Acta Odontol. Scand.	0001-6357	TITLE	0	0	3459	LONGTERM|GENE|GN|DICTIONARY	interferon gamma receptor 1	interferon-gamma receptor-1	20#47		Polymorphisms in an interferon-gamma receptor-1 gene marker and susceptibility to periodontitis.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_1/3	1	2	3459	SYMBOL|()|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	198#204	14763782-2-178-187	Interferon (IFN)-gamma is a cytokine that plays a pivotal role in the defense against infection, and mutations in the gene coding for the ligand binding chain (alpha, R1) of the IFN-gamma receptor (IFNGR1) confer suseptibility on infections caused by poorly virulent mycobacteria.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_2/3	2	3	3459	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	69#75	14763782-2-178-187	Using an intronic (CA)n polymorphic microsatellite marker within the IFNGR1 gene we investigated whether genetic polymorphisms are associated with periodontitis.
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_3/3	3	6	3459	SYMBOL|DICTIONARY|EXTRACTED	ifngr1	IFNGR1	54#60	14763782-2-178-187	We therefore cannot find any evidence to suggest that IFNGR1, as a single dominant gene, contributes to susceptibility to periodontitis.
14558082	2003	Arthritis Rheum.	0004-3591	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	21#37		Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis.
14558082	2003	Arthritis Rheum.	0004-3591	TITLE	0	0	55801	LONGTERM|GENE|GN|DICTIONARY	interleukin 26	interleukin-26	38#52		Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis.
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3458	LONGTERM|DICTIONARY	interferon gamma	interferon-gamma	42#58		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3458	SYMBOL|EXTRACTED|()	ifngamma	IFNgamma	60#68	14558082-1-42-58	To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	LONGTERM|DICTIONARY	interleukin 26	interleukin-26	70#84		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	SYMBOL|DICTIONARY	il 26	IL-26	86#91		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	55801	SYMBOL|GENE|GN|DICTIONARY	ak155	AK155	103#108		To determine whether polymorphisms in the interferon-gamma (IFNgamma)/interleukin-26 (IL-26; formerly, AK155) gene cluster contribute to sex-based differential susceptibility to rheumatoid arthritis (RA).
14558082	2003	Arthritis Rheum.	0004-3591	METHODS	2	2	3458	SYMBOL|EXTRACTED	ifngamma	IFNgamma	81#89	14558082-1-42-58	Four microsatellite markers, located in a 118-kb interval that contains both the IFNgamma and IL-26 genes on chromosome 12q15, were typed in 251 patients with RA and 198 unrelated healthy controls (all of whom lived in Northern Ireland) by means of polymerase chain reaction-based fragment analysis.
14558082	2003	Arthritis Rheum.	0004-3591	METHODS	2	2	55801	SYMBOL|GENE|GN|DICTIONARY	il 26	IL-26	94#99		Four microsatellite markers, located in a 118-kb interval that contains both the IFNgamma and IL-26 genes on chromosome 12q15, were typed in 251 patients with RA and 198 unrelated healthy controls (all of whom lived in Northern Ireland) by means of polymerase chain reaction-based fragment analysis.
14558082	2003	Arthritis Rheum.	0004-3591	RESULTS	3	3	55801	SYMBOL|GENE|GN|DICTIONARY	il 26	IL-26	51#56		Marker D12S2510, which is located 3 kb 3' from the IL-26 gene, was significantly associated with RA in women (corrected P [P(corr)] = 0.008, 2 degrees of freedom [2 df]) but not in men (P = 0.99, 2 df).
14558082	2003	Arthritis Rheum.	0004-3591	CONCLUSION	4	5	3458	SYMBOL|EXTRACTED	ifngamma	IFNgamma	57#65	14558082-1-42-58	Our results demonstrate that common polymorphisms in the IFNgamma/IL-26 gene region may contribute to sex bias in susceptibility to RA, by distorting the propensity of female carriers versus male carriers to contract this disease.
14558082	2003	Arthritis Rheum.	0004-3591	CONCLUSION	4	5	55801	SYMBOL|GENE|GN|DICTIONARY	il 26	IL-26	66#71		Our results demonstrate that common polymorphisms in the IFNgamma/IL-26 gene region may contribute to sex bias in susceptibility to RA, by distorting the propensity of female carriers versus male carriers to contract this disease.
14508190	2004	J. Hypertens.	0263-6352	TITLE	0	0	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	24#39		An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	LONGTERM|DICTIONARY|GENE|GA	angiotensinogen	angiotensinogen	31#46		To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	48#51	14508190-1-31-46	To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	63#66	14508190-1-31-46	To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	OBJECTIVE	1	1	183	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	agt	AGT	136#139	14508190-1-31-46	To evaluate the association of angiotensinogen (AGT) gene with AGT level and hypertension based on the overall genetic variation of the AGT gene in among African-Americans.
14508190	2004	J. Hypertens.	0263-6352	METHODS	2	2	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	55#58	14508190-1-31-46	All non-rare single nucleotide polymorphisms (SNPs) in AGT were identified by resequencing 24 individuals.
14508190	2004	J. Hypertens.	0263-6352	METHODS	2	4	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	23#26	14508190-1-31-46	Association studies of AGT level and hypertension were performed using these five tagging SNPs.
14508190	2004	J. Hypertens.	0263-6352	RESULTS	3	5	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	32#35	14508190-1-31-46	No significant association with AGT level or hypertension was found in analyses of each of the five single SNPs.
14508190	2004	J. Hypertens.	0263-6352	RESULTS	3	6	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	92#95	14508190-1-31-46	However, one of the haplotypes defined by these five SNPs was significantly associated with AGT level (P = 0.046), although this haplotype was not associated with hypertension.
14508190	2004	J. Hypertens.	0263-6352	CONCLUSIONS	4	9	183	SYMBOL|DICTIONARY|EXTRACTED	agt	AGT	73#76	14508190-1-31-46	These strategies appeared to yield a modest increase in precision at the AGT locus with respect to the physiological intermediate, but did not lead to significant association of the molecular markers with hypertension.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	1	7450	SYMBOL|()|DICTIONARY|EXTRACTED	vwf	VWF	81#84	14521605-1-58-79	Interaction between platelet glycoprotein (GP)Ibalpha and von Willebrand factor (VWF) has critical roles in both physiological hemostasis and thrombosis.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	216#219	14521605-1-58-79	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
14521605	2004	J. Thromb. Haemost.	1538-7933	PATIENTS AND METHODS	3	9	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	29#32	14521605-1-58-79	We examined the 125I-labeled VWF binding using a series of recombinant GPIbalpha fragments with different residues at position 233 (G233S, G233A, G233K, and G233D) together with naturally occurring mutations previously reported in patients (G233V and M239V).
14521605	2004	J. Thromb. Haemost.	1538-7933	RESULTS	4	12	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	17#20	14521605-1-58-79	The 125I-labeled VWF binding to mutant compared with the wild type displayed three patterns, gain-of-function (G233S, G233V, and M239V), equivalent function (G233A), and loss-of-function (G233K and G233D).
14521605	2004	J. Thromb. Haemost.	1538-7933	CONCLUSIONS	5	13	7450	SYMBOL|DICTIONARY|EXTRACTED	vwf	VWF	94#97	14521605-1-58-79	The G233S is a molecular basis of plt-VWD, and residue 233 plays critical roles in regulating VWF binding.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin converting enzyme	275#304		In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	306#309	14974362-3-275-304	In our studies on the hypertension in kidney disease we have choosen the evaluation of incidence of hypertension in the early stage of primary glomerulonephritis (GN) and the comparison of distribution of genotypes and alleles depending on insertion/deletion polymorphism of angiotensin converting enzyme (ACE) gene in patients with early stage of GN and healthy subjects.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_3/3	3	6	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	113#116	14974362-3-275-304	Among 50 patients with early stage of GN the distribution of genotypes and alleles depending on the polymorphism ACE gene was significantly different from 100 healthy controls.
14974362	2004	Pol. Merkur. Lekarski	1426-9686	ALL_TEXT_3/3	3	8	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	59#62	14974362-3-275-304	Further studies are needed for verification of the role of ACE gene polymorphism in the predisposition to development of GN and associated arterial hypertension.
12963757	2004	Neurology	1526-632X	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	20#24		Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.
12963757	2004	Neurology	1526-632X	OBJECTIVE	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	29#33		To study the hypotheses that APOE-epsilon4 allele may interact with blood pressure to affect Alzheimer's disease (AD) occurrence and that antihypertensive therapy could modify such an effect.
12963757	2004	Neurology	1526-632X	RESULTS	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		APOE-epsilon4 allele, high systolic pressure (> or = 140 mm Hg), and low diastolic pressure (<70 mm Hg) were associated with an increased risk of AD.
12963757	2004	Neurology	1526-632X	RESULTS	3	6	348	SYMBOL|DICTIONARY	apoe	APOE	0#4		APOE-epsilon4 allele combined with low diastolic pressure greatly increased the risk of AD independent of antihypertensive drug use.
12963757	2004	Neurology	1526-632X	RESULTS	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	76#80		Antihypertensive therapy significantly reduced the risk of AD regardless of APOE-epsilon4 status and counteracted the combined risk effect of the epsilon4 allele with high systolic pressure on the disease.
12963757	2004	Neurology	1526-632X	CONCLUSIONS	4	9	348	SYMBOL|DICTIONARY	apoe	APOE	82#86		Antihypertensive therapy decreases the risk of Alzheimer's disease exerted by the APOE-epsilon4 allele.
12928282	2003	Br J Ophthalmol	0007-1161	TITLE	0	0	6247	SYMBOL|GENE|GN|DICTIONARY	xlrs1	XLRS1	90#95		Clinical features of X linked juvenile retinoschisis associated with new mutations in the XLRS1 gene in Italian families.
12928282	2003	Br J Ophthalmol	0007-1161	AIMS	1	1	6247	SYMBOL|GENE|GN|DICTIONARY	xlrs1	XLRS1	132#137		To describe the clinical phenotype of X linked juvenile retinoschisis in eight Italian families with six different mutations in the XLRS1 gene.
12928282	2003	Br J Ophthalmol	0007-1161	METHODS	2	3	6247	SYMBOL|GENE|GN|DICTIONARY	xlrs1	XLRS1	28#33		The coding sequences of the XLRS1 gene were amplified by polymerase chain reaction and directly sequenced on an automated sequencer.
12928282	2003	Br J Ophthalmol	0007-1161	RESULTS	3	4	6247	SYMBOL|DICTIONARY	xlrs1	XLRS1	14#19		Six different XLRS1 mutations were identified; two of these mutations Ile81Asn and the Trp122Cys, have not been previously described.
12928282	2003	Br J Ophthalmol	0007-1161	CONCLUSION	4	7	6247	LONGTERM|GENE|GN|DICTIONARY	retinoschisin	retinoschisin	161#174		The severe RS phenotypes associated with Trp112Cys and to Trp122Cys mutations suggest that these mutations determine a notable alteration in the function of the retinoschisin protein.
12907273	2003	Brain Dev.	0387-7604	ALL_TEXT_3/3	3	5	6323	SYMBOL|GENE|GN|DICTIONARY	scn1a	SCN1A	66#71		One patient with TSME and two of the three patients with BSME had SCN1A gene mutations that lead to truncation of the associated protein.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	TITLE	0	0	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	98#104		Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter mutation in the COL2A1 gene.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	METHODS	2	2	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	86#92		Clinical examination and linkage analysis of both families using markers flanking the COL2A1 gene associated with Stickler syndrome type 1, the loci for Wagner disease/erosive vitreoretinopathy (5q14.3), high myopia (18p11.31 and 12q21-q23), and nonsyndromic congenital retinal nonattachment (10q21).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	4	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	67#73		The RRD cosegregated fully with a chromosomal region harboring the COL2A1 gene with maximum lod scores of 6.09 (family A) and 4.97 (family B).
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	5	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	68#74		In family B, an Arg453Ter mutation was identified in exon 30 of the COL2A1 gene, that was previously described in a patient with classic Stickler syndrome.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	RESULTS	3	6	1280	SYMBOL|GENE|GN|DICTIONARY	col2a1	COL2A1	108#114		In family A, DNA sequence analysis revealed no mutation in the coding region and at the splice sites of the COL2A1 gene.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	7	1280	SYMBOL|DICTIONARY	col2a1	COL2A1	57#63		In two large families with RRD, linkage was found at the COL2A1 locus.
12939326	2003	Invest. Ophthalmol. Vis. Sci.	0146-0404	CONCLUSIONS	4	9	1280	SYMBOL|DICTIONARY	col2a1	COL2A1	100#106		In contrast, the Arg453Ter mutation and other protein-truncating mutations in the helical domain of COL2A1 have been associated until now with classic Stickler syndrome.
14502680	2004	Mov. Disord.	0885-3185	ALL_TEXT_1/3	1	1	131	SYMBOL|GENE|GN|DICTIONARY	adh7	ADH7	57#61		A polymerase chain reaction and direct sequencing of the ADH7 gene were carried out in 50 controls and 50 patients with probable multiple system atrophy (MSA).
12960748	2004	Psychiatr. Genet.	0955-8829	OBJECTIVE	1	1	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	121#127		The purpose of this study was to examine whether the neuroleptic-induced extrapyramidal symptoms are associated with the CYP2D6 activity.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|GENE|GN|DICTIONARY	cyp2d6	CYP2D6	4#10		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	31#37		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	41#47		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	51#57		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	61#67		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	METHODS	2	2	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	76#82		The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	24#30		The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	4	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	73#79		The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	5	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	161#167		The steady-state serum haloperidol levels per daily dosage were observed to be significantly higher in schizophrenic patients with the mutant-type homozygote of CYP2D6*2, while this difference was trend level in those of CYP2D6*10.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	5	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	221#227		The steady-state serum haloperidol levels per daily dosage were observed to be significantly higher in schizophrenic patients with the mutant-type homozygote of CYP2D6*2, while this difference was trend level in those of CYP2D6*10.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	76#82		However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	RESULTS	3	6	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	98#104		However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	52#58		The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12960748	2004	Psychiatr. Genet.	0955-8829	CONCLUSION	4	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	65#71		The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
12939427	2004	Neurology	1526-632X	TITLE	0	0	4155	LONGTERM|GENE|GN|GT|DICTIONARY	myelin basic protein	Myelin basic protein	0#20		Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	LONGTERM|GENE|GT|DICTIONARY|GA	myelin basic protein	myelin basic protein	4#24		The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	1	4155	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	26#29	12939427-1-4-24	The myelin basic protein (MBP) gene may confer genetic susceptibility to multiple sclerosis (MS).
12939427	2004	Neurology	1526-632X	BACKGROUND	1	2	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	97#100	12939427-1-4-24	The association of MS with alleles of the (TGGA)n variable number tandem repeat (VNTR) 5' to the MBP gene is the subject of conflicting reports.
12939427	2004	Neurology	1526-632X	OBJECTIVE	2	3	4155	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mbp	MBP	54#57	12939427-1-4-24	To study possible MS association with VNTR alleles of MBP gene in ethnic Italians and ethnic Russians.
12939427	2004	Neurology	1526-632X	METHODS	3	4	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	147#150	12939427-1-4-24	Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
12939427	2004	Neurology	1526-632X	METHODS	3	5	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	66#69	12939427-1-4-24	The phenotype, allele, and genotype frequencies for two groups of MBP alleles were determined.
12939427	2004	Neurology	1526-632X	RESULTS	4	7	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	The distribution of MBP alleles and genotypes in the two ethnic groups, including both MS patients and control subjects, was very similar.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	133#136	12939427-1-4-24	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	31#34	12939427-1-4-24	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	4155	SYMBOL|DICTIONARY|EXTRACTED	mbp	MBP	20#23	12939427-1-4-24	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12913211	2004	Neurology	1526-632X	TITLE	0	0	246744	LONGTERM|GENE|GN|DICTIONARY	saitohin	Saitohin	26#34		Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy.
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	1	246744	LONGTERM|GENE|GN|DICTIONARY	saitohin	Saitohin	82#90		Recent reports are inconclusive in showing that the Q7R polymorphism of the novel Saitohin gene, nested in intron 9 of the tau gene, is associated with AD.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	4436	SYMBOL|DICTIONARY	msh2	MSH2	22#26		[Mutation analysis on MSH2 and MLH1 genes in patients of colorectal cancer at early age].
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	4292	SYMBOL|GENE|GN|DICTIONARY	mlh1	MLH1	31#35		[Mutation analysis on MSH2 and MLH1 genes in patients of colorectal cancer at early age].
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4436	SYMBOL|DICTIONARY	msh2	MSH2	101#105		To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	4292	SYMBOL|DICTIONARY	mlh1	MLH1	110#114		To investigate the etiological role of function and construction alteration in mismatch repair genes MSH2 and MLH1 in the patients onset of colorectal cancers (CRC) at early ages.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4436	SYMBOL|GENE|GN|DICTIONARY	msh2	MSH2	35#39		A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
12930688	2004	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	4292	SYMBOL|GENE|GN|DICTIONARY	mlh1	MLH1	82#86		A large DNA (exon 1-6) deletion in MSH2 gene and a missense mutation Met242Ile in MLH1 gene were unveiled in CRC tissues of two patients with MSI(+)-H.
14567462	2004	Dig Liver Dis	1590-8658	AIMS	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	139#190		In patients with with primary sclerosing cholangitis we investigated the major histocompatibility complex (MHC) genes and mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
14567462	2004	Dig Liver Dis	1590-8658	AIMS	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	192#196	14567462-1-139-190	In patients with with primary sclerosing cholangitis we investigated the major histocompatibility complex (MHC) genes and mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	162#170		In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	172#180		In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	232#236	14567462-1-139-190	In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	15#19		Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	66#70		Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3123	SYMBOL|DICTIONARY	drb1	DRB1	120#124		Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA DRB1	39#47		The frequency of patients positive for HLA DRB1*01, *1601 or *04 related haplotypes was significantly increased (32 vs. 14%, p<0.00025).
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	0#4		DRB1*07, DQA1*0201, DQB1*02 haplotype frequency was significantly decreased (4 vs. 15%, p<0.001).
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	15#23		After removing HLA-DRB1*01, *1601, *04 related haplotype sharing patients, HLA-DRB1*03, DQA1*0501, DQB1*02 haplotype frequency was significantly increased (32 vs. 14%, p<0.01).
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	75#83		After removing HLA-DRB1*01, *1601, *04 related haplotype sharing patients, HLA-DRB1*03, DQA1*0501, DQB1*02 haplotype frequency was significantly increased (32 vs. 14%, p<0.01).
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	8	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	31#35	14567462-1-139-190	No mutations were found on the CFTR gene and the allelic frequency of the 5T polymorphism in intron 8 was not increased.
12928685	2003	Eye (Lond)	0950-222X	TITLE	0	0	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	8#23		Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
12928685	2003	Eye (Lond)	0950-222X	PURPOSE	1	3	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	55#70		Numerous studies have shown that two genetic variants, factor V Leiden and prothrombin 20210A, cause a procoagulant state.
12928685	2003	Eye (Lond)	0950-222X	PURPOSE	1	5	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	93#108		The purpose of the present study was therefore to investigate a possible association between factor V Leiden, prothrombin 20210A, and retinal artery occlusion.
12928685	2003	Eye (Lond)	0950-222X	METHODS	2	7	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	16#31		The presence of factor V Leiden and prothrombin 20210A alleles was determined by polymerase chain reaction.
12928685	2003	Eye (Lond)	0950-222X	RESULTS	3	9	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	16#31		Distribution of factor V Leiden genotypes revealed no significant difference among the two groups (heterozygosity: eight patients vs 11 controls, P=0.47).
12928685	2003	Eye (Lond)	0950-222X	CONCLUSION	4	11	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	22#37		Our data suggest that factor V Leiden and prothrombin 20210A do not play a major role in patients with retinal artery occlusion.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	4353	LONGTERM|GENE|GN|DICTIONARY	myeloperoxidase	myeloperoxidase	114#129		Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	4353	LONGTERM|DICTIONARY	myeloperoxidase	Myeloperoxidase	0#15		Myeloperoxidase (MPO) is an oxidative enzyme present in phagocytes and atherosclerotic lesions.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	4353	SYMBOL|()|DICTIONARY|EXTRACTED	mpo	MPO	17#20	12915675-1-0-15	Myeloperoxidase (MPO) is an oxidative enzyme present in phagocytes and atherosclerotic lesions.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	4353	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mpo	MPO	4#7	12915675-1-0-15	The MPO gene has a promoter polymorphism -463G/A, which leads to high (GG) and low expression (AG, AA) genotypes.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	177#180	12915675-1-0-15	We investigated the effect of long-term hormone replacement therapy (HRT) on the progression of atherosclerosis in a 5-yr follow-up study of postmenopausal women with different MPO genotypes.
12915675	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	6	4353	SYMBOL|DICTIONARY|EXTRACTED	mpo	MPO	125#128	12915675-1-0-15	The atherosclerosis severity score (ASC) for abdominal aorta and carotid arteries was determined by ultrasonography, and the MPO genotype was analyzed.
12888635	2003	J. Nutr.	0022-3166	ALL_TEXT_1/3	1	3	154	SYMBOL|GENE|GN|DICTIONARY	beta 2 adrenoceptor	beta(2)-adrenoceptor	173#193		A case-control study (obese subjects vs. normal weight controls) was conducted to assess a possible effect modification on obesity risk of the Gln27Glu polymorphism for the beta(2)-adrenoceptor gene depending on dietary intake.
12828656	2003	J. Periodont. Res.	0022-3484	TITLE	0	0	4049	LONGTERM|DICTIONARY	lymphotoxin alpha	lymphotoxin-alpha	31#48		Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population.
12828656	2003	J. Periodont. Res.	0022-3484	BACKGROUND	1	2	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		Tumor necrosis factor (TNF), a pluripotent proinflammatory cytokine that is able to induce tissue destruction and bone resorption, has been implicated in the pathogenesis of periodontal disease.
12828656	2003	J. Periodont. Res.	0022-3484	BACKGROUND	1	2	7124	SYMBOL|EXTRACTED|()	tnf	TNF	23#26	12828656-2-0-21	Tumor necrosis factor (TNF), a pluripotent proinflammatory cytokine that is able to induce tissue destruction and bone resorption, has been implicated in the pathogenesis of periodontal disease.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	137#140	12828656-2-0-21	In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF-alpha	217#226		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	4049	LONGTERM|DICTIONARY|GENE|GA	lymphotoxin alpha	lymphotoxin alpha	338#355		In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	METHODS	2	3	4049	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	357#365	12828656-3-338-355	In this study, we investigated an association between chronic periodontitis and two previously described bi-allelic polymorphisms in the TNF locus: a G to A transition at position -308 in the 5'promoter region of the TNF-alpha gene and an NcoI restriction fragment length polymorphism (RFLP) in the first intron (position +252A/G) of the lymphotoxin alpha (LT-alpha) gene.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	5	4049	SYMBOL|EXTRACTED	lt alpha	LT-alpha	136#144	12828656-3-338-355	The TNF-alpha (-308G/A) polymorphism itself showed no association with chronic periodontitis, whereas the frequency distribution of the LT-alpha (+252A/G) genotypes showed statistically significant differences between patients and the reference group.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	6	4049	SYMBOL|EXTRACTED	lt alpha	LT-alpha	43#51	12828656-3-338-355	The proportion of individuals carrying the LT-alpha 1/1 genotype was significantly lower in the group of patients with chronic periodontitis (0.8%) than in the control group (8.8%) (P < 0.0094, Pcorr < 0.05).
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	7	4049	SYMBOL|EXTRACTED	lt alpha	LT-alpha	97#105	12828656-3-338-355	However, the significant differences in the frequencies of the combined genotypes (TNF-alpha and LT-alpha) between the control and the patient groups were found using a simulation by applying the Monte-Carlo method (P < 0.01).
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	8	4049	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	71#79	12828656-3-338-355	Our data suggest that combined genotypes composed of the TNF-alpha and LT-alpha gene polymorphisms may influence the susceptibility to chronic periodontitis.
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	9	4049	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lt alpha	LT-alpha	115#123	12828656-3-338-355	We also showed that, comparing the two genes, the 1/1 genotype of the NcoI polymorphism in the first intron of the LT-alpha gene is a more informative marker and it may be one of the protective genetic factors against chronic periodontitis in our population.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	20#25		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	27#32		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	34#39		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	41#46		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	52#58		Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	12#47		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	49#54		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	91#96		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	101#106		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	113#118		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	1555	SYMBOL|DICTIONARY	p450	p450	147#151		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	1	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	153#159		The role of methylenetetrahydrofolate reductase (MTHFR C677T), glutathione S-transferases (GSTM1 and GSTT1 null, GSTP1 Ile105Val), and cytochromes p450 (CYP1A1*2A) genotypes in the etiology of childhood leukemia was simultaneously investigated.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_1/3	1	3	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	17#22		The frequency of MTHFR genotype was insignificantly higher in ALL (7.7%) and ANLL (6.3%) than in controls (4.4%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	26#31		Equal distribution of the GSTM1 null genotype was detected between ALL patients and controls (55%), while its incidence was slightly higher in ANLL patients (61.3%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	9#14		Although GSTT1 null genotype was insignificantly lower in ALL patients (20.9%) than controls (22.7%), it was significantly underrepresented in ANLL patients (6.5%) (P = 0.05, OR 0.24, 95% CI 0.05-1.03).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_2/3	2	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	28#33		The homozygous frequency of GSTP1 genotype did not differ significantly between groups of ALL (3.7%), ANLL patients (9.1%) and controls (4.9%).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	7	1543	SYMBOL|NUMBER|DICTIONARY	cyp1a1	CYP1A1	11#17		Homozygous CYP1A1*2A genotype was underrepresented in ALL patients (1%) as compared to control (4.8%) but the differences did not reach to statistical significance (OR 0.21; 95% CI 0.03-1.72).
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	161#166		These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
12827651	2003	Am. J. Hematol.	0361-8609	ALL_TEXT_3/3	3	10	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	193#199		These results suggested that there are no significant associations between the studied genotypes and the risk of developing either form of acute leukemia except GSTT1 null and homozygosity for CYP1A1 genotypes that may play protective roles in the development of ANLL in Turkish children.
12880539	2004	Ann. Clin. Biochem.	0004-5632	TITLE	0	0	348	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India.
12880539	2004	Ann. Clin. Biochem.	0004-5632	OBJECTIVES	1	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	52#68		However, there are no reports regarding the role of apolipoprotein E (apo E) gene polymorphisms in premature myocardial infarction (MI) in this population.
12880539	2004	Ann. Clin. Biochem.	0004-5632	OBJECTIVES	1	2	348	SYMBOL|()|GENE|GN|DICTIONARY	apo e	apo E	70#75		However, there are no reports regarding the role of apolipoprotein E (apo E) gene polymorphisms in premature myocardial infarction (MI) in this population.
12880539	2004	Ann. Clin. Biochem.	0004-5632	OBJECTIVES	1	3	348	SYMBOL|GENE|GN|DICTIONARY	apo e	apo E	38#43		This study aimed to study the role of apo E gene polymorphisms in premature MI patients and their relation to serum lipid levels.
12880539	2004	Ann. Clin. Biochem.	0004-5632	DESIGN AND METHODS	2	4	348	SYMBOL|GENE|GN|DICTIONARY	apo e	Apo E	0#5		Apo E gene polymorphisms were analysed in 35 patients with MI aged <40 years and in 45 age- and sex-matched controls using polymerase chain reaction-restriction fragment length polymorphism.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	7040	LONGTERM|DICTIONARY	latency associated peptide	latency-associated peptide	25#51		A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	7040	SYMBOL|GENE|GN|DICTIONARY	tgfb1	TGFB1	51#56		CED is caused by various missense mutations in the TGFB1 gene that encodes TGFbeta1, the most common of which is an arginine-cysteine amino acid change at codon 218 (R218C) in the latency-associated peptide domain of TGFbeta1.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	latency associated peptide	latency-associated peptide	180#206		CED is caused by various missense mutations in the TGFB1 gene that encodes TGFbeta1, the most common of which is an arginine-cysteine amino acid change at codon 218 (R218C) in the latency-associated peptide domain of TGFbeta1.
12918850	2003	J. Heart Valve Dis.	0966-8519	TITLE	0	0	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	20#31		Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse.
12918850	2003	J. Heart Valve Dis.	0966-8519	BACKGROUND AND AIM OF THE STUDY	1	1	2006	LONGTERM|DICTIONARY	elastin	elastin	53#60		Fibrillin is one of the structural components of the elastin-associated microfibrils found in the mitral valve.
12918850	2003	J. Heart Valve Dis.	0966-8519	BACKGROUND AND AIM OF THE STUDY	1	4	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	85#96		Hence, a case-controlled study was performed to investigate the relationship between fibrillin-1 gene polymorphisms and risk of MVP in Taiwan Chinese.
12918850	2003	J. Heart Valve Dis.	0966-8519	METHODS	2	6	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	49#60		Polymorphisms of exon 15, 27 and intron C of the fibrillin-1 gene (FBN1) were identified by polymerase chain reaction-based restriction analysis.
12918850	2003	J. Heart Valve Dis.	0966-8519	METHODS	2	6	2200	SYMBOL|()|DICTIONARY|EXTRACTED	fbn1	FBN1	67#71	12918850-6-49-60	Polymorphisms of exon 15, 27 and intron C of the fibrillin-1 gene (FBN1) were identified by polymerase chain reaction-based restriction analysis.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	7	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	122#126	12918850-6-49-60	A significant difference was seen in genotype distribution or allelic frequency between MVP cases and controls for either FBN1 exon 15 polymorphism (p = 0.012 and 0.002, respectively) or exon 27 polymorphism (p = 0.04 and 0.02, respectively).
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	8	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	49#53	12918850-6-49-60	Odds ratios (OR) for risk of MVP associated with FBN1 exon 15 TT and exon 27 GG genotypes were 2.40 (95% CI 1.32-4.39) and 3.61 (95% CI 1.01-12.89), respectively.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	9	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	35#39	12918850-6-49-60	OR for risk of MVP associated with FBN1 exon 15 T and exon 27 G alleles were 2.24 (95% CI 1.32-3.81) and 1.66 (95% CI 1.07-2.56), respectively.
12918850	2003	J. Heart Valve Dis.	0966-8519	RESULTS	3	10	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	59#63	12918850-6-49-60	There was no significant difference in the distribution of FBN1 intron C genotypes (p = 0.58) and allelic frequency (p = 0.34) between MVP cases and controls.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	45#49	12918850-6-49-60	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12918850	2003	J. Heart Valve Dis.	0966-8519	CONCLUSION	4	11	2200	SYMBOL|DICTIONARY|EXTRACTED	fbn1	FBN1	116#120	12918850-6-49-60	Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.
12930595	2004	Thyroid	1050-7256	TITLE	0	0	7253	LONGTERM|GENE|GN|GT|DICTIONARY	thyrotropin receptor	thyrotropin receptor	67#87		Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins.
12930595	2004	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7253	SYMBOL|EXTRACTED|()	tshr	TSHr	28#32	12930595-1-13-26	Thyrotropin (TSH) receptor (TSHr) mutations have been investigated in relation to Graves' disease (GD) genetic susceptibility under the hypothesis that a modified antigen may have novel immunogenic properties.
12930595	2004	Thyroid	1050-7256	ALL_TEXT_1/3	1	3	7253	SYMBOL|EXTRACTED	tshr	TSHr	60#64	12930595-1-13-26	Polymerase chain reaction products of exon 1 and 10e of the TSHr were generated from 164 GD patients (109 Chinese, 34 Malays, and 21 Indians) and 240 individuals with no thyroid illnesses (74 Chinese, 84 Malays, and 82 Indians).
12930595	2004	Thyroid	1050-7256	ALL_TEXT_3/3	3	10	7253	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tshr	TSHr	91#95	12930595-1-13-26	Together with recent identification of disease susceptibility markers in the region of the TSHr gene, these results are supportive of genetic factors existing in this region that may be in linkage disequilibrium with the inheritance of various TSHr polymorphisms.
12930595	2004	Thyroid	1050-7256	ALL_TEXT_3/3	3	10	7253	SYMBOL|EXTRACTED	tshr	TSHr	244#248	12930595-1-13-26	Together with recent identification of disease susceptibility markers in the region of the TSHr gene, these results are supportive of genetic factors existing in this region that may be in linkage disequilibrium with the inheritance of various TSHr polymorphisms.
15258326	2004	Dis. Markers	0278-0240	TITLE	0	0	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	0#5		GSTT1 gene deletion is associated with lung cancer in Mexican patients.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	127#132		It catalyzes the reduction of glutathione to its thioester; thus, deficiency in GST activity due to homozygous deletion of the GSTT1 gene (null genotype) may play a role in the induction of lung cancer by smoking.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	3	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	31#36		We studied the distribution of GSTT1 gene deletion in peripheral blood DNA samples from 178 healthy controls (41 nonsmokers, 63 passive smokers and 74 smokers) and 52 lung cancer patients.
15258326	2004	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	104#109		Comparisons between groups showed that there was an increased lung cancer risk for individuals with the GSTT1 null genotype.
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5166	LONGTERM|DICTIONARY	pyruvate dehydrogenase kinase 4	pyruvate dehydrogenase kinase 4	25#56		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5166	SYMBOL|()|DICTIONARY|EXTRACTED	pdk4	PDK4	58#62	15776585-0-25-56	[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5445	LONGTERM|DICTIONARY	paraoxonase 2	paraoxonase 2	65#78		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	5445	SYMBOL|()|DICTIONARY|EXTRACTED	pon2	PON2	80#84	15776585-0-65-78	[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	2169	LONGTERM|DICTIONARY	fatty acid binding protein 2	fatty acid binding protein 2	91#119		[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	TITLE	0	0	2169	SYMBOL|()|DICTIONARY|EXTRACTED	fabp2	FABP2	121#126	15776585-0-91-119	[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal].
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	LONGTERM|DICTIONARY	pyruvate dehydrogenase kinase 4	Pyruvate Dehydrogenase Kinase 4	122#153		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5166	SYMBOL|()|DICTIONARY|EXTRACTED	pdk4	PDK4	155#159	15776585-0-25-56	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	LONGTERM|DICTIONARY	paraoxonase 2	Paraoxonase 2	162#175		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	5445	SYMBOL|()|DICTIONARY|EXTRACTED	pon2	PON2	177#181	15776585-0-65-78	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	LONGTERM|DICTIONARY	fatty acid binding protein 2	Fatty Acid Binding Protein 2	187#215		We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_1/3	1	1	2169	SYMBOL|()|DICTIONARY|EXTRACTED	fabp2	FABP2	217#222	15776585-0-91-119	We reported a study about three candidate genes which may be involved in non-insulin dependent diabetes mellitus (NIDDM): Pyruvate Dehydrogenase Kinase 4 (PDK4), Paraoxonase 2 (PON2) and Fatty Acid Binding Protein 2 (FABP2).
15776585	2005	Dakar Med	0049-1101	ALL_TEXT_3/3	3	4	5166	SYMBOL|DICTIONARY|EXTRACTED	pdk4	PDK4	138#142	15776585-0-25-56	The genotype frequency in the senegalese population was quite similar as compared to reported frequency in white populations excepted for PDK4 polymorphism.
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED|()	cr1	CR1	21#24	1352745-0-7-10	Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
1352745	1992	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1378	SYMBOL|EXTRACTED	cr1	CR1	131#134	1352745-0-7-10	Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|DICTIONARY	c3br	C3bR	51#55		Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|EXTRACTED	cr1	CR1	58#61	1352745-0-7-10	Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	1	1378	SYMBOL|DICTIONARY	cd35	CD35	64#68		Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1378	SYMBOL|EXTRACTED	cr1	CR1	10#13	1352745-0-7-10	Defective CR1 expression was found in 26% of the patients with IDDM compared with 9% of the controls (P less than 0.05) and 0% of the siblings.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	4	1378	SYMBOL|EXTRACTED	cr1	CR1	73#76	1352745-0-7-10	The presence of a 6.9 kb (L) CR1 gene fragment was associated with a low CR1 expression in the patients (P less than 0.05) and especially in the controls (P less than 0.001).
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	5	1378	SYMBOL|EXTRACTED	cr1	CR1	107#110	1352745-0-7-10	No significant association was found between the presence or absence of the HLA risk antigens for IDDM and CR1 expression.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1378	SYMBOL|EXTRACTED	cr1	CR1	37#40	1352745-0-7-10	The results confirm that erythrocyte CR1 expression is genetically determined, but the CR1 deficiency associated with IDDM seems to be an acquired rather than a genetic phenomenon.
1352745	1992	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	6	1378	SYMBOL|EXTRACTED	cr1	CR1	87#90	1352745-0-7-10	The results confirm that erythrocyte CR1 expression is genetically determined, but the CR1 deficiency associated with IDDM seems to be an acquired rather than a genetic phenomenon.
1363805	1993	Hum. Mutat.	1059-7794	TITLE	0	0	34	SYMBOL|()|GENE|GN|DICTIONARY	mcad	MCAD	54#58		Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene.
1363805	1993	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	7	34	SYMBOL|GENE|GN|DICTIONARY	mcad	MCAD	102#106		In addition to tabulating the mutations, the acyl-CoA dehydrogenase gene family, the structure of the MCAD gene and the evolution of 985A-->G mutation are briefly discussed.
16154235	2006	Neurobiol. Aging	1558-1497	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	25#59		Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	2	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	49#83		Converging evidence points to a pivotal role for vascular endothelial growth factor (VEGF) in neuronal protection, and the lack of activity of this in neurodegenerative disorders.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	2	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	85#89	16154235-2-49-83	Converging evidence points to a pivotal role for vascular endothelial growth factor (VEGF) in neuronal protection, and the lack of activity of this in neurodegenerative disorders.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	16154235-2-49-83	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	3	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	148#152	16154235-2-49-83	The VEGF gene is located at 6p21.3, a site several studies have shown to have significant linkage with AD, and a functional polymorphism within the VEGF promoter may alter the risk of developing AD.
16154235	2006	Neurobiol. Aging	1558-1497	ALL_TEXT_3/3	3	5	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	22#26	16154235-2-49-83	No association of the VEGF promoter polymorphism with the risk of developing AD was observed.
16183801	2006	J. Med. Genet.	1468-6244	TITLE	0	0	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	28#33		Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	4204	SYMBOL|DICTIONARY	mecp2	MECP2	0#5		MECP2 mutations are identifiable in approximately 80% of classic Rett syndrome (RTT), but less frequently in atypical RTT.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	2	4204	SYMBOL|DICTIONARY	mecp2	MECP2	150#155		We recruited 110 patients who fulfilled the diagnostic criteria for Rett syndrome and were referred to Cardiff for molecular analysis, but in whom an MECP2 mutation was not identifiable.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_2/3	2	3	4204	SYMBOL|DICTIONARY	mecp2	MECP2	19#24		Dosage analysis of MECP2 was carried out using multiplex ligation dependent probe amplification or quantitative fluorescent PCR.
16183801	2006	J. Med. Genet.	1468-6244	ALL_TEXT_3/3	3	7	4204	SYMBOL|DICTIONARY	mecp2	MECP2	133#138		Five patients with large deletions had additional congenital anomalies, which was significantly more than in RTT patients with other MECP2 mutations (2/193; p<0.0001).
16257277	2006	Bone	8756-3282	TITLE	0	0	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	9#13		-511 C/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone.
16257277	2006	Bone	8756-3282	INTRODUCTION	1	3	3553	SYMBOL|DICTIONARY	il1	IL1	82#85		We have assessed whether genetic variability in genes coding of proteins from the IL1 pathway clustered in chromosome 2 is associated with clinical characteristics and the therapeutic response of patients with PDB.
16257277	2006	Bone	8756-3282	METHODS	2	4	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	60#64		We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
16257277	2006	Bone	8756-3282	METHODS	2	4	3554	SYMBOL|GENE|GN|DICTIONARY	il1r1	IL1R1	112#117		We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
16257277	2006	Bone	8756-3282	METHODS	2	4	3557	SYMBOL|GENE|GN|DICTIONARY	il1rn	IL1RN	194#199		We have studied -511 C/T and +3953 T/C polymorphisms of the IL1B gene, a HinfI polymorphism in the 5'UTR of the IL1R1 gene, and a variable number of tandem repeats (VNTR) in the intron 2 of the IL1RN gene, in 165 patients diagnosed as suffering from PDB and in 122 healthy controls.
16257277	2006	Bone	8756-3282	RESULTS	3	8	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	37#41		However, the -511 CC genotype of the IL1B gene was associated with a higher percentage of resistance to BSP (49% vs. 20%; P = 0.00 for all BSP, 60% vs. 39%, P = 0.17 for etidronate, 50% vs. 37% P = 0.53 for clodronate, 48 vs. 34% P = 0.05 for tiludronate and 50% vs. 4% P = 0.01 for risedronate).
16257277	2006	Bone	8756-3282	CONCLUSIONS	4	9	3553	SYMBOL|GENE|GN|DICTIONARY	il1b	IL1B	53#57		Our results suggest that the -511 CC genotype of the IL1B gene could be related to resistance to bisphosphonates in patients with PDB.
16160007	2006	Blood	0006-4971	TITLE	0	0	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	14#22		Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation.
16160007	2006	Blood	0006-4971	ALL_TEXT_1/3	1	1	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	25#33		Sequence analysis of the ADAMTS13 locus of 2 patients with hereditary thrombotic thrombocytopenic purpura (TTP) revealed the homozygous presence of 4 single nucleotide polymorphisms (SNPs) (R7W, Q448E, P618A, A732V) and a rare missense mutation (R1336W).
16160007	2006	Blood	0006-4971	ALL_TEXT_2/3	2	3	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	84#92		Introduction of polymorphisms R7W, Q448E, and A732V had no or only minor effects on ADAMTS13 secretion.
16160007	2006	Blood	0006-4971	ALL_TEXT_2/3	2	4	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	77#85		In contrast, P618A, R1336W, and the A732V-P618A combination strongly reduced ADAMTS13-specific activity and antigen levels.
16160007	2006	Blood	0006-4971	ALL_TEXT_3/3	3	5	11093	SYMBOL|DICTIONARY	adamts13	ADAMTS13	55#63		Surprisingly, R7W and Q448E were positive modifiers of ADAMTS13 secretion in the context of P618A and A732V but neither could rescue the severely reduced specific activity conferred by P618A.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	14#30		Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	OBJECTIVE	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	33#49		To investigate the effect of the apolipoprotein E (ApoE) epsilon4 allele on the efficacy and tolerability of galantamine treatment.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	OBJECTIVE	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	51#55	16254428-1-33-49	To investigate the effect of the apolipoprotein E (ApoE) epsilon4 allele on the efficacy and tolerability of galantamine treatment.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	5	348	SYMBOL|EXTRACTED	apoe	ApoE	46#50	16254428-1-33-49	Of the 202 subjects, 115 carried at least one ApoE epsilon4 allele and 87 did not.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	6	348	SYMBOL|EXTRACTED	apoe	ApoE	8#12	16254428-1-33-49	In both ApoE epsilon4 carriers and ApoE epsilon4 noncarriers, significant improvements were detected relative to baseline on ADAS-cog/11, CIBIC-plus, DAD and BEHAVE-AD.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	6	348	SYMBOL|EXTRACTED	apoe	ApoE	35#39	16254428-1-33-49	In both ApoE epsilon4 carriers and ApoE epsilon4 noncarriers, significant improvements were detected relative to baseline on ADAS-cog/11, CIBIC-plus, DAD and BEHAVE-AD.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	7	348	SYMBOL|EXTRACTED	apoe	ApoE	152#156	16254428-1-33-49	ApoE epsilon4 noncarriers showed better improvement in mean total BEHAVE-AD score and mean psychosis (delusions and hallucinations) subscale score than ApoE epsilon4 carriers.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	57#61	16254428-1-33-49	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
16254428	2006	Dement Geriatr Cogn Disord	1420-8008	RESULTS	3	8	348	SYMBOL|EXTRACTED	apoe	ApoE	103#107	16254428-1-33-49	The incidence of weight loss was significantly higher in ApoE epsilon4 carriers (n = 11; 9.6%) than in ApoE epsilon4 noncarriers (n = 1; 1.2%) during this 16-week study, even though 92% of patients who complained of weight loss completed this 16-week trial successfully.
16189508	2006	Mol. Psychiatry	1359-4184	TITLE	0	0	3084	LONGTERM|GENE|GN|DICTIONARY	neuregulin 1	Neuregulin 1	38#50		Extreme population differences across Neuregulin 1 gene, with implications for association studies.
16189508	2006	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	1	3084	LONGTERM|DICTIONARY	neuregulin 1	Neuregulin 1	0#12		Neuregulin 1 (NRG1) is one of the most exciting candidate genes for schizophrenia in recent years since its first association with the disease in an Icelandic population.
16189508	2006	Mol. Psychiatry	1359-4184	ALL_TEXT_1/3	1	1	3084	SYMBOL|()|DICTIONARY|EXTRACTED	nrg1	NRG1	14#18	16189508-1-0-12	Neuregulin 1 (NRG1) is one of the most exciting candidate genes for schizophrenia in recent years since its first association with the disease in an Icelandic population.
16189508	2006	Mol. Psychiatry	1359-4184	ALL_TEXT_3/3	3	10	3084	SYMBOL|DICTIONARY|EXTRACTED	nrg1	NRG1	38#42	16189508-1-0-12	In summary, our findings suggest that NRG1 presents extreme population differences in allele and haplotype frequencies.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	2626	SYMBOL|DICTIONARY	gata4	GATA4	0#5		GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_2/3	2	2	2626	SYMBOL|()|DICTIONARY	gata4	GATA4	179#184		The administration of d-myo-inositol 1,4,5-tris-phosphate increased the expression of nuclear factor of activated T-cells and cardiac-restricted zinc finger transcription factor (GATA4).
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	3	2626	SYMBOL|GFAM|FN|DICTIONARY	gata4	GATA4	86#91		Real-time quantitative RT-PCR showed that d-myo-inositol 1,4,5-tris-phosphate-induced GATA4 mRNA was significantly enhanced even in the presence of the calcineurin inhibitor, cyclosporine A.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	3	23523	LONGTERM|DICTIONARY	calcineurin inhibitor	calcineurin inhibitor	152#173		Real-time quantitative RT-PCR showed that d-myo-inositol 1,4,5-tris-phosphate-induced GATA4 mRNA was significantly enhanced even in the presence of the calcineurin inhibitor, cyclosporine A.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	5	2626	SYMBOL|DICTIONARY	gata4	GATA4	100#105		The study shows that d-myo-inositol 1,4,5-tris-phosphate-induced cardiac hypertrophy is mediated by GATA4 but independent from the calcineurin pathway.
16182378	2006	J. Neuroimmunol.	0165-5728	TITLE	0	0	1234	SYMBOL|DICTIONARY	ccr5	CCR5	36#40		CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	2	1230	SYMBOL|DICTIONARY	ccr1	CCR1	61#65		Infiltrating monocytes in lesions of all patterns co-express CCR1 and CCR5.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	2	1234	SYMBOL|DICTIONARY	ccr5	CCR5	70#74		Infiltrating monocytes in lesions of all patterns co-express CCR1 and CCR5.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	3	1234	SYMBOL|DICTIONARY	ccr5	CCR5	91#95		However, in pattern II lesions, the number of CCR1 cells is decreased, while the number of CCR5 expressing cells is increased in late active versus early active regions.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	4	1230	SYMBOL|DICTIONARY	ccr1	CCR1	13#17		In contrast, CCR1 and CCR5 cells were equal in all regions of pattern III lesions.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	6	1234	SYMBOL|DICTIONARY	ccr5	CCR5	14#18		A deletion in CCR5 (CCR5*Delta32), which encodes a truncated, non-functional protein, has been associated with late onset of MS and a favorable prognosis.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	6	1234	SYMBOL|DICTIONARY	ccr5	CCR5	20#24		A deletion in CCR5 (CCR5*Delta32), which encodes a truncated, non-functional protein, has been associated with late onset of MS and a favorable prognosis.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	9	1234	SYMBOL|DICTIONARY	ccr5	CCR5	51#55		There was no association of carrier status for the CCR5*Delta32 mutation with disease severity as analyzed using the disease severity score (ranking of EDSS/duration stratified by duration), age of onset, gender or disease course (bout onset versus primary progressive).
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	56#60		Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	78#82		Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	120#124		Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	13	1234	SYMBOL|DICTIONARY	ccr5	CCR5	183#187		Despite similar numbers of T-lymphocytes, there were no CCR5+ T-cells nor was CCR5 expressed in the CNS of a homozygous CCR5*Delta32 MS patient, and heterozygous patients had reduced CCR5 expression compared to wild type patients.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	14	1234	SYMBOL|DICTIONARY	ccr5	CCR5	0#4		CCR5*Delta32 has a dose effect on CCR5 expression in the CNS, but is neither necessary for development of MS, nor CD3+ T cell recruitment into the CNS.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	14	1234	SYMBOL|DICTIONARY	ccr5	CCR5	34#38		CCR5*Delta32 has a dose effect on CCR5 expression in the CNS, but is neither necessary for development of MS, nor CD3+ T cell recruitment into the CNS.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_1/3	1	1	6121	SYMBOL|DICTIONARY	rpe65	RPE65	68#73		The short- and long-term effects of gene therapy using AAV-mediated RPE65 transfer to canine retinal pigment epithelium were investigated in dogs affected with disease caused by RPE65 deficiency.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_1/3	1	1	6121	SYMBOL|DICTIONARY	rpe65	RPE65	178#183		The short- and long-term effects of gene therapy using AAV-mediated RPE65 transfer to canine retinal pigment epithelium were investigated in dogs affected with disease caused by RPE65 deficiency.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_1/3	1	2	6121	SYMBOL|GFAM|FN|DICTIONARY	rpe65	RPE65	71#76		Results with AAV 2/2, 2/1, and 2/5 vector pseudotypes, human or canine RPE65 cDNA, and constitutive or tissue-specific promoters were similar.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_3/3	3	8	6121	SYMBOL|GENE|GN|DICTIONARY	rpe65	RPE65	0#5		RPE65 protein expression was limited to retinal pigment epithelium of treated areas.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_3/3	3	9	6121	SYMBOL|DICTIONARY	rpe65	RPE65	15#20		Subretinal AAV-RPE65 vector is well tolerated and does not elicit high antibody levels to the vector or the protein in ocular fluids or serum.
16226919	2006	Mol. Ther.	1525-0016	ALL_TEXT_3/3	3	11	6121	SYMBOL|DICTIONARY	rpe65	RPE65	194#199		Successful, stable restoration of rod and cone photoreceptor function in these dogs has important implications for treatment of human patients affected with Leber congenital amaurosis caused by RPE65 mutations.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	TITLE	0	0	7122	SYMBOL|DICTIONARY	cldn5	CLDN5	38#43		A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_1/3	1	1	7122	SYMBOL|GENE|GN|DICTIONARY	cldn5	CLDN5	62#67		The present study attempts to test the combined effect of the CLDN5 gene and those for the phospholipid metabolism pathway, including PTGS1, PTGS2, PLA2G4A and PLA2G4C.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_1/3	1	1	5742	SYMBOL|DICTIONARY	ptgs1	PTGS1	134#139		The present study attempts to test the combined effect of the CLDN5 gene and those for the phospholipid metabolism pathway, including PTGS1, PTGS2, PLA2G4A and PLA2G4C.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_1/3	1	1	5743	SYMBOL|DICTIONARY	ptgs2	PTGS2	141#146		The present study attempts to test the combined effect of the CLDN5 gene and those for the phospholipid metabolism pathway, including PTGS1, PTGS2, PLA2G4A and PLA2G4C.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_1/3	1	1	5321	SYMBOL|DICTIONARY	pla2g4a	PLA2G4A	148#155		The present study attempts to test the combined effect of the CLDN5 gene and those for the phospholipid metabolism pathway, including PTGS1, PTGS2, PLA2G4A and PLA2G4C.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_1/3	1	1	8605	SYMBOL|DICTIONARY	pla2g4c	PLA2G4C	160#167		The present study attempts to test the combined effect of the CLDN5 gene and those for the phospholipid metabolism pathway, including PTGS1, PTGS2, PLA2G4A and PLA2G4C.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_2/3	2	3	5321	SYMBOL|GENE|GN|DICTIONARY	pla2g4a	PLA2G4A	105#112		The transmission disequilibrium test (TDT) showed that BanI-SNP located in the 5'-flanking region of the PLA2G4A gene was associated with schizophrenia (chi(2) = 5.16, P = 0.023) although the others failed to show such allelic associations.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	5	7122	SYMBOL|GENE|GN|DICTIONARY	cldn5	CLDN5	116#121		The conditioning on genotype test, but not on allele test, revealed a strong association for the combination of the CLDN5 gene with the PLA2G4A gene (chi(2) = 10.17, df = 2, P = 0.006).
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	5	5321	SYMBOL|GENE|GN|DICTIONARY	pla2g4a	PLA2G4A	136#143		The conditioning on genotype test, but not on allele test, revealed a strong association for the combination of the CLDN5 gene with the PLA2G4A gene (chi(2) = 10.17, df = 2, P = 0.006).
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	6	5321	SYMBOL|DICTIONARY	pla2g4a	PLA2G4A	37#44		The present results suggest that the PLA2G4A locus may be involved in schizophrenia and its combination with the CLDN5 gene may increase further the risk for the illness.
16181776	2006	Prostaglandins Leukot. Essent. Fatty Acids	0952-3278	ALL_TEXT_3/3	3	6	7122	SYMBOL|GENE|GN|DICTIONARY	cldn5	CLDN5	113#118		The present results suggest that the PLA2G4A locus may be involved in schizophrenia and its combination with the CLDN5 gene may increase further the risk for the illness.
16222672	2006	Am. J. Med. Genet. A	1552-4825	TITLE	0	0	2697	SYMBOL|DICTIONARY	gja1	GJA1	28#32		Letter to the editor: Novel GJA1 mutation in oculodentodigital dysplasia.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	TITLE	0	0	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	28#33		Functional polymorphisms of HSPA5: possible association with bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	65#70		Previously, we preliminarily reported the genetic association of HSPA5 (GRP78/BiP) with bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	2	3309	SYMBOL|DICTIONARY	grp78	GRP78	72#77		Previously, we preliminarily reported the genetic association of HSPA5 (GRP78/BiP) with bipolar disorder.
16168956	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	8	3309	SYMBOL|DICTIONARY	hspa5	HSPA5	51#56		These findings suggested promotor polymorphisms of HSPA5 may affect the interindividual variability of ER stress response and may confer a genetic risk factor for bipolar disorder.
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	2	64127	SYMBOL|DICTIONARY	card15	CARD15	45#51		In a previous study, a Crohn's disease gene, CARD15, was demonstrated to be associated with psoriatic arthritis (PsA).
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	6583	SYMBOL|DICTIONARY	slc22a4	SLC22A4	133#140		Recently, a functional haplotype of 2 single-nucleotide polymorphisms (SNPs) mapping to the organic cation transporter (OCTN) genes, SLC22A4 and SLC22A5, was identified as a second Crohn's disease susceptibility locus.
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	3	6584	SYMBOL|DICTIONARY	slc22a5	SLC22A5	145#152		Recently, a functional haplotype of 2 single-nucleotide polymorphisms (SNPs) mapping to the organic cation transporter (OCTN) genes, SLC22A4 and SLC22A5, was identified as a second Crohn's disease susceptibility locus.
16255050	2005	Arthritis Rheum.	0004-3591	OBJECTIVE	1	4	6583	SYMBOL|GENE|GN|DICTIONARY	slc22a4	SLC22A4	4#11		The SLC22A4 gene has also been associated with rheumatoid arthritis.
16255050	2005	Arthritis Rheum.	0004-3591	METHODS	2	6	64127	SYMBOL|DICTIONARY	card15	CARD15	17#23		Association with CARD15 and OCTN was investigated in UK Caucasian patients with PsA (n = 472) and population controls (n = 594), using 5' allelic discrimination assays (TaqMan).
16255050	2005	Arthritis Rheum.	0004-3591	RESULTS	3	9	64127	SYMBOL|DICTIONARY	card15	CARD15	27#33		No association of PsA with CARD15 was detected.
16255050	2005	Arthritis Rheum.	0004-3591	RESULTS	3	10	6584	SYMBOL|DICTIONARY	slc22a5	SLC22A5	64#71		In contrast, a functional SNP mapping to the promoter region of SLC22A5 (rs2631367) was associated with PsA (for CC versus GG, odds ratio 1.65, 95% confidence interval 1.13-2.41, uncorrected P = 0.005).
16211375	2006	Diabetologia	0012-186X	TITLE	0	0	59272	LONGTERM|DICTIONARY	angiotensin i converting enzyme 2	angiotensin I converting enzyme 2	35#68		Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	LONGTERM|DICTIONARY	angiotensin i converting enzyme 2	Angiotensin I converting enzyme 2	0#33		Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	2	59272	SYMBOL|()|DICTIONARY|EXTRACTED	ace2	ACE2	35#39	16211375-2-0-33	Angiotensin I converting enzyme 2 (ACE2), a new component of the RAS, has been implicated in kidney disease, hypertension and cardiac function.
16211375	2006	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	3	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	82#86	16211375-2-0-33	Based on this, the aim of the present study was to evaluate whether variations in ACE2 are associated with diabetic nephropathy.
16211375	2006	Diabetologia	0012-186X	RESULTS	3	7	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	12#16	16211375-2-0-33	None of the ACE2 polymorphisms was associated with diabetic nephropathy, and this finding was supported by the haplotype analysis.
16211375	2006	Diabetologia	0012-186X	RESULTS	3	8	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	4#8	16211375-2-0-33	The ACE2 polymorphisms were not associated with blood pressure, BMI or HbA(1)c.
16211375	2006	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	9	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	37#41	16211375-2-0-33	In Finnish type 1 diabetic patients, ACE2 polymorphisms are not associated with diabetic nephropathy or any studied risk factor for this complication.
16211375	2006	Diabetologia	0012-186X	CONCLUSIONS/INTERPRETATION	4	10	59272	SYMBOL|DICTIONARY|EXTRACTED	ace2	ACE2	58#62	16211375-2-0-33	Further studies are necessary to assess a minor effect of ACE2.
16219118	2006	Psychol Med	0033-2917	TITLE	0	0	3084	LONGTERM|DICTIONARY	neuregulin 1	Neuregulin 1	0#12		Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance.
16219118	2006	Psychol Med	0033-2917	TITLE	0	0	3084	SYMBOL|DICTIONARY	nrg1	NRG1	14#18		Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance.
16219118	2006	Psychol Med	0033-2917	BACKGROUND	1	2	3084	LONGTERM|DICTIONARY	neuregulin 1	neuregulin 1	25#37		A gene from this region, neuregulin 1 (NRG1 ), known to be involved with glutamatergic function, has been found to be associated in some studied samples.
16219118	2006	Psychol Med	0033-2917	BACKGROUND	1	2	3084	SYMBOL|DICTIONARY	nrg1	NRG1	39#43		A gene from this region, neuregulin 1 (NRG1 ), known to be involved with glutamatergic function, has been found to be associated in some studied samples.
16219118	2006	Psychol Med	0033-2917	METHOD	2	4	3084	SYMBOL|DICTIONARY	nrg1	NRG1	58#62		We genotyped 14 single nucleotide polymorphisms (SNPs) in NRG1 including those reported to comprise schizophrenia-associated haplotypes in Icelandic, Scottish, Irish, and Chinese Han populations.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	7	3084	SYMBOL|DICTIONARY	nrg1	NRG1	43#47		Our failure to find an association between NRG1 and schizophrenia might reflect different linkage disequilibrium (LD) patterns found in different populations, disease allelic heterogeneity, clinical heterogeneity of schizophrenia, or inadequate statistical power deriving from moderate sample size.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	8	3084	SYMBOL|DICTIONARY	nrg1	NRG1	0#4		NRG1, if a true gene for schizophrenia, accounts for a small fraction of the disease in most populations.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	9	3084	SYMBOL|DICTIONARY	nrg1	NRG1	20#24		The confirmation of NRG1 as a schizophrenia susceptibility gene will require studies with a comprehensive set of markers and in larger samples.
16219118	2006	Psychol Med	0033-2917	CONCLUSIONS	4	10	3084	SYMBOL|DICTIONARY	nrg1	NRG1	40#44		The possibility remains that reports of NRG1 association might reflect false positives.
16234515	2005	J. Clin. Oncol.	0732-183X	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	55#60		Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
16234515	2005	J. Clin. Oncol.	0732-183X	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	65#70		Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
16234515	2005	J. Clin. Oncol.	0732-183X	PURPOSE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	141#146		The purpose of this study was to estimate the extent of protection offered against breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and time elapsed since surgery.
16234515	2005	J. Clin. Oncol.	0732-183X	PURPOSE	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	150#155		The purpose of this study was to estimate the extent of protection offered against breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and time elapsed since surgery.
16234515	2005	J. Clin. Oncol.	0732-183X	PATIENTS AND METHODS	2	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	100#105		We analyzed 1,439 patients with breast cancer and 1,866 matched controls derived from a registry of BRCA1 and BRCA2 carriers.
16234515	2005	J. Clin. Oncol.	0732-183X	PATIENTS AND METHODS	2	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	110#115		We analyzed 1,439 patients with breast cancer and 1,866 matched controls derived from a registry of BRCA1 and BRCA2 carriers.
16234515	2005	J. Clin. Oncol.	0732-183X	RESULTS	3	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	112#117		A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15).
16234515	2005	J. Clin. Oncol.	0732-183X	RESULTS	3	4	675	SYMBOL|DICTIONARY	brca2	BRCA2	176#181		A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15).
16234515	2005	J. Clin. Oncol.	0732-183X	RESULTS	3	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	116#121		The risk reduction was greater if the oophorectomy was performed before age 40 (OR = 0.36; 95% CI, 0.20 to 0.64 for BRCA1 carriers) than after age 40 (OR = 0.53; 95% CI, 0.30 to 0.91).
16234515	2005	J. Clin. Oncol.	0732-183X	CONCLUSION	4	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	88#93		Oophorectomy is an effective means of reducing the risk of breast cancer in carriers of BRCA1 mutations.
16234515	2005	J. Clin. Oncol.	0732-183X	CONCLUSION	4	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	47#52		The data suggest oophorectomy is protective in BRCA2 carriers as well, but needs to be confirmed in other studies.
16230376	2005	Cancer Res.	0008-5472	TITLE	0	0	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	13#25		Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
16230376	2005	Cancer Res.	0008-5472	TITLE	0	0	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	30#62		Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	16#28		Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7124	LONGTERM|DICTIONARY	transforming growth factor alpha	transforming growth factor-alpha	33#65		Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	7039	LONGTERM|()|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	67#76	16230376-1-33-65	Serum levels of amphiregulin and transforming growth factor-alpha (TGF-alpha), which were identified previously to be expressed at high levels in non-small cell lung cancer (NSCLC) with poor response to gefitinib, were examined by ELISA using blood samples taken from 50 patients with advanced NSCLCs.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	52#64		Of 14 cases that revealed above the cutoff line for amphiregulin in serum, 12 responded poorly to gefitinib, whereas 18 of the 36 cases showing below the cutoff revealed partial response (PR) or stable disease (SD; P = 0.026).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	46#55	16230376-1-33-65	Thirteen of 15 patients who were positive for TGF-alpha responded poorly to gefitinib, whereas 18 of the 35 patients with negative TGF-alpha levels turned out to be relatively good responders (P = 0.014).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	3	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	131#140	16230376-1-33-65	Thirteen of 15 patients who were positive for TGF-alpha responded poorly to gefitinib, whereas 18 of the 35 patients with negative TGF-alpha levels turned out to be relatively good responders (P = 0.014).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	45#57		Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	61#70	16230376-1-33-65	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	216#228		Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	232#241	16230376-1-33-65	Gefitinib-treated NSCLC patients whose serum amphiregulin or TGF-alpha was positive showed a poorer tumor-specific survival (P = 0.037 and 0.002, respectively, by univariate analysis) compared with those whose serum amphiregulin or TGF-alpha concentrations were negative.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	7	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	79#88	16230376-1-33-65	Multivariate analysis showed an independent association between positivity for TGF-alpha and shorter survival times among NSCLC patients treated with gefitinib (P = 0.034).
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	374	LONGTERM|DICTIONARY	amphiregulin	Amphiregulin	0#12		Amphiregulin or TGF-alpha positivity in NSCLC tissues was significantly higher in male, nonadenocarcinomas, and smokers.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	16#25	16230376-1-33-65	Amphiregulin or TGF-alpha positivity in NSCLC tissues was significantly higher in male, nonadenocarcinomas, and smokers.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	374	LONGTERM|DICTIONARY	amphiregulin	amphiregulin	36#48		Our data suggest that the status of amphiregulin and TGF-alpha in serum can be an important predictor of the resistance to gefitinib among patients with advanced NSCLC.
16230376	2005	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	7039	LONGTERM|DICTIONARY|EXTRACTED	tgf alpha	TGF-alpha	53#62	16230376-1-33-65	Our data suggest that the status of amphiregulin and TGF-alpha in serum can be an important predictor of the resistance to gefitinib among patients with advanced NSCLC.
16194568	2006	Neuropeptides	0143-4179	TITLE	0	0	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	57#71		Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	neuropeptide y	neuropeptide Y	8#22		Changed neuropeptide Y (NPY) system in the hippocampus has been reported in various experimental epileptic models.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	1	4852	SYMBOL|()|DICTIONARY|EXTRACTED	npy	NPY	24#27	16194568-1-8-22	Changed neuropeptide Y (NPY) system in the hippocampus has been reported in various experimental epileptic models.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_1/3	1	2	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	However, there have been little data concerning the alteration in the NPY system in the epileptic hippocampus following treatment of anti-epileptic drugs (AEDs).
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_2/3	2	3	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	124#127	16194568-1-8-22	In the present study, therefore, we performed analyses of effects of vigabatrin (VGB) and zonisamide (ZNS) treatment on the NPY system in the hippocampus of the seizure sensitive (SS) gerbils.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_2/3	2	4	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	14#17	16194568-1-8-22	In SS gerbil, NPY immunoreactivity in the hippocampus was lower than that in seizure resistant gerbil.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	5	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	39#42	16194568-1-8-22	Following VGB treatment, the number of NPY immunoreactive neurons and NPY mRNA expression were increased in the hilus and the hippocampus proper.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	5	4852	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	Following VGB treatment, the number of NPY immunoreactive neurons and NPY mRNA expression were increased in the hilus and the hippocampus proper.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	6	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	65#68	16194568-1-8-22	In contrast, ZNS treatment markedly elevated only the density of NPY immunoreactive fibers in the dentate gyrus, not in the hippocampus proper, as compared with saline-treated animals.
16194568	2006	Neuropeptides	0143-4179	ALL_TEXT_3/3	3	8	4852	SYMBOL|DICTIONARY|EXTRACTED	npy	NPY	70#73	16194568-1-8-22	These findings suggest that AEDs treatments may distinctly affect the NPY system in the SS gerbil hippocampus.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	TITLE	0	0	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	24#57		Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	LONGTERM|DICTIONARY	endothelial nitric oxide synthase	endothelial nitric oxide synthase	74#107		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	4846	SYMBOL|EXTRACTED|()	enos	eNOS	109#113	16168297-1-74-107	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	von willebrand factor	von Willebrand factor	182#203		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	7450	SYMBOL|EXTRACTED|()	vwf	vWF	205#208	16168297-1-182-203	This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3553	SYMBOL|DICTIONARY	il 1b	IL-1b	231#236		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	BACKGROUND	2	2	4846	SYMBOL|EXTRACTED	enos	eNOS	30#34	16168297-1-74-107	Genetic polymorphism G894T on eNOS has been associated with increased cardiovascular risk.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	RESULTS	4	8	7450	SYMBOL|EXTRACTED	vwf	vWF	24#27	16168297-1-182-203	During the acute phase, vWF was higher in GT+TT (121.02 +/- 5.47%) versus GG (84.6 +/- 7.1%, p < 0.01), an effect persisting after one year (90.4 +/- 3.8 vs. 73.1 +/- 4.6%, p < 0.01).
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	RESULTS	4	9	3569	SYMBOL|DICTIONARY	il 6	IL-6	52#56		During the acute phase, GT+TT had higher ox-LDL and IL-6 (131.2 +/- 6.4 IU/l and 8.5 +/- 0.7 pg/ml) compared with GG (101.7 +/- 9.64 IU/l and 6.2 +/- 0.8 pg/ml, p < 0.05 for both), but no difference was found at one year.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	4846	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	enos	eNOS	26#30	16168297-1-74-107	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	7450	SYMBOL|EXTRACTED	vwf	vWF	179#182	16168297-1-182-203	G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	CONCLUSIONS	5	10	3569	SYMBOL|DICTIONARY	il 6	IL-6	184#188		G894T polymorphism on the eNOS gene increases the risk for premature MI and modifies the response of vascular endothelium during the acute phase of MI by affecting the release of vWF, IL-6, and oxidative stress status, an effect diminished one year after the event.
16133961	2005	Dig. Dis. Sci.	0163-2116	TITLE	0	0	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	97#104		A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_1/3	1	1	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	49#56		Omeprazole is mainly metabolized in the liver by CYP2C19, a genetically determined enzyme, while rabeprazole is mainly nonenzymatically degraded with a minor involvement by CYP2C19.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_1/3	1	1	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	173#180		Omeprazole is mainly metabolized in the liver by CYP2C19, a genetically determined enzyme, while rabeprazole is mainly nonenzymatically degraded with a minor involvement by CYP2C19.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_1/3	1	2	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	139#146		We investigated the gastric ulcer healing effect of omeprazole versus rabeprazole evaluated endoscopically with reference to the different CYP2C19 genotypes.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	5	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	157#164		The endoscopic improvement of gastric ulcer size and ulcer healing rates using a thin rubber disc with a diameter of 6 mm, were evaluated in relation to the CYP2C19 genotypic status.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	6	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	111#118		The mean 2-week posttreatment ulcer size value by rabeprazole did not significantly differ among the different CYP2C19 genotypes, whereas the mean value in the homozygous extensive metabolizer patients treated with omeprazole was significantly (P = 0.0057) greater than in those with rabeprazole.
16133961	2005	Dig. Dis. Sci.	0163-2116	ALL_TEXT_3/3	3	8	1557	SYMBOL|DICTIONARY	cyp2c19	CYP2C19	198#205		Although both omeprazole and rabeprazole showed a high healing rate of gastric ulcer after the 8-week treatment period, the healing effect of rabeprazole appears to be relatively independent of the CYP2C19 status, resulting in an earlier repair of gastric mucosal damage evaluated endoscopically compared to that of omeprazole.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	LONGTERM|DICTIONARY	thyroid peroxidase	Thyroid peroxidase	0#18		Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	1	7173	SYMBOL|()|DICTIONARY|EXTRACTED	tpo	TPO	20#23	16187919-1-0-18	Thyroid peroxidase (TPO) deficiency is frequently involved in total iodide organification defects (TIOD).
16187919	2006	Thyroid	1050-7256	ALL_TEXT_1/3	1	3	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	31#34	16187919-1-0-18	However, a single heterozygous TPO mutation is reported in a high percentage (approximately 20%) of patients with typical TIOD phenotype.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_2/3	2	6	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	4#7	16187919-1-0-18	Two TPO frameshift mutations were documented: a C deletion at 477 in exon 5, and a GGCC duplication at 1277 in exon 8.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	7	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	59#62	16187919-1-0-18	Unaffected family members, heterozygous for one of the two TPO mutations, were also studied in order to evaluate in vivo the functional activity of a single TPO allele.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	7	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	157#160	16187919-1-0-18	Unaffected family members, heterozygous for one of the two TPO mutations, were also studied in order to evaluate in vivo the functional activity of a single TPO allele.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	10	7173	SYMBOL|DICTIONARY|EXTRACTED	tpo	TPO	124#127	16187919-1-0-18	The results show that the TIOD phenotype in the propositus is associated to a compound heterozygous pattern, while a single TPO mutation does not significantly affect in vivo the efficiency of iodide organification.
16187919	2006	Thyroid	1050-7256	ALL_TEXT_3/3	3	11	7173	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tpo	TPO	33#36	16187919-1-0-18	Therefore, extensive analyses of TPO gene and 2p25 locus are needed in the frequent TIOD cases in whom conventional investigations disclosed only one mutant allele.
16230779	2006	Endocrine	1355-008X	TITLE	0	0	5979	SYMBOL|DICTIONARY	ret	RET	0#3		RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.
16230779	2006	Endocrine	1355-008X	ALL_TEXT_2/3	2	4	5979	SYMBOL|DICTIONARY	ret	RET	133#136		Herein, we studied 100 individuals (50 patients and 50 controls) aiming to compare the frequencies of G691S, L769L, S836S, and S904S RET polymorphisms observed in patients with respect to controls.
16230779	2006	Endocrine	1355-008X	ALL_TEXT_2/3	2	6	5979	SYMBOL|DICTIONARY	ret	RET	213#216		"To test the contributory role of the above polymorphisms for the development of ""C""-cell hyperplasia, we studied a group of 10 individuals selected for having a positive pentagastrin test despite the absence of a RET germline mutation."
16167465	2005	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	1815	LONGTERM|GENE|GT|DICTIONARY	dopamine d4 receptor	dopamine D4 receptor	49#69		Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	LONGTERM|GENE|GT|DICTIONARY	dopamine d4 receptor	Dopamine D4 receptor	0#20		Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	1815	SYMBOL|()|DICTIONARY|EXTRACTED	drd4	DRD4	22#26	16167465-1-0-20	Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_1/3	1	1	6532	SYMBOL|()|GENE|GN|DICTIONARY	sert	SERT	55#59		Dopamine D4 receptor (DRD4) and serotonin transporter (SERT) gene polymorphisms were studied, as possible genetic risk factors for substance dependence.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	3	1815	SYMBOL|DICTIONARY|EXTRACTED	drd4	DRD4	60#64	16167465-1-0-20	Improved methods were applied for genotype detection of the DRD4 polymorphisms (exon 3 48 bp VNTR; -521 C/T SNP and 120 bp duplication in the 5' flanking region) and the SERT gene polymorphisms (5-hydroxytriptamin transporter linked polymorphic region [5-HTTLPR] in the 5' flanking region and the intron 2 VNTR [STin2]).
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	3	6532	SYMBOL|GENE|GN|DICTIONARY	sert	SERT	170#174		Improved methods were applied for genotype detection of the DRD4 polymorphisms (exon 3 48 bp VNTR; -521 C/T SNP and 120 bp duplication in the 5' flanking region) and the SERT gene polymorphisms (5-hydroxytriptamin transporter linked polymorphic region [5-HTTLPR] in the 5' flanking region and the intron 2 VNTR [STin2]).
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_2/3	2	4	1815	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	drd4	DRD4	44#48	16167465-1-0-20	Association between the -521 C/T SNP of the DRD4 promoter region and substance dependence was significant in the subgroup of heroin dependents (p = 0.044).
16167465	2005	Neuropsychopharmacol Hung	1419-8711	ALL_TEXT_3/3	3	5	1815	SYMBOL|DICTIONARY|EXTRACTED	drd4	DRD4	118#122	16167465-1-0-20	The other analyzed polymorphisms did not show any significant association, but an interaction between -521 C/T SNP of DRD4 and the 5-HTTLPR polymorphisms was observed.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|GENE|GN|DICTIONARY	ptpn22	PTPN22	54#60		The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	1	26191	SYMBOL|DICTIONARY	lyp	LYP	109#112		The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	2	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	54#60		An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	8	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	44#50		The transmission disequilibrium test of the PTPN22-620W allele revealed linkage and association for RF+ RA (61% of transmission, P = 0.037).
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	43#49		This study is the first to show linkage of PTPN22 to RF+ RA, consistent with PTPN22 as a new RA gene.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	77#83		This study is the first to show linkage of PTPN22 to RF+ RA, consistent with PTPN22 as a new RA gene.
16135441	2005	Yi Chuan	0253-9772	TITLE	0	0	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	18#28		[Variation of the peripherin gene in Chinese with or without high myopia].
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	LONGTERM|GENE|GN|DICTIONARY	peripherin	peripherin	35#45		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	1	5630	SYMBOL|DICTIONARY	prph	PRPH	51#55		To analyze the relationship of the peripherin gene(PRPH, OMIM17071) mutations with high myopia,genomic DNA was collected from 180 probands with high myopia (<or=-6.0 dipoters) and 60 unrelated persons without high myopia.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_1/3	1	2	5630	SYMBOL|GENE|GN|DICTIONARY	prph	PRPH	24#28		The coding sequences of PRPH gene in 240 subjects were analyzed using exon-by-exon PCR-heteroduplex-SSCP analysis and sequencing.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_3/3	3	5	5630	SYMBOL|GENE|GN|DICTIONARY	prph	PRPH	46#50		Eight nucleotide variations were found in the PRPH gene.
16135441	2005	Yi Chuan	0253-9772	ALL_TEXT_3/3	3	6	5630	SYMBOL|GENE|GN|DICTIONARY	prph	PRPH	43#47		We found no evidence that mutations in the PRPH gene are responsible for the high myopia in Chinese.
20018409	2012	Neurobiol. Aging	1558-1497	TITLE	0	0	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	0#5		LRRK2 variant associated with Alzheimer's disease.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	LONGTERM|DICTIONARY	leucine rich repeat kinase 2	leucine-rich repeat kinase-2	140#168		Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_1/3	1	1	120892	SYMBOL|()|DICTIONARY|EXTRACTED	lrrk2	LRRK2	170#175	20018409-1-140-168	Overlapping neurodegenerative pathologies (including Alzheimer's disease, AD) have been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_2/3	2	2	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	14#19	20018409-1-140-168	We analyzed a LRRK2 PD (R1628P) risk variant in a group of 885 subjects comprising of AD and controls.
20018409	2012	Neurobiol. Aging	1558-1497	ALL_TEXT_3/3	3	5	120892	SYMBOL|DICTIONARY|EXTRACTED	lrrk2	LRRK2	4#9	20018409-1-140-168	The LRRK2 R1628P variant increases the risk of AD in our population and our in vitro findings suggest that it is a functional variant and predisposes to apoptosis.
19523860	2011	Urol. Oncol.	1873-2496	TITLE	0	0	7157	SYMBOL|DICTIONARY	tp53	TP53	12#16		The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	58#62		Several studies have investigated the association between TP53 Arg72Pro and an increased risk of developing bladder tumors, with controversial results.
19524323	2011	Neurobiol. Aging	1558-1497	TITLE	0	0	64102	LONGTERM|DICTIONARY	tenomodulin	Tenomodulin	0#11		Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
19524323	2011	Neurobiol. Aging	1558-1497	TITLE	0	0	348	SYMBOL|DICTIONARY	apoe	APOE	22#26		Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	10#15		Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	37#42		Homozygous and compound heterozygous MUTYH mutations predispose for MUTYH-associated polyposis (MAP).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	4	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	24#29		Yet, the involvement of MUTYH mutations in families with both breast cancer and colorectal cancer is unclear.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	5	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	28#33		Here, we have genotyped the MUTYH p.Tyr179Cys, p.Gly396Asp and p.Pro405Leu founder mutations in 153 Dutch families with breast cancer patients and colorectal cancer patients.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	26#31		As anticipated, biallelic MUTYH mutations were identified among 13% of 15 polyposis families, which was significantly increased compared to the absence of biallelic MUTYH mutations in the population (P = 0.0001).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	7	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	165#170		As anticipated, biallelic MUTYH mutations were identified among 13% of 15 polyposis families, which was significantly increased compared to the absence of biallelic MUTYH mutations in the population (P = 0.0001).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	8	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	30#35		Importantly, six heterozygous MUTYH mutations were identified among non-polyposis families with breast and colorectal cancer.
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	10	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	21#26		Importantly, the 11% MUTYH frequency among FCRC-AMS negative families was almost fivefold higher than the reported frequencies for FCRC-AMS negative families unselected for the presence of breast cancer patients (P = 0.03).
20191381	2011	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	11	4595	SYMBOL|DICTIONARY	mutyh	MUTYH	49#54		Together, our results indicate that heterozygous MUTYH mutations are associated with families that include both breast cancer patients and colorectal cancer patients, independent of which tumour type is more prevalent in the family.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	TITLE	0	0	79068	SYMBOL|DICTIONARY	fto	FTO	0#3		FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study).
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_1/3	1	1	79068	SYMBOL|DICTIONARY	fto	FTO	43#46		The fat mass and obesity associated gene ( FTO) is associated with bodyweight and obesity.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_1/3	1	2	79068	SYMBOL|DICTIONARY	fto	FTO	44#47		The aim of this study was to investigate if FTO genotype affects weight gain in adulthood.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_2/3	2	5	79068	SYMBOL|DICTIONARY	fto	FTO	0#3		FTO genotype was assessed by genotyping of the SNP rs1421085.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_2/3	2	6	79068	SYMBOL|DICTIONARY	fto	FTO	29#32		A strong association between FTO and obesity was found, consistent with an additive gene effect.
20373279	2011	Exp. Clin. Endocrinol. Diabetes	1439-3646	ALL_TEXT_3/3	3	11	79068	SYMBOL|DICTIONARY	fto	FTO	15#18		In conclusion, FTO was associated with obesity, but not with weight gain in adults during 11 years of follow-up.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	TITLE	0	0	412	SYMBOL|GENE|GN|DICTIONARY	sts	STS	16#19		Analysis of the STS gene in 40 patients with recessive X-linked ichthyosis: a high frequency of partial deletions in a Spanish population.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	OBJECTIVES	2	4	412	SYMBOL|GENE|GN|DICTIONARY	sts	STS	40#43		Previous reports of partial deletion of STS gene in cases of RXLI prompted us to determine the incidence of these abnormalities in a Spanish population.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	METHODS	3	5	412	SYMBOL|GENE|GN|DICTIONARY	sts	STS	41#44		We have studied exons 1, 5 and 10 of the STS gene by polymerase chain reaction in 40 patients with clinical features of RXLI.
20383754	2011	Obes Surg	1708-0428	TITLE	0	0	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	Vitamin D receptor	0#18		Vitamin D receptor polymorphisms in secondary hyperparathyroidism after Scopinaro's biliopancreatic diversion.
20383754	2011	Obes Surg	1708-0428	BACKGROUND	1	2	7421	LONGTERM|GENE|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	228#246		Individual differences in calcium absorption determine chronic secondary hyperparathyroidism after biliopancreatic diversion in half of the patients who have normal levels of 25-hydroxyvitamin D. We aimed to evaluate if certain vitamin D receptor polymorphisms may be responsible for the latter.
20383754	2011	Obes Surg	1708-0428	METHODS	2	4	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	64#82		Genotyping for restriction-length-fragment polymorphisms of the vitamin D receptor gene was carried out for FOK1, BSM1, APA1, and TAQ1, and haplotype structure was also constructed.
20383754	2011	Obes Surg	1708-0428	METHODS	2	4	57862	SYMBOL|DICTIONARY	apa1	APA1	120#124		Genotyping for restriction-length-fragment polymorphisms of the vitamin D receptor gene was carried out for FOK1, BSM1, APA1, and TAQ1, and haplotype structure was also constructed.
20383754	2011	Obes Surg	1708-0428	RESULTS	3	5	57862	SYMBOL|DICTIONARY	apa1	APA1	228#232		There were no differences in the allelic or genotypes distribution of the four studied polymorphisms between patients and controls (P = 0.352 and P = 0.301 for FOK1, P = 0.733 and P = 0.924 for BSM1, P = 0.974 and P = 0.992 for APA1, and P = 0.995 and P = 0.928 for TAQ1, respectively).
20383754	2011	Obes Surg	1708-0428	RESULTS	3	7	5741	SYMBOL|DICTIONARY	pth	PTH	55#58		Furthermore, haplotypes were not associated with serum PTH levels or with the ratio between serum PTH and 25-hydroxyvitamin D levels.
20383754	2011	Obes Surg	1708-0428	RESULTS	3	7	5741	SYMBOL|DICTIONARY	pth	PTH	98#101		Furthermore, haplotypes were not associated with serum PTH levels or with the ratio between serum PTH and 25-hydroxyvitamin D levels.
20383754	2011	Obes Surg	1708-0428	CONCLUSION	4	8	7421	LONGTERM|GENE|GN|GT|DICTIONARY	vitamin d receptor	vitamin D receptor	144#162		Chronic secondary hyperparathyroidism after biliopancreatic diversion in patients with normal levels of 25-hydroxyvitamin D is not dependent on vitamin D receptor gene polymorphisms.
20361264	2010	Fam. Cancer	1573-7292	TITLE	0	0	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	0#7		RASSF1A polymorphism in familial breast cancer.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	1	11186	SYMBOL|()|DICTIONARY	rassf1a	RASSF1A	88#95		Inactivation or loss of the tumour suppressor Ras associated domain family 1 isoform A (RASSF1A) allele has been described in breast cancer.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	56#63		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	152#157		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	162#167		Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	21#28		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	121#126		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	134#139		We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_2/3	2	4	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	4#11		The RASSF1A p.A331S variant was not more common in the familial breast cancer cases than in the controls (P = 0.27).
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_3/3	3	5	672	SYMBOL|DICTIONARY	brca1	BRCA1	51#56		Subset analysis demonstrated no association in the BRCA1 (P = 0.26), BRCA2 (P = 0.16) or BRCA negative (P = 0.30) samples.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_3/3	3	5	675	SYMBOL|DICTIONARY	brca2	BRCA2	69#74		Subset analysis demonstrated no association in the BRCA1 (P = 0.26), BRCA2 (P = 0.16) or BRCA negative (P = 0.30) samples.
20361264	2010	Fam. Cancer	1573-7292	ALL_TEXT_3/3	3	6	11186	SYMBOL|DICTIONARY	rassf1a	RASSF1A	11#18		Hence, the RASSF1A p.A331S polymorphism is not confirmed as a significant germline contributor to familial breast cancer susceptibility.
20393813	2010	J. Mol. Neurosci.	1559-1166	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	31#44		Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.
20393813	2010	J. Mol. Neurosci.	1559-1166	TITLE	0	0	3586	LONGTERM|GENE|GN|DICTIONARY	interleukin 10	interleukin-10	49#63		Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	85#90		The aim of the study was to identify whether polymorphisms of interleukin (IL)-6 and IL-10 are risk factors for the development of paranoid schizophrenia in case-control study.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	5	3569	SYMBOL|DICTIONARY	il 6	IL-6	0#4		IL-6 (-174G/C; rs 1800795) and IL-10 (-1082G/A; rs 1800896) promoter polymorphisms in patients with paranoid schizophrenia and healthy individuals were genotyped using polymerase chain reaction-restriction fragment length polymorphism method.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	31#36		IL-6 (-174G/C; rs 1800795) and IL-10 (-1082G/A; rs 1800896) promoter polymorphisms in patients with paranoid schizophrenia and healthy individuals were genotyped using polymerase chain reaction-restriction fragment length polymorphism method.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	15#19		Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	24#29		Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	120#124		Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	6	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	129#134		Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	7	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	45#49		The presence of allele C at position -174 of IL-6 promoter sequence may correlate with increasing risk of paranoid schizophrenia in the Polish population, but research on a broadened group of people is needed.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	8	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	46#51		The presence of allele G at position -1082 of IL-10 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	9	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	52#57		The coexistence of genotype GG at position -1082 of IL-10 promoter sequence and genotype GC at position -174 of IL-6 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_3/3	3	9	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	112#116		The coexistence of genotype GG at position -1082 of IL-10 promoter sequence and genotype GC at position -174 of IL-6 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
19937159	2011	Neuromolecular Med.	1559-1174	TITLE	0	0	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	0#5		HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_1/3	1	1	3356	SYMBOL|()|DICTIONARY	htr2a	HTR2A	76#81		Several recent investigations reported that the serotonin 2A receptor gene (HTR2A) was associated with selective serotonin reuptake inhibitors (SSRIs) in major depressive disorder.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_1/3	1	2	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	58#63		There have also been two reported association analyses of HTR2A with SSRI response in Japanese MDD patients, but the results were rather inconsistent and both studies had the problem of small sample sizes.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	3	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	270#275		Therefore, we conducted a replication association study using a sample larger than those in the two original Japanese studies (265 MDD patients), and found that four SNPs, two functional SNPs (-A1438G: rs6311 and T102C: rs6313) and two SNPs (rs7997012 and rs1928040) in HTR2A, were associated with the therapeutic response to SSRIs.
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	4	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	0#5		HTR2A was associated with the therapeutic response SSRIs in Japanese MDD patients in a haplotype-wise analysis (P(all markers) = 0.0136), and a significant association between rs1928040 in HTR2A and SSRI response was detected in MDD (P(allele-wise analysis) = 0.0252).
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_2/3	2	4	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	189#194		HTR2A was associated with the therapeutic response SSRIs in Japanese MDD patients in a haplotype-wise analysis (P(all markers) = 0.0136), and a significant association between rs1928040 in HTR2A and SSRI response was detected in MDD (P(allele-wise analysis) = 0.0252).
19937159	2011	Neuromolecular Med.	1559-1174	ALL_TEXT_3/3	3	6	3356	SYMBOL|DICTIONARY	htr2a	HTR2A	31#36		In conclusion, we suggest that HTR2A may play an important role in the pathophysiology of the therapeutic response to SSRIs in Japanese MDD patients.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	TITLE	0	0	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	0#6		IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	3486	LONGTERM|DICTIONARY	insulin like growth factor binding protein 3	insulin-like growth factor binding protein 3	42#86		Published data on the association between insulin-like growth factor binding protein 3 (IGFBP3) A-202C polymorphism and breast cancer risk are inconclusive.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_1/3	1	1	3486	SYMBOL|()|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	88#94	20084546-1-42-86	Published data on the association between insulin-like growth factor binding protein 3 (IGFBP3) A-202C polymorphism and breast cancer risk are inconclusive.
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_2/3	2	5	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	71#77	20084546-1-42-86	Overall, significantly elevated breast cancer risk was associated with IGFBP3 C allele when all studies were pooled into the meta-analysis (CC vs. AA: OR = 1.06, 95% CI = 1.02-1.11; dominant model: OR = 1.04, 95% CI = 1.00-1.07).
20084546	2010	Breast Cancer Res. Treat.	1573-7217	ALL_TEXT_3/3	3	9	3486	SYMBOL|DICTIONARY|EXTRACTED	igfbp3	IGFBP3	52#58	20084546-1-42-86	In conclusion, this meta-analysis suggests that the IGFBP3 C allele is a low-penetrant risk factor for developing breast cancer.
20402821	2010	Int. J. Immunogenet.	1744-313X	TITLE	0	0	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	16#44		Polymorphism of glutathione S-transferase M1 and T1 gene loci in COPD.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	25#30		Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	5	2952	SYMBOL|GENE|GN|DICTIONARY	gstt1	GSTT1	35#40		Genetic polymorphisms of GSTM1 and GSTT1 genes in 50 COPD patients and 50 healthy controls were investigated using multiplex polymerase chain reaction-restriction fragment length polymorphism techniques to determine whether polymorphisms of these genes are linked to genetic susceptibility to COPD.All subjects were males and smokers.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_2/3	2	6	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	17#22		The frequency of GSTM1 homozygous null genotype was 28.0% in COPD cases when compared with controls (32.0%).
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	89#94		The difference was not significant showing that risk of COPD was not associated with the GSTM1 null genotypes.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	8	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	48#53		The frequencies of homozygous null genotypes of GSTT1 were significantly higher in COPD cases as compared with controls (40% versus 14.0%) suggesting that the theta-glutathione S-transferases null genotype may be associated with the susceptibility to COPD.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	122#127		No significant differences were observed when comparisons were performed according to severity of disease and smoking for GSTM1 and GSTT1.
20402821	2010	Int. J. Immunogenet.	1744-313X	ALL_TEXT_3/3	3	9	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	132#137		No significant differences were observed when comparisons were performed according to severity of disease and smoking for GSTM1 and GSTT1.
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	2	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	0#4		MEFV gene, which is the main factor in familial Mediterranean fever, is an intracellular regulator of inflammation.
20483145	2010	J. Neurol. Sci.	1878-5883	PURPOSE	1	3	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	75#79		This study was designed to determine if known mutations in pyrin domain of MEFV gene are involved in MS and associated with MS morbidity.
20483145	2010	J. Neurol. Sci.	1878-5883	RESULTS	3	9	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	71#75		The mean time to reach EDSS score 3.0 was earlier in the patients with MEFV gene mutation (p=0.02) and the relapse rate was slightly higher among the MS patients carrying MEFV gene mutation (p=0.04).
20483145	2010	J. Neurol. Sci.	1878-5883	RESULTS	3	9	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	171#175		The mean time to reach EDSS score 3.0 was earlier in the patients with MEFV gene mutation (p=0.02) and the relapse rate was slightly higher among the MS patients carrying MEFV gene mutation (p=0.04).
20483145	2010	J. Neurol. Sci.	1878-5883	CONCLUSION	4	10	4210	SYMBOL|DICTIONARY	mefv	MEFV	73#77		The results of this study supported the hypothesis that MS patients with MEFV mutation seem to have the susceptibility to develop a more progressive disease.
20483145	2010	J. Neurol. Sci.	1878-5883	CONCLUSION	4	11	4210	SYMBOL|DICTIONARY	mefv	MEFV	34#38		Moreover, these data suggest that MEFV mutations may increase the risk of MS development.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor alpha	Tumor necrosis factor-alpha	0#27		Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	2	7124	SYMBOL|GENE|GN|DICTIONARY	tnf alpha	TNF-alpha	0#9		TNF-alpha gene polymorphisms are associated with rejection after organ transplantation and aGVHD in matched related donor blood and marrow transplantation (BMT) recipients.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	5	7133	SYMBOL|()|DICTIONARY	tnfrsf1b	TNFRSF1B	121#129		Recipient single-nucleotide polymorphisms (SNPs) in TNF-alpha and TNF receptor superfamily members 1A (TNFRSF1A) and 1B (TNFRSF1B) were investigated.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	13	7132	SYMBOL|DICTIONARY	tnfrsf1a	TNFRSF1A	40#48		No correlation between selected SNPs in TNFRSF1A or TNFRSF1B and the incidence or severity of aGVHD was found.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	13	7133	SYMBOL|DICTIONARY	tnfrsf1b	TNFRSF1B	52#60		No correlation between selected SNPs in TNFRSF1A or TNFRSF1B and the incidence or severity of aGVHD was found.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_1/3	1	2	5020	SYMBOL|()|DICTIONARY|EXTRACTED	oxt	OXT	36#39	20196918-2-26-34	Previous findings connect oxytocin (OXT) with schizophrenia and antipsychotic action.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_2/3	2	3	5020	SYMBOL|DICTIONARY|EXTRACTED	oxt	OXT	27#30	20196918-2-26-34	Therefore, we evaluated if OXT and OXT receptor (OXTR) genes might play a role in the symptom severity and clozapine treatment response in schizophrenia subjects.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_2/3	2	3	5020	SYMBOL|GENE|GN|DICTIONARY|GA|EXTRACTED	oxt	OXT	35#38	20196918-2-26-34	Therefore, we evaluated if OXT and OXT receptor (OXTR) genes might play a role in the symptom severity and clozapine treatment response in schizophrenia subjects.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_2/3	2	4	5020	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oxt	OXT	29#32	20196918-2-26-34	The rs2740204 variant in the OXT gene was significantly associated with treatment response (after 1000 permutations p=0.042) and nominally associated with negative symptoms in our sample.
20196918	2010	Int. J. Neuropsychopharmacol.	1469-5111	ALL_TEXT_3/3	3	6	5020	SYMBOL|DICTIONARY|EXTRACTED	oxt	OXT	84#87	20196918-2-26-34	Additional association studies in independent samples will be able evaluate whether OXT and OXTR genes are truly playing a role in the clozapine treatment outcome.
19395426	2010	J. Psychopharmacol. (Oxford)	1461-7285	TITLE	0	0	1576	SYMBOL|DICTIONARY	cyp3a4	CYP3A4	87#93		Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
19395426	2010	J. Psychopharmacol. (Oxford)	1461-7285	ALL_TEXT_1/3	1	1	1576	SYMBOL|DICTIONARY	cyp3a4	CYP3A4	136#142		In this study, we examined the relationships between plasma concentrations of risperidone and 9-hydroxyrisperidone and polymorphisms of CYP3A4.
19395426	2010	J. Psychopharmacol. (Oxford)	1461-7285	ALL_TEXT_2/3	2	4	1576	SYMBOL|NUMBER|DICTIONARY	cyp3a4	CYP3A4	0#6		CYP3A4*1G was found to be associated with the change in total PANSS scores (Kruskal-Wallis test, P = 0.021), which was not significant on adjusting for multiple testing.
19395426	2010	J. Psychopharmacol. (Oxford)	1461-7285	ALL_TEXT_3/3	3	5	1576	SYMBOL|GENE|GN|DICTIONARY	cyp3a4	CYP3A4	80#86		Our study has, for the first time, conducted a genetic association study of the CYP3A4 gene with risperidone response.
20166877	2010	Autoimmunity	1607-842X	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptpn22	PTPN22	47#53		Allele and haplotype frequency distribution in PTPN22 gene across variable ethnic groups: Implications for genetic association studies for autoimmune diseases.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY|GENE|GA	protein tyrosine phosphatase non receptor type 22	protein tyrosine phosphatase non-receptor type 22	30#79		The rs2476601-T allele at the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene has been consistently associated with several autoimmune diseases in European-derived populations.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ptpn22	PTPN22	81#87	20166877-1-30-79	The rs2476601-T allele at the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene has been consistently associated with several autoimmune diseases in European-derived populations.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	2	26191	SYMBOL|DICTIONARY|EXTRACTED	ptpn22	PTPN22	83#89	20166877-1-30-79	However, little is known about the allele and haplotype frequency distributions in PTPN22 among populations derived from other ethnic groups.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_1/3	1	3	26191	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ptpn22	PTPN22	124#130	20166877-1-30-79	In the present study, the allele and haplotype frequency distributions of six single nucleotide polymorphisms (SNPs) in the PTPN22 gene were compared among Brazilian populations and HapMap phase 3 dataset.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_3/3	3	8	26191	SYMBOL|DICTIONARY|EXTRACTED	ptpn22	PTPN22	104#110	20166877-1-30-79	Individual genetic ancestries were not associated with the rs2476601-T allele, but were associated with PTPN22 haplotypes in Brazilian, Mexican, and African-American admixed populations.
20166877	2010	Autoimmunity	1607-842X	ALL_TEXT_3/3	3	9	26191	SYMBOL|DICTIONARY|EXTRACTED	ptpn22	PTPN22	100#106	20166877-1-30-79	Our results suggest caution in the interpretation of results found in association studies involving PTPN22 polymorphisms in admixed populations.
20130978	2010	Cancer Causes Control	1573-7225	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	64#69		Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
20130978	2010	Cancer Causes Control	1573-7225	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	74#79		Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	85#90		In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	675	SYMBOL|DICTIONARY	brca2	BRCA2	95#100		In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
20130978	2010	Cancer Causes Control	1573-7225	OBJECTIVE	1	3	672	SYMBOL|NUMBER|DICTIONARY	brca1	BRCA1	102#107		In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	7#12		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	14#19		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	TITLE	0	0	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	21#26		GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	52#57		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	81#86		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	110#115		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	2	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	130#135		Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	37#42		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	109#114		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	161#166		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_1/3	1	4	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	216#221		Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_2/3	2	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.150, 95% confidence interval (CI): 1.060-1.248, random effects); no significant association was detected for Chinese subjects (pooled OR=1.025, 95% CI: 0.903-1.163, fixed effects).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	9	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	11#16		Similarly, GSTT1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.312, 95% CI: 1.119-1.538, random effects); the association in Chinese subjects was not significant (pooled OR=1.068, 95% CI: 0.788-1.449, random effects).
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	10	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	11#16		Concerning GSTP1 Ile105Val no significant associations were demonstrated in either race.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	11	2938	SYMBOL|DICTIONARY	gsta1	GSTA1	0#5		GSTA1 *A/*B polymorphism was not associated with colorectal cancer risk.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	12	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	0#5		GSTM1 and GSTT1 null genotypes confer additional risk for colorectal cancer in Caucasian populations.
20207535	2010	Eur. J. Cancer	1879-0852	ALL_TEXT_3/3	3	12	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	10#15		GSTM1 and GSTT1 null genotypes confer additional risk for colorectal cancer in Caucasian populations.
20485448	2010	J. Hum. Genet.	1435-232X	TITLE	0	0	4210	SYMBOL|DICTIONARY	mefv	MEFV	143#147		Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_1/3	1	1	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	126#130		Familial Mediterranean fever (FMF) is an autoinflammatory disorder generally caused by recessively inherited mutations in the MEFV gene.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_2/3	2	4	4210	SYMBOL|GENE|GN|DICTIONARY	mefv	MEFV	119#123		We selected a subset of 63 heterozygous, homozygous and asymptomatic normal individuals and completely sequenced their MEFV genes (exons) to discover any other mutations potentially missed by currently used screening method.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_3/3	3	8	4210	SYMBOL|DICTIONARY	mefv	MEFV	64#68		Therefore, our study supports the rising evidence that a single MEFV mutation could be associated with mild FMF symptoms.
20485448	2010	J. Hum. Genet.	1435-232X	ALL_TEXT_3/3	3	9	4210	SYMBOL|DICTIONARY	mefv	MEFV	114#118		However, heterozygous patients presenting with severe phenotype should be further analyzed for less common second MEFV mutation using gene sequencing.
20197096	2010	Neuroimage	1095-9572	ALL_TEXT_2/3	2	3	2904	SYMBOL|GENE|GN|DICTIONARY	grin2b	GRIN2B	39#45		One SNP, rs10845840, is located in the GRIN2B gene which encodes the N-methyl-d-aspartate (NMDA) glutamate receptor NR2B subunit.
20197096	2010	Neuroimage	1095-9572	ALL_TEXT_2/3	2	3	2904	SYMBOL|GFAM|FN|DICTIONARY	nr2b	NR2B	116#120		One SNP, rs10845840, is located in the GRIN2B gene which encodes the N-methyl-d-aspartate (NMDA) glutamate receptor NR2B subunit.
20237358	2010	Reprod Sci	1933-7205	TITLE	0	0	6347	LONGTERM|DICTIONARY	monocyte chemotactic protein 1	monocyte chemotactic protein 1	47#77		Significantly elevated concentration of plasma monocyte chemotactic protein 1 of patients with pelvic inflammatory disease.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	LONGTERM|DICTIONARY	monocyte chemotactic protein 1	monocyte chemotactic protein 1	49#79		Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	1	6347	SYMBOL|()|DICTIONARY|EXTRACTED	mcp 1	MCP-1	81#86	20237358-1-49-79	Our goal was to compare the expression of plasma monocyte chemotactic protein 1 (MCP-1) and the gene polymorphism in patients with pelvic inflammatory disease (PID) and healthy controls.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	2	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	175#180	20237358-1-49-79	The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were, respectively, used to measure the plasma MCP-1 level and MCP-1 polymorphism in 70 healthy controls and in 64 patients with PID before and after they received routine treatment protocols.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_1/3	1	2	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	191#196	20237358-1-49-79	The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were, respectively, used to measure the plasma MCP-1 level and MCP-1 polymorphism in 70 healthy controls and in 64 patients with PID before and after they received routine treatment protocols.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	3	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	16#21	20237358-1-49-79	We found plasma MCP-1 was significantly elevated in patients with PID compared to that in normal controls and decreased significantly compared to that in patients with PID after they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	35#40	20237358-1-49-79	The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	152#170		The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_2/3	2	4	1401	SYMBOL|()|DICTIONARY|EXTRACTED	crp	CRP	172#175	20237358-4-152-170	The increased expression of plasma MCP-1 was significantly correlated with the cell counts of white blood cells (WBCs) in blood and the level of plasma C-reactive protein (CRP) of patients with PID before they received treatment.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_3/3	3	5	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	33#38	20237358-1-49-79	There was no association between MCP-1 -2518G/A SNP and its gene expression levels and PID susceptibility.
20237358	2010	Reprod Sci	1933-7205	ALL_TEXT_3/3	3	6	6347	SYMBOL|DICTIONARY|EXTRACTED	mcp 1	MCP-1	16#21	20237358-1-49-79	Elevated plasma MCP-1 could be a biological marker for the diagnosis and to be a new strategy for target therapy of pelvic inflammatory disease.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	131#139		The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	4	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	144#152		The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	28#36		An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	66#74		An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	6	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	107#115		An increased frequencies of HLA-DRB1*0401 (OR = 2.67, P < 0.001), HLA-DQB1*0302 (OR = 3.28, P = 0.001) and HLA-DQB1*0401 (OR = 6.26, P = 0.005) alleles were found in the patients with primary DCM compared with healthy controls.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	7	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	17#25		Individuals with HLA-DRB1*1301 (OR = 0.24, P < 0.001) and HLA-DQB1*0201 (OR = 0.49, P = 0.002) alleles have a protective effect against primary DCM.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	7	3119	SYMBOL|DICTIONARY	hla dqb1	HLA-DQB1	58#66		Individuals with HLA-DRB1*1301 (OR = 0.24, P < 0.001) and HLA-DQB1*0201 (OR = 0.49, P = 0.002) alleles have a protective effect against primary DCM.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	67#71		Two haplotypes were associated with increased risk of primary DCM: DRB1*0401/DQB1*0302 (OR = 4.53, P = 0.002) and DRB1*0401/DQB1*0401 (OR = 9.42, P = 0.004).
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	114#118		Two haplotypes were associated with increased risk of primary DCM: DRB1*0401/DQB1*0302 (OR = 4.53, P = 0.002) and DRB1*0401/DQB1*0401 (OR = 9.42, P = 0.004).
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_1/3	1	1	217	SYMBOL|()|DICTIONARY	aldh2	ALDH2	26#31		Aldehyde dehydrogenase-2 (ALDH2) is a key enzyme of alcohol metabolism, catalyzing the conversion of aldehyde to acetic acid.
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_1/3	1	2	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	42#47		The G-to-A polymorphism in exon 12 of the ALDH2 gene, which causes Glu-to-Lys substitution at codon 504, has been shown to be an independent risk factor for acute myocardial infarction (AMI).
20467232	2010	Tohoku J. Exp. Med.	1349-3329	ALL_TEXT_3/3	3	8	217	SYMBOL|GENE|GN|DICTIONARY	aldh2	ALDH2	22#27		Thus, the A allele in ALDH2 gene is associated with the elevated plasma levels of hs-CRP after the onset of AMI, suggesting a higher susceptibility of the myocardium to ischemic injuries.
20211941	2010	Toxicol. Sci.	1096-0929	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	37#41		Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_1/3	1	1	4780	SYMBOL|()|DICTIONARY	nrf2	Nrf2	36#40		Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that is known to regulate a variety of cytoprotective genes through the antioxidant response element (ARE).
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_1/3	1	3	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	65#69		Furthermore, in neural systems, astrocyte-specific activation of Nrf2 is known to protect neurons.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	44#48		In previous work, our laboratory found that Nrf2 protects from intrastriatal injections of the mitochondrial complex II inhibitor malonate.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	5	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	82#86		Here, we extend these results to show that multiple methods of astrocyte-specific Nrf2 overexpression provide protection from neurotoxicity in vivo.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	6	2670	SYMBOL|DICTIONARY	gfap	GFAP	0#4		GFAP-Nrf2 transgenic mice are significantly more resistant to malonate lesioning.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	6	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	5#9		GFAP-Nrf2 transgenic mice are significantly more resistant to malonate lesioning.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	88#92		This outcome is associated with an increased basal resistance, but more so, an enhanced Nrf2 response to lesioning that attenuated the ensuing neurotoxicity.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	8	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	78#82		Furthermore, striatal transplantation of neuroprogenitor cells overexpressing Nrf2 that differentiate into astrocytes after grafting also significantly reduced malonate toxicity.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	9	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	55#59		Overall, these data establish that enhanced astrocytic Nrf2 response and Nrf2 preconditioning are both sufficient to protect from acute lesions from mitochondrial complex II inhibition.
20211941	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_3/3	3	9	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	73#77		Overall, these data establish that enhanced astrocytic Nrf2 response and Nrf2 preconditioning are both sufficient to protect from acute lesions from mitochondrial complex II inhibition.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	STUDY DESIGN	2	3	2321	LONGTERM|DICTIONARY	fms like tyrosine kinase 1	fms-like tyrosine kinase 1	136#162		Maternal DNA was extracted, and 124 tagging single nucleotide polymorphisms in 6 genes (vascular endothelial growth factor A, B, and C; fms-like tyrosine kinase 1 and 4; endoglin) were genotyped.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	STUDY DESIGN	2	3	2022	LONGTERM|DICTIONARY	endoglin	endoglin	170#178		Maternal DNA was extracted, and 124 tagging single nucleotide polymorphisms in 6 genes (vascular endothelial growth factor A, B, and C; fms-like tyrosine kinase 1 and 4; endoglin) were genotyped.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	7	2321	LONGTERM|DICTIONARY	fms like tyrosine kinase 1	fms-like tyrosine kinase 1	20#46		In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	7	7424	LONGTERM|DICTIONARY	vascular endothelial growth factor c	vascular endothelial growth factor C	189#225		In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	2321	LONGTERM|DICTIONARY	fms like tyrosine kinase 1	fms-like tyrosine kinase 1	20#46		In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	2324	LONGTERM|DICTIONARY	fms like tyrosine kinase 4	fms-like tyrosine kinase 4	94#120		In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	RESULTS	3	8	7424	LONGTERM|DICTIONARY	vascular endothelial growth factor c	vascular endothelial growth factor C	172#208		In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	TITLE	0	0	1029	SYMBOL|DICTIONARY	p16	p16	15#18		Implication of p16 inactivation in tumorigenic activity of respiratory epithelial cell lines and adenocarcinoma cell line established from plutonium-induced lung tumor in rat.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	23#26		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	112#115		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	182#185		To investigate whether p16 inactivation is involved in the development of rat pulmonary tumors, we compared the p16 status and tumorigenicity of cell lines which indicated different p16 status.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_2/3	2	5	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	32#35		Methylation-specific PCR of the p16 promoter region revealed that SV40T2 cells were unmethylated, BP cells displayed heterogeneous methylation, and BP(P)Tu and RTiv3 cells were completely methylated.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	55#58		Methylation-specific PCR and PCR of genomic DNA in the p16 region did not amplify product in PuD2 cells, indicating deletion of p16.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	128#131		Methylation-specific PCR and PCR of genomic DNA in the p16 region did not amplify product in PuD2 cells, indicating deletion of p16.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_3/3	3	8	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	59#62		The demethylating agent 5Aza2dC partially demethylated the p16 promoter region of BP(P)Tu, BP and RTiv3 cells, increasing expression of the p16 transcript and decreasing growth of the cells.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_3/3	3	8	1029	SYMBOL|DICTIONARY	p16	p16	140#143		The demethylating agent 5Aza2dC partially demethylated the p16 promoter region of BP(P)Tu, BP and RTiv3 cells, increasing expression of the p16 transcript and decreasing growth of the cells.
20135361	2010	In Vitro Cell. Dev. Biol. Anim.	1543-706X	ALL_TEXT_3/3	3	9	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	52#55		These results indicate that hypermethylation of the p16 promoter region occurs early in neoplastic transformation before acquisition of tumorigenicity in rat respiratory epithelium.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_1/3	1	2	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	97#100	20179607-2-66-95	An association between the insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE) gene and the progression of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy has been reported.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_1/3	1	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	86#89	20179607-2-66-95	The aim of this study was to investigate the pharmacogenetic interactions between the ACE insertion/deletion polymorphism and the response to cibenzoline in patients with HOCM.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_2/3	2	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	4#7	20179607-2-66-95	The ACE insertion/deletion polymorphism was genotyped.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_3/3	3	11	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	28#31	20179607-2-66-95	Patients with HOCM with the ACE D allele had a high LVPG.
20179607	2010	J. Cardiovasc. Pharmacol.	1533-4023	ALL_TEXT_3/3	3	12	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	62#65	20179607-2-66-95	Cibenzoline was more effective in patients with HOCM with the ACE D allele.
19874431	2010	J Eur Acad Dermatol Venereol	1468-3083	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	filaggrin	27#36		Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.
19874431	2010	J Eur Acad Dermatol Venereol	1468-3083	BACKGROUND	1	1	2312	LONGTERM|GENE|GN|DICTIONARY	filaggrin	filaggrin	27#36		Recently, mutations in the filaggrin gene (FLG) have been shown to be a major predisposing factor for atopic dermatitis (AD).
19710694	2010	J Hum Hypertens	1476-5527	TITLE	0	0	5029	LONGTERM|DICTIONARY|GENE|GA	purinergic receptor p2y g protein coupled 2	purinergic receptor P2Y, G-protein coupled, 2	4#49		The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men.
19710694	2010	J Hum Hypertens	1476-5527	TITLE	0	0	5029	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	51#56	19710694-0-4-49	The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men.
19710694	2010	J Hum Hypertens	1476-5527	ALL_TEXT_1/3	1	1	5029	SYMBOL|DICTIONARY|EXTRACTED	p2ry2	P2RY2	0#5		P2RY2 has an important function in the regulation of blood pressure by activating adenosine triphosphate (ATP).
19710694	2010	J Hum Hypertens	1476-5527	ALL_TEXT_1/3	1	2	5029	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	75#80	19710694-0-4-49	The aim of this study was to investigate the association between the human P2RY2 gene and essential hypertension (EH) through a haplotype-based case-control study that included two gender groups.
19710694	2010	J Hum Hypertens	1476-5527	ALL_TEXT_1/3	1	3	5029	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	125#130	19710694-0-4-49	The 273 EH patients and 255 age-matched controls were genotyped for five single-nucleotide polymorphisms (SNPs) of the human P2RY2 gene (rs4944831, rs1783596, rs4944832, rs4382936 and rs10898909).
19710694	2010	J Hum Hypertens	1476-5527	ALL_TEXT_3/3	3	9	5029	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	p2ry2	P2RY2	96#101	19710694-0-4-49	In conclusion, the present results indicate that rs4944831 and the T-A-G haplotype of the human P2RY2 gene might be genetic markers for EH in Japanese men.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|DICTIONARY|GENE|GA	myg1	MYG1	33#37		Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	c12orf10	C12orf10	39#47	20377893-0-33-37	Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
20377893	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	60314	SYMBOL|DICTIONARY	myg1	Myg1	138#142		Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	1	60314	SYMBOL|DICTIONARY	myg1	MYG1	0#4		MYG1 (Melanocyte proliferating gene 1, also C12orf10 in human) is a ubiquitous nucleo-mitochondrial protein, involved in early developmental processes and in adult stress/illness conditions.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	1	60314	LONGTERM|DICTIONARY	melanocyte proliferating gene 1	Melanocyte proliferating gene 1	6#37		MYG1 (Melanocyte proliferating gene 1, also C12orf10 in human) is a ubiquitous nucleo-mitochondrial protein, involved in early developmental processes and in adult stress/illness conditions.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	1	60314	SYMBOL|DICTIONARY|EXTRACTED	c12orf10	C12orf10	44#52	20377893-0-33-37	MYG1 (Melanocyte proliferating gene 1, also C12orf10 in human) is a ubiquitous nucleo-mitochondrial protein, involved in early developmental processes and in adult stress/illness conditions.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	60314	SYMBOL|GFAM|FN|DICTIONARY	myg1	MYG1	24#28		We recently showed that MYG1 mRNA expression is elevated in the skin of vitiligo patients.
20377893	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	55#59		Our aim was to examine nine known polymorphisms in the MYG1 gene, to investigate their functionality, and to study their association with vitiligo susceptibility.
20377893	2010	BMC Med. Genet.	1471-2350	METHODS	2	4	60314	SYMBOL|DICTIONARY	myg1	MYG1	51#55		Nine single nucleotide polymorphisms (SNPs) in the MYG1 locus were investigated by SNPlex assay and/or sequencing in vitiligo patients (n = 124) and controls (n = 325).
20377893	2010	BMC Med. Genet.	1471-2350	METHODS	2	5	60314	SYMBOL|DICTIONARY	myg1	MYG1	0#4		MYG1 expression in skin biopsies was detected by quantitative-real time PCR (Q-RT-PCR) and polymorphisms were further analysed using luciferase and YFP reporters in the cell culture.
20377893	2010	BMC Med. Genet.	1471-2350	RESULTS	3	6	60314	SYMBOL|GFAM|FN|DICTIONARY	myg1	MYG1	87#91		Control subjects with -119G promoter allele (rs1465073) exhibited significantly higher MYG1 mRNA levels than controls with -119C allele (P = 0.01).
20377893	2010	BMC Med. Genet.	1471-2350	RESULTS	3	10	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	Myg1	147#151		Additionally, we showed that glutamine in the fourth position (in Arg4Gln polymorphism) completely eliminated mitochondrial entrance of YFP-tagged Myg1 protein in cell culture.
20377893	2010	BMC Med. Genet.	1471-2350	RESULTS	3	11	60314	SYMBOL|NUMBER|DICTIONARY	myg1	Myg1	76#80		The analysis of available EST, cDNA and genomic DNA sequences revealed that Myg1 4Gln allele is remarkably present in human populations but is never detected in homozygous state according to the HapMap database.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	33#37		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|DICTIONARY	myg1	Myg1	124#128		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20377893	2010	BMC Med. Genet.	1471-2350	CONCLUSIONS	4	12	60314	SYMBOL|GENE|GN|DICTIONARY	myg1	MYG1	179#183		Our study demonstrated that both MYG1 promoter polymorphism -119C/G and Arg4Gln polymorphism in the mitochondrial signal of Myg1 have a functional impact on the regulation of the MYG1 gene and promoter polymorphism (-119C/G) is related with suspectibility for actively progressing vitiligo.
20350254	2010	Ann. Med.	1365-2060	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin-18	0#14		Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	1	3606	LONGTERM|DICTIONARY	interleukin 18	Interleukin-18	0#14		Interleukin-18 (IL-18) is a pro-atherosclerotic cytokine.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	1	3606	SYMBOL|()|DICTIONARY|EXTRACTED	il 18	IL-18	16#21	20350254-1-0-14	Interleukin-18 (IL-18) is a pro-atherosclerotic cytokine.
20350254	2010	Ann. Med.	1365-2060	BACKGROUND AND AIM	1	2	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	30#35	20350254-1-0-14	We wanted to evaluate whether IL-18 gene polymorphism associates independently of risk factors, with early subclinical markers of atherosclerosis (intima-media thickness (IMT), coronary artery compliance (CAC), and flow-mediated dilatation (FMD)) in a population of young healthy Caucasian adults.
20350254	2010	Ann. Med.	1365-2060	RESULTS	3	4	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	100#105	20350254-1-0-14	Five studied tagSNPs formed six major haplotypes, which accounted for 99.9% of all variation of the IL-18 gene.
20350254	2010	Ann. Med.	1365-2060	RESULTS	3	5	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	48#53	20350254-1-0-14	According to adjusted analysis of variance, the IL-18 gene polymorphism did not associate with subclinical atherosclerosis in the whole study population.
20350254	2010	Ann. Med.	1365-2060	CONCLUSIONS	4	9	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	50#55	20350254-1-0-14	Among all study subjects, the polymorphism of the IL-18 gene is not associated with subclinical markers of atherosclerosis.
20350254	2010	Ann. Med.	1365-2060	CONCLUSIONS	4	10	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	29#34	20350254-1-0-14	However, among men one major IL-18 haplotype seemed to associate with substantially lower IMT values.
20197243	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	30#51		Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer.
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	244#248	20197243-2-100-121	Among never-active smokers, a long duration of passive smoking was associated with an increased risk of breast cancer (odds ratio (OR) 1.86 (95% confidence interval (95% CI) 1.01-3.44) (test for trend (p=0.07)); that risk was more elevated for NAT2 slow acetylators (OR 2.76, 95% CI 1.16-6.59) (and highest in extremely slow acetylators), but not elevated for NAT2 fast acetylators (OR 1.17, 95% CI 0.42-3.23).
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	5	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	360#364	20197243-2-100-121	Among never-active smokers, a long duration of passive smoking was associated with an increased risk of breast cancer (odds ratio (OR) 1.86 (95% confidence interval (95% CI) 1.01-3.44) (test for trend (p=0.07)); that risk was more elevated for NAT2 slow acetylators (OR 2.76, 95% CI 1.16-6.59) (and highest in extremely slow acetylators), but not elevated for NAT2 fast acetylators (OR 1.17, 95% CI 0.42-3.23).
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	130#134	20197243-2-100-121	Among active smokers more than 20 pack-years of smoking was associated with an OR of 1.34 (95% CI 0.92-1.96); more elevated among NAT2 fast acetylators OR 1.93 (95% CI 1.01-3.69) but not elevated among NAT2 slow acetylators.
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	6	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	202#206	20197243-2-100-121	Among active smokers more than 20 pack-years of smoking was associated with an OR of 1.34 (95% CI 0.92-1.96); more elevated among NAT2 fast acetylators OR 1.93 (95% CI 1.01-3.69) but not elevated among NAT2 slow acetylators.
20197243	2010	Cancer Epidemiol	1877-783X	RESULTS	3	7	10	SYMBOL|DICTIONARY|EXTRACTED	nat2	NAT2	15#19	20197243-2-100-121	Women who were NAT2 fast acetylators in the highest quartile for duration of active smoking had an OR of 2.74 (95% CI 1.42-5.27), with a significant test of trend (p=0.005).
19673907	2011	Cephalalgia	1468-2982	TITLE	0	0	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	0#5		MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.
19673907	2011	Cephalalgia	1468-2982	TITLE	0	0	1636	SYMBOL|DICTIONARY	ace	ACE	18#21		MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_1/3	1	1	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	31#36		Data on the association of the MTHFR 677C→T and ACE D/I polymorphisms with migraine severity, measured by attack frequency, are scarce.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_1/3	1	1	1636	SYMBOL|DICTIONARY	ace	ACE	48#51		Data on the association of the MTHFR 677C→T and ACE D/I polymorphisms with migraine severity, measured by attack frequency, are scarce.
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_3/3	3	6	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	4#9		The MTHFR 677TT genotype was associated with a reduced risk for MA, which only appeared for attacks fewer than six times/year (age-adjusted odds ratio 0.78; 95% confidence interval 0.61, 0.99).
19673907	2011	Cephalalgia	1468-2982	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY	ace	ACE	57#60		We did not find a specific pattern of association of the ACE D/I polymorphism with attack frequency for MA or MoA.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_1/3	1	2	7422	SYMBOL|DICTIONARY	vegf	VEGF	47#51		Our previous single-locus analysis showed that VEGF and HSP70-hom polymorphisms were significantly associated with PCa susceptibility and prognosis.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_2/3	2	4	7422	SYMBOL|NUMBER|DICTIONARY	vegf	VEGF	57#61		Three tagging polymorphisms, the HSP70-hom 2437 T/C, the VEGF-1154 G/A, and the VEGF-634 G/C SNPs were genotyped in 101 cases and 80 controls.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_2/3	2	4	7422	SYMBOL|NUMBER|DICTIONARY	vegf	VEGF	80#84		Three tagging polymorphisms, the HSP70-hom 2437 T/C, the VEGF-1154 G/A, and the VEGF-634 G/C SNPs were genotyped in 101 cases and 80 controls.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	7422	SYMBOL|DICTIONARY	vegf	VEGF	64#68		Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	7422	SYMBOL|DICTIONARY	vegf	VEGF	79#83		Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	8	3305	SYMBOL|DICTIONARY	hsp70 hom	HSP70-hom	62#71		Our findings confirm the role of at-risk haplotype across the HSP70-hom/VEGF gene cluster in determining susceptibility to PCa.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	8	7422	SYMBOL|GENE|GN|DICTIONARY	vegf	VEGF	72#76		Our findings confirm the role of at-risk haplotype across the HSP70-hom/VEGF gene cluster in determining susceptibility to PCa.
19842025	2010	Inflammation	1573-2576	TITLE	0	0	3576	LONGTERM|GENE|GN|DICTIONARY	interleukin 8	interleukin-8	15#28		Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	LONGTERM|DICTIONARY	interleukin 8	Interleukin-8	0#13		Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	1	3576	SYMBOL|()|DICTIONARY|EXTRACTED	il 8	IL-8	15#19	19842025-1-0-13	Interleukin-8 (IL-8), a CXC chemokine with multiple biological functions, plays an important role in the pathogenesis of oral lichen planus (OLP).
19842025	2010	Inflammation	1573-2576	ALL_TEXT_1/3	1	2	3576	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 8	IL-8	102#106	19842025-1-0-13	The aim of this study was to investigate the association of single nucleotide polymorphisms (SNPs) of IL-8 gene with OLP in a Chinese population.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_2/3	2	3	3576	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 8	IL-8	17#21	19842025-1-0-13	Four SNPs of the IL-8 gene at positions -845 T/C (rs2227532), -738 T/A, -251 A/T (rs4073) and +781 C/T (rs2227306) were analyzed in 109 patients with OLP and 101 normal controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
19842025	2010	Inflammation	1573-2576	ALL_TEXT_3/3	3	6	3576	SYMBOL|DICTIONARY|EXTRACTED	il 8	IL-8	28#32	19842025-1-0-13	The study suggests that the IL-8 polymorphisms may be associated with the severity of OLP in this Chinese cohort.
20196834	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	15#19		Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	TITLE	0	0	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	29#35		Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	39#45		Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	9817	SYMBOL|DICTIONARY	keap1	KEAP1	50#55		Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.
20196834	2010	BMC Med. Genet.	1471-2350	METHODS	2	5	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	72#78		Eight tag single nucleotide polymorphisms representing the variation in NFE2L2 and three representing the variation in KEAP1 were chosen using HapMap data and were genotyped using TaqMan Allelic Discrimination.
20196834	2010	BMC Med. Genet.	1471-2350	METHODS	2	5	9817	SYMBOL|DICTIONARY	keap1	KEAP1	119#124		Eight tag single nucleotide polymorphisms representing the variation in NFE2L2 and three representing the variation in KEAP1 were chosen using HapMap data and were genotyped using TaqMan Allelic Discrimination.
20196834	2010	BMC Med. Genet.	1471-2350	RESULTS	3	6	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	27#33		We identified a protective NFE2L2 haplotype in both of our European case-control materials.
20196834	2010	BMC Med. Genet.	1471-2350	RESULTS	3	9	9817	SYMBOL|DICTIONARY	keap1	KEAP1	21#26		Genetic variation in KEAP1 did not show any associations.
20196834	2010	BMC Med. Genet.	1471-2350	CONCLUSION	4	10	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	37#43		These data suggest that variation in NFE2L2 modifies the Parkinson's disease process and provide another link between oxidative stress and neurodegeneration.
19904240	2010	Am. J. Gastroenterol.	1572-0241	TITLE	0	0	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	0#5		IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|()|DICTIONARY	il 1b	IL-1B	35#40		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	1	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	126#131		The association of interleukin-1B (IL-1B)-511 polymorphism with gastric cancer is still controversial, and the association of IL-1B-511 polymorphism with subtypes of gastric cancer is still largely unknown.
19904240	2010	Am. J. Gastroenterol.	1572-0241	OBJECTIVES	1	2	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	48#53		We investigated whether the association between IL-1B-511 polymorphism and gastric cancer risk varies by clinically important tumor characteristics and the prognostic value of this polymorphism in a large population-based case-control study among Chinese.
19904240	2010	Am. J. Gastroenterol.	1572-0241	METHODS	2	5	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	16#21		Polymorphism in IL-1B-511 was analyzed by PCR-restriction fragment length polymorphism on 501 gastric cancers and 500 healthy controls.
19904240	2010	Am. J. Gastroenterol.	1572-0241	RESULTS	3	6	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	43#48		Compared with the CC genotype, carriers of IL-1B-511 TT genotype had an increased gastric cancer risk (odds ratio (OR)=1.97, 95% confidence interval (CI)=1.29-3.01, P=0.0016).
19904240	2010	Am. J. Gastroenterol.	1572-0241	RESULTS	3	10	3553	SYMBOL|NUMBER|DICTIONARY	il 1b	IL-1B	0#5		IL-1B-511 genotypes were not associated with the prognosis of gastric cancer patients.
19904240	2010	Am. J. Gastroenterol.	1572-0241	CONCLUSIONS	4	11	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	0#5		IL-1B polymorphism influences certain subtypes of gastric cancer according to the clinical and pathological features.
20042177	2010	Am. J. Ophthalmol.	1879-1891	TITLE	0	0	5444	LONGTERM|GENE|GN|DICTIONARY	paraoxonase 1	paraoxonase 1	21#34		Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	2	5444	LONGTERM|DICTIONARY	paraoxonase 1	Paraoxonase 1	0#13		Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	2	5444	SYMBOL|()|DICTIONARY|EXTRACTED	pon1	PON1	15#19	20042177-2-0-13	Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD.
20042177	2010	Am. J. Ophthalmol.	1879-1891	PURPOSE	1	3	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	32#36	20042177-2-0-13	This study investigated whether PON1 gene polymorphisms associate with AMD.
20042177	2010	Am. J. Ophthalmol.	1879-1891	METHODS	3	7	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	13#17	20042177-2-0-13	All exons of PON1 were evaluated by single-strand conformation polymorphism and direct sequence analysis.
20042177	2010	Am. J. Ophthalmol.	1879-1891	RESULTS	4	8	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	106#110	20042177-2-0-13	Six missense changes (Leu55Met, Met127Arg, His155Arg, Gln192Arg, Gln192Glu, Ala252Gly) were identified in PON1.
20042177	2010	Am. J. Ophthalmol.	1879-1891	CONCLUSION	5	12	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	32#36	20042177-2-0-13	We report a weak association of PON1 Leu55Met with an increased risk of wet AMD, replicating previous reports.
20042177	2010	Am. J. Ophthalmol.	1879-1891	CONCLUSION	5	15	5444	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	pon1	PON1	153#157	20042177-2-0-13	We believe that Met127Arg, His155Arg, and Ala252Gly play minor roles in AMD susceptibility because of their limited frequency and/or location within the PON1 gene.
20220260	2010	Ann Saudi Med	0975-4466	BACKGROUND AND OBJECTIVES	1	1	729230	SYMBOL|DICTIONARY	ccr2	CCR2	74#78		Genomic scan analyses have suggested that the chemokine receptor cluster (CCR2, CCR3, CCR5 <300 kb span) on the short arm of chromosome 3 may contribute to susceptibility to HIV-1 infection and to the expression of a number of inflammatory diseases.
20220260	2010	Ann Saudi Med	0975-4466	BACKGROUND AND OBJECTIVES	1	1	1232	SYMBOL|DICTIONARY	ccr3	CCR3	80#84		Genomic scan analyses have suggested that the chemokine receptor cluster (CCR2, CCR3, CCR5 <300 kb span) on the short arm of chromosome 3 may contribute to susceptibility to HIV-1 infection and to the expression of a number of inflammatory diseases.
20220260	2010	Ann Saudi Med	0975-4466	BACKGROUND AND OBJECTIVES	1	1	1234	SYMBOL|DICTIONARY	ccr5	CCR5	86#90		Genomic scan analyses have suggested that the chemokine receptor cluster (CCR2, CCR3, CCR5 <300 kb span) on the short arm of chromosome 3 may contribute to susceptibility to HIV-1 infection and to the expression of a number of inflammatory diseases.
20220260	2010	Ann Saudi Med	0975-4466	METHODS	2	5	8464	SYMBOL|DICTIONARY	spt 3	SPT 3	49#54		Atopy was defined as a positive skin prick test (SPT 3 mm) to a panel of common inhaled allergens.
20220260	2010	Ann Saudi Med	0975-4466	RESULTS	3	6	729230	SYMBOL|DICTIONARY	ccr2	CCR2	68#72		From a panel of ten known SNPs, only three polymorphisms: -G190A in CCR2, -T51C in CCR3, and a 32 bp deletion in CCR5 were found to occur at clinically relevant frequencies.
20220260	2010	Ann Saudi Med	0975-4466	RESULTS	3	6	1232	SYMBOL|DICTIONARY	ccr3	CCR3	83#87		From a panel of ten known SNPs, only three polymorphisms: -G190A in CCR2, -T51C in CCR3, and a 32 bp deletion in CCR5 were found to occur at clinically relevant frequencies.
20220260	2010	Ann Saudi Med	0975-4466	RESULTS	3	6	1234	SYMBOL|DICTIONARY	ccr5	CCR5	113#117		From a panel of ten known SNPs, only three polymorphisms: -G190A in CCR2, -T51C in CCR3, and a 32 bp deletion in CCR5 were found to occur at clinically relevant frequencies.
20220260	2010	Ann Saudi Med	0975-4466	CONCLUSION	4	10	729230	SYMBOL|GENE|GN|DICTIONARY	ccr2	CCR2	168#172		The previous association of the CCR532 deletion with protection from childhood asthma appears to be explained by linkage disequilibrium with the -G190A mutation in the CCR2 receptor gene.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	31#36		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	4968	SYMBOL|DICTIONARY	ogg1	OGG1	64#68		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2068	SYMBOL|DICTIONARY	ercc2	ERCC2	96#101		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2072	SYMBOL|DICTIONARY	ercc4	ERCC4	113#118		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	METHODS	2	5	2073	SYMBOL|DICTIONARY	ercc5	ERCC5	134#139		Genotyping of polymorphisms of XRCC1 (Arg194Trp and Arg399Gln), OGG1 (Ser326Cys and Arg229Gln), ERCC2 Lys751Gln, ERCC4 Ser662Pro, and ERCC5 His1104Asp was performed and used to evaluate breast cancer susceptibility.
20183911	2010	Ann. Surg. Oncol.	1534-4681	RESULTS	3	6	2073	SYMBOL|NUMBER|DICTIONARY	ercc5	ERCC5	40#45		Of the nonsynonymous polymorphisms, the ERCC5 1104Asp variant was significantly associated with breast cancer (odds ratio = 1.42; 95% confidence interval = 1.08-1.97), and this association was more pronounced in women with lengthy estrogen exposure.
20010906	2010	Int J Obes (Lond)	1476-5497	TITLE	0	0	4828	LONGTERM|GENE|GN|DICTIONARY	neuromedin b	neuromedin B	81#93		Influence of maternal educational level on the association between the rs3809508 neuromedin B gene polymorphism and the risk of obesity in the HELENA study.
20010906	2010	Int J Obes (Lond)	1476-5497	OBJECTIVE	1	1	4828	LONGTERM|DICTIONARY	neuromedin b	Neuromedin B	0#12		Neuromedin B (NMB) is a bombesin-like peptide, which inhibits food intake and modulates stress-related behaviour.
20010906	2010	Int J Obes (Lond)	1476-5497	OBJECTIVE	1	1	4828	SYMBOL|()|DICTIONARY|EXTRACTED	nmb	NMB	14#17	20010906-1-0-12	Neuromedin B (NMB) is a bombesin-like peptide, which inhibits food intake and modulates stress-related behaviour.
20010906	2010	Int J Obes (Lond)	1476-5497	OBJECTIVE	1	2	4828	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nmb	NMB	3#6	20010906-1-0-12	An NMB gene polymorphism (P73T) has been earlier associated with obesity and abnormal eating behaviour in adults.
20010906	2010	Int J Obes (Lond)	1476-5497	METHODS	2	3	4828	SYMBOL|DICTIONARY|EXTRACTED	nmb	NMB	29#32	20010906-1-0-12	The association between four NMB polymorphisms and obesity-related phenotypes was investigated in the Healthy Lifestyle in Europe by Nutrition in Adolescence cross-sectional study (n=1144, 12-17-year-old European adolescents).
20010906	2010	Int J Obes (Lond)	1476-5497	METHODS	2	4	4828	SYMBOL|DICTIONARY|EXTRACTED	nmb	NMB	38#41	20010906-1-0-12	This population was genotyped for the NMB rs1107179, rs17598561, rs3809508 and rs1051168 (P73T) polymorphisms.
20010906	2010	Int J Obes (Lond)	1476-5497	CONCLUSION	4	12	4828	SYMBOL|DICTIONARY|EXTRACTED	nmb	NMB	48#51	20010906-1-0-12	In European adolescents, the TT genotype of the NMB rs3809508 polymorphism was associated with a higher risk of obesity.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|GENE|GN|DICTIONARY	ptpn11	PTPN11	13#19		Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
20006740	2010	Mitochondrion	1872-8278	ALL_TEXT_1/3	1	1	5781	SYMBOL|DICTIONARY	ptpn11	PTPN11	133#139		Mutations in PTPN11 gene was responsible for approximately 50% of the Noonan syndrome (NS), however, we did not find any mutation in PTPN11 in any of seven NS patients analysed.
19642078	2010	Musculoskeletal Care	1557-0681	OBJECTIVES	1	3	10599	SYMBOL|()|DICTIONARY	slco1b1	SLCO1B1	210#217		Several factors increase the risk of developing statin-induced myopathy, including the single nucleotide polymorphism (SNP) rs4149056, located within the gene encoding solute carrier organic anion transporter (SLCO1B1).
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	Tumor necrosis factor	0#21		Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	7124	SYMBOL|()|DICTIONARY|EXTRACTED	tnf	TNF	23#26	20047977-0-0-21	Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
20047977	2010	Am. J. Epidemiol.	1476-6256	TITLE	0	0	4049	LONGTERM|DICTIONARY	lymphotoxin alpha	lymphotoxin-alpha	32#49		Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor	tumor necrosis factor	118#139		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	7124	SYMBOL|()|DICTIONARY|EXTRACTED	tnf	TNF	141#144	20047977-0-0-21	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	150#164		In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	1	3586	SYMBOL|()|DICTIONARY|EXTRACTED	il10	IL10	166#170	20047977-1-150-164	In an International Lymphoma Epidemiology Consortium pooled analysis, polymorphisms in 2 immune-system-related genes, tumor necrosis factor (TNF) and interleukin-10 (IL10), were associated with non-Hodgkin lymphoma (NHL) risk.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	2	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	184#187	20047977-0-0-21	Here, 8,847 participants were added to previous data (patients diagnosed from 1989 to 2005 in 14 case-control studies; 7,999 cases, 8,452 controls) for testing of polymorphisms in the TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A (rs1800890, rs1800896), and nucleotide-binding oligomerization domain containing 2 (NOD2) 3020insC (rs2066847) genes.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	2	4049	LONGTERM|DICTIONARY	lymphotoxin alpha	lymphotoxin-alpha	209#226		Here, 8,847 participants were added to previous data (patients diagnosed from 1989 to 2005 in 14 case-control studies; 7,999 cases, 8,452 controls) for testing of polymorphisms in the TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A (rs1800890, rs1800896), and nucleotide-binding oligomerization domain containing 2 (NOD2) 3020insC (rs2066847) genes.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	2	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	252#256	20047977-1-150-164	Here, 8,847 participants were added to previous data (patients diagnosed from 1989 to 2005 in 14 case-control studies; 7,999 cases, 8,452 controls) for testing of polymorphisms in the TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A (rs1800890, rs1800896), and nucleotide-binding oligomerization domain containing 2 (NOD2) 3020insC (rs2066847) genes.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_1/3	1	2	64127	SYMBOL|()|NUMBER|DICTIONARY|EXTRACTED	nod2	NOD2	350#354	20047977-2-294-348	Here, 8,847 participants were added to previous data (patients diagnosed from 1989 to 2005 in 14 case-control studies; 7,999 cases, 8,452 controls) for testing of polymorphisms in the TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A (rs1800890, rs1800896), and nucleotide-binding oligomerization domain containing 2 (NOD2) 3020insC (rs2066847) genes.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	84#87	20047977-0-0-21	"Consistent with previous findings, odds ratios were increased for ""new"" participant TNF -308A carriers (NHL: per-allele odds ratio (OR(allelic)) = 1.10, P(trend) = 0.001; diffuse large B-cell lymphoma (DLBCL): OR(allelic) = 1.23, P(trend) = 0.004)."
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	59#62	20047977-0-0-21	In the combined population, odds ratios were increased for TNF -308A carriers (NHL: OR(allelic) = 1.13, P(trend) = 0.0001; DLBCL: OR(allelic) = 1.25, P(trend) = 3.7 x 10(-6); marginal zone lymphoma: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) = 0.006; mycosis fungoides: OR(allelic) = 1.44, P(trend) = 0.015).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	6	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	15#18	20047977-0-0-21	The LTA 252A>G/TNF -308G>A haplotype containing the LTA/TNF variant alleles was strongly associated with DLBCL (P = 2.9 x 10(-8)).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	6	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	56#59	20047977-0-0-21	The LTA 252A>G/TNF -308G>A haplotype containing the LTA/TNF variant alleles was strongly associated with DLBCL (P = 2.9 x 10(-8)).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	39#43	20047977-1-150-164	Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	7	3586	SYMBOL|DICTIONARY|EXTRACTED	il10	IL10	85#89	20047977-1-150-164	Results suggested associations between IL10 -3575T>A and DLBCL (P(trend) = 0.02) and IL10 -1082A>G and mantle cell lymphoma (P(trend) = 0.04).
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	72#75	20047977-0-0-21	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
20047977	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	8	7124	SYMBOL|DICTIONARY|EXTRACTED	tnf	TNF	127#130	20047977-0-0-21	These findings strengthen previous results for DLBCL and the LTA 252A>G/TNF -308A locus and provide robust evidence that these TNF/LTA gene variants, or others in linkage disequilibrium, are involved in NHL etiology.
20068450	2010	Anesthesiology	1528-1175	METHODS	2	4	5173	LONGTERM|DICTIONARY	prodynorphin	prodynorphin	15#27		The changes in prodynorphin messenger RNA expression and dynorphin A (1-17)-like immunoreactivity in the mouse spinal cord were determined after the intraplantar injection of complete Freund's adjuvant in mice.
20068450	2010	Anesthesiology	1528-1175	RESULTS	3	7	5173	LONGTERM|DICTIONARY	prodynorphin	prodynorphin	31#43		These effects were not seen in prodynorphin knockout mice.
20068450	2010	Anesthesiology	1528-1175	RESULTS	3	8	5173	LONGTERM|DICTIONARY	prodynorphin	Prodynorphin	0#12		Prodynorphin messenger RNA expression and dynorphin A (1-17)-like immunoreactivity on the ipsilateral side of the spinal cord were markedly increased in complete Freund's adjuvant-injected mice.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	5	10466	SYMBOL|GENE|GN|DICTIONARY	cog5	COG5	91#95		The C allele of rs3815148 on chromosome 7q22 (minor allele frequency 23%; intron 12 of the COG5 gene) was associated with a 1.14-fold increased risk (95% confidence interval 1.09-1.19) of knee and/or hand OA (P = 8 x 10(-8)) and also with a 30% increased risk of knee OA progression (95% confidence interval 1.03-1.64) (P = 0.03).
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	6	2845	SYMBOL|DICTIONARY	gpr22	GPR22	88#93		This SNP is in almost complete linkage disequilibrium with rs3757713 (68 kb upstream of GPR22), which is associated with GPR22 expression levels in lymphoblast cell lines (P = 4 x 10(-12)).
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	6	2845	SYMBOL|DICTIONARY	gpr22	GPR22	121#126		This SNP is in almost complete linkage disequilibrium with rs3757713 (68 kb upstream of GPR22), which is associated with GPR22 expression levels in lymphoblast cell lines (P = 4 x 10(-12)).
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	7	2845	SYMBOL|()|DICTIONARY	gpr22	GPR22	86#91		Immunohistochemistry experiments revealed that G protein-coupled receptor protein 22 (GPR22) was absent in normal mouse articular cartilage or synovium.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	8	2845	SYMBOL|DICTIONARY	gpr22	GPR22	9#14		However, GPR22-positive chondrocytes were found in the upper layers of the articular cartilage of mouse knee joints that were challenged with in vivo papain treatment or methylated bovine serum albumin treatment.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	9	2845	SYMBOL|DICTIONARY	gpr22	GPR22	0#5		GPR22-positive chondrocyte-like cells were also found in osteophytes in instability-induced OA.
20112360	2010	Arthritis Rheum.	0004-3591	CONCLUSION	4	11	2845	SYMBOL|GENE|GN|DICTIONARY	gpr22	GPR22	10#15		Since the GPR22 gene encodes a G protein-coupled receptor, this is potentially an interesting therapeutic target.
19892319	2010	Biol. Psychiatry	1873-2402	TITLE	0	0	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	Catechol-o-methyltransferase	0#28		Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia.
19892319	2010	Biol. Psychiatry	1873-2402	BACKGROUND	1	1	1312	LONGTERM|DICTIONARY	catechol o methyltransferase	catechol-O-methyltransferase	54#82		A valine(158)methionine (val(158)met) polymorphism in catechol-O-methyltransferase (COMT) modulates cortical dopaminergic catabolism and has been associated with schizophrenia.
19892319	2010	Biol. Psychiatry	1873-2402	BACKGROUND	1	1	1312	SYMBOL|()|DICTIONARY|EXTRACTED	comt	COMT	84#88	19892319-1-54-82	A valine(158)methionine (val(158)met) polymorphism in catechol-O-methyltransferase (COMT) modulates cortical dopaminergic catabolism and has been associated with schizophrenia.
19892319	2010	Biol. Psychiatry	1873-2402	METHODS	2	4	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	160#164	19892319-1-54-82	Twenty-five medication-free patients (28 +/- 6 years; 19 male patients) and 47 healthy individuals (29 +/- 8 years; 33 male individuals) were genotyped for the COMT val(158)met polymorphism and underwent two 60-second radiolabeled water ([(15)O]H(2)O) regional cerebral blood flow (rCBF) positron emission tomography scans (10 mCi/scan) during rest.
19892319	2010	Biol. Psychiatry	1873-2402	METHODS	2	5	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	68#72	19892319-1-54-82	Data were analyzed with a random-effects general linear model using COMT genotype as a covariate.
19892319	2010	Biol. Psychiatry	1873-2402	CONCLUSIONS	4	7	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	134#138	19892319-1-54-82	In schizophrenia, brain structures important for executive and affective processing show activity that is differentially predicted by COMT allelic variation in an opposing manner even at rest, providing evidence for the salience of prefrontal dopaminergic tone in task-independent, basal-level neural activity.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	TITLE	0	0	7349	LONGTERM|DICTIONARY	urocortin	urocortin	35#44		Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	TITLE	0	0	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	72#101		Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	1	7349	LONGTERM|DICTIONARY	urocortin	urocortin	28#37		Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	1	7349	SYMBOL|EXTRACTED|()	ucn	Ucn	39#42	20237592-1-28-37	Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	1	7349	SYMBOL|EXTRACTED	ucn	Ucn	62#65	20237592-1-28-37	Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	91#120		Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|DICTIONARY|EXTRACTED	ace	ACE	122#125	20237592-1-91-120	Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	2	7349	SYMBOL|EXTRACTED	ucn	Ucn	100#103	20237592-1-28-37	Therefore, the present investigation was designed to explore the effect of long-term treatment with Ucn on somatic ACE (sACE) and other components of the renin-angiotensin system (RAS).
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	115#118	20237592-1-91-120	Therefore, the present investigation was designed to explore the effect of long-term treatment with Ucn on somatic ACE (sACE) and other components of the renin-angiotensin system (RAS).
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	7349	SYMBOL|EXTRACTED	ucn	Ucn	47#50	20237592-1-28-37	After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	183	LONGTERM|DICTIONARY	angiotensin ii	angiotensin II	116#130		After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_2/3	2	5	7349	SYMBOL|EXTRACTED	ucn	Ucn	35#38	20237592-1-28-37	Serum sACE activity was reduced by Ucn, although tissue sACE activity and tissue sACE mRNA were elevated.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_2/3	2	6	7349	SYMBOL|EXTRACTED	ucn	Ucn	48#51	20237592-1-28-37	Chymase activity was observed to be enhanced by Ucn, whereas the ACE inhibitor enalapril failed to influence chymase.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_2/3	2	6	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	65#68	20237592-1-91-120	Chymase activity was observed to be enhanced by Ucn, whereas the ACE inhibitor enalapril failed to influence chymase.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	8	7349	SYMBOL|EXTRACTED	ucn	Ucn	104#107	20237592-1-28-37	Meanwhile, a significant decrease of the systolic blood pressure (SBP) was observed after the long-term Ucn administration, and there was a significant positive correlation (r2 = 0.6993) between serum ACE activity and SBP.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	201#204	20237592-1-91-120	Meanwhile, a significant decrease of the systolic blood pressure (SBP) was observed after the long-term Ucn administration, and there was a significant positive correlation (r2 = 0.6993) between serum ACE activity and SBP.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	1392	LONGTERM|GENE|GT|DICTIONARY	corticotropin releasing factor	corticotropin-releasing factor	22#52		Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	1392	SYMBOL|()|DICTIONARY|EXTRACTED	crf	CRF	54#57	20237592-9-22-52	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	7349	SYMBOL|EXTRACTED	ucn	Ucn	187#190	20237592-1-28-37	Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	10	7349	SYMBOL|EXTRACTED	ucn	Ucn	168#171	20237592-1-28-37	Our findings further support the hypothesis that the changes of sACE activity and the production of other RAS components may play roles in the vasodilatory property of Ucn via the activation of the ERK1/2 pathway.
19875396	2010	Europace	1532-2092	ALL_TEXT_1/3	1	1	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	18#23		A patient with an SCN5A p.W822X nonsense mutation, localized in the transmembrane region DII-S4 of the Na(v)1.5 sodium channel and leading to a non-expression of the mutant allele, was prescribed the selective serotonin reuptake inhibitor (SSRI) fluvoxamine (Floxyfral), 100 mg per day.
19875396	2010	Europace	1532-2092	ALL_TEXT_3/3	3	5	6331	SYMBOL|DICTIONARY	scn5a	SCN5A	96#101		In our patient, no arrhythmia occurred but the proarrhythmic potential of SSRI in patients with SCN5A mutations cannot be excluded.
19773262	2010	Haematologica	1592-8721	TITLE	0	0	6125	SYMBOL|DICTIONARY	rpl5	RPL5	82#86		Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	TITLE	0	0	6135	SYMBOL|DICTIONARY	rpl11	RPL11	91#96		Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	4	6223	SYMBOL|GENE|GN|DICTIONARY	rps19	RPS19	15#20		Defects in the RPS19 gene, encoding the ribosomal protein S19, are the main known cause of Diamond-Blackfan anemia and account for more than 25% of cases.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	4	6223	LONGTERM|DICTIONARY	ribosomal protein s19	ribosomal protein S19	40#61		Defects in the RPS19 gene, encoding the ribosomal protein S19, are the main known cause of Diamond-Blackfan anemia and account for more than 25% of cases.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6229	SYMBOL|DICTIONARY	rps24	RPS24	13#18		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6218	SYMBOL|DICTIONARY	rps17	RPS17	20#25		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	5	6165	SYMBOL|DICTIONARY	rpl35a	RPL35A	31#37		Mutations in RPS24, RPS17, and RPL35A described in a minority of patients show that Diamond-Blackfan anemia is a disorder of ribosome biogenesis.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	6	6125	SYMBOL|DICTIONARY	rpl5	RPL5	15#19		Two new genes (RPL5, RPL11), encoding for ribosomal proteins of the large subunit, have been reported to be involved in a considerable percentage of patients.
19773262	2010	Haematologica	1592-8721	BACKGROUND	1	6	6135	SYMBOL|DICTIONARY	rpl11	RPL11	21#26		Two new genes (RPL5, RPL11), encoding for ribosomal proteins of the large subunit, have been reported to be involved in a considerable percentage of patients.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6208	SYMBOL|DICTIONARY	rps14	RPS14	98#103		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6217	SYMBOL|DICTIONARY	rps16	RPS16	105#110		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6229	SYMBOL|DICTIONARY	rps24	RPS24	112#117		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6125	SYMBOL|DICTIONARY	rpl5	RPL5	119#123		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6135	SYMBOL|DICTIONARY	rpl11	RPL11	125#130		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6165	SYMBOL|DICTIONARY	rpl35a	RPL35A	136#142		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	DESIGN AND METHODS	2	7	6223	SYMBOL|DICTIONARY	rps19	RPS19	217#222		In this genotype-phenotype analysis we screened the coding sequence and intron-exon boundaries of RPS14, RPS16, RPS24, RPL5, RPL11, and RPL35A in 92 Italian patients with Diamond-Blackfan anemia who were negative for RPS19 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	8	6125	SYMBOL|DICTIONARY	rpl5	RPL5	52#56		About 20% of the patients screened had mutations in RPL5 or RPL11, and only 1.6% in RPS24.
19773262	2010	Haematologica	1592-8721	RESULTS	3	8	6135	SYMBOL|DICTIONARY	rpl11	RPL11	60#65		About 20% of the patients screened had mutations in RPL5 or RPL11, and only 1.6% in RPS24.
19773262	2010	Haematologica	1592-8721	RESULTS	3	8	6229	SYMBOL|DICTIONARY	rps24	RPS24	84#89		About 20% of the patients screened had mutations in RPL5 or RPL11, and only 1.6% in RPS24.
19773262	2010	Haematologica	1592-8721	RESULTS	3	10	6208	SYMBOL|DICTIONARY	rps14	RPS14	27#32		No mutations were found in RPS14, RPS16, or RPL35A.
19773262	2010	Haematologica	1592-8721	RESULTS	3	10	6217	SYMBOL|DICTIONARY	rps16	RPS16	34#39		No mutations were found in RPS14, RPS16, or RPL35A.
19773262	2010	Haematologica	1592-8721	RESULTS	3	10	6165	SYMBOL|DICTIONARY	rpl35a	RPL35A	44#50		No mutations were found in RPS14, RPS16, or RPL35A.
19773262	2010	Haematologica	1592-8721	RESULTS	3	11	6125	SYMBOL|DICTIONARY	rpl5	RPL5	86#90		Remarkably, we observed a higher percentage of somatic malformations in patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	11	6135	SYMBOL|DICTIONARY	rpl11	RPL11	95#100		Remarkably, we observed a higher percentage of somatic malformations in patients with RPL5 and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6125	SYMBOL|DICTIONARY	rpl5	RPL5	40#44		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	RESULTS	3	12	6135	SYMBOL|DICTIONARY	rpl11	RPL11	122#127		A close association was evident between RPL5 mutations and craniofacial malformations, and between hand malformations and RPL11 mutations.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6125	SYMBOL|DICTIONARY	rpl5	RPL5	74#78		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
19773262	2010	Haematologica	1592-8721	CONCLUSIONS	4	14	6135	SYMBOL|DICTIONARY	rpl11	RPL11	83#88		Genotype-phenotype data suggest that mutation screening should begin with RPL5 and RPL11 in patients with Diamond-Blackfan anemia with malformations.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	0#4		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	TITLE	0	0	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	14#20		Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	39#45		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	9817	SYMBOL|DICTIONARY	keap1	KEAP1	50#55		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY	nrf2	Nrf2	103#107		We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	4	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	21#27		Genetic variation in NFE2L2 and KEAP1 was tagged by eight and three tag single nucleotide polymorphisms (SNPs), respectively.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	4	9817	SYMBOL|DICTIONARY	keap1	KEAP1	32#37		Genetic variation in NFE2L2 and KEAP1 was tagged by eight and three tag single nucleotide polymorphisms (SNPs), respectively.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	0#6		NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_2/3	2	6	9817	SYMBOL|DICTIONARY	keap1	KEAP1	11#16		NFE2L2 and KEAP1 were not associated with risk of AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	33#39		However, one haplotype allele of NFE2L2 was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular cataract (p(c)=0.019).
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	8	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	21#27		Another haplotype of NFE2L2 was associated with 4 years later age at surgery for cortical cataract (p(c)=0.009).
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	4780	SYMBOL|DICTIONARY	nfe2l2	NFE2L2	28#34		Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	9	9817	SYMBOL|DICTIONARY	keap1	KEAP1	38#43		Our findings do not support NFE2L2 or KEAP1 as susceptibility genes for AD or cataract.
20064547	2010	Mech. Ageing Dev.	1872-6216	ALL_TEXT_3/3	3	10	4780	SYMBOL|GENE|GN|DICTIONARY	nfe2l2	NFE2L2	32#38		However, common variants of the NFE2L2 gene may affect disease progression, potentially altering clinically recognized disease onset.
19996333	2010	Thorax	1468-3296	BACKGROUND	1	1	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	55#60		Inducible nitric oxide (NO) synthase (iNOS, encoded by NOS2A) produces NO in response to environmental stimuli, which can result in nitrosative stress.
19996333	2010	Thorax	1468-3296	BACKGROUND	1	2	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	92#97		Because nitrosative stress affects respiratory health, it was hypothesised that variants in NOS2A are associated with asthma incidence and lung function growth during adolescence.
19996333	2010	Thorax	1468-3296	METHODS	2	4	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	49#54		24 single nucleotide polymorphisms (SNPs) of the NOS2A region (with seven promoter SNPs in one haplotype block), spanning 20 kb upstream and 10 kb downstream were genotyped.
19996333	2010	Thorax	1468-3296	METHODS	2	5	4843	SYMBOL|DICTIONARY	nos2a	NOS2A	24#29		Association between the NOS2A region and asthma or lung function growth was tested using genetic block-specific principal component and haplotype analyses.
19996333	2010	Thorax	1468-3296	RESULT	3	9	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	100#105		"Furthermore, the increased asthma risk associated with h0111101 was restricted to children with the GSTM1 ""null"" genotype (interaction p=0.002, HR 1.89, 95% CI 1.34 to 2.60)."
19996333	2010	Thorax	1468-3296	CONCLUSION	4	10	4843	SYMBOL|GENE|GN|DICTIONARY	nos2a	NOS2A	25#30		Common haplotypes in the NOS2A promoter are associated with new-onset asthma and lung function growth.
19996333	2010	Thorax	1468-3296	CONCLUSION	4	11	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	51#56		"These effects are stronger in adolescents with the GSTM1 ""null"" genotype."
19388002	2010	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	1	775	SYMBOL|()|GENE|GN|DICTIONARY	cacna1c	CACNA1C	74#81		Variations in voltage-dependent calcium channel L-type, alpha 1C subunit (CACNA1C) gene have been associated with bipolar disorder in a recent meta-analysis of genome-wide association studies [Ferreira et al., 2008].
19388002	2010	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_1/3	1	3	775	SYMBOL|GENE|GN|DICTIONARY	cacna1c	CACNA1C	217#224		Caucasian non-Hispanic participants in the STAR*D study of treatment for depression for whom DNA was available (N = 1213) were genotyped at two single-nucleotide polymorphisms (SNPs) (rs10848635 and rs1006737) in the CACNA1C gene.
20208132	2010	Cell. Oncol.	1875-8606	TITLE	0	0	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	37#46		PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	1	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	18#27		The importance of caspase-2 activation for mediating apoptosis in cancer is not clear and seems to differ between different tumour types.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	75#84		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	55367	SYMBOL|DICTIONARY	pidd	PIDD	185#189		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	2	8738	SYMBOL|DICTIONARY	raidd	RAIDD	194#199		Furthermore, only few data have been obtained concerning the expression of caspase-2, which can be alternatively spliced into caspase-2L and caspase-2S, and the other PIDDosome members PIDD and RAIDD in human tumours in vivo.
20208132	2010	Cell. Oncol.	1875-8606	BACKGROUND	1	3	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	133#142		We, therefore, investigated their expression in renal cell carcinomas (RCCs) of the clear cell type in vivo and analysed the role of caspase-2 in chemotherapy-induced apoptosis in RCCs in vitro.
20208132	2010	Cell. Oncol.	1875-8606	METHODS	2	4	835	LONGTERM|DICTIONARY	caspase 2	Caspase-2	80#89		The analyses were performed by semiquantitative real-time PCR, Western Blot and Caspase-2 Assay.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	5	835	LONGTERM|GFAM|FN|DICTIONARY	caspase 2	caspase-2	180#189		Our in vivo results showed an overall decrease in proapoptotic caspase-2L expression during tumour progression due to an increase in the relative share of caspase-2S mRNA in total caspase-2 mRNA expression.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	6	55367	SYMBOL|DICTIONARY	pidd	PIDD	46#50		Furthermore, an increase in the expression of PIDD and RAIDD could be observed.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	6	8738	SYMBOL|DICTIONARY	raidd	RAIDD	55#60		Furthermore, an increase in the expression of PIDD and RAIDD could be observed.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	7	596	SYMBOL|DICTIONARY	bcl 2	BCL-2	27#32		In contrast, antiapoptotic BCL-2 expression increased only during early tumour stages, whereas expression decreased in pT3 RCCs.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	8	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	10#19		In vitro, caspase-2 activation in RCC cell lines coincidenced with sensitivity of tumour cells towards Topotecan-induced apoptosis.
20208132	2010	Cell. Oncol.	1875-8606	RESULTS	3	9	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	23#32		However, inhibition of caspase-2 could not prevent Topotecan-induced apoptosis.
20208132	2010	Cell. Oncol.	1875-8606	CONCLUSION	4	12	835	LONGTERM|DICTIONARY	caspase 2	caspase-2	27#36		Furthermore, it shows that caspase-2 participates in chemotherapy-induced apoptosis in RCCs although it is not mandatory for it.
20208132	2010	Cell. Oncol.	1875-8606	CONCLUSION	4	13	596	SYMBOL|GFAM|FN|DICTIONARY	bcl 2	BCL-2	42#47		Additionally, inhibition of antiapoptotic BCL-2 family members might provide a possible way to overcome chemotherapy resistance of RCCs.
19892845	2010	Clin. Chem.	1530-8561	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	77#82		Alternative splicing and molecular characterization of splice site variants: BRCA1 c.591C>T as a case study.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	25#30		Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
19892845	2010	Clin. Chem.	1530-8561	METHODS	2	4	672	SYMBOL|DICTIONARY	brca1	BRCA1	65#70		Denaturing gradient gel electrophoresis was used to genotype the BRCA1 c.591C>T variant in 685 index cases of B(O)C families, 326 sporadic breast cancer cases, and 450 healthy controls from Spain.
19892845	2010	Clin. Chem.	1530-8561	METHODS	2	6	672	SYMBOL|DICTIONARY	brca1	BRCA1	141#146		In vitro splicing analysis was performed in 7 c.591C>T carriers and 10 noncarriers. cDNAs were PCR-amplified with primers designed to detect BRCA1 alternative splicing isoforms.
19892845	2010	Clin. Chem.	1530-8561	RESULTS	3	10	672	SYMBOL|DICTIONARY	brca1	BRCA1	114#119		c.591C>T was detected in B(O)C families (1.5%), breast cancer cases (0.3%), and controls (0.9%). c.591C>T induced BRCA1 exon 9 skipping and modified the relative expression of Delta(9,10), Delta(9,10,11B), Delta11B, and full-length isoforms.
19892845	2010	Clin. Chem.	1530-8561	CONCLUSIONS	4	14	672	SYMBOL|DICTIONARY	brca1	BRCA1	46#51		Our data support a nonpathogenic role for the BRCA1 c.591C>T variant.
19892845	2010	Clin. Chem.	1530-8561	CONCLUSIONS	4	15	672	SYMBOL|DICTIONARY	brca1	BRCA1	99#104		Naturally occurring alternative splicing isoforms need to be considered when assessing the role of BRCA1 UVs on splicing.
19891592	2010	DNA Cell Biol.	1557-7430	TITLE	0	0	4627	SYMBOL|DICTIONARY	myh9	MYH9	35#39		Association among polymorphisms at MYH9, environmental factors, and nonsyndromic orofacial clefts in western China.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	4627	SYMBOL|()|DICTIONARY	myh9	MYH9	33#37		Myosin heavy chain 9, nonmuscle (MYH9) and environmental factors have been shown to be associated with nonsyndromic cleft lip with or without cleft palate in several populations.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	2	4627	SYMBOL|DICTIONARY	myh9	MYH9	47#51		Our study aimed to confirm the contribution of MYH9 and environmental factors to nonsyndromic orofacial cleft risk in western Han Chinese.
19891592	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_3/3	3	7	4627	SYMBOL|DICTIONARY	myh9	MYH9	99#103		Risk factors identified in our study may provide a better understanding of the etiological role of MYH9 and influence of environmental factors in nonsyndromic orofacial cleft incidence.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	TITLE	0	0	3596	LONGTERM|DICTIONARY	interleukin 13	Interleukin 13	0#14		Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	3566	SYMBOL|DICTIONARY	il4r	IL4R	9#13		IL13 and IL4R polymorphisms are associated with asthma and show gene-gene interaction in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3596	SYMBOL|DICTIONARY	il13	IL13	15#19		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	METHODS	2	5	3566	SYMBOL|DICTIONARY	il4r	IL4R	24#28		Association of IL13 and IL4R polymorphisms in relation to rhinitis, asthma, serum IgE and skin test response was studied in: (1) 188 trios ascertained through a proband with rhinitis who were clinically not affected by asthma; (2) 407 trios with an asthmatic proband, and (3) 118 asthma cases and 102 unrelated healthy controls using family-based association testing, logistic regression, and analysis of variance as appropriate.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	7	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		IL13 C-1111T (rs1800925) was significantly associated with rhinitis and atopic phenotypes in rhinitis trios that were not affected by clinical asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	8	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		IL13 Arg130Gln (rs20541) and G870A (rs1295685) were consistently associated with asthma and serum IgE in both asthma populations.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	9	3566	SYMBOL|DICTIONARY	il4r	IL4R	0#4		IL4R Glu375Ala (rs1805011) and Ser411Leu (rs1805013) were associated with asthma in the asthma case-control population.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3596	SYMBOL|DICTIONARY	il13	IL13	28#32		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3566	SYMBOL|DICTIONARY	il4r	IL4R	48#52		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3596	SYMBOL|DICTIONARY	il13	IL13	68#72		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	RESULTS	3	10	3566	SYMBOL|DICTIONARY	il4r	IL4R	86#90		Combining risk genotypes of IL13 Arg130Gln with IL4R Glu375Ala, and IL13 C-1111T with IL4R Ser478Pro yielded increased risks for asthma compared to their separate effects.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	11	3596	SYMBOL|DICTIONARY	il13	IL13	0#4		IL13 polymorphisms were associated with asthma and rhinitis without clinical asthma; thus, these polymorphisms may constitute a common etiologic pathway for their development.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	12	3596	SYMBOL|DICTIONARY	il13	IL13	71#75		In addition, the study replicates a previously reported interaction of IL13 and IL4R polymorphisms in asthma.
20484924	2010	Int. Arch. Allergy Immunol.	1423-0097	CONCLUSION	4	12	3566	SYMBOL|DICTIONARY	il4r	IL4R	80#84		In addition, the study replicates a previously reported interaction of IL13 and IL4R polymorphisms in asthma.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	TITLE	0	0	4060	LONGTERM|GENE|GN|DICTIONARY	lumican	lumican	19#26		Association of the lumican gene functional 3'-UTR polymorphism with high myopia.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	4060	LONGTERM|GENE|GN|DICTIONARY	lumican	lumican	4#11		The lumican gene (LUM) encodes a major extracellular component of the fibrous mammalian sclera.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	3	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	46#49	19643966-1-4-11	Single-nucleotide polymorphisms (SNPs) in the LUM gene were determined in an investigation of whether LUM gene polymorphisms correlate with high myopia.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	3	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	102#105	19643966-1-4-11	Single-nucleotide polymorphisms (SNPs) in the LUM gene were determined in an investigation of whether LUM gene polymorphisms correlate with high myopia.
19643966	2010	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	11	4060	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lum	LUM	32#35	19643966-1-4-11	These observations suggest that LUM gene polymorphisms contribute to the development of high myopia.
20198856	2010	Mol. Biol. (Mosk.)	0026-8984	ALL_TEXT_1/3	1	1	5428	SYMBOL|()|DICTIONARY	polg1	POLG1	121#126		"Study is devoted to ""genes for mitochondria""--genes of mitochondrial genome and mitochondrial DNA polymerase gamma gene (POLG1)."
20198856	2010	Mol. Biol. (Mosk.)	0026-8984	ALL_TEXT_1/3	1	2	5428	SYMBOL|DICTIONARY	polg1	POLG1	69#74		We compared frequencies of polymorphisms in mitochondrial DNA and in POLG1 between healthy individuals and patients with arterial hypertension, as well as between patients with and without left ventricular hypertrophy.
20198856	2010	Mol. Biol. (Mosk.)	0026-8984	ALL_TEXT_2/3	2	3	5428	SYMBOL|DICTIONARY	polg1	POLG1	96#101		We did not discover significant differences of distribution of C allele of MspI-polymorphism in POLG1 in studied group.
19774492	2010	Mol. Biol. Rep.	1573-4978	TITLE	0	0	7128	SYMBOL|GENE|GN|DICTIONARY	tnfaip3	TNFAIP3	40#47		A single-nucleotide polymorphism of the TNFAIP3 gene is associated with systemic lupus erythematosus in Chinese Han population.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_2/3	2	3	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	140#147		Recently, several genome-wide association studies (GWA) in European population have found many novel susceptibility genes for SLE including TNFAIP3.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_2/3	2	4	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	28#35		In order to examine whether TNFAIP3 is associated with SLE in Chinese Han population, we genotyped one of its non-synonymous mutation SNP rs2230926, showing significant association evidence with SLE in European population, with 1,420 cases and 4,461 controls of Chinese Han by using Sequenom MassArray system.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_3/3	3	6	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	28#35		Interestingly, rs2230926 of TNFAIP3 was also associated with arthritis, ANA and some other subphenotypes of the disease.
19774492	2010	Mol. Biol. Rep.	1573-4978	ALL_TEXT_3/3	3	7	7128	SYMBOL|DICTIONARY	tnfaip3	TNFAIP3	47#54		Our findings suggest that SNP rs2230926 in the TNFAIP3 might be a common genetic factor for SLE within different populations in terms of Chinese Han and European population.
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	65#81		Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
20389122	2010	Neuroepidemiology	1423-0208	BACKGROUND	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	83#87	20389122-2-65-81	Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD).
20389122	2010	Neuroepidemiology	1423-0208	RESULTS	3	9	348	SYMBOL|DICTIONARY	apoe4	APOE4	100#105		A lower initial MMSE score was associated with higher mortality for probable AD, PD, and MCI, while APOE4 predicted mortality for PD and LBD.
20389122	2010	Neuroepidemiology	1423-0208	CONCLUSIONS	4	12	348	SYMBOL|DICTIONARY	apoe4	APOE4	23#28		A lower MMSE score and APOE4 presence predicted higher mortality for some patient groups.
19800393	2010	Neurosci. Lett.	1872-7972	TITLE	0	0	120892	SYMBOL|DICTIONARY	lrrk2	LRRK2	72#77		Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patients.
19800393	2010	Neurosci. Lett.	1872-7972	ALL_TEXT_1/3	1	1	120892	SYMBOL|DICTIONARY	lrrk2	LRRK2	49#54		The results of mutation screening of 24 exons of LRRK2 in 60 Iranian Parkinson's Disease patients are presented.
20020061	2010	PLoS ONE	1932-6203	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal Growth Factor Receptor	78#110		KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	2	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		KRAS mutations were retrospectively studied using polymerase chain reactions and subsequent sequencing of codons 12 and 13 (exon 2) in 110 patients with metastatic colorectal tumors.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	3845	SYMBOL|DICTIONARY	kras	KRAS	13#17		Mutations in KRAS were observed in 37 (34%) of primary tumors and in 40 (36%) of related metastases, yielding a 94% level of concordance (kappa index 0.86).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	3845	SYMBOL|DICTIONARY	kras	KRAS	40#44		Patients with primary tumors possessing KRAS mutations had a shorter disease-free survival period after metastasis resection (12.0 vs 18.0 months; P = 0.035) than those who did not.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	3845	SYMBOL|DICTIONARY	kras	KRAS	23#27		A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054).
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	8	3845	SYMBOL|DICTIONARY	kras	KRAS	170#174		To further evaluate this finding we analyzed 120 additional patients with unresectable metastatic colorectal cancer who previously had their primary tumors evaluated for KRAS mutational status for clinical purposes.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	9	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		Separately, the analysis of these 120 patients showed a tendency towards a higher degree of KRAS mutations in primary tumors of patients with lung metastases, although it did not reach statistical significance.
20020061	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	10	3845	SYMBOL|DICTIONARY	kras	KRAS	53#57		Taken together the group of 230 patients showed that KRAS was mutated significantly more often in the primary tumors of patients with lung metastases (57% vs 35%; P = 0.006).
20020061	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	11	3845	SYMBOL|DICTIONARY	kras	KRAS	31#35		Our results suggest a role for KRAS mutations in the propensity of primary colorectal tumors to metastasize to the lung.
19687159	2010	Eur. Heart J.	1522-9645	TITLE	0	0	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	Interleukin 18	0#14		Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
19687159	2010	Eur. Heart J.	1522-9645	AIMS	1	1	3606	LONGTERM|DICTIONARY|GENE|GA	interleukin 18	interleukin 18	4#18		The interleukin 18 (IL-18) gene has a single nucleotide promoter region (-137) G-to-C polymorphism (rs187238) which leads to attenuated transcriptional activity of the gene and to lower production of pro-atherogenic IL-18.
19687159	2010	Eur. Heart J.	1522-9645	AIMS	1	1	3606	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	20#25	19687159-1-4-18	The interleukin 18 (IL-18) gene has a single nucleotide promoter region (-137) G-to-C polymorphism (rs187238) which leads to attenuated transcriptional activity of the gene and to lower production of pro-atherogenic IL-18.
19687159	2010	Eur. Heart J.	1522-9645	AIMS	1	1	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	216#221	19687159-1-4-18	The interleukin 18 (IL-18) gene has a single nucleotide promoter region (-137) G-to-C polymorphism (rs187238) which leads to attenuated transcriptional activity of the gene and to lower production of pro-atherogenic IL-18.
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	5	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	96#101	19687159-1-4-18	According to adjusted logistic regression analysis, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of SCD due to coronary heart disease (CHD) (P = 0.011) and the severity of autopsy-verified CAD (P = 0.026).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	149#154	19687159-1-4-18	According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3606	SYMBOL|DICTIONARY|EXTRACTED	il 18	IL-18	192#197	19687159-1-4-18	According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	METHODS AND RESULTS	2	8	3458	LONGTERM|GFAM|FN|DICTIONARY	interferon gamma	interferon-gamma	219#235		According to gene expression analysis of atherosclerotic tissue samples obtained from live patients, hypertension also interacted significantly with IL-18 genotype affecting the expression of IL-18 (P = 0.030) mRNA and interferon-gamma mRNA (P = 0.004).
19687159	2010	Eur. Heart J.	1522-9645	CONCLUSION	3	9	3606	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 18	IL-18	28#33	19687159-1-4-18	Hypertension interacts with IL-18 gene promoter -137 G/C polymorphism, affecting the risk of SCD and the development of coronary atherosclerosis.
19902201	2010	Immunogenetics	1432-1211	TITLE	0	0	7128	SYMBOL|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	15#22		Association of TNFAIP3 polymorphism with rheumatic heart disease in Chinese Han population.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	LONGTERM|DICTIONARY|GENE|GA	tumor necrosis factor alpha induced protein 3	tumor necrosis factor-alpha-induced protein 3	131#176		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7128	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	178#185	19902201-1-131-176	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	SYMBOL|()|GENE|GN|DICTIONARY	traf1	TRAF1	245#250		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	727	SYMBOL|EXTRACTED|()|GENE|GN	c5	C5	282#284	19902201-1-258-280	In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	727	SYMBOL|EXTRACTED|GENE|GN	c5	C5	103#105	19902201-1-258-280	We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	135#142	19902201-1-131-176	We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	2	7185	SYMBOL|GENE|GN|DICTIONARY	traf1	TRAF1	173#178		We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_2/3	2	3	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	75#82	19902201-1-131-176	However, we determined that the tSNP, rs582757, located at intron_5 of the TNFAIP3 gene, associated with RHD in Chinese Han population.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_3/3	3	7	7128	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnfaip3	TNFAIP3	61#68	19902201-1-131-176	Therefore, we report a new genetic variant (rs582757) in the TNFAIP3 gene that associated with the prevalence of RHD in Chinese Han population.
19539307	2010	J Psychiatr Res	1879-1379	TITLE	0	0	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	109#115		A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	4	55300	LONGTERM|DICTIONARY	phosphatidylinositol 4 kinase type ii beta	phosphatidylinositol 4-kinase type-II beta	19#61		The candidate gene phosphatidylinositol 4-kinase type-II beta (PI4K2B) lies within one of these regions.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	4	55300	SYMBOL|()|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	63#69	19539307-4-19-61	The candidate gene phosphatidylinositol 4-kinase type-II beta (PI4K2B) lies within one of these regions.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	5	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	0#6		PI4K2B is a strong functional candidate as it is a member of the phosphatidylinositol pathway, which is targeted by lithium for therapeutic effect in bipolar disorder.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_2/3	2	6	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	43#49	19539307-4-19-61	Two approaches were undertaken to test the PI4K2B candidate gene as a susceptibility factor for psychiatric illness.
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	7	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	69#75	19539307-4-19-61	First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P=0.005, permuted global P=0.039).
19539307	2010	J Psychiatr Res	1879-1379	ALL_TEXT_3/3	3	9	55300	SYMBOL|DICTIONARY|EXTRACTED	pi4k2b	PI4K2B	37#43	19539307-4-19-61	There is no evidence to suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has not been excluded.
19952026	2010	Radiology	1527-1315	PURPOSE	1	1	1080	LONGTERM|DICTIONARY	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	54#105		To evaluate the hierarchical phenotypic expression of cystic fibrosis transmembrane conductance regulator (CFTR) genotypes in the respiratory system as has been documented in the pancreas.
19952026	2010	Radiology	1527-1315	PURPOSE	1	1	1080	SYMBOL|()|DICTIONARY|EXTRACTED	cftr	CFTR	107#111	19952026-1-54-105	To evaluate the hierarchical phenotypic expression of cystic fibrosis transmembrane conductance regulator (CFTR) genotypes in the respiratory system as has been documented in the pancreas.
19952026	2010	Radiology	1527-1315	MATERIALS AND METHODS	2	5	1080	SYMBOL|DICTIONARY|EXTRACTED	cftr	CFTR	9#13	19952026-1-54-105	By using CFTR class of mutations, two groups were created: group S (severe disease) and group M (mild disease).
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3663	SYMBOL|DICTIONARY	irf5	IRF5	44#48		[Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	50#55		[Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3663	SYMBOL|DICTIONARY	irf5	IRF5	59#63		To investigate two single nucleotide polymorphism sites of IRF5 and TLR-9 and to detect their relationship with SLE (systemic lupus erythematosus) in a Han population from Shandong province.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	68#73		To investigate two single nucleotide polymorphism sites of IRF5 and TLR-9 and to detect their relationship with SLE (systemic lupus erythematosus) in a Han population from Shandong province.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	3663	SYMBOL|DICTIONARY	irf 5	IRF-5	54#59		The polymorphisms of rs2004640 G/T, rs10954213 G/A in IRF-5 and rs187084C/T, rs352139A/G in TLR-9 were detected with PCR-RFLP in 92 cases of SLE and 88 healthy controls.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	2	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	92#97		The polymorphisms of rs2004640 G/T, rs10954213 G/A in IRF-5 and rs187084C/T, rs352139A/G in TLR-9 were detected with PCR-RFLP in 92 cases of SLE and 88 healthy controls.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	10	3663	SYMBOL|DICTIONARY	irf5	IRF5	48#52		The polymorphism of rs2004640 and rs10954213 in IRF5 may be associated with SLE in the population of Han nationality from Shandong province.
20137629	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	11	54106	SYMBOL|DICTIONARY	tlr 9	TLR-9	54#59		However, the polymorphism of rs187084 and rs352139 in TLR-9 is not associated with SLE.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|()|DICTIONARY|EXTRACTED	cfhr3	CFHR3	110#115	19553609-1-79-108	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|()|DICTIONARY	cfhr1	CFHR1	124#129		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	196#201	19553609-1-79-108	To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	PURPOSE	1	1	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	206#211		To develop an assay for determining the number of copies of the genes encoding complement factor H related 3 (CFHR3) and 1 (CFHR1) and determine the contribution of copy number variation (CNV) at CFHR3 and CFHR1 to the development of age-related macular degeneration (AMD).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	METHODS	2	2	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	114#119	19553609-1-79-108	A multiplex ligation-dependent probe amplification (MLPA) assay was developed to quantify the number of copies of CFHR3 and CFHR1 in humans.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	METHODS	2	2	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	124#129		A multiplex ligation-dependent probe amplification (MLPA) assay was developed to quantify the number of copies of CFHR3 and CFHR1 in humans.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	4	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	73#78	19553609-1-79-108	The MLPA assay provided a consistent estimate of the number of copies of CFHR3 and CFHR1 in 500 of the 501 samples.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	4	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	83#88		The MLPA assay provided a consistent estimate of the number of copies of CFHR3 and CFHR1 in 500 of the 501 samples.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	5	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	84#89	19553609-1-79-108	Four different combinations of CNVs were observed with frequencies as follows: both CFHR3 and CFHR1 deletion (14%), CFHR3-only deletion (0.4%), CFHR1-only deletion (1.1%), and CFHR1 duplication (0.1%).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	5	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	94#99		Four different combinations of CNVs were observed with frequencies as follows: both CFHR3 and CFHR1 deletion (14%), CFHR3-only deletion (0.4%), CFHR1-only deletion (1.1%), and CFHR1 duplication (0.1%).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	5	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	116#121	19553609-1-79-108	Four different combinations of CNVs were observed with frequencies as follows: both CFHR3 and CFHR1 deletion (14%), CFHR3-only deletion (0.4%), CFHR1-only deletion (1.1%), and CFHR1 duplication (0.1%).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	5	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	144#149		Four different combinations of CNVs were observed with frequencies as follows: both CFHR3 and CFHR1 deletion (14%), CFHR3-only deletion (0.4%), CFHR1-only deletion (1.1%), and CFHR1 duplication (0.1%).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	5	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	176#181		Four different combinations of CNVs were observed with frequencies as follows: both CFHR3 and CFHR1 deletion (14%), CFHR3-only deletion (0.4%), CFHR1-only deletion (1.1%), and CFHR1 duplication (0.1%).
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	27#32	19553609-1-79-108	Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	37#42		Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	6	3075	SYMBOL|DICTIONARY	cfh	CFH	210#213		Deletion of both copies of CFHR3 and CFHR1 decreased the odds of having AMD eightfold (95% CI 2-36) and always occurred on a protective haplotype, never on the risk haplotype tagged by the Y402H risk allele in CFH.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	7	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	40#45	19553609-1-79-108	The protection conferred by deletion of CFHR3 and CFHR1 could not be distinguished from the absence of the risk haplotype.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	RESULTS	3	7	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	50#55		The protection conferred by deletion of CFHR3 and CFHR1 could not be distinguished from the absence of the risk haplotype.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	9	10878	SYMBOL|DICTIONARY|EXTRACTED	cfhr3	CFHR3	12#17	19553609-1-79-108	Deletion of CFHR3 and CFHR1 protected against the development of AMD at least in part because the deletion tagged a protective haplotype and did not occur on the risk haplotype.
19553609	2009	Invest. Ophthalmol. Vis. Sci.	1552-5783	CONCLUSIONS	4	9	3078	SYMBOL|DICTIONARY	cfhr1	CFHR1	22#27		Deletion of CFHR3 and CFHR1 protected against the development of AMD at least in part because the deletion tagged a protective haplotype and did not occur on the risk haplotype.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	17#22		Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	24#29		Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	83990	SYMBOL|()|DICTIONARY|EXTRACTED	brip1	BRIP1	49#54	19484476-1-0-47	BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	59348	LONGTERM|DICTIONARY	zinc finger protein 350	zinc finger protein 350	60#83		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	59348	SYMBOL|()|DICTIONARY|EXTRACTED	znf350	ZNF350	85#91	19484476-1-60-83	BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	103#108		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	METHODS	2	3	83990	SYMBOL|DICTIONARY|EXTRACTED	brip1	BRIP1	101#106	19484476-1-0-47	We focused on potentially functional single nucleotide polymorphisms (SNPs) in the coding regions of BRIP1, ZNF350 and BRCA1 and pairwise-tagging approach was used to minimize the number of SNPs.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	METHODS	2	3	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	108#114	19484476-1-60-83	We focused on potentially functional single nucleotide polymorphisms (SNPs) in the coding regions of BRIP1, ZNF350 and BRCA1 and pairwise-tagging approach was used to minimize the number of SNPs.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	METHODS	2	3	672	SYMBOL|DICTIONARY	brca1	BRCA1	119#124		We focused on potentially functional single nucleotide polymorphisms (SNPs) in the coding regions of BRIP1, ZNF350 and BRCA1 and pairwise-tagging approach was used to minimize the number of SNPs.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	5	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	41#47	19484476-1-60-83	All of the five SNPs except rs2278415 of ZNF350 conferred a modestly increased risk, although, with no statistical significance.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	66#72	19484476-1-60-83	Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	672	SYMBOL|DICTIONARY	brca1	BRCA1	176#181		Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	RESULTS	3	6	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	209#215	19484476-1-60-83	Joint effect analyses indicated that all the variant genotypes of ZNF350 polymorphisms accounted for increased breast cancer risk among subjects carrying variant homozygote of BRCA1 rs799917, particularly for ZNF350 rs4986773 (OR = 2.03, 95%CI = 1.02-4.05, the test for gene-gene interaction P (int) = 0.059).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	CONCLUSION	4	7	59348	SYMBOL|DICTIONARY|EXTRACTED	znf350	ZNF350	10#16	19484476-1-60-83	BRCA1 and ZNF350 may jointly contribute to individuals' susceptibility of breast cancer in Chinese women.
19423162	2009	Leuk. Res.	1873-5835	TITLE	0	0	4193	SYMBOL|DICTIONARY	mdm2	MDM2	8#12		Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
19423162	2009	Leuk. Res.	1873-5835	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	53#56		Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	4193	SYMBOL|GENE|GN|DICTIONARY	mdm2	MDM2	58#62		A single nucleotide polymorphism (SNP) in the promoter of MDM2 gene, SNP309 T>G (a T-G exchange at nucleotide 309 in the first intron), can increase the expression level of MDM2, thereby causing an impairment of p53 tumor suppressor activity.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	4193	SYMBOL|DICTIONARY	mdm2	MDM2	173#177		A single nucleotide polymorphism (SNP) in the promoter of MDM2 gene, SNP309 T>G (a T-G exchange at nucleotide 309 in the first intron), can increase the expression level of MDM2, thereby causing an impairment of p53 tumor suppressor activity.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	p53	p53	18#21		A G-C exchange at p53 codon 72 polymorphism results in a substitution of proline (Pro) for arginine (Arg) in the transactivation domain, which was shown to alter the primary structure of the p53 protein.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	2	7157	SYMBOL|GENE|GN|DICTIONARY	p53	p53	191#194		A G-C exchange at p53 codon 72 polymorphism results in a substitution of proline (Pro) for arginine (Arg) in the transactivation domain, which was shown to alter the primary structure of the p53 protein.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	4193	SYMBOL|DICTIONARY	mdm2	MDM2	28#32		To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	p53	p53	44#47		To investigate whether that MDM2 SNP309 and p53 codon 72 polymorphism should be at least partially responsible for genetic susceptibility to acute myeloid leukemia (AML), both polymorphisms were determined in a case-control study consisting of 231 AML patients and 128 normal individuals.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	5	4193	SYMBOL|DICTIONARY	mdm2	MDM2	4#8		The MDM2 SNP309G allele was associated with increased risk of AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	6	7157	SYMBOL|DICTIONARY	p53	p53	17#20		Furthermore, the p53 codon 72 and MDM2 SNP309 polymorphisms did not associate with age of onset and any other clinical parameters studied.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	6	4193	SYMBOL|DICTIONARY	mdm2	MDM2	34#38		Furthermore, the p53 codon 72 and MDM2 SNP309 polymorphisms did not associate with age of onset and any other clinical parameters studied.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	p53	p53	9#12		When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	4193	SYMBOL|DICTIONARY	mdm2	MDM2	17#21		When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	4193	SYMBOL|DICTIONARY	mdm2	MDM2	94#98		When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	p53	p53	106#109		When the p53 and MDM2 polymorphisms were combined, no multiplicative joint effect between the MDM2 GG and p53 Pro/Pro genotypes exists in the risk of developing AML.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	8	4193	SYMBOL|DICTIONARY	mdm2	MDM2	31#35		These results suggest that the MDM2 SNP309 homozygous GG genotype may be a genetic susceptibility factor in the pathogenesis of AML.
19406470	2009	Leuk. Res.	1873-5835	TITLE	0	0	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	24#27		Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin 6	20#33		The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il6	IL6	35#38	19406470-1-20-33	The serum levels of interleukin 6 (IL6) are known to be elevated in two diseases of the elderly age, myelodysplastic syndrome (MDS) and multiple myeloma (MM).
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY|EXTRACTED	il6	IL6	197#200	19406470-1-20-33	Authors suppose that one of the possible causes of this elevation could be a difference between these patients and healthy subjects in the frequency of polymorphic variants of the genes regulating IL6 levels.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	116#119	19406470-1-20-33	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	3	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	133#136	19406470-1-20-33	Scarce and contradictory comparative data are available for MM and to our best knowledge this is the first study on IL6 promoter and IL6 receptor (IL6R) polymorphism in MDS.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	58#61	19406470-1-20-33	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_2/3	2	4	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	122#125	19406470-1-20-33	Therefore we determined the Asp358Ala polymorphism of the IL6 receptor gene and the -174 G>C promoter polymorphism of the IL6 gene in blood samples of 102 MDS and 100 MM patients and 99 age- and sex-matched hospitalized controls had been tested for this purpose as well.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	5	3569	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il6	IL6	96#99	19406470-1-20-33	There was no significant difference between patients with either disease and controls regarding IL6 promoter/L-6R.
19406470	2009	Leuk. Res.	1873-5835	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY|EXTRACTED	il6	IL6	55#58	19406470-1-20-33	Authors therefore assume other mechanisms causing high IL6 levels are not related to either of these polymorphisms.
19846968	2009	Anticancer Res.	1791-7530	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	20#25		Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.
19846968	2009	Anticancer Res.	1791-7530	BACKGROUND	1	2	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	37#42		Because of the important role of the XRCC1 gene in DNA repair, we wanted to test the effects of the Arg194Trp and Arg399Gln polymorphisms of XRCC1 on the clinical outcome of head and neck cancer.
19846968	2009	Anticancer Res.	1791-7530	BACKGROUND	1	2	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	141#146		Because of the important role of the XRCC1 gene in DNA repair, we wanted to test the effects of the Arg194Trp and Arg399Gln polymorphisms of XRCC1 on the clinical outcome of head and neck cancer.
19846968	2009	Anticancer Res.	1791-7530	RESULTS	3	7	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	71#76		A significant difference was found between the patients with different XRCC1 194 polymorph status in clinical stage SIII.
19648156	2009	Br J Anaesth	1471-6771	TITLE	0	0	6261	SYMBOL|DICTIONARY	ryr1	RYR1	21#25		Genetic variation in RYR1 and malignant hyperthermia phenotypes.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	SYMBOL|DICTIONARY	ryr1	RYR1	87#91		Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	1	6261	LONGTERM|GENE|GT|DICTIONARY	skeletal muscle ryanodine receptor	skeletal muscle ryanodine receptor	115#149		Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor.
19648156	2009	Br J Anaesth	1471-6771	BACKGROUND	1	2	6261	SYMBOL|DICTIONARY	ryr1	RYR1	48#52		Our primary aim was to assess whether different RYR1 variants are associated with quantitative differences in MH phenotype.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	37#41		We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	137#141		We then undertook the most extensive RYR1 genotype-phenotype correlation in MH to date using 504 individuals from 204 MH families and 23 RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	METHODS	2	5	6261	SYMBOL|DICTIONARY	ryr1	RYR1	102#106		We also determined the association between a clinical phenotype and both the laboratory phenotype and RYR1 genotype.
19648156	2009	Br J Anaesth	1471-6771	RESULTS	3	8	6261	SYMBOL|DICTIONARY	ryr1	RYR1	13#17		The specific RYR1 variant was a significant determinant of the severity of each laboratory phenotype (P<0.0001).
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	9	6261	SYMBOL|DICTIONARY	ryr1	RYR1	54#58		The MH phenotype differs significantly with different RYR1 variants.
19648156	2009	Br J Anaesth	1471-6771	CONCLUSIONS	4	11	6261	SYMBOL|DICTIONARY	ryr1	RYR1	42#46		Differences in phenotype severity between RYR1 variants may explain the variability in clinical penetrance of MH during anaesthesia and why some variants have been associated with exercise-induced rhabdomyolysis and heat stroke.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	TITLE	0	0	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	2	2312	SYMBOL|()|DICTIONARY|EXTRACTED	flg	FLG	11#14	19408338-2-0-9	Filaggrin (FLG) loss-of-function variants (null-alleles) are associated with eczema and asthma in association with eczema.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	BACKGROUND	1	3	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	42#45	19408338-2-0-9	The aim was to assess the contribution of FLG null-alleles to pediatric IBD susceptibility and to coexistent atopy (eczema, asthma, allergic rhinitis, or food allergy).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	METHODS	2	4	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	0#3		FLG variants (R501X and 2282del4) were genotyped in 403 children with IBD, 683 parents, and 996 population controls.
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	5	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	47#50	19408338-2-0-9	In all, 11% of IBD patients carried at least 1 FLG null-allele compared to 11% of population controls (P > 0.4).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	7	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	14#17	19408338-2-0-9	The effect of FLG null-alleles was strongest for eczema (19% versus 7%, P = 0.0003; OR 3.3, 95% CI 1.7-6.6) and food allergy (28% versus 8%, P = 0.0001; OR 4.5, 95% CI 2.0-10.0).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	RESULTS	3	9	2312	SYMBOL|DICTIONARY|EXTRACTED	flg	FLG	86#89	19408338-2-0-9	Logistic regression analysis of IBD cases confirmed the association of carriage of an FLG null-allele with atopy (P = 0.01; OR 2.4, 95% CI 1.2-5.1) and co-occurrence of different forms of atopy (P = 0.003; OR 3.5, 95% CI 1.5-8.1).
19408338	2009	Inflamm. Bowel Dis.	1536-4844	CONCLUSIONS	4	10	2312	LONGTERM|DICTIONARY	filaggrin	Filaggrin	0#9		Filaggrin null-alleles have no effect on IBD susceptibility but contribute to coexistent eczema and food allergy.
19267885	2010	J. Cell. Mol. Med.	1582-4934	TITLE	0	0	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	49#54		One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders.
19267885	2010	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	2	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	159#164		The current study investigated the metabolites in the methionine cycle, the transsulphuration pathway, folate, vitamin B(12) and the C677T polymorphism of the MTHFR gene in three groups of children diagnosed with AD (n= 15), AS (n= 5) and PDD-NOS (n= 19) and their age- and sex-matched controls (n= 25).
19267885	2010	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	7	4524	SYMBOL|GENE|GN|DICTIONARY	mthfr	MTHFR	19#24		The results of the MTHFR gene analysis showed a normal distribution of the C677T polymorphism in children with ASDs, but the frequency of the 677T allele was slightly more prevalent in AD patients.
19631393	2009	J. Neuroimmunol.	1872-8421	TITLE	0	0	4318	LONGTERM|DICTIONARY	matrix metalloproteinase 9	Matrix metalloproteinase-9	0#26		Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
19631393	2009	J. Neuroimmunol.	1872-8421	ALL_TEXT_2/3	2	2	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	61#66		This study was carried out in order to determine whether the MMP-9 C(-1562)T and (CA)(13-25) polymorphisms are associated with MS. A total of 165 patients (92 whites/73 mulattos) and 191 controls (96 whites/95 mulattos) were enrolled in the study.
19753311	2009	Mol. Vis.	1090-0535	PURPOSE	1	3	1128	SYMBOL|()|DICTIONARY	chrm1	CHRM1	154#159		Our specific aim in this study was to examine the association between high myopia and polymorphisms within the muscarinic acetylcholine receptors 1 gene (CHRM1).
19753311	2009	Mol. Vis.	1090-0535	RESULTS	3	9	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	49#54		Logistic regression test revealed S1, S2, and S4 CHRM1 as all being significant in the development of high myopia.
19753311	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	11	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	56#61		Our results suggest that the S2 and S4 polymorphisms of CHRM1 are associated with susceptibility for developing high myopia.
19753311	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	12	1128	SYMBOL|DICTIONARY	chrm1	CHRM1	15#20		S1, S2, and S4 CHRM1 had a co-operative association with high myopia.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	28#36		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
19624571	2009	Ann. Hum. Genet.	1469-1809	TITLE	0	0	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	41#46		Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	1	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	16#24		The role of the KIAA0391 and PSMA6 genes in predisposing individuals to disease is still not fully understood.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	1	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	29#34		The role of the KIAA0391 and PSMA6 genes in predisposing individuals to disease is still not fully understood.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	163#171		We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	2	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	176#181		We evaluated by molecular beacon-based genotyping assays the roles of five single nucleotide polymorphisms (SNPs) in the chromosomal region 14q13.2 harbouring the KIAA0391 and PSMA6 gene cluster in coronary artery disease (CAD) in the Saudi population.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	3	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	82#90		Two of the studied SNPs rs8008319 (denoted as 1) and rs7157492 (2), reside in the KIAA0391 locus, two others rs1048990 (3) and rs12878391 (4) are components of the PSMA6, while rs4981283 (5) resides downstream of both genes.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_1/3	1	3	5687	SYMBOL|DICTIONARY	psma6	PSMA6	164#169		Two of the studied SNPs rs8008319 (denoted as 1) and rs7157492 (2), reside in the KIAA0391 locus, two others rs1048990 (3) and rs12878391 (4) are components of the PSMA6, while rs4981283 (5) resides downstream of both genes.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	9692	SYMBOL|DICTIONARY	kiaa0391	KIAA0391	75#83		Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19624571	2009	Ann. Hum. Genet.	1469-1809	ALL_TEXT_3/3	3	8	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	88#93		Our study identified haplotypes in the chromosomal region encompassing the KIAA0391 and PSMA6 genes as a possible genetic link between CAD and MI.
19723304	2009	BMC Med. Genet.	1471-2350	TITLE	0	0	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	48#52		Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	64127	SYMBOL|DICTIONARY	nod2	Nod2	111#115		The most significant finding in the IBD research has been identification of mutations in the gene that encodes Nod2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	2	64127	LONGTERM|()|GENE|GN|DICTIONARY	nucleotide binding oligomerization domain 2	nucleotide-binding oligomerization domain 2	117#160		The most significant finding in the IBD research has been identification of mutations in the gene that encodes Nod2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	3	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	Nod1	38#42		However, a very similar gene encoding Nod1 protein still has not been well documented for its association with ulcerative colitis patients.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	4	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	29#33		Detection of polymorphism in NOD1 gene using SNP analysis has been attempted in the present study.
19723304	2009	BMC Med. Genet.	1471-2350	BACKGROUND	1	5	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	103#107		We evaluated frequency and significance of mutations present in the nucleotide-binding domain (NBD) of NOD1 gene in context to Indian population.
19723304	2009	BMC Med. Genet.	1471-2350	METHODS	2	7	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	34#38		Exon 6 locus in the NBD domain of NOD1 gene was amplified and sequenced.
19723304	2009	BMC Med. Genet.	1471-2350	RESULTS	3	9	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	109#113		We have demonstrated DHPLC screening technique to show the presence of SNPs in Exon 6 locus of NBD domain of NOD1 gene.
19723304	2009	BMC Med. Genet.	1471-2350	CONCLUSION	4	14	10392	SYMBOL|GENE|GN|DICTIONARY	nod1	NOD1	105#109		We propose that the location of mutations in the Exon 6 spanning the ATP and Mg2+ binding site of NBD in NOD1 gene may affect the process of oligomerization and subsequent function of the LRR domain.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	TITLE	0	0	2645	LONGTERM|GENE|GN|DICTIONARY	glucokinase	Glucokinase	0#11		Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	INTRODUCTION	1	1	2645	LONGTERM|GENE|GN|DICTIONARY	glucokinase	glucokinase	17#28		Mutations in the glucokinase gene (GCK) produce a subtype of Maturity onset diabetes in the young (MODY), named MODY 2.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	INTRODUCTION	1	1	2645	SYMBOL|DICTIONARY	mody 2	MODY 2	112#118		Mutations in the glucokinase gene (GCK) produce a subtype of Maturity onset diabetes in the young (MODY), named MODY 2.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	INTRODUCTION	1	3	2645	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gck	GCK	79#82	19358091-1-17-28	The aim of this work was to study the nature and frequency of mutations in the GCK gene, in a MODY clinically characterized Argentinean population.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	MATERIAL AND METHODS	2	5	2645	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gck	GCK	82#85	19358091-1-17-28	The study methodology consisted in PCR amplification of the coding regions of the GCK gene, SSCP electrophoresis analysis of the amplified fragments and direct sequencing of the fragments with abnormal electrophoresis pattern.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	RESULTS	3	6	2645	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gck	GCK	60#63	19358091-1-17-28	We identified a total of six patients with mutations in the GCK gene.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	RESULTS	3	8	2645	SYMBOL|DICTIONARY	mody 2	MODY 2	53#59		With that data, we could establish the prevalence of MODY 2 among the patients in study reaching to 8.6%.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	DISCUSSION	4	9	2645	SYMBOL|DICTIONARY	mody 2	MODY 2	163#169		The main contribution of this study is to inform about two novel mutations not described to date and to make an approach to the establishment of the prevalence of MODY 2 in the population under study.
19358091	2009	Exp. Clin. Endocrinol. Diabetes	1439-3646	DISCUSSION	4	10	2645	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gck	GCK	66#69	19358091-1-17-28	These findings contribute to confirm the allelic heterogeneity of GCK gene mutations and may provide an insight into the structure-function relationship of the GCK.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	OBJECTIVE	1	3	1812	SYMBOL|DICTIONARY	drd1	DRD1	40#44		Polymorphisms within dopamine receptors DRD1, DRD2, DRD3 and DRD4 have previously been investigated in a few interesting studies that are reviewed here and extended using our patient cohort.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	OBJECTIVE	1	3	1813	SYMBOL|DICTIONARY	drd2	DRD2	46#50		Polymorphisms within dopamine receptors DRD1, DRD2, DRD3 and DRD4 have previously been investigated in a few interesting studies that are reviewed here and extended using our patient cohort.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	OBJECTIVE	1	3	1814	SYMBOL|DICTIONARY	drd3	DRD3	52#56		Polymorphisms within dopamine receptors DRD1, DRD2, DRD3 and DRD4 have previously been investigated in a few interesting studies that are reviewed here and extended using our patient cohort.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	OBJECTIVE	1	3	1815	SYMBOL|DICTIONARY	drd4	DRD4	61#65		Polymorphisms within dopamine receptors DRD1, DRD2, DRD3 and DRD4 have previously been investigated in a few interesting studies that are reviewed here and extended using our patient cohort.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	METHODS	2	5	1812	SYMBOL|DICTIONARY	drd1	DRD1	35#39		These measures were related to the DRD1 (A-48G), DRD2 (ser311cys; C-ins/del), DRD3 (ser9gly) and DRD4 (VNTR) genotype and allele frequencies.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	METHODS	2	5	1813	SYMBOL|DICTIONARY	drd2	DRD2	49#53		These measures were related to the DRD1 (A-48G), DRD2 (ser311cys; C-ins/del), DRD3 (ser9gly) and DRD4 (VNTR) genotype and allele frequencies.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	METHODS	2	5	1814	SYMBOL|DICTIONARY	drd3	DRD3	78#82		These measures were related to the DRD1 (A-48G), DRD2 (ser311cys; C-ins/del), DRD3 (ser9gly) and DRD4 (VNTR) genotype and allele frequencies.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	METHODS	2	5	1815	SYMBOL|DICTIONARY	drd4	DRD4	97#101		These measures were related to the DRD1 (A-48G), DRD2 (ser311cys; C-ins/del), DRD3 (ser9gly) and DRD4 (VNTR) genotype and allele frequencies.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1814	SYMBOL|DICTIONARY	drd3	DRD3	35#39		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	RESULTS	3	6	1815	SYMBOL|DICTIONARY	drd4	DRD4	65#69		Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
19235789	2010	Int J Geriatr Psychiatry	1099-1166	CONCLUSION	4	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	106#110		Our data, in combination with a review of the literature, reveal a potential role for the VNTR variant of DRD4 in the development of depression in AD patients.
19264732	2009	J. Med. Genet.	1468-6244	TITLE	0	0	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	117#122		Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
19264732	2009	J. Med. Genet.	1468-6244	BACKGROUND	1	3	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	87#92		The syndrome can be either caused by a submicroscopic 9q34.3 deletion or by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene.
19264732	2009	J. Med. Genet.	1468-6244	BACKGROUND	1	3	79813	SYMBOL|GENE|GN|DICTIONARY	ehmt1	EHMT1	140#145		The syndrome can be either caused by a submicroscopic 9q34.3 deletion or by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene.
19264732	2009	J. Med. Genet.	1468-6244	METHODS AND RESULTS	2	7	79813	SYMBOL|GENE|GN|DICTIONARY	ehmt1	EHMT1	32#37		Direct sequence analysis of the EHMT1 gene in 24 patients exhibiting the 9qSTD phenotype without such deletion identified six patients with an intragenic EHMT1 mutation.
19264732	2009	J. Med. Genet.	1468-6244	METHODS AND RESULTS	2	7	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	154#159		Direct sequence analysis of the EHMT1 gene in 24 patients exhibiting the 9qSTD phenotype without such deletion identified six patients with an intragenic EHMT1 mutation.
19264732	2009	J. Med. Genet.	1468-6244	CONCLUSIONS	3	10	79813	SYMBOL|GENE|GN|DICTIONARY	ehmt1	EHMT1	35#40		Therefore, the authors confirm the EHMT1 gene to be the major determinant of the 9qSTDS phenotype.
19264732	2009	J. Med. Genet.	1468-6244	CONCLUSIONS	3	11	79813	SYMBOL|DICTIONARY	ehmt1	EHMT1	130#135		Interestingly, five of six patients who had reached adulthood had developed severe psychiatric pathology, which may indicate that EHMT1 haploinsufficiency is associated with neurodegeneration in addition to neurodevelopmental defect.
19698145	2009	J Neuroinflammation	1742-2094	TITLE	0	0	3569	SYMBOL|DICTIONARY	il 6	IL-6	78#82		Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.
19698145	2009	J Neuroinflammation	1742-2094	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	87#92		Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	160#173		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	SYMBOL|GENE|GN|DICTIONARY	il 6	IL-6	175#179		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3569	SYMBOL|DICTIONARY	il6	IL6	187#190		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	LONGTERM|DICTIONARY	interleukin 10	interleukin-10	229#243		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	245#250		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	BACKGROUND	1	2	3586	SYMBOL|DICTIONARY	il10	IL10	258#262		An interaction associated with the risk of AD has been reported between polymorphisms in the regulatory regions of the genes for the pro-inflammatory cytokine, interleukin-6 (IL-6, gene: IL6), and the anti-inflammatory cytokine, interleukin-10 (IL-10, gene: IL10).
19698145	2009	J Neuroinflammation	1742-2094	RESULTS	3	4	3569	SYMBOL|DICTIONARY	il6	IL6	34#37		We replicated the interaction.For IL6 rs2069837 AA x IL10 rs1800871 CC, the synergy factor (SF) was 1.63 (95% confidence interval: 1.10-2.41, p = 0.01), controlling for centre, age, gender and apolipoprotein E epsilon4 (APOEepsilon4) genotype.
19698145	2009	J Neuroinflammation	1742-2094	RESULTS	3	4	3586	SYMBOL|DICTIONARY	il10	IL10	53#57		We replicated the interaction.For IL6 rs2069837 AA x IL10 rs1800871 CC, the synergy factor (SF) was 1.63 (95% confidence interval: 1.10-2.41, p = 0.01), controlling for centre, age, gender and apolipoprotein E epsilon4 (APOEepsilon4) genotype.
19698145	2009	J Neuroinflammation	1742-2094	CONCLUSION	4	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	38#42		We suggest that dysregulation of both IL-6 and IL-10 in some elderly people, due in part to genetic variations in the two genes, contributes to the development of AD.
19698145	2009	J Neuroinflammation	1742-2094	CONCLUSION	4	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	47#52		We suggest that dysregulation of both IL-6 and IL-10 in some elderly people, due in part to genetic variations in the two genes, contributes to the development of AD.
19638460	2009	Clin. Cancer Res.	1078-0432	RESULTS	3	9	1557	SYMBOL|NUMBER|DICTIONARY	cyp2c19	CYP2C19	114#121		Analysis of polymorphisms important for the metabolism of the drugs used in the trial showed that carriers of the CYP2C19*2 variant of cytochrome P450 required higher VPA doses to achieve the target VPA plasma concentration of 50 microg/mL on day 1 of 5-AZA treatment (P = 0.0021).
19700865	2009	J. Genet.	0973-7731	TITLE	0	0	4313	LONGTERM|GENE|GN|DICTIONARY	matrix metalloproteinase 2	matrix metalloproteinase-2	15#41		Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
19415413	2009	J. Neurol.	1432-1459	TITLE	0	0	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	5#10		CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6355	SYMBOL|DICTIONARY	ccl8	CCL8	105#109		CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	110#115		CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	2	6355	SYMBOL|DICTIONARY	ccl8	CCL8	67#71		A few Single Nucleotide Polymorphisms (SNPs) have been reported in CCL8/MCP-2, all of which are located in the same linkage block.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	2	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	72#77		A few Single Nucleotide Polymorphisms (SNPs) have been reported in CCL8/MCP-2, all of which are located in the same linkage block.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	ccl8	CCL8	20#24		The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	4	6355	SYMBOL|DICTIONARY	mcp 2	MCP-2	25#30		The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	5	6355	SYMBOL|DICTIONARY	ccl8	CCL8	0#4		CCL8/MCP rs1133763 SNP, or other variants in linkage disequilibrium with this variant, likely do not influence the susceptibility to AD or FTLD in Caucasians.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	22#30		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|DICTIONARY	nampt	NAMPT	37#42		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
19300429	2009	Obesity (Silver Spring)	1930-7381	TITLE	0	0	10135	SYMBOL|DICTIONARY|EXTRACTED	pbef1	PBEF1	43#48		A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	1	10135	SYMBOL|DICTIONARY|GENE|GA	nampt	NAMPT	67#72		Visfatin was recently reported as a novel adipokine encoded by the NAMPT (PBEF1) gene.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	1	10135	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	pbef1	PBEF1	74#79	19300429-1-67-72	Visfatin was recently reported as a novel adipokine encoded by the NAMPT (PBEF1) gene.
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_1/3	1	2	10135	SYMBOL|GENE|GN|DICTIONARY	visfatin	visfatin	108#116		This study was aimed at investigation of the possibility that single-nucleotide polymorphisms (SNPs) in the visfatin gene are associated with either obesity or type 2 diabetes (T2D).
19300429	2009	Obesity (Silver Spring)	1930-7381	ALL_TEXT_2/3	2	6	10135	SYMBOL|DICTIONARY	nampt	NAMPT	49#54		One rare SNP, rs10487818, located in intron 4 of NAMPT was associated with severe obesity, with a minor allele frequency of 1.6% in controls, 0.4% in the class III obese adults and, remarkably, 0% in the severely obese children.
19350278	2009	Pediatr. Nephrol.	1432-198X	TITLE	0	0	6092	SYMBOL|DICTIONARY	robo2	ROBO2	17#22		Mutations in the ROBO2 and SLIT2 genes are rare causes of familial vesico-ureteral reflux.
19350278	2009	Pediatr. Nephrol.	1432-198X	TITLE	0	0	9353	SYMBOL|GENE|GN|DICTIONARY	slit2	SLIT2	27#32		Mutations in the ROBO2 and SLIT2 genes are rare causes of familial vesico-ureteral reflux.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_1/3	1	2	9353	SYMBOL|GENE|GN|DICTIONARY	slit2	SLIT2	4#9		The SLIT2 protein and its receptor, ROBO2, have key functions in the formation of the ureteric bud.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_1/3	1	2	6092	SYMBOL|DICTIONARY	robo2	ROBO2	36#41		The SLIT2 protein and its receptor, ROBO2, have key functions in the formation of the ureteric bud.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_1/3	1	3	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	35#40		Two recent studies have found that ROBO2 gene missense mutations are associated with VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	9353	SYMBOL|DICTIONARY	slit2	SLIT2	76#81		In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	4	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	86#91		In the study reported here, we investigated the genetic contribution of the SLIT2 and ROBO2 genes in non-syndromic familial VUR by mutation screening of 54 unrelated patients with primary VUR.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	5	6092	SYMBOL|GENE|GN|DICTIONARY	robo2	ROBO2	78#83		Direct sequencing of all 26 exons and the exon-intron boundaries revealed six ROBO2 gene variants, two of which were new.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_2/3	2	6	9353	SYMBOL|GENE|GN|DICTIONARY	slit2	SLIT2	79#84		Direct sequencing of all 37 exons and the exon-intron boundaries identified 20 SLIT2 gene variants, two of which were new.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_3/3	3	9	6092	SYMBOL|DICTIONARY	robo2	ROBO2	34#39		We conclude that gene variants in ROBO2 and SLIT2 are rare causes of VUR in humans.
19350278	2009	Pediatr. Nephrol.	1432-198X	ALL_TEXT_3/3	3	9	9353	SYMBOL|DICTIONARY	slit2	SLIT2	44#49		We conclude that gene variants in ROBO2 and SLIT2 are rare causes of VUR in humans.
19549929	2009	Toxicol Pathol	1533-1601	TITLE	0	0	7137	LONGTERM|DICTIONARY	cardiac troponin i	cardiac troponin I	17#35		Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_1/3	1	1	7137	LONGTERM|DICTIONARY	cardiac troponin i	Cardiac troponin I	0#18		Cardiac troponin I is a useful biomarker of myocardial injury, but its use in mice and application to early drug discovery are not well described.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_2/3	2	4	2170	LONGTERM|DICTIONARY	fatty acid binding protein 3	fatty acid binding protein 3	89#117		Increased cTnI concentration was of greater magnitude and longer duration than increased fatty acid binding protein 3 concentration, aspartate aminotransferase activity, and creatine kinase activity in serum.
19419979	2009	Biol Res Nurs	1099-8004	TITLE	0	0	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor alpha	54#81		Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	LONGTERM|DICTIONARY	tumor necrosis factor alpha	tumor necrosis factor-alpha	118#145		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_1/3	1	2	7124	SYMBOL|NUMBER|DICTIONARY	tnfa	TNFA	147#151		In this study, we sought to determine whether a functional genetic variation in a prominent proinflammatory cytokine, tumor necrosis factor-alpha (TNFA-308G>A [rs1800629] promoter polymorphism) was associated with overall ratings of sleep disturbance and fatigue as well as with the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_2/3	2	4	7124	SYMBOL|DICTIONARY	tnfa	TNFA	64#68		Multiple linear regression was used to assess the effect of the TNFA genotype and other covariates on mean sleep disturbance and fatigue scores.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_3/3	3	5	7124	SYMBOL|DICTIONARY	tnfa	TNFA	65#69		Hierarchical linear modeling was used to determine the effect of TNFA genotype on the trajectories of these symptoms.
19419979	2009	Biol Res Nurs	1099-8004	ALL_TEXT_3/3	3	8	7124	SYMBOL|GENE|GN|DICTIONARY	tnfa	TNFA	106#110		Findings provide preliminary evidence of an association between a functional promoter polymorphism in the TNFA gene and the severity of sleep disturbance and morning fatigue in oncology patients and their family caregivers.
19458483	2010	Cancer Biol. Ther.	1555-8576	TITLE	0	0	2073	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ercc5	ERCC5	0#5		ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.
19458483	2010	Cancer Biol. Ther.	1555-8576	ALL_TEXT_1/3	1	1	2073	LONGTERM|DICTIONARY|GENE|GA	excision repair cross complementation group 5	excision repair cross complementation group 5	102#147		This study aimed to investigate whether single nucleotide polymorphisms (SNPs) in the promoter of the excision repair cross complementation group 5 (ERCC5) gene influences response to oxaliplatin-based chemotherapy.
19458483	2010	Cancer Biol. Ther.	1555-8576	ALL_TEXT_1/3	1	1	2073	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ercc5	ERCC5	149#154	19458483-1-102-147	This study aimed to investigate whether single nucleotide polymorphisms (SNPs) in the promoter of the excision repair cross complementation group 5 (ERCC5) gene influences response to oxaliplatin-based chemotherapy.
19458483	2010	Cancer Biol. Ther.	1555-8576	ALL_TEXT_1/3	1	3	2073	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ercc5	ERCC5	93#98	19458483-1-102-147	To this end, six polymorphisms (-1415C>T, -763A>G, -413C>T, +25A>G, +202C>T, +372C>T) in the ERCC5 promoter were selected for investigation.
19458483	2010	Cancer Biol. Ther.	1555-8576	ALL_TEXT_3/3	3	10	2073	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ercc5	ERCC5	35#40	19458483-1-102-147	Therefore, these data suggest that ERCC5 promoter polymorphisms at -763 and +25 may be important predictors of response to oxaliplatin chemotherapy.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	TITLE	0	0	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	22#26		Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_1/3	1	2	5728	SYMBOL|DICTIONARY	pten	PTEN	180#184		It is known that there are variations in genetic alterations in tumors that develop in patients with different ethnic backgrounds; thus, we aimed to evaluate the incidence of MMAC/PTEN mutations and protein expression among various low grade gliomas of Turkish patients.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_1/3	1	3	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	63#67		We investigated 28 low grade gliomas for mutations of the MMAC/PTEN gene using single strand conformational polymorphism method followed by DNA sequencing.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_2/3	2	4	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	32#36		Additionally, the level of MMAC/PTEN protein expression in the tissues of 26 tumors was assessed by immunohistochemistry.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_2/3	2	5	5728	SYMBOL|DICTIONARY	pten	PTEN	27#31		In our investigation, MMAC/PTEN mutations were detected in 2 of 28 tumors (7.14%).
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	8	5728	SYMBOL|GENE|GN|DICTIONARY	pten	PTEN	36#40		Moreover, it was observed that MMAC/PTEN protein expression was reduced to 73.08% of tumors.
19350382	2009	Cell. Mol. Neurobiol.	1573-6830	ALL_TEXT_3/3	3	9	5728	SYMBOL|DICTIONARY	pten	PTEN	28#32		In conclusion, reduced MMAC/PTEN expression by genetic and/or epigenetic mechanisms in low grade gliomas might be associated with glioma tumorigenesis.
19228880	2009	FASEB J.	1530-6860	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	52#57		A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
19228880	2009	FASEB J.	1530-6860	TITLE	0	0	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	85#90		A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	LONGTERM|DICTIONARY	glutathione s transferase m1	glutathione S-transferase M1	113#141		Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	gstm1	GSTM1	143#148	19228880-1-113-141	Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	1	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	257#262	19228880-1-113-141	Although a number of studies have been conducted to address the relation between a gene deletion polymorphism of glutathione S-transferase M1 (GSTM1) and breast cancer, no definite conclusion has been reached and no clear risk pattern has yet to emerge for GSTM1.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	2	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	121#126	19228880-1-113-141	We first conducted case-control studies that included 1920 subjects using a genotyping method allowing the definition of GSTM1-null (-/-), homozygous wild-type (+/+), and heterozygous (+/-) genotypes.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	22#27	19228880-1-113-141	The results show that GSTM1(-/-) confers an increased risk for breast cancer development compared with that in GSTM1-present individuals (+/+ and +/-), which was subsequently confirmed by a meta-analysis of all of the 41 relevant studies (odds ratio: 1.10, P<0.001).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_1/3	1	3	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	111#116	19228880-1-113-141	The results show that GSTM1(-/-) confers an increased risk for breast cancer development compared with that in GSTM1-present individuals (+/+ and +/-), which was subsequently confirmed by a meta-analysis of all of the 41 relevant studies (odds ratio: 1.10, P<0.001).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	28#33	19228880-1-113-141	Unexpectedly, we found that GSTM1(+/+) is also a risk genotype compared with GSTM1(+/-).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	77#82	19228880-1-113-141	Unexpectedly, we found that GSTM1(+/+) is also a risk genotype compared with GSTM1(+/-).
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_2/3	2	5	2944	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gstm1	GSTM1	60#65	19228880-1-113-141	Furthermore, we identified a functional polymorphism in the GSTM1 promoter region associated with breast cancer.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_2/3	2	6	7020	SYMBOL|DICTIONARY	ap 2alpha	AP-2alpha	47#56		The variant allele modifies DNA binding to the AP-2alpha transcription factor, resulting in reduced promoter activity and mRNA expression.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	65#70	19228880-1-113-141	It seems that approximately 60-70% expression from one allele of GSTM1 could suffice for protection against breast cancer; null activity and overactivity of GSTM1 are both disadvantageous.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	157#162	19228880-1-113-141	It seems that approximately 60-70% expression from one allele of GSTM1 could suffice for protection against breast cancer; null activity and overactivity of GSTM1 are both disadvantageous.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	49#54	19228880-1-113-141	These results indicate a U-shaped association of GSTM1 with breast cancer, which challenges the linear gene-dosage effect of GSTM1 that was previously proposed.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	9	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	125#130	19228880-1-113-141	These results indicate a U-shaped association of GSTM1 with breast cancer, which challenges the linear gene-dosage effect of GSTM1 that was previously proposed.
19228880	2009	FASEB J.	1530-6860	ALL_TEXT_3/3	3	10	2944	SYMBOL|DICTIONARY|EXTRACTED	gstm1	GSTM1	46#51	19228880-1-113-141	We recommend that a more complicated role for GSTM1 should be considered in breast cancer risk prediction.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	93#98		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	2	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	108#113		The aim of this study was to evaluate the impact of the composite IL-1 genotype (allele 2 at IL-1A -889 and IL-1B +3954) in the association between acute myocardial infarction (AMI) and periodontitis.
19563289	2009	J. Periodontol.	0022-3492	RESULTS	3	9	3552	SYMBOL|DICTIONARY	il 1a	IL-1A	84#89		No significant differences were observed in the allele frequencies of the gene loci IL-1A -889 and IL-1B +C3954 between patients with AMI and controls.
19563289	2009	J. Periodontol.	0022-3492	RESULTS	3	9	3553	SYMBOL|DICTIONARY	il 1b	IL-1B	99#104		No significant differences were observed in the allele frequencies of the gene loci IL-1A -889 and IL-1B +C3954 between patients with AMI and controls.
19509271	2009	Mol. Cancer Ther.	1538-8514	TITLE	0	0	1268	LONGTERM|DICTIONARY	cannabinoid receptor 1	Cannabinoid receptor 1	0#22		Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	1268	LONGTERM|DICTIONARY	cannabinoid receptor 1	cannabinoid receptor 1	64#86		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	1268	SYMBOL|EXTRACTED|()	cb1	CB1	88#91	19509271-1-64-86	Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	5077	SYMBOL|DICTIONARY	pax3	PAX3	192#196		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	2308	SYMBOL|DICTIONARY	fkhr	FKHR	197#201		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	5081	SYMBOL|DICTIONARY	pax7	PAX7	205#209		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	1	2308	SYMBOL|DICTIONARY	fkhr	FKHR	210#214		Gene expression profiling has revealed that the gene coding for cannabinoid receptor 1 (CB1) is highly up-regulated in rhabdomyosarcoma biopsies bearing the typical chromosomal translocations PAX3/FKHR or PAX7/FKHR.
19509271	2009	Mol. Cancer Ther.	1538-8514	ALL_TEXT_1/3	1	2	1268	SYMBOL|EXTRACTED	cb1	CB1	189#192	19509271-1-64-86	Because cannabinoid receptor agonists are capable of reducing proliferation and inducing apoptosis in diverse cancer cells such as glioma, breast cancer, and melanoma, we evaluated whether CB1 is a potential drug target in rhabdomyosarcoma.
19715891	2010	Transplant. Proc.	1873-2623	TITLE	0	0	4153	LONGTERM|GENE|GN|DICTIONARY	mannose binding lectin	mannose-binding lectin	13#35		Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	1	4153	LONGTERM|DICTIONARY	mannose binding lectin	Mannose-binding lectin	0#22		Mannose-binding lectin (MBL) is a component of the innate immune system that binds the surface of pathogens, activating the complement pathway and acting as opsonin.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	1	4153	SYMBOL|()|DICTIONARY|EXTRACTED	mbl	MBL	24#27	19715891-1-0-22	Mannose-binding lectin (MBL) is a component of the innate immune system that binds the surface of pathogens, activating the complement pathway and acting as opsonin.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	2	4153	SYMBOL|DICTIONARY	mbl2	MBL2	43#47		Certain single-nucleotide polymorphisms of MBL2 are associated with a decrease in the circulating levels of MBL.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	2	4153	SYMBOL|DICTIONARY|EXTRACTED	mbl	MBL	108#111	19715891-1-0-22	Certain single-nucleotide polymorphisms of MBL2 are associated with a decrease in the circulating levels of MBL.
19715891	2010	Transplant. Proc.	1873-2623	BACKGROUND	1	3	4153	SYMBOL|DICTIONARY	mbl2	MBL2	41#45		Our aim was to evaluate the influence of MBL2 polymorphisms in the invasiveness of Cytomegalovirus (CMV) disease after solid organ transplantation.
19715891	2010	Transplant. Proc.	1873-2623	METHODS	2	5	4153	SYMBOL|DICTIONARY	mbl2	MBL2	0#4		MBL2 genotyping was performed by sequencing of exon 1 (wild-type allele A and variants B, C, and D) and promoter regions (alleles H and L, X and Y, and P and Q).
19715891	2010	Transplant. Proc.	1873-2623	METHODS	2	6	4153	SYMBOL|DICTIONARY	mbl2	MBL2	44#48		In the case of liver transplantation, donor MBL2 genotypes were analyzed.
19446452	2009	Breast	1532-3080	TITLE	0	0	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	0#5		XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis.
19446452	2009	Breast	1532-3080	ALL_TEXT_1/3	1	1	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	56#61		We performed a meta-analysis to investigate the role of XRCC1 polymorphisms Arg194Trp, Arg280His and Arg399Gln in breast cancer.
19357349	2009	Carcinogenesis	1460-2180	TITLE	0	0	4092	SYMBOL|DICTIONARY	smad7	SMAD7	42#47		Association of common genetic variants in SMAD7 and risk of colon cancer.
19357349	2009	Carcinogenesis	1460-2180	ALL_TEXT_1/3	1	1	4092	SYMBOL|DICTIONARY	smad7	SMAD7	86#91		Two recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer.
19478460	2009	J. Clin. Invest.	1558-8238	TITLE	0	0	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	63#83		Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|GENE|GN|DICTIONARY	slc6a3	SLC6A3	24#30		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	LONGTERM|DICTIONARY	dopamine transporter	dopamine transporter	59#79		Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	1	6531	SYMBOL|()|DICTIONARY|EXTRACTED	dat	DAT	81#84	19478460-1-59-79	Genetic variants of the SLC6A3 gene that encodes the human dopamine transporter (DAT) have been linked to a variety of neuropsychiatric disorders, particularly attention deficit hyperactivity disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_1/3	1	2	6531	SYMBOL|DICTIONARY	slc6a3	Slc6a3	28#34		In addition, the homozygous Slc6a3 knockout mouse displays a hyperactivity phenotype.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_2/3	2	3	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	141#147		Here, we analyzed 2 unrelated consanguineous families with infantile parkinsonism-dystonia (IPD) syndrome and identified homozygous missense SLC6A3 mutations (p.L368Q and p.P395L) in both families.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_2/3	2	4	6531	SYMBOL|DICTIONARY|EXTRACTED	dat	DAT	132#135	19478460-1-59-79	Functional studies demonstrated that both mutations were loss-of-function mutations that severely reduced levels of mature (85-kDa) DAT while having a differential effect on the apparent binding affinity of dopamine.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	5	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	34#40		Thus, in humans, loss-of-function SLC6A3 mutations that impair DAT-mediated dopamine transport activity are associated with an early-onset complex movement disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	5	6531	SYMBOL|DICTIONARY|EXTRACTED	dat	DAT	63#66	19478460-1-59-79	Thus, in humans, loss-of-function SLC6A3 mutations that impair DAT-mediated dopamine transport activity are associated with an early-onset complex movement disorder.
19478460	2009	J. Clin. Invest.	1558-8238	ALL_TEXT_3/3	3	6	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	54#60		Identification of the molecular basis of IPD suggests SLC6A3 as a candidate susceptibility gene for other movement disorders associated with parkinsonism and/or dystonic features.
19384265	2009	Pharmacogenet. Genomics	1744-6872	TITLE	0	0	4524	SYMBOL|DICTIONARY	mthfr	MTHFR	43#48		The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.
19298594	2009	Br. J. Haematol.	1365-2141	TITLE	0	0	10456	SYMBOL|GENE|GN|DICTIONARY	hax1	HAX1	25#29		Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	0#5		TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	3142	SYMBOL|DICTIONARY	hlx1	HLX1	71#75		TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	30009	SYMBOL|()|DICTIONARY|EXTRACTED	tbx21	TBX21	48#53	19362357-1-20-46	The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3142	SYMBOL|DICTIONARY	hlx1	HLX1	248#252		The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	32#37	19362357-1-20-46	The role of genetic variants in TBX21 alone and in combination with HLX1 polymorphisms was investigated in the development of T(H)2-associated atopy and asthma.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	3142	SYMBOL|DICTIONARY	hlx1	HLX1	68#72		The role of genetic variants in TBX21 alone and in combination with HLX1 polymorphisms was investigated in the development of T(H)2-associated atopy and asthma.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	3	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	4#9	19362357-1-20-46	The TBX21 gene was resequenced in 37 adult volunteers.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	5	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	37#42	19362357-1-20-46	Effects of promoter polymorphisms on TBX21 gene expression were studied by reporter gene assays.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	6	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	43#48	19362357-1-20-46	Furthermore, the impact of combinations of TBX21 and HLX1 polymorphisms on the development of asthma was assessed by using a risk score model.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	6	3142	SYMBOL|DICTIONARY	hlx1	HLX1	53#57		Furthermore, the impact of combinations of TBX21 and HLX1 polymorphisms on the development of asthma was assessed by using a risk score model.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	8	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	49#54	19362357-1-20-46	Forty-three polymorphisms were identified in the TBX21 gene.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	11	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	0#5		TBX21 promoter polymorphisms contained in 2 blocks significantly influenced TBX21 promoter activity.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	11	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	76#81	19362357-1-20-46	TBX21 promoter polymorphisms contained in 2 blocks significantly influenced TBX21 promoter activity.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	12	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	42#47	19362357-1-20-46	In a risk score model, the combination of TBX21 and HLX1 polymorphisms increased the asthma risk by more than 3-fold.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	12	3142	SYMBOL|DICTIONARY	hlx1	HLX1	52#56		In a risk score model, the combination of TBX21 and HLX1 polymorphisms increased the asthma risk by more than 3-fold.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	13	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	24#29	19362357-1-20-46	These data suggest that TBX21 polymorphisms contribute to the development of asthma, potentially by altering TBX21 promoter activity.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	13	30009	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tbx21	TBX21	109#114	19362357-1-20-46	These data suggest that TBX21 polymorphisms contribute to the development of asthma, potentially by altering TBX21 promoter activity.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	14	30009	SYMBOL|DICTIONARY|EXTRACTED	tbx21	TBX21	34#39	19362357-1-20-46	A risk score model indicates that TBX21 and HLX1 polymorphisms may have synergistic effects on asthma risk.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	CONCLUSIONS	5	14	3142	SYMBOL|DICTIONARY	hlx1	HLX1	44#48		A risk score model indicates that TBX21 and HLX1 polymorphisms may have synergistic effects on asthma risk.
19190538	2009	Pediatr. Res.	1530-0447	ALL_TEXT_1/3	1	1	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	85#90		Rett Syndrome (RTT) is caused in more than 60% of cases by nonsense mutations in the MECP2 gene.
19190538	2009	Pediatr. Res.	1530-0447	ALL_TEXT_2/3	2	5	4204	SYMBOL|DICTIONARY	mecp2	MECP2	111#116		HeLa cells were transfected with eukaryotic expression vectors carrying mutant alleles of frequently occurring MECP2 nonsense mutations that were N-terminally fused to a FLAG tag.
19190538	2009	Pediatr. Res.	1530-0447	ALL_TEXT_3/3	3	10	4204	SYMBOL|GENE|GN|DICTIONARY	mecp2	MECP2	85#90		We have shown that aminoglycoside-mediated read-through of nonsense mutations in the MECP2 gene can be achieved in vitro with efficiency comparable with that seen in other disorders.
19450125	2009	Pharmacogenomics	1744-8042	TITLE	0	0	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	0#6		UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	1	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	12#18		Variants in UGT1A1 have previously been associated with toxicity from irinotecan chemotherapy.
19450125	2009	Pharmacogenomics	1744-8042	AIMS	1	2	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	80#86		We conducted a pragmatic prospective cohort study to establish the relevance of UGT1A1 variants in the prediction of severe diarrhea and neutropenia in patients with colorectal cancer receiving irinotecan in a routine clinical setting.
19450125	2009	Pharmacogenomics	1744-8042	MATERIALS &amp; METHODS	2	3	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	14#20		Genotyping of UGT1A1*28 and c.-3156G>A was undertaken in an unselected, prospective cohort of 96 individuals treated with irinotecan at a single major UK oncology centre.
19450125	2009	Pharmacogenomics	1744-8042	RESULTS	3	7	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	33#39		No association was found between UGT1A1*28 or c.-3156G>A and neutropenia.
19450125	2009	Pharmacogenomics	1744-8042	RESULTS	3	8	54658	SYMBOL|NUMBER|DICTIONARY	ugt1a1	UGT1A1	44#50		However, individuals carrying two copies of UGT1A1*28 (p = 0.04; OR: 14; 95% CI: 1.1-185) or c.-3156G>A (p = 0.03) had a significantly increased risk of diarrhea over all cycles.
19450125	2009	Pharmacogenomics	1744-8042	CONCLUSION	4	9	54658	SYMBOL|DICTIONARY	ugt1a1	UGT1A1	27#33		Our findings indicate that UGT1A1 genotyping is not a good predictor of hematological toxicity in patients treated with intermediate irinotecan doses.
19495527	2010	Singapore Med J	0037-5675	TITLE	0	0	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MECP2	0#5		MECP2 mutations in Malaysian Rett syndrome patients.
19495527	2010	Singapore Med J	0037-5675	INTRODUCTION	1	2	4204	LONGTERM|DICTIONARY	methyl cpg binding protein 2	methyl-CpG-binding protein-2	85#113		The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28.
19495527	2010	Singapore Med J	0037-5675	INTRODUCTION	1	2	4204	SYMBOL|()|DICTIONARY|EXTRACTED	mecp2	MECP2	115#120	19495527-2-85-113	The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28.
19495527	2010	Singapore Med J	0037-5675	INTRODUCTION	1	3	4204	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	116#121	19495527-2-85-113	In the present study, denaturing high-performance liquid chromatography (DHPLC) was used to detect mutations in the MECP2 gene in 20 Malaysian RS patients.
19495527	2010	Singapore Med J	0037-5675	METHODS	2	4	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MECP2	63#68	19495527-2-85-113	Polymerase chain reaction (PCR) was carried out to amplify the MECP2 coding exons 2, 3, and 4 in a total of eight reactions (exons 2, 3a, 3b, 4a, 4b, 4c, 4d and 4e).
19495527	2010	Singapore Med J	0037-5675	RESULTS	3	6	4204	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	17#22	19495527-2-85-113	Mutations in the MECP2 gene were detected in 13 of the 20 (65 percent) RS patients.
19495527	2010	Singapore Med J	0037-5675	CONCLUSION	4	9	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MECP2	135#140	19495527-2-85-113	Through the use of post-PCR high-performance liquid chromatography, 65 percent of 20 RS patients were found to have mutation(s) in the MECP2.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	TITLE	0	0	28	SYMBOL|DICTIONARY	abo	ABO	21#24		[Correlation between ABO blood type gene and attention-deficit hyperactivity disorder in children].
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	OBJECTIVE	1	1	28	SYMBOL|DICTIONARY	abo	ABO	39#42		To investigate the correlation between ABO blood type gene and attention-deficit hyperactivity disorder (ADHD) in children.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	METHODS	2	2	28	SYMBOL|DICTIONARY	abo	ABO	0#3		ABO blood types were determined using glass sheet method in 96 children with ADHD and their parents.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	METHODS	2	4	28	SYMBOL|GENE|GN|DICTIONARY	abo	ABO	152#155		Haplotype-based haplotype relative risk (HHRR), transmission-disequilibrium test (TDT) and Chi-square test were used to examine the association between ABO gene and ADHD.
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	RESULTS	3	5	28	SYMBOL|DICTIONARY	abo	ABO	60#63		TDT results showed significant differences in the allele of ABO between the 96 children with ADHD and within-family controls (chi2=6.017, df=2, P< 0.05).
19470260	2009	Zhongguo Dang Dai Er Ke Za Zhi	1008-8830	CONCLUSIONS	4	8	28	SYMBOL|DICTIONARY	abo	ABO	30#33		There was correlation between ABO blood type gene and ADHD in children.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	10	SYMBOL|DICTIONARY	nat2	NAT2	78#82		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	97#102		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_2/3	2	4	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	107#112		We have conducted this case-control study to assess the role of smoking, slow NAT2 variants, and GSTM1 and GSTT1 null genotypes in bladder cancer development in North Tunisia.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	5	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	46#51		In all groups of patients, we have shown that GSTM1 and GSTT1 null genotypes did not appear to be a factor affecting bladder cancer susceptibility.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	5	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	56#61		In all groups of patients, we have shown that GSTM1 and GSTT1 null genotypes did not appear to be a factor affecting bladder cancer susceptibility.
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	6	10	SYMBOL|DICTIONARY	nat2	NAT2	8#12		For the NAT2 slow acetylator genotype, the NAT2*5/*7 diplotype was found to have a 7-fold increased risk of bladder (OR=7.14; 95% CI: 1.30-51.41).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	6	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	43#47		For the NAT2 slow acetylator genotype, the NAT2*5/*7 diplotype was found to have a 7-fold increased risk of bladder (OR=7.14; 95% CI: 1.30-51.41).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	10	SYMBOL|DICTIONARY	nat2	NAT2	27#31		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	91#96		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	7	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	100#105		Furthermore, we found that NAT2 slow acetylator individuals temporarily carrying wild-type GSTT1 or GSTM1 null genotypes have a strong increased risk of bladder cancer (OR= 26 and 22.17, respectively).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	8	10	SYMBOL|DICTIONARY	nat2	NAT2	89#93		This cumulative effect was estimated at 12 for smokers harboring slow or an intermediate NAT2, GSTM1 null, and wild-type GSTT1 genotypes compared to non-smokers carrying rapid NAT2, wild-type GSTM,1 and GSTT1 null genotypes (p=0.02; OR=12; CI 95% 1-323.76).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	8	2944	SYMBOL|DICTIONARY	gstm1	GSTM1	95#100		This cumulative effect was estimated at 12 for smokers harboring slow or an intermediate NAT2, GSTM1 null, and wild-type GSTT1 genotypes compared to non-smokers carrying rapid NAT2, wild-type GSTM,1 and GSTT1 null genotypes (p=0.02; OR=12; CI 95% 1-323.76).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	8	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	121#126		This cumulative effect was estimated at 12 for smokers harboring slow or an intermediate NAT2, GSTM1 null, and wild-type GSTT1 genotypes compared to non-smokers carrying rapid NAT2, wild-type GSTM,1 and GSTT1 null genotypes (p=0.02; OR=12; CI 95% 1-323.76).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	8	10	SYMBOL|DICTIONARY	nat2	NAT2	176#180		This cumulative effect was estimated at 12 for smokers harboring slow or an intermediate NAT2, GSTM1 null, and wild-type GSTT1 genotypes compared to non-smokers carrying rapid NAT2, wild-type GSTM,1 and GSTT1 null genotypes (p=0.02; OR=12; CI 95% 1-323.76).
19380028	2009	Cancer Genet. Cytogenet.	1873-4456	ALL_TEXT_3/3	3	8	2952	SYMBOL|DICTIONARY	gstt1	GSTT1	203#208		This cumulative effect was estimated at 12 for smokers harboring slow or an intermediate NAT2, GSTM1 null, and wild-type GSTT1 genotypes compared to non-smokers carrying rapid NAT2, wild-type GSTM,1 and GSTT1 null genotypes (p=0.02; OR=12; CI 95% 1-323.76).
19220408	2009	Epilepsia	1528-1167	PURPOSE	1	1	8645	SYMBOL|DICTIONARY	task 2	TASK-2	209#215		To identify the modulation of Tandem of P-domains in a weak inwardly rectifying K(+) channel (TWIK)-related acid-sensitive K(+) (TASK)-2 channel expressions in epilepsy, we conducted a comparative analysis of TASK-2 channel immunoreactivity in the hippocampus of a pilocarpine-induced rat epilepsy model.
19220408	2009	Epilepsia	1528-1167	METHODS	2	2	8645	SYMBOL|DICTIONARY	task 2	TASK-2	47#53		We performed and immunohistochemical study for TASK-2 and double immunofluorescent staining for TASK-2 and glial fibrillary acidic protein (GFAP) in the rat hippocampus of pilocarpine-induced epilepsy models.
19220408	2009	Epilepsia	1528-1167	METHODS	2	2	8645	SYMBOL|DICTIONARY	task 2	TASK-2	96#102		We performed and immunohistochemical study for TASK-2 and double immunofluorescent staining for TASK-2 and glial fibrillary acidic protein (GFAP) in the rat hippocampus of pilocarpine-induced epilepsy models.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	3	8645	SYMBOL|DICTIONARY	task 2	TASK-2	20#26		In control animals, TASK-2 immunoreactivity was strongly detected in CA1-3 pyramidal layers and dentate granule cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	8645	SYMBOL|DICTIONARY	task 2	TASK-2	31#37		After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	5	8645	SYMBOL|DICTIONARY	task 2	TASK-2	13#19		In addition, TASK-2 immunoreactivity is gradually increased in perivascular regions following SE.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	6	8645	SYMBOL|DICTIONARY	task 2	TASK-2	64#70		Double immunofluorescent study revealed that the enhancement of TASK-2 immunoreactivity in perivascular regions is caused by increase in the number of TASK-2 immunoreactive endfeet of perivascular astrocytes.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	6	8645	SYMBOL|DICTIONARY	task 2	TASK-2	151#157		Double immunofluorescent study revealed that the enhancement of TASK-2 immunoreactivity in perivascular regions is caused by increase in the number of TASK-2 immunoreactive endfeet of perivascular astrocytes.
19220408	2009	Epilepsia	1528-1167	DISCUSSION	4	7	8645	SYMBOL|DICTIONARY	task 2	TASK-2	35#41		Our findings suggest that elevated TASK-2 immunoreactivity in neurons may contribute to rapid adaptive responses (presumably for extracellular alkalinization), which result in hyperpolarization and regulate seizure activity.
19220408	2009	Epilepsia	1528-1167	DISCUSSION	4	8	8645	SYMBOL|DICTIONARY	task 2	TASK-2	25#31		In contrast, upregulated TASK-2 immunoreactivity in perivascular regions may be involved in abnormalities of blood flow regulation or brain-blood barrier impairment.
19262575	2009	Genes Immun.	1476-5470	TITLE	0	0	3562	LONGTERM|GENE|GN|DICTIONARY	interleukin 3	interleukin 3	21#34		Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	LONGTERM|DICTIONARY	interleukin 3	interleukin 3	71#84		Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	SYMBOL|()|DICTIONARY|EXTRACTED	il3	IL3	86#89	19262575-5-71-84	Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	3562	SYMBOL|DICTIONARY|EXTRACTED	il3	IL3	223#226	19262575-5-71-84	Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5' flanking region of IL3, fully accounted for the association signal at this locus.
19262575	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	8	3562	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il3	IL3	49#52	19262575-5-71-84	This study provides convincing evidence that the IL3 gene is a susceptibility locus for GD in the Chinese population.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	6775	SYMBOL|DICTIONARY	stat4	STAT4	52#57		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	640	SYMBOL|DICTIONARY	blk	BLK	62#65		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	TITLE	0	0	54899	SYMBOL|DICTIONARY	pxk	PXK	75#78		Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	6775	SYMBOL|DICTIONARY	stat4	STAT4	160#165		Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	640	SYMBOL|DICTIONARY	blk	BLK	167#170		Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_1/3	1	2	54899	SYMBOL|DICTIONARY	pxk	PXK	175#178		Using 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong, and 278 SLE patients and 383 controls in Thailand, we studied association of STAT4, BLK and PXK with the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	3	6775	SYMBOL|DICTIONARY	stat4	STAT4	34#39		Our data confirmed association of STAT4 (rs7574865, odds ratio (OR) =1.71, P=3.55 x 10(-23)) and BLK (rs13277113, OR=0.77, P=1.34 x 10(-5)) with SLE.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	3	640	SYMBOL|DICTIONARY	blk	BLK	97#100		Our data confirmed association of STAT4 (rs7574865, odds ratio (OR) =1.71, P=3.55 x 10(-23)) and BLK (rs13277113, OR=0.77, P=1.34 x 10(-5)) with SLE.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_2/3	2	4	6775	SYMBOL|DICTIONARY	stat4	STAT4	32#37		It was showed that rs7574865 of STAT4 is also linked to hematologic disorders and potentially some other subphenotypes of the disease.
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	5	6775	SYMBOL|DICTIONARY	stat4	STAT4	33#38		More than one genetic variant in STAT4 were found to be associated with the disease independently in our populations (rs7601754, OR=0.59, P=1.39 x 10(-9), and P=0.00034 when controlling the effect of rs7574865).
19225526	2009	Genes Immun.	1476-5470	ALL_TEXT_3/3	3	6	54899	SYMBOL|DICTIONARY	pxk	PXK	104#107		With the same set of samples, however, our study did not detect any significant disease association for PXK, a risk factor for populations of European origin (rs6445975, joint P=0.36, OR=1.06, 95% confidence interval: 0.93-1.21).
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	tp53	TP53	89#93		To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	1026	SYMBOL|DICTIONARY	cdkn1a	CDKN1A	169#175		To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	215#221		To assess the role of genetic variants on the disease, we genotyped polymorphisms in the TP53 (rs17878362:A(1)>A(2), rs1042522:G>C, rs12947788:C>T, and rs17884306:G>A), CDKN1A (rs1801270:C>A and rs1059234:C>T), and CDKN2A (rs3731249:G>A, rs11515:C>G, and rs3088440:C>T) genes in 614 hospital-based CRC cases and 614 matched controls from the country.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	97#101		We observed differential distribution of major haplotypes arising from four polymorphisms in the TP53 gene between cases and controls (global P<0.0001).
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	5	2641	SYMBOL|DICTIONARY	gcg	GCG	36#39		The two most common haplotypes, A(1)GCG and A(2)CCG, were present in 81% of the cases compared to 71% of the controls.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	2641	SYMBOL|DICTIONARY	gcg	GCG	48#51		In comparison to the most common haplotype (A(1)GCG), the haplotype A(2)CCG was associated with an increased risk (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.07-1.82), while the four other haplotypes A(1)CCG (OR, 0.60; 95% CI, 0.45-0.79), A(2)GCG (OR, 0.53; 95% CI, 0.35-0.81), A(1)GTG (OR, 0.31; 95% CI, 0.15-0.64), and A(1)GCA (OR, 0.19; 95% CI, 0.07-0.51) were associated with a decreased risk.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	2641	SYMBOL|DICTIONARY	gcg	GCG	255#258		In comparison to the most common haplotype (A(1)GCG), the haplotype A(2)CCG was associated with an increased risk (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.07-1.82), while the four other haplotypes A(1)CCG (OR, 0.60; 95% CI, 0.45-0.79), A(2)GCG (OR, 0.53; 95% CI, 0.35-0.81), A(1)GTG (OR, 0.31; 95% CI, 0.15-0.64), and A(1)GCA (OR, 0.19; 95% CI, 0.07-0.51) were associated with a decreased risk.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	32#36		The effect of haplotypes in the TP53 gene was similar in colon (global P<0.0001) and rectal cancers (P=0.006).
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	1026	SYMBOL|DICTIONARY	cdkn1a	CDKN1A	68#74		No association with the disease was observed with haplotypes of the CDKN1A and CDKN2A polymorphisms.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	1029	SYMBOL|DICTIONARY	cdkn2a	CDKN2A	79#85		No association with the disease was observed with haplotypes of the CDKN1A and CDKN2A polymorphisms.
19224585	2009	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	7157	SYMBOL|GENE|GN|DICTIONARY	tp53	TP53	73#77		The results from this study suggest that prevalent haplotypes within the TP53 gene may modulate CRC risks in the population.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	6261	SYMBOL|()|GENE|GN|DICTIONARY	ryr1	RYR1	60#64		Today, genetic investigations on ryanodine receptor type 1 (RYR1) gene and alpha1 subunit of the dihydropyridine receptor (DHPR) (CACNA1S) gene have improved the procedures associated with MH diagnosis.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	779	SYMBOL|()|GENE|GN|DICTIONARY	cacna1s	CACNA1S	130#137		Today, genetic investigations on ryanodine receptor type 1 (RYR1) gene and alpha1 subunit of the dihydropyridine receptor (DHPR) (CACNA1S) gene have improved the procedures associated with MH diagnosis.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	6261	SYMBOL|DICTIONARY	ryr1	RYR1	45#49		In approximately 50% of MH cases a causative RYR1 mutation was found.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	4	6261	SYMBOL|DICTIONARY	ryr1	RYR1	35#39		Molecular genetic testing based on RYR1 mutations for MH diagnosis is challenging, because the causative mutations, most of which are private, are distributed throughout the RYR1 gene.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	4	6261	SYMBOL|GENE|GN|DICTIONARY	ryr1	RYR1	174#178		Molecular genetic testing based on RYR1 mutations for MH diagnosis is challenging, because the causative mutations, most of which are private, are distributed throughout the RYR1 gene.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	7	6261	SYMBOL|DICTIONARY	ryr1	RYR1	49#53		Performing an in-depth mutation screening of the RYR1 transcript sequence in 36 unrelated MH susceptible (MHS) patients, we identified 17 novel, five rare, and eight non-disease-causing variants in 23 patients.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	6261	SYMBOL|DICTIONARY	ryr1	RYR1	70#74		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	779	SYMBOL|DICTIONARY	cacna1s	CACNA1S	86#93		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
19191329	2009	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	8	6261	SYMBOL|DICTIONARY	ryr1	RYR1	113#117		The 13 remaining MHS patients presented no known variants, neither in RYR1 nor in the CACNA1S binding regions to RYR1.
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	OBJECTIVE	1	2	6531	SYMBOL|()|DICTIONARY	slc6a3	SLC6A3	140#146		One potential moderating factor is variation in brain DA activity, which is influenced by dopamine-related genes: the DA transporter (DAT) (SLC6A3), the DA D2 receptor (DRD2), and the DA D4 receptor (DRD4) genes.
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	OBJECTIVE	1	2	1813	SYMBOL|()|DICTIONARY	drd2	DRD2	169#173		One potential moderating factor is variation in brain DA activity, which is influenced by dopamine-related genes: the DA transporter (DAT) (SLC6A3), the DA D2 receptor (DRD2), and the DA D4 receptor (DRD4) genes.
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	OBJECTIVE	1	2	1815	SYMBOL|()|GENE|GN|DICTIONARY	drd4	DRD4	200#204		One potential moderating factor is variation in brain DA activity, which is influenced by dopamine-related genes: the DA transporter (DAT) (SLC6A3), the DA D2 receptor (DRD2), and the DA D4 receptor (DRD4) genes.
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	RESULTS	3	7	6531	SYMBOL|DICTIONARY	slc6a3	SLC6A3	32#38		There was an interaction of DAT SLC6A3 and DRD2 genotypes and dose, because 9/9 DAT children showed a stronger effect of dose when compared with the 9/10 and 10/10 children (p < 0.001) and DRD2 A2/A2 children showed a stronger effect of dose when compared with A1/A1 and A1/A2 children combined (p = 0.007).
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	RESULTS	3	7	1813	SYMBOL|DICTIONARY	drd2	DRD2	43#47		There was an interaction of DAT SLC6A3 and DRD2 genotypes and dose, because 9/9 DAT children showed a stronger effect of dose when compared with the 9/10 and 10/10 children (p < 0.001) and DRD2 A2/A2 children showed a stronger effect of dose when compared with A1/A1 and A1/A2 children combined (p = 0.007).
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	RESULTS	3	7	1813	SYMBOL|DICTIONARY	drd2	DRD2	189#193		There was an interaction of DAT SLC6A3 and DRD2 genotypes and dose, because 9/9 DAT children showed a stronger effect of dose when compared with the 9/10 and 10/10 children (p < 0.001) and DRD2 A2/A2 children showed a stronger effect of dose when compared with A1/A1 and A1/A2 children combined (p = 0.007).
19364291	2009	J Child Adolesc Psychopharmacol	1557-8992	RESULTS	3	8	1815	SYMBOL|DICTIONARY	drd4	DRD4	48#52		There was no significant interaction of dose by DRD4 genotype.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	TITLE	0	0	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	32#36		Association of the 3' region of COMT with schizophrenia in Taiwan.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	1	1312	LONGTERM|DICTIONARY|GENE|GA	catechol o methyltransferase	catechol-O-methyltransferase	71#99		The Val108/158Met (rs4680) single nucleotide polymorphism (SNP) in the catechol-O-methyltransferase (COMT) gene contributes to genetic susceptibility to schizophrenia, which is specifically related to impairments in executive functioning.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	1	1312	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	101#105	19369177-1-71-99	The Val108/158Met (rs4680) single nucleotide polymorphism (SNP) in the catechol-O-methyltransferase (COMT) gene contributes to genetic susceptibility to schizophrenia, which is specifically related to impairments in executive functioning.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	BACKGROUND/PURPOSE	1	2	1312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	90#94	19369177-1-71-99	A different genomic region composed of three SNPs (rs737865, rs4680, rs165599) within the COMT gene has been reported to be significantly associated with schizophrenia in Ashkenazi Jews.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	CONCLUSION	4	10	1312	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	comt	COMT	68#72	19369177-1-71-99	The SNP rs165599, which has been mapped to the 3'-UTR region of the COMT gene, was significantly associated with schizophrenia in our family study, and possibly associated with the age of onset, delusion/hallucination symptom dimension, and CPT performance.
19369177	2009	J. Formos. Med. Assoc.	0929-6646	CONCLUSION	4	11	1312	SYMBOL|DICTIONARY|EXTRACTED	comt	COMT	11#15	19369177-1-71-99	Therefore, COMT may contribute to the genetic risk for schizophrenia not through the Val108/158Met polymorphism, but through other variants that are situated 3' to this region, in the Taiwanese population.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	965	SYMBOL|DICTIONARY	cd58	CD58	16#20		The role of the CD58 locus in multiple sclerosis.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|GENE|GN|DICTIONARY	cd58	CD58	71#75		A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	lfa 3	LFA-3	125#130		A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	2	965	SYMBOL|DICTIONARY	cd58	CD58	266#270		A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	3	965	SYMBOL|DICTIONARY	cd58	CD58	25#29		These efforts identify a CD58 variant that provides further evidence of association with MS (P = 1.1 x 10(-6), OR 0.82) and the single protective effect within the CD58 locus is captured by the rs2300747(G) allele.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	3	965	SYMBOL|DICTIONARY	cd58	CD58	164#168		These efforts identify a CD58 variant that provides further evidence of association with MS (P = 1.1 x 10(-6), OR 0.82) and the single protective effect within the CD58 locus is captured by the rs2300747(G) allele.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	4	965	SYMBOL|GFAM|FN|DICTIONARY	cd58	CD58	84#88		This protective rs2300747(G) allele is associated with a dose-dependent increase in CD58 mRNA expression in lymphoblastic cell lines (P = 1.1 x 10(-10)) and in peripheral blood mononuclear cells from MS subjects (P = 0.0037).
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|DICTIONARY	cd58	CD58	35#39		This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	965	SYMBOL|GFAM|FN|DICTIONARY	cd58	CD58	133#137		This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	965	SYMBOL|DICTIONARY	cd58	CD58	77#81		Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	50943	SYMBOL|DICTIONARY	foxp3	FoxP3	180#185		Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	965	SYMBOL|GENE|GN|DICTIONARY	cd58	CD58	212#216		Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	3559	SYMBOL|DICTIONARY	cd25	CD25	274#278		Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19429005	2009	Neurosci. Lett.	0304-3940	TITLE	0	0	9749	SYMBOL|DICTIONARY	phactr2	Phactr2	0#7		Phactr2 and Parkinson's disease.
19429005	2009	Neurosci. Lett.	0304-3940	ALL_TEXT_2/3	2	2	9749	SYMBOL|GENE|GN|DICTIONARY	phactr2	Phactr2	106#113		The present study reevaluates data from the first GWAS and focuses on the SNP (rs11155313, located in the Phactr2 gene) with the lowest P-value in the Tier 2 patient-control series.
19262484	2010	Hypertens. Res.	1348-4214	ALL_TEXT_3/3	3	6	125	SYMBOL|DICTIONARY	adh1b	ADH1B	97#102		Among the SNPs tested, significant association (P<0.001) with drinking behavior was observed for ADH1B Arg47His (rs1229984) and ALDH2 Glu487Lys (rs671) polymorphisms.
19262484	2010	Hypertens. Res.	1348-4214	ALL_TEXT_3/3	3	6	217	SYMBOL|DICTIONARY	aldh2	ALDH2	128#133		Among the SNPs tested, significant association (P<0.001) with drinking behavior was observed for ADH1B Arg47His (rs1229984) and ALDH2 Glu487Lys (rs671) polymorphisms.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	52#81		This study aimed to clarify the association between angiotensin-converting enzyme (ACE) gene polymorphisms and infant wheezing, and to determine whether an association may contribute to early prediction of persistent wheezing and asthma.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	83#86	19383228-1-52-81	This study aimed to clarify the association between angiotensin-converting enzyme (ACE) gene polymorphisms and infant wheezing, and to determine whether an association may contribute to early prediction of persistent wheezing and asthma.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_2/3	2	3	1636	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	49#52	19383228-1-52-81	The insertion/deletion (I/D) polymorphism of the ACE gene was determined by polymerase chain reaction.
19383228	2009	J. Int. Med. Res.	0300-0605	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	40#43	19383228-1-52-81	It is concluded that the DD genotype of ACE is a risk factor for recurrent wheezing in early childhood.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	10111	SYMBOL|DICTIONARY	rad50	Rad50	0#5		Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	672	SYMBOL|DICTIONARY	brca1	BRCA1	0#5		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	675	SYMBOL|DICTIONARY	brca2	BRCA2	10#15		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	472	SYMBOL|DICTIONARY	atm	ATM	113#116		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	11200	SYMBOL|DICTIONARY	chek2	Chek2	120#125		BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	10111	SYMBOL|DICTIONARY	rad50	Rad50	182#187		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4361	SYMBOL|DICTIONARY	mre11	Mre11	188#193		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	4683	SYMBOL|DICTIONARY	nbs1	Nbs1	194#198		Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	10111	SYMBOL|DICTIONARY	rad50	Rad50	41#46		In particular, the c.687delT mutation in Rad50 conferred an odds ratio of 4.3 for the risk of breast cancer in a study of Finnish breast cancer families.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	6	10111	SYMBOL|DICTIONARY	rad50	Rad50	0#5		Rad50 was analyzed in its entirety for 231 familial cases, with no clearly deleterious mutations detected.
19190165	2009	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_3/3	3	7	10111	SYMBOL|DICTIONARY	rad50	Rad50	69#74		These data together suggest that although founder mutations may make Rad50 a significant breast cancer risk factor in certain populations, it is not a factor in others.
19571538	2009	Cardiology	1421-9751	TITLE	0	0	51085	SYMBOL|DICTIONARY	mlxipl	MLXIPL	26#32		G771C Polymorphism in the MLXIPL Gene Is Associated with a Risk of Coronary Artery Disease in the Chinese: A Case-Control Study.
19571538	2009	Cardiology	1421-9751	OBJECTIVES	1	1	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	130#136		Previously, a genome-wide scan has identified a nonsynonymous single nucleotide polymorphism (rs3812316, G771C, Gln241His) in the MLXIPL gene that is associated with the level of plasma triglycerides.
19571538	2009	Cardiology	1421-9751	METHODS	2	4	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	40#46		The genotype of the polymorphism in the MLXIPL gene was determined in 352 CAD patients and 152 CAD-free subjects.
19571538	2009	Cardiology	1421-9751	METHODS	2	5	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	51#57		All of the participants were selected to study the MLXIPL gene rs3812316 polymorphism using the polymerase chain reaction restriction fragment length polymorphism method.
19571538	2009	Cardiology	1421-9751	CONCLUSION	4	9	51085	SYMBOL|GENE|GN|DICTIONARY	mlxipl	MLXIPL	35#41		The gene sequence variation in the MLXIPL gene may serve as a novel genetic marker for the risk of significant CAD.
19420919	2009	Cerebrovasc. Dis.	1421-9786	TITLE	0	0	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	0#10		E-selectin genetic variation as a susceptibility factor for ischemic stroke.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_1/3	1	1	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	24#34		The polymorphism of the E-selectin gene has been implicated in the pathogenesis of atherosclerosis.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_2/3	2	4	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	76#86		Participants were evaluated for known cerebrovascular risk factors, and the E-selectin S128R and L554F genotypes were established using the polymerase chain reaction (PCR) method.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_2/3	2	5	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	68#78		The frequency of minor allele (R) and heterozygous (RS) genotype of E-selectin S128R polymorphism was significantly higher in the stroke patients than in the controls.
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_2/3	2	6	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	36#46		Evaluation of genetic variation for E-selectin L554F polymorphisms revealed that the frequency of minor allele (F) and its heterozygous genotype (LF) is almost 4 times higher in the stroke patients than the controls (16.7 vs. 4.3 and 33.4 vs. 8.5, respectively).
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_3/3	3	8	6401	LONGTERM|GENE|GN|DICTIONARY	e selectin	E-selectin	38#48		The combination of 2 minor alleles of E-selectin genes appeared to be the strongest susceptibility factor for ischemic stroke (adjusted OR: 5.89, 95% CI: 2.84-12.21, p = 0.0001).
19420919	2009	Cerebrovasc. Dis.	1421-9786	ALL_TEXT_3/3	3	9	6401	LONGTERM|DICTIONARY	e selectin	E-selectin	32#42		Our study demonstrates that the E-selectin S128R and L554F polymorphisms are associated with susceptibility to ischemic stroke.
20037740	2011	Comp. Funct. Genomics	1532-6268	TITLE	0	0	3576	LONGTERM|DICTIONARY	interleukin 8	interleukin-8	15#28		Association of interleukin-8 with cachexia from patients with low-third gastric cancer.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|GENE|GN|DICTIONARY	il 8	IL-8	20#24		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	2	3576	SYMBOL|DICTIONARY	il 8	IL-8	72#76		The polymorphism of IL-8 gene, which may affect the production level of IL-8, may be associated with cancer cachexia.Methods.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	3	3576	SYMBOL|DICTIONARY	il 8	IL-8	10#14		The serum IL-8 level in our study was examined by radioimmunoassay.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_2/3	2	4	3576	SYMBOL|GENE|GN|DICTIONARY	il 8	IL-8	81#85		We also analyzed single nucleotide polymorphisms (SNPs) -251 A/T and +781 C/T of IL-8 gene, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).Results.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_2/3	2	5	3576	SYMBOL|DICTIONARY	il 8	IL-8	20#24		The serum levels of IL-8 were significantly elevated in patients with low-third gastric cancer compared with controls, and were further up-regulated in patients with cachexia than those without (Z = -3.134, P = .002).
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_3/3	3	9	3576	SYMBOL|DICTIONARY	il 8	IL-8	0#4		IL-8 appears to be associated with cachexia from patients with low-third gastric cancer.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5698	SYMBOL|DICTIONARY	lmp2	LMP2	31#35		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5696	SYMBOL|DICTIONARY	lmp7	LMP7	51#55		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_1/3	1	1	5687	SYMBOL|DICTIONARY	psma6	PSMA6	75#80		Large multifunctional protease LMP2 (Arg60-->His), LMP7 (Lys145-->Gln) and PSMA6 (C(-8)-->G) gene allelic polymorphisms in 147 young patients with essential hypertension and in 208 practically healthy people were determinated.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_2/3	2	2	5698	SYMBOL|GENE|GN|DICTIONARY	lmp2	LMP2	77#81		It was shown that interrelation of genotypes Arg/Arg, Arg/His and His/His in LMP2 gene polymorphisms account 42.5 %, 46.4% and 11.1% correspondingly (in control--63.9%, 28.6%, 7.5%; P = 0.001 by c2-test).
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	3	5687	SYMBOL|DICTIONARY	psma6	PSMA6	20#25		Allelic variants of PSMA6 dispense the next manner: C/C--76.2%, C/G--21.1%, G/G--2.7% in adolescents with EH (in control--69.8%, 29.7% and 0.5% correspondingly, P = 0,047).
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	4	5696	SYMBOL|GENE|GN|DICTIONARY	lmp7	LMP7	12#16		Analysis of LMP7 gene polymorphism showed identical frequency of different genotypes in patients (Lys/Lys--92.4%, Lys/Gln--7.6%, Gln/Gln--0%) and practically healthy people (97.3%, 2.7%, 0% correspondingly; P = 0.16).
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	5	5698	SYMBOL|DICTIONARY	lmp2	LMP2	26#30		Obtained data suggest the LMP2 and PSMA6 gene polymorphisms significance as the risk factors of essential hypertension in adolescents.
19526842	2009	Fiziol Zh	2522-9028	ALL_TEXT_3/3	3	5	5687	SYMBOL|GENE|GN|DICTIONARY	psma6	PSMA6	35#40		Obtained data suggest the LMP2 and PSMA6 gene polymorphisms significance as the risk factors of essential hypertension in adolescents.
19811440	2009	Immunol. Invest.	1532-4311	TITLE	0	0	7099	SYMBOL|DICTIONARY	tlr4	TLR4	0#4		TLR4 and IL-18 gene variants in chronic periodontitis: impact on disease susceptibility and severity.
19811440	2009	Immunol. Invest.	1532-4311	TITLE	0	0	3606	SYMBOL|GENE|GN|DICTIONARY	il 18	IL-18	9#14		TLR4 and IL-18 gene variants in chronic periodontitis: impact on disease susceptibility and severity.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	1	7099	LONGTERM|GENE|GN|DICTIONARY	toll like receptor 4	Toll-like receptor 4	60#80		The aim of the study was to assess whether genotypes in the Toll-like receptor 4 gene and in the promoter of the interleukin-18 gene are associated with the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	1	3606	LONGTERM|GENE|GN|DICTIONARY	interleukin 18	interleukin-18	113#127		The aim of the study was to assess whether genotypes in the Toll-like receptor 4 gene and in the promoter of the interleukin-18 gene are associated with the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	2	7099	SYMBOL|GENE|GN|DICTIONARY	tlr4	TLR4	88#92		108 chronic periodontitis patients and 76 controls were genotyped for c.896A>G/1196C>T (TLR4 gene) and for c.-368G>C/ c.-838C>A (IL-18 promoter).
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_1/3	1	2	3606	SYMBOL|GENE|GN|DICTIONARY	il 18	IL-18	129#134		108 chronic periodontitis patients and 76 controls were genotyped for c.896A>G/1196C>T (TLR4 gene) and for c.-368G>C/ c.-838C>A (IL-18 promoter).
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_2/3	2	4	7099	SYMBOL|DICTIONARY	tlr4	TLR4	40#44		Periodontitis severity in patients with TLR4 c.896AG/1196CT genotype was significantly higher than wildtype carriers.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	8	3606	SYMBOL|DICTIONARY	il 18	IL-18	30#35		The results did not show that IL-18 and TLR4 variants have an effect on the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	8	7099	SYMBOL|DICTIONARY	tlr4	TLR4	40#44		The results did not show that IL-18 and TLR4 variants have an effect on the susceptibility to chronic periodontitis.
19811440	2009	Immunol. Invest.	1532-4311	ALL_TEXT_3/3	3	9	7099	SYMBOL|DICTIONARY	tlr4	TLR4	62#66		Considering the low number of periodontitis patients carrying TLR4 variants (11%), a comparison of the periodontitis severity depending on the genotype has to be interpreted cautiously.
19602897	2009	Intervirology	1423-0100	TITLE	0	0	3077	SYMBOL|DICTIONARY	hfe	HFE	30#33		Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
19602897	2009	Intervirology	1423-0100	OBJECTIVES	1	1	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	116#119		We studied the status of hepatic iron deposition and its relationship with blood iron indices, liver histology, and HFE gene mutations in Korean patients with chronic hepatitis C (CH-C).
19602897	2009	Intervirology	1423-0100	METHODS	2	3	3077	SYMBOL|GENE|GN|DICTIONARY	hfe	HFE	171#174		The hepatic iron deposition, histological activity and fibrosis were assessed by appropriate pathological scoring systems, clinical data including serum iron indices, and HFE gene mutation.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	5621	SYMBOL|DICTIONARY	prnp	PRNP	64#68		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	23627	SYMBOL|DICTIONARY	prnd	PRND	70#74		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	10858	SYMBOL|DICTIONARY	cyp46	CYP46	76#81		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	TITLE	0	0	348	SYMBOL|GENE|GN|DICTIONARY	apoe	APOE	87#91		Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	348	SYMBOL|DICTIONARY	apoe	APOE	38#42		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	5621	SYMBOL|DICTIONARY	prnp	PRNP	44#48		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	23627	SYMBOL|DICTIONARY	prnd	PRND	50#54		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_1/3	1	1	10858	SYMBOL|GENE|GN|DICTIONARY	cyp46	CYP46	60#65		We studied eight polymorphisms within APOE, PRNP, PRND, and CYP46 genes in 213 Polish late-onset patients with Alzheimer's disease (AD) and 171 non-demented elderly controls.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	348	SYMBOL|DICTIONARY	apoe	APOE	108#112		Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	5621	SYMBOL|DICTIONARY	prnp	PRNP	130#134		Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	23627	SYMBOL|DICTIONARY	prnd	PRND	159#163		Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19363267	2009	J. Alzheimers Dis.	1875-8908	ALL_TEXT_3/3	3	5	10858	SYMBOL|DICTIONARY	cyp46	CYP46	190#195		Logistic regression analysis showed that the highest risk for AD was found for individuals who co-inherited APOE epsilon4 allele, PRNP codon 129 homozygosity, PRND codon 174 Thr allele, and CYP46 rs754203 g allele.
19276544	2009	J. Alzheimers Dis.	1387-2877	TITLE	0	0	9846	SYMBOL|GENE|GN|DICTIONARY	gab2	GAB2	15#19		Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|()|GENE|GN|DICTIONARY	gab2	GAB2	75#79		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	175#191		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	193#197	19276544-1-175-191	A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_2/3	2	2	9846	SYMBOL|DICTIONARY	gab2	GAB2	42#46		In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_2/3	2	2	9846	SYMBOL|DICTIONARY	gab2	GAB2	147#151		In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	3	9846	SYMBOL|GENE|GN|DICTIONARY	gab2	GAB2	46#50		Our results support a possible implication of GAB2 genetic variant in AD.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	4	348	SYMBOL|EXTRACTED	apoe	ApoE	50#54	19276544-1-175-191	However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_3/3	3	4	9846	SYMBOL|DICTIONARY	gab2	GAB2	113#117		However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	3	6247	SYMBOL|GENE|GN|DICTIONARY	rs1	RS1	48#51		We characterized the mutational spectrum of the RS1 gene in Korean patients with XLRS, and aimed to provide genetic information of XLRS in an Asian population.
19580347	2009	Neoplasma	0028-2685	TITLE	0	0	3091	SYMBOL|()|GENE|GN|DICTIONARY	hif 1alpha	HIF-1alpha	54#64		Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer.
19580347	2009	Neoplasma	0028-2685	ALL_TEXT_1/3	1	1	3091	SYMBOL|()|GENE|GN|DICTIONARY	hif 1alpha	HIF-1alpha	79#89		The C1772T, G1790A and C111A polymorphisms of Hypoxia-inducible factor-1alpha (HIF-1alpha) gene were analyzed in a hospital-based Malaysian population using PCR-RFLP method.
19580347	2009	Neoplasma	0028-2685	ALL_TEXT_2/3	2	3	3091	SYMBOL|DICTIONARY	hif 1alpha	HIF-1alpha	40#50		We investigated the association between HIF-1alpha polymorphisms and breast cancer risk, and clinico-pathological parameters in the population.
20072949	2010	Pol J Pathol	1233-9687	TITLE	0	0	1586	SYMBOL|DICTIONARY	cyp17	CYP17	4#9		The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
20072949	2010	Pol J Pathol	1233-9687	TITLE	0	0	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	14#19		The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_1/3	1	2	1586	SYMBOL|DICTIONARY	cyp17	CYP17	37#42		We hypothesise that polymorphisms of CYP17 and CYP19 gene can predict higher incidence of breast cancer.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_1/3	1	2	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	47#52		We hypothesise that polymorphisms of CYP17 and CYP19 gene can predict higher incidence of breast cancer.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_2/3	2	3	1586	SYMBOL|DICTIONARY	cyp17	CYP17	121#126		In the present work the distribution of genotypes and frequency of alleles of the T/C polymorphism in promoter region of CYP17 and Trp/Arg polymorphism in codon 39 of CYP19 gene in breast cancer women were investigated.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_2/3	2	3	1588	SYMBOL|GENE|GN|DICTIONARY	cyp19	CYP19	167#172		In the present work the distribution of genotypes and frequency of alleles of the T/C polymorphism in promoter region of CYP17 and Trp/Arg polymorphism in codon 39 of CYP19 gene in breast cancer women were investigated.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_3/3	3	5	1586	SYMBOL|DICTIONARY	cyp17	CYP17	61#66		The distribution of the genotypes of the T/C polymorphism of CYP17 in patients differed significantly (p < 0.05) from those predicted by the Hardy-Weinberg equilibrium.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_3/3	3	7	1588	SYMBOL|DICTIONARY	cyp19	CYP19	74#79		However, the distribution of the genotypes of the Trp/Arg polymorphism of CYP19 in both control and patients did not differ significantly (p > 0.05) from those predicted by the Hardy-Weinberg distribution.
20072949	2010	Pol J Pathol	1233-9687	ALL_TEXT_3/3	3	8	1586	SYMBOL|GENE|GN|DICTIONARY	cyp17	CYP17	64#69		The results support the hypothesis that the T/C polymorphism of CYP17 gene may be associated with the incidence of breast cancer in women from Lodz region of Poland.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	8#16		Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	21#27		Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	SYMBOL|()|DICTIONARY	ptpn22	PTPN22	195#201		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	METHODS	2	4	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	15#23		Genotyping for HLA-DRB1 and PTPN22 C1858T single nucleotide polymorphism (SNP) (rs2476601) was carried out by group-specific PCR amplification and by real-time PCR allelic discrimination, respectively.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	METHODS	2	4	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	28#34		Genotyping for HLA-DRB1 and PTPN22 C1858T single nucleotide polymorphism (SNP) (rs2476601) was carried out by group-specific PCR amplification and by real-time PCR allelic discrimination, respectively.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	46#54		In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	59#63		In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	5	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	68#72		In Hungarian patients JIA was associated with HLA-DRB1*01, DRB1*08, DRB1*13 (p=0.048, p=0.002, p=0.019, respectively) with marked differences between the disease subtypes classified according to the ILAR criteria.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	6	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	32#38		There was no association of the PTPN22 C1858T SNP with JIA (p=0.66).
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	54#60		No correlation was found between the presence of this PTPN22 SNP and HLA-DRB1 alleles.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	RESULTS	3	7	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	69#77		No correlation was found between the presence of this PTPN22 SNP and HLA-DRB1 alleles.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	8	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	33#41		Our results confirm that certain HLA-DRB1 alleles reported previously as susceptibility factors are strongly associated with JIA in a Hungarian population.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	9	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	32#38		However, C1858T polymorphism of PTPN22, another candidate gene of autoimmunity seems to be independent of JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	108#114		Our data taken together with various findings in different populations suggest that associations related to PTPN22 seem to be more ethnicity-specific in contrast to the general and less population-dependent role of HLA-DRB1 in JIA.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	CONCLUSIONS	4	10	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	215#223		Our data taken together with various findings in different populations suggest that associations related to PTPN22 seem to be more ethnicity-specific in contrast to the general and less population-dependent role of HLA-DRB1 in JIA.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	SYMBOL|()|NUMBER|DICTIONARY	ptpn22	PTPN22	50#56		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_2/3	2	3	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	41#47		We therefore examined the association of PTPN22 1858 C>T polymorphism with susceptibility to SLE in the Polish population, among patients with SLE (n=150) and controls (n=300).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_2/3	2	4	26191	SYMBOL|NUMBER|DICTIONARY	ptpn22	PTPN22	31#37		We found a contribution of the PTPN22 1858 C>T polymorphism to the incidence of SLE.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	5	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	15#21		Women with the PTPN22 TT and PTPN22 CT genotypes displayed a 2.016-fold increased risk of SLE (95% CI=1.324 - 3.070, P=0.0014).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	5	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	29#35		Women with the PTPN22 TT and PTPN22 CT genotypes displayed a 2.016-fold increased risk of SLE (95% CI=1.324 - 3.070, P=0.0014).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	6	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	65#71		However, we did not observe an increased risk for the homozygous PTPN22 TT genotype OR= 2.552 (95% CI=0.6748-9.64, p=0.1675).
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_3/3	3	7	26191	SYMBOL|GENE|GN|DICTIONARY	ptpn22	PTPN22	71#77		Our results confirm an association of the 1858 C>T polymorphism of the PTPN22 gene with SLE, which was previously observed in other populations.
19360675	2009	Autism Res	1939-3806	TITLE	0	0	6532	SYMBOL|DICTIONARY	sert	SERT	44#48		A large-scale screen for coding variants in SERT/SLC6A4 in autism spectrum disorders.
19360675	2009	Autism Res	1939-3806	TITLE	0	0	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	49#55		A large-scale screen for coding variants in SERT/SLC6A4 in autism spectrum disorders.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	70#76		In the current study we explored the hypothesis that rare variants in SLC6A4 contribute to autism susceptibility and to rigid-compulsive behaviors in autism.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_2/3	2	2	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	174#180		We made use of a large number of unrelated cases with autism spectrum disorders (approximately 350) and controls (approximately 420) and screened for rare exonic variants in SLC6A4 by a high-throughput method followed by sequencing.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	4	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	74#80		Furthermore, we did not observe an association of rare coding variants in SLC6A4 with rigid-compulsive traits scores in the cases.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	5	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	76#82		These results do not support a significant role for rare coding variants in SLC6A4 in autism spectrum disorders, nor do they support a significant role for SLC6A4 in rigid-compulsive traits in these disorders.
19360675	2009	Autism Res	1939-3806	ALL_TEXT_3/3	3	5	6532	SYMBOL|DICTIONARY	slc6a4	SLC6A4	156#162		These results do not support a significant role for rare coding variants in SLC6A4 in autism spectrum disorders, nor do they support a significant role for SLC6A4 in rigid-compulsive traits in these disorders.
19360657	2009	Autism Res	1939-3806	TITLE	0	0	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	59#65		Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	1	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	60#66		Reports identified the neuronal glutamate transporter gene, SLC1A1 (OMIM 133550, chromosome 9p24), as a positional and functional candidate gene for obsessive-compulsive disorder (OCD).
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	2	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	243#249		The presence of obsessions and compulsions similar to OCD in autism, the identification of this region in a genome-wide linkage analysis of individuals with autism spectrum disorders (ASDs), and the hypothesized role of glutamate in ASDs make SLC1A1 a candidate gene for ASD as well.
19360657	2009	Autism Res	1939-3806	ALL_TEXT_1/3	1	3	6505	SYMBOL|DICTIONARY	slc1a1	SLC1A1	32#38		To test for association between SLC1A1 and autism, we typed three single nucleotide polymorphisms (SNPs, rs301430, rs301979, rs301434) previously associated with OCD in 86 strictly defined trios with autism.
1930854	1991	Am. J. Hypertens.	0895-7061	TITLE	0	0	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	19#38		Elevated levels of parathyroid hormone in essential hypertensive patients with increased erythrocyte potassium efflux.
1930854	1991	Am. J. Hypertens.	0895-7061	ALL_TEXT_3/3	3	6	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	77#96		As compared with controls those patients presented elevated plasma levels of parathyroid hormone (P less than .05).
1930854	1991	Am. J. Hypertens.	0895-7061	ALL_TEXT_3/3	3	7	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	54#73		In addition, a positive correlation was found between parathyroid hormone and quinine-sensitive K+ efflux in the above ten hypertensives (R = 0.85, P less than .001).
1930854	1991	Am. J. Hypertens.	0895-7061	ALL_TEXT_3/3	3	8	5741	LONGTERM|DICTIONARY	parathyroid hormone	parathyroid hormone	40#59		These results suggest that an excess of parathyroid hormone may be involved in the increase of Ca(2+)-dependent K+ efflux present in some essential hypertensive patients.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	28695	SYMBOL|DICTIONARY	tcra	TCRA	81#85		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	6957	SYMBOL|DICTIONARY	tcrb	TCRB	87#91		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	6965	SYMBOL|DICTIONARY	tcrg	TCRG	96#100		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	7070	SYMBOL|DICTIONARY|EXTRACTED	thy1	THY1	107#111		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	915	SYMBOL|DICTIONARY	cd3d	CD3D	113#117		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	TITLE	0	0	2113	SYMBOL|DICTIONARY	ets1	ETS1	122#126		Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	28695	SYMBOL|DICTIONARY	tcra	TCRA	99#103		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6957	SYMBOL|DICTIONARY	tcrb	TCRB	105#109		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	6965	SYMBOL|DICTIONARY	tcrg	TCRG	115#119		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|DICTIONARY	thy 1	Thy-1	206#211		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	7070	SYMBOL|()|DICTIONARY|EXTRACTED	thy1	THY1	213#217	1982251-1-206-211	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	915	SYMBOL|()|DICTIONARY	cd3d	CD3D	226#230		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	2113	SYMBOL|()|DICTIONARY	ets1	ETS1	259#263		Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	28695	SYMBOL|DICTIONARY	tcra	TCRA	112#116		Only eight of the 17 enzymes examined revealed restriction fragment length polymorphism (RFLP), with the use of TCRA, TCRB, and TCRG.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	6957	SYMBOL|DICTIONARY	tcrb	TCRB	118#122		Only eight of the 17 enzymes examined revealed restriction fragment length polymorphism (RFLP), with the use of TCRA, TCRB, and TCRG.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	2	6965	SYMBOL|DICTIONARY	tcrg	TCRG	128#132		Only eight of the 17 enzymes examined revealed restriction fragment length polymorphism (RFLP), with the use of TCRA, TCRB, and TCRG.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	6	7070	SYMBOL|DICTIONARY|EXTRACTED	thy1	THY1	0#4		THY1 and CD3D genes were polymorphic after MspI digestion but no significant association was observed.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_2/3	2	6	915	SYMBOL|GENE|GN|DICTIONARY	cd3d	CD3D	9#13		THY1 and CD3D genes were polymorphic after MspI digestion but no significant association was observed.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_3/3	3	7	2113	SYMBOL|GENE|GN|DICTIONARY	ets1	ETS1	16#20		Conversely, the ETS1 gene showed polymorphism after TaqI, SstI, and AvaII were used.
1980685	1991	J. Lipid Res.	0022-2275	TITLE	0	0	335	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein a i	apolipoprotein A-I	6#24		Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia.
1980685	1991	J. Lipid Res.	0022-2275	ALL_TEXT_1/3	1	1	335	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein a i	apolipoprotein A-I	3#21		An apolipoprotein A-I gene promoter polymorphism, due to an adenine (A) to guanine (G) transition 78 base pairs upstream from the transcription initiation site, was studied by amplification of the corresponding region of the apoA-I gene, DNA sequencing, and allele-specific oligonucleotide hybridization.
1980685	1991	J. Lipid Res.	0022-2275	ALL_TEXT_1/3	1	1	335	SYMBOL|GENE|GN|DICTIONARY	apoa i	apoA-I	225#231		An apolipoprotein A-I gene promoter polymorphism, due to an adenine (A) to guanine (G) transition 78 base pairs upstream from the transcription initiation site, was studied by amplification of the corresponding region of the apoA-I gene, DNA sequencing, and allele-specific oligonucleotide hybridization.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_1/3	1	1	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	17#20		The frequency of C4A gene deletion was studied in Japanese patients with systemic lupus erythematosus (SLE) and was compared with healthy controls.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_2/3	2	3	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	99#102		They were hybridized with C4 complementary DNA by the Southern blotting method and the deletion of C4A gene was judged from restriction fragment length polymorphism.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	6	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	34#37		On the other hand the deletion of C4A gene was not found in Japanese patients with SLE (0%), or in healthy controls (0.6%).
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	7	720	SYMBOL|GENE|GN|DICTIONARY	c4a	C4A	206#209		Our results indicate that C4AQ0 may contribute to the pathogenesis of SLE beyond the ethnical differences but Japanese patients with SLE have a different genetic background from Caucasian patients with the C4A gene deleted.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	8	4292	SYMBOL|NUMBER|DICTIONARY	mlh1	MLH1	59#63		Nineteen SNPs were evaluated in the key MMR genes: five in MLH1, 10 in MSH2, and 4 in PMS2.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	8	4436	SYMBOL|DICTIONARY	msh2	MSH2	71#75		Nineteen SNPs were evaluated in the key MMR genes: five in MLH1, 10 in MSH2, and 4 in PMS2.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	8	5395	SYMBOL|DICTIONARY	pms2	PMS2	86#90		Nineteen SNPs were evaluated in the key MMR genes: five in MLH1, 10 in MSH2, and 4 in PMS2.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	9	4292	SYMBOL|DICTIONARY	mlh1	MLH1	32#36		Among Caucasian men, one SNP in MLH1 (rs9852810) was associated with overall prostate cancer risk [odds ratio, 1.21; 95% confidence interval (95% CI), 1.02, 1.44; P = 0.03], more aggressive prostate cancer (odds ratio, 1.49; 95% CI, 1.15, 1.91; P < 0.01), and prostate cancer recurrence (hazard ratio, 1.83; 95% CI, 1.18, 2.86; P < 0.01), but not prostate cancer-specific mortality.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	RESULTS	3	10	4292	SYMBOL|DICTIONARY	mlh1	MLH1	30#34		A nonsynonymous coding SNP in MLH1, rs1799977 (I219V), was also found to be associated with more aggressive disease.
20056646	2010	Cancer Epidemiol. Biomarkers Prev.	1538-7755	CONCLUSION	4	12	4292	SYMBOL|DICTIONARY	mlh1	MLH1	109#113		This population-based case-control study provides evidence for a possible association with a gene variant in MLH1 in relation to the risk of overall prostate cancer, more aggressive disease, and prostate cancer recurrence, which warrants replication.
26437028	2016	Nat. Genet.	1546-1718	TITLE	0	0	118856	SYMBOL|DICTIONARY	mmp21	MMP21	0#5		MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	118856	SYMBOL|DICTIONARY	mmp21	MMP21	129#134		By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	118856	LONGTERM|DICTIONARY	matrix metallopeptidase 21	matrix metallopeptidase 21	145#171		By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	118856	SYMBOL|DICTIONARY	mmp21	Mmp21	13#18		In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.
26437028	2016	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	118856	SYMBOL|DICTIONARY	mmp21	mmp21	35#40		In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.
26141506	2015	Chem. Biol. Interact.	1872-7786	ALL_TEXT_2/3	2	6	2353	SYMBOL|GENE|GN|DICTIONARY	fos	Fos	168#171		Ninety minutes after the treatment, the animals were perfused, the lumbar spinal cord collected, crioprotected, cut and submitted in an immunofluorescence protocol for Fos protein.
26095815	2016	Placenta	1532-3102	TITLE	0	0	23526	LONGTERM|DICTIONARY	minor histocompatibility antigen ha 1	minor histocompatibility antigen HA-1	30#67		Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women.
26095815	2016	Placenta	1532-3102	RESULTS	3	7	23526	SYMBOL|GENE|GN|DICTIONARY	ha 1	HA-1	0#4		HA-1 protein expression was higher in the syncytiotrophoblast of first trimester as compared to second trimester and term placentas (P<0.01).
26095815	2016	Placenta	1532-3102	RESULTS	3	10	23526	SYMBOL|GENE|GN|DICTIONARY	ha 1	HA-1	0#4		HA-1 protein expression was increased in syncytial nuclear aggregates and the syncytiotrophoblast of preeclamptic vs. control placentas (P = 0.02 and 0.03, respectively).
25466283	2015	Am. J. Hum. Genet.	1537-6605	TITLE	0	0	84942	SYMBOL|DICTIONARY	wdr73	WDR73	30#35		Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_1/3	1	2	84942	SYMBOL|DICTIONARY	wdr73	WDR73	88#93		Through a combination of autozygosity mapping and whole-exome sequencing, we identified WDR73 as a gene in which mutations cause Galloway-Mowat syndrome in two unrelated families.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	3	84942	SYMBOL|DICTIONARY	wdr73	WDR73	0#5		WDR73 encodes a WD40-repeat-containing protein of unknown function.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_2/3	2	4	84942	SYMBOL|DICTIONARY	wdr73	WDR73	19#24		Here, we show that WDR73 was present in the brain and kidney and was located diffusely in the cytoplasm during interphase but relocalized to spindle poles and astral microtubules during mitosis.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	5	84942	SYMBOL|DICTIONARY	wdr73	WDR73	40#45		Fibroblasts from one affected child and WDR73-depleted podocytes displayed abnormal nuclear morphology, low cell viability, and alterations of the microtubule network.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	6	84942	SYMBOL|DICTIONARY	wdr73	WDR73	24#29		These data suggest that WDR73 plays a crucial role in the maintenance of cell architecture and cell survival.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	7	84942	SYMBOL|DICTIONARY	wdr73	WDR73	12#17		Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability, and homogenous brain MRI features.
25466283	2015	Am. J. Hum. Genet.	1537-6605	ALL_TEXT_3/3	3	8	84942	SYMBOL|DICTIONARY	wdr73	WDR73	0#5		WDR73 is another example of a gene involved in a disease affecting both the kidney glomerulus and the CNS.
25256182	2015	Stroke	1524-4628	RESULTS	3	6	100048912	SYMBOL|DICTIONARY	cdkn2bas	CDKN2BAS	90#98		Genome-wide evidence of association was detected in the discovery sample on chromosome 9 (CDKN2BAS; rs10733376: P<1.0×10(-11)), in a gene previously associated with IA.
25256182	2015	Stroke	1524-4628	RESULTS	3	7	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	37#42		A novel region on chromosome 7, near HDAC9, was associated with IA (rs10230207; P=4.14×10(-8)).
25256182	2015	Stroke	1524-4628	CONCLUSIONS	4	11	9734	SYMBOL|DICTIONARY	hdac9	HDAC9	137#142		This region on chromosome 7 has been previously associated with ischemic stroke and the large vessel stroke occlusive subtype (including HDAC9), suggesting a possible genetic link between this stroke subtype and IA.
25356585	2015	PLoS ONE	1932-6203	TITLE	0	0	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	50#61		Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	7037	LONGTERM|GENE|GT|DICTIONARY	transferrin receptor	transferrin receptor	178#198		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	7037	SYMBOL|()|DICTIONARY|EXTRACTED	tfrc	TFRC	200#204	25356585-5-178-198	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9289	LONGTERM|DICTIONARY	g protein coupled receptor 56	G protein-coupled receptor 56	210#239		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9289	SYMBOL|()|DICTIONARY|EXTRACTED	gpr56	GPR56	241#246	25356585-5-210-239	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	64167	LONGTERM|DICTIONARY	endoplasmic reticulum aminopeptidase 2	endoplasmic reticulum aminopeptidase 2	293#331		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	64167	SYMBOL|()|DICTIONARY|EXTRACTED	erap2	ERAP2	333#338	25356585-5-293-331	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9945	LONGTERM|DICTIONARY	glutamine fructose 6 phosphate transaminase 2	glutamine-fructose-6-phosphate transaminase 2	341#386		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	9945	SYMBOL|()|DICTIONARY|EXTRACTED	gfpt2	GFPT2	388#393	25356585-5-341-386	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	399#410		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1513	SYMBOL|()|DICTIONARY|EXTRACTED	ctsk	CTSK	412#416	25356585-5-399-410	Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	5	1363	LONGTERM|DICTIONARY	carboxypeptidase e	carboxypeptidase E	465#483		Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	6	972	SYMBOL|DICTIONARY	cd74	CD74	201#205		Seventy five protease inhibitor genes were differentially expressed, of which 3 genes were highly overexpressed, the genes coding for stefin B (CSTB), peptidase inhibitor 3 (PI3 also named elafin) and CD74.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	8	1513	SYMBOL|DICTIONARY|EXTRACTED	ctsk	CTSK	0#4		CTSK overexpression was validated using RT-qPCR in GBM tissues as well.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	9	1513	LONGTERM|DICTIONARY	cathepsin k	Cathepsin K	0#11		Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells.
25356585	2015	PLoS ONE	1932-6203	RESULTS	3	9	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	116#127		Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells.
25356585	2015	PLoS ONE	1932-6203	CONCLUSIONS	4	10	1513	LONGTERM|DICTIONARY	cathepsin k	cathepsin K	52#63		The presence of high levels of inactive proforms of cathepsin K in GBM tissues and cells indicate that in GBM the proteolytic/collagenolytic role is not its primary function but it plays rather a different yet unknown role.
25015659	2015	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	3	6709	LONGTERM|DICTIONARY	alpha ii spectrin	alpha-II spectrin	14#31		Non-erythroid alpha-II spectrin is a cytoskeletal protein cleaved by the protease calpain when this enzyme is activated by dysregulation of calcium in injured cells.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	tp53	TP53	101#105		Genes with a significant frequency (false discovery rate (FDR)<0.05) of non-silent mutations include TP53 (47.1%), KRAS (7.8%) and ERBB3 (11.8%).
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	4	3845	SYMBOL|DICTIONARY	kras	KRAS	115#119		Genes with a significant frequency (false discovery rate (FDR)<0.05) of non-silent mutations include TP53 (47.1%), KRAS (7.8%) and ERBB3 (11.8%).
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	4	2065	SYMBOL|DICTIONARY	erbb3	ERBB3	131#136		Genes with a significant frequency (false discovery rate (FDR)<0.05) of non-silent mutations include TP53 (47.1%), KRAS (7.8%) and ERBB3 (11.8%).
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	1956	SYMBOL|DICTIONARY	egfr	EGFR	36#40		Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2064	SYMBOL|DICTIONARY	erbb2	ERBB2	42#47		Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2065	SYMBOL|DICTIONARY	erbb3	ERBB3	49#54		Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	2066	SYMBOL|DICTIONARY	erbb4	ERBB4	56#61		Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.
24868163	2014	Vasc Health Risk Manag	1178-2048	RESULTS	3	6	1401	LONGTERM|GENE|GT|DICTIONARY	c reactive protein	C-reactive protein	199#217		There was no correlation between Cd, Pb, or Hg and severity of CAD although severity correlated positively with atherosclerosis parameters (uric acid, creatinine, triglycerides, blood urea nitrogen, C-reactive protein) and negatively with high density lipoprotein cholesterol.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	TITLE	0	0	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		"ALDH2 is associated to alcohol dependence and is the major genetic determinant of ""daily maximum drinks"" in a GWAS study of an isolated rural Chinese sample."
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	5	217	SYMBOL|DICTIONARY	aldh2	ALDH2	38#43		Significant associations found in the ALDH2 region for AD (minimum P = 4.73 × 10(-8)) and two AD-related phenotypes: flushing response (minimum P = 4.75 × 10(-26)) and maximum drinks in a 24-hr period (minimum P = 1.54 × 10(-16)).
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	6	160762	SYMBOL|DICTIONARY	ccdc63	CCDC63	53#59		Association of previous candidate SNP, rs10774610 in CCDC63, was confirmed but resulted from linkage disequilibrium with ALDH2.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_2/3	2	6	217	SYMBOL|DICTIONARY	aldh2	ALDH2	121#126		Association of previous candidate SNP, rs10774610 in CCDC63, was confirmed but resulted from linkage disequilibrium with ALDH2.
24277619	2014	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-485X	ALL_TEXT_3/3	3	7	217	SYMBOL|DICTIONARY	aldh2	ALDH2	0#5		ALDH2 is strongly associated with flushing response, AD, and maximum drinks in males, with nonsynonymous SNP rs671 explaining 29.2%, 7.9%, and 22.9% of phenotypic variation, respectively, in this sample.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	114#117		Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	68#71		The cytotoxicity was suppressed by preincubation with the selective CB1 receptor antagonist AM251, but not with the selective CB2 receptor antagonist AM630.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	1269	SYMBOL|GENE|GN|DICTIONARY	cb2	CB2	126#129		The cytotoxicity was suppressed by preincubation with the selective CB1 receptor antagonist AM251, but not with the selective CB2 receptor antagonist AM630.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	6	308	LONGTERM|DICTIONARY	annexin v	annexin-V	13#22		Furthermore, annexin-V-positive cells were found among the treated forebrain cells.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	7	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	58#67		Synthetic cannabinoid treatment induced the activation of caspase-3, and preincubation with a caspase-3 inhibitor significantly suppressed the cytotoxicity.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	7	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	94#103		Synthetic cannabinoid treatment induced the activation of caspase-3, and preincubation with a caspase-3 inhibitor significantly suppressed the cytotoxicity.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	8	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	57#66		These synthetic cannabinoids induced apoptosis through a caspase-3-dependent mechanism in the forebrain cultures.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	119#122		Our results indicate that the cytotoxicity of synthetic cannabinoids towards primary neuronal cells is mediated by the CB1 receptor, but not by the CB2 receptor, and further suggest that caspase cascades may play an important role in the apoptosis induced by these synthetic cannabinoids.
24211273	2014	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1269	SYMBOL|GENE|GN|DICTIONARY	cb2	CB2	148#151		Our results indicate that the cytotoxicity of synthetic cannabinoids towards primary neuronal cells is mediated by the CB1 receptor, but not by the CB2 receptor, and further suggest that caspase cascades may play an important role in the apoptosis induced by these synthetic cannabinoids.
23698071	2013	J. Invest. Dermatol.	1523-1747	TITLE	0	0	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	24#32		Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_1/3	1	2	1387	SYMBOL|DICTIONARY	cbp	CBP	37#40		The transcriptional coactivator p300/CBP possesses both histone acetyltransferase (HAT) activity and scaffolding properties that directly influence the transcriptional activation of targeted genes.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	1387	SYMBOL|DICTIONARY	cbp	CBP	53#56		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	1387	SYMBOL|DICTIONARY	cbp	CBP	135#138		We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	5	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	25#33		Global assessment of the p300 HAT transcriptome in human melanoma identified functional roles in promoting cell cycle progression, chromatin assembly, and activation of DNA repair pathways through direct transcriptional regulatory mechanisms.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_3/3	3	7	2033	SYMBOL|DICTIONARY	p300 hat	p300 HAT	32#40		Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7077	SYMBOL|DICTIONARY	timp 2	TIMP-2	152#158		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7124	SYMBOL|DICTIONARY	tnf a	TNF-a	164#169		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	4318	SYMBOL|DICTIONARY	mmp 9	MMP-9	262#267		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	2	4317	SYMBOL|DICTIONARY	mmp 8	MMP-8	0#5		MMP-8 level is elevated as compared to control only in periodontitis patients with metallic restorations.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_2/3	2	3	7076	SYMBOL|DICTIONARY	timp	TIMP	148#152		The character of correlative relationships between the parameters studied in various patients'groups demonstrate relative similarity of MMP, IL and TIMP secretion regulation in patients with intact periodontal.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_3/3	3	6	4313	SYMBOL|DICTIONARY	mmp 2	MMP-2	89#94		The presence of chromium-cobalt or chromium-nickel constructions leads to an increase of MMP-2, IL-lf and IL-6 content in oral fluid.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_3/3	3	6	3569	SYMBOL|DICTIONARY	il 6	IL-6	106#110		The presence of chromium-cobalt or chromium-nickel constructions leads to an increase of MMP-2, IL-lf and IL-6 content in oral fluid.
23768946	2014	Neuromuscul. Disord.	1873-2364	TITLE	0	0	7148	SYMBOL|GENE|GN|DICTIONARY	tnxb	TNXB	39#43		Compound heterozygous mutations of the TNXB gene cause primary myopathy.
23768946	2014	Neuromuscul. Disord.	1873-2364	ALL_TEXT_3/3	3	6	7148	SYMBOL|GENE|GN|DICTIONARY	tnxb	TNXB	137#141		Compound heterozygous mutations were identified: a previously reported 30kb deletion and a non-synonymous novel missense mutation in the TNXB gene.
23505205	2013	Hum. Mutat.	1098-1004	TITLE	0	0	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	6#11		Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain.
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	155#160		Since the publication of our initial report of four point mutations and 10 deletions, we have identified an additional 38 novel nonsynonymous mutations of FOXF1 (nine nonsense, seven frameshift, one inframe deletion, 20 missense, and one no stop).
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	5	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	55#60		This report represents an up to date list of all known FOXF1 mutations to the best of our knowledge.Majority of the cases are sporadic.
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	113#118		Twenty five mutations (60%) are located within the putative DNA-binding domain, indicating its plausible role in FOXF1 function.Five mutations map to the second exon.
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	75#80		We identified two additional genic and eight genomic deletions upstream to FOXF1.
23505205	2013	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	2294	SYMBOL|DICTIONARY	foxf1	FOXF1	100#105		These results corroborate and extend our previous observations and further establish involvement of FOXF1 in ACD/MPV and lung organogenesis.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	9	1786	LONGTERM|DICTIONARY	dna methyltransferase 1	DNA methyltransferase 1	13#36		PDGF-induced DNA methyltransferase 1 (DNMT1) expression was mediated by activation of PI3K/Akt and ERK signaling in RASM cells.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	9	1786	SYMBOL|()|DICTIONARY|EXTRACTED	dnmt1	DNMT1	38#43	23423710-9-13-36	PDGF-induced DNA methyltransferase 1 (DNMT1) expression was mediated by activation of PI3K/Akt and ERK signaling in RASM cells.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	1786	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	dnmt1	DNMT1	23#28	23423710-9-13-36	Selective depletion of DNMT1 protein by Aza-CdR inhibited PDGF-induced RASM cell phenotypic switching, revealing DNMT1-mediated DNA methylation was implicated in asthmatic ASM remodeling.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	1786	SYMBOL|DICTIONARY|EXTRACTED	dnmt1	DNMT1	113#118	23423710-9-13-36	Selective depletion of DNMT1 protein by Aza-CdR inhibited PDGF-induced RASM cell phenotypic switching, revealing DNMT1-mediated DNA methylation was implicated in asthmatic ASM remodeling.
23423710	2013	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	11	1786	SYMBOL|DICTIONARY|EXTRACTED	dnmt1	DNMT1	36#41	23423710-9-13-36	We proposed for the first time that DNMT1 played a key role in PDGF-induced RASM cell phenotypic switching and Aza-CdR is promising in intervening ASM remodeling in asthma.
23566200	2013	Immunology	1365-2567	ALL_TEXT_1/3	1	2	151306	SYMBOL|DICTIONARY	tgr5	TGR5	0#4		TGR5, a transmembrane receptor of BAs, is an immunomodulative factor, but its detailed mechanism remains unclear.
23566200	2013	Immunology	1365-2567	ALL_TEXT_1/3	1	3	151306	SYMBOL|DICTIONARY	tgr5	TGR5	79#83		Here, we aimed to delineate how BAs operate in immunological responses via the TGR5 pathway in human mononuclear cell lineages.
23566200	2013	Immunology	1365-2567	ALL_TEXT_1/3	1	4	151306	SYMBOL|DICTIONARY	tgr5	TGR5	12#16		We examined TGR5 expression in human peripheral blood monocytes, several types of in vitro differentiated macrophages (Mϕs) and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	929	SYMBOL|DICTIONARY	cd14	CD14	145#149		Mϕs differentiated with macrophage colony-stimulating factor and interferon-γ (Mγ-Mϕs), which are similar to the human intestinal lamina propria CD14(+) Mϕs that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated Mϕ and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	5	151306	SYMBOL|DICTIONARY	tgr5	TGR5	272#276		Mϕs differentiated with macrophage colony-stimulating factor and interferon-γ (Mγ-Mϕs), which are similar to the human intestinal lamina propria CD14(+) Mϕs that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated Mϕ and dendritic cells.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	6	151306	SYMBOL|DICTIONARY	tgr5	TGR5	22#26		We also showed that a TGR5 agonist and two types of BAs, deoxycholic acid and lithocholic acid, could inhibit tumour necrosis factor-α production in Mγ-Mϕs stimulated by commensal bacterial antigen or lipopolysaccharide.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	7	151306	SYMBOL|DICTIONARY	tgr5	TGR5	43#47		This inhibitory effect was mediated by the TGR5-cAMP pathway to induce phosphorylation of c-Fos that regulated nuclear factor-κB p65 activation.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	7	5970	SYMBOL|DICTIONARY	p65	p65	129#132		This inhibitory effect was mediated by the TGR5-cAMP pathway to induce phosphorylation of c-Fos that regulated nuclear factor-κB p65 activation.
23566200	2013	Immunology	1365-2567	ALL_TEXT_2/3	2	8	151306	SYMBOL|DICTIONARY	tgr5	TGR5	18#22		Next, we analysed TGR5 levels in lamina propria mononuclear cells (LPMCs) obtained from the intestinal mucosa of patients with CD.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	9	151306	SYMBOL|DICTIONARY	tgr5	TGR5	79#83		Compared with non-inflammatory bowel disease, inflamed CD LPMCs contained more TGR5 transcripts.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	10	929	SYMBOL|DICTIONARY	cd14	CD14	22#26		Among LPMCs, isolated CD14(+) intestinal Mϕs from patients with CD expressed TGR5.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	10	151306	SYMBOL|DICTIONARY	tgr5	TGR5	77#81		Among LPMCs, isolated CD14(+) intestinal Mϕs from patients with CD expressed TGR5.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	11	929	SYMBOL|DICTIONARY	cd14	CD14	23#27		In isolated intestinal CD14(+) Mϕs, a TGR5 agonist could inhibit tumour necrosis factor-α production.
23566200	2013	Immunology	1365-2567	ALL_TEXT_3/3	3	11	151306	SYMBOL|DICTIONARY	tgr5	TGR5	38#42		In isolated intestinal CD14(+) Mϕs, a TGR5 agonist could inhibit tumour necrosis factor-α production.
23264560	2013	Dis Model Mech	1754-8411	TITLE	0	0	4838	SYMBOL|DICTIONARY	nodal	NODAL	0#5		NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos.
23264560	2013	Dis Model Mech	1754-8411	TITLE	0	0	6469	SYMBOL|DICTIONARY	shh	SHH	10#13		NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_2/3	2	6	4838	SYMBOL|DICTIONARY	nodal	NODAL	73#78		Screening for HPE-associated genes in humans suggests the involvement of NODAL or SHH signaling, or both.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_2/3	2	8	4838	SYMBOL|DICTIONARY	nodal	NODAL	106#111		SB-505124, a selective inhibitor of transforming growth factor-B type I receptors was used to inhibit the NODAL pathway.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	9	6469	SYMBOL|DICTIONARY	shh	SHH	36#39		Cyclopamine was used to inhibit the SHH pathway.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	11	4838	SYMBOL|DICTIONARY	nodal	NODAL	42#47		We also investigated double inhibition of NODAL and SHH pathways from the onset of gastrulation by using subthreshold inhibitor concentrations.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	11	6469	SYMBOL|DICTIONARY	shh	SHH	52#55		We also investigated double inhibition of NODAL and SHH pathways from the onset of gastrulation by using subthreshold inhibitor concentrations.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	12	4838	SYMBOL|DICTIONARY	nodal	NODAL	22#27		The inhibitors of the NODAL and SHH pathways, even at low concentration, acted synergistically to promote an HPE-like phenotype.
23264560	2013	Dis Model Mech	1754-8411	ALL_TEXT_3/3	3	12	6469	SYMBOL|DICTIONARY	shh	SHH	32#35		The inhibitors of the NODAL and SHH pathways, even at low concentration, acted synergistically to promote an HPE-like phenotype.
23313952	2013	Nat. Genet.	1546-1718	TITLE	0	0	4665	SYMBOL|DICTIONARY	nab2	NAB2	28#32		Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
23313952	2013	Nat. Genet.	1546-1718	TITLE	0	0	6778	SYMBOL|GENE|GN|DICTIONARY	stat6	STAT6	33#38		Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	2	4665	SYMBOL|DICTIONARY	nab2	NAB2	47#51		A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	2	6778	SYMBOL|DICTIONARY	stat6	STAT6	87#92		A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	3	4665	SYMBOL|DICTIONARY	nab2	NAB2	76#80		Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	3	6778	SYMBOL|GENE|GN|DICTIONARY	stat6	STAT6	81#86		Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4665	SYMBOL|DICTIONARY	nab2	NAB2	14#18		Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	6778	SYMBOL|DICTIONARY	stat6	STAT6	19#24		Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	4665	SYMBOL|DICTIONARY	nab2	NAB2	154#158		Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	5	6778	SYMBOL|DICTIONARY	stat6	STAT6	193#198		Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	6	4665	SYMBOL|DICTIONARY	nab2	NAB2	22#26		Overexpression of the NAB2-STAT6 gene fusion induced proliferation in cultured cells and activated the expression of EGR-responsive genes.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	6	6778	SYMBOL|GENE|GN|DICTIONARY	stat6	STAT6	27#32		Overexpression of the NAB2-STAT6 gene fusion induced proliferation in cultured cells and activated the expression of EGR-responsive genes.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	4665	SYMBOL|DICTIONARY	nab2	NAB2	24#28		These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
23313952	2013	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	6778	SYMBOL|DICTIONARY	stat6	STAT6	29#34		These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.
23142968	2013	Psychiatr. Genet.	1473-5873	TITLE	0	0	55733	SYMBOL|DICTIONARY	hhat	HHAT	72#76		Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene.
23142968	2013	Psychiatr. Genet.	1473-5873	RESULTS	3	6	55733	SYMBOL|GENE|GN|DICTIONARY	hhat	HHAT	95#99		We found a significant association between schizophrenia and the intronic SNP rs7527939 in the HHAT gene (P-value of 6.49×10 with an odds ratio of 2.63, 95% confidence interval of 1.89-3.66).
23142968	2013	Psychiatr. Genet.	1473-5873	CONCLUSION	4	8	55733	SYMBOL|DICTIONARY	hhat	HHAT	125#129		We suggest rs7527939 to be the strongest indicator of susceptibility to schizophrenia in the Bulgarian population within the HHAT locus.
23055271	2013	Ann. Neurol.	1531-8249	TITLE	0	0	10318	SYMBOL|DICTIONARY	tnip1	TNIP1	61#66		Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
23055271	2013	Ann. Neurol.	1531-8249	RESULTS	3	6	3106	SYMBOL|DICTIONARY	hla b	HLA-B	40#45		By imputation and conditional analyses, HLA-B*08 proves to be the major associated allele (p = 2.87 × 10(-113) ; OR, 6.41).
23055271	2013	Ann. Neurol.	1531-8249	RESULTS	3	7	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	45#51		In addition to the expected association with PTPN22 (rs2476601; OR, 1.71; p = 8.2 × 10(-10) ), an imputed coding variant (rs2233290) at position 151 (Pro→Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR, 1.91; p = 3.2 × 10(-10) ).
23055271	2013	Ann. Neurol.	1531-8249	RESULTS	3	7	10318	LONGTERM|DICTIONARY	tnfaip3 interacting protein 1	TNFAIP3-interacting protein 1	166#195		In addition to the expected association with PTPN22 (rs2476601; OR, 1.71; p = 8.2 × 10(-10) ), an imputed coding variant (rs2233290) at position 151 (Pro→Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR, 1.91; p = 3.2 × 10(-10) ).
23055271	2013	Ann. Neurol.	1531-8249	RESULTS	3	7	10318	SYMBOL|DICTIONARY	tnip1	TNIP1	197#202		In addition to the expected association with PTPN22 (rs2476601; OR, 1.71; p = 8.2 × 10(-10) ), an imputed coding variant (rs2233290) at position 151 (Pro→Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR, 1.91; p = 3.2 × 10(-10) ).
23055271	2013	Ann. Neurol.	1531-8249	RESULTS	3	7	26191	SYMBOL|DICTIONARY	ptpn22	PTPN22	236#242		In addition to the expected association with PTPN22 (rs2476601; OR, 1.71; p = 8.2 × 10(-10) ), an imputed coding variant (rs2233290) at position 151 (Pro→Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR, 1.91; p = 3.2 × 10(-10) ).
23055271	2013	Ann. Neurol.	1531-8249	INTERPRETATION	4	8	10318	SYMBOL|DICTIONARY	tnip1	TNIP1	19#24		The association at TNIP1 in EOMG implies disease mechanisms involving ubiquitin-dependent dysregulation of NF-κB signaling.
23055271	2013	Ann. Neurol.	1531-8249	INTERPRETATION	4	9	3106	SYMBOL|DICTIONARY	hla b	HLA-B	48#53		The localization of the major HLA signal to the HLA-B*08 allele suggests that CD8(+) T cells may play a key role in disease initiation or pathogenesis.
23007406	2013	Blood	1528-0020	ALL_TEXT_2/3	2	6	5836	SYMBOL|GENE|GN|DICTIONARY	pygl	PYGL	33#37		The C allele at rs7142143 in the PYGL gene was associated with 3.6-fold higher risk of relapse than the T allele (P = 6.7 × 10(-9)).
23007406	2013	Blood	1528-0020	ALL_TEXT_3/3	3	7	5142	SYMBOL|DICTIONARY	pde4b	PDE4B	56#61		Fourteen of the 134 relapse SNPs, including variants in PDE4B and ABCB1, were also associated with antileukemic drug pharmacokinetics and/or pharmacodynamics.
23007406	2013	Blood	1528-0020	ALL_TEXT_3/3	3	7	5243	SYMBOL|DICTIONARY	abcb1	ABCB1	66#71		Fourteen of the 134 relapse SNPs, including variants in PDE4B and ABCB1, were also associated with antileukemic drug pharmacokinetics and/or pharmacodynamics.
22772592	2012	Mol. Pharmacol.	1521-0111	TITLE	0	0	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	0#6		CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	1	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	127#133		Bietti's crystalline corneoretinal dystrophy (BCD) is a recessive degenerative eye disease caused by germline mutations in the CYP4V2 gene.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_1/3	1	3	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	192#198		In the present study, we analyzed the expression of CYP4 family members in human tissues and conducted functional studies with the wild-type and p.H331P enzymes, to elucidate the link between CYP4V2 activity and BCD.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_2/3	2	4	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	52#58		Expression analysis of 17 CYP1 to CYP4 genes showed CYP4V2 to be a major cytochrome P450 in ARPE-19 cells (a human cell line spontaneously generated from normal human retinal pigmented epithelium) and the only detectable CYP4 transcript.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_2/3	2	5	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	47#53		Immunohistochemical analyses demonstrated that CYP4V2 protein was present in epithelial cells of the retina and cornea and the enzyme was localized to endoplasmic reticulum.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_2/3	2	6	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	26#32		Recombinant reconstituted CYP4V2 protein metabolized eicosapentaenoic acid and docosahexaenoic acid (an important constituent of the retina) to their respective ω-hydroxylated products at rates similar to those observed with purified CYP4F2, which is an established hepatic polyunsaturated fatty acid (PUFA) hydroxylase.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_2/3	2	6	8529	SYMBOL|DICTIONARY	cyp4f2	CYP4F2	234#240		Recombinant reconstituted CYP4V2 protein metabolized eicosapentaenoic acid and docosahexaenoic acid (an important constituent of the retina) to their respective ω-hydroxylated products at rates similar to those observed with purified CYP4F2, which is an established hepatic polyunsaturated fatty acid (PUFA) hydroxylase.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_3/3	3	8	285440	SYMBOL|DICTIONARY	cyp4v2	CYP4V2	38#44		Finally, overexpression of functional CYP4V2 in HepG2 cells altered lipid homeostasis.
22772592	2012	Mol. Pharmacol.	1521-0111	ALL_TEXT_3/3	3	9	285440	SYMBOL|GENE|GN|DICTIONARY	cyp4v2	CYP4V2	21#27		We demonstrated that CYP4V2 protein is expressed at high levels in ocular target tissues of BCD, that the enzyme is metabolically active toward PUFAs, and that the functional deficit among patients with BCD who carry the H331P variant is most likely a consequence of the instability of the mutant protein.
21992601	2012	J. Cell. Mol. Med.	1582-4934	TITLE	0	0	952	SYMBOL|GENE|GN|DICTIONARY	cd38	CD38	15#19		Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	1	952	SYMBOL|DICTIONARY	cd38	CD38	0#4		CD38 is a multifunctional protein involving in a number of signalling pathways.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	2	952	SYMBOL|DICTIONARY	cd38	CD38	23#27		Given that the lack of CD38 is considered as a dedifferentiation marker of lymphocytes and other cells, we hypothesized that CD38 and its signalling pathway may participate in the epithelial-to-mesenchymal transition (EMT) process of podocytes and thereby regulates the integrity of glomerular structure and function.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	2	952	SYMBOL|DICTIONARY	cd38	CD38	125#129		Given that the lack of CD38 is considered as a dedifferentiation marker of lymphocytes and other cells, we hypothesized that CD38 and its signalling pathway may participate in the epithelial-to-mesenchymal transition (EMT) process of podocytes and thereby regulates the integrity of glomerular structure and function.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	3	952	SYMBOL|DICTIONARY	cd38	CD38	64#68		Western blot analysis and RT-PCR demonstrated that renal tissue CD38 expression was lacking in CD38(-/-) mice or substantially reduced in renal CD38 shRNA-transfected WT (CD38-shRNA) mice compared to CD38(+/+) littermates.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	3	952	SYMBOL|DICTIONARY	cd38	CD38	95#99		Western blot analysis and RT-PCR demonstrated that renal tissue CD38 expression was lacking in CD38(-/-) mice or substantially reduced in renal CD38 shRNA-transfected WT (CD38-shRNA) mice compared to CD38(+/+) littermates.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	3	952	SYMBOL|DICTIONARY	cd38	CD38	144#148		Western blot analysis and RT-PCR demonstrated that renal tissue CD38 expression was lacking in CD38(-/-) mice or substantially reduced in renal CD38 shRNA-transfected WT (CD38-shRNA) mice compared to CD38(+/+) littermates.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	3	952	SYMBOL|DICTIONARY	cd38	CD38	171#175		Western blot analysis and RT-PCR demonstrated that renal tissue CD38 expression was lacking in CD38(-/-) mice or substantially reduced in renal CD38 shRNA-transfected WT (CD38-shRNA) mice compared to CD38(+/+) littermates.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_1/3	1	3	952	SYMBOL|DICTIONARY	cd38	CD38	200#204		Western blot analysis and RT-PCR demonstrated that renal tissue CD38 expression was lacking in CD38(-/-) mice or substantially reduced in renal CD38 shRNA-transfected WT (CD38-shRNA) mice compared to CD38(+/+) littermates.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	51062	SYMBOL|ALPHA|DICTIONARY	fsp 1	FSP-1	170#175		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	1674	LONGTERM|DICTIONARY	desmin	desmin	187#193		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	952	SYMBOL|DICTIONARY	cd38	CD38	215#219		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	952	SYMBOL|DICTIONARY	cd38	CD38	229#233		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	952	SYMBOL|DICTIONARY	cd38	CD38	257#261		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	70#74		Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	83#87		Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	5	952	SYMBOL|DICTIONARY	cd38	CD38	111#115		Morphological examinations showed profound injury in the glomeruli of CD38(-/-) or CD38-shRNA mice compared to CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	35#39		This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	6	952	SYMBOL|DICTIONARY	cd38	CD38	48#52		This enhanced glomerular injury in CD38(-/-) or CD38-shRNA mice was accompanied by increased albuminuria and proteinuria.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	7	952	SYMBOL|DICTIONARY	cd38	CD38	227#231		DOCA/high salt treatment further decreased the expression of epithelial markers and increased the abundance of mesenchymal markers, which were accompanied by more increased glomerular damage index and mean arterial pressure in CD38(-/-) and CD38-shRNA mice than CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	7	952	SYMBOL|DICTIONARY	cd38	CD38	241#245		DOCA/high salt treatment further decreased the expression of epithelial markers and increased the abundance of mesenchymal markers, which were accompanied by more increased glomerular damage index and mean arterial pressure in CD38(-/-) and CD38-shRNA mice than CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	7	952	SYMBOL|DICTIONARY	cd38	CD38	262#266		DOCA/high salt treatment further decreased the expression of epithelial markers and increased the abundance of mesenchymal markers, which were accompanied by more increased glomerular damage index and mean arterial pressure in CD38(-/-) and CD38-shRNA mice than CD38(+/+) mice.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	8	952	SYMBOL|DICTIONARY	cd38	CD38	43#47		In vitro studies showed that inhibition of CD38 enhances the EMT in podocytes.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_3/3	3	9	952	SYMBOL|DICTIONARY	cd38	CD38	69#73		In conclusion, our observations reveal that the normal expression of CD38 importantly contributes to the differentiation and function of podocytes and the defect of this gene expression may be a critical mechanism inducing EMT and consequently resulting in glomerular injury and sclerosis.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	10558	SYMBOL|DICTIONARY	sptlc1	SPTLC1	221#227		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	338382	SYMBOL|DICTIONARY	rab7	RAB7	229#233		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	65125	SYMBOL|DICTIONARY	wnk1	WNK1	235#239		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	65125	SYMBOL|DICTIONARY	hsn2	HSN2	240#244		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	54463	SYMBOL|DICTIONARY	fam134b	FAM134B	246#253		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4914	SYMBOL|DICTIONARY	ntrk1	NTRK1	255#260		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4914	SYMBOL|()|DICTIONARY|EXTRACTED	trka	TRKA	262#266	22302274-3-255-260	To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	3	4803	SYMBOL|DICTIONARY	ngfb	NGFB	272#276		To study the frequency of mutations in these genes and the associated phenotypes, we screened 140 index patients in our inherited neuropathy cohort with a clinical diagnosis of HSAN for mutations in the coding regions of SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 (TRKA) and NGFB.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	10558	SYMBOL|DICTIONARY	sptlc1	SPTLC1	82#88		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	338382	SYMBOL|DICTIONARY	rab7	RAB7	90#94		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	65125	SYMBOL|DICTIONARY	wnk1	WNK1	96#100		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	65125	SYMBOL|DICTIONARY	hsn2	HSN2	101#105		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	54463	SYMBOL|DICTIONARY	fam134b	FAM134B	107#114		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	4914	SYMBOL|DICTIONARY	ntrk1	NTRK1	116#121		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_2/3	2	4	4803	SYMBOL|DICTIONARY	ngfb	NGFB	126#130		We identified 25 index patients with mutations in six genes associated with HSAN (SPTLC1, RAB7, WNK1/HSN2, FAM134B, NTRK1 and NGFB); 20 of which appear to be pathogenic giving an overall mutation frequency of 14.3%.
22302274	2013	J. Neurol.	1432-1459	ALL_TEXT_3/3	3	6	10558	SYMBOL|DICTIONARY	sptlc1	SPTLC1	28#34		The p.Cys133Trp mutation in SPTLC1 is the most common cause of HSAN in the UK population and should be screened first in all patients with sporadic or autosomal dominant HSAN.
22388936	2012	Hum. Mol. Genet.	1460-2083	TITLE	0	0	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	34#41		Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
22388936	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	3	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	133#140		We present a family with typical NCL pathology in which we performed exome sequencing and identified a single homozygous mutation in ATP13A2 that fully segregates with disease within the family.
22388936	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	4	23400	SYMBOL|DICTIONARY	atp13a2	ATP13A2	13#20		Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset.
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	41#54		Progesterone modulates the expression of interleukin-6 in cultured term human uterine cervical fibroblasts.
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	PROBLEM	1	2	3569	LONGTERM|DICTIONARY	interleukin 6	interleukin-6	68#81		This study was undertaken to evaluate the effect of progesterone on interleukin-6 (IL-6) production in human uterine cervical fibroblasts (UCFs) treated with lipopolysaccharides (LPS).
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	PROBLEM	1	2	3569	SYMBOL|()|DICTIONARY|EXTRACTED	il 6	IL-6	83#87	22122352-2-68-81	This study was undertaken to evaluate the effect of progesterone on interleukin-6 (IL-6) production in human uterine cervical fibroblasts (UCFs) treated with lipopolysaccharides (LPS).
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	METHOD OF STUDY	2	5	3569	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	il 6	IL-6	0#4		IL-6 mRNA and protein expressions were examined by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	RESULTS	3	6	3569	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	il 6	IL-6	85#89	22122352-2-68-81	Lipopolysaccharides stimulation induced a clear time- and dose-dependent increase in IL-6 mRNA and protein levels in UCFs (P < 0.05).
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	RESULTS	3	7	3569	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	il 6	IL-6	73#77	22122352-2-68-81	Progesterone treatment significantly attenuated LPS-induced increases in IL-6 mRNA and protein expressions in UCFs (P < 0.05).
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	RESULTS	3	8	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	47#51	22122352-2-68-81	Estrogen exposure had no effect on LPS-induced IL-6 up-regulation and did not modulate the effects of progesterone.
22122352	2012	Am. J. Reprod. Immunol.	1600-0897	CONCLUSION	4	9	3569	SYMBOL|DICTIONARY|EXTRACTED	il 6	IL-6	191#195	22122352-2-68-81	Our preliminary results suggest that vaginal progesterone might prevent spontaneous preterm labor through a mechanism involving anti-inflammatory effects on UCFs, particularly suppression of IL-6 production.
22322133	2013	Blood Coagul. Fibrinolysis	1473-5733	ALL_TEXT_2/3	2	2	2160	SYMBOL|GENE|GN|DICTIONARY	f11	F11	4#7		The F11 gene was analyzed and a novel missense mutation I463S in exon 12 was identified in heterozygosity in the proband.
21983886	2012	Arch. Toxicol.	1432-0738	TITLE	0	0	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	37#42		Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
21983886	2012	Arch. Toxicol.	1432-0738	TITLE	0	0	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	47#52		Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	1	2052	LONGTERM|DICTIONARY	microsomal epoxide hydrolase	Microsomal epoxide hydrolase	0#28		Microsomal epoxide hydrolase, EPHX1, plays a central role in the detoxification of potentially genotoxic epoxide intermediates.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	1	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	30#35		Microsomal epoxide hydrolase, EPHX1, plays a central role in the detoxification of potentially genotoxic epoxide intermediates.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_1/3	1	2	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	72#77		In this study, we firstly aimed to investigate the relationship between EPHX1 Tyr113His and His139Arg variants, and the risk of incidence of childhood acute lymphoblastic leukemia (ALL) in Turkish population, comprised of 190 healthy controls and 167 ALL patients.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_2/3	2	6	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	49#54		We also evaluated whether haplotype analysis for EPHX1 Tyr113His polymorphism together with DNA protein XRCC1 Arg399Gln variant known for its deficient DNA repair capacity would represent more prominent risk factors for the development of childhood ALL.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_2/3	2	6	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	104#109		We also evaluated whether haplotype analysis for EPHX1 Tyr113His polymorphism together with DNA protein XRCC1 Arg399Gln variant known for its deficient DNA repair capacity would represent more prominent risk factors for the development of childhood ALL.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	7	2052	SYMBOL|DICTIONARY	ephx1	EPHX1	53#58		Accordingly, the co-presence of Tyr113His variant of EPHX1 and Arg399Gln variant of XRCC1 in the same individuals significantly increased the risk of childhood ALL up to 2.1-fold (OR = 2.1, P = 0.03).
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	7	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	84#89		Accordingly, the co-presence of Tyr113His variant of EPHX1 and Arg399Gln variant of XRCC1 in the same individuals significantly increased the risk of childhood ALL up to 2.1-fold (OR = 2.1, P = 0.03).
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	9	2052	SYMBOL|NUMBER|DICTIONARY	ephx1	EPHX1	32#37		In conclusion, individuals with EPHX1 113His/His slow activity genotype may not detoxify reactive carcinogenic epoxides efficiently, binding of reactive epoxides to DNA cause DNA damage.
22213154	2012	Hum. Mutat.	1098-1004	TITLE	0	0	5076	SYMBOL|DICTIONARY	pax2	PAX2	10#14		Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	2	5076	SYMBOL|DICTIONARY	pax2	PAX2	34#38		Mutations in the paired-box gene, PAX2, have been identified in approximately half of individuals with classic findings of renal hypoplasia/dysplasia and abnormalities of the optic nerve.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	3	5076	SYMBOL|GENE|GN|DICTIONARY	pax2	PAX2	130#134		Prior to 2011, there was no actively maintained locus-specific database (LSDB) cataloguing the extent of genetic variation in the PAX2 gene and phenotypic variation in individuals with renal coloboma syndrome.
22213154	2012	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	5076	SYMBOL|DICTIONARY	pax2	PAX2	83#87		An LSDB was created using the Leiden Open Variation Database platform: www.lovd.nl/PAX2.
22264700	2012	Pediatr. Neurol.	1873-5150	ALL_TEXT_1/3	1	2	7054	LONGTERM|GENE|GN|DICTIONARY	tyrosine hydroxylase	tyrosine hydroxylase	145#165		From 1999 to May 2011, we enrolled six infants who had been diagnosed with tyrosine hydroxylase deficiency by identifying point mutations on the tyrosine hydroxylase gene.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1269	LONGTERM|DICTIONARY	cannabinoid receptor 2	Cannabinoid receptor-2	0#22		Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	1269	SYMBOL|EXTRACTED|()	cb2	CB2	24#27	22119709-0-0-22	Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	60#65		Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	1269	LONGTERM|DICTIONARY	cannabinoid receptor 2	cannabinoid receptor-2	35#57		Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	1269	SYMBOL|EXTRACTED|()	cb2	CB2	59#62	22119709-0-0-22	Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_1/3	1	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	107#112		Here, we investigate the effect of cannabinoid receptor-2 (CB2) agonist, JWH-133, after chronic colitis in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	5	3586	SYMBOL|DICTIONARY	il 10	IL-10	135#140		JWH-133 effectively attenuated the overall clinical score, and reversed colitis-associated pathogenesis and decrease in body weight in IL-10(-/-) mice.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	9	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	62#65	22119709-0-0-22	Treatment with aminoalkylindole 6-iodo-pravadoline (AM630), a CB2 receptor antagonist, reversed the colitis protection provided by JWH-133 treatment.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	11	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	64#67	22119709-0-0-22	These findings suggest that JWH-133 mediates its effect through CB2 receptors, and ameliorates chronic colitis by inducing apoptosis in activated T cells, reducing the numbers of activated T cells, and suppressing induction of mast cells, NK cells, and neutrophils at sites of inflammation in the LP.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_3/3	3	12	1269	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cb2	CB2	40#43	22119709-0-0-22	These results support the idea that the CB2 receptor agonists may serve as a therapeutic modality against IBD.
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	100048912	SYMBOL|DICTIONARY	cdkn2bas	CDKN2BAS	170#178		The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63-0.75], p = 1.86×10⁻¹⁸), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21-1.43], p = 3.87×10⁻¹¹).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	6495	SYMBOL|DICTIONARY	six1	SIX1	264#268		The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63-0.75], p = 1.86×10⁻¹⁸), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21-1.43], p = 3.87×10⁻¹¹).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	5	4990	SYMBOL|DICTIONARY	six6	SIX6	269#273		The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63-0.75], p = 1.86×10⁻¹⁸), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21-1.43], p = 3.87×10⁻¹¹).
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_2/3	2	6	100048912	SYMBOL|GENE|GN|DICTIONARY	cdkn2bas	CDKN2BAS	91#99		In sub-group analysis two loci were significantly associated with NPG: 9p21 containing the CDKN2BAS gene (rs2157719 [G], OR = 0.58 [95% CI 0.50-0.67], p = 1.17×10⁻¹²) and a probable regulatory region on 8q22 (rs284489 [G], OR = 0.62 [95% CI 0.53-0.72], p = 8.88×10⁻¹⁰).
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	2	540	SYMBOL|DICTIONARY	atp7b	ATP7B	99#104		In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	4	540	SYMBOL|DICTIONARY	atp7b	Atp7b	80#85		Using Positron Emission Tomography-Computed Tomography (PET-CT) imaging of live Atp7b(-/-) mice at different stages of disease, a longitudinal metal analysis, and characterization of copper-binding molecules, we show that urinary copper elevation is a specific regulatory process mediated by distinct molecules.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	5	540	SYMBOL|DICTIONARY	atp7b	Atp7b	108#113		PET-CT and atomic absorption spectroscopy directly demonstrate an age-dependent decrease in the capacity of Atp7b(-/-) livers to accumulate copper, concomitant with an increase in urinary copper.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	7	1317	SYMBOL|DICTIONARY	ctr1	Ctr1	102#106		Instead, the urinary copper increase is associated with the down-regulation of the copper-transporter Ctr1 in the liver and appearance of a 2 kDa Small Copper Carrier, SCC, in the urine.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	8	1317	SYMBOL|DICTIONARY	ctr1	Ctr1	56#60		SCC is also elevated in the urine of the liver-specific Ctr1(-/-) knockouts, which have normal ATP7B function, suggesting that SCC is a normal metabolite carrying copper in the serum.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	8	540	SYMBOL|DICTIONARY	atp7b	ATP7B	95#100		SCC is also elevated in the urine of the liver-specific Ctr1(-/-) knockouts, which have normal ATP7B function, suggesting that SCC is a normal metabolite carrying copper in the serum.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	9	1317	SYMBOL|DICTIONARY	ctr1	Ctr1	101#105		In agreement with this hypothesis, partially purified SCC-Cu competes with free copper for uptake by Ctr1.
22802922	2013	PLoS ONE	1932-6203	ALL_TEXT_3/3	3	10	1317	SYMBOL|DICTIONARY	ctr1	Ctr1	33#37		Thus, hepatic down-regulation of Ctr1 allows switching to an SCC-mediated removal of copper via kidney when liver function is impaired.
21750109	2012	Hum. Mol. Genet.	1460-2083	TITLE	0	0	6563	SYMBOL|DICTIONARY	slc14a1	SLC14A1	50#57		European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.
21750109	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	6563	SYMBOL|DICTIONARY	slc14a1	SLC14A1	0#7		SLC14A1 codes for UTs that define the Kidd blood group and are crucial for the maintenance of a constant urea concentration gradient in the renal medulla and, through this, the kidney's ability to concentrate urine.
21750109	2012	Hum. Mol. Genet.	1460-2083	ALL_TEXT_3/3	3	7	6563	LONGTERM|DICTIONARY	kidd blood group	Kidd blood group	38#54		SLC14A1 codes for UTs that define the Kidd blood group and are crucial for the maintenance of a constant urea concentration gradient in the renal medulla and, through this, the kidney's ability to concentrate urine.
21565994	2012	Biol. Reprod.	1529-7268	TITLE	0	0	3948	LONGTERM|DICTIONARY	lactate dehydrogenase c	Lactate dehydrogenase C	0#23		Lactate dehydrogenase C and energy metabolism in mouse sperm.
21565994	2012	Biol. Reprod.	1529-7268	ALL_TEXT_1/3	1	1	3948	LONGTERM|GENE|GN|DICTIONARY	lactate dehydrogenase c	lactate dehydrogenase C	69#92		We demonstrated previously that disruption of the germ cell-specific lactate dehydrogenase C gene (Ldhc) led to male infertility due to defects in sperm function, including a rapid decline in sperm ATP levels, a decrease in progressive motility, and a failure to develop hyperactivated motility.
21565994	2012	Biol. Reprod.	1529-7268	ALL_TEXT_1/3	1	2	2597	LONGTERM|DICTIONARY	glyceraldehyde 3 phosphate dehydrogenase	glyceraldehyde 3-phosphate dehydrogenase	165#205		We hypothesized that lack of LDHC disrupts glycolysis by feedback inhibition, either by causing a defect in renewal of the NAD(+) cofactor essential for activity of glyceraldehyde 3-phosphate dehydrogenase, sperm (GAPDHS), or an accumulation of pyruvate.
21565994	2012	Biol. Reprod.	1529-7268	ALL_TEXT_2/3	2	6	3939	SYMBOL|DICTIONARY	ldha	LDHA	43#47		This supported our earlier conclusion that LDHA, an LDH isozyme present in the principal piece of the flagellum, is responsible for the residual LDH activity in sperm lacking LDHC, but suggested that LDHC has an additional role in the maintenance of energy metabolism in sperm.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1b	135#141		Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	2	9149	SYMBOL|DICTIONARY	dyrk1b	dyrk1B	33#39		The serine/threonine kinase Mirk/dyrk1B was expressed in each of seven ovarian cancer cell lines and in 21 of 28 resected human ovarian cancers, and upregulated in 60% of the cancers.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_1/3	1	3	9149	SYMBOL|GENE|GN|DICTIONARY	mirk	Mirk	116#120		Some ovarian cancer cells were found in a G0 quiescent state, with the highest fraction in a line with an amplified Mirk gene.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	9	595	LONGTERM|DICTIONARY	cyclin d1	cyclin D1	52#61		Mirk contributed to G0 arrest by destabilization of cyclin D1.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	11	9149	SYMBOL|GENE|GN|DICTIONARY	mirk	Mirk	83#87		Because Mirk is expressed at low levels in most normal adult tissues, the elevated Mirk protein levels in ovarian cancers may present a novel therapeutic target, in particular for quiescent tumor cells which are difficult to eradicate by conventional therapies targeting dividing cells.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	TITLE	0	0	6275	SYMBOL|DICTIONARY	s100a4	S100A4	46#52		Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	BACKGROUND	1	2	6275	SYMBOL|DICTIONARY	s100a4	S100A4	0#6		S100A4, a calcium-binding protein, is implicated in promoting metastasis formation in colon cancer.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	3	6275	SYMBOL|DICTIONARY	s100a4	S100A4	41#47		To identify a transcription inhibitor of S100A4, high-throughput screening of 1280 pharmacologically active compounds was performed using a human colon cancer cell line expressing a S100A4 promoter-driven luciferase (LUC) reporter gene construct (HCT116-S1004p-LUC).
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	3	6275	SYMBOL|GENE|GN|DICTIONARY	s100a4	S100A4	182#188		To identify a transcription inhibitor of S100A4, high-throughput screening of 1280 pharmacologically active compounds was performed using a human colon cancer cell line expressing a S100A4 promoter-driven luciferase (LUC) reporter gene construct (HCT116-S1004p-LUC).
21685359	2011	J. Natl. Cancer Inst.	1460-2105	METHODS	2	5	6275	SYMBOL|GFAM|FN|DICTIONARY	s100a4	S100A4	126#132		Colon cancer cell lines (HCT116, SW620, LS174T, SW480, and DLD-1) were treated with 1 μM niclosamide to analyze the effect on S100A4 mRNA and protein expression by quantitative reverse transcription-polymerase chain reaction and immunoblot assays, and effects on cell migration, invasion, proliferation, and colony formation were also assessed in vitro.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	RESULTS	3	8	6275	SYMBOL|GFAM|FN|DICTIONARY	s100a4	S100A4	8#14		Reduced S100A4 mRNA and protein expression, and inhibited cell migration, invasion, proliferation, and colony formation were observed in niclosamide-treated colon cancer cells in vitro.
21685359	2011	J. Natl. Cancer Inst.	1460-2105	CONCLUSION	4	11	6275	SYMBOL|DICTIONARY	s100a4	S100A4	21#27		Niclosamide inhibits S100A4-induced metastasis formation in a mouse model of colon cancer and has therapeutic potential.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	2056	LONGTERM|DICTIONARY	erythropoietin	Erythropoietin	0#14		Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	76#85		Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_1/3	1	2	2056	LONGTERM|DICTIONARY	erythropoietin	Erythropoietin	0#14		Erythropoietin provides renoprotection, but its effects and mechanisms on kidney preservation are not fully defined.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_1/3	1	3	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	152#166		Porcine kidneys, subjected to 10 min warm ischemia, underwent 16 h cold storage followed by 2 h normothermic hemoperfusion with or without 5000 units/L erythropoietin.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_2/3	2	4	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	150#164		Apoptotic cells were increased in tubular lumens and interstitial areas by normothermic perfusion alone, but decreased in tubular areas by additional erythropoietin.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_2/3	2	5	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	138#152		Myeloperoxidase+ cells, free cells and cell debris in tubular lumens were gradually increased by cold storage, normothermic perfusion and erythropoietin in normothermic perfusion.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_2/3	2	6	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	13#22		Accordingly, caspase-3 activity as well as its active proteins was increased by normothermic perfusion and furthered by erythropoietin.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_2/3	2	6	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	120#134		Accordingly, caspase-3 activity as well as its active proteins was increased by normothermic perfusion and furthered by erythropoietin.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	7	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	214#228		In contrast, macrophage L1 protein positive cells in tubulointerstitial areas, cytokine interleukin (IL)-1β activation, tubular dilation and vacuolation were raised by normothermic perfusion, but all alleviated by erythropoietin, with higher urine output.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	8	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	226#240		The migration of myeloperoxidase+ cells with apoptotic features and apoptotic cells with polymorphous nuclei from tubulointerstitial areas into tubular lumens was widely displayed in the kidneys, especially those preserved by erythropoietin in normothermic perfusion.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	9	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	67#81		HSP70 protein was enhanced by normothermic perfusion regardless of erythropoietin.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	10	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	13#27		In addition, erythropoietin induced a dose-dependent increase in caspase-3 precursor in porcine proximal tubular cells (LLC-PK1) and also stimulated caspase-3 cleavage in cisplatin-treated cells.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	10	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	65#74		In addition, erythropoietin induced a dose-dependent increase in caspase-3 precursor in porcine proximal tubular cells (LLC-PK1) and also stimulated caspase-3 cleavage in cisplatin-treated cells.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	10	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	149#158		In addition, erythropoietin induced a dose-dependent increase in caspase-3 precursor in porcine proximal tubular cells (LLC-PK1) and also stimulated caspase-3 cleavage in cisplatin-treated cells.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	2056	LONGTERM|DICTIONARY	erythropoietin	erythropoietin	15#29		In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1β in isolated haemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	836	LONGTERM|DICTIONARY	caspase 3	caspase-3	219#228		In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1β in isolated haemoperfused kidneys.
21153458	2011	Tumour Biol.	1423-0380	TITLE	0	0	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	41#46		Methylation status and overexpression of COX-2 in Tunisian patients with ductal invasive breast carcinoma.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	LONGTERM|DICTIONARY	cyclooxygenase 2	cyclooxygenase-2	48#64		Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	1	5743	SYMBOL|()|DICTIONARY|EXTRACTED	cox 2	COX-2	66#71	21153458-1-48-64	Inflammation and hormonal signalling induce the cyclooxygenase-2 (COX-2) expression in solid tumours including breast cancer, which in turn affects cell proliferation, apoptosis and metastasis.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	59#64	21153458-1-48-64	The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	2064	SYMBOL|DICTIONARY	erbb2	ERBB2	177#182		The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	2	7157	SYMBOL|DICTIONARY	tp53	TP53	187#191		The aim of this study was to investigate the expression of COX-2 and its association with clinical parameters, patient's survival, hormones receptors (oestrogen, progesterone), ERBB2 and TP53 expression in 83 cases of infiltrating ductal breast carcinomas.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_1/3	1	3	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	59#64	21153458-1-48-64	Moreover, the methylation status at the CpG islands of the COX-2 gene promoter was also explored in 70 specimens.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_2/3	2	4	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	54#59	21153458-1-48-64	We showed that tumours exhibiting moderate to intense COX-2 immunostaining were significantly more frequent in patients over 45 years old (p = 0.027).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_2/3	2	5	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	26#31	21153458-1-48-64	Moreover, a high level of COX-2 expression correlated with a shorter survival time (p log-rank = 0.04) and was an independent prognostic factor (p = 0.022; HR 6.4; 95% CI = 1.3-31.4).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_2/3	2	6	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	43#48	21153458-1-48-64	On the other hand, hypermethylation of the COX-2 gene promoter was observed in 27% of cases and strongly associated with smaller tumours (<5 cm, p = 0.011).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_3/3	3	7	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	38#43	21153458-1-48-64	Furthermore, patients with methylated COX-2 pattern have a better 4-year disease-free survival (p = 0.022) as well as a prolonged overall survival (p log-rank test = 0.034).
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_3/3	3	8	5743	SYMBOL|DICTIONARY|EXTRACTED	cox 2	COX-2	35#40	21153458-1-48-64	In conclusion, we showed that high COX-2 expression was associated with reduced survival and was an independent prognostic factor.
21153458	2011	Tumour Biol.	1423-0380	ALL_TEXT_3/3	3	9	5743	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cox 2	COX-2	33#38	21153458-1-48-64	However, hypermethylation of the COX-2 promoter correlated with a better overall survival in Tunisian patients with breast carcinoma.
21040232	2012	Eur. J. Neurol.	1468-1331	TITLE	0	0	6324	SYMBOL|GENE|GN|DICTIONARY	scn1b	SCN1B	73#78		New mutation c.374C>T and a putative disease-associated haplotype within SCN1B gene in Tunisian families with febrile seizures.
21040232	2012	Eur. J. Neurol.	1468-1331	METHODS	2	6	6324	SYMBOL|GENE|GN|DICTIONARY	scn1b	SCN1B	128#133		According to the results obtained by statistical analyses for the six studied families and in agreement with the involvement of SCN1B gene in the GEFS+ syndrome in previous studies, SCN1B on GEFS+1 locus was considered as one of the potential candidate genes and was tested for mutations by direct sequencing.
21040232	2012	Eur. J. Neurol.	1468-1331	METHODS	2	6	6324	SYMBOL|DICTIONARY	scn1b	SCN1B	182#187		According to the results obtained by statistical analyses for the six studied families and in agreement with the involvement of SCN1B gene in the GEFS+ syndrome in previous studies, SCN1B on GEFS+1 locus was considered as one of the potential candidate genes and was tested for mutations by direct sequencing.
21040232	2012	Eur. J. Neurol.	1468-1331	RESULTS	3	7	6324	SYMBOL|GENE|GN|DICTIONARY	scn1b	SCN1B	29#34		A sequencing analysis of the SCN1B gene revealed a novel mutation (c.374G>T) that changed an arginine residue with leucine at position 125 of the protein.
21040232	2012	Eur. J. Neurol.	1468-1331	CONCLUSION	4	10	6324	SYMBOL|DICTIONARY	scn1b	SCN1B	25#30		Our results support that SCN1B is the gene responsible in one amongst the six FS Tunisian families studied and might contribute to the FS susceptibility for the five others.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	TITLE	0	0	593	SYMBOL|GENE|GN|DICTIONARY	bckdha	BCKDHA	82#88		Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	ALL_TEXT_1/3	1	4	593	SYMBOL|DICTIONARY	bckdha	BCKDHA	38#44		We screened all coding regions of the BCKDHA, BCKDHB and DBT genes for abnormalities using direct sequencing.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	ALL_TEXT_1/3	1	4	594	SYMBOL|DICTIONARY	bckdhb	BCKDHB	46#52		We screened all coding regions of the BCKDHA, BCKDHB and DBT genes for abnormalities using direct sequencing.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	ALL_TEXT_2/3	2	8	593	SYMBOL|DICTIONARY	bckdha	BCKDHA	71#77		Three patients were either homozygous or compound heterozygous for the BCKDHA mutations.
21844576	2012	Ann. Clin. Lab. Sci.	1550-8080	ALL_TEXT_3/3	3	11	594	SYMBOL|DICTIONARY	bckdhb	BCKDHB	46#52		These patients had no mutations in either the BCKDHB or the DBT gene.
21285140	2011	Am J Psychiatry	1535-7228	TITLE	0	0	7434	SYMBOL|DICTIONARY|EXTRACTED	vipr2	VIPR2	123#128		Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	6	9378	SYMBOL|DICTIONARY	nrxn1	NRXN1	247#252		In analyses of MGS data combined with other available data sets, odds ratios of 7.5 or greater were observed for previously reported deletions in chromosomes 1q21.1, 15q13.3, and 22q11.21, duplications in 16p11.2, and exon-disrupting deletions in NRXN1.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7037	SYMBOL|DICTIONARY	tfrc	TFRC	129#133		The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	622	SYMBOL|DICTIONARY	bdh1	BDH1	137#141		The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7434	LONGTERM|DICTIONARY	vasoactive intestinal peptide receptor 2	vasoactive intestinal peptide receptor 2	257#297		The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	7434	SYMBOL|()|DICTIONARY|EXTRACTED	vipr2	VIPR2	299#304	21285140-7-257-297	The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	RESULTS	3	7	29035	SYMBOL|DICTIONARY	c16orf72	C16orf72	334#342		The most consistently supported candidate associations across data sets included a 1.6-Mb deletion in chromosome 3q29 (21 genes, TFRC to BDH1) that was previously described in a mild-moderate mental retardation syndrome, exonic duplications in the gene for vasoactive intestinal peptide receptor 2 (VIPR2), and exonic duplications in C16orf72.
21285140	2011	Am J Psychiatry	1535-7228	CONCLUSIONS	4	9	9378	SYMBOL|DICTIONARY	nrxn1	NRXN1	138#143		The data strongly confirm the association of schizophrenia with 1q21.1, 15q13.3, and 22q11.21 deletions, 16p11.2 duplications, and exonic NRXN1 deletions.
21285140	2011	Am J Psychiatry	1535-7228	CONCLUSIONS	4	11	7434	SYMBOL|DICTIONARY|EXTRACTED	vipr2	VIPR2	50#55	21285140-7-257-297	Additional candidate genes and regions, including VIPR2, were identified.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	7850	SYMBOL|DICTIONARY	il1r2	IL1R2	248#253		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3577	SYMBOL|DICTIONARY	il8ra	IL8RA	255#260		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3579	SYMBOL|DICTIONARY	il8rb	IL8RB	261#266		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3575	SYMBOL|DICTIONARY	il7r	IL7R	268#272		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3593	SYMBOL|DICTIONARY	il12b	IL12B	274#279		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	1611	SYMBOL|DICTIONARY	dap	DAP	281#284		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	639	SYMBOL|DICTIONARY	prdm1	PRDM1	286#291		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3717	SYMBOL|DICTIONARY	jak2	JAK2	293#297		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	3663	SYMBOL|DICTIONARY	irf5	IRF5	299#303		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	2768	SYMBOL|DICTIONARY	gna12	GNA12	305#310		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	4	4046	SYMBOL|DICTIONARY	lsp1	LSP1	315#319		After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1.
21094227	2011	Toxicol. Lett.	1879-3169	TITLE	0	0	3565	SYMBOL|DICTIONARY	il 4	IL-4	0#4		IL-4 mediates dicloxacillin-induced liver injury in mice.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_2/3	2	8	3565	SYMBOL|DICTIONARY	il 4	IL-4	18#22		Neutralization of IL-4 suppressed the hepatotoxicity of dicloxacillin, and recombinant mouse IL-4 administration (0.5 or 2.0 μg/mouse, i.p.) exacerbated it.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_2/3	2	8	3565	SYMBOL|DICTIONARY	il 4	IL-4	93#97		Neutralization of IL-4 suppressed the hepatotoxicity of dicloxacillin, and recombinant mouse IL-4 administration (0.5 or 2.0 μg/mouse, i.p.) exacerbated it.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	9	11251	SYMBOL|()|DICTIONARY|EXTRACTED	crth2	CRTh2	69#74	21094227-9-0-67	Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) is a cognate receptor for prostaglandin (PG) D(2), and is suggested to be involved in Th2-dependent allergic inflammation.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	TITLE	0	0	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	LONGTERM|GENE|GT|DICTIONARY	brain derived neurotrophic factor	brain-derived neurotrophic factor	4#37		The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	1	627	SYMBOL|()|DICTIONARY|EXTRACTED	bdnf	BDNF	39#43	21300947-1-4-37	The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD).
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	2	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	44#48	21300947-1-4-37	However, genetic association studies of the BDNF gene with AD have produced equivocal results.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONTEXT	1	3	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	60#64	21300947-1-4-37	Imaging-genetics strategies may clarify the manner in which BDNF gene variation predicts the risk of AD via characterization of its effects on at-risk structures or neural networks susceptible in this disorder.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	OBJECTIVE	2	4	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	25#29	21300947-1-4-37	To determine whether the BDNF Val66Met gene variant interacts with age to predict brain and cognitive measures in healthy volunteers across the adult lifespan in an intermediate phenotype pattern related to AD by examining (1) cortical thickness, (2) fractional anisotropy of white matter tracts (ie, white matter integrity), and (3) episodic memory performance.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	MAIN OUTCOME MEASURES	6	8	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	The BDNF Val66Met genotype, apolipoprotein E genotype, cortical thickness, microstructural integrity of white matter tracts, and episodic memory performance were evaluated.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	MAIN OUTCOME MEASURES	6	8	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	28#44		The BDNF Val66Met genotype, apolipoprotein E genotype, cortical thickness, microstructural integrity of white matter tracts, and episodic memory performance were evaluated.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	RESULTS	7	9	627	SYMBOL|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	The BDNF Val66Met polymorphism interacted with age to predict (1) cortical thickness (prominently at the entorhinal cortex and temporal gyri), (2) fractional anisotropy of white matter tracts (prominently at white matter tracts connecting to the medial temporal lobe), and (3) episodic memory performance.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONCLUSIONS	8	11	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	4#8	21300947-1-4-37	The BDNF gene confers risk in an age-dependent manner on the brain structures and cognitive functions that are consistent with the neural circuitry vulnerable in the earliest stages of AD.
21300947	2011	Arch. Gen. Psychiatry	1538-3636	CONCLUSIONS	8	12	627	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	bdnf	BDNF	61#65	21300947-1-4-37	Our novel findings provide convergent evidence in vivo for a BDNF genetic mechanism of susceptibility in an intermediate phenotype related to AD.
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	2	641	SYMBOL|GENE|GN|DICTIONARY	blm	BLM	17#20		Mutations of the BLM gene (encoding a BLM helicase) may form a structure of the etiology of this disease.
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	2	641	SYMBOL|DICTIONARY	blm	BLM	38#41		Mutations of the BLM gene (encoding a BLM helicase) may form a structure of the etiology of this disease.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	TITLE	0	0	410	SYMBOL|DICTIONARY	arsa	ARSA	67#71		Adult-type metachromatic leukodystrophy with compound heterozygous ARSA mutations: a case report and phenotypic comparison with a previously reported case.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	113#128		Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by a deficiency of arylsulfatase A. MLD is a heterogeneous disease with variable age at onset and variable clinical features.
21265945	2011	Psychiatry Clin. Neurosci.	1440-1819	ALL_TEXT_2/3	2	3	410	SYMBOL|DICTIONARY	arsa	ARSA	85#89		She was diagnosed with MLD by genetic analysis, which revealed compound heterozygous ARSA missense mutations (p.G99D and p.T409I).
21270338	2011	Sci Transl Med	1946-6242	TITLE	0	0	7389	LONGTERM|DICTIONARY	uroporphyrinogen decarboxylase	Uroporphyrinogen decarboxylase	0#30		Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	LONGTERM|DICTIONARY	uroporphyrinogen decarboxylase	Uroporphyrinogen decarboxylase	0#30		Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_1/3	1	3	7389	SYMBOL|()|DICTIONARY|EXTRACTED	urod	UROD	32#36	21270338-3-0-30	Uroporphyrinogen decarboxylase (UROD), a key regulator of heme biosynthesis, was identified from an RNA interference-based high-throughput screen as a tumor-selective radiosensitizing target for HNC.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	4	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		UROD knockdown plus radiation induced caspase-mediated apoptosis and cell cycle arrest in HNC cells in vitro and suppressed the in vivo tumor-forming capacity of HNC cells, as well as delayed the growth of established tumor xenografts in mice.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_2/3	2	6	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	10#14	21270338-3-0-30	Moreover, UROD was significantly overexpressed in HNC patient biopsies.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	7	7389	SYMBOL|GFAM|FN|DICTIONARY|EXTRACTED	urod	UROD	19#23	21270338-3-0-30	Lower preradiation UROD mRNA expression correlated with improved disease-free survival, suggesting that UROD could potentially be used to predict radiation response.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	7	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	104#108	21270338-3-0-30	Lower preradiation UROD mRNA expression correlated with improved disease-free survival, suggesting that UROD could potentially be used to predict radiation response.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	8	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	0#4		UROD down-regulation also radiosensitized several different models of human cancer, as well as sensitized tumors to chemotherapeutic agents, including 5-fluorouracil, cisplatin, and paclitaxel.
21270338	2011	Sci Transl Med	1946-6242	ALL_TEXT_3/3	3	9	7389	SYMBOL|DICTIONARY|EXTRACTED	urod	UROD	29#33	21270338-3-0-30	Thus, our study has revealed UROD as a potent tumor-selective sensitizer for both radiation and chemotherapy, with potential relevance to many human malignancies.
21264219	2011	PLoS ONE	1932-6203	TITLE	0	0	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	0#5		DIA1R is an X-linked gene related to Deleted In Autism-1.
21264219	2011	PLoS ONE	1932-6203	TITLE	0	0	205428	LONGTERM|DICTIONARY	deleted in autism 1	Deleted In Autism-1	37#56		DIA1R is an X-linked gene related to Deleted In Autism-1.
21264219	2011	PLoS ONE	1932-6203	BACKGROUND	1	3	205428	LONGTERM|DICTIONARY|GENE|GA	deleted in autism 1	Deleted-In-Autism-1	98#117		Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene.
21264219	2011	PLoS ONE	1932-6203	BACKGROUND	1	3	205428	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	dia1	DIA1	119#123	21264219-3-98-117	Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	90#94	21264219-3-98-117	Using a bioinformatics-based approach, we have identified a human gene closely related to DIA1, we term DIA1R (DIA1-Related).
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	104#109		Using a bioinformatics-based approach, we have identified a human gene closely related to DIA1, we term DIA1R (DIA1-Related).
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	79742	SYMBOL|EXTRACTED|()	dia1 related	DIA1-Related	111#123	21264219-4-104-109	Using a bioinformatics-based approach, we have identified a human gene closely related to DIA1, we term DIA1R (DIA1-Related).
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	6#10	21264219-3-98-117	While DIA1 is autosomal (chromosome 3, position 3q24), DIA1R localizes to the X chromosome at position Xp11.3 and is known to escape X-inactivation.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	55#60		While DIA1 is autosomal (chromosome 3, position 3q24), DIA1R localizes to the X chromosome at position Xp11.3 and is known to escape X-inactivation.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	44#48	21264219-3-98-117	The gene products are of similar size, with DIA1 encoding 430, and DIA1R 433, residues.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	79742	SYMBOL|NUMBER|DICTIONARY	dia1r	DIA1R	67#72		The gene products are of similar size, with DIA1 encoding 430, and DIA1R 433, residues.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	25#29	21264219-3-98-117	At the amino acid level, DIA1 and DIA1R are 62% similar overall (28% identical), and both encode signal peptides for targeting to the secretory pathway.
21264219	2011	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	34#39		At the amino acid level, DIA1 and DIA1R are 62% similar overall (28% identical), and both encode signal peptides for targeting to the secretory pathway.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	64#69		Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	9	79742	SYMBOL|DICTIONARY	dia1r	DIA1R	129#134		Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	10	205428	SYMBOL|DICTIONARY|EXTRACTED	dia1	DIA1	50#54	21264219-3-98-117	Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.
21264219	2011	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	10	79742	SYMBOL|GENE|GN|DICTIONARY	dia1r	DIA1R	59#64		Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	TITLE	0	0	636	SYMBOL|DICTIONARY	bicd1	BICD1	41#46		Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	MEASUREMENTS AND MAIN RESULTS	4	6	636	SYMBOL|DICTIONARY	bicd1	BICD1	65#70		we identified association of a single-nucleotide polymorphism in BICD1 with the presence or absence of emphysema (P = 5.2 × 10(-7) with at least mild emphysema vs. control subjects; P = 4.8 × 10(-8) with moderate and more severe emphysema vs. control subjects).
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	CONCLUSIONS	5	7	636	SYMBOL|DICTIONARY	bicd1	BICD1	44#49		our study suggests that genetic variants in BICD1 are associated with qualitative emphysema in COPD.
20709820	2011	Am. J. Respir. Crit. Care Med.	1535-4970	CONCLUSIONS	5	8	636	SYMBOL|DICTIONARY	bicd1	BICD1	12#17		Variants in BICD1 are associated with length of telomeres, which suggests that a mechanism linked to accelerated aging may be involved in the pathogenesis of emphysema.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	8	6470	SYMBOL|DICTIONARY	shmt	SHMT	63#67		We observed that interactions between MTHFR677, MTHFR1298, and SHMT polymorphisms may have a significant impact on genetic instability in lung cancer patients.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	272#277		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	4524	SYMBOL|NUMBER|DICTIONARY	mthfr	MTHFR	283#288		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	9	6470	SYMBOL|DICTIONARY	shmt	SHMT	299#303		With regard to cytogenetic alterations, our results showed that lymphocytes from lung cancer patients exposed to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] had considerably increased frequency of cytogenetic damage in presence of MTHFR 677, MTHFR 1298, and SHMT allelic variants.
21074862	2011	J. Neuroimmunol.	1872-8421	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	39#47		We examined several autoantibodies and HLA-DRB1 genotyping in 260 Japanese MG patients.Sixty-two MG patients had thymoma.
21074862	2011	J. Neuroimmunol.	1872-8421	ALL_TEXT_3/3	3	6	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	0#8		HLA-DRB1 genotyping failed to detect statistical differences in specific alleles between each group and healthy controls.
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_1/3	1	1	51082	SYMBOL|DICTIONARY	polr1d	POLR1D	84#90		We identified a deletion of a gene encoding a subunit of RNA polymerases I and III, POLR1D, in an individual with Treacher Collins syndrome (TCS).
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_2/3	2	2	51082	SYMBOL|DICTIONARY	polr1d	POLR1D	66#72		Subsequently, we detected 20 additional heterozygous mutations of POLR1D in 252 individuals with TCS.
21131976	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	9533	SYMBOL|DICTIONARY	polr1c	POLR1C	56#62		Furthermore, we discovered mutations in both alleles of POLR1C in three individuals with TCS.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_1/3	1	1	4204	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MECP2	131#136	21966470-1-101-129	Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mecp2	MeCP2	41#46		These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
21966470	2012	PLoS ONE	1932-6203	ALL_TEXT_2/3	2	3	4204	SYMBOL|DICTIONARY|EXTRACTED	mecp2	MeCP2	150#155		These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|DICTIONARY|EXTRACTED	ptger3	PTGER3	288#294	21966456-1-277-280	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	2	5733	SYMBOL|EXTRACTED	ep3	EP3	22#25	21966456-1-249-275	We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	2	5733	SYMBOL|EXTRACTED	ep3	EP3	133#136	21966456-1-249-275	We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	3	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP).
21966456	2012	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	48#51	21966456-1-249-275	We performed immunohistological analysis of the EP3 protein and evaluated the immunohistological staining of EP3 protein in the conjunctival epithelium of patients with ocular surface diseases.
21966456	2012	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	109#112	21966456-1-249-275	We performed immunohistological analysis of the EP3 protein and evaluated the immunohistological staining of EP3 protein in the conjunctival epithelium of patients with ocular surface diseases.
21966456	2012	PLoS ONE	1932-6203	CONCLUSIONS	3	9	5733	SYMBOL|EXTRACTED	ep3	EP3	55#58	21966456-1-249-275	We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases.
21966456	2012	PLoS ONE	1932-6203	CONCLUSIONS	3	10	5733	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	ep3	EP3	19#22	21966456-1-249-275	The examination of EP3 protein expression in conjunctival epithelium may aid in the differential diagnosis of various ocular surface diseases.
21151597	2011	Mol. Vis.	1090-0535	TITLE	0	0	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	17#22		Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population.
21151597	2011	Mol. Vis.	1090-0535	PURPOSE	1	1	149233	LONGTERM|GENE|GT|DICTIONARY|GA	interleukin 23 receptor	interleukin-23 receptor	80#103		The aim of the study was to investigate the association of polymorphisms of the interleukin-23 receptor (IL23R) gene with Fuchs' syndrome in a Chinese Han population.
21151597	2011	Mol. Vis.	1090-0535	PURPOSE	1	1	149233	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	il23r	IL23R	105#110	21151597-1-80-103	The aim of the study was to investigate the association of polymorphisms of the interleukin-23 receptor (IL23R) gene with Fuchs' syndrome in a Chinese Han population.
21151597	2011	Mol. Vis.	1090-0535	METHODS	2	2	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	86#91	21151597-1-80-103	Three single-nucleotide polymorphisms (SNPs), rs7517847, rs11209032 and rs17375018 of IL23R were genotyped in 138 Chinese Han patients with Fuchs' syndrome and 407 healthy controls by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.Data were analyzed by χ(2) analysis.
21151597	2011	Mol. Vis.	1090-0535	RESULTS	3	7	149233	SYMBOL|DICTIONARY|EXTRACTED	il23r	IL23R	99#104	21151597-1-80-103	Additionally, analysis according to gender did not show any influence of sex on the association of IL23R with Fuchs' syndrome.
21151597	2011	Mol. Vis.	1090-0535	CONCLUSIONS	4	8	149233	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il23r	IL23R	61#66	21151597-1-80-103	Our results suggested that the rs11209032 AA genotype of the IL23R gene may predispose for Fuchs' syndrome in Chinese patients.
21187522	2011	Anticancer Res.	1791-7530	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		KRAS genotyping as biomarker in colorectal cancer: a comparison of three commercial kits on histologic material.
21187522	2011	Anticancer Res.	1791-7530	BACKGROUND/AIM	1	1	3845	SYMBOL|DICTIONARY	kras	KRAS	20#24		The crucial role of KRAS status in new colorectal cancer target therapy raises the issue regarding which testing method to use.
21187522	2011	Anticancer Res.	1791-7530	PATIENTS AND METHODS	2	3	3845	SYMBOL|DICTIONARY	kras	KRAS	14#18		A group of 40 KRAS wild-type (wt), 40 codon 12-mutated and 32 codon-13 mutated samples, previously evaluated by real-time PCR (TheraScreen kit), used as reference method, were analysed by Ampli-set-K-RAS and K-RAS StripAssay kit (herein called kit A and B, respectively) based on two different technologies.
20630504	2011	Fertil. Steril.	1556-5653	TITLE	0	0	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	17#28		A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	84467	LONGTERM|GENE|GN|DICTIONARY	fibrillin 3	fibrillin-3	82#93		In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF) β and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20977478	2011	J. Neurochem.	1471-4159	TITLE	0	0	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	70#75		Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	TITLE	0	0	6470	SYMBOL|()|DICTIONARY|EXTRACTED	shmt1	SHMT1	77#82	20977478-0-70-75	Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_1/3	1	3	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	266#271		Our previous quantitative trait loci analysis using C57BL/6 (B6) mice with better PPI performance and C3H/He (C3) with lower PPI score, shows that genes for both D-serine synthesizing enzyme and enzyme for reversible conversion between glycine and L-serine (Srr and Shmt1, respectively) are located in the same PPI-quantitative trait loci peak.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_2/3	2	8	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	37#42		There were promoter polymorphisms in Shmt1, which elicit lower transcriptional activity in B6 compared to C3 conforming to the results of brain expression levels, but no functional genetic variants in Srr.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	10	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	SHMT1	4#9	20977478-0-70-75	The SHMT1 levels were higher in schizophrenic brains compared to controls, but no changes in SRR levels.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	11	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	SHMT1	42#47	20977478-0-70-75	We detected a nominal association between SHMT1 and schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	12	6470	SYMBOL|DICTIONARY|EXTRACTED	shmt1	Shmt1	27#32		These results suggest that Shmt1 (SHMT1), but not Srr, is likely to be one of the genetic components regulating PPI in mice and possibly relevant to schizophrenia.
20977478	2011	J. Neurochem.	1471-4159	ALL_TEXT_3/3	3	12	6470	SYMBOL|()|DICTIONARY|EXTRACTED	shmt1	SHMT1	34#39	20977478-0-70-75	These results suggest that Shmt1 (SHMT1), but not Srr, is likely to be one of the genetic components regulating PPI in mice and possibly relevant to schizophrenia.
21110240	2011	Swiss Med Wkly	1424-3997	TITLE	0	0	348	SYMBOL|DICTIONARY|EXTRACTED	apoe	APOE	0#4		APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E (ApoE), an important glycoprotein in the transport, uptake and redistribution of cholesterol, is necessary in nerve tissue repair.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	1	348	SYMBOL|EXTRACTED|()	apoe	ApoE	18#22	21110240-1-0-16	Apolipoprotein E (ApoE), an important glycoprotein in the transport, uptake and redistribution of cholesterol, is necessary in nerve tissue repair.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	4#8	21110240-2-4-8	The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE ε4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|()|DICTIONARY|EXTRACTED	apoe	APOE	15#19	21110240-2-4-8	The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE ε4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	2	348	SYMBOL|ALPHA|DICTIONARY|EXTRACTED	apoe	APOE	114#118	21110240-2-4-8	The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE ε4 allele and Alzheimer's disease.
21110240	2011	Swiss Med Wkly	1424-3997	PRINCIPLES	1	4	348	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apoe	APOE	91#95	21110240-2-4-8	The aim of this study was to assess (multicentre assessment) the possible influence of the APOE gene on the susceptibility of primary progressive MS (PPMS) in Hungary.
20810130	2011	J. Neurol. Sci.	1878-5883	TITLE	0	0	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	18#26		Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	1	3123	SYMBOL|NUMBER|DICTIONARY	hla drb1	HLA-DRB1	110#118		Multiple sclerosis (MS) has been consistently associated with the HLA-DR2 haplotype and particularly with the HLA-DRB1*15 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	drb1	DRB1	60#64		Epistatic interactions between both parental alleles in the DRB1 loci have been shown to modify the MS susceptibility risk.
20810130	2011	J. Neurol. Sci.	1878-5883	BACKGROUND AND OBJECTIVE	1	3	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	51#59		This study investigated the frequencies of various HLA-DRB1 genotypes, their impact on MS susceptibility and their correlation with the clinical severity in a Spanish population.
20810130	2011	J. Neurol. Sci.	1878-5883	METHODS	2	4	3123	SYMBOL|DICTIONARY	drb1	DRB1	65#69		A genotype was considered as the combination of the two parental DRB1 alleles.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	8	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	28#32		Three of them contained the DRB1*15 allele (DRB1*03/15, DRB1*04/15, and DRB1*08/15) and the fourth was homozygote for the DRB1*03 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	44#48		Three of them contained the DRB1*15 allele (DRB1*03/15, DRB1*04/15, and DRB1*08/15) and the fourth was homozygote for the DRB1*03 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	56#60		Three of them contained the DRB1*15 allele (DRB1*03/15, DRB1*04/15, and DRB1*08/15) and the fourth was homozygote for the DRB1*03 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	72#76		Three of them contained the DRB1*15 allele (DRB1*03/15, DRB1*04/15, and DRB1*08/15) and the fourth was homozygote for the DRB1*03 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	122#126		Three of them contained the DRB1*15 allele (DRB1*03/15, DRB1*04/15, and DRB1*08/15) and the fourth was homozygote for the DRB1*03 allele.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	51#55		The highest odds ratio was found with the genotype DRB1*08/15 (OR=3.88, 95% CI=1.83-8.26, p<0.01), followed by DRB1*03/03 (OR=3.15, 95% CI=1.93-5.14, p<0.01), DRB1*03/15 (OR=2.72, 95% CI=1.88-3.94, p<0.01) and DRB1*04/15 (OR=2.54, 95% CI=1.64-3.98, p<0.01).
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	111#115		The highest odds ratio was found with the genotype DRB1*08/15 (OR=3.88, 95% CI=1.83-8.26, p<0.01), followed by DRB1*03/03 (OR=3.15, 95% CI=1.93-5.14, p<0.01), DRB1*03/15 (OR=2.72, 95% CI=1.88-3.94, p<0.01) and DRB1*04/15 (OR=2.54, 95% CI=1.64-3.98, p<0.01).
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	159#163		The highest odds ratio was found with the genotype DRB1*08/15 (OR=3.88, 95% CI=1.83-8.26, p<0.01), followed by DRB1*03/03 (OR=3.15, 95% CI=1.93-5.14, p<0.01), DRB1*03/15 (OR=2.72, 95% CI=1.88-3.94, p<0.01) and DRB1*04/15 (OR=2.54, 95% CI=1.64-3.98, p<0.01).
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	210#214		The highest odds ratio was found with the genotype DRB1*08/15 (OR=3.88, 95% CI=1.83-8.26, p<0.01), followed by DRB1*03/03 (OR=3.15, 95% CI=1.93-5.14, p<0.01), DRB1*03/15 (OR=2.72, 95% CI=1.88-3.94, p<0.01) and DRB1*04/15 (OR=2.54, 95% CI=1.64-3.98, p<0.01).
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		The DRB1*01/04 and the DRB1*15/15 genotypes were associated with a shorter time to reach an EDSS score of 6.
20810130	2011	J. Neurol. Sci.	1878-5883	RESULTS	3	10	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	23#27		The DRB1*01/04 and the DRB1*15/15 genotypes were associated with a shorter time to reach an EDSS score of 6.
20810130	2011	J. Neurol. Sci.	1878-5883	CONCLUSIONS	4	11	3123	SYMBOL|DICTIONARY	hla drb1	HLA-DRB1	68#76		Our results show the importance of epistatic interactions among the HLA-DRB1 alleles, modifying the risk for MS as well as its clinical severity.
20959826	2011	Br. J. Cancer	1532-1827	TITLE	0	0	3845	SYMBOL|DICTIONARY	kras	KRAS	0#4		KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis.
20959826	2011	Br. J. Cancer	1532-1827	BACKGROUND	1	2	3845	SYMBOL|DICTIONARY	kras	KRAS	163#167		In this retrospective study, high-resolution melting analysis (HRMA) was validated and implemented for screening of 164 colorectal cancer (CRC) patients to detect KRAS hot-spot mutations and to evaluate its prognostic value.
20959826	2011	Br. J. Cancer	1532-1827	METHODS	2	5	3845	SYMBOL|DICTIONARY	kras	KRAS	24#28		The prognostic value of KRAS mutations in CRC was evaluated using survival analysis.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	7	3845	SYMBOL|DICTIONARY	kras	KRAS	137#141		Kaplan-Meier survival curves revealed a significantly shorter overall (OS) and disease-free survival (DFS) for CRC patients harbouring a KRAS mutation.
20959826	2011	Br. J. Cancer	1532-1827	RESULTS	3	8	3845	SYMBOL|DICTIONARY	kras	KRAS	92#96		In the Cox regression analysis, only when colon and rectal cancer were analysed separately, KRAS mutation was a negative predictor for OS in patients with rectal cancer and DFS in those with stage II colon cancer.
20959826	2011	Br. J. Cancer	1532-1827	CONCLUSIONS	4	9	3845	SYMBOL|DICTIONARY	kras	KRAS	50#54		HRMA was found to be a valid screening method for KRAS mutation detection.
20959826	2011	Br. J. Cancer	1532-1827	CONCLUSIONS	4	10	3845	SYMBOL|DICTIONARY	kras	KRAS	4#8		The KRAS mutation came forward as a negative predictive factor for OS in patients with rectal cancer and for DFS in stage II colon cancer patients.
20724907	2010	Am. J. Med. Sci.	1538-2990	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	25#41		Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease.
20724907	2010	Am. J. Med. Sci.	1538-2990	TITLE	0	0	2876	LONGTERM|GENE|GN|DICTIONARY	glutathione peroxidase 1	glutathione peroxidase 1	46#70		Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	67#83		The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	LONGTERM|DICTIONARY	glutathione peroxidase 1	glutathione peroxidase 1	96#120		The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	INTRODUCTION	1	1	2876	SYMBOL|()|DICTIONARY|EXTRACTED	gpx1	GPX1	122#126	20724907-1-96-120	The main objective of this study is to determine the prevalence of apolipoprotein E (Apo E) and glutathione peroxidase 1 (GPX1) polymorphisms and their influence on the development of Alzheimer disease (AD) in the Ecuadorian population.
20724907	2010	Am. J. Med. Sci.	1538-2990	RESULTS	3	8	2876	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gpx1	GPX1	81#85	20724907-1-96-120	The authors found a positive association between ε4 and ε2 alleles of Apo E. The GPX1 gene shows an association of leu allele, whereas pro allele shows a negative association.
20724907	2010	Am. J. Med. Sci.	1538-2990	CONCLUSIONS	4	10	2876	SYMBOL|DICTIONARY|EXTRACTED	gpx1	GPX1	83#87	20724907-1-96-120	Apo E is not a risk factor, nor a protective one for AD, whereas the leu allele of GPX1 is a possible risk factor for the disease.
20662556	2010	DNA Cell Biol.	1557-7430	TITLE	0	0	3603	LONGTERM|GENE|GN|DICTIONARY	interleukin 16	interleukin-16	18#32		Association of an interleukin-16 gene polymorphism with the risk and pain phenotype of endometriosis.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	3603	LONGTERM|DICTIONARY	interleukin 16	Interleukin-16	0#14		Interleukin-16 (IL-16), a proinflammatory cytokine, plays a pivotal role in inflammatory diseases as well as in the pathogenesis of endometriosis.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	1	3603	SYMBOL|()|DICTIONARY|EXTRACTED	il 16	IL-16	16#21	20662556-1-0-14	Interleukin-16 (IL-16), a proinflammatory cytokine, plays a pivotal role in inflammatory diseases as well as in the pathogenesis of endometriosis.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_1/3	1	2	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	57#62	20662556-1-0-14	The aim of this study was to evaluate the association of IL-16 gene polymorphisms with the risk and clinical phenotypes of endometriosis in Chinese women.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_2/3	2	3	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	63#68	20662556-1-0-14	We analyzed rs4778889 T/C, rs11556218 T/G polymorphisms of the IL-16 gene in 230 patients with endometriosis and 203 controls in a Chinese population, using a polymerase chain reaction-high resolution melting analysis strategy and DNA sequencing methods.
20662556	2010	DNA Cell Biol.	1557-7430	ALL_TEXT_3/3	3	6	3603	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	il 16	IL-16	63#68	20662556-1-0-14	Our results suggest that the rs4778889 T/C polymorphism of the IL-16 gene may be associated with risk of endometriosis in the Chinese population, especially in patients with pain phenotype.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	Epidermal growth factor receptor	0#32		Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	SYMBOL|()|DICTIONARY|EXTRACTED	egfr	EGFR	34#38	20939760-0-0-32	Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
20939760	2011	Exp. Lung Res.	1521-0499	TITLE	0	0	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	55#59	20939760-0-0-32	Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_1/3	1	3	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	epidermal growth factor receptor	8#40		Mutated epidermal growth factor receptor (EGFR) status is a known predictor of response to tyrosine kinase inhibitors (TKIs), and immunohistochemistry may be a less costly way of predicting presence of mutation.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_1/3	1	3	1956	SYMBOL|()|DICTIONARY|EXTRACTED	egfr	EGFR	42#46	20939760-0-0-32	Mutated epidermal growth factor receptor (EGFR) status is a known predictor of response to tyrosine kinase inhibitors (TKIs), and immunohistochemistry may be a less costly way of predicting presence of mutation.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_2/3	2	4	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	36#40	20939760-0-0-32	In this study, mutation analysis of EGFR in 218 cases of NSCLC was performed.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_2/3	2	5	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	78#82	20939760-0-0-32	One hundred thirty tissue samples were examined via immunohistochemistry of p-EGFR (Y1045 and Y1068) and correlated with mutation status.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	7	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	77#81	20939760-0-0-32	Phosphorylation at Y1045 was noted in 52% of cases, but in 71% of cases with EGFR mutation (P = .003).
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	8	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	75#79	20939760-0-0-32	Phosphorylation of Y1068 was seen in 55% of cases but in 73% of cases with EGFR mutation (P = .006).
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	9	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	23#27	20939760-0-0-32	This study correlating EGFR mutation with p-EGFR expression in resected NSCLC is one of the largest to date, although TKI response could not be assessed.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	9	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	44#48	20939760-0-0-32	This study correlating EGFR mutation with p-EGFR expression in resected NSCLC is one of the largest to date, although TKI response could not be assessed.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	10	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	121#125	20939760-0-0-32	The data show that, among Chinese patients, detection of p-1045 and p-1068 expression with immunohistochemistry predicts EGFR mutations.
20939760	2011	Exp. Lung Res.	1521-0499	ALL_TEXT_3/3	3	11	1956	SYMBOL|DICTIONARY|EXTRACTED	egfr	EGFR	34#38	20939760-0-0-32	Immunohistochemical analysis of p-EGFR may be useful to predict responses to TKI therapy, although future studies are necessary.
20691689	2010	Gastroenterology	1528-0012	METHODS	2	4	9965	SYMBOL|DICTIONARY	fgf19	FGF19	164#169		We assessed gastrointestinal and colonic transit, stool characteristics, and associations of transit with fasting serum 7αC4 (surrogate of bile acid synthesis) and FGF19 (negative regulator of bile acid synthesis) levels.
20691689	2010	Gastroenterology	1528-0012	RESULTS	3	9	9965	SYMBOL|DICTIONARY	fgf19	FGF19	28#33		Fasting serum 7αC4 (but not FGF19) was positively associated with colonic transit (r(s) = 0.749, P = .003, placebo group).
20691689	2010	Gastroenterology	1528-0012	RESULTS	3	10	2264	SYMBOL|DICTIONARY	fgfr4	FGFR4	21#26		Genetic variation in FGFR4 was associated with AC t(½) in response to CDC (uncorrected P = .015); αKlothoβ variant showed a gene-by-treatment interaction based on patient subgroup (uncorrected P = .0088).
20659174	2011	Genes Brain Behav.	1601-183X	TITLE	0	0	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	30#35		Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	3164	SYMBOL|DICTIONARY	nr4a1	NR4A1	168#173		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	4929	SYMBOL|DICTIONARY	nr4a2	NR4A2	198#203		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	3	8013	SYMBOL|DICTIONARY	nr4a3	NR4A3	228#233		We have, therefore, analysed the association of six single nucleotide polymorphisms (SNPs) within the three genes belonging to the NR4A orphan nuclear receptor family, NR4A1 (rs2603751, rs2701124), NR4A2 (rs12803, rs834835) and NR4A3 (rs1131339, rs1405209), with the degree of smoking in a sample of 204 unrelated schizophrenia patients, which included 126 smokers and 78 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_2/3	2	4	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	16#21		SNPs within the NR4A3 gene (rs1131339 and rs1405209) were significantly associated with heavy smoking in this cohort, using a stepwise analysis of the escalated number of cigarettes smoked per day (P = 0.008 and 0.006, respectively; satisfying the Nyholt significance threshold of 0.009, an adjustment for multiple testing).
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	5	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	49#54		We then repeated the association analysis of the NR4A3 markers (rs1131339 and rs1405209) in a larger cohort of 319 patients with bipolar disorder, which included 167 smokers and 152 non-smokers.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	6	8013	SYMBOL|DICTIONARY	nr4a3	NR4A3	64#69		We have replicated the positive association with smoking of the NR4A3 SNP rs1131339 in this group (P = 0.04), providing an important confirmation of the involvement of the NR4A3 gene in nicotine addiction in patients with mental health disease, a population significantly at risk for nicotine addiction.
20659174	2011	Genes Brain Behav.	1601-183X	ALL_TEXT_3/3	3	6	8013	SYMBOL|GENE|GN|DICTIONARY	nr4a3	NR4A3	172#177		We have replicated the positive association with smoking of the NR4A3 SNP rs1131339 in this group (P = 0.04), providing an important confirmation of the involvement of the NR4A3 gene in nicotine addiction in patients with mental health disease, a population significantly at risk for nicotine addiction.
20703234	2011	Hypertens. Res.	1348-4214	ALL_TEXT_1/3	1	1	185	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	at1r	AT1R	126#130	20703234-1-94-124	Mounting evidence suggests the potential susceptibility of individuals with a mutation in the angiotensin II type I receptor (AT1R) gene to hypertension.
20703234	2011	Hypertens. Res.	1348-4214	ALL_TEXT_3/3	3	12	185	SYMBOL|DICTIONARY|EXTRACTED	at1r	AT1R	55#59	20703234-1-94-124	Our study pooled previous findings and showed that the AT1R +1166 C allele conferred an increased risk of hypertension.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	TITLE	0	0	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	88#93		Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	TITLE	0	0	2950	SYMBOL|GENE|GN|DICTIONARY	gstp1	GSTP1	98#103		Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	LONGTERM|DICTIONARY	excision repair cross complementation group 1	excision repair cross-complementation Group 1	224#269		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2067	SYMBOL|()|DICTIONARY|EXTRACTED	ercc1	ERCC1	271#276	20979931-2-224-269	We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	METHODS	2	2	2950	SYMBOL|()|GENE|GN|DICTIONARY	gstp1	GSTP1	315#320		We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced neuropathy and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and glutathione-S-transferases pi 1 (GSTP1) genes.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	3	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	8#13	20979931-2-224-269	For the ERCC1 C118T polymorphism, Grade 1 chronic neuropathy developed earlier in patients with C/T and T/T genotypes (median number of treatment cycles at onset = 6) than in those with the reference C/C genotype (7 cycles; p = 0.0162 by the generalized Wilcoxon test).
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	4	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	8#13		For the GSTP1 Ile105Val polymorphism, chronic neuropathy developed earlier in patients with the reference Ile/Ile genotype (6 cycles) than in those with Ile/Val and Val/Val genotypes (9 cycles; p = 0.0321).
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	5	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	0#5		ERCC1 C118T and GSTP1 Ile105Val polymorphisms were not significantly associated with an increased risk of developing Grade 2 or more severe chronic neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	RESULTS	3	5	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	16#21		ERCC1 C118T and GSTP1 Ile105Val polymorphisms were not significantly associated with an increased risk of developing Grade 2 or more severe chronic neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2067	SYMBOL|DICTIONARY|EXTRACTED	ercc1	ERCC1	25#30	20979931-2-224-269	Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
20979931	2011	Int J Clin Pharmacol Ther	0946-1965	CONCLUSIONS	4	6	2950	SYMBOL|DICTIONARY	gstp1	GSTP1	42#47		Our results suggest that ERCC1, C118T and GSTP1 Ile105Val polymorphisms are more strongly related to the time until onset of neuropathy than to the grade of neuropathy.
20724655	2011	J. Lipid Res.	1539-7262	TITLE	0	0	338	LONGTERM|GENE|GN|DICTIONARY	apolipoprotein b	Apolipoprotein B	0#16		Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	LONGTERM|DICTIONARY	apolipoprotein b	apolipoprotein B	47#63		We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_2/3	2	3	338	SYMBOL|()|DICTIONARY|EXTRACTED	apob	APOB	65#69	20724655-3-47-63	We sought to determine if genetic variation in apolipoprotein B (APOB), an essential core of triglyceride-rich lipoprotein formation, may account for some of the inter-individual differences observed in triglyceride (TG) response to fenofibrate treatment.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	5	338	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	apob	APOB	21#25	20724655-3-47-63	Associations of four APOB gene single nucleotide polymorphisms (SNP) (rs934197, rs693, rs676210, and rs1042031) were tested for association with the TG response to fenofibrate using a mixed growth curve model where the familial structure was modeled as a random effect and cardiovascular risk factors were included as covariates.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	6	338	SYMBOL|DICTIONARY|EXTRACTED	apob	APOB	60#64	20724655-3-47-63	Three of these four SNPs changed the amino acid sequence of APOB, and the fourth was in the promoter region.
20724655	2011	J. Lipid Res.	1539-7262	ALL_TEXT_3/3	3	7	338	SYMBOL|DICTIONARY|EXTRACTED	apob	APOB	61#65	20724655-3-47-63	TG response to fenofibrate treatment was associated with one APOB SNP, rs676210 (Pro2739Leu), such that participants with the TT genotype of rs676210 had greater TG lowering than those with the CC genotype (additive model, P = 0.0017).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	4	51311	SYMBOL|DICTIONARY	tlr8	TLR8	0#4		TLR8 and TLR9 contribute to the recognition of viruses.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	4	54106	SYMBOL|DICTIONARY	tlr9	TLR9	9#13		TLR8 and TLR9 contribute to the recognition of viruses.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	51311	SYMBOL|DICTIONARY	tlr8	TLR8	29#33		We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	51311	SYMBOL|DICTIONARY	tlr8	TLR8	43#47		We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	54106	SYMBOL|DICTIONARY	tlr9	TLR9	57#61		We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_2/3	2	5	54106	SYMBOL|NUMBER|DICTIONARY	tlr9	TLR9	75#79		We investigated frequency of TLR8 Met1Val, TLR8 -129C/G, TLR9 -1486T/C and TLR9 2458G/A polymorphisms in CCHF patients and healthy controls.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	8	51311	SYMBOL|DICTIONARY	tlr8	TLR8	74#78		We found that heterozygous plus homozygous mutant genotypes frequency for TLR8 Met1Val and for TLR9 -1486T/C were significantly higher in CCHF patients than controls (p = 0.038 and p = 0.009, respectively).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	8	54106	SYMBOL|DICTIONARY	tlr9	TLR9	95#99		We found that heterozygous plus homozygous mutant genotypes frequency for TLR8 Met1Val and for TLR9 -1486T/C were significantly higher in CCHF patients than controls (p = 0.038 and p = 0.009, respectively).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	9	51311	SYMBOL|DICTIONARY	tlr8	TLR8	17#21		The frequency of TLR8 -129G/G genotype in the fatal CCHF patients was significantly higher than that of the non-fatal patients (p = 0.026).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	10	54106	SYMBOL|DICTIONARY	tlr9	TLR9	17#21		The frequency of TLR9 -1486C/C genotype was significantly higher in fatal CCHF patients than in healthy controls (p = 0.009) and in patients with severe disease compared to non-severe disease (p = 0.044).
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	51311	SYMBOL|DICTIONARY	tlr8	TLR8	26#30		Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	51311	SYMBOL|DICTIONARY	tlr8	TLR8	40#44		Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
20674764	2011	Microbes Infect.	1769-714X	ALL_TEXT_3/3	3	11	54106	SYMBOL|DICTIONARY	tlr9	TLR9	58#62		Our findings suggest that TLR8 Met1Val, TLR8 -129C/G, and TLR9 -1486T/C polymorphisms are important on clinical course of CCHF disease.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	TITLE	0	0	3458	LONGTERM|DICTIONARY	interferon gamma	Interferon-gamma	0#16		Interferon-gamma low producer genotype +5644 over presented in patients with focal brucellosis.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_1/3	1	3	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	93#102		This study aimed to determine the influence of the polymorphism within the +5644 position of IFN-gamma gene on the susceptibility to brucellosis.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_2/3	2	4	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	81#90		We investigated the allelic and genotypes distribution of A5644G polymorphism in IFN-gamma gene in an Iranian population comprising 259 patients with brucellosis and 238 healthy controls.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_2/3	2	6	3458	SYMBOL|GENE|GN|DICTIONARY	ifn gamma	IFN-gamma	59#68		Allelic and genotype frequencies of G5644A polymorphism of IFN-gamma gene were not significantly differed between patients with brucellosis and controls (p > 0.05).
20564317	2010	Prostate	1097-0045	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	44#79		Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
20564317	2010	Prostate	1097-0045	TITLE	0	0	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	81#86		Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
20564317	2010	Prostate	1097-0045	BACKGROUND	1	1	4524	LONGTERM|DICTIONARY|GENE|GA	methylenetetrahydrofolate reductase	methylenetetrahydrofolate reductase	46#81		We hypothesized that genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene are associated with prostate cancer risk.
20564317	2010	Prostate	1097-0045	BACKGROUND	1	1	4524	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	mthfr	MTHFR	83#88	20564317-1-46-81	We hypothesized that genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene are associated with prostate cancer risk.
20564317	2010	Prostate	1097-0045	METHODS	2	2	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	19#24	20564317-1-46-81	We genotyped three MTHFR polymorphisms (C677T, A1298C, and G1793A) and measured serum total homocysteine (tHcy), folate, and vitamin B12 levels in a case-control study of 174 cases and 348 normal healthy controls.
20564317	2010	Prostate	1097-0045	RESULTS	3	4	4524	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	mthfr	MTHFR	18#23	20564317-1-46-81	We found that the MTHFR 677TT and 1298CC genotypes were associated with an about 40% reduction in risk of prostate cancer (adjusted OR = 0.59, 95% CI = 0.41-0.94, and adjusted OR = 0.58, 95% CI = 0.32-0.91, respectively) compared to the 677CC, and 1298AA genotypes.
20564317	2010	Prostate	1097-0045	CONCLUSION	4	9	4524	SYMBOL|DICTIONARY|EXTRACTED	mthfr	MTHFR	34#39	20564317-1-46-81	These data suggest that all three MTHFR polymorphisms may play a pivotal role in the developing prostate cancer.
20638926	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	44#48		The c.469+46_56del mutation in the homeobox MSX1 gene--a novel risk factor in breast cancer?
20638926	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	145#149		The aim of this study was to investigate the association of a 11 nucleotide deletion, the c.469+46_56del mutation, in the intron of the homeobox MSX1 gene and breast cancer occurrence and characteristics.
20638926	2010	Cancer Epidemiol	1877-783X	RESULTS	3	4	2064	SYMBOL|DICTIONARY	her2	HER2	159#163		We did not observe any association between genotypes of this mutation and lymph node status, Bloom-Richardson grading, estrogen and progesterone receptors and HER2 expression.
20638926	2010	Cancer Epidemiol	1877-783X	CONCLUSIONS	4	5	4487	SYMBOL|GENE|GN|DICTIONARY	msx1	MSX1	59#63		The del/del genotype of the c.469+46_56del mutation in the MSX1 gene may be associated with the increased risk of breast cancer in Polish population and may be considered as an early marker in this disease.
20638924	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	7157	SYMBOL|DICTIONARY	p53	p53	29#32		Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy.
20638924	2010	Cancer Epidemiol	1877-783X	TITLE	0	0	5243	SYMBOL|GENE|GN|DICTIONARY	mdr1	MDR1	37#41		Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy.
20638924	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	5243	SYMBOL|()|GENE|GN|DICTIONARY	mdr1	MDR1	82#86		To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy.
20638924	2010	Cancer Epidemiol	1877-783X	RESULTS	2	2	7157	SYMBOL|DICTIONARY	p53	p53	100#103		Observed allelic frequencies were: TSER, (2) 0.54 and (3) 0.46; MTHFR C677T, (C) 0.59 and (T) 0.41; p53 Arg72Pro, (Arg) 0.73 and (Pro) 0.27; MDR1 C3435T, (C) 0.52 and (T) 0.48.
20638924	2010	Cancer Epidemiol	1877-783X	RESULTS	2	2	5243	SYMBOL|DICTIONARY	mdr1	MDR1	141#145		Observed allelic frequencies were: TSER, (2) 0.54 and (3) 0.46; MTHFR C677T, (C) 0.59 and (T) 0.41; p53 Arg72Pro, (Arg) 0.73 and (Pro) 0.27; MDR1 C3435T, (C) 0.52 and (T) 0.48.
20638924	2010	Cancer Epidemiol	1877-783X	RESULTS	2	3	7157	SYMBOL|DICTIONARY	p53	p53	19#22		MTHFR allele T and p53 allele Pro were strongly associated with toxicity due to chemotherapy (odds ratio, 7.1 (95% confidence interval, 1.4-36.1; p=0.018) and 7.0 (95% confidence interval, 1.2-40.5; p=0.029), respectively).
20638924	2010	Cancer Epidemiol	1877-783X	CONCLUSION	3	4	7157	SYMBOL|DICTIONARY	p53	p53	54#57		We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	266812	SYMBOL|DICTIONARY	nap1l5	NAP1L5	93#99		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	7350	SYMBOL|DICTIONARY	ucp1	UCP1	133#137		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
20622171	2010	Diabetes	1939-327X	RESULTS	3	9	3600	SYMBOL|DICTIONARY	il15	IL15	142#146		Several CNVs disrupt known candidate genes for obesity, such as a 3.3-Mb deletion disrupting NAP1L5 and a 2.1-Mb deletion disrupting UCP1 and IL15.
20615671	2011	Eur. Psychiatry	1778-3585	TITLE	0	0	84062	SYMBOL|()|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	42#48		Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	1	84062	LONGTERM|DICTIONARY	dystrobrevin binding protein 1	Dystrobrevin binding protein 1	0#30		Dystrobrevin binding protein 1 (DTNBP1), or dysbindin, is thought to be critical in regulating the glutamatergic system.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	1	84062	SYMBOL|()|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	32#38	20615671-1-0-30	Dystrobrevin binding protein 1 (DTNBP1), or dysbindin, is thought to be critical in regulating the glutamatergic system.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	3	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	0#6		DTNBP1 is widely expressed in brain, levels are reduced in brains of schizophrenia patients and a DTNBP1 polymorphism has been associated with reduced brain expression.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_1/3	1	3	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	98#104	20615671-1-0-30	DTNBP1 is widely expressed in brain, levels are reduced in brains of schizophrenia patients and a DTNBP1 polymorphism has been associated with reduced brain expression.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	4	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	36#42	20615671-1-0-30	Despite numerous genetic studies no DTNBP1 polymorphism has been strongly implicated in schizophrenia aetiology.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	5	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	76#82	20615671-1-0-30	Using a haplotype block-based gene-tagging approach we genotyped 13 SNPs in DTNBP1 to investigate possible associations with DTNBP1 and schizophrenia.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_2/3	2	5	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	125#131	20615671-1-0-30	Using a haplotype block-based gene-tagging approach we genotyped 13 SNPs in DTNBP1 to investigate possible associations with DTNBP1 and schizophrenia.
20615671	2011	Eur. Psychiatry	1778-3585	ALL_TEXT_3/3	3	10	84062	SYMBOL|DICTIONARY|EXTRACTED	dtnbp1	DTNBP1	27#33	20615671-1-0-30	These results suggest that DTNBP1 is a good candidate for schizophrenia risk and rs9370822 is either functionally important or in disequilibrium with a functional SNP, although our observations should be viewed with caution until they are independently replicated.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	TITLE	0	0	9156	SYMBOL|DICTIONARY|EXTRACTED	exo1	EXO1	10#14		Impact of EXO1 polymorphism in susceptibility to colorectal cancer.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	LONGTERM|DICTIONARY	exonuclease 1	exonuclease 1	65#78		One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	1	9156	SYMBOL|()|DICTIONARY|EXTRACTED	exo1	EXO1	80#84	20854105-1-65-78	One candidate gene for colorectal cancer (CRC) susceptibility is exonuclease 1 (EXO1).
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	2	2237	SYMBOL|DICTIONARY	rad2	RAD2	18#22		It is a member of RAD2 nuclease family, which plays a major role in mismatch repair, DNA replication, and recombination.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	BACKGROUND AND AIM	1	4	9156	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	exo1	EXO1	109#113	20854105-1-65-78	The aim of the present study was to examine the association between the L757P polymorphism at exon 13 of the EXO1 gene and the risk of CRC in Iranian patients.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	METHODS	2	6	9156	SYMBOL|DICTIONARY|EXTRACTED	exo1	EXO1	4#8	20854105-1-65-78	The EXO1 polymorphism, P757L, was analyzed by polymerase chain reaction-restriction fragment length polymorphism.
20854105	2011	Genet Test Mol Biomarkers	1945-0257	CONCLUSIONS	4	10	9156	SYMBOL|DICTIONARY|EXTRACTED	exo1	EXO1	69#73	20854105-1-65-78	Our results provide evidence diagnosing that the Leu/Leu genotype of EXO1 showed an inverse association with CRC.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	241	SYMBOL|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	0#7		ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	TITLE	0	0	4048	SYMBOL|DICTIONARY|EXTRACTED	lta4h	LTA4H	12#17		ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	241	LONGTERM|GENE|GT|DICTIONARY	arachidonate 5 lipoxygenase activating protein	arachidonate 5-lipoxygenase-activating protein	34#80		To identify modulating effects of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	241	SYMBOL|()|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	82#89	20810156-2-34-80	To identify modulating effects of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	4048	LONGTERM|DICTIONARY|GENE|GA	leukotriene a 4 hydrolase	leukotriene A(4) hydrolase	95#121		To identify modulating effects of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	OBJECTIVE	2	2	4048	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lta4h	LTA4H	123#128	20810156-2-95-121	To identify modulating effects of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	3	241	SYMBOL|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	78#85	20810156-2-34-80	In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	3	4048	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lta4h	LTA4H	90#95	20810156-2-95-121	In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	4	4048	SYMBOL|DICTIONARY|EXTRACTED	lta4h	LTA4H	57#62	20810156-2-95-121	In heterozygotes and homozygotes for the minor allele at LTA4H single nucleotide polymorphism (SNP) rs2540491 and heterozygotes for the major allele at LTA4H SNP rs2540487, leukotriene modifier use was associated with a clinically significant increase in percent change in FEV(1) after albuterol administration of 7.10% (P = .002), 10.06% (P = .001), and 10.03% (P < .001), respectively.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	4	4048	SYMBOL|DICTIONARY|EXTRACTED	lta4h	LTA4H	152#157	20810156-2-95-121	In heterozygotes and homozygotes for the minor allele at LTA4H single nucleotide polymorphism (SNP) rs2540491 and heterozygotes for the major allele at LTA4H SNP rs2540487, leukotriene modifier use was associated with a clinically significant increase in percent change in FEV(1) after albuterol administration of 7.10% (P = .002), 10.06% (P = .001), and 10.03% (P < .001), respectively.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	5	241	SYMBOL|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	32#39	20810156-2-34-80	Presence of the major allele at ALOX5AP SNP rs10507391 or the minor allele at ALOX5AP SNP rs9551963 augmented this response.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	5	241	SYMBOL|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	78#85	20810156-2-34-80	Presence of the major allele at ALOX5AP SNP rs10507391 or the minor allele at ALOX5AP SNP rs9551963 augmented this response.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	7	4048	SYMBOL|DICTIONARY|EXTRACTED	lta4h	LTA4H	0#5		LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma.
20810156	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	7	241	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	alox5ap	ALOX5AP	10#17	20810156-2-34-80	LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma.
20543710	2011	J. Glaucoma	1536-481X	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	4	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein E	0#16		Apolipoprotein E (Apo-E) is directly involved in these amyloid deposition and fibrils formation.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	4	348	SYMBOL|()|DICTIONARY|EXTRACTED	apo e	Apo-E	18#23	20543710-4-0-16	Apolipoprotein E (Apo-E) is directly involved in these amyloid deposition and fibrils formation.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	5	348	SYMBOL|GENE|GN|DICTIONARY	apoe	APOE	17#21		The ε4 allele of APOE gene was shown to be associated both with an increased risk for coronary heart disease and late-onset Alzheimer disease.
20543710	2011	J. Glaucoma	1536-481X	PURPOSE	1	6	348	SYMBOL|DICTIONARY	apoe	APOE	49#53		In this study, we therefore investigated whether APOE alleles are associated with PEX syndrome and/or PEX glaucoma (PEXG) in 2 large cohorts of German and Italian origin.
20543710	2011	J. Glaucoma	1536-481X	METHODS	2	7	348	SYMBOL|DICTIONARY	apoe	APOE	13#17		The 3 common APOE alleles ε2, ε3, and ε4 were genotyped in 661 unrelated patients (459 PEXG and 202 PEX patients) and 342 healthy individuals of German origin and furthermore in 209 unrelated patients (133 PEXG and 76 PEX patients) and 190 healthy individuals of Italian origin using TaqMan assays for allelic discrimination.
20543710	2011	J. Glaucoma	1536-481X	CONCLUSION	4	11	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		Our data show that APOE genotypes are not associated with PEX and PEXG in either Germans or Italians.
20722399	2011	Chem. Res. Toxicol.	1520-5010	TITLE	0	0	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	14#18		Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_1/3	1	2	4780	LONGTERM|DICTIONARY	nuclear factor erythroid 2 related factor 2	nuclear factor erythroid 2-related factor 2	25#68		The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is key in mediating the protective antioxidant response against various environmental toxicants, but emerging data suggest that constitutive activation of Nrf2 contributes to a malignant phenotype.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_1/3	1	2	4780	SYMBOL|()|DICTIONARY|EXTRACTED	nrf2	Nrf2	70#74	20722399-2-25-68	The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is key in mediating the protective antioxidant response against various environmental toxicants, but emerging data suggest that constitutive activation of Nrf2 contributes to a malignant phenotype.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_1/3	1	2	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	231#235	20722399-2-25-68	The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is key in mediating the protective antioxidant response against various environmental toxicants, but emerging data suggest that constitutive activation of Nrf2 contributes to a malignant phenotype.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_2/3	2	3	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	78#82	20722399-2-25-68	The purpose of this study was to characterize the interactions and effects of Nrf2 activation on cell proliferation induced by MC-LR treatment.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_2/3	2	4	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	83#87	20722399-2-25-68	Treatment of HepG2 and Hep3B cells with MC-LR resulted in significant increases in Nrf2-ARE binding activities in the nuclear fractions and upregulation of its downstream genes HO-1 and NQO1.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_2/3	2	4	1728	SYMBOL|DICTIONARY	nqo1	NQO1	186#190		Treatment of HepG2 and Hep3B cells with MC-LR resulted in significant increases in Nrf2-ARE binding activities in the nuclear fractions and upregulation of its downstream genes HO-1 and NQO1.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	5	9817	SYMBOL|DICTIONARY	keap1	Keap1	80#85		A possible mechanism may be that MC-LR binds to the cytosolic regulator protein Keap1 to liberate Nrf2.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	5	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	98#102	20722399-2-25-68	A possible mechanism may be that MC-LR binds to the cytosolic regulator protein Keap1 to liberate Nrf2.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	6	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	0#4		Nrf2 knockdown inhibited MC-LR-induced cell proliferation and cell cycle progression.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	68#72	20722399-2-25-68	Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
20722399	2011	Chem. Res. Toxicol.	1520-5010	ALL_TEXT_3/3	3	7	4780	SYMBOL|DICTIONARY|EXTRACTED	nrf2	Nrf2	154#158	20722399-2-25-68	Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.
20570322	2010	Gynecol. Oncol.	1095-6859	TITLE	0	0	672	SYMBOL|DICTIONARY	brca1	BRCA1	14#19		Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	TITLE	0	0	675	SYMBOL|DICTIONARY	brca2	BRCA2	24#29		Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	OBJECTIVES	1	1	672	SYMBOL|DICTIONARY	brca1	BRCA1	60#65		The purpose of this study is to determine the prevalence of BRCA1 and BRCA2 mutations among a large series of women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	OBJECTIVES	1	1	675	SYMBOL|DICTIONARY	brca2	BRCA2	70#75		The purpose of this study is to determine the prevalence of BRCA1 and BRCA2 mutations among a large series of women with carcinoma of the fallopian tube.
20570322	2010	Gynecol. Oncol.	1095-6859	METHODS	2	6	672	SYMBOL|DICTIONARY	brca1	BRCA1	151#156		Each subject was approached to provide her family history and ethnic background and to provide a blood sample for genetic testing for mutations in the BRCA1 and BRCA2 genes.
20570322	2010	Gynecol. Oncol.	1095-6859	METHODS	2	6	675	SYMBOL|GENE|GN|DICTIONARY	brca2	BRCA2	161#166		Each subject was approached to provide her family history and ethnic background and to provide a blood sample for genetic testing for mutations in the BRCA1 and BRCA2 genes.
20570322	2010	Gynecol. Oncol.	1095-6859	RESULTS	3	8	672	SYMBOL|DICTIONARY	brca1	BRCA1	79#84		Thirty-three patients (30.6%) were found to have a deleterious mutation; 23 in BRCA1 (21.3%) and 10 in BRCA2 (9.3%).
20570322	2010	Gynecol. Oncol.	1095-6859	RESULTS	3	8	675	SYMBOL|DICTIONARY	brca2	BRCA2	103#108		Thirty-three patients (30.6%) were found to have a deleterious mutation; 23 in BRCA1 (21.3%) and 10 in BRCA2 (9.3%).
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	13	672	SYMBOL|DICTIONARY	brca1	BRCA1	73#78		Approximately 30% of women with fallopian tube cancer have a mutation in BRCA1 or BRCA2.
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	13	675	SYMBOL|DICTIONARY	brca2	BRCA2	82#87		Approximately 30% of women with fallopian tube cancer have a mutation in BRCA1 or BRCA2.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	LONGTERM|DICTIONARY	signal transducer and activator of transcription 3	signal transducer and activator of transcription 3	32#82		The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	6774	SYMBOL|()|DICTIONARY|EXTRACTED	stat3	STAT3	84#89	20816194-2-32-82	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	METHODS	3	4	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	100#105	20816194-2-32-82	The clinical phenotype (suggested by a National Institutes of Health [NIH] score of >or=40 points), STAT3 genotype, and T(H)17 cell counts were compared in a cohort of 78 patients suspected of having HIES.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	5	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	13#18	20816194-2-32-82	Heterozygous STAT3 missense mutations and in-frame deletions were identified in 48 patients, all but 2 with an NIH score >or=40 points.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	6	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	14#19	20816194-2-32-82	Patients with STAT3 mutations with HIES showed significantly lower T(H)17 cell counts compared with patients with wild-type STAT3 and control subjects.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	6	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	124#129	20816194-2-32-82	Patients with STAT3 mutations with HIES showed significantly lower T(H)17 cell counts compared with patients with wild-type STAT3 and control subjects.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	7	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	30#35	20816194-2-32-82	Only 1 patient with wild-type STAT3 had both an NIH score >or=40 points and abnormal T(H)17 cell counts (<or=0.2% of CD4(+) cells), with this exception being identified with a homozygous dedicator of cytogenesis 8 protein (DOCK8) mutation.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	7	81704	SYMBOL|()|DICTIONARY	dock8	DOCK8	223#228		Only 1 patient with wild-type STAT3 had both an NIH score >or=40 points and abnormal T(H)17 cell counts (<or=0.2% of CD4(+) cells), with this exception being identified with a homozygous dedicator of cytogenesis 8 protein (DOCK8) mutation.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	8	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	78#83	20816194-2-32-82	Pathologic shedding of primary teeth was present in 3 patients with wild-type STAT3 and 33 patients with STAT3 mutations.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	8	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	105#110	20816194-2-32-82	Pathologic shedding of primary teeth was present in 3 patients with wild-type STAT3 and 33 patients with STAT3 mutations.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	80#85	20816194-2-32-82	Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	RESULTS	4	9	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	230#235	20816194-2-32-82	Internal abscesses and severe infections were exclusively seen in patients with STAT3 mutations, who also had increased pneumatocele formation and skeletal or connective tissue manifestations compared with patients with wild-type STAT3.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	10	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	26#31	20816194-2-32-82	We expanded the number of STAT3 mutations and validated that the NIH score sensitively identifies patients with HIES.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	CONCLUSION	5	11	6774	SYMBOL|DICTIONARY|EXTRACTED	stat3	STAT3	134#139	20816194-2-32-82	Based on our patient cohort, we propose key findings that, when combined with T(H)17 cell numbers, predict patients with AD-HIES with STAT3 mutations, supporting early diagnosis of AD-HIES.
20663522	2010	J. Urol.	1527-3792	TITLE	0	0	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin a	56#70		Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
20663522	2010	J. Urol.	1527-3792	TITLE	0	0	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	75#87		Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
20663522	2010	J. Urol.	1527-3792	PURPOSE	1	1	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	45#59		We investigated the clinical significance of chromogranin A and endothelin-1 polymorphism and expression in prostate cancer.
20663522	2010	J. Urol.	1527-3792	PURPOSE	1	1	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	64#76		We investigated the clinical significance of chromogranin A and endothelin-1 polymorphism and expression in prostate cancer.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	2	1113	SYMBOL|DICTIONARY	chga	CHGA	14#18		We analyzed 2 CHGA polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in DNA samples of 435 patients with prostate cancer and 316 age matched male controls.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1113	LONGTERM|DICTIONARY	chromogranin a	Chromogranin A	0#14		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
20663522	2010	J. Urol.	1527-3792	MATERIALS AND METHODS	2	3	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	19#31		Chromogranin A and endothelin-1 expression was evaluated by immunohistochemistry in prostate specimens of 114 men with prostate cancer who underwent radical retropubic prostatectomy and in 27 with bladder cancer who underwent radical cystectomy and served as controls.
20663522	2010	J. Urol.	1527-3792	RESULTS	3	4	1113	SYMBOL|DICTIONARY	chga	CHGA	8#12		For the CHGA Glu264Asp polymorphism men with the GG genotype were at 2.05 times higher risk for prostate cancer than men with the CC genotype (p = 0.014).
20663522	2010	J. Urol.	1527-3792	RESULTS	3	5	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	35#49		In men with prostate cancer higher chromogranin A immunohistochemistry grade was associated with higher stage and higher Gleason score (p = 0.011 and 0.044, respectively).
20663522	2010	J. Urol.	1527-3792	RESULTS	3	6	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	34#48		Multivariate analysis showed that chromogranin A immunohistochemistry grade was an independent variable for predicting biochemical failure after radical prostatectomy (p = 0.023).
20663522	2010	J. Urol.	1527-3792	RESULTS	3	7	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	7#19		Higher endothelin-1 expression was observed in prostate cancers (p = 0.011), especially those with a higher Gleason score (p = 0.042).
20663522	2010	J. Urol.	1527-3792	RESULTS	3	8	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	46#60		There was no significant relationship between chromogranin A polymorphisms, and chromogranin A and endothelin-1 expression.
20663522	2010	J. Urol.	1527-3792	RESULTS	3	8	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	80#94		There was no significant relationship between chromogranin A polymorphisms, and chromogranin A and endothelin-1 expression.
20663522	2010	J. Urol.	1527-3792	RESULTS	3	8	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	99#111		There was no significant relationship between chromogranin A polymorphisms, and chromogranin A and endothelin-1 expression.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	9	1113	LONGTERM|DICTIONARY	chromogranin a	chromogranin A	31#45		Polymorphism and expression of chromogranin A and endothelin-1 have clinical significance in prostate cancer.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	9	1906	LONGTERM|DICTIONARY	endothelin 1	endothelin-1	50#62		Polymorphism and expression of chromogranin A and endothelin-1 have clinical significance in prostate cancer.
20663522	2010	J. Urol.	1527-3792	CONCLUSIONS	4	10	1113	LONGTERM|DICTIONARY	chromogranin a	Chromogranin A	0#14		Chromogranin A expression was an independent predictor of biochemical failure after prostatectomy in patients with localized prostate cancer.
20799519	2010	P R Health Sci J	0738-0658	TITLE	0	0	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	49#55		Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients.
20799519	2010	P R Health Sci J	0738-0658	BACKGROUND	1	1	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	4#10		The CYP2D6 liver enzyme, which metabolizes 25-30% of common medications, is highly polymorphic.
20799519	2010	P R Health Sci J	0738-0658	BACKGROUND	1	3	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	42#48		The goal of the study was to identify the CYP2D6 alleles associated with reduced or negligible activities present in the Puerto Rican population.
20799519	2010	P R Health Sci J	0738-0658	METHODS	2	4	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	130#136		The study cohort comprised 40 Puerto Rican psychiatric patients referred because of suspected intolerance of drugs metabolized by CYP2D6, and five subjects without suspected adverse responses to these drugs.
20799519	2010	P R Health Sci J	0738-0658	METHODS	2	6	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	31#37		Genomic DNA was queried for 27 CYP2D6 alleles using the Roche AmpliChip P450 test.
20799519	2010	P R Health Sci J	0738-0658	RESULTS	3	7	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	67#73		A total of 12 alleles were identified.The most common alleles were CYP2D6*1 > *2 > *4 > *41.
20799519	2010	P R Health Sci J	0738-0658	RESULTS	3	10	1565	SYMBOL|NUMBER|DICTIONARY	cyp2d6	CYP2D6	53#59		Only one subject carried two non-functional alleles (CYP2D6*5/*40), and was predicted to be a poor metabolizer.
20799519	2010	P R Health Sci J	0738-0658	CONCLUSIONS	4	12	1565	SYMBOL|DICTIONARY	cyp2d6	CYP2D6	79#85		Nonetheless, our findings strongly suggest that Puerto Ricans exhibit distinct CYP2D6 allele frequencies and harbor a non-functional allele that is rare or absent in other populations and are highly valuable for the emerging practice of Personalized Medicine in admixed populations like Puerto Ricans.
20812194	2010	Genet. Mol. Res.	1676-5680	TITLE	0	0	5444	LONGTERM|DICTIONARY	paraoxonase 1	paraoxonase-1	25#38		The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis.
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	1	5444	LONGTERM|DICTIONARY	paraoxonase 1	Paraoxonase-1	0#13		Paraoxonase-1 (PON1) is a high-density lipoprotein-associated enzyme that exhibits antioxidant and antiatherogenic activities.
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	1	5444	SYMBOL|()|DICTIONARY|EXTRACTED	pon1	PON1	15#19	20812194-1-0-13	Paraoxonase-1 (PON1) is a high-density lipoprotein-associated enzyme that exhibits antioxidant and antiatherogenic activities.
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_2/3	2	4	5444	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	pon1	PON1	22#26	20812194-1-0-13	The prevalence of the PON1 55MM genotype was significantly greater among rheumatoid arthritis patients (17%) when compared to control subjects (5.2%) (odds ratio (OR) = 3.75; 95% confidence interval (CI) = 1.87-11.8, P = 0.025).
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	6	5444	SYMBOL|DICTIONARY|EXTRACTED	pon1	PON1	94#98	20812194-1-0-13	There were no significant differences in the -107C/T polymorphism in the promoter sequence of PON1 between rheumatoid arthritis and normal subjects (chi(2) = 0.861, P = 0.650).
20812194	2010	Genet. Mol. Res.	1676-5680	ALL_TEXT_3/3	3	7	5444	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	pon1	PON1	19#23	20812194-1-0-13	In conclusion, the PON1 55MM genotype is a risk factor for rheumatoid arthritis.
20553853	2011	J. Neurol. Sci.	1878-5883	TITLE	0	0	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	47#52		Association of polymorphism of DNA repair gene XRCC1 with sporadic late-onset Alzheimer's disease and age of onset in elderly Han Chinese.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	4	7515	SYMBOL|()|GENE|GN|DICTIONARY	xrcc1	XRCC1	83#88		A functional polymorphism (Arg194Trp) of X-ray repair cross-complementing group 1 (XRCC1) gene may be associated with the repair efficiency of DNA damage which may have a role in AD.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	5	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	11#16		Therefore, XRCC1 Arg194Trp polymorphism may be a good candidate for genetic risk analysis in AD.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_2/3	2	6	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	44#49		A case-control study from Turkey found that XRCC1 194Trp was associated with late-onset AD (LOAD).
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_3/3	3	7	7515	SYMBOL|GENE|GN|DICTIONARY	xrcc1	XRCC1	34#39		In order to determine whether the XRCC1 gene Arg194Trp polymorphism contributes to the risk for LOAD in elderly Han Chinese, we have investigated it in 212 sporadic LOAD patients and 203 healthy controls from Chinese.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_3/3	3	8	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	59#64		No significantly increased risk of LOAD in the carriers of XRCC1 194Trp allele (OR=1.04, 95% CI 0.70-1.52, P=0.860) was observed.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_3/3	3	10	7515	SYMBOL|NUMBER|DICTIONARY	xrcc1	XRCC1	87#92		After stratifying by APOE epsilon4 status, no increased LOAD risks associated with the XRCC1 194Trp allele carriers were observed.
20553853	2011	J. Neurol. Sci.	1878-5883	ALL_TEXT_3/3	3	11	7515	SYMBOL|DICTIONARY	xrcc1	XRCC1	50#55		Our findings suggest that it is unlikely that the XRCC1 Arg194Trp polymorphism plays a major role in the pathogenesis of LOAD in elderly Han Chinese and does not support the previous findings that 194Trp allele confers an increased risk for LOAD.
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_1/3	1	3	1378	SYMBOL|GENE|GN|DICTIONARY	cr1	CR1	170#173		A recent large genome-wide association study (GWAS) has identified significant association of two single nucleotide polymorphisms (SNPs) (rs6656401 and rs3818361) in the CR1 gene with AD in Caucasians.
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_3/3	3	7	348	SYMBOL|DICTIONARY	apoe	APOE	19#23		In the subgroup of APOE epsilon4 non-carriers, both the A of rs6656401 and T allele of rs3818361 were observed to be significantly higher in case than in controls (P=0.002 and P=0.035, respectively).
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_3/3	3	10	1378	SYMBOL|GENE|GN|DICTIONARY	cr1	CR1	56#59		This study provides the evidence that variations in the CR1 gene play an important role in the pathogenesis of sporadic LOAD in the Han Chinese population.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	7916	SYMBOL|DICTIONARY	bat2	BAT2	18#22		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	4160	SYMBOL|GENE|GN|DICTIONARY	mc4r	MC4R	27#31		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	79068	SYMBOL|DICTIONARY	fto	FTO	60#63		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	89866	SYMBOL|DICTIONARY	sec16b	SEC16B	65#71		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	3	25970	SYMBOL|GENE|GN|DICTIONARY	sh2b1	SH2B1	77#82		Two SNPs near the BAT2 and MC4R genes and 3 SNPs within the FTO, SEC16B, and SH2B1 genes were significantly associated with body mass index (weight (kg)/height (m)(2)), body weight, and the prevalence of obesity.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	7916	SYMBOL|()|DICTIONARY	bat2	BAT2	67#71		The per-allele increase in body mass index ranged from 0.16 units (BAT2) to 0.38 units (SH2B1).
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_2/3	2	4	25970	SYMBOL|()|DICTIONARY	sh2b1	SH2B1	88#93		The per-allele increase in body mass index ranged from 0.16 units (BAT2) to 0.38 units (SH2B1).
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	7916	SYMBOL|DICTIONARY	bat2	BAT2	88#92		Odds ratios for obesity ranged from 1.46 (95% confidence interval (CI): 1.12, 1.92) for BAT2 to 2.16 (95% CI: 1.39, 3.37) for MC4R.
20616199	2010	Am. J. Epidemiol.	1476-6256	ALL_TEXT_3/3	3	5	4160	SYMBOL|DICTIONARY	mc4r	MC4R	126#130		Odds ratios for obesity ranged from 1.46 (95% confidence interval (CI): 1.12, 1.92) for BAT2 to 2.16 (95% CI: 1.39, 3.37) for MC4R.
20610570	2010	Endocrinology	1945-7170	TITLE	0	0	3569	LONGTERM|DICTIONARY	interleukin 6	Interleukin-6	0#13		Interleukin-6 is an essential determinant of on-time parturition in the mouse.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY	il 6	IL-6	0#4		IL-6 abundance in amniotic fluid and uterine tissues increases in late gestation or with infection-associated preterm labor.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il 6	IL-6	70#74		A role in regulation of labor onset is suggested by observations that IL-6 increases expression of genes controlling prostaglandin synthesis and signaling in isolated uterine cells, but whether IL-6 is essential for normal parturition is unknown.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	il 6	IL-6	194#198		A role in regulation of labor onset is suggested by observations that IL-6 increases expression of genes controlling prostaglandin synthesis and signaling in isolated uterine cells, but whether IL-6 is essential for normal parturition is unknown.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_1/3	1	3	3569	SYMBOL|DICTIONARY	il 6	IL-6	38#42		To evaluate the physiological role of IL-6 in parturition in mice, we investigated the effect of Il6 null mutation on the timing of parturition and expression of genes associated with uterine activation.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_2/3	2	6	5743	SYMBOL|GFAM|FN|DICTIONARY	ptgs2	Ptgs2	145#150		The characteristic late-gestation elevation in uterine expression of Oxtr mRNA encoding oxytocin receptor, and peripartal increases in Ptgfr and Ptgs2 mRNAs regulating prostaglandin synthesis and signaling were delayed by 24 h in Il6 null mutant mice.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_3/3	3	7	5734	SYMBOL|GFAM|FN|DICTIONARY	ptger4	Ptger4	12#18		Conversely, Ptger4 mRNA encoding the prostaglandin E receptor-4 was abnormally elevated in late-gestation in Il6 null mutant mice.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_3/3	3	8	3569	SYMBOL|DICTIONARY	il 6	IL-6	30#34		Administration of recombinant IL-6 from d 11.5 postcoitum until term restored the normal timing of delivery and normalized Ptger4 mRNA expression in late gestation.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_3/3	3	8	5734	SYMBOL|GFAM|FN|DICTIONARY	ptger4	Ptger4	123#129		Administration of recombinant IL-6 from d 11.5 postcoitum until term restored the normal timing of delivery and normalized Ptger4 mRNA expression in late gestation.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_3/3	3	9	3569	SYMBOL|DICTIONARY	il 6	IL-6	17#21		We conclude that IL-6 has a key role in controlling the progression of events culminating in parturition and that it acts downstream of luteolysis in the uterus to regulate genes involved in the prostaglandin-mediated uterine activation cascade.
20631561	2010	J Clin Psychopharmacol	1533-712X	TITLE	0	0	2166	SYMBOL|DICTIONARY	faah	FAAH	26#30		Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
20631561	2010	J Clin Psychopharmacol	1533-712X	TITLE	0	0	1268	SYMBOL|DICTIONARY|EXTRACTED	cnr1	CNR1	71#75		Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_2/3	2	3	1268	LONGTERM|DICTIONARY|GENE|GA	cannabinoid receptor 1	cannabinoid receptor 1	97#119		Therefore, we investigated the 1359 G/A (rs1049353) single nucleotide polymorphisms (SNP) of the cannabinoid receptor 1 (CNR1) gene, which codes the endocannabinoid CB1 receptor, and the complementary DNA (cDNA) 385C/A (rs324420) SNP of the FAAH gene, which codes the endocannabinoid degrading enzyme, for their role in BW changes induced by antipsychotic drugs.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_2/3	2	3	1268	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cnr1	CNR1	121#125	20631561-3-97-119	Therefore, we investigated the 1359 G/A (rs1049353) single nucleotide polymorphisms (SNP) of the cannabinoid receptor 1 (CNR1) gene, which codes the endocannabinoid CB1 receptor, and the complementary DNA (cDNA) 385C/A (rs324420) SNP of the FAAH gene, which codes the endocannabinoid degrading enzyme, for their role in BW changes induced by antipsychotic drugs.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_2/3	2	3	1268	SYMBOL|GENE|GN|DICTIONARY	cb1	CB1	165#168		Therefore, we investigated the 1359 G/A (rs1049353) single nucleotide polymorphisms (SNP) of the cannabinoid receptor 1 (CNR1) gene, which codes the endocannabinoid CB1 receptor, and the complementary DNA (cDNA) 385C/A (rs324420) SNP of the FAAH gene, which codes the endocannabinoid degrading enzyme, for their role in BW changes induced by antipsychotic drugs.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_2/3	2	3	2166	SYMBOL|GENE|GN|DICTIONARY	faah	FAAH	241#245		Therefore, we investigated the 1359 G/A (rs1049353) single nucleotide polymorphisms (SNP) of the cannabinoid receptor 1 (CNR1) gene, which codes the endocannabinoid CB1 receptor, and the complementary DNA (cDNA) 385C/A (rs324420) SNP of the FAAH gene, which codes the endocannabinoid degrading enzyme, for their role in BW changes induced by antipsychotic drugs.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_3/3	3	7	2166	SYMBOL|GFAM|FN|DICTIONARY	faah	FAAH	39#43		Genotype and allele frequencies of the FAAH cDNA 385C/A SNP but not of the CNR1 1359 G/A SNP significantly differed between subjects who gained more than 7% of BW and those who did not, with both AC and AA genotypes and the A allele being significantly more frequent in patients who gained more than 7% of their baseline BW.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_3/3	3	7	1268	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cnr1	CNR1	75#79	20631561-3-97-119	Genotype and allele frequencies of the FAAH cDNA 385C/A SNP but not of the CNR1 1359 G/A SNP significantly differed between subjects who gained more than 7% of BW and those who did not, with both AC and AA genotypes and the A allele being significantly more frequent in patients who gained more than 7% of their baseline BW.
20631561	2010	J Clin Psychopharmacol	1533-712X	ALL_TEXT_3/3	3	8	2166	SYMBOL|GENE|GN|DICTIONARY	faah	FAAH	129#133		Present findings, although obtained in a small population and in a naturalistic setting, suggest that the cDNA 385C/A SNP of the FAAH gene may predispose subjects to get a clinically meaningful weight gain after antipsychotic exposure.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	7	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	20#35		Genetic analysis of factor V Leiden (G1691A) and prothrombin (G20210A) gene mutations were done at diagnosis.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	7	2147	LONGTERM|DICTIONARY|GENE|GA	prothrombin	prothrombin	49#60		Genetic analysis of factor V Leiden (G1691A) and prothrombin (G20210A) gene mutations were done at diagnosis.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	80150	LONGTERM|DICTIONARY	l asparaginase	L-asparaginase	94#108		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	2153	LONGTERM|DICTIONARY	factor v leiden	factor V Leiden	300#315		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
20546854	2010	Thromb. Res.	1879-2472	METHODS	2	8	2147	LONGTERM|GENE|GN|DICTIONARY	prothrombin	prothrombin	319#330		LMWH was given once daily subcutaneously at a dose of 1mg/kg, starting with the first dose of L-asparaginase (day 12 of induction, day 8 of consolidation) until one week after the last dose (day 40 of induction, day 25 of consolidation), to patients with inherited thrombophilia stemming from either factor V Leiden or prothrombin gene mutation.
20546854	2010	Thromb. Res.	1879-2472	RESULTS	3	11	2147	LONGTERM|DICTIONARY|GENE|GA	prothrombin	prothrombin	25#36		Three of these six had a prothrombin (PT) gene mutation and received prophylactic LMWH.
20546854	2010	Thromb. Res.	1879-2472	RESULTS	3	11	2147	SYMBOL|EXTRACTED|()|GENE|GN	pt	PT	38#40	20546854-11-25-36	Three of these six had a prothrombin (PT) gene mutation and received prophylactic LMWH.
20546854	2010	Thromb. Res.	1879-2472	CONCLUSION	4	13	2147	SYMBOL|EXTRACTED|GENE|GN	pt	PT	43#45	20546854-11-25-36	It is suggested that patients with ALL and PT gene mutation may have a higher risk of clotting complications in comparison to patients with factor V Leiden mutation.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	3	3665	SYMBOL|DICTIONARY	irf 7	IRF-7	85#90		We found that instillation of silica is followed by the upregulation of IFN-beta and IRF-7 and that granulocytes (GR1(+)) and macrophages/dendritic cells (CD11c(+)) are major producers of type I IFN in response to silica.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	3	3687	SYMBOL|DICTIONARY	cd11c	CD11c	155#160		We found that instillation of silica is followed by the upregulation of IFN-beta and IRF-7 and that granulocytes (GR1(+)) and macrophages/dendritic cells (CD11c(+)) are major producers of type I IFN in response to silica.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3665	SYMBOL|DICTIONARY	irf 7	IRF-7	56#61		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	6357	SYMBOL|DICTIONARY	ccl2	CCL2	151#155		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	24#30		Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	32#37		Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
20628598	2010	PLoS ONE	1932-6203	TITLE	0	0	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	42#45		Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	LONGTERM|DICTIONARY	melatonin receptor 1b	melatonin receptor 1B	28#49		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	4544	SYMBOL|()|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	51#57	20628598-1-28-49	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	LONGTERM|GENE|GT|DICTIONARY	islet specific glucose 6 phosphatase catalytic subunit related protein	islet-specific glucose 6 phosphatase catalytic subunit-related protein	60#130		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	57818	SYMBOL|()|DICTIONARY|EXTRACTED	g6pc2	G6PC2	132#137	20628598-1-60-130	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	LONGTERM|DICTIONARY	glucokinase	glucokinase	140#151		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2645	SYMBOL|()|DICTIONARY|EXTRACTED	gck	GCK	153#156	20628598-1-140-151	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	LONGTERM|GENE|GT|DICTIONARY	glucokinase regulatory protein	glucokinase regulatory protein	162#192		Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	BACKGROUND	1	1	2646	SYMBOL|()|DICTIONARY|EXTRACTED	gckr	GCKR	194#198	20628598-1-162-192	Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG).
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	45#51	20628598-1-28-49	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	64#69	20628598-1-60-130	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	95#98	20628598-1-140-151	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	3	2646	SYMBOL|DICTIONARY|EXTRACTED	gckr	GCKR	113#117	20628598-1-162-192	Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	16#22	20628598-1-28-49	The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	4	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	60#65	20628598-1-60-130	The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	5	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	77#80	20628598-1-140-151	In addition to our previous report for association with FPG, the A-allele of GCK rs1799884 was also associated with reduced homeostasis model assessment of beta-cell function (HOMA-B) (P=0.0015).
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	6	2646	SYMBOL|DICTIONARY|EXTRACTED	gckr	GCKR	14#18	20628598-1-162-192	Together with GCKR rs780094, the risk alleles of these SNPs exhibited dosage effect in their associations with increased FPG (P=2.9x10(-9)) and reduced HOMA-B (P=1.1x10(-3)).
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	53#59	20628598-1-28-49	Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG.
20628598	2010	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	75#80	20628598-1-60-130	Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	4544	SYMBOL|DICTIONARY|EXTRACTED	mtnr1b	MTNR1B	19#25	20628598-1-28-49	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	57818	SYMBOL|DICTIONARY|EXTRACTED	g6pc2	G6PC2	27#32	20628598-1-60-130	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20628598	2010	PLoS ONE	1932-6203	CONCLUSIONS/SIGNIFICANCE	3	8	2645	SYMBOL|DICTIONARY|EXTRACTED	gck	GCK	37#40	20628598-1-140-151	Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.
20683028	2010	Anticancer Res.	1791-7530	TITLE	0	0	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	19#25		Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
20683028	2010	Anticancer Res.	1791-7530	TITLE	0	0	10	LONGTERM|DICTIONARY	n acetyltransferase 2	N-acetyltransferase 2	53#74		Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	2	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	Cytochrome P450 1B1	0#19		Cytochrome P450 1B1 (CYP1B1) and N-acetyltransferase2 (NAT2) have complementary role in metabolism of xenobiotics such as arylamines and heterocyclic amines, CYP1B1 also hyroxylates 17-beta oestradiol.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	2	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	21#27	20683028-2-0-19	Cytochrome P450 1B1 (CYP1B1) and N-acetyltransferase2 (NAT2) have complementary role in metabolism of xenobiotics such as arylamines and heterocyclic amines, CYP1B1 also hyroxylates 17-beta oestradiol.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	2	10	SYMBOL|()|DICTIONARY	nat2	NAT2	55#59		Cytochrome P450 1B1 (CYP1B1) and N-acetyltransferase2 (NAT2) have complementary role in metabolism of xenobiotics such as arylamines and heterocyclic amines, CYP1B1 also hyroxylates 17-beta oestradiol.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	2	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	158#164	20683028-2-0-19	Cytochrome P450 1B1 (CYP1B1) and N-acetyltransferase2 (NAT2) have complementary role in metabolism of xenobiotics such as arylamines and heterocyclic amines, CYP1B1 also hyroxylates 17-beta oestradiol.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	3	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	0#6		CYP1B1*3 polymorphism and seven missense and four silent polymorphisms of NAT2 were investigated.
20683028	2010	Anticancer Res.	1791-7530	BACKGROUND	1	3	10	SYMBOL|DICTIONARY	nat2	NAT2	74#78		CYP1B1*3 polymorphism and seven missense and four silent polymorphisms of NAT2 were investigated.
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	5	10	SYMBOL|DICTIONARY	nat2	NAT2	20#24		The distribution of NAT2 activity in the healthy control group was found to be correlated with that of healthy caucasians.
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	6	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	43#47		Patients had slow acetylator phenotypes of NAT2, 1.8 times higher than controls but no statistical differences were found (p=0.07).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	7	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	17#21		In addition, the NAT2*5 alelle was more statistically correlated with breast cancer patients rather than the controls (p=0.02).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	8	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	10#14		Moreover, NAT2*5B was the most frequent haplotype of the NAT2*5 family (p=0.000).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	8	10	SYMBOL|NUMBER|DICTIONARY	nat2	NAT2	57#61		Moreover, NAT2*5B was the most frequent haplotype of the NAT2*5 family (p=0.000).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	9	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	52#58	20683028-2-0-19	Breast cancer patients were detected to posses more CYP1B1*3 mutant alleles than the controls (p=0.043).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	10	1545	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	23#29	20683028-2-0-19	The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).
20683028	2010	Anticancer Res.	1791-7530	RESULTS AND CONCLUSION	3	10	10	SYMBOL|DICTIONARY	nat2	NAT2	49#53		The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	TITLE	0	0	7422	LONGTERM|GENE|GN|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	15#49		Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	1	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	Vascular endothelial growth factor	0#34		Vascular endothelial growth factor (VEGF) is a major angiogenic factor involved in a number of pathological processes, including neovascularization, a crucial step in the development of solid malignancies.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	1	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	36#40	20973260-1-0-34	Vascular endothelial growth factor (VEGF) is a major angiogenic factor involved in a number of pathological processes, including neovascularization, a crucial step in the development of solid malignancies.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	BACKGROUND	1	2	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	81#85	20973260-1-0-34	The aim of this study was to investigate the association of polymorphisms in the VEGF gene with susceptibility to epithelial ovarian cancer (EOC).
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	METHODS	2	4	7422	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	vegf	VEGF	18#22	20973260-1-0-34	Genotyping of the VEGF gene polymorphisms at j460C/T, j1154G/A, j2578C/A, and +936C/T were performed by polymerase chain reaction and restriction fragment length polymorphism analysis.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	55#59	20973260-1-0-34	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
20973260	2010	Int. J. Gynecol. Cancer	1525-1438	CONCLUSIONS	4	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	160#164	20973260-1-0-34	The study suggested a possible association between the VEGF -1154G/A polymorphism with susceptibility to EOC, but there is no support for an association of the VEGF -460C/T, +936C/T, and -2578C/A polymorphisms with the risk for EOC.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	13#18		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	4204	SYMBOL|DICTIONARY	mecp2	MECP2	131#136		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
20513142	2010	Hum. Mutat.	1098-1004	TITLE	0	0	6792	SYMBOL|DICTIONARY	cdkl5	CDKL5	141#146		Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	4	4208	SYMBOL|GENE|GN|DICTIONARY	mef2c	MEF2C	29#34		Both deletions contained the MEF2C gene, which is located proximally to the previously defined smallest region of overlap.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	5	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	67#72		Nevertheless, due to its known role in neurogenesis, we considered MEF2C as a phenocritical candidate gene for the 5q14.3q15 microdeletion phenotype.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	6	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	153#158		We therefore performed mutational analysis in 362 patients with severe mental retardation and found two truncating and two missense de novo mutations in MEF2C, establishing defects in this transcription factor as a novel relatively frequent autosomal dominant cause of severe mental retardation accounting for as much as 1.1% of patients.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	4204	SYMBOL|DICTIONARY	mecp2	MECP2	38#43		In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	6792	SYMBOL|DICTIONARY	cdkl5	CDKL5	48#53		In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	125#130		In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	4204	SYMBOL|DICTIONARY	mecp2	MECP2	215#220		In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	7	6792	SYMBOL|DICTIONARY	cdkl5	CDKL5	225#230		In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5.
20513142	2010	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	8	4208	SYMBOL|DICTIONARY	mef2c	MEF2C	67#72		We therefore conclude that the phenotypic overlap of patients with MEF2C mutations and atypical Rett syndrome is due to the involvement of a common pathway.
20514303	2010	J. Korean Med. Sci.	1598-6357	TITLE	0	0	2322	SYMBOL|DICTIONARY	flt3	FLT3	25#29		High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_1/3	1	1	2322	SYMBOL|DICTIONARY	flt3	FLT3	162#166		Identification of prognostic factors and risk-based post-remission therapy was proposed to improve the outcomes of acute myeloid leukemia (AML) and a mutation of FLT3 has been reported to be a risk factor, especially for pediatric patients.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_1/3	1	2	2322	SYMBOL|DICTIONARY	flt3	FLT3	10#14		Recently, FLT3 expression level was implicated to have prognostic significance in adults, but little is known for childhood AML.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_2/3	2	3	2322	SYMBOL|DICTIONARY	flt3	FLT3	59#63		To define the prognostic significance, transcript level of FLT3 was analyzed in 52 pediatric AML patients.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_2/3	2	4	2322	SYMBOL|DICTIONARY	flt3	FLT3	26#30		The median copy number of FLT3 was 4.6x10(3) (40-5.9x10(7) copies)/1.0x10(6) GAPDH copy, and the relapse free survival of patients with high transcript level of FLT3 (>10(6) copy number) (0%) was significantly lower than that of the others (53.2%).
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_2/3	2	4	2597	SYMBOL|DICTIONARY	gapdh	GAPDH	77#82		The median copy number of FLT3 was 4.6x10(3) (40-5.9x10(7) copies)/1.0x10(6) GAPDH copy, and the relapse free survival of patients with high transcript level of FLT3 (>10(6) copy number) (0%) was significantly lower than that of the others (53.2%).
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_2/3	2	4	2322	SYMBOL|DICTIONARY	flt3	FLT3	161#165		The median copy number of FLT3 was 4.6x10(3) (40-5.9x10(7) copies)/1.0x10(6) GAPDH copy, and the relapse free survival of patients with high transcript level of FLT3 (>10(6) copy number) (0%) was significantly lower than that of the others (53.2%).
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_3/3	3	5	2322	SYMBOL|DICTIONARY	flt3	FLT3	25#29		High transcript level of FLT3 was associated with a markedly high risk of relapse.
20514303	2010	J. Korean Med. Sci.	1598-6357	ALL_TEXT_3/3	3	6	2322	SYMBOL|DICTIONARY	flt3	FLT3	120#124		The development of new therapeutic scheme such as a frontline allogeneic stem cell transplantation or administration of FLT3 inhibitor is needed to improve outcomes.
20522430	2010	J. Med. Genet.	1468-6244	TITLE	0	0	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	50#55		Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome.
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	1	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	24#29		BACKGROUND Mutations in SCN1A can cause genetic epilepsy with febrile seizures plus (GEFS+, inherited missense mutations) or Dravet syndrome (DS, de novo mutations of all types).
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	2	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	124#129		Although the mutational spectra are distinct, these disorders share major features and 10% of DS patients have an inherited SCN1A mutation.
20522430	2010	J. Med. Genet.	1468-6244	ALL_TEXT_1/3	1	3	6323	SYMBOL|DICTIONARY	scn1a	SCN1A	139#144		OBJECTIVES AND PATIENTS 19 selected families with at least one DS patient were studied to describe the mechanisms accounting for inherited SCN1A mutations in DS.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	15#20		Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	30#33		Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
20504252	2010	Pharmacogenomics	1744-8042	TITLE	0	0	51141	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	insig2	INSIG2	37#43		Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
20504252	2010	Pharmacogenomics	1744-8042	AIM	2	4	3358	SYMBOL|()|DICTIONARY	htr2c	HTR2C	145#150		We aimed to contribute to the replication and extension of prior association findings and investigated the genes encoding serotonin 2C receptor (HTR2C), insulin-induced gene 2 (INSIG2) and leptin (LEP).
20504252	2010	Pharmacogenomics	1744-8042	AIM	2	4	51141	LONGTERM|DICTIONARY	insulin induced gene 2	insulin-induced gene 2	153#175		We aimed to contribute to the replication and extension of prior association findings and investigated the genes encoding serotonin 2C receptor (HTR2C), insulin-induced gene 2 (INSIG2) and leptin (LEP).
20504252	2010	Pharmacogenomics	1744-8042	AIM	2	4	51141	SYMBOL|()|DICTIONARY|EXTRACTED	insig2	INSIG2	177#183	20504252-4-153-175	We aimed to contribute to the replication and extension of prior association findings and investigated the genes encoding serotonin 2C receptor (HTR2C), insulin-induced gene 2 (INSIG2) and leptin (LEP).
20504252	2010	Pharmacogenomics	1744-8042	AIM	2	4	3952	SYMBOL|()|DICTIONARY|EXTRACTED	lep	LEP	197#200	20504252-4-189-195	We aimed to contribute to the replication and extension of prior association findings and investigated the genes encoding serotonin 2C receptor (HTR2C), insulin-induced gene 2 (INSIG2) and leptin (LEP).
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	35#40		We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	42#45	20504252-4-189-195	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	5	51141	SYMBOL|DICTIONARY|EXTRACTED	insig2	INSIG2	50#56	20504252-4-153-175	We investigated the association of HTR2C, LEP and INSIG2 SNPs with antipsychotic-induced BWG in 128 German schizophrenic patients.
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	6	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	40#45		Genotyping was performed for nine SNPs (HTR2C: rs498207, rs3813928, rs6318 and rs3813929; INSIG2: rs17587100, rs10490624, rs17047764 and rs7566605; LEP: rs7799039).
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	6	51141	SYMBOL|DICTIONARY|EXTRACTED	insig2	INSIG2	90#96	20504252-4-153-175	Genotyping was performed for nine SNPs (HTR2C: rs498207, rs3813928, rs6318 and rs3813929; INSIG2: rs17587100, rs10490624, rs17047764 and rs7566605; LEP: rs7799039).
20504252	2010	Pharmacogenomics	1744-8042	PATIENTS &amp; METHODS	3	6	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	148#151	20504252-4-189-195	Genotyping was performed for nine SNPs (HTR2C: rs498207, rs3813928, rs6318 and rs3813929; INSIG2: rs17587100, rs10490624, rs17047764 and rs7566605; LEP: rs7799039).
20504252	2010	Pharmacogenomics	1744-8042	RESULTS	4	8	3358	SYMBOL|DICTIONARY	htr2c	HTR2C	45#50		We report a significant association of three HTR2C SNPs (rs498207, rs3813928 and rs3813929) and of the respective haplotype with antipsychotic-induced BWG.
20504252	2010	Pharmacogenomics	1744-8042	RESULTS	4	11	51141	SYMBOL|DICTIONARY|EXTRACTED	insig2	INSIG2	29#35	20504252-4-153-175	No association was found for INSIG2 and LEP SNPs.
20504252	2010	Pharmacogenomics	1744-8042	RESULTS	4	11	3952	SYMBOL|DICTIONARY|EXTRACTED	lep	LEP	40#43	20504252-4-189-195	No association was found for INSIG2 and LEP SNPs.
20504252	2010	Pharmacogenomics	1744-8042	CONCLUSION	5	12	3358	SYMBOL|GENE|GN|DICTIONARY	htr2c	HTR2C	92#97		The results contribute to the accumulating evidence for an association of the X-chromosomal HTR2C gene with antipsychotic-induced BWG.
20504252	2010	Pharmacogenomics	1744-8042	CONCLUSION	5	13	3358	SYMBOL|GENE|GN|DICTIONARY	htr2c	HTR2C	53#58		The proposed underlying mechanisms include decreased HTR2C gene expression with reduced 5-HT-modulated activation of hypothalamic proopiomelanocortin-neurons, and inverse 5-HT(2C) agonism in the presence of D(2) receptor antagonism.
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	16#20		[Association of MICA gene polymorphism and serum soluble MICA level with colorectal cancer].
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	RESULTS	3	5	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	72#76		Neither the extracellular nor the transmembrane region polymorphisms of MICA gene were associated with the occurrence and the different stages of colorectal cancer.
20533278	2010	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	CONCLUSION	4	8	100507436	SYMBOL|GENE|GN|DICTIONARY	mica	MICA	59#63		Although there was no genetic susceptibility attributed to MICA gene polymorphism with regard to development of colorectal cancer, serum levels of soluble MICA may be a diagnostic marker of advanced stages.
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	79068	SYMBOL|DICTIONARY	fto	FTO	80#83		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	4160	SYMBOL|DICTIONARY	mc4r	MC4R	85#89		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	129787	SYMBOL|DICTIONARY	tmem18	TMEM18	91#97		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	132789	SYMBOL|DICTIONARY	gnpda2	GNPDA2	99#105		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	79047	SYMBOL|DICTIONARY	kctd15	KCTD15	107#113		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	257194	SYMBOL|DICTIONARY	negr1	NEGR1	115#120		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	627	SYMBOL|DICTIONARY	bdnf	BDNF	122#126		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20520848	2010	PLoS Med.	1549-1676	METHODS AND FINDINGS	2	4	2119	SYMBOL|DICTIONARY	etv5	ETV5	132#136		"Eight variants that showed individual associations with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an ""obesity-risk-allele score"" comprising the total number of risk alleles (range: 2-15 alleles) in each child with complete genotype data (n = 7,146)."
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	1956	LONGTERM|GENE|GT|DICTIONARY	epidermal growth factor receptor	epidermal growth factor receptor	153#185		Detection of K-ras gene status in colorectal cancer will help to select the patients likely to benefit from the monoclonal antibody therapy of targeting epidermal growth factor receptor.
20555002	2010	In Vivo	0258-851X	TITLE	0	0	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	20#54		Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis.
20555002	2010	In Vivo	0258-851X	BACKGROUND/AIMS	1	2	7422	LONGTERM|GENE|GT|DICTIONARY	vascular endothelial growth factor	vascular endothelial growth factor	8#42		Whether vascular endothelial growth factor (VEGF) -460 C/T and +405 G/C polymorphisms are associated with susceptibility to endometriosis was investigated.
20555002	2010	In Vivo	0258-851X	BACKGROUND/AIMS	1	2	7422	SYMBOL|()|DICTIONARY|EXTRACTED	vegf	VEGF	44#48	20555002-2-8-42	Whether vascular endothelial growth factor (VEGF) -460 C/T and +405 G/C polymorphisms are associated with susceptibility to endometriosis was investigated.
20555002	2010	In Vivo	0258-851X	RESULTS	3	7	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	20555002-2-8-42	The VEGF +405 G/C genotype frequencies among the cases and controls were CC 55.8% and 35%; GC 30.8% and 50.0%; GG 13.5% and 15.0%, respectively.
20555002	2010	In Vivo	0258-851X	RESULTS	3	9	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	58#62	20555002-2-8-42	Patients with endometriosis had a higher incidence of the VEGF +405 CC genotype compared with the controls (p=0.027).
20555002	2010	In Vivo	0258-851X	RESULTS	3	10	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	11#15	20555002-2-8-42	Women with VEGF +405 CC genotype had 2.3-fold higher risk for endometriosis.
20555002	2010	In Vivo	0258-851X	RESULTS	3	11	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	0#4		VEGF +405 GC genotype and G allele in the control group was higher than the endometriosis group (p=0.039, p=0.027 respectively).
20555002	2010	In Vivo	0258-851X	RESULTS	3	12	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	20555002-2-8-42	The VEGF -460 C/T genotype frequencies among the cases were CC 21.2%, CT 26.9% and TT 51.9%; the C and T allelic frequencies were 34.6% and 65.3%, respectively.
20555002	2010	In Vivo	0258-851X	RESULTS	3	13	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	4#8	20555002-2-8-42	The VEGF -460 genotype frequencies among the controls were CC 31.70%, CT 18.3% and TT 50.0%; the C and T allelic frequencies were 40.8% and 59.1%, respectively (p>0.05).
20555002	2010	In Vivo	0258-851X	RESULTS	3	14	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	41#45	20555002-2-8-42	There was linkage disequilibrium between VEGF -460 C/T and +405 G/C polymorphisms (D': 0.197, r(2)=0.013).
20555002	2010	In Vivo	0258-851X	RESULTS	3	15	7422	SYMBOL|NUMBER|DICTIONARY|EXTRACTED	vegf	VEGF	21#25	20555002-2-8-42	We observed that the VEGF 460T/405C haplotype frequency was significantly higher in patients compared to controls (p=0.011).
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	41#45	20555002-2-8-42	Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	79#83	20555002-2-8-42	Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20555002	2010	In Vivo	0258-851X	CONCLUSION	4	16	7422	SYMBOL|DICTIONARY|EXTRACTED	vegf	VEGF	154#158	20555002-2-8-42	Our data suggest that the CC genotype of VEGF +405 and 460T/405C haplotypes of VEGF may be associated with the risk of endometriosis, but the G allele of VEGF +405 appears to be protective against endometriosis.
20644276	2010	Neurol India	0028-3886	TITLE	0	0	348	LONGTERM|DICTIONARY	apolipoprotein e	Apolipoprotein-E	0#16		Apolipoprotein-E genotypes and myasthenia gravis.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	3	348	LONGTERM|DICTIONARY	apolipoprotein e	apolipoprotein E	52#68		This case-control study, studied the association of apolipoprotein E (Apo-E) alleles with MG. Anti-AChR antibody was measured using radio receptor immunoassay.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	3	348	SYMBOL|()|DICTIONARY|EXTRACTED	apo e	Apo-E	70#75	20644276-3-52-68	This case-control study, studied the association of apolipoprotein E (Apo-E) alleles with MG. Anti-AChR antibody was measured using radio receptor immunoassay.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_2/3	2	4	348	SYMBOL|DICTIONARY|EXTRACTED	apo e	Apo-E	0#5		Apo-E genotypes were analyzed in 120 MG patients and 120 healthy subjects.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_3/3	3	5	348	SYMBOL|DICTIONARY|EXTRACTED	apo e	Apo-E	88#93	20644276-3-52-68	Comparison between patients with MG and controls showed no significant association with Apo-E allelic variants.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	TITLE	0	0	3952	LONGTERM|GENE|GN|DICTIONARY	leptin	leptin	37#43		Relationship between variants of the leptin gene and obesity and metabolic biomarkers in Brazilian individuals.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	OBJECTIVE	1	1	3952	LONGTERM|GENE|GN|DICTIONARY	leptin	leptin	41#47		The relationship between variants of the leptin gene (LEP) and obesity and metabolic biomarkers was investigated in Brazilian individuals.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	SUBJECTS AND METHODS	2	3	3952	LONGTERM|DICTIONARY	leptin	leptin	7#13		Plasma leptin, glycemia, serum lipid measurements and LEP -2548G>A and 3'HVR polymorphisms were analyzed.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	4	3952	LONGTERM|DICTIONARY	leptin	leptin	100#106		The LEP -2548GG genotype was associated with a 2.2% and 2.0% increase in BMI (p = 0.009) and plasma leptin (p = 0.031), respectively.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	6	3952	LONGTERM|DICTIONARY	leptin	leptin	123#129		LEP I/G combined genotypes (I/IGG, I/IGA and I/IIGG) were associated with obesity, and increased BMI, waist circumference, leptin and triglycerides (p < 0.05).
20560254	2010	Turk. J. Pediatr.	0041-4301	ALL_TEXT_2/3	2	4	2706	SYMBOL|GENE|GN|DICTIONARY	gjb2	GJB2	80#84		We additionally compared the HRV values obtained from children with and without GJB2 gene mutations.
20560254	2010	Turk. J. Pediatr.	0041-4301	ALL_TEXT_3/3	3	6	2706	SYMBOL|DICTIONARY	gjb2	GJB2	100#104		There were also no significant differences in HRV parameters between deaf children with and without GJB2 mutations.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	RESULTS	3	9	6720	SYMBOL|DICTIONARY	srebp 1c	SREBP-1c	76#84		After a hyperinsulinemic clamp, there was an overall upregulation of PGC1α, SREBP-1c, SREBP-2, and ACC-2.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	RESULTS	3	9	6721	SYMBOL|DICTIONARY	srebp 2	SREBP-2	86#93		After a hyperinsulinemic clamp, there was an overall upregulation of PGC1α, SREBP-1c, SREBP-2, and ACC-2.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	RESULTS	3	9	597	SYMBOL|DICTIONARY	acc 2	ACC-2	99#104		After a hyperinsulinemic clamp, there was an overall upregulation of PGC1α, SREBP-1c, SREBP-2, and ACC-2.
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	RESULTS	3	10	6721	SYMBOL|DICTIONARY	srebp 2	SREBP-2	20#27		The upregulation of SREBP-2 was more pronounced in IGT men (p = 0.049).
20699619	2010	J Nutrigenet Nutrigenomics	1661-6499	CONCLUSIONS	4	12	6721	SYMBOL|DICTIONARY	srebp 2	SREBP-2	0#7		SREBP-2 shows altered insulin responsiveness in IGT men compared with NGT men, while there were no differences in basal gene expression.
9886312	1999	Br. J. Haematol.	0007-1048	TITLE	0	0	2815	SYMBOL|DICTIONARY	gpix	GPIX	126#130		A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2815	SYMBOL|DICTIONARY	gpix	GPIX	122#126		We describe a new variant of Bernard-Soulier syndrome characterized by almost normal amounts of GPIb and severely reduced GPIX and GPV.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	3	2815	SYMBOL|DICTIONARY	gpix	GPIX	41#45		Sequence analysis of the gene coding for GPIX revealed a T-to-C substitution at base 1811, leading to a Leu40Pro conversion, whereas no defects were found in the coding region of the GPIbalpha gene.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	3	2811	SYMBOL|GENE|GN|DICTIONARY	gpibalpha	GPIbalpha	183#192		Sequence analysis of the gene coding for GPIX revealed a T-to-C substitution at base 1811, leading to a Leu40Pro conversion, whereas no defects were found in the coding region of the GPIbalpha gene.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	4	2815	SYMBOL|DICTIONARY	gpix	GPIX	156#160		Allele-specific restriction enzyme analysis showed that the propositus and one of his sisters. both with severe bleeding diathesis. were homozygous for the GPIX mutation: the members of the family with mild bleeding diathesis and/or giant platelets in the peripheral blood were heterozygous, whereas the healthy ones were homozygous for the normal allele.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2815	SYMBOL|DICTIONARY	gpix	GPIX	218#222		Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	6403	SYMBOL|DICTIONARY	gmp 140	GMP-140	239#246		Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
9865924	1999	Clin. Cancer Res.	1078-0432	TITLE	0	0	1728	SYMBOL|()|DICTIONARY|EXTRACTED	nqo1	NQO1	59#63	9865924-0-35-57	A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
9865924	1999	Clin. Cancer Res.	1078-0432	TITLE	0	0	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	152#156	9865924-0-35-57	A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	32#36	9865924-0-35-57	NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	1	1728	LONGTERM|DICTIONARY	dt diaphorase	DT-diaphorase	38#51		NAD(P)H:quinone oxidoreductase (NQO1; DT-diaphorase) is elevated in certain tumors, such as non-small cell lung cancer (NSCLC).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	2	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	80#84	9865924-0-35-57	Compounds such as mitomycin C and streptonigrin are efficiently bioactivated by NQO1 and have been used in an enzyme-directed approach to chemotherapy.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	3	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	162#166	9865924-0-35-57	Previously, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) was identified as a potential antitumor agent based on its high rate of bioactivation by human NQO1 and its selective cytotoxicity to cells containing elevated NQO1.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_1/3	1	3	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	227#231	9865924-0-35-57	Previously, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) was identified as a potential antitumor agent based on its high rate of bioactivation by human NQO1 and its selective cytotoxicity to cells containing elevated NQO1.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	4	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	110#114	9865924-0-35-57	RH1, a water-soluble analogue of MeDZQ synthesized in this work, was a better substrate for recombinant human NQO1 than the parent compound.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	82#86	9865924-0-35-57	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	5	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	245#249	9865924-0-35-57	RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_2/3	2	6	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	108#112	9865924-0-35-57	RH1 exhibited a greater selective toxicity (ratio of IC50s in H596:H460 and BE:HT29) to cells with elevated NQO1 activity relative to MeDZQ.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	7	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	126#130	9865924-0-35-57	Additionally, we report the establishment of a stable line of BE human colon carcinoma cells transfected with wild-type human NQO1 (BE-NQ7).
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	8	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	23#27	9865924-0-35-57	BE cells are devoid of NQO1 activity due to a homozygous point mutation in the NQO1 gene.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	8	1728	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nqo1	NQO1	79#83	9865924-0-35-57	BE cells are devoid of NQO1 activity due to a homozygous point mutation in the NQO1 gene.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	9	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	188#192	9865924-0-35-57	In comparison to the parental cell line, RH1, MeDZQ, and mitomycin C were significantly more cytotoxic to BE-NQ7 cells (17-, 7-, and 3-fold, respectively), confirming that the presence of NQO1 is sufficient to increase cytotoxicity of these antitumor quinones.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	48#52	9865924-0-35-57	These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
9865924	1999	Clin. Cancer Res.	1078-0432	ALL_TEXT_3/3	3	10	1728	SYMBOL|DICTIONARY|EXTRACTED	nqo1	NQO1	118#122	9865924-0-35-57	These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
9823305	1998	Cancer Res.	0008-5472	TITLE	0	0	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	cytochrome P450 1B1	15#34		Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
9823305	1998	Cancer Res.	0008-5472	TITLE	0	0	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	36#42	9823305-0-15-34	Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	1545	LONGTERM|DICTIONARY	cytochrome p450 1b1	cytochrome P450 1B1	140#159		A key enzyme involved in the production of potentially carcinogenic estrogen metabolites and the activation of environmental carcinogens is cytochrome P450 1B1 (CYP1B1), the predominant member of the CYP1 family expressed in normal breast tissue and breast cancer.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	1	1545	SYMBOL|()|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	161#167	9823305-0-15-34	A key enzyme involved in the production of potentially carcinogenic estrogen metabolites and the activation of environmental carcinogens is cytochrome P450 1B1 (CYP1B1), the predominant member of the CYP1 family expressed in normal breast tissue and breast cancer.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	34#40	9823305-0-15-34	Because of the preeminent role of CYP1B1 in mammary estrogen/carcinogen metabolism, we examined the CYP1B1 gene to determine whether genetic differences could account for interindividual differences in breast cancer risk.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_1/3	1	2	1545	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	100#106	9823305-0-15-34	Because of the preeminent role of CYP1B1 in mammary estrogen/carcinogen metabolism, we examined the CYP1B1 gene to determine whether genetic differences could account for interindividual differences in breast cancer risk.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	37#43	9823305-0-15-34	To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_2/3	2	6	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	127#133	9823305-0-15-34	To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	8#14	9823305-0-15-34	Because CYP1B1 is known to be involved in mammary estrogen metabolism, we investigated whether the estrogen receptor status is influenced by the CYP1B1 genotypes.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	8	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	145#151	9823305-0-15-34	Because CYP1B1 is known to be involved in mammary estrogen metabolism, we investigated whether the estrogen receptor status is influenced by the CYP1B1 genotypes.
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	9	5241	LONGTERM|GENE|GT|DICTIONARY	progesterone receptor	progesterone receptor	132#153		Caucasian patients with the m1 Val/Val genotype have a significantly higher percentage of estrogen receptor-positive (P = 0.02) and progesterone receptor-positive breast cancers (P = 0.003).
9823305	1998	Cancer Res.	0008-5472	ALL_TEXT_3/3	3	11	1545	SYMBOL|DICTIONARY|EXTRACTED	cyp1b1	CYP1B1	28#34	9823305-0-15-34	These data suggest that the CYP1B1 polymorphisms in exon 3 are not associated with increased breast cancer risk but that the m1 polymorphism may be functionally important for steroid receptor expression in breast cancer of Caucasian patients.
9861562	1999	Infection	0300-8126	TITLE	0	0	3558	LONGTERM|DICTIONARY	interleukin 2	interleukin-2	15#28		Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	1	3558	LONGTERM|DICTIONARY	interleukin 2	interleukin-2	120#133		In a pilot study the safety and therapeutic effects of an immunostimulatory intralymphatic treatment with natural human interleukin-2 (IL-2) in combination with zidovudine were evaluated in nine patients with AIDS.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	1	3558	SYMBOL|()|DICTIONARY|EXTRACTED	il 2	IL-2	135#139	9861562-1-120-133	In a pilot study the safety and therapeutic effects of an immunostimulatory intralymphatic treatment with natural human interleukin-2 (IL-2) in combination with zidovudine were evaluated in nine patients with AIDS.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	2	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	13#17	9861562-1-120-133	Therapy with IL-2 consisted of one subcutaneous injection of 0.1 microgram/kg IL-2, followed by four intralymphatic IL-2 infusions of 0.1 microgram/kg each within a period of up to 15 days.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	2	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	78#82	9861562-1-120-133	Therapy with IL-2 consisted of one subcutaneous injection of 0.1 microgram/kg IL-2, followed by four intralymphatic IL-2 infusions of 0.1 microgram/kg each within a period of up to 15 days.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	2	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	116#120	9861562-1-120-133	Therapy with IL-2 consisted of one subcutaneous injection of 0.1 microgram/kg IL-2, followed by four intralymphatic IL-2 infusions of 0.1 microgram/kg each within a period of up to 15 days.
9861562	1999	Infection	0300-8126	ALL_TEXT_1/3	1	3	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	133#137	9861562-1-120-133	Enlargement of lymph nodes was seen in six and a transient increase of CD4 cells in five out of nine persons in association with the IL-2 therapy.
9861562	1999	Infection	0300-8126	ALL_TEXT_3/3	3	7	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	160#164	9861562-1-120-133	Six participants showed a favourable course of disease with survival of 25 to 54 months (median 30 months) despite a previous diagnosis of manifest AIDS before IL-2 therapy.
9861562	1999	Infection	0300-8126	ALL_TEXT_3/3	3	8	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	77#81	9861562-1-120-133	This pilot study demonstrates that a combination therapy with intralymphatic IL-2 and zidovudine can induce positive immunomodulatory effects, even in the presence of manifest AIDS.
9861562	1999	Infection	0300-8126	ALL_TEXT_3/3	3	9	3558	SYMBOL|DICTIONARY|EXTRACTED	il 2	IL-2	88#92	9861562-1-120-133	Further studies should explore the tolerability and effects of a prolonged therapy with IL-2 in combination with a more potent antiviral drug combination therapy.
9714430	1998	Am. J. Med. Genet.	0148-7299	TITLE	0	0	4023	LONGTERM|DICTIONARY|GENE|GA	lipoprotein lipase	lipoprotein lipase	31#49		Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.
9714430	1998	Am. J. Med. Genet.	0148-7299	TITLE	0	0	4023	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	51#54	9714430-0-31-49	Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	4023	LONGTERM|DICTIONARY|GENE|GA	lipoprotein lipase	lipoprotein lipase	17#35		Mutations in the lipoprotein lipase (LPL) gene are the most important cause of familial chylomicronemia with over 70 mutations being recorded to date.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	4023	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	37#40	9714430-0-31-49	Mutations in the lipoprotein lipase (LPL) gene are the most important cause of familial chylomicronemia with over 70 mutations being recorded to date.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	3	4023	SYMBOL|DICTIONARY|EXTRACTED	lpl	LPL	94#97	9714430-0-31-49	Here we report on the molecular analysis of the family of a patient previously reported to be LPL deficient on the basis of compound heterozygosity for the Arg243His and Ile225Thr mutations, the latter being the first and only mutation identified in the loop region of LPL.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	3	4023	SYMBOL|DICTIONARY|EXTRACTED	lpl	LPL	269#272	9714430-0-31-49	Here we report on the molecular analysis of the family of a patient previously reported to be LPL deficient on the basis of compound heterozygosity for the Arg243His and Ile225Thr mutations, the latter being the first and only mutation identified in the loop region of LPL.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	6	4023	SYMBOL|DICTIONARY|EXTRACTED	lpl	LPL	35#38	9714430-0-31-49	An examination of maternity, using LPL restriction fragment length polymorphisms four polymorphic CA repeats and ApoE genotypes, was consistent with correct biological parentage for the propositus.
9714430	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	7	4023	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	112#115	9714430-0-31-49	Therefore, we conclude that the Ile225Thr mutation constitutes a de novo event, the first to be reported in the LPL gene.
9550468	1998	Arthritis Rheum.	0004-3591	TITLE	0	0	3586	SYMBOL|DICTIONARY	il 10	IL-10	27#32		Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
9550468	1998	Arthritis Rheum.	0004-3591	TITLE	0	0	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	37#42		Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	77#82		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	3586	SYMBOL|DICTIONARY	il 10	IL-10	84#89		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	1493	SYMBOL|DICTIONARY	ctla 4	CTLA-4	102#108		To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	METHODS	2	2	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	34#39		First, intragenic markers for the bcl-2, IL-10, Fas-L, and CTLA-4 genes were characterized and their extent of polymorphism in normal populations was determined.
9550468	1998	Arthritis Rheum.	0004-3591	METHODS	2	2	3586	SYMBOL|DICTIONARY	il 10	IL-10	41#46		First, intragenic markers for the bcl-2, IL-10, Fas-L, and CTLA-4 genes were characterized and their extent of polymorphism in normal populations was determined.
9550468	1998	Arthritis Rheum.	0004-3591	METHODS	2	2	1493	SYMBOL|GENE|GN|DICTIONARY	ctla 4	CTLA-4	59#65		First, intragenic markers for the bcl-2, IL-10, Fas-L, and CTLA-4 genes were characterized and their extent of polymorphism in normal populations was determined.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	4#9		The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	3586	SYMBOL|DICTIONARY	il 10	IL-10	22#27		The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	5	1493	SYMBOL|GENE|GN|DICTIONARY	ctla 4	CTLA-4	45#51		No association was found between SLE and the CTLA-4 gene.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	6	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	85#90		Further analysis revealed a synergistic effect between susceptibility alleles of the bcl-2 and IL-10 genes in determining disease susceptibility.
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	6	3586	SYMBOL|GENE|GN|DICTIONARY	il 10	IL-10	95#100		Further analysis revealed a synergistic effect between susceptibility alleles of the bcl-2 and IL-10 genes in determining disease susceptibility.
9550468	1998	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	596	SYMBOL|DICTIONARY	bcl 2	bcl-2	73#78		The results suggest that individuals carrying specific genotypes of both bcl-2 and IL-10 are at significant risk of developing SLE.
9550468	1998	Arthritis Rheum.	0004-3591	CONCLUSION	4	8	3586	SYMBOL|DICTIONARY	il 10	IL-10	83#88		The results suggest that individuals carrying specific genotypes of both bcl-2 and IL-10 are at significant risk of developing SLE.
9535411	1998	Hypertension	0194-911X	TITLE	0	0	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	53#68		Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_1/3	1	1	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	165#180		This study examined the association between the development of nephropathy in non-insulin-dependent diabetes mellitus (NIDDM) patients and M235T polymorphism in the angiotensinogen gene.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	3	183	LONGTERM|DICTIONARY	angiotensinogen	angiotensinogen	111#126		In addition to a standardized examination, blood was drawn for DNA and determination of M235T genotypes at the angiotensinogen locus.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	8#23		For the angiotensinogen gene, the frequency of the genotype 235T/235T, known to be associated with essential hypertension, was higher among case subjects with nephropathy than in control subjects without this complication.
9535411	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	183	LONGTERM|GENE|GN|DICTIONARY	angiotensinogen	angiotensinogen	30#45		DNA polymorphism M235T in the angiotensinogen gene, which is associated with higher expression of this gene, contributes to the risk of diabetic nephropathy in NIDDM men but not in women.
9521595	1998	Hum. Genet.	0340-6717	TITLE	0	0	1080	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	16#20		Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I).
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	LONGTERM|DICTIONARY|GENE|GA	cystic fibrosis transmembrane conductance regulator	cystic fibrosis transmembrane conductance regulator	128#179		In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9521595	1998	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	1080	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	cftr	CFTR	181#185	9521595-1-128-179	In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix.
9475597	1998	Am. J. Med. Genet.	0148-7299	TITLE	0	0	2332	SYMBOL|DICTIONARY	fmr 1	FMR-1	27#32		Distribution of (CGG)n and FMR-1 associated microsatellite alleles in a normal Chilean population.
9475597	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	2477	SYMBOL|DICTIONARY	fraxa	FRAXA	110#115		We report on the allele distribution in a normal Chilean population at 2 microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
9475597	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_1/3	1	1	2332	SYMBOL|GENE|GN|DICTIONARY	fmr 1	FMR-1	165#170		We report on the allele distribution in a normal Chilean population at 2 microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
9475597	1998	Am. J. Med. Genet.	0148-7299	ALL_TEXT_3/3	3	5	2332	SYMBOL|DICTIONARY	fmr 1	FMR-1	37#42		A striking linkage disequilibrium of FMR-1 alleles with FRAXAC1 alleles was observed.
9498099	1998	Clin. Chim. Acta	0009-8981	TITLE	0	0	4023	LONGTERM|GENE|GN|DICTIONARY	lipoprotein lipase	lipoprotein lipase	38#56		A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_2/3	2	2	4023	LONGTERM|DICTIONARY	lipoprotein lipase	lipoprotein lipase	23#41		A partial reduction in lipoprotein lipase (LPL) activity due to a mutation in the LPL gene, is often an associating factor.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_2/3	2	2	4023	SYMBOL|()|DICTIONARY|EXTRACTED	lpl	LPL	43#46	9498099-2-23-41	A partial reduction in lipoprotein lipase (LPL) activity due to a mutation in the LPL gene, is often an associating factor.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_2/3	2	2	4023	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	82#85	9498099-2-23-41	A partial reduction in lipoprotein lipase (LPL) activity due to a mutation in the LPL gene, is often an associating factor.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_3/3	3	3	4023	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	lpl	LPL	23#26	9498099-2-23-41	Here we report a novel LPL gene mutation (Glu421Lys), in a previously healthy primigravid woman who died from hypertriglyceridemia-induced pancreatitis during the last trimester of pregnancy.
9498099	1998	Clin. Chim. Acta	0009-8981	ALL_TEXT_3/3	3	4	4023	SYMBOL|DICTIONARY|EXTRACTED	lpl	LPL	100#103	9498099-2-23-41	The patient was heterozygous for this mutation which a charge inversion in the C-terminal domain of LPL resulting in a moderate reduction in catalytic activity, both in vivo and in vitro.
9554754	1998	Hum. Mutat.	1059-7794	TITLE	0	0	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	60#77		A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	51#68		Several mutations have been described in the human androgen receptor gene including constitutional mutations in androgen insensitivity syndrome, somatic mutations in prostate cancer and triplet expansions in Kennedy's disease (Gottlieb et al.1997).
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	2	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	115#132		Here we report on two siblings with complete androgen insensitivity and a novel missense mutation, D695V, in their androgen receptor gene.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_2/3	2	4	367	LONGTERM|GENE|GN|GT|DICTIONARY	androgen receptor	androgen receptor	156#173		We found both siblings to be hemizygous for a new adenine to thymine transversion at the second nucleotide of codon 695 within the fourth exon of the human androgen receptor gene.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	5	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	114#131		The resulting missense mutation D695V is located at the amino-terminal border of the ligand-binding domain of the androgen receptor.
9554754	1998	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	8	367	LONGTERM|GENE|GT|DICTIONARY	androgen receptor	androgen receptor	166#183		We suggest that the existence of three pathological amino acid substitutions for aspartic acid 695 most likely reflects the essential role of this residue for normal androgen receptor function in male sexual differentiation.
9747038	1998	J. Hum. Genet.	1434-5161	TITLE	0	0	5354	SYMBOL|()|GENE|GN|DICTIONARY	plp	PLP	97#100		Connatal Pelizaeus-Merzbacher disease: a missense mutation in exon 4 of the proteolipid protein (PLP) gene.
9747038	1998	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	1	5354	SYMBOL|()|GENE|GN|DICTIONARY	plp	PLP	41#44		We investigated the proteolipid protein (PLP) gene in two brothers in a Japanese family with a connatal form of Pelizaeus-Merzbacher disease (PMD).
9747038	1998	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	2	5354	SYMBOL|GENE|GN|DICTIONARY	plp	PLP	25#28		Direct sequencing of the PLP gene revealed an A-to-T transition in exon 4, which led to an Asp-to-Val substitution at residue 202.
9747038	1998	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	5	5354	SYMBOL|GENE|GN|DICTIONARY	plp	PLP	113#116		A correlation between the clinical severity of the disease in the brothers and the Asp202-to-Val mutation in the PLP gene was suggested.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	97#106		Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_1/3	1	1	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	54#63		Two different mutations of the active-site Lys-296 in rhodopsin, K296E and K296M, have been found to cause autosomal dominant retinitis pigmentosa (ADRP).
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	3	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	141#150		Previous work has highlighted the potential of retinylamine analogs as active-site directed inactivators of constitutively active mutants of rhodopsin with the idea that these or related compounds might be used therapeutically for cases of ADRP involving mutations of the active-site Lys.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	4	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	113#122		Unfortunately, however, amine derivatives of 11-cis-retinal, although highly effective against a K296G mutant of rhodopsin, were without affect on the two naturally occurring ADRP mutants, presumably because of the greater steric bulk of Glu and Met side chains in comparison to Gly.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	61#66		Three novel mutations and a de novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	1	190	SYMBOL|DICTIONARY	dax 1	DAX-1	4#9		The DAX-1 [DSS (dosage sensitive sex)-AHC critical region on the X, gene 1] gene is responsible for X-linked adrenal hypoplasia congenita (AHC).
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	2	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	9#14		However, DAX-1 protein structure-function relationships are not well understood.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	16#21		We analyzed the DAX-1 gene from seven patients in six kindreds with X-linked AHC and identified one frameshift mutation, two missense mutations, and three deletion mutations.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	8	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	79#84		The tryptophan (Trp) at position 291 and lysine (Lys) at position 382 in human DAX-1 protein are highly conserved among other related orphan nuclear receptor superfamily members.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	182#187		These findings suggest that: 1) Trp at position 291 and Lys at position 382, located in the C-terminal presumptive ligand binding domain, are important to the functional role of the DAX-1 protein in adrenal embryogenesis and/or in hypothalamic-pituitary activity; and 2) molecular analysis of the DAX-1 gene may help genetic counseling, even in cases with deletion mutation, because a detection of de novo deletion may exclude another affected or carrier child.
9360549	1997	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	190	SYMBOL|GENE|GN|DICTIONARY	dax 1	DAX-1	297#302		These findings suggest that: 1) Trp at position 291 and Lys at position 382, located in the C-terminal presumptive ligand binding domain, are important to the functional role of the DAX-1 protein in adrenal embryogenesis and/or in hypothalamic-pituitary activity; and 2) molecular analysis of the DAX-1 gene may help genetic counseling, even in cases with deletion mutation, because a detection of de novo deletion may exclude another affected or carrier child.
9382152	1997	Am. J. Med. Genet.	0148-7299	TITLE	0	0	4693	SYMBOL|GENE|GN|DICTIONARY	norrin	norrin	52#58		Two new missense mutations (A105T and C110G) in the norrin gene in two Italian families with Norrie disease and familial exudative vitreoretinopathy.
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1956	SYMBOL|GENE|GN|DICTIONARY	egfr	EGFR	15#19		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	43#48		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
9217972	1997	Brain Pathol.	1015-6305	TITLE	0	0	1029	SYMBOL|GENE|GN|DICTIONARY	mts1	MTS1	54#58		Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	1956	SYMBOL|DICTIONARY	egfr	EGFR	131#135		Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	1	7157	SYMBOL|DICTIONARY	tp53	TP53	204#208		Glioblastoma multiforme (GBM) can be divided into genetic subsets: approximately one-third of GBM, primarily in older adults, have EGFR amplification; another one-third, primarily in younger adults, have TP53 mutation.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	2	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	58#63		The majority of GBM also have homozygous deletions of the CDKN2 (p16/MTS1) gene, resulting in cell cycle deregulation and elevated proliferation indices.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	2	1029	SYMBOL|GENE|GN|DICTIONARY	mts1	MTS1	69#73		The majority of GBM also have homozygous deletions of the CDKN2 (p16/MTS1) gene, resulting in cell cycle deregulation and elevated proliferation indices.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	38#43		We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	1956	SYMBOL|DICTIONARY	egfr	EGFR	88#92		We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_1/3	1	3	7157	SYMBOL|DICTIONARY	tp53	TP53	110#114		We evaluated the relationship between CDKN2 deletions and the GBM subsets as defined by EGFR amplification or TP53 mutation in 70 GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	4	1956	SYMBOL|DICTIONARY	egfr	EGFR	29#33		Twenty-eight cases (40%) had EGFR amplification, 21 (30%) had TP53 mutation, and 21 (30%) had neither change.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	4	7157	SYMBOL|DICTIONARY	tp53	TP53	62#66		Twenty-eight cases (40%) had EGFR amplification, 21 (30%) had TP53 mutation, and 21 (30%) had neither change.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	5	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	0#5		CDKN2 deletions were present in 36 (51%) GBM.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	6	1956	SYMBOL|DICTIONARY	egfr	EGFR	19#23		Of the 28 GBM with EGFR amplification, 20 (71%) had CDKN2 deletion (p = 0.0078).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	52#57		Of the 28 GBM with EGFR amplification, 20 (71%) had CDKN2 deletion (p = 0.0078).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	28#33		The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	69#73		The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	1956	SYMBOL|DICTIONARY	egfr	EGFR	115#119		The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	7	7157	SYMBOL|DICTIONARY	tp53	TP53	138#142		The remaining 16 cases with CDKN2 loss were divided between GBM with TP53 mutations (6 cases) and GBM with neither EGFR amplification nor TP53 mutation (10 cases).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	6#11		Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	1956	SYMBOL|DICTIONARY	egfr	EGFR	58#62		Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	8	7157	SYMBOL|DICTIONARY	tp53	TP53	100#104		Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	0#5		CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	9	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	98#103		CDKN2 deletions occurred in GBM from patients somewhat older than those patients with GBM lacking CDKN2 deletion (mean age 53 vs. 48 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1956	SYMBOL|DICTIONARY	egfr	EGFR	28#32		Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	59#64		Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	10	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	143#148		Specifically among GBM with EGFR amplification, those with CDKN2 deletions also occurred in patients slightly older than those few GBM without CDKN2 deletions (mean age 55 vs. 51 years).
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	16#21		The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
9217972	1997	Brain Pathol.	1015-6305	ALL_TEXT_3/3	3	11	1956	SYMBOL|DICTIONARY	egfr	EGFR	49#53		The presence of CDKN2 deletions in most GBM with EGFR amplification and in generally older patients may provide one explanation for the potentially more aggressive nature of such tumors.
9197423	1997	Cardiology	0008-6312	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	angiotensin-converting enzyme	46#75		Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	68#97		The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	1	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	99#102	9197423-1-68-97	The relationship of an insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene to left-ventricular hypertrophy in individuals with essential hypertension (EH) was investigated in a large population of Japanese men and women.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_1/3	1	2	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	4#7	9197423-1-68-97	The ACE genotype of 762 subjects with EH (425 men and 337 women) and 1,157 healthy controls (604 men and 553 women) was determined by polymerase chain reaction analysis.
9197423	1997	Cardiology	0008-6312	ALL_TEXT_2/3	2	3	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	20#23	9197423-1-68-97	The distribution of ACE genotypes did not differ significantly between patients with EH and control in both men and women.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	2	5972	LONGTERM|DICTIONARY	renin	renin	38#43		Experimental studies suggest that the renin-angiotensin system is involved in neointimal hyperplasia after arterial injury.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	3	1636	SYMBOL|DICTIONARY	ace	ACE	45#48		In humans, the plasma and cellular levels of ACE are associated with an I/D genetic polymorphism in the ACE gene, DD patients having higher levels.
9236417	1997	Circulation	0009-7322	BACKGROUND	1	3	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	104#107		In humans, the plasma and cellular levels of ACE are associated with an I/D genetic polymorphism in the ACE gene, DD patients having higher levels.
9236417	1997	Circulation	0009-7322	CONCLUSIONS	3	10	5972	LONGTERM|DICTIONARY	renin	renin	31#36		These results suggest that the renin-angiotensin system may be implicated in the pathogenesis of restenosis after coronary stenting.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	SYMBOL|EXTRACTED|()	pf4	PF4	47#50	9158107-0-28-45	Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	SYMBOL|EXTRACTED	pf4	PF4	94#97	9158107-0-28-45	Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	5196	SYMBOL|EXTRACTED	pf4	PF4	61#64	9158107-0-28-45	Affected patients commonly develop antibodies that recognize PF4/heparin complexes that may form on the surface of activated platelets and on the endothelium.
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	3	5196	SYMBOL|EXTRACTED	pf4	PF4	47#50	9158107-0-28-45	However, it has not been established that anti-PF4/heparin antibodies are responsible for the clinical manifestations of HIT.
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	4	5196	SYMBOL|EXTRACTED	pf4	PF4	113#116	9158107-0-28-45	To address this issue, we employed a recently developed model of active immunity to study the effect of IgG anti-PF4/heparin antibody in vivo.
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_2/3	2	8	5196	SYMBOL|EXTRACTED	pf4	PF4	73#76	9158107-0-28-45	Based on this experience, naive BALB/c mice were immunized with IgG anti-PF4/heparin antibodies isolated from two patients with HIT.
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	9	5196	SYMBOL|EXTRACTED	pf4	PF4	49#52	9158107-0-28-45	The actively immunized mice developed mouse anti-PF4/heparin antibody (Ab3).
9158107	1997	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_3/3	3	11	5196	SYMBOL|EXTRACTED	pf4	PF4	57#60	9158107-0-28-45	The results of this study support the importance of anti-PF4/heparin antibodies in the pathogenesis of HIT.
9070496	1997	Cancer	0008-543X	RESULTS	3	15	5243	LONGTERM|DICTIONARY	p glycoprotein	P-glycoprotein	94#108		Anti-Fas MoAb did not affect the intracellular accumulation of doxorubicin, the expression of P-glycoprotein, or the expression of the antioxidant glutathione S-transferase-pi mRNA.
9042911	1997	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	7372	SYMBOL|GENE|GN|DICTIONARY	ump synthase	UMP synthase	31#43		Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.
9042911	1997	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	7372	LONGTERM|DICTIONARY	orotate phosphoribosyltransferase	orotate phosphoribosyltransferase	128#161		Uridine monophosphate (UMP) synthase is a bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT) and orotidine-5'-monophosphate decarboxylase (ODC).
9042911	1997	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	7372	SYMBOL|()|DICTIONARY|EXTRACTED	oprt	OPRT	163#167	9042911-1-128-161	Uridine monophosphate (UMP) synthase is a bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT) and orotidine-5'-monophosphate decarboxylase (ODC).
9042911	1997	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	8	7372	SYMBOL|DICTIONARY|EXTRACTED	oprt	OPRT	181#185	9042911-1-128-161	We further establish the identity of two polymorphisms, G213A (v = .26) and 440Gpoly (v = .27) located in exons 3 and 6, respectively, which did not significantly compromise either OPRT or ODC function.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	19#22		Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	595	SYMBOL|DICTIONARY	prad 1	PRAD-1	89#95		Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16	p16	85#88		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	p16ink4a	p16INK4A	90#98		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	mts1	MTS1	100#104		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	1	1029	SYMBOL|DICTIONARY	cdkn2	CDKN2	106#111		Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found in tumor cell lines from a variety of neoplasms.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	2	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	38#41		Recent studies have reported frequent p16 gene deletions in cell lines from squamous cell carcinomas of the head and neck (SCCHN), although the prevalence of alterations was variable in primary tumors.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_1/3	1	3	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	77#80		This study determined the prevalence of point mutations and deletions of the p16 gene in 33 SCCHN.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	32#35		In addition, the association of p16 gene alterations and abnormalities of p53, PRAD-1 (cyclin D1), and the presence of human papillomavirus (HPV) was examined.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	4	595	SYMBOL|DICTIONARY	prad 1	PRAD-1	79#85		In addition, the association of p16 gene alterations and abnormalities of p53, PRAD-1 (cyclin D1), and the presence of human papillomavirus (HPV) was examined.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	5	1029	SYMBOL|DICTIONARY	p16	p16	34#37		We found an overall prevalence of p16 alterations of 36% (nine deletions, three single base substitutions, including one polymorphism).
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	47#50		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	1029	SYMBOL|DICTIONARY	p16	p16	97#100		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	595	SYMBOL|DICTIONARY	prad 1	PRAD-1	105#111		Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_3/3	3	7	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	88#91		In addition, of the five tumors with human papillomavirus detected, only one also had a p16 gene alteration.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_3/3	3	8	1029	SYMBOL|GENE|GN|DICTIONARY	p16	p16	58#61		The results indicate a potentially important role for the p16 gene in head and neck tumorigenesis.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_1/3	1	1	2705	SYMBOL|()|DICTIONARY	cx32	Cx32	47#51		Mutations in the gap junction gene connexin32 (Cx32) cause the X-linked form of Charcot-Marie-Tooth disease, an inherited demyelinating neuropathy.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_1/3	1	2	2705	SYMBOL|GENE|GN|DICTIONARY	cx32	Cx32	85#89		More than 130 different mutations have been described, affecting all portions of the Cx32 protein.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_2/3	2	3	2705	SYMBOL|GENE|GN|DICTIONARY	cx32	Cx32	33#37		In transfected cells, the mutant Cx32 proteins encoded by some Cx32 mutations fall to reach the cell surface; other mutant proteins reach the cell surface, but only one of these forms functional gap junctions.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_2/3	2	3	2705	SYMBOL|DICTIONARY	cx32	Cx32	63#67		In transfected cells, the mutant Cx32 proteins encoded by some Cx32 mutations fall to reach the cell surface; other mutant proteins reach the cell surface, but only one of these forms functional gap junctions.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_2/3	2	4	2705	SYMBOL|DICTIONARY	cx32	Cx32	21#25		In peripheral nerve, Cx32 is localized to incisures and paranodes, regions of noncompact myelin within the myelin sheath.
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_3/3	3	5	2705	SYMBOL|DICTIONARY	cx32	Cx32	32#36		"This localization suggests that Cx32 forms ""reflexive"" gap junctions that allow ions and small molecules to diffuse directly across the myelin sheath, which is a thousandfold shorter distance than the circumferential pathway through the Schwann cell cytoplasm."
9361298	1997	Neurobiol. Dis.	0969-9961	ALL_TEXT_3/3	3	6	2705	SYMBOL|DICTIONARY	cx32	Cx32	0#4		Cx32 mutations may interrupt this shorter pathway or have other toxic effects, thereby injuring myelinating Schwann cells and their axons.
8942447	1997	Am J Psychiatry	0002-953X	TITLE	0	0	3123	SYMBOL|GENE|GN|DICTIONARY	hla drb1	HLA DRB1	27#35		Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	2	3119	SYMBOL|DICTIONARY	hla dqb1	HLA DQB1	4#12		The HLA DQB1*0602 allele was also studied because of previous reports of genetic association between it and schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	RESULTS	3	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	17#21		The frequency of DRB1*04 alleles was significantly lower in both the schizophrenic patients and the unrelated mothers of schizophrenic offspring than in the healthy comparison subjects.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	0#4		DRB1*04 alleles may partially account for the genetic predisposition to schizophrenia.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	9	3123	SYMBOL|DICTIONARY	drb1	DRB1	100#104		Alternatively, it may be that maternal B lymphocytes that do not express the DR4 antigen encoded by DRB1*04 respond to influenza virus by producing antibodies that perturb neurodevelopment, thus underpinning a proportion of schizophrenia cases.
8909447	1996	Neurology	0028-3878	TITLE	0	0	5621	LONGTERM|GENE|GN|GT|DICTIONARY	prion protein	prion protein	16#29		Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease.
8909447	1996	Neurology	0028-3878	ALL_TEXT_1/3	1	1	5621	LONGTERM|GENE|GT|DICTIONARY|GA	prion protein	prion protein	50#63		Four point mutations and one insertion within the prion protein (PrP) gene have been tightly linked to the development of inherited prion disease.
8909447	1996	Neurology	0028-3878	ALL_TEXT_1/3	1	1	5621	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	65#68	8909447-1-50-63	Four point mutations and one insertion within the prion protein (PrP) gene have been tightly linked to the development of inherited prion disease.
8909447	1996	Neurology	0028-3878	ALL_TEXT_1/3	1	2	5621	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	125#128	8909447-1-50-63	We developed a denaturing gradient gel electrophoresis system that allowed us to screen the entire open reading frame of the PrP gene.
8909447	1996	Neurology	0028-3878	ALL_TEXT_2/3	2	3	5621	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	prp	PrP	50#53	8909447-1-50-63	Using this system, we found a new mutation of the PrP gene in a patient with pathologically confirmed Creutzfeldt-Jakob disease and a negative family history for dementia.
8909447	1996	Neurology	0028-3878	ALL_TEXT_3/3	3	5	5621	SYMBOL|EXTRACTED	prp	PrP	9#12	8909447-1-50-63	The same PrP mutation was identified in another younger member of the pedigree but was not present in more than 200 alleles tested.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	1	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	177#180	8822954-1-32-59	We report here two new cases of glucose phosphate isomerase (GPI) deficiency associated with hemolytic anemia and present the results of molecular analysis of the five Japanese GPI variants.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	2	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	17#20	8822954-1-32-59	A Japanese girl (GPI Fukuoka) had an episode of prolonged neonatal jaundice and at 3 years of age was admitted due to acute hemolytic crisis occurring with upper respiratory tract infection.
8822954	1996	Blood	0006-4971	ALL_TEXT_1/3	1	3	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	21#24	8822954-1-32-59	Red blood cell (RBC) GPI activity was decreased to 11.8% of normal and the reduced glutathione (GSH) level of RBCs was slightly decreased.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	4	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	28#31	8822954-1-32-59	A 54-year-old Japanese man (GPI Iwate) was hospitalized due to chronic active hepatitis, and compensated hemolysis was noted.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	5	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	4#7	8822954-1-32-59	RBC GPI activity of the proband was decreased to 18.8%, and the GSH content was about half of the normal mean value.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	6	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	197#200	8822954-1-32-59	Sequencing of the reticulocyte GPIcDNA showed homozygous missense mutations 1028CAG-->CGG (343Gln-->Arg), 14ACC-->A7C (5Thr-->lle), 671ACG-->A7G (224Thr-->Met), and 1615GAC-->AAC (539Asp-->Asn) in GPI Narita, GPI Matsumoto, GPI Iwate, and GPI Fukuoka, respectively.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	6	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	209#212	8822954-1-32-59	Sequencing of the reticulocyte GPIcDNA showed homozygous missense mutations 1028CAG-->CGG (343Gln-->Arg), 14ACC-->A7C (5Thr-->lle), 671ACG-->A7G (224Thr-->Met), and 1615GAC-->AAC (539Asp-->Asn) in GPI Narita, GPI Matsumoto, GPI Iwate, and GPI Fukuoka, respectively.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	6	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	224#227	8822954-1-32-59	Sequencing of the reticulocyte GPIcDNA showed homozygous missense mutations 1028CAG-->CGG (343Gln-->Arg), 14ACC-->A7C (5Thr-->lle), 671ACG-->A7G (224Thr-->Met), and 1615GAC-->AAC (539Asp-->Asn) in GPI Narita, GPI Matsumoto, GPI Iwate, and GPI Fukuoka, respectively.
8822954	1996	Blood	0006-4971	ALL_TEXT_2/3	2	6	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	239#242	8822954-1-32-59	Sequencing of the reticulocyte GPIcDNA showed homozygous missense mutations 1028CAG-->CGG (343Gln-->Arg), 14ACC-->A7C (5Thr-->lle), 671ACG-->A7G (224Thr-->Met), and 1615GAC-->AAC (539Asp-->Asn) in GPI Narita, GPI Matsumoto, GPI Iwate, and GPI Fukuoka, respectively.
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	7	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	19#22	8822954-1-32-59	We also identified GPI Kinki as a compound heterozygote of 1124ACA-->AGA(375Thr-->Arg)/ 1615GAC-->AAC(539Asp-->Asn).
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	8	2821	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	gpi	GPI	89#92	8822954-1-32-59	Our findings, together with the previous results of other investigators, showed that the GPI gene mutations so far identified were heterogeneous, although most GPI variants had common biochemical characteristics such as heat instability and normal kinetics.
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	8	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	160#163	8822954-1-32-59	Our findings, together with the previous results of other investigators, showed that the GPI gene mutations so far identified were heterogeneous, although most GPI variants had common biochemical characteristics such as heat instability and normal kinetics.
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	9	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	227#230	8822954-1-32-59	Several amino acid substitutions were identified in the proximity of the catalytically important amino acid residues such as Ser/Asp 159/160, Asp341, and Lys518, which have been identified in the structural analysis of the pig GPI.
8822954	1996	Blood	0006-4971	ALL_TEXT_3/3	3	10	2821	SYMBOL|DICTIONARY|EXTRACTED	gpi	GPI	40#43	8822954-1-32-59	The molecular characterization of human GPI variants, therefore, may provide new insights into the genotype-phenotype correlation of GPI deficiency as well as the structure-function relationship of this enzyme.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	5663	LONGTERM|DICTIONARY|GENE|GA	presenilin 1	presenilin-1	111#123		Previous work suggests an association between allele 1 and the 1-1 genotype of an intronic polymorphism in the presenilin-1 (PS-1) gene and late onset Alzheimer's disease.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_1/3	1	1	5663	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ps 1	PS-1	125#129	8930979-1-111-123	Previous work suggests an association between allele 1 and the 1-1 genotype of an intronic polymorphism in the presenilin-1 (PS-1) gene and late onset Alzheimer's disease.
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_3/3	3	3	5663	SYMBOL|EXTRACTED	ps 1	PS-1	23#27	8930979-1-111-123	No interaction between PS-1 and ApoE genotype was detected and the findings remained significant when the effects of ApoE were taken into account (p = 0.03, one-tailed).
8930979	1997	Neuroreport	0959-4965	ALL_TEXT_3/3	3	4	5663	SYMBOL|EXTRACTED	ps 1	PS-1	31#35	8930979-1-111-123	These results suggest that the PS-1 polymorphism, or a locus in linkage disequilibrium with it, acts as a risk factor for late onset AD.
8757534	1996	Br. J. Haematol.	0007-1048	TITLE	0	0	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	24#38		A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	1	2235	LONGTERM|GENE|GN|DICTIONARY	ferrochelatase	ferrochelatase	88#102		Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by mutations of the ferrochelatase gene.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	2235	LONGTERM|DICTIONARY	ferrochelatase	ferrochelatase	95#109		We investigated a Japanese patient with a dominant form of erythropoietic protoporphyria for a ferrochelatase mutation.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_2/3	2	3	2235	LONGTERM|GFAM|FN|DICTIONARY	ferrochelatase	ferrochelatase	35#49		Sequence analysis of the proband's ferrochelatase cDNA revealed a T to C point mutation at nucleotide 557.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2235	LONGTERM|DICTIONARY	ferrochelatase	ferrochelatase	15#29		An increase in ferrochelatase activity was not observed in the crude extract of E. coli over-expressing the mutant protein compared with the control, whereas a marked increase in activity was observed in that over-expressing the wild type.
8757534	1996	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	6	2235	LONGTERM|DICTIONARY	ferrochelatase	ferrochelatase	41#55		Prediction of the secondary structure of ferrochelatase suggested that the Ile186-->Thr mutation changed the original beta-sheet structure to an alpha helix in the region including amino acid residue of mutation.
8741319	1996	Acta Paediatr Jpn	0374-5600	TITLE	0	0	7490	SYMBOL|GENE|GN|DICTIONARY	wt1	WT1	42#45		A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
8741319	1996	Acta Paediatr Jpn	0374-5600	ALL_TEXT_2/3	2	2	7490	SYMBOL|GENE|GN|DICTIONARY	wt1	WT1	65#68		Denys-Drash syndrome was suspected and molecular analysis of the WT1 gene was performed, although no Wilms' tumor was identified.
8884076	1997	Clin. Genet.	0009-9163	ALL_TEXT_1/3	1	1	1281	SYMBOL|()|DICTIONARY	col3a1	COL3A1	185#191		Three patients with Ehlers-Danlos syndrome type IV (EDS IV) and biochemical evidence of structural defects in collagen III were investigated for mutations within the collagen III gene (COL3A1).
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	5	3356	SYMBOL|NUMBER|DICTIONARY	5 ht2a	5-HT2A	40#46		In arteries from sham rats, ketanserin (5-HT2A/5-HT2C selective), LY53857 (5-HT2 selective) and spiperone (5-HT2A/5-HT2C selective) shifted contraction to 5-HT (pKB = 8.58, 8.35 and 9.52, respectively) indicating that a 5-HT2A receptor mediates contraction in arteries from normotensive rats.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	5	3358	SYMBOL|DICTIONARY	5 ht2c	5-HT2C	47#53		In arteries from sham rats, ketanserin (5-HT2A/5-HT2C selective), LY53857 (5-HT2 selective) and spiperone (5-HT2A/5-HT2C selective) shifted contraction to 5-HT (pKB = 8.58, 8.35 and 9.52, respectively) indicating that a 5-HT2A receptor mediates contraction in arteries from normotensive rats.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	5	3356	SYMBOL|NUMBER|DICTIONARY	5 ht2a	5-HT2A	107#113		In arteries from sham rats, ketanserin (5-HT2A/5-HT2C selective), LY53857 (5-HT2 selective) and spiperone (5-HT2A/5-HT2C selective) shifted contraction to 5-HT (pKB = 8.58, 8.35 and 9.52, respectively) indicating that a 5-HT2A receptor mediates contraction in arteries from normotensive rats.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	5	3358	SYMBOL|DICTIONARY	5 ht2c	5-HT2C	114#120		In arteries from sham rats, ketanserin (5-HT2A/5-HT2C selective), LY53857 (5-HT2 selective) and spiperone (5-HT2A/5-HT2C selective) shifted contraction to 5-HT (pKB = 8.58, 8.35 and 9.52, respectively) indicating that a 5-HT2A receptor mediates contraction in arteries from normotensive rats.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	5	3356	SYMBOL|GENE|GN|DICTIONARY	5 ht2a	5-HT2A	220#226		In arteries from sham rats, ketanserin (5-HT2A/5-HT2C selective), LY53857 (5-HT2 selective) and spiperone (5-HT2A/5-HT2C selective) shifted contraction to 5-HT (pKB = 8.58, 8.35 and 9.52, respectively) indicating that a 5-HT2A receptor mediates contraction in arteries from normotensive rats.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_2/3	2	8	3357	SYMBOL|GENE|GN|DICTIONARY	5 ht2b	5-HT2B	79#85		Thus, contraction in arteries from DOCA-salt rats is predominantly mediated by 5-HT2B receptors.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_3/3	3	9	3356	SYMBOL|GENE|GN|DICTIONARY	5 ht2a	5-HT2A	66#72		Unlike the 5-HT receptor in the sham mesenteric artery and aorta (5-HT2A receptor), the 5-HT receptor in DOCA-salt mesenteric arteries and stomach fundus (5-HT2B receptor) were relatively insensitive to phenoxybenzamine (10-300 nM).
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_3/3	3	9	3357	SYMBOL|GENE|GN|DICTIONARY	5 ht2b	5-HT2B	155#161		Unlike the 5-HT receptor in the sham mesenteric artery and aorta (5-HT2A receptor), the 5-HT receptor in DOCA-salt mesenteric arteries and stomach fundus (5-HT2B receptor) were relatively insensitive to phenoxybenzamine (10-300 nM).
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_3/3	3	10	3357	SYMBOL|GENE|GN|DICTIONARY	5 ht2b	5-HT2B	28#34		These data suggest that the 5-HT2B receptor is insensitive to phenoxybenzamine, is increased in number or, alternatively, has increased G protein coupling.
8627522	1996	J. Pharmacol. Exp. Ther.	0022-3565	ALL_TEXT_3/3	3	12	3357	SYMBOL|GENE|GN|DICTIONARY	5 ht2b	5-HT2B	51#57		PCR analyses indicated an increase in mRNA for the 5-HT2B receptor in mesenteric arteries of DOCA-salt hypertensive arteries, supporting an increase in receptor number.
8837968	1996	Acta Psychiatr Scand	0001-690X	TITLE	0	0	4908	LONGTERM|DICTIONARY|GENE|GA	neurotrophin 3	neurotrophin-3	26#40		An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia.
8837968	1996	Acta Psychiatr Scand	0001-690X	TITLE	0	0	4908	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	nt 3	NT-3	42#46	8837968-0-26-40	An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	LONGTERM|DICTIONARY	neurotrophin 3	neurotrophin-3	154#168		Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_1/3	1	1	4908	SYMBOL|EXTRACTED|()	nt 3	NT-3	170#174	8837968-0-26-40	Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder.
8837968	1996	Acta Psychiatr Scand	0001-690X	ALL_TEXT_2/3	2	2	4908	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	nt 3	NT-3	89#93	8837968-0-26-40	The A3/147 bp allele of a dinucleotide repeat polymorphism in the promoter region of the NT-3 gene has been reported as occurring more frequently in a sample of Japanese schizophrenics compared to controls.
7581378	1995	Hum. Mol. Genet.	0964-6906	TITLE	0	0	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	51#56		Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	LONGTERM|DICTIONARY|GENE|GA	fibroblast growth factor receptor 2	fibroblast growth factor receptor 2	26#61		Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	2263	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	63#68	7581378-1-26-61	Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been recently identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson-Weiss, Pfeiffer, and Apert syndromes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	27#32	7581378-1-26-61	Identical mutations in the FGFR2 gene have been reported to cause both Pfeiffer and Crouzon syndrome phenotypes.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	60#65	7581378-1-26-61	We now report the finding of a mutation in exon IIIc of the FGFR2 gene in a kindred affected with Crouzon syndrome (C1043 to G; Ala344Gly) that is identical to the mutation previously associated with Jackson-Weiss syndrome.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	231#236	7581378-1-26-61	We also report finding in a Crouzon kindred a mutation in the 3' end of exon IIIu (formerly referred to as exon 5, exon 7, or exon U) (A878 to C; Gln289Pro) which encodes the amino terminal portion of the Ig-like III domain of the FGFR2 protein.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	32#37	7581378-1-26-61	This exon is common to both the FGFR2 and the KGFR spliceoforms of the FGFR2 gene, unlike all previously reported Crouzon mutations, which have been found only in the FGFR2 spliceoform.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	2263	SYMBOL|DICTIONARY	kgfr	KGFR	46#50		This exon is common to both the FGFR2 and the KGFR spliceoforms of the FGFR2 gene, unlike all previously reported Crouzon mutations, which have been found only in the FGFR2 spliceoform.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	2263	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	fgfr2	FGFR2	71#76	7581378-1-26-61	This exon is common to both the FGFR2 and the KGFR spliceoforms of the FGFR2 gene, unlike all previously reported Crouzon mutations, which have been found only in the FGFR2 spliceoform.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	167#172	7581378-1-26-61	This exon is common to both the FGFR2 and the KGFR spliceoforms of the FGFR2 gene, unlike all previously reported Crouzon mutations, which have been found only in the FGFR2 spliceoform.
7581378	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	8	2263	SYMBOL|DICTIONARY|EXTRACTED	fgfr2	FGFR2	47#52	7581378-1-26-61	The data implies that second-site mutations in FGFR2 itself (outside of exon IIIc) or in other genes may determine specific aspects of the phenotypes of craniosynostosis syndromes.
7706479	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_2/3	2	5	5313	SYMBOL|GENE|GN|DICTIONARY	pklr	PKLR	230#234		The remaining six mutations were as follows: two nonsense mutations, 721T and 808T; a nucleotide deletion, 307C; a nucleotide insertion, 1089GG; a three nucleotide in frame deletion, 391-392-393 and a deletion of 1149 bp from the PKLR gene that resulted in the loss of exon 11.
7706461	1995	J. Clin. Invest.	0021-9738	TITLE	0	0	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	129#134		Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.
7706461	1995	J. Clin. Invest.	0021-9738	TITLE	0	0	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	148#153		Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	1	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	44#49		To gain insight into region of the platelet GPIIb-IIIa complex involved in receptor biogenesis and function, we examined the biochemical properties of a defective GPIIb-IIIa complex from patient suffering from type II Glanzmann thrombasthenia.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	1	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	163#168		To gain insight into region of the platelet GPIIb-IIIa complex involved in receptor biogenesis and function, we examined the biochemical properties of a defective GPIIb-IIIa complex from patient suffering from type II Glanzmann thrombasthenia.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	2	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	107#112		Flow cytometric as well as immunoblot analysis of patient platelets showed significantly reduced levels of GPIIb and GPIIIa compared with a normal control.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_1/3	1	2	3690	SYMBOL|DICTIONARY	gpiiia	GPIIIa	117#123		Flow cytometric as well as immunoblot analysis of patient platelets showed significantly reduced levels of GPIIb and GPIIIa compared with a normal control.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_2/3	2	4	3674	SYMBOL|GFAM|FN|DICTIONARY	gpiib	GPIIb	44#49		Sequence analysis of PCR-amplified platelet GPIIb mRNA revealed an Arg327-->His amino acid substitution between the second and third calcium-binding domains of the GPIIb heavy chain, a residue that is highly conserved among integrin alpha-subunits.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_2/3	2	4	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	164#169		Sequence analysis of PCR-amplified platelet GPIIb mRNA revealed an Arg327-->His amino acid substitution between the second and third calcium-binding domains of the GPIIb heavy chain, a residue that is highly conserved among integrin alpha-subunits.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	5	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	31#36		The recombinant His327 form of GPIIb was found to be fully capable of associating with GPIIIa, therefore the role of the calcium-binding domains in intersubunit association was further examined by constructing amino-terminal segments of GPIIb that ended before the first, second, and third calcium-binding domains.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	5	3690	SYMBOL|DICTIONARY	gpiiia	GPIIIa	87#93		The recombinant His327 form of GPIIb was found to be fully capable of associating with GPIIIa, therefore the role of the calcium-binding domains in intersubunit association was further examined by constructing amino-terminal segments of GPIIb that ended before the first, second, and third calcium-binding domains.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	5	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	237#242		The recombinant His327 form of GPIIb was found to be fully capable of associating with GPIIIa, therefore the role of the calcium-binding domains in intersubunit association was further examined by constructing amino-terminal segments of GPIIb that ended before the first, second, and third calcium-binding domains.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	6	3690	SYMBOL|DICTIONARY	gpiiia	GPIIIa	49#55		All three fragments were found to associate with GPIIIa, demonstrating that the calcium-binding domains of GPIIb are not necessary for initial complex formation.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	6	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	107#112		All three fragments were found to associate with GPIIIa, demonstrating that the calcium-binding domains of GPIIb are not necessary for initial complex formation.
7706461	1995	J. Clin. Invest.	0021-9738	ALL_TEXT_3/3	3	7	3674	SYMBOL|DICTIONARY	gpiib	GPIIb	57#62		Regions amino-terminal to the calcium-binding domains of GPIIb may play a heretofore unappreciated role in integrin subunit association.
7783416	1995	Kidney Int.	0085-2538	TITLE	0	0	1636	SYMBOL|GENE|GN|DICTIONARY	ace	ACE	15#18		Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
7783416	1995	Kidney Int.	0085-2538	ALL_TEXT_1/3	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin i converting enzyme	angiotensin I converting enzyme	128#159		In patients with type 1 diabetes an association has been found between an insertion/deletion (I/D) polymorphism in the gene for angiotensin I converting enzyme and the presence of diabetic nephropathy.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	12#18		Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	1	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	0#6		CYP1A1 is a gene of the cytochrome P-450 family that has been proposed to be a biomarker of cancer risk.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_1/3	1	2	1543	SYMBOL|GENE|GN|DICTIONARY	cyp1a1	CYP1A1	101#107		We introduce a polymerase chain reaction-based assay to measure allelic variability in exon 7 of the CYP1A1 gene.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	3	1543	LONGTERM|GENE|GN|DICTIONARY	aryl hydrocarbon hydroxylase	aryl hydrocarbon hydroxylase	83#111		This genetic variant is associated with an amino acid change at residue 462 in the aryl hydrocarbon hydroxylase protein product.
8000303	1995	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	4	1543	SYMBOL|DICTIONARY	cyp1a1	CYP1A1	27#33		Previously, measurement of CYP1A1 genotypes at this variant site required two assays, one to detect each allele.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	0#6		IGF-II gene is prevalently expressed during prenatal development and its gene activity is regulated by genomic imprinting, in that the allele inherited from the father is active and the allele inherited from the mother is inactive in most normal tissues.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	0#6		IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	3	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	88#94	7981680-1-0-29	IGF-II expression is activated in several types of human neoplasms and an alteration of IGF-II imprinting has been described in Beckwith-Wiedemann syndrome and Wilms' tumor.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	44#50	7981680-1-0-29	Here we show that monoallelic expression of IGF-II gene is conserved in normal adult muscle tissue whereas two or more copies of active IGF-II alleles, arising by either relaxation of imprinting or duplication of the active allele, are found in 9 out of 11 (82%) rhabdomyosarcomas retaining heterozygosity at 11p15, regardless of the histological subtype.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_2/3	2	4	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	136#142	7981680-1-0-29	Here we show that monoallelic expression of IGF-II gene is conserved in normal adult muscle tissue whereas two or more copies of active IGF-II alleles, arising by either relaxation of imprinting or duplication of the active allele, are found in 9 out of 11 (82%) rhabdomyosarcomas retaining heterozygosity at 11p15, regardless of the histological subtype.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	6#12	7981680-1-0-29	Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	5	3481	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	igf ii	IGF-II	168#174	7981680-1-0-29	Since IGF-II has been indicated as an autocrine growth factor for rhabdomyosarcoma cells, these findings strongly suggest that acquisition of a double dosage of active IGF-II gene is an important step for the initiation or progression of rhabdomyosarcoma tumorigenesis.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_3/3	3	6	3481	SYMBOL|DICTIONARY|EXTRACTED	igf ii	IGF-II	191#197	7981680-1-0-29	Among different types of muscle tumors, relaxation of imprinting seems to arise prevalently in rhabdomyosarcomas, since we have detected only one case of partial reactivation of the maternal IGF-II allele out of 7 leiomyosarcomas tested.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_1/3	1	1	3126	SYMBOL|GENE|GN|DICTIONARY	dr4	DR4	4#7		HLA-DR4 gene was studied by polymerase chain reaction method in 95 patients with rheumatoid arthritis(RA) and 130 normal controls in a Shanghai population.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_1/3	1	3	3126	SYMBOL|GENE|GN|DICTIONARY	dr4	DR4	19#22		The second exon of DR4 gene was also analysed by PCR-RFLP technique.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	4#8		The DRB1 *0405 (Dw15) was the most common allele, accounting for 48% of DR4 positive normal individuals and also is a principal subtype associated with RA susceptibility (RR = 3.1, P < 0.005).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	7	3123	SYMBOL|DICTIONARY	drb1	DRB1	82#86		All subtypes that were positively associated with RA susceptibility had the RRAA (DRB1* 0404, 0405.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	24#28		0408 and 0410) or KRAA (DRB1 * 0401) sequences, while the negatively associated ones (DRB1 0402, 0403 and 0406) had not.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	8	3123	SYMBOL|DICTIONARY	drb1	DRB1	86#90		0408 and 0410) or KRAA (DRB1 * 0401) sequences, while the negatively associated ones (DRB1 0402, 0403 and 0406) had not.
7769500	1995	J Hypertens Suppl	0952-1178	TITLE	0	0	3643	LONGTERM|GENE|GN|GT|DICTIONARY	insulin receptor	insulin receptor	74#90		Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension.
7769500	1995	J Hypertens Suppl	0952-1178	OBJECTIVE	1	1	3643	LONGTERM|GENE|GN|GT|DICTIONARY	insulin receptor	insulin receptor	58#74		To determine whether a microsatellite polymorphism of the insulin receptor gene (INSR) is associated with essential hypertension, as has been demonstrated previously for an RsaI restriction fragment length polymorphism (RFLP), and to examine blood pressure and plasma lipid profiles in relation to genotype.
7902317	1994	Hum. Genet.	0340-6717	TITLE	0	0	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	95#110		An adult-type metachromatic leukodystrophy caused by substitution of serine for glycine-122 in arylsulfatase A.
7902317	1994	Hum. Genet.	0340-6717	ALL_TEXT_1/3	1	1	410	LONGTERM|DICTIONARY	arylsulfatase a	arylsulfatase A	140#155		Metachromatic leukodystrophy (MLD) is a lysosomal storage disease with autosomal recessive inheritance caused by a deficiency of the enzyme arylsulfatase A (ASA).
8281141	1994	Hum. Mol. Genet.	0964-6906	TITLE	0	0	2200	LONGTERM|DICTIONARY	fibrillin 1	fibrillin-1	31#42		Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains.
8281141	1994	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	2200	LONGTERM|GENE|GN|DICTIONARY	fibrillin 1	fibrillin-1	29#40		Previously, mutations in the fibrillin-1 gene on chromosome 15 (FBN1) have been reported to cause MFS.
8281141	1994	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	2	2200	SYMBOL|()|DICTIONARY	fbn1	FBN1	64#68		Previously, mutations in the fibrillin-1 gene on chromosome 15 (FBN1) have been reported to cause MFS.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_2/3	2	2	1437	LONGTERM|GENE|GT|DICTIONARY	granulocyte macrophage colony stimulating factor	granulocyte-macrophage colony stimulating factor	174#222		We conducted a Phase I trial to evaluate the toxicity of the combination of m-BACOD (methotrexate, Bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone) with granulocyte-macrophage colony stimulating factor (GMCSF) in these patients.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_2/3	2	2	1437	SYMBOL|()|DICTIONARY|EXTRACTED	gmcsf	GMCSF	224#229	7680712-2-174-222	We conducted a Phase I trial to evaluate the toxicity of the combination of m-BACOD (methotrexate, Bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone) with granulocyte-macrophage colony stimulating factor (GMCSF) in these patients.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	3	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	116#121	7680712-2-174-222	A total of 17 patients were entered and treated at three dose levels of m-BACOD in combination with a fixed dose of GMCSF.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	4	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	51#56	7680712-2-174-222	Eight patients received standard dose m-BACOD plus GMCSF without experiencing dose-limiting hematologic toxicity, although significant nonhematologic toxicity was seen.
7680712	1993	J. Acquir. Immune Defic. Syndr.	0894-9255	ALL_TEXT_3/3	3	5	1437	SYMBOL|DICTIONARY|EXTRACTED	gmcsf	GMCSF	112#117	7680712-2-174-222	We conclude that it is feasible to treat patients with HIV-associated lymphoma using standard dose m-BACOD plus GMCSF, but further study is needed to determine whether full-dose regimens improve survival when compared with reduced dose regimens in these individuals.
8094979	1993	Biol. Psychiatry	0006-3223	TITLE	0	0	1813	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d2 receptor	dopamine D2 receptor	68#88		Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese.
8094979	1993	Biol. Psychiatry	0006-3223	ALL_TEXT_1/3	1	1	1813	LONGTERM|GENE|GN|GT|DICTIONARY	dopamine d2 receptor	dopamine D2 receptor	89#109		The allelic association of TaqI A restriction fragment length polymorphism (RFLP) of the dopamine D2 receptor gene with alcoholism was examined in 78 Japanese alcoholics and compared with Japanese controls.
2480601	1990	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	4	5354	SYMBOL|GENE|GN|DICTIONARY	plp	PLP	84#87		With the jimpy mouse mutation as a precedent, we focused our attention on the human PLP gene, which is found at Xq22.
2480601	1990	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_2/3	2	5	5354	SYMBOL|GENE|GN|DICTIONARY	plp	PLP	67#70		The polymerase chain reaction was used to amplify the exons of the PLP gene of an affected male from a large Indiana PMD kindred.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	3350	SYMBOL|GENE|GN|DICTIONARY	5 ht1a	5-HT1A	15#21		Stimulation of 5-HT1A receptors with 8-hydroxy-di-N,N-propylaminotetralin (8-OH-DPAT) and blockade of 5-HT1B receptors with cyanopindolol resulted in seizure protection.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_2/3	2	3	3351	SYMBOL|GENE|GN|DICTIONARY	5 ht1b	5-HT1B	102#108		Stimulation of 5-HT1A receptors with 8-hydroxy-di-N,N-propylaminotetralin (8-OH-DPAT) and blockade of 5-HT1B receptors with cyanopindolol resulted in seizure protection.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	6	3350	SYMBOL|DICTIONARY	5 ht1a	5-HT1A	128#134		In conclusion, the present study suggests that the inhibition of pilocarpine-induced seizures may be mediated by stimulation of 5-HT1A and by blockade of 5-HT1B receptors, located probably on the cholinergic terminals.
2533336	1990	Neurosci. Res.	0168-0102	ALL_TEXT_3/3	3	6	3351	SYMBOL|GENE|GN|DICTIONARY	5 ht1b	5-HT1B	154#160		In conclusion, the present study suggests that the inhibition of pilocarpine-induced seizures may be mediated by stimulation of 5-HT1A and by blockade of 5-HT1B receptors, located probably on the cholinergic terminals.
6991409	1980	Hypertension	0194-911X	TITLE	0	0	5972	LONGTERM|DICTIONARY	renin	renin	33#38		Suppression of stimulated plasma renin by clonidine in the dog.
6991409	1980	Hypertension	0194-911X	ALL_TEXT_1/3	1	1	5972	LONGTERM|DICTIONARY	renin	renin	51#56		The mechanism by which clonidine suppresses plasma renin activity (PRA) was investigated in dogs anesthetized with pentobarbital.
6991409	1980	Hypertension	0194-911X	ALL_TEXT_3/3	3	6	5972	LONGTERM|DICTIONARY	renin	renin	101#106		When return of reservoir fluid was prevented, animals became hypotensive after central clonidine and renin tended to increase.
6991409	1980	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	5972	LONGTERM|DICTIONARY	renin	renin	57#62		These results indicate that clonidine reduces stimulated renin by a central mechanism that is dependent upon the integrity of the sympathetic innervation of the kidney.
6991409	1980	Hypertension	0194-911X	ALL_TEXT_3/3	3	8	5972	LONGTERM|DICTIONARY	renin	renin	18#23		Other stimuli for renin release may override the inhibitory effect of central clonidine.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	2475	LONGTERM|DICTIONARY	mammalian target of rapamycin	mammalian target of rapamycin	40#69		PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	TITLE	0	0	21977	SYMBOL|EXTRACTED|()	mtor	mTOR	71#75	23440206-0-40-69	PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_1/3	1	1	21977	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mtor	mTOR	142#146	23440206-0-40-69	Despite their nearly universal activation of mammalian target of rapamycin (mTOR) signaling, glioblastomas (GBMs) are strikingly resistant to mTOR-targeted therapy.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	2	5371	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	pml	PML	170#173	23440206-2-146-168	We analyzed GBM cell lines, patient-derived tumor cell cultures, and clinical samples from patients in phase 1 clinical trials, and find that the promyelocytic leukemia (PML) gene mediates resistance to mTOR-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_2/3	2	2	21977	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	mtor	mTOR	203#207	23440206-0-40-69	We analyzed GBM cell lines, patient-derived tumor cell cultures, and clinical samples from patients in phase 1 clinical trials, and find that the promyelocytic leukemia (PML) gene mediates resistance to mTOR-targeted therapies.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	7#11	23440206-0-40-69	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	21977	SYMBOL|EXTRACTED	mtor	mTOR	217#221	23440206-0-40-69	Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	4	21977	SYMBOL|EXTRACTED	mtor	mTOR	86#90	23440206-0-40-69	Low doses of the PML inhibitor, arsenic trioxide, abrogate PML expression and reverse mTOR kinase inhibitor resistance in vivo, thus markedly inhibiting tumor growth and promoting tumor cell death in mice.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	5	21977	SYMBOL|EXTRACTED	mtor	mTOR	48#52	23440206-0-40-69	These results identify a unique role for PML in mTOR and EGFR inhibitor resistance and provide a strong rationale for a combination therapeutic strategy to overcome it.
9535412	1998	Hypertension	0194-911X	TITLE	0	0	1636	LONGTERM|GENE|GN|GT|DICTIONARY	angiotensin converting enzyme	Angiotensin-converting enzyme	0#29		Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	3	1636	LONGTERM|GENE|GT|DICTIONARY|GA	angiotensin converting enzyme	angiotensin-converting enzyme	108#137		In both hypertensive and normotensive groups, a deletion (D)/insertion (I) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene was determined by polymerase chain reaction.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	3	1636	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	ace	ACE	139#142	9535412-3-108-137	In both hypertensive and normotensive groups, a deletion (D)/insertion (I) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene was determined by polymerase chain reaction.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	202#208		The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_2/3	2	4	966	SYMBOL|DICTIONARY	min 1	min(-1	270#276		The response to acetylcholine was significantly reduced in hypertensive patients versus control subjects: at the highest dose (30 microg/min), forearm blood flow was 13.9+/-6.3 mL x 100 mL tissue(-1) x min(-1) in hypertensives versus 27.1+/-9.7 mL x 100 mL tissue(-1) x min(-1) in the controls (P<.001); similarly, vascular resistance was 10.6+/-5.6 U in hypertensive patients and 4.9+/-1.9 U in normotensive subjects.
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	5	966	SYMBOL|DICTIONARY	min 1	min(-1	264#270		In the hypertensive group, the patients with DD genotype showed significantly less endothelium-dependent vasodilation compared with ID+II genotypes (at the highest dose of acetylcholine, forearm blood flow was 12.1+/-4.2 versus 17.0+/-4.1 mL x 100 mL tissue(-1) x min(-1)) (P<.005).
9535412	1998	Hypertension	0194-911X	ALL_TEXT_3/3	3	7	1636	SYMBOL|DICTIONARY|EXTRACTED	ace	ACE	37#40	9535412-3-108-137	In conclusion, our data suggest that ACE polymorphism affects endothelium-dependent vasodilation in hypertensive patients and confirm that hypertensive patients had a blunted response to the endothelium-dependent agent acetylcholine.
10200057	1999	Hum. Mutat.	1059-7794	TITLE	0	0	5053	SYMBOL|GENE|GN|DICTIONARY	pah	PAH	38#41		Two novel mutations in exon 11 of the PAH gene (V1163del TG and P362T) associated with classic phenylketonuira and mild phenylketonuria. Mutations in brief no. 143. Online.
10200057	1999	Hum. Mutat.	1059-7794	ALL_TEXT_2/3	2	3	5053	SYMBOL|GENE|GN|DICTIONARY	pah	PAH	114#117		Two novel mutations 1163/1164delTG and P362T in exon 11 have been detected during the mutational screening of the PAH gene in 84 families.
10200057	1999	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	6	5053	SYMBOL|GENE|GN|DICTIONARY	pah	PAH	51#54		We report here two new mutations in exon 11 of the PAH gene (GenBank U49897), V1163delTG and P362T (using cDNA sequence), detected during the analysis of 57 PKU and 36 HPA patients belonging to 84 unrelated families detected under a neonatal screening program performed in Catalonia.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	LONGTERM|DICTIONARY	ornithine aminotransferase	ornithine aminotransferase	34#60		A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	TITLE	0	0	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	62#65	1301936-0-34-60	A 15-bp deletion in exon 5 of the ornithine aminotransferase (OAT) locus associated with gyrate atrophy.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	4942	SYMBOL|()|DICTIONARY|EXTRACTED	oat	OAT	166#169	1301936-0-34-60	Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive disorder in which a deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) leads to progressive blindness.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	2	4942	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oat	OAT	97#100	1301936-0-34-60	Previously, we and others have reported a number of missense mutations and splice defects in the OAT gene associated with GA.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_2/3	2	3	4942	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	oat	OAT	137#140	1301936-0-34-60	In the present case, through sequencing of the PCR amplified cDNA products, we have detected a novel 15-bp deletion within exon 5 of the OAT gene which retains the original reading frame.
1301936	1993	Hum. Mutat.	1059-7794	ALL_TEXT_3/3	3	5	4942	SYMBOL|DICTIONARY|EXTRACTED	oat	OAT	40#43	1301936-0-34-60	The alternate, apparently nonexpressing OAT allele in this patient was inherited from the father, who displays only the normal length PCR product.
19131637	2009	Clin. Chem.	1530-8561	TITLE	0	0	19	SYMBOL|DICTIONARY	atp-binding cassette a1	ATP-binding cassette A1	36#59		Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
19131637	2009	Clin. Chem.	1530-8561	BACKGROUND	1	1	19	SYMBOL|DICTIONARY	atp-binding cassette a1	ATP-binding cassette A1	0#23		ATP-binding cassette A1 (ABCA1) and cholesteryl ester transfer protein (CETP) play important roles in the reverse cholesterol transport pathway.
19115972	2009	Clin. Infect. Dis.	1537-6591	ALL_TEXT_1/3	1	1	3106	SYMBOL|NUMBER|DICTIONARY	human leukocyte antigen allele (hla)-b	Human leukocyte antigen allele (HLA)-B	0#38		Human leukocyte antigen allele (HLA)-B*5701 is associated with abacavir hypersensitivity.
19022862	2009	Brain	1460-2156	ALL_TEXT_1/3	1	1	3123	SYMBOL|NUMBER|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	79#107		Genetic susceptibility to multiple sclerosis (MS) is associated with the human leukocyte antigen (HLA) DRB1*1501 allele.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|DICTIONARY	slc4a2/anion exchanger 2	SLC4A2/anion exchanger 2	129#153		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	6522	SYMBOL|DICTIONARY|GENE|GA	slc4a2/anion exchanger 2	SLC4A2/anion exchanger 2	129#153		The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	161#184		Cytochrome P450 1B1 (CYP1B1) is a major enzyme in the initial catabolic step of estradiol (E2) metabolism and belongs to the multitude of genes regulated by the estrogen receptor alpha (ERalpha).
17967524	2008	Eur J Surg Oncol	1532-2157	ALL_TEXT_1/3	1	1	4524	LONGTERM|DICTIONARY	5'-10'-methylenetetrahydrofolate reductase	5'-10'-methylenetetrahydrofolate reductase	27#69		Polymorphisms of the genes 5'-10'-methylenetetrahydrofolate reductase (MTHFR, 677CT and 1298AC), methionine synthase (MTR, 2756AC) and methionine synthase reductase (MTRR, 66AC) provoke variations in enzyme activity, which can lead to alterations in the metabolism of folates and in the synthesis of S-adenosyl-methionine (SAM), the most active methyl donor in the body.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	7	1397	SYMBOL|DICTIONARY|EXTRACTED	crp > 2	CRP > 2	64#71	18753723-4-56-74	To predict the presence of complex lesions, IL-6 > 5.8 ng/L and CRP > 2.6 mg/L had sensitivities of 86% and 74%, and specificities of 61% and 62%, respectively.
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	8	1397	SYMBOL|DICTIONARY|EXTRACTED	crp > 2	CRP > 2	46#53	18753723-4-56-74	By multivariate analysis, IL-6 > 5.8 ng/L and CRP > 2.6 mg/L were independently related to the presence of complex coronary plaque (P = 0.0002 and 0.004, respectively).
18753723	2008	Int Heart J	1349-2365	ALL_TEXT_3/3	3	9	1397	SYMBOL|DICTIONARY|EXTRACTED	crp > 2	CRP > 2	20#27	18753723-4-56-74	IL-6 > 5.8 ng/L and CRP > 2.6 mg/L were associated with a 4.5-fold increase in the odds of having complex coronary plaque (P < 0.005).
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	12	1234	LONGTERM|DICTIONARY	ccr5	CCR5	23#27		The chemokine receptor CCR5-del32 frameshift mutation is associated with low levels of C-reactive protein, decreased intima-media thickness, and cardiovascular disease risk.
18436884	2008	Stroke	1524-4628	CONCLUSIONS	4	13	1234	LONGTERM|DICTIONARY	ccr5	CCR5	78#82		These findings are consistent with the hypothesis that the chemokine receptor CCR5 is involved in the mediation of low-grade systemic inflammation and may play a role in human atherosclerosis and cardiovascular disease.
18393292	2008	Hepatology	1527-3350	TITLE	0	0	5111	LONGTERM|DICTIONARY	cyclin	cyclin	65#71		TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
18318767	2008	Br. J. Haematol.	1365-2141	ALL_TEXT_1/3	1	1	1757	SYMBOL|()|GENE|GN|DICTIONARY	secretion-associated and ras-related (sar)	secretion-associated and RAS-related (SAR)	88#130		The hydroxycarbamide (HC)-inducible small guanosine triphosphate (GTP)-binding protein, secretion-associated and RAS-related (SAR) protein has recently been shown to play a pivotal role in HBG induction and erythroid maturation by causing cell apoptosis and G1/S-phase arrest.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	2214	SYMBOL|DICTIONARY	fcgr3a-v212f	FCGR3A-V212F	13#25		Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.
18396210	2008	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	1	3553	SYMBOL|GENE|GN|DICTIONARY	interleukin (il)-1	Interleukin (IL)-1	0#18		Interleukin (IL)-1 gene polymorphisms affect several inflammatory diseases, including cancer.
18194365	2008	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	48#92		The functional (R620W) variant of human PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been implicated in the risk to several autoimmune disorders, including type 1 diabetes, Graves' disease, rheumatoid arthritis and systemic lupus erythematosus.
18080216	2009	Fam. Cancer	1389-9600	ALL_TEXT_1/3	1	3	27306	SYMBOL|PLURAL|DICTIONARY	gsts	GSTs	91#95		In the present case-control study, undertaken to examine the influence of polymorphisms of GSTs in familial and sporadic breast cancer susceptibility, 597 women including 222 sporadic breast cancer patients, 125 familial breast cancer patients and 250 females with no history of cancer as controls were genotyped by PCR based methods.
18075470	2008	Pharmacogenet. Genomics	1744-6872	INTRODUCTION	1	1	1544	SYMBOL|NUMBER|DICTIONARY	cyp 1a2	CYP 1A2	21#28		Cytochrome P450 1A2 (CYP 1A2) is responsible for more than 90% of caffeine clearance.
18273796	2008	Genet. Mol. Res.	1676-5680	ALL_TEXT_1/3	1	2	1934	SYMBOL|EXTRACTED|()	beta3	beta3	31#36	18273796-2-24-29	The adrenergic receptor beta3 (beta3-AR), leptin (LEP) and leptin receptor (LEPR) genes have been intensively evaluated in the search of variants that could be related to obesity and its cardiometabolic complications.
17905396	2008	C. R. Biol.	1631-0691	ALL_TEXT_1/3	1	2	1806	LONGTERM|GENE|GN|DICTIONARY	dihydropyrimidine dehydrogenase gene	dihydropyrimidine dehydrogenase gene	92#128		The aim of this population study is to evaluate gene variations in the coding region of the dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	6	3105	SYMBOL|DICTIONARY	hla-a or -b	HLA-A or -B	56#67		No significant association was observed with any of the HLA-A or -B antigens.
18036860	2008	Transfus Clin Biol	1246-7820	RESULTS	3	6	3106	SYMBOL|DICTIONARY	hla-a or -b	HLA-A or -B	56#67		No significant association was observed with any of the HLA-A or -B antigens.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	6573	SYMBOL|()|GENE|GN|DICTIONARY	reduced folate carrier (rfc) protein	reduced folate carrier (RFC) protein	4#40		The reduced folate carrier (RFC) protein (SLC19A1-gene) has central role in the uptake and intracellular accumulation of folates.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_1/3	1	1	6573	SYMBOL|EXTRACTED|()	slc19a1	SLC19A1	42#49	17404734-1-28-31	The reduced folate carrier (RFC) protein (SLC19A1-gene) has central role in the uptake and intracellular accumulation of folates.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_2/3	2	6	6573	SYMBOL|GENE|GN|DICTIONARY	rfc protein	RFC protein	25#36		Western blot analysis of RFC protein was performed in respect of the identified SLC19A1 genotypes.
17404734	2008	Rheumatol. Int.	0172-8172	ALL_TEXT_3/3	3	10	6573	SYMBOL|GENE|GN|DICTIONARY	rfc protein	RFC protein	107#118		Western blot analysis revealed that the non-wild type allele of polymorphism -43T>C is associated with low RFC protein expression levels.
17419075	2007	Osteoarthr. Cartil.	1063-4584	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	Estrogen receptor alpha	0#23		Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor (er) alpha	estrogen receptor (ER) alpha	66#94		This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
17419075	2007	Osteoarthr. Cartil.	1063-4584	PURPOSE	1	1	2099	LONGTERM|GENE|GN|DICTIONARY	estrogen receptor (er) alpha	estrogen receptor (ER) alpha	66#94		This study evaluated the association between polymorphisms in the estrogen receptor (ER) alpha gene (ESR1) and prevalent and incident radiographic hip osteoarthritis (RHOA) in a large, well-defined prospective cohort of elderly Caucasian women.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_1/3	1	3	4313	SYMBOL|DICTIONARY	mmp-9 and -2	MMP-9 and -2	47#59		We investigated the activity and expression of MMP-9 and -2 in ethanol-induced acute gastric ulceration in rats.
17603938	2007	Free Radic. Biol. Med.	0891-5849	ALL_TEXT_1/3	1	3	4318	SYMBOL|DICTIONARY	mmp-9 and -2	MMP-9 and -2	47#59		We investigated the activity and expression of MMP-9 and -2 in ethanol-induced acute gastric ulceration in rats.
17459075	2007	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	36#68		Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
17459075	2007	Clin. Exp. Immunol.	0009-9104	ALL_TEXT_1/3	1	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	63#95		Like other autoimmune disorders, the possible role of specific cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in predisposing to SSc has been hypothesized, but it remains controversial.
17514530	2007	Curr. Eye Res.	0271-3683	ALL_TEXT_1/3	1	1	2952	LONGTERM|DICTIONARY	glutathione-s-transferase t1	glutathione-S-transferase T1	118#146		In this study, we aimed to determine the effects of genetic polymorphisms of glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) on risk of developing different subtypes of age-related cataract in the Turkish population.
17082176	2007	Carcinogenesis	0143-3334	ALL_TEXT_1/3	1	1	1728	LONGTERM|NUMBER|DICTIONARY	nadp(h):quinone oxidoreductase 1	NADP(H):quinone oxidoreductase 1	0#32		NADP(H):quinone oxidoreductase 1 (NQO1) and microsomal epoxide hydrolase (EPHX1, also mEH) are attractive candidate enzymes for association with colorectal neoplasia because they metabolize a number of compounds including polycyclic aromatic hydrocarbons (PAHs) that have been linked with colorectal carcinogenesis.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3558	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3565	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
17203290	2007	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	2	3569	SYMBOL|DICTIONARY	interleukins (il)-2, -4, and -6	interleukins (IL)-2, -4, and -6	34#65		This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD.
17309100	2007	Proteomics	1615-9853	ALL_TEXT_1/3	1	1	3569	SYMBOL|DICTIONARY	interleukin (il)-6	Interleukin (IL)-6	0#18		Interleukin (IL)-6 is a circulatory, pleiotropic cytokine with multiple roles in the immune system.
17257320	2007	Tissue Antigens	0001-2815	TITLE	0	0	3123	SYMBOL|DICTIONARY	drb1	DRB1	56#60		Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	drb1	DRB1	61#65		In this study, the association between HBV infection and HLA-DRB1 alleles in Han individuals in northwestern China was studied for the first time.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	9	3123	SYMBOL|NUMBER|DICTIONARY	drb1	DRB1	34#38		But the allele frequencies of HLA-DRB1*15 (6.9% of HBV-infected patients vs 13.4% of spontaneously cleared controls Pc = 0.039, OR = 0.48, P < 0.05) were obviously lower than that of the spontaneously cleared controls.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	33#37		The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17257320	2007	Tissue Antigens	0001-2815	ALL_TEXT_3/3	3	10	3123	SYMBOL|DICTIONARY	drb1	DRB1	49#53		The above data indicate that HLA-DRB1*03 and HLA-DRB1*07 are related to susceptibility to chronic HBV infection, and DRB1*15 is negatively related to persistence to chronic HBV infection among people in northwestern China.
17341859	2007	Dermatology (Basel)	1018-8665	TITLE	0	0	6256	SYMBOL|GENE|GN|GT|DICTIONARY	retinoid x receptor	retinoid X receptor	6#25		Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata.
17643058	2007	Int. Arch. Allergy Immunol.	1423-0097	BACKGROUND	1	3	2950	LONGTERM|DICTIONARY	glutathione s-transferase p1	Glutathione S-transferase P1	0#28		Glutathione S-transferase P1 (GSTP1), the abundant isoform of glutathione S-transferases (GSTs) in lung epithelium, plays a key role in cellular protection against oxidative stress.
16757160	2007	Respir Med	0954-6111	TITLE	0	0	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	0#13		IL-4 receptor genetic polymorphisms and asthma in Asian populations.
16757160	2007	Respir Med	0954-6111	BACKGROUND	1	2	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	12#25		The gene of IL-4 receptor alpha chain is a candidate gene for asthma and atopy.
16757160	2007	Respir Med	0954-6111	OBJECTIVES	2	3	3566	SYMBOL|GENE|GN|DICTIONARY	il-4 receptor	IL-4 receptor	57#70		To determine whether Ile50Val and Q576R polymorphisms of IL-4 receptor alpha chain gene were associated with asthma and higher level of total IgE in Chinese, Malay and Indian populations.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	6	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor-a	tumor necrosis factor-A	121#144		In a case-control study including 482 controls and 181 patients with GC, interleukin (IL)-8 -251, IL-1B-511, IL-1RN, and tumor necrosis factor-A (TNFA) -857 polymorphisms were genotyped.
16788379	2006	Pharmacogenet. Genomics	1744-6872	OBJECTIVE	1	2	4255	LONGTERM|DICTIONARY|GENE|GA	o-methylguanine dna methyltransferase	O-methylguanine DNA methyltransferase	4#41		The O-methylguanine DNA methyltransferase (MGMT) gene has a dual role in repairing alkylation damage and in inhibiting ER-mediated cell proliferation.
12767526	2003	Cancer Lett.	0304-3835	TITLE	0	0	1543	SYMBOL|DICTIONARY	cytochrome p450 (cyp) 1a1	cytochrome P450 (CYP) 1A1	43#68		Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study.
16416283	2007	J. Cancer Res. Clin. Oncol.	0171-5216	PURPOSE	1	1	2944	LONGTERM|DICTIONARY	glutathione s-transferase mu	glutathione S-transferase mu	98#126		Polycyclic aromatic hydrocarbons are activated by cytochrome P450 1A1 (CYP1A1) and inactivated by glutathione S-transferase mu (GSTM1).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	25	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_1/3	1	1	613	SYMBOL|DICTIONARY	bcr/abl1	BCR/ABL1	171#179		NPM1 gene mutations are the most frequent genetic lesion in the 60% of adult acute myeloid leukemias (AMLs) with normal karyotype and no evidence of typical fusion genes (BCR/ABL1, PML/RARA, AML1/ETO, CBFB/MYH11, DEK/CAN).
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	1234	LONGTERM|GENE|GT|NUMBER|DICTIONARY	cc chemokine receptor 5	CC chemokine receptor 5	213#236		There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16614115	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	ALL_TEXT_2/3	2	6	1234	SYMBOL|EXTRACTED|()	ccr5	CCR5	238#242	16614115-6-216-234	There was no overall association between pancreatic cancer risk and tumor necrosis factor-alpha (TNF-A -308G/A), regulated upon activation, normally T cell-expressed, and presumably secreted (RANTES -403G/A), and CC chemokine receptor 5 (CCR5-Delta32) polymorphisms.
16538170	2006	Pharmacogenet. Genomics	1744-6872	ALL_TEXT_1/3	1	1	1543	SYMBOL|NUMBER|DICTIONARY|GENE|GA	cytochrome p450 1	cytochrome P450 1	97#114		The aryl hydrocarbon receptor (AhR) is a key regulator of the transcriptional expression for the cytochrome P450 1 (CYP1) genes.
16495393	2006	N. Engl. J. Med.	1533-4406	BACKGROUND	1	2	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	37#45		Women with tumors that overexpressed HER2/neu were also assigned to receive concomitant treatment with trastuzumab or no such treatment.
16495393	2006	N. Engl. J. Med.	1533-4406	METHODS	2	4	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	44#52		The 232 women whose tumors had an amplified HER2/neu gene were further assigned to receive or not to receive nine weekly trastuzumab infusions.
16495393	2006	N. Engl. J. Med.	1533-4406	METHODS	2	4	2064	SYMBOL|GENE|GN|DICTIONARY	her2/neu	HER2/neu	44#52		The 232 women whose tumors had an amplified HER2/neu gene were further assigned to receive or not to receive nine weekly trastuzumab infusions.
16495393	2006	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	11	2064	SYMBOL|DICTIONARY	her2/neu	HER2/neu	150#158		A short course of trastuzumab administered concomitantly with docetaxel or vinorelbine is effective in women with breast cancer who have an amplified HER2/neu gene.
16495393	2006	N. Engl. J. Med.	1533-4406	CONCLUSIONS	4	11	2064	SYMBOL|GENE|GN|DICTIONARY	her2/neu	HER2/neu	150#158		A short course of trastuzumab administered concomitantly with docetaxel or vinorelbine is effective in women with breast cancer who have an amplified HER2/neu gene.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16481299	2006	HBPD INT	1499-3872	BACKGROUND	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	85#105		The aims of this study are to investigate the frequencies of human leukocyte antigen HLA-A, -B, and -DRB1 alleles in Chinese patients with PBC by polymerase chain reaction (PCR)-based techniques, and to assess the correlation of the above-mentioned HLA with some clinical and laboratory features.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	2	3074	SYMBOL|DICTIONARY|GENE|GA	alpha-subunit) and hexb	alpha-subunit) and HEXB	134#157		Both their serum HexA and HexB enzymatic activities were below reference range, suggesting inheritance of mutations in both the HEXA (alpha-subunit) and HEXB (beta-subunit) genes.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	LONGTERM|DICTIONARY	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	5327	SYMBOL|EXTRACTED|()	tissue plasminogen activator (t-pa	tissue plasminogen activator (t-PA	52#86	17131847-1-52-80	1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	7450	LONGTERM|GENE|GT|DICTIONARY	type-1, von willebrand factor	type-1, von Willebrand factor	106#135		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	1636	LONGTERM|GENE|GT|DICTIONARY	angiotensin converting enzyme i	angiotensin converting enzyme I	243#274		1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	4	7124	SYMBOL|EXTRACTED|()	tnf)alpha	TNF)alpha	107#116	16507146-4-84-105	The aim of the present study was to analyze the effect of antimalarial treatment on tumor necrosis factor (TNF)alpha serum levels and evaluate the possible influence of TNFalpha and IL-10 functional genetic polymorphisms on the response to antimalarial drugs.
16391475	2006	Dement Geriatr Cogn Disord	1420-8008	ALL_TEXT_2/3	2	5	348	LONGTERM|DICTIONARY	apolipoprotein e upsilon4	apolipoprotein E upsilon4	74#99		We also tested BDNF Val66Met-C270T haplotypes for an interaction with the apolipoprotein E upsilon4 (APOE4) allele in AD.
16322490	2006	Stroke	1524-4628	METHODS	2	4	7124	LONGTERM|DICTIONARY	il-6-572g>c) and tumor necrosis factor-alpha	IL-6-572G>C) and tumor necrosis factor-alpha	91#135		We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6-174G>C; IL-6-572G>C) and tumor necrosis factor-alpha (TNF-alpha-238G>A; TNF-alpha-308G>A).
16359492	2006	Congenit Anom (Kyoto)	0914-3505	ALL_TEXT_1/3	1	1	1387	LONGTERM|GENE|GN|GT|DICTIONARY	creb-binding protein gene	CREB-binding protein gene	25#50		Mutations in the CREBBP (CREB-binding protein gene) cause Rubinstein-Taybi syndrome (RSTS).
16318816	2007	Zhonghua Wai Ke Za Zhi	0529-5815	OBJECTIVE	1	1	1543	LONGTERM|DICTIONARY	cytochrome p-450 cyp1a1	cytochrome P-450 CYP1A1	87#110		To study the possible relationship between the single nucleotide polymorphism (SNP) of cytochrome P-450 CYP1A1 (CYP1A1) m1, m2 and GSTM1 [null] genotype and genetic susceptibility to prostate cancer (PC).
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_1/3	1	1	22914	SYMBOL|GENE|GN|DICTIONARY	nkg2d receptor	NKG2D receptor	119#133		Major histocompatibility complex (MHC) class I chain-related A (MICA) molecules deliver activating signals through the NKG2D receptor expressed on the surface of natural killer (NK), CD8alphabeta and gammadelta T cells, and the MICA gene is polymorphic.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	70#93		Variation in the coding sequence and flanking splice junctions of the estrogen receptor alpha (ERalpha) gene does not play an important role in genetic susceptibility to bipolar disorder or bipolar affective puerperal psychosis.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	2	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor alpha	estrogen receptor alpha	4#27		The estrogen receptor alpha (ERalpha) gene in particular has been a subject of interest and has recently been intensively screened for variations of potential relevance to psychiatric disorders, resulting in the identification of four mutations in individuals with bipolar disorder or puerperal psychosis.
12747597	2003	Clin. Chem. Lab. Med.	1434-6621	ALL_TEXT_3/3	3	8	1636	SYMBOL|DICTIONARY	ace	ACE	44#47		This study does not support the role of the ACE I/D and AT1R A1166C polymorphisms in the determination of the left ventricular size and performance in patients with significant coronary atherosclerosis.
12750963	2004	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4015	LONGTERM|GENE|GN|DICTIONARY	lysyl oxidase gene	lysyl oxidase gene	128#146		In the present study, we focus on 5q31, where three candidate genes, fibroblast growth factor 1 (FGF1), fibrillin 2 (FBN2), and lysyl oxidase gene ( LOX) lie, and evaluate associations with IA.
12189593	2002	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	5	6309	SYMBOL|DICTIONARY	3beta-hydroxysteroid-delta(5)-desaturase	3beta-hydroxysteroid-Delta(5)-desaturase	16#56		The activity of 3beta-hydroxysteroid-Delta(5)-desaturase (SC5D), the enzyme involved in this reaction, was deficient in the patient's fibroblasts.
12167522	2002	J Affect Disord	0165-0327	INTRODUCTION	1	2	3356	SYMBOL|GENE|GN|DICTIONARY	5-ht2a receptor	5-HT2A receptor	54#69		There is also emerging evidence that variation of the 5-HT2A receptor gene (HTR2A) contributes to both SAD and ADHD.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	1	354	LONGTERM|DICTIONARY|GENE|GA	prostate-specific antigen (psa)	prostate-specific antigen (PSA)	50#81		We have identified two novel polymorphisms in the prostate-specific antigen (PSA) gene promoter regions, the A-AA allele and G-A allele.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_1/3	1	1	354	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	prostate-specific antigen (psa)	prostate-specific antigen (PSA)	50#81	12168876-1-50-75	We have identified two novel polymorphisms in the prostate-specific antigen (PSA) gene promoter regions, the A-AA allele and G-A allele.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	2064	SYMBOL|DICTIONARY	c-erbb-2	c-erbB-2	80#88		We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	neuropeptide y (npy)	Neuropeptide Y (NPY)	0#20		Neuropeptide Y (NPY) and peptide YY (PYY) are members of the pancreatic polypeptide family which have a high degree of primary and tertiary structural homology.
11709213	2002	J. Inorg. Biochem.	0162-0134	ALL_TEXT_1/3	1	1	4852	SYMBOL|()|DICTIONARY|EXTRACTED	neuropeptide y (npy)	Neuropeptide Y (NPY)	0#20	11709213-1-0-14	Neuropeptide Y (NPY) and peptide YY (PYY) are members of the pancreatic polypeptide family which have a high degree of primary and tertiary structural homology.
11769724	2002	Zhonghua Nei Ke Za Zhi	0578-1426	TITLE	0	0	348	LONGTERM|NUMBER|DICTIONARY	apolipoprotein e 4	Apolipoprotein E 4	1#19		[Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
11583755	2001	Lancet	0140-6736	ALL_TEXT_2/3	2	2	1493	LONGTERM|NUMBER|DICTIONARY|GENE|GA	cytotoxic t lymphocyte antigen-4	cytotoxic T lymphocyte antigen-4	125#157		We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene.
11517440	2001	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	1	3586	SYMBOL|DICTIONARY	interleukin (il)-10	interleukin (IL)-10	66#85		In total, 116 children were investigated to determine whether the interleukin (IL)-10 polymorphism influences the age at primary Epstein-Barr virus (EBV) infection.
10702401	2000	Am. J. Pathol.	0002-9440	TITLE	0	0	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	15#18		Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
10702401	2000	Am. J. Pathol.	0002-9440	TITLE	0	0	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	19#23		Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	3	2130	SYMBOL|DICTIONARY	ews	EWS	24#27		The most common type of EWS-FLI1 fusion transcript, type 1, is associated with a favorable prognosis and appears to encode a functionally weaker transactivator, compared to other fusion types.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_1/3	1	3	2313	SYMBOL|DICTIONARY	fli1	FLI1	28#32		The most common type of EWS-FLI1 fusion transcript, type 1, is associated with a favorable prognosis and appears to encode a functionally weaker transactivator, compared to other fusion types.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	4	3480	SYMBOL|EXTRACTED|()	igf-1r)	IGF-1R)	258#265	10702401-4-228-256	We sought to determine whether the observed covariation of structure, function, and clinical course correlates with tumor cell kinetic parameters such as proliferative rate and apoptosis, and with expression of the receptor for insulin-like growth factor I (IGF-1R).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	58#61		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	62#66		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2130	SYMBOL|DICTIONARY	ews	EWS	78#81		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	5	2313	SYMBOL|DICTIONARY	fli1	FLI1	82#86		In a group of 86 ES/PNET with defined EWS-ETS fusions (45 EWS-FLI1 type 1, 27 EWS-FLI1 non-type 1, 14 EWS-ERG), we assessed proliferation rate by immunostaining for Ki-67 using MIB1 antibody (n = 85), apoptosis by TUNEL assay (n = 66), and IGF-1R expression by immunostaining with antibody 1H7 (n = 78).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2130	SYMBOL|GFAM|FN|DICTIONARY	ews	EWS	51#54		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2313	SYMBOL|GFAM|FN|DICTIONARY	fli1	FLI1	55#59		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2130	SYMBOL|DICTIONARY	ews	EWS	94#97		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_2/3	2	6	2313	SYMBOL|DICTIONARY	fli1	FLI1	98#102		Ki-67 proliferative index was lower in tumors with EWS-FLI1 type 1 than those with non-type 1 EWS-FLI1, whether analyzed as a continuous (P = 0.049) or categorical (P = 0.047) variable.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	7	2313	SYMBOL|DICTIONARY	type 1 ews-fli1	type 1 EWS-FLI1	96#111		Logistic regression analysis suggests that this association was secondary to the association of type 1 EWS-FLI1 and lower IGF-1R expression (P = 0.04).
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	8	2130	SYMBOL|DICTIONARY	ews	EWS	10#13		Comparing EWS-FLI1 to EWS-ERG cases, Ki-67 proliferative index was higher in the latter (P = 0.01, Mann-Whitney test; P = 0.02, Fisher's exact test), but there was no significant difference in IGF-1R.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	8	2313	SYMBOL|DICTIONARY	fli1	FLI1	14#18		Comparing EWS-FLI1 to EWS-ERG cases, Ki-67 proliferative index was higher in the latter (P = 0.01, Mann-Whitney test; P = 0.02, Fisher's exact test), but there was no significant difference in IGF-1R.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	10	2130	SYMBOL|DICTIONARY	ews	EWS	90#93		Our results suggest that clinical and functional differences between alternative forms of EWS-FLI1 are paralleled by differences in proliferative rate, possibly mediated by differential regulation of the IGF-1R pathway.
10702401	2000	Am. J. Pathol.	0002-9440	ALL_TEXT_3/3	3	10	2313	SYMBOL|DICTIONARY	fli1	FLI1	94#98		Our results suggest that clinical and functional differences between alternative forms of EWS-FLI1 are paralleled by differences in proliferative rate, possibly mediated by differential regulation of the IGF-1R pathway.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3105	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3106	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
12694583	2004	Tissue Antigens	0001-2815	ALL_TEXT_1/3	1	2	3123	SYMBOL|DICTIONARY	hla-a, -b, and -drb1	HLA-A, -B, and -DRB1	79#99		To evaluate the association of HLA type in Taiwanese with Graves' disease, the HLA-A, -B, and -DRB1 alleles in a total of 236 Taiwanese adults with Graves' disease and 533 racially matched normal control subjects were examined using the PCR-SSOP (sequence specific oligonucleotide probe) technique.
16111806	2006	Cancer Lett.	0304-3835	TITLE	0	0	7037	LONGTERM|GENE|GT|NUMBER|DICTIONARY	transferrin receptor 1	transferrin receptor 1	25#47		Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer.
16111806	2006	Cancer Lett.	0304-3835	ALL_TEXT_1/3	1	1	7037	LONGTERM|GENE|GT|NUMBER|DICTIONARY	transferrin receptor 1	transferrin receptor 1	45#67		In this study, the level and distribution of transferrin receptor 1 (TfR1) and ferritin in colorectal carcinoma and in normal colon epithelium has been determined relative to the tumor stage and iron status of patients using immunohistochemical staining methods.
15993987	2006	Neurobiol. Aging	0197-4580	ALL_TEXT_1/3	1	1	348	LONGTERM|DICTIONARY	apolipoprotein e epsilon4/epsilon4	apolipoprotein E epsilon4/epsilon4	35#69		The reduced antioxidant defense in apolipoprotein E epsilon4/epsilon4 carriers may contribute to beta-amyloidosis.
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	4313	SYMBOL|DICTIONARY	matrix metalloproteinase (mmp) 2	matrix metalloproteinase (MMP) 2	95#127		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	LONGTERM|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
16082623	2005	Br J Surg	0007-1323	BACKGROUND	1	1	5054	SYMBOL|GENE|GN|DICTIONARY	plasminogen activator inhibitor (pai) 1	plasminogen activator inhibitor (PAI) 1	154#193		The aim of the study was to investigate the effect of functional polymorphisms in promoters of matrix metalloproteinase (MMP) 2, MMP-3, MMP-9, MMP-12 and plasminogen activator inhibitor (PAI) 1 genes on the growth rate of small abdominal aortic aneurysms (AAA).
15956286	2005	Blood	0006-4971	ALL_TEXT_1/3	1	1	3779	LONGTERM|DICTIONARY	beta1	beta1	95#100		The discoid form of platelets is maintained by a marginal band of tightly coiled microtubules. beta1-tubulin is the major isoform within platelet and megakaryocyte microtubules.
15956286	2005	Blood	0006-4971	ALL_TEXT_1/3	1	2	3779	LONGTERM|DICTIONARY	beta1	beta1	145#150		In 24.2% of 33 unrelated inherited macrothrombocytopenia patients and in 10.6% of 272 subjects of a healthy population a P for Q substitution in beta1-tubulin was found in the highly conserved residue 43.
15956286	2005	Blood	0006-4971	ALL_TEXT_1/3	1	3	3779	LONGTERM|DICTIONARY	beta1	beta1	76#81		Heterozygous carriers of the Q43P variant showed a reduced platelet protein beta1-tubulin expression.
15956286	2005	Blood	0006-4971	ALL_TEXT_2/3	2	4	3779	LONGTERM|DICTIONARY	beta1	beta1	60#65		Transfection of green fluorescent protein (GFP)-tagged Q43P beta1-tubulin in megakaryocytic MEG01 cells resulted in a disturbed tubulin organization.
15956286	2005	Blood	0006-4971	ALL_TEXT_2/3	2	6	3779	LONGTERM|DICTIONARY	beta1	beta1	37#42		In addition, platelets with the Q43P beta1-tubulin variant had reduced adenosine triphosphate (ATP) secretion, thrombin receptor activating peptide (TRAP)-induced aggregation and collagen adhesion.
15956286	2005	Blood	0006-4971	ALL_TEXT_2/3	2	6	100187907	LONGTERM|GENE|GT|DICTIONARY	thrombin receptor activating peptide	thrombin receptor activating peptide	111#147		In addition, platelets with the Q43P beta1-tubulin variant had reduced adenosine triphosphate (ATP) secretion, thrombin receptor activating peptide (TRAP)-induced aggregation and collagen adhesion.
15956286	2005	Blood	0006-4971	ALL_TEXT_3/3	3	7	3779	LONGTERM|DICTIONARY	beta1	beta1	27#32		The prevalence of the Q43P beta1-tubulin variant was also 2 times higher (odds ratio, [OR] = 2.1;95% confidence interval [CI], 1.22-3.59) among control subjects than among patients with cardiovascular disease (10.4% versus 5.2%, P < .001).
15956286	2005	Blood	0006-4971	ALL_TEXT_3/3	3	9	3779	LONGTERM|DICTIONARY	beta1	beta1	74#79		This study thus presents the functional consequences of the platelet Q43P beta1-tubulin substitution that is frequent in the healthy population and may protect men against arterial thrombosis.
16043121	2005	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2833	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	c-x-c motif) receptor 3 (cxcr3)	C-X-C motif) receptor 3 (CXCR3)	15#46	16043121-1-4-38	The chemokine (C-X-C motif) receptor 3 (CXCR3) gene, on chromosome Xq13, is known to have critical roles in inflammatory and immune responses.
16128377	2006	Acta Cardiol	0001-5385	BACKGROUND	1	3	1636	SYMBOL|DICTIONARY	ace	ACE	40#43		We also investigated the effects of the ACE-I/D genotypes on diastolic function by echocardiography in healthy subjects without any risk factors and any events after 6 years of follow-up.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	13	1636	SYMBOL|DICTIONARY	ace	ACE	7#10		3) the ACE-II group (n = 124, 45 F/79 M, mean age 42.5 +/- 6.9 years) with 2 hypertensive subjects (1.6%) and I HF subject.
16128377	2006	Acta Cardiol	0001-5385	RESULTS	3	14	1636	SYMBOL|DICTIONARY	ace	ACE	135#138		The incidence of hypertension and cardiovascular events, was significantly higher in the ACE-DD (53 cases, 23%) than in the ACE-ID and ACE-II groups (20 and 3 cases, 5.9% and 2.4%, respectively), p = 0.0001.
15809232	2005	Alcohol Alcohol.	0735-0414	RESULTS	3	6	1636	SYMBOL|DICTIONARY	ace	ACE	33#36		No association was shown between ACE I/D polymorphism and carotid atherosclerosis.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	LONGTERM|DICTIONARY	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87		To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
15940757	2005	J. Rheumatol.	0315-162X	OBJECTIVE	1	1	2944	SYMBOL|()|DICTIONARY|EXTRACTED	glutathione s-transferase (gst) m1	glutathione S-transferase (GST) M1	53#87	15940757-1-53-78	To determine the effects of genetic polymorphisms of glutathione S-transferase (GST) M1, GSTT1, and GSTP on risk and severity of rheumatoid arthritis (RA) in a Korean population.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3105	SYMBOL|DICTIONARY	hla-a/b	HLA-A/B	104#111		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	METHODS	2	2	3106	SYMBOL|DICTIONARY	hla-a/b	HLA-A/B	104#111		High resolution DQB 1 of 103 sarcoidosis patients was obtained by sequence-based typing; low resolution HLA-A/B/DRB 1 typing was performed by serological and molecular methods.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	TITLE	0	0	186	LONGTERM|GFAM|FN|DICTIONARY	angiotensin ii type2 receptor	angiotensin II type2 receptor	88#117		Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	3	3558	SYMBOL|DICTIONARY	interleukin (il)-2	interleukin (IL)-2	138#156		Ninety patients with stage IV melanoma were treated with biochemotherapy, including cisplatin, vinblastine, and dacarbazine combined with interleukin (IL)-2 and IFN-alpha either with or without tamoxifen.
15459589	2005	Am. Heart J.	1097-6744	TITLE	0	0	6404	LONGTERM|DICTIONARY	p-selectin glycoprotein ligand	P-selectin glycoprotein ligand	17#47		Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction.
15459589	2005	Am. Heart J.	1097-6744	BACKGROUND	1	3	6404	LONGTERM|DICTIONARY	p-selectin glycoprotein ligand	P-selectin glycoprotein ligand	122#152		Recently, we have demonstrated the functional relevance of a variable number of tandem repeats polymorphism affecting the P-selectin glycoprotein ligand (PSGL-1).
15466944	2005	J Am Coll Nutr	0731-5724	METHODS	2	7	4524	LONGTERM|DICTIONARY|GENE|GA	5,10-methylenetetrahydrofolate reductase	5,10-methylenetetrahydrofolate reductase	0#40		5,10-methylenetetrahydrofolate reductase (MTHFR) enzyme polymorphism was analyzed by polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_2/3	2	4	1636	SYMBOL|DICTIONARY	ace	ACE	60#63		We analyzed the frequencies of 894 G/T (Glu298Asp) eNOS and ACE I/D polymorphisms in Mexican patients with ED (n=53) and in an age-matched control group (n=62).
15292102	2005	J. Androl.	0196-3635	ALL_TEXT_3/3	3	9	1636	SYMBOL|DICTIONARY	ace	ACE	33#36		No association was found between ACE I/D polymorphism and ED in the population studied.
15307921	2004	AIDS Res. Hum. Retroviruses	0889-2229	TITLE	0	0	1234	LONGTERM|GENE|GT|NUMBER|DICTIONARY|GA	cc-chemokine receptor 5	CC-chemokine receptor 5	57#80		Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction.
15308875	2004	Am. J. Nephrol.	0250-8095	BACKGROUND	1	2	7040	SYMBOL|GENE|GN|DICTIONARY	tgf-beta(1)	TGF-beta(1)	30#41		We evaluated the influence of TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms on the clinical manifestations of focal segmental glomerulosclerosis (FSGS).
15308875	2004	Am. J. Nephrol.	0250-8095	CONCLUSION	4	10	7040	SYMBOL|GENE|GN|DICTIONARY	tgf-beta(1)	TGF-beta(1)	26#37		Our results indicate that TGF-beta(1) gene Arg(25)-->Pro, TNF alpha gene G-308A and IL-6 gene G-174C polymorphisms are not risk factors or markers of progression in focal segmental glomerulosclerosis.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	1	7124	SYMBOL|EXTRACTED|()	tnf)-alpha	TNF)-alpha	23#33	15189946-1-0-21	Tumor necrosis factor (TNF)-alpha has been implicated in the pathophysiology of heart failure.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	43#52	15189946-1-0-21	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	54#72		We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	8	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	17#26	15189946-1-0-21	Polymorphisms of TNF-alpha within the promoter at position -308a-->g, IL-6 within the promoter at position -174c-->g, IL-10 within the promoter at position -1082a-->g/-819t-->c and -819t-->c/-592a-->c, TGF-beta1 at codon 10t-->c and codon 25c-->g, and IFN-gamma at intron 1 at position + 874t-->a were studied.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	11	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	55#64	15189946-1-0-21	There were no significant differences in median plasma TNF-alpha levels between the TNF-1 and the TNF-2 groups, but TGF-beta1 levels were higher in the survivors than in the nonsurvivors (median, 866 pg/mL; range, 384 to 1,966 pg/mL; vs median, 454 pg/mL; range, 167 to 1,266 pg/mL, respectively; p = 0.02).
15142050	2004	Clin Transplant	0902-0063	INTRODUCTION	1	4	348	SYMBOL|GENE|GN|DICTIONARY	apolipoprotein (apo) e	Apolipoprotein (apo) E	0#22		Apolipoprotein (apo) E gene code forms three major isoforms (E2, E3, and E4) with variable effects on lipid metabolism.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3105	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3106	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	1	3123	SYMBOL|DICTIONARY	hla-a, -b, -drb1	HLA-A, -B, -DRB1	129#145		To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT), the HLA-A, -B, -DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling technique.
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3105	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3106	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3123	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3105	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3106	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15228651	2004	Zhongguo Shi Yan Xue Ye Xue Za Zhi	1009-2137	ALL_TEXT_1/3	1	3	3123	SYMBOL|DICTIONARY	hla-a, -b and -drb1	HLA-A, -B and -DRB1	131#150		"Third step, SPDBV software of SWISS-MODEL server was used to modeling the three-dimensional structures of each different allele of HLA-A, -B and -DRB1 between patients and donors and the parameter ""root mean square deviation"" (RMSD) was used to indicate the structure differences."
15110323	2004	Mol. Genet. Metab.	1096-7192	TITLE	0	0	1374	SYMBOL|NUMBER|DICTIONARY	cpt 1a	CPT 1A	19#25		Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
15110323	2004	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	3	1374	SYMBOL|NUMBER|DICTIONARY	cpt 1a	CPT 1A	40#46		The disorder is due to mutations in the CPT 1A gene for which few patients have been characterized.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_1/3	1	1	3482	SYMBOL|()|GENE|GN|DICTIONARY	igf2r	Igf2r	48#53		To elucidate whether the M6p/Igf2 receptor (M6p/Igf2r) gene might be involved in exogenous and endogenous liver carcinogenesis, we investigated its alteration in hepatocellular carcinomas (HCCs) induced by N-nitrosodiethylamine (DEN) and by a choline-deficient L-amino acid-defined (CDAA) diet in rats.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_2/3	2	4	3482	SYMBOL|GENE|GN|DICTIONARY	igf2r	Igf2r	145#150		Total RNA was extracted from individual HCCs for assessment of mutations within exons 27, 28, 31, 33, and 34, and aberrant transcript of the M6p/Igf2r gene by reverse transcription (RT)-polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and RT-PCR analyses, respectively.
15057872	2004	Mol. Carcinog.	0899-1987	ALL_TEXT_3/3	3	7	3482	SYMBOL|GENE|GN|DICTIONARY	igf2r	Igf2r	50#55		These results suggest that alterations of the M6p/Igf2r gene may be involved in both exogenous and endogenous liver carcinogenesis with the different patterns and frequencies.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	3308	SYMBOL|DICTIONARY	hsp70	Hsp70	85#90		Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	8	3308	SYMBOL|DICTIONARY	hsp70	Hsp70	59#64		These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
15380041	2005	Arthritis Res. Ther.	1478-6362	TITLE	0	0	2099	LONGTERM|GENE|GT|DICTIONARY	estrogen receptor-alpha	Estrogen receptor-alpha	0#23		Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVES	1	2	3458	LONGTERM|DICTIONARY|GENE|GA	interferon gamma (ifn-gamma	interferon gamma (IFN-gamma	112#139		In this study we have examined the potential association of a CA repeat polymorphism in the first intron of the interferon gamma (IFN-gamma) gene with disease susceptibility and clinical expression of these conditions.
15675129	2005	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVES	1	2	3458	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	interferon gamma (ifn-gamma	interferon gamma (IFN-gamma	112#139	15675129-2-112-128	In this study we have examined the potential association of a CA repeat polymorphism in the first intron of the interferon gamma (IFN-gamma) gene with disease susceptibility and clinical expression of these conditions.
14697747	2004	Clin. Immunol.	1521-6616	TITLE	0	0	1234	LONGTERM|DICTIONARY	ccr5	CCR5	37#41		Prevalence of the chemokine receptor CCR5-Delta32 gene mutation in periodontal disease.
12939427	2004	Neurology	1526-632X	METHODS	3	4	3126	SYMBOL|GENE|GN|DICTIONARY	leukocyte antigen (hla) class ii drb1	leukocyte antigen (HLA) class II DRB1	181#218		Two hundred sixty-nine unrelated patients with definite MS and 385 unrelated healthy control subjects from Italy and Russia were genotyped for the MBP VNTR region and for the human leukocyte antigen (HLA) class II DRB1 gene.
14567462	2004	Dig Liver Dis	1590-8658	METHODS	2	2	7124	LONGTERM|GENE|GT|DICTIONARY	tumour necrosis factor a	tumour necrosis factor A	192#216		In 64 PSC patients and 183 normal controls of the same population (Northern Italy), allelic polymorphisms at the DNA level were investigated in MHC region genes: HLA-DRB1, HLA-DQB1 and HLA-B, tumour necrosis factor A (TNFA), and in CFTR gene, with polymerase chain reaction-based methodologies.
12828656	2003	J. Periodont. Res.	0022-3484	TITLE	0	0	7124	LONGTERM|GENE|GN|DICTIONARY	tumor necrosis factor	tumor necrosis factor	67#88		Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	5	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	4#13	12828656-2-0-21	The TNF-alpha (-308G/A) polymorphism itself showed no association with chronic periodontitis, whereas the frequency distribution of the LT-alpha (+252A/G) genotypes showed statistically significant differences between patients and the reference group.
12828656	2003	J. Periodont. Res.	0022-3484	RESULTS	3	7	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	83#92	12828656-2-0-21	However, the significant differences in the frequencies of the combined genotypes (TNF-alpha and LT-alpha) between the control and the patient groups were found using a simulation by applying the Monte-Carlo method (P < 0.01).
12828656	2003	J. Periodont. Res.	0022-3484	CONCLUSION	4	8	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	57#66	12828656-2-0-21	Our data suggest that combined genotypes composed of the TNF-alpha and LT-alpha gene polymorphisms may influence the susceptibility to chronic periodontitis.
12850481	2004	Blood Cells Mol. Dis.	1079-9796	TITLE	0	0	54658	SYMBOL|DICTIONARY	ugt1 a1	UGT1 A1	72#79		Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
12850481	2004	Blood Cells Mol. Dis.	1079-9796	ALL_TEXT_1/3	1	2	54658	SYMBOL|DICTIONARY	ugt1 a1	UGT1 A1	168#175		The molecular basis of this syndrome usually concerns an additional dinucleotide insertion (TA) in the A(TA)(n)TAA configuration residing in the promoter region of the UGT1 A1 gene.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	7048	SYMBOL|GFAM|FN|DICTIONARY	tgfbeta type ii receptor	TGFbeta type II receptor	204#228		Osteoclast formation was enhanced approximately 5-fold (P < 0.001) and bone resorption approximately 10-fold (P < 0.001) in CED patients, and the increase in osteoclast formation was inhibited by soluble TGFbeta type II receptor.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_3/3	3	4	1432	LONGTERM|DICTIONARY	p38	p38	237#240		The effect of d-myo-inositol 1,4,5-tris-phosphate was blocked after inhibition of inositol-trisphosphate receptors but not after inhibition of c-Raf/mitogen-activated protein kinase kinase (MEK)/mitogen-activated protein kinase (ERK) or p38 mitogen-activated protein kinase pathways.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	7	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	30#42		We studied the association of CCR5*Delta32 with the course and severity of MS in 221 patients from a population-based cohort in Olmsted County, MN, and with patterns of immunopathology in 94 patients with biopsy-derived, pathologically confirmed demyelinating disease participating in the MS Lesion Project.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	12	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	23#35		Carrier status for the CCR5*Delta32 mutation was not associated with patterns of immunopathology in MS.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_3/3	3	15	1234	SYMBOL|DICTIONARY	ccr5*delta32	CCR5*Delta32	113#125		Furthermore it does not segregate with patterns of immunopathology in MS. We did not find an association between CCR5*Delta32 mutation and disease severity and age of onset in MS.
16168297	2005	J. Am. Coll. Cardiol.	1558-3597	OBJECTIVES	1	1	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	211#229		This study sought to evaluate the effect of genetic polymorphism G894T on endothelial nitric oxide synthase (eNOS); on the risk for myocardial infarction (MI); and on the release of von Willebrand factor (vWF), interleukin (IL)-6, IL-1b, and oxidized low-density lipoprotein (ox-LDL) levels during the acute phase of MI and one year after the event.
16230779	2006	Endocrine	1355-008X	ALL_TEXT_1/3	1	2	5979	LONGTERM|DICTIONARY	ret	RET	21#24		Somatic mutations of RET proto-oncogene have been reported at a variable frequency ranging from 23% to 69%.
16277672	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase nonreceptor type 22	protein tyrosine phosphatase nonreceptor type 22	4#52		The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation.
20393813	2010	J. Mol. Neurosci.	1559-1166	ALL_TEXT_2/3	2	4	3569	SYMBOL|DICTIONARY	interleukin (il)-6	interleukin (IL)-6	62#80		The aim of the study was to identify whether polymorphisms of interleukin (IL)-6 and IL-10 are risk factors for the development of paranoid schizophrenia in case-control study.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	LONGTERM|GENE|GT|DICTIONARY	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33		Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	1	7124	SYMBOL|EXTRACTED|()	tumor necrosis factor (tnf)-alpha	Tumor necrosis factor (TNF)-alpha	0#33	20100586-1-0-21	Tumor necrosis factor (TNF)-alpha plays a significant role in conditioning related toxicities and the development of acute graft-versus-host disease (aGVHD).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	5	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	52#61	20100586-1-0-21	Recipient single-nucleotide polymorphisms (SNPs) in TNF-alpha and TNF receptor superfamily members 1A (TNFRSF1A) and 1B (TNFRSF1B) were investigated.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	5	7132	SYMBOL|GENE|GN|DICTIONARY|EXTRACTED	tnf receptor superfamily members 1a	TNF receptor superfamily members 1A	66#101	20100586-1-0-21	Recipient single-nucleotide polymorphisms (SNPs) in TNF-alpha and TNF receptor superfamily members 1A (TNFRSF1A) and 1B (TNFRSF1B) were investigated.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	5	7132	SYMBOL|()|DICTIONARY	tnfrsf1a) and 1b	TNFRSF1A) and 1B	103#119		Recipient single-nucleotide polymorphisms (SNPs) in TNF-alpha and TNF receptor superfamily members 1A (TNFRSF1A) and 1B (TNFRSF1B) were investigated.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_1/3	1	5	7133	SYMBOL|()|DICTIONARY	tnfrsf1a) and 1b	TNFRSF1A) and 1B	103#119		Recipient single-nucleotide polymorphisms (SNPs) in TNF-alpha and TNF receptor superfamily members 1A (TNFRSF1A) and 1B (TNFRSF1B) were investigated.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_2/3	2	9	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	43#52	20100586-1-0-21	Significant associations were seen between TNF-alpha variant alleles and the severity of aGVHD (grade II-IV and grade III-IV), especially when analyzed in whites only (n = 165).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	11	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	48#57	20100586-1-0-21	Severe (grade III-IV) aGVHD was associated with TNF-alpha -1031C allele (HR, 2.38; P = .03), -863A allele (HR, 3.18; P = .003), and d4/d4 genotype (HR, 2.82; P = .01).
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_3/3	3	14	7124	SYMBOL|EXTRACTED	tnf-alpha	TNF-alpha	90#99	20100586-1-0-21	Our findings indicate clinically important relationships between genetic polymorphisms in TNF-alpha and the severity of aGVHD in this cohort.
20130978	2010	Cancer Causes Control	1573-7225	METHODS	2	5	672	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	35#42		All participants were screened for BRCA1/2 mutations and 181 carriers were identified.
20130978	2010	Cancer Causes Control	1573-7225	METHODS	2	5	675	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	35#42		All participants were screened for BRCA1/2 mutations and 181 carriers were identified.
20130978	2010	Cancer Causes Control	1573-7225	CONCLUSION	4	10	672	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	115#122		For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers.
20130978	2010	Cancer Causes Control	1573-7225	CONCLUSION	4	10	675	SYMBOL|NUMBER|DICTIONARY	brca1/2	BRCA1/2	115#122		For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers.
20136773	2010	Tissue Antigens	1399-0039	ALL_TEXT_2/3	2	5	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla)-drb1 and -dqb1	leukocyte antigen (HLA)-DRB1 and -DQB1	10#48		The human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles were analyzed in 76 patients with primary DCM and 111 ethnically matched healthy controls using polymerase chain reaction-sequence specific primers technique.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	STUDY DESIGN	2	3	7422	LONGTERM|DICTIONARY	vascular endothelial growth factor a, b	vascular endothelial growth factor A, B	88#127		Maternal DNA was extracted, and 124 tagging single nucleotide polymorphisms in 6 genes (vascular endothelial growth factor A, B, and C; fms-like tyrosine kinase 1 and 4; endoglin) were genotyped.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	STUDY DESIGN	2	3	7423	LONGTERM|DICTIONARY	vascular endothelial growth factor a, b	vascular endothelial growth factor A, B	88#127		Maternal DNA was extracted, and 124 tagging single nucleotide polymorphisms in 6 genes (vascular endothelial growth factor A, B, and C; fms-like tyrosine kinase 1 and 4; endoglin) were genotyped.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	2321	LONGTERM|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	7424	LONGTERM|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	2321	LONGTERM|GENE|GN|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20223440	2010	Am. J. Obstet. Gynecol.	1097-6868	CONCLUSION	4	9	7424	LONGTERM|GENE|GN|DICTIONARY	fms-like tyrosine kinase 1 and vascular endothelial growth factor c	fms-like tyrosine kinase 1 and vascular endothelial growth factor C	26#93		Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	3305	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	7422	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	3305	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	TITLE	0	0	7422	SYMBOL|DICTIONARY	vegf/hsp70-hom	VEGF/HSP70-hom	23#37		Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_1/3	1	2	3308	SYMBOL|DICTIONARY	hsp70	HSP70	56#61		Our previous single-locus analysis showed that VEGF and HSP70-hom polymorphisms were significantly associated with PCa susceptibility and prognosis.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_2/3	2	4	3308	SYMBOL|NUMBER|DICTIONARY	hsp70	HSP70	33#38		Three tagging polymorphisms, the HSP70-hom 2437 T/C, the VEGF-1154 G/A, and the VEGF-634 G/C SNPs were genotyped in 101 cases and 80 controls.
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	3305	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	7422	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	3305	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	5	7422	SYMBOL|DICTIONARY	vegf and hsp70-hom	VEGF and HSP70-hom	29#47		For the combined analysis of VEGF and HSP70-hom, we found a positive gradient in the odds ratios (ORs) related to the number of high-risk genotypes with a 3.53-fold increase of prostate carcinoma risk (OR = 3.53; p = 0.015).
20096741	2010	Hum. Immunol.	1879-1166	ALL_TEXT_3/3	3	6	3308	SYMBOL|DICTIONARY	hsp70	HSP70	53#58		Furthermore, the TAG and CAG haplotypes at positions HSP70-hom, VEGF -1154 and VEGF -634 exhibited a two-fold (OR = 0.46; p = 0.014) and a seven-fold (OR = 0.14; p = 0.00005) reduction in PCa risk, respectively.
20068450	2010	Anesthesiology	1528-1175	METHODS	2	4	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	57#74		The changes in prodynorphin messenger RNA expression and dynorphin A (1-17)-like immunoreactivity in the mouse spinal cord were determined after the intraplantar injection of complete Freund's adjuvant in mice.
20068450	2010	Anesthesiology	1528-1175	METHODS	2	5	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	139#156		The signal intensity in different brain regions after the intraplantar injection of complete Freund's adjuvant or intrathecal injection of dynorphin A (1-17) was measured by a pharmacological functional magnetic resonance imaging analysis.
20068450	2010	Anesthesiology	1528-1175	RESULTS	3	8	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	42#59		Prodynorphin messenger RNA expression and dynorphin A (1-17)-like immunoreactivity on the ipsilateral side of the spinal cord were markedly increased in complete Freund's adjuvant-injected mice.
20068450	2010	Anesthesiology	1528-1175	RESULTS	3	9	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	38#55		Furthermore, intrathecal injection of dynorphin A (1-17) at relatively high doses caused pain-associated behaviors and a remarkable increase in the activities of the cingulate cortex, somatosensory cortex, insular cortex, and medial and lateral thalamic nuclei in mice.
20068450	2010	Anesthesiology	1528-1175	CONCLUSIONS	4	10	5173	LONGTERM|DICTIONARY	dynorphin a (1-17	dynorphin A (1-17	47#64		These findings indicate that spinally released dynorphin A (1-17) by noxious stimuli leads to the direct activation of ascending pain transmission.
20112360	2010	Arthritis Rheum.	0004-3591	RESULTS	3	7	2845	LONGTERM|GENE|GN|GT|DICTIONARY	g protein-coupled receptor protein 22	G protein-coupled receptor protein 22	47#84		Immunohistochemistry experiments revealed that G protein-coupled receptor protein 22 (GPR22) was absent in normal mouse articular cartilage or synovium.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5594	LONGTERM|NUMBER|DICTIONARY	extracellular signal-regulated kinase 1/2	extracellular signal-regulated kinase 1/2	85#126		Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5595	LONGTERM|NUMBER|DICTIONARY	extracellular signal-regulated kinase 1/2	extracellular signal-regulated kinase 1/2	85#126		Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5594	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	128#134		Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	9	5595	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	128#134		Pretreatment with the corticotropin-releasing factor (CRF) blocker astressin and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway blocker PD98059 abolished these effects of Ucn.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	10	5594	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	198#204		Our findings further support the hypothesis that the changes of sACE activity and the production of other RAS components may play roles in the vasodilatory property of Ucn via the activation of the ERK1/2 pathway.
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_3/3	3	10	5595	SYMBOL|NUMBER|DICTIONARY	erk1/2	ERK1/2	198#204		Our findings further support the hypothesis that the changes of sACE activity and the production of other RAS components may play roles in the vasodilatory property of Ucn via the activation of the ERK1/2 pathway.
19892845	2010	Clin. Chem.	1530-8561	BACKGROUND	1	1	672	LONGTERM|DICTIONARY	breast cancer 1	breast cancer 1	32#47		Deleterious mutations in BRCA1 (breast cancer 1, early onset; MIM 113705) increase breast and ovarian cancer [B(O)C] risk; however, many variants cannot be readily classified as deleterious or neutral.
19902201	2010	Immunogenetics	1432-1211	ALL_TEXT_1/3	1	1	7185	LONGTERM|GENE|GN|GT|DICTIONARY	tumor necrosis factor receptor-associated factor 1	tumor necrosis factor receptor-associated factor 1	193#243		In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD).
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	56916	LONGTERM|DICTIONARY	helicase 1	helicase 1	37#47		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19484476	2009	J. Cancer Res. Clin. Oncol.	1432-1335	PURPOSE	1	1	672	LONGTERM|DICTIONARY	brca1	BRCA1	0#5		BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures.
19423162	2009	Leuk. Res.	1873-5835	ALL_TEXT_1/3	1	1	7157	LONGTERM|DICTIONARY	p53	p53	212#215		A single nucleotide polymorphism (SNP) in the promoter of MDM2 gene, SNP309 T>G (a T-G exchange at nucleotide 309 in the first intron), can increase the expression level of MDM2, thereby causing an impairment of p53 tumor suppressor activity.
19698145	2009	J Neuroinflammation	1742-2094	RESULTS	3	4	348	LONGTERM|DICTIONARY	apolipoprotein e epsilon4	apolipoprotein E epsilon4	193#218		We replicated the interaction.For IL6 rs2069837 AA x IL10 rs1800871 CC, the synergy factor (SF) was 1.63 (95% confidence interval: 1.10-2.41, p = 0.01), controlling for centre, age, gender and apolipoprotein E epsilon4 (APOEepsilon4) genotype.
19638460	2009	Clin. Cancer Res.	1078-0432	RESULTS	3	9	4051	SYMBOL|DICTIONARY	cytochrome p450	cytochrome P450	135#150		Analysis of polymorphisms important for the metabolism of the drugs used in the trial showed that carriers of the CYP2C19*2 variant of cytochrome P450 required higher VPA doses to achieve the target VPA plasma concentration of 50 microg/mL on day 1 of 5-AZA treatment (P = 0.0021).
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6347	SYMBOL|DICTIONARY	ccl2/monocyte chemoattractant protein (mcp)-1	CCL2/Monocyte Chemoattractant Protein (MCP)-1	0#45		CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19415413	2009	J. Neurol.	1432-1459	ALL_TEXT_1/3	1	1	6347	SYMBOL|DICTIONARY	ccl2/monocyte chemoattractant protein (mcp)-1	CCL2/Monocyte Chemoattractant Protein (MCP)-1	0#45		CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration.
19563289	2009	J. Periodontol.	0022-3492	BACKGROUND	1	1	3552	SYMBOL|DICTIONARY	interleukin (il)-1	interleukin (IL)-1	26#44		Recent data indicate that interleukin (IL)-1 polymorphism may influence the susceptibility to periodontitis and coronary heart diseases.
20037740	2011	Comp. Funct. Genomics	1532-6268	ALL_TEXT_1/3	1	1	3576	SYMBOL|DICTIONARY	interleukin (il)-8	Interleukin (IL)-8	11#29		Background.Interleukin (IL)-8 has been implicated in the development of cancer cachexia.
19276544	2009	J. Alzheimers Dis.	1387-2877	ALL_TEXT_1/3	1	1	9846	SYMBOL|DICTIONARY	grb-associated binding protein 2	GRB-associated binding protein 2	41#73		A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	128#156		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210888	2009	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	2	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase n22	protein tyrosine phosphatase N22	161#193		The present study was undertaken to investigate the association of polymorphisms in two candidate genes for autoimmunity, human leukocyte antigen (HLA) DRB1 and protein tyrosine phosphatase N22 (PTPN22) with JIA in Hungarian patients.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	TITLE	0	0	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	42#86		Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland.
19210878	2009	Clin. Exp. Rheumatol.	0392-856X	ALL_TEXT_1/3	1	1	26191	LONGTERM|DICTIONARY	protein tyrosine phosphatase non-receptor 22	protein tyrosine phosphatase non-receptor 22	4#48		The protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C>T poly-morphic variant gene (rs2476601) displays an association with systemic lupus erythematosus (SLE) and other autoimmune diseases.
24640096	2014	Klin. Lab. Diagn.	0869-2084	ALL_TEXT_1/3	1	1	7076	SYMBOL|NUMBER|DICTIONARY	timp-1	TIMP-1	142#148		Results of comparative immunoenzymatic study of matrix metalloproteinase (MMP) 2, 8 and 9, interleukins (IL) If and 6, tissue MMP inhibitors (TIMP-1and TIMP-2) and TNF-a in oral fluid of patients with different teeth and denture constructive materials show that MMP-9 content in oral fluid can serve as a marker of chronic generalized periodontitis because it is elevated in all patients irrespective of presence or absence of metallic tooth restorations.
21992601	2012	J. Cell. Mol. Med.	1582-4934	ALL_TEXT_2/3	2	4	7082	LONGTERM|DICTIONARY	zo-1 and podocin	ZO-1 and podocin	103#119		Confocal fluorescent microscopy demonstrated the reduced expression of epithelial markers (P-Cadherin, ZO-1 and podocin) and increased expression of mesenchymal markers (FSP-1, α-SMA and desmin) in the glomeruli of CD38(-/-) and CD38-shRNA mice compared to CD38(+/+) mice.
21983886	2012	Arch. Toxicol.	1432-0738	ALL_TEXT_3/3	3	10	7515	LONGTERM|DICTIONARY	xrcc1	XRCC1	52#57		With the inadequate polymorphic DNA repair protein, XRCC1, this situation ultimately leads to significantly increased susceptibility for childhood ALL.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_2/3	2	7	3565	SYMBOL|DICTIONARY	interleukin (il)-4	interleukin (IL)-4	100#118		Dicloxacillin administration induced Th2 (helper T cells)-mediated factors and increased the plasma interleukin (IL)-4 level.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	9	9464	LONGTERM|DICTIONARY	th2	Th2	58#61		Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) is a cognate receptor for prostaglandin (PG) D(2), and is suggested to be involved in Th2-dependent allergic inflammation.
21966456	2012	PLoS ONE	1932-6203	BACKGROUND	1	1	5733	SYMBOL|()|GENE|GN|DICTIONARY|EXTRACTED	e receptor 3 (ep3)	E receptor 3 (EP3)	263#281	21966456-1-249-275	In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms.
20674764	2011	Microbes Infect.	1769-714X	TITLE	0	0	51311	LONGTERM|DICTIONARY	toll-like receptor 8 and 9	Toll-like receptor 8 and 9	0#26		Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
20674764	2011	Microbes Infect.	1769-714X	TITLE	0	0	54106	LONGTERM|DICTIONARY	toll-like receptor 8 and 9	Toll-like receptor 8 and 9	0#26		Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
20513754	2010	Toxicol. Sci.	1096-0929	ALL_TEXT_2/3	2	4	3454	SYMBOL|DICTIONARY	ifnar-	IFNAR-	45#51		Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	6	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		LEP I/G combined genotypes (I/IGG, I/IGA and I/IIGG) were associated with obesity, and increased BMI, waist circumference, leptin and triglycerides (p < 0.05).
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	RESULTS	3	8	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		LEP I/G combined genotypes were not associated with hypertension, hyperglycemia, dyslipidemia and coronary artery disease.
20520958	2010	Arq Bras Endocrinol Metabol	1677-9487	CONCLUSIONS	4	9	3952	SYMBOL|DICTIONARY	lep	LEP	0#3		LEP I/G combined genotypes are associated with obesity-related metabolic biomarkers and phenotype in a gender-dependent manner.
9391065	1998	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	6010	LONGTERM|DICTIONARY	rhodopsin	rhodopsin	143#152		The 11-cis C19 retinylamine analog 1 inhibits constitutive activation of transducin by these mutants and their constitutive phosphorylation by rhodopsin kinase, and it does so in the presence of continuous illumination from room lights.
9236417	1997	Circulation	0009-7322	METHODS AND RESULTS	2	4	1636	SYMBOL|DICTIONARY	ace	ACE	48#51		We investigated a possible relation between the ACE I/D polymorphism and restenosis in 146 patients who underwent successful implantation of a Palmaz-Schatz stent and had 6-month follow-up angiography.
9236417	1997	Circulation	0009-7322	CONCLUSIONS	3	9	1636	SYMBOL|DICTIONARY	ace	ACE	4#7		The ACE I/D polymorphism influences the level of late luminal loss after coronary stent implantation.
9158107	1997	Clin. Exp. Immunol.	0009-9104	TITLE	0	0	5196	LONGTERM|DICTIONARY	anti-platelet factor 4	anti-platelet factor 4	23#45		Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
8942447	1997	Am J Psychiatry	0002-953X	OBJECTIVE	1	1	3123	SYMBOL|DICTIONARY	leukocyte antigen (hla) drb1	leukocyte antigen (HLA) DRB1	35#63		The authors investigated the human leukocyte antigen (HLA) DRB1*04 gene in schizophrenic patients because it is positively associated with rheumatoid arthritis, an autoimmune disease that exhibits a strong negative association with schizophrenia.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	3481	LONGTERM|DICTIONARY	insulin-like growth factor ii (igf-ii	Insulin-like growth factor II (IGF-II	0#37		Insulin-like growth factor II (IGF-II) is a mitogen for many cell types and an important modulator of muscle growth and differentiation.
7981680	1995	Hum. Mol. Genet.	0964-6906	ALL_TEXT_1/3	1	1	3481	SYMBOL|()|DICTIONARY|EXTRACTED	insulin-like growth factor ii (igf-ii	Insulin-like growth factor II (IGF-II	0#37	7981680-1-0-29	Insulin-like growth factor II (IGF-II) is a mitogen for many cell types and an important modulator of muscle growth and differentiation.
23440206	2013	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	3	1956	SYMBOL|GENE|GN|DICTIONARY	egf receptor	EGF receptor	27#39		Direct mTOR inhibitors and EGF receptor (EGFR) inhibitors that block downstream mTOR signaling promote nuclear PML expression in GBMs, and genetic overexpression and knockdown approaches demonstrate that PML prevents mTOR and EGFR inhibitor-dependent cell death.
10318961	1999	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	6	1268	LONGTERM|DICTIONARY	cb1	CB1	91#94	NaN	Delta9-THC-induced ring-catalepsy, hypomobility, and hypothermia were completely absent in CB1 mutant mice.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	145258	LONGTERM|DICTIONARY	gsc	Gsc	19#22	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	3	14910	LONGTERM|DICTIONARY	rosa26	ROSA26	100#106	NaN	In these chimeras, Gsc-null cells were marked with beta-galactosidase (beta-gal) activity using the ROSA26 lacZ allele.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	1	145258	LONGTERM|DICTIONARY	goosecoid	Goosecoid	61#70	NaN	Mice homozygous for a targeted deletion of the homeobox gene Goosecoid (Gsc) have multiple craniofacial defects.
10433910	1999	Development	0950-1991	ALL_TEXT_1/3	1	1	145258	LONGTERM|DICTIONARY	gsc	Gsc	72#75	NaN	Mice homozygous for a targeted deletion of the homeobox gene Goosecoid (Gsc) have multiple craniofacial defects.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3117	LONGTERM|DICTIONARY	dqa1	DQA1	19#23	NaN	HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11157139	2001	Rheumatology (Oxford)	1462-0324	METHODS	2	2	3119	LONGTERM|DICTIONARY	dqb1	DQB1	10#14	NaN	HLA DRB1, DQB1 and DQA1 genotypes were determined by the polymerase chain reaction using sequence-specific primers in 83 Caucasoid British patients with APS.
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3117	LONGTERM|DICTIONARY	dqa1	DQA1	18#22	NaN	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3117	LONGTERM|DICTIONARY	dqa1	DQA1	52#56	NaN	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	0#4	NaN	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	42#46	NaN	DQB1*0604/5/6/7/9-DQA1*0102-DRB1*1302 and DQB1*0303-DQA1*0201-DRB1*0701 haplotypes showed significantly positive correlations with APS [P=0.0087 and P=0.0012, respectively].
11157139	2001	Rheumatology (Oxford)	1462-0324	RESULTS	3	5	350	LONGTERM|DICTIONARY	beta 2gpi	beta 2GPI	116#125	NaN	The association of the former was enhanced in primary APS patients with anti-beta 2-glycoprotein I antibodies (anti-beta 2GPI) [odds ratio 6.2, 95% confidence interval (2.2-17.6), P=0.0014, corrected P=0.042].
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	165#169	NaN	In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	4	3119	LONGTERM|DICTIONARY	dqb1	DQB1	97#101	NaN	As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602.
11179016	2001	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	3119	LONGTERM|DICTIONARY	dqb1	DQB1	68#72	NaN	Relative risks for narcolepsy were next calculated for heterozygous DQB1*0602/other HLA class II allelic combinations.
11357375	2001	Genetika	0016-6758	ALL_TEXT_1/3	1	1	2876	LONGTERM|DICTIONARY	gpx1	GPX1	143#147	NaN	Allelic and genotypic distributions of the polymorphic markers C1167T and Pro197Leu of the genes of catalase (CAT) and glutathione peroxidase (GPX1), respectively, were studied in patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypertension without complications (the control group, n = 52) and with complications: myocardial infarction (MI, n = 53) or stroke (n = 50).
11397889	2001	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	4843	LONGTERM|DICTIONARY	inducible nitric oxide synthase	inducible nitric oxide synthase	21#52	NaN	Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes.
11450852	2001	J. Hum. Genet.	1434-5161	TITLE	0	0	2778	LONGTERM|DICTIONARY	gsalpha	Gsalpha	21#28	NaN	Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia.
11450852	2001	J. Hum. Genet.	1434-5161	ALL_TEXT_2/3	2	3	2778	LONGTERM|DICTIONARY	gsalpha	Gsalpha	113#120	NaN	Here, a novel frameshift mutation (delG at codon 88) in exon 4, and a missense mutation (R231H) in exon 9 of the Gsalpha gene were identified in two Japanese patients with sporadic PHP-Ia.
11450852	2001	J. Hum. Genet.	1434-5161	ALL_TEXT_3/3	3	7	2778	LONGTERM|DICTIONARY	gsalpha	Gsalpha	25#32	NaN	We report here one novel Gsalpha mutation, and note that mutations in Japanese patients with PHP-Ia are probably heterogeneous.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	8#11	NaN	Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
11556548	2001	J. Neuropathol. Exp. Neurol.	0022-3069	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	46#49	NaN	Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_2/3	2	5	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	94#103	NaN	Mutations occurred in 80% +/- and 75% +/+ carcinomas, but in only 50% of the adenomas of both TGF-beta1 genotypes.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	1026	LONGTERM|DICTIONARY	p21	p21	95#98	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	89#94	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	104#109	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	k-ras	K-ras	262#267	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	40#49	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	218#227	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	311#320	NaN	Since the growth inhibitory activity of TGF-beta1 in epithelial cells is associated with K-ras p21, and K-ras mutations commonly occur in chemically-induced mouse lung tumors, we postulated that tumors in heterozygous TGF-beta1 mice might be more likely to have K-ras mutations compared with tumors in wildtype TGF-beta1 mice.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	3	3845	LONGTERM|DICTIONARY	k-ras	K-ras	83#88	NaN	Urethane-induced lung tumors in AJBL6 TGF-beta1 +/- and +/+ mice were examined for K-ras mutations by polymerase chain reaction/single strand conformation polymorphism analysis and sequencing.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_1/3	1	3	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	38#47	NaN	Urethane-induced lung tumors in AJBL6 TGF-beta1 +/- and +/+ mice were examined for K-ras mutations by polymerase chain reaction/single strand conformation polymorphism analysis and sequencing.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_3/3	3	10	3845	LONGTERM|DICTIONARY	k-ras	K-ras	172#177	NaN	It appears that the mechanism of enhanced susceptibility of TGF-beta1+/- mice to urethane-induced lung carcinogenesis does not involve selective development of tumors with K-ras mutations.
11641043	2002	Toxicol. Lett.	0378-4274	ALL_TEXT_3/3	3	10	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	60#69	NaN	It appears that the mechanism of enhanced susceptibility of TGF-beta1+/- mice to urethane-induced lung carcinogenesis does not involve selective development of tumors with K-ras mutations.
11719088	2002	Mutat. Res.	0027-5107	TITLE	0	0	3845	LONGTERM|DICTIONARY	k-ras	K-ras	40#45	NaN	DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.
11719088	2002	Mutat. Res.	0027-5107	ALL_TEXT_3/3	3	8	3845	LONGTERM|DICTIONARY	k-ras	K-ras	28#33	NaN	Mutation at codon 12 of the K-ras gene was found in 25 (81%) of 31 pancreatic tumors, including three G-to-A transitions and 22 G-to-T transversions.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	6	338	LONGTERM|DICTIONARY	apob	apoB	72#76	NaN	Individuals with hyperlipidemia at baseline and/or follow-up had higher apoB levels than those with consistently normal lipids (P<0.05), whereas small LDL size was associated with concurrent hyperlipidemia.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apoe	apoE	238#242	NaN	Among individuals who were normolipidemic at baseline, the following variables were independently associated with development of hyperlipidemia over 20 years: older age at baseline, male sex, greater increase in BMI during follow-up, and apoE alleles epsilon 2 or epsilon 4.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	338	LONGTERM|DICTIONARY	apob	apoB	15#19	NaN	In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11730829	2002	Atherosclerosis	0021-9150	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apoe	apoE	58#62	NaN	In conclusion, apoB is associated with hyperlipidemia and apoE polymorphism is associated with later onset of hyperlipidemia in FCHL.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	104#111	NaN	In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	158#165	NaN	In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	3630	LONGTERM|DICTIONARY	insulin	insulin	218#225	NaN	In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_1/3	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	148#151	NaN	In 141 Caucasian girls, who presented with precocious pubarche, hyperinsulinemia was assessed from mean insulin levels during an oral glucose load (MSI), and insulin sensitivity was determined from fasting glucose and insulin levels.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	7	5928	LONGTERM|DICTIONARY	msi	MSI	168#171	NaN	However among precocious pubarche girls, INS VNTR genotype was related to the severity of phenotype; I/I and I/III genotypes had lower birth weights (P < 0.01), higher MSI (P < 0.005), and lower insulin sensitivity (P < 0.005) than III/III girls.
11739440	2001	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	8	5928	LONGTERM|DICTIONARY	msi	MSI	73#76	NaN	In precocious pubarche girls, birth weight was also inversely related to MSI (r = -0.29; P < 0.0005), total cholesterol (r = -0.38; P < 0.0005), and low density lipoprotein cholesterol (r = -0.44; P < 0.0005).
11756990	2002	J. Infect. Dis.	0022-1899	ALL_TEXT_1/3	1	2	3126	LONGTERM|DICTIONARY	leukocyte antigen (hla) class ii	leukocyte antigen (HLA) class II	36#68	NaN	In order to determine whether human leukocyte antigen (HLA) class II polymorphisms modulate anti-influenza antibody responses to vaccination, a cohort of HLA-typed at-risk donors was investigated.
11895223	2002	Clin. Endocrinol. (Oxf)	0300-0664	CONCLUSIONS	4	9	3117	LONGTERM|DICTIONARY	dqa1	DQA1	171#175	NaN	Jamaican patients with Graves' disease share the DRB3 *0101 susceptible allele and the DRB4 *01 protective allele but not the susceptible haplotype DRB1 *0301, DRB3*0101, DQA1*0501 with Caucasians.
11948460	2002	Int. J. Cancer	0020-7136	TITLE	0	0	999	LONGTERM|DICTIONARY	e-cadherin	E-cadherin	22#32	NaN	Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	4	3569	LONGTERM|DICTIONARY	il-6	IL-6	40#44	NaN	The results showed the frequency of the IL-6prom G allele was significantly increased in AD, although IL-6vntr polymorphism was not.
11992567	2002	Am. J. Med. Genet.	0148-7299	ALL_TEXT_2/3	2	4	3569	LONGTERM|DICTIONARY	il-6	IL-6	102#106	NaN	The results showed the frequency of the IL-6prom G allele was significantly increased in AD, although IL-6vntr polymorphism was not.
12006918	2002	J Cardiovasc Risk	1350-6277	DESIGN AND METHODS	2	3	3990	LONGTERM|DICTIONARY	hl	HL	11#13	NaN	We studied HL -514 C/T in 562 Caucasian CHD patients aged under 50 years and in 642 Caucasian community recruited subjects without historical evidence of CHD.
12007670	2002	Eur Neuropsychopharmacol	0924-977X	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.
12034804	2002	Neurology	0028-3878	TITLE	0	0	3552	LONGTERM|DICTIONARY	interleukin-1	interleukin-1	4#17	NaN	Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
12081984	2002	Circulation	1524-4539	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Témoins de l'Infarctus du Myocarde (ECTIM).
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	5	7157	LONGTERM|DICTIONARY	p53	p53	65#68	NaN	We also performed immunostaining analysis for estrogen receptor, p53, MIB-1 and c-erbB-2 on all the tumors.
12168876	2002	Anticancer Res.	0250-7005	ALL_TEXT_3/3	3	6	7157	LONGTERM|DICTIONARY	p53	p53	150#153	NaN	At the time of diagnosis, the A-AA allele occurred more frequently in the tumors characterized by small tumor size, good to moderate differentiation, p53-negativity and low tumor proliferation activity.
12170472	2002	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	54578	LONGTERM|DICTIONARY	udp-glucuronosyltransferase 1f	UDP-glucuronosyltransferase 1F	25#55	NaN	[Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_2/3	2	6	348	LONGTERM|DICTIONARY	apo e	apo E	41#46	NaN	Multivariate analysis indicated an age x apo E interaction on postprandial TG (P <.01), since the unfavorable effect of E2 and E4 allele on TG AUIC was unmasked by aging.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	7	348	LONGTERM|DICTIONARY	apo e	apo E	28#33	NaN	In addition, a fasting TG x apo E interaction on postprandial TG was shown (P <.01), and the correlation between fasting TG and TG AUIC was actually restricted to E2 or E4 carriers.
12200750	2002	Metab. Clin. Exp.	0026-0495	ALL_TEXT_3/3	3	9	348	LONGTERM|DICTIONARY	apo e	apo E	42#47	NaN	Our results indicate interactions between apo E polymorphism and aging, fasting TG level and BMI that may be important for analyzing postprandial TG clearance in NIDDM.
12209087	2002	J. Allergy Clin. Immunol.	0091-6749	ALL_TEXT_1/3	1	3	3497	LONGTERM|DICTIONARY	ige	IgE	116#119	NaN	The aim of this study was to investigate association of a CA-repeat marker in this gene with asthma and total serum IgE levels in the North Indian population.
12358323	2003	Eur. Respir. J.	0903-1936	ALL_TEXT_3/3	3	8	659	LONGTERM|DICTIONARY	bone morphogenetic protein receptor 2	bone morphogenetic protein receptor 2	49#86	NaN	In conclusion, the present authors have detected bone morphogenetic protein receptor 2 mutations that appear to be rare in the general population but may combine with exposure to fenfluramine derivatives to greatly increase the risk of developing severe pulmonary arterial hypertension.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	11#14	NaN	Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p16	p16	60#63	NaN	Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	127#130	NaN	Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_3/3	3	8	1029	LONGTERM|DICTIONARY	p14	p14	137#140	NaN	Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases.
12378512	2002	Hum. Pathol.	0046-8177	TITLE	0	0	7157	LONGTERM|DICTIONARY	p53	p53	25#28	NaN	Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	1029	LONGTERM|DICTIONARY	p14	p14	15#18	NaN	Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12378512	2002	Hum. Pathol.	0046-8177	ALL_TEXT_1/3	1	3	1029	LONGTERM|DICTIONARY	p16	p16	25#28	NaN	Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing.
12394840	2002	Transplantation	0041-1337	BACKGROUND	1	5	348	LONGTERM|DICTIONARY	apo e2	Apo E2	0#6	NaN	Apo E2 has also been found to increase risk of diabetic nephropathy and so may be more prevalent in PTX candidates.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	5327	LONGTERM|DICTIONARY	t-pa	t-PA	140#144	NaN	The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for t-PA or the plasma concentration of t-PA antigen.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_1/3	1	2	5327	LONGTERM|DICTIONARY	t-pa	t-PA	176#180	NaN	The present study examined whether there was an association between essential hypertension and either a polymorphism in the gene coding for t-PA or the plasma concentration of t-PA antigen.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	7	5327	LONGTERM|DICTIONARY	t-pa	t-PA	61#65	NaN	There was no evidence of an association between the level of t-PA antigen and risk of hypertension.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	8	5327	LONGTERM|DICTIONARY	t-pa	t-PA	117#121	NaN	Thus, in this case control study, neither the presence of the insertion allele of the Alu-repeat polymorphism of the t-PA nor the level of t-PA antigen were associated with the risk of essential hypertension.
12484521	2003	Hypertens. Res.	0916-9636	ALL_TEXT_3/3	3	8	5327	LONGTERM|DICTIONARY	t-pa	t-PA	139#143	NaN	Thus, in this case control study, neither the presence of the insertion allele of the Alu-repeat polymorphism of the t-PA nor the level of t-PA antigen were associated with the risk of essential hypertension.
12492589	2003	Br. J. Haematol.	0007-1048	TITLE	0	0	2212	LONGTERM|DICTIONARY	fcgamma receptor iia	Fcgamma receptor IIa	0#20	NaN	Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	45#52	NaN	We have examined the frequency of these four ERalpha variations in a case control study using a group of mixed gender bipolar individuals (N = 231), further classified into subsets of parous bipolar females with (N = 112) and without (N = 50) puerperal psychosis, and a non-psychiatric comparison group (N = 110).
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	5	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	89#96	NaN	We found no evidence in our case control sample to support the involvement of any of the ERalpha variations in either the aetiology of bipolar disorder or puerperal triggering of bipolar episodes.
12627470	2003	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	87#94	NaN	We conclude that variation in the coding sequence and flanking splice junctions of the ERalpha gene does not play an important pathogenic role in the majority of cases of Bipolar Disorder or Bipolar Affective Puerperal Psychosis.
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	11	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	129#161	NaN	In parallel, decreased deposition of extracellular matrix and lessened interstitial fibrosis as well as reduced amounts of renal transforming growth factor-beta1 (TGF-beta1) could be demonstrated.
12631109	2004	Kidney Int.	0085-2538	RESULTS	3	11	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	163#172	NaN	In parallel, decreased deposition of extracellular matrix and lessened interstitial fibrosis as well as reduced amounts of renal transforming growth factor-beta1 (TGF-beta1) could be demonstrated.
12669197	2004	Diabetologia	0012-186X	TITLE	0	0	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	18#28	NaN	T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects.
12669197	2004	Diabetologia	0012-186X	AIMS/HYPOTHESIS	1	1	3172	LONGTERM|DICTIONARY	hepatocyte nuclear factor (hnf)-4alpha	hepatocyte nuclear factor (HNF)-4alpha	13#51	NaN	Mutations in hepatocyte nuclear factor (HNF)-4alpha gene cause a form of maturity-onset diabetes of the young (MODY1).
12669197	2004	Diabetologia	0012-186X	METHODS	2	5	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	154#164	NaN	We screened 423 unrelated Japanese patients with late-onset Type 2 diabetes and 354 unrelated non-diabetic control subjects for the T130I mutation in the HNF-4alpha gene.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	10	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	32#42	NaN	Our findings suggest that T130I-HNF-4alpha is a loss-of-function mutation in hepatocytes and that this mutation is associated with late-onset Type 2 diabetes in Japanese subjects.
12669197	2004	Diabetologia	0012-186X	CONCLUSION/INTERPRETATION	4	11	3172	LONGTERM|DICTIONARY	hnf-4alpha	HNF-4alpha	26#36	NaN	The T130I mutation in the HNF-4alpha gene might be involved in the development of Type 2 diabetes in the Japanese population.
12699434	2003	Clin. Endocrinol. (Oxf)	0300-0664	TITLE	0	0	1392	LONGTERM|DICTIONARY	corticotrophin-releasing hormone	corticotrophin-releasing hormone	30#62	NaN	Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing's disease.
12800193	2003	Int. J. Cancer	0020-7136	ALL_TEXT_1/3	1	2	3845	LONGTERM|DICTIONARY	ki-ras	ki-ras	219#225	NaN	To characterize the CC531 model at the molecular level, we screened for mutations in genes covering important signal-transduction pathways that are known to play major roles during colon carcinogenesis, the wnt and the ki-ras signaling pathways.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	5	7040	LONGTERM|DICTIONARY	tgfbeta1	TGFbeta1	12#20	NaN	Total serum TGFbeta1 levels were similar in affected and unaffected subjects, but concentrations of active TGFbeta1 in conditioned medium of osteoclast cultures was higher in the three CED patients than in the unaffected family member.
12843182	2003	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	5	7040	LONGTERM|DICTIONARY	tgfbeta1	TGFbeta1	107#115	NaN	Total serum TGFbeta1 levels were similar in affected and unaffected subjects, but concentrations of active TGFbeta1 in conditioned medium of osteoclast cultures was higher in the three CED patients than in the unaffected family member.
12880539	2004	Ann. Clin. Biochem.	0004-5632	CONCLUSION	4	9	348	LONGTERM|DICTIONARY	apo e4	apo E4	37#43	NaN	Based on the robust association, the apo E4 allele should be considered as an independent risk factor for premature MI in Asian Indians.
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	2	3009	LONGTERM|DICTIONARY	h1/h2	H1/H2	100#105	NaN	The authors show that this polymorphism is in complete linkage disequilibrium with the extended tau H1/H2 haplotype and that the Q variant and QQ genotype of Q7R are strongly associated with progressive supranuclear palsy, implicating it as a possibly important pathogenic candidate.
12913211	2004	Neurology	1526-632X	ALL_TEXT	1	2	6019	LONGTERM|DICTIONARY	h1/h2	H1/H2	100#105	NaN	The authors show that this polymorphism is in complete linkage disequilibrium with the extended tau H1/H2 haplotype and that the Q variant and QQ genotype of Q7R are strongly associated with progressive supranuclear palsy, implicating it as a possibly important pathogenic candidate.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	2	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	Myotrophin is a myocardial hypertrophy-inducing factor initially demonstrated in hypertrophied and cardiomyopathic hearts.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	TITLE	0	0	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	Myotrophin in human heart failure.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	OBJECTIVES	1	1	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	59#69	NaN	The goal of this study was to investigate plasma levels of myotrophin in heart failure (HF) and their relationship to gender and disease severity.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	3	4790	LONGTERM|DICTIONARY	nuclear factor kappa b	nuclear factor kappa B	70#92	NaN	Recent evidence suggests an interaction with the transcription factor nuclear factor kappa B (NFkappaB), which is activated in HF and modulates myocardial protein expression.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	BACKGROUND	2	3	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	94#102	NaN	Recent evidence suggests an interaction with the transcription factor nuclear factor kappa B (NFkappaB), which is activated in HF and modulates myocardial protein expression.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	METHODS	3	7	136319	LONGTERM|DICTIONARY	myotrophin	Myotrophin	0#10	NaN	Myotrophin was measured in plasma extracts of 120 HF patients and 130 age- and gender-matched normal controls.
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	RESULTS	4	9	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	15#25	NaN	Log normalized myotrophin levels were significantly elevated in HF patients (mean +/- SEM [geometric mean, range], 2.402 +/- 0.021 [252, 72 to 933] vs. 2.268 +/- 0.021 [185, 28 to 501] fmol/ml, p < 0.0005).
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	RESULTS	4	11	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	44#54	NaN	However, males with HF had higher levels of myotrophin than females (p < 0.001).
12932609	2003	J. Am. Coll. Cardiol.	0735-1097	CONCLUSIONS	5	13	136319	LONGTERM|DICTIONARY	myotrophin	myotrophin	45#55	NaN	There is evidence of early activation of the myotrophin system in HF, which is more evident in males.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	3126	LONGTERM|DICTIONARY	dr4	DR4	167#170	NaN	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	8	8795	LONGTERM|DICTIONARY	dr5	DR5	176#179	NaN	When MS patients and healthy control subjects were stratified according to HLA-DRB1 phenotypes, a significant association of MS with MBP alleles was found only in the DR4- and DR5-positive subgroups.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	3126	LONGTERM|DICTIONARY	dr4	DR4	130#133	NaN	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
12939427	2004	Neurology	1526-632X	RESULTS	4	9	8795	LONGTERM|DICTIONARY	dr5	DR5	139#142	NaN	A significant association with MBP alleles was also observed in the nonstratified groups, owing mainly to the contribution of the DR4- and DR5-positive individuals.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	3126	LONGTERM|DICTIONARY	dr4	DR4	121#124	NaN	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	CONCLUSION	5	10	8795	LONGTERM|DICTIONARY	dr5	DR5	130#133	NaN	Polymorphism of the MBP or another gene in its vicinity appears to contribute to the etiology of MS for the subgroups of DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	TITLE	0	0	3126	LONGTERM|DICTIONARY	dr4	DR4	51#54	NaN	Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12939427	2004	Neurology	1526-632X	TITLE	0	0	8795	LONGTERM|DICTIONARY	dr5	DR5	60#63	NaN	Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians.
12948282	2003	Cancer Causes Control	0957-5243	TITLE	0	0	6648	LONGTERM|DICTIONARY	manganese superoxide dismutase	Manganese superoxide dismutase	0#30	NaN	Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
1363805	1993	Hum. Mutat.	1059-7794	ALL_TEXT_1/3	1	1	34	LONGTERM|DICTIONARY	medium chain acyl-coa dehydrogenase	Medium chain acyl-CoA dehydrogenase	0#35	NaN	Medium chain acyl-CoA dehydrogenase (MCAD) catalyzes the first reaction of the beta-oxidation cycle for 4-10-carbon fatty acids.
14521605	2004	J. Thromb. Haemost.	1538-7933	TITLE	0	0	2811	LONGTERM|DICTIONARY	glycoprotein ibalpha	glycoprotein Ibalpha	53#73	NaN	Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	128#137	NaN	Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha.
14521605	2004	J. Thromb. Haemost.	1538-7933	BACKGROUND	1	3	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	26#35	NaN	To date, two mutations in GPIbalpha, G233V and M239V, have been reported in four unrelated families with plt-VWD.
14521605	2004	J. Thromb. Haemost.	1538-7933	OBJECTIVE	2	4	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	54#63	NaN	The present study aimed to determine whether G233S of GPIbalpha, a new mutation observed in plt-VWD patients, causes the plt-VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	24#28	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	75#79	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3117	LONGTERM|DICTIONARY	dqa1	DQA1	129#133	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	35#39	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	86#90	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14567462	2004	Dig Liver Dis	1590-8658	RESULTS	3	3	3119	LONGTERM|DICTIONARY	dqb1	DQB1	138#142	NaN	Frequencies of DRB1*01, DQA1*0101, DQB1*0102 (14 vs. 8%, p<0.05), DRB1*16, DQA1*0102, DQB1*0502 (8 vs. 3%, p<0.025) and DRB1*04, DQA1*03, DQB1*0301 (10 vs. 4%, p<0.005) haplotypes were more elevated in PSC patients.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	OBJECTIVES	2	3	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	51#59	NaN	To investigate non-anglosaxic ethnic influences on beta 2AR polymorphisms and its correlations to asthma severity.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	METHODS	3	4	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	175#183	NaN	Sixty-six Israeli Jewish and Arab asthmatics who had near-fatal asthma and/or severe nocturnal asthma and/or steroid-dependency were investigated for genetic polymorphisms of beta 2AR and compared to matched controls.
14650112	2004	Isr. Med. Assoc. J.	1565-1088	CONCLUSIONS	5	9	154	LONGTERM|DICTIONARY	beta 2ar	beta 2AR	28#36	NaN	The genetic distribution of beta 2AR polymorphisms in severe Israeli asthmatics is not different from that of non-asthmatic Israelis and therefore its clinical impact on asthma is probably minimal.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_1/3	1	1	5925	LONGTERM|DICTIONARY	prb	pRB	52#55	NaN	The expressions of E2F1 and retinoblastoma protein (pRB) were analyzed in 165 lymph node-positive breast cancers.
14672398	2004	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	5925	LONGTERM|DICTIONARY	prb	pRB	47#50	NaN	E2F1 expression was significantly increased in pRB-expressing tumors and was associated with an S-phase fraction.
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	28938	LONGTERM|DICTIONARY	l-1	L-1	92#95	NaN	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	7	28938	LONGTERM|DICTIONARY	l-1	L-1	144#147	NaN	For all MTHFR genotypes combined, the OR for MI in the lowest quartile of folate (<5.4 nmol L-1) compared with the highest quartile (>10.4 nmol L-1) was 3.0 (95% CI 1.7, 5.1).
14717963	2004	J. Thromb. Haemost.	1538-7933	ALL_TEXT_2/3	2	8	28938	LONGTERM|DICTIONARY	l-1	L-1	121#124	NaN	A 2-fold increased risk of MI was found in women with the TT genotype who had folate levels below the median of 7.4 nmol L-1 compared with CC genotype and folate levels above the median (OR = 2.0; 95% CI 1.0, 3.7).
14763782	2004	Acta Odontol. Scand.	0001-6357	ALL_TEXT_1/3	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	Interferon (IFN)-gamma	0#22	NaN	Interferon (IFN)-gamma is a cytokine that plays a pivotal role in the defense against infection, and mutations in the gene coding for the ligand binding chain (alpha, R1) of the IFN-gamma receptor (IFNGR1) confer suseptibility on infections caused by poorly virulent mycobacteria.
15024131	2004	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	ALL_TEXT_3/3	3	7	925	LONGTERM|DICTIONARY	cd8	CD8	178#181	NaN	Individuals with abacavir hypersensitivity demonstrated increased monocyte tumor necrosis factor expression in response to ex vivo abacavir stimulation, which was abrogated with CD8(+) T cell depletion.
15048896	2004	Ann. Neurol.	0364-5134	ALL_TEXT_2/3	2	4	348	LONGTERM|DICTIONARY	apoe	ApoE	34#38	NaN	Ninety-nine MS patients underwent ApoE genotyping, clinical examination, and magnetic resonance imaging at baseline and after 2.7 +/- 1.1 years to assess lesion load (LL) and BVC.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_1/3	1	2	51497	LONGTERM|DICTIONARY	th1	Th1	39#42	NaN	Evidence suggests that an imbalance in Th1/Th2 responses may play a key role in the development of autoimmune diabetes.
15057267	2005	Genes Immun.	1466-4879	ALL_TEXT_3/3	3	5	3587	LONGTERM|DICTIONARY	il-10r	IL-10R	93#99	NaN	Three promoter polymorphisms (-1082G/A, -819C/T, -592C/A) and two CA-repeat microsatellites (IL-10R and IL-10G at -4 and -1.1 kb) were tested in a case-control study with 294 T1D patients and 574 healthy controls.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_1/3	1	3	672	LONGTERM|DICTIONARY	brca	BRCA	37#41	NaN	We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients.
15082902	2004	J. Korean Med. Sci.	1011-8934	ALL_TEXT_3/3	3	9	672	LONGTERM|DICTIONARY	brca	BRCA	28#32	NaN	These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.
15142050	2004	Clin Transplant	0902-0063	RESULTS	3	14	348	LONGTERM|DICTIONARY	apo e	apo E	165#170	NaN	Multiple regression analysis showed that allograft functions were negatively correlated with elevated acute phase reactants (p < 0.01) and only the age, but not the apo E genotypes, was an independent risk factor for atherosclerotic vascular disease (p < 0.01).
15142050	2004	Clin Transplant	0902-0063	DISCUSSION	4	17	348	LONGTERM|DICTIONARY	apo e4	apo E4	21#27	NaN	The ultimate role of apo E4 gene polymorphism as a risk factor for development and progression of atherosclerosis in RTRs should be sought in further studies.
15189946	2004	Chest	0012-3692	STUDY OBJECTIVES	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	interferon (IFN)-gamma	124#146	NaN	We explored a possible association between TNF-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta, and interferon (IFN)-gamma cytokine polymorphisms, their in vivo production, and mortality from cardiogenic shock.
15189946	2004	Chest	0012-3692	MEASUREMENTS AND RESULTS	6	12	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	213#222	NaN	There were no significant differences in TNF-2 polymorphism between the patients with cardiogenic shock and a group of healthy control subjects (7 of 33 patients vs 13 of 48 subjects, respectively; p = 0.61), but IFN-gamma polymorphism was less common in the cardiogenic shock group (p = 0.034).
15279649	2004	Eur. J. Oral Sci.	0909-8836	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	71#80	NaN	As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis.
15287851	2005	Liver Int.	1478-3223	RESULTS	3	8	28924	LONGTERM|DICTIONARY	a2-4	A2-4	83#87	NaN	For C282Y heterozygous patients, the odds ratios for marked inflammatory activity (A2-4) and advanced liver fibrosis or cirrhosis (F2-4) are 4.9 and 4.6, respectively, compared with patients carrying homozygous wild-type alleles.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	TITLE	0	0	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	111#122	NaN	Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_2/3	2	4	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	116#127	NaN	The aim of this study was to investigate the putative influence of the PPAR-gamma gene Pro12Ala polymorphism on the adiponectin levels in PCOS and healthy women.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	10	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	36#47	NaN	No significant differences in serum adiponectin concentrations were observed between and within genotype groups in PCOS and control women.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	40#51	NaN	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
15472214	2004	J. Clin. Endocrinol. Metab.	0021-972X	ALL_TEXT_3/3	3	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	180#191	NaN	In conclusion, our results confirm that adiponectin concentrations are similar in PCOS and controls and demonstrate no effect of the PPAR-gamma gene Pro12Ala polymorphism on serum adiponectin levels.
15523642	2005	Hum. Mutat.	1098-1004	TITLE	0	0	4763	LONGTERM|DICTIONARY	nf1	NF1	142#145	NaN	Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_1/3	1	3	4763	LONGTERM|DICTIONARY	nf1	NF1	193#196	NaN	Using cDNA-based mutation detection analysis, we have identified one missense and six nonsense mutations that lead to different extents of exon-lacking transcripts in neurofibromatosis type 1 (NF1) patients.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_2/3	2	6	4763	LONGTERM|DICTIONARY	nf1	NF1	48#51	NaN	Therefore, we examined the wild-type and mutant NF1 sequences with two available ESE-prediction programs.
15523642	2005	Hum. Mutat.	1098-1004	ALL_TEXT_3/3	3	9	4763	LONGTERM|DICTIONARY	nf1	NF1	165#168	NaN	Our results suggest that the wild-type sequences function as ESE elements, whose disruption is responsible for the mutation-associated exon skipping observed in the NF1 patients.
15660776	2005	Epilepsia	0013-9580	CONCLUSIONS	4	8	348	LONGTERM|DICTIONARY	apoe	ApoE	111#115	NaN	These results provide evidence for an alteration in cognitive performance as a function of the presence of the ApoE epsilon4 allele and point to the critical role of disease duration itself for cognitive impairment in TLE.
15660776	2005	Epilepsia	0013-9580	RESULTS	3	6	348	LONGTERM|DICTIONARY	apoe	ApoE	18#22	NaN	The effect of the ApoE genotype was independent of both the age at epilepsy onset and disease duration as well as of a low educational level, which were separately associated with VLD (p values = 0.045, 0.001, and 0.001, respectively).
15660776	2005	Epilepsia	0013-9580	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy.
15660776	2005	Epilepsia	0013-9580	PURPOSE	1	1	348	LONGTERM|DICTIONARY	apoe	ApoE	60#64	NaN	To clarify the possible role of other factors including the ApoE epsilon4 allele for memory decline in temporal lobe epilepsy (TLE).
15660776	2005	Epilepsia	0013-9580	RESULTS	3	5	348	LONGTERM|DICTIONARY	apoe	ApoE	19#23	NaN	The presence of an ApoE epsilon4 allele was associated with an increased risk of VLD (OR, 4.18; 95% CI, 1.66-10.55).
15670652	2005	Neurosci. Lett.	0304-3940	TITLE	0	0	6622	LONGTERM|DICTIONARY	alpha-synuclein	alpha-synuclein	51#66	NaN	Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
15709194	2005	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	3	3439	LONGTERM|DICTIONARY	ifn-alpha	IFN-alpha	161#170	NaN	Ninety patients with stage IV melanoma were treated with biochemotherapy, including cisplatin, vinblastine, and dacarbazine combined with interleukin (IL)-2 and IFN-alpha either with or without tamoxifen.
15837080	2005	Int. J. Cardiol.	0167-5273	BACKGROUND	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	97#105	NaN	Thrombomodulin (TM) is the anticoagulant endothelial cell membrane-bound protein cofactor in the thrombin-mediated activation of protein C. Recently, conflicting data have been reported regarding the possible contribution of the TM -33G>A polymorphism to coronary artery disease (CAD) or myocardial infarction (MI) in some Asian populations.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	2	1524	LONGTERM|DICTIONARY	cx3cr1	CX3CR1	23#29	NaN	The M280 allele of the CX3CR1T280M polymorphism modulates leukocyte recruitment and is associated with lower prevalence of cardiovascular disease.
15886814	2005	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	6376	LONGTERM|DICTIONARY	fractalkine	fractalkine	53#64	NaN	Several lines of evidence suggest that the chemokine fractalkine (FKN) and its receptor CX3CR1 contribute to the accumulation of leukocytes in the atherosclerotic plaque.
15886814	2005	Thromb. Haemost.	0340-6245	TITLE	0	0	6376	LONGTERM|DICTIONARY	fractalkine	fractalkine	139#150	NaN	Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
15912506	2005	Ann. Neurol.	0364-5134	TITLE	0	0	5133	LONGTERM|DICTIONARY	pd-1	PD-1	2#6	NaN	A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	10	5133	LONGTERM|DICTIONARY	pd-1	PD-1	37#41	NaN	In conclusion, our data suggest that PD-1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD-1-mediated inhibition of T-cell activation.
15912506	2005	Ann. Neurol.	0364-5134	ALL_TEXT_3/3	3	10	5133	LONGTERM|DICTIONARY	pd-1	PD-1	149#153	NaN	In conclusion, our data suggest that PD-1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD-1-mediated inhibition of T-cell activation.
15987458	2006	Breast Cancer Res.	1465-542X	RESULTS	3	7	597	LONGTERM|DICTIONARY	a1/a1	A1/A1	88#93	NaN	The only associations near statistical significance were that postmenopausal women with A1/A1 (wild-type) genotype had an increased risk of breast cancer if they had ever used hormone replacement therapy (OR 2.40, 95% CI 1.0 to 5.7; P = 0.05) and if they had menopause after age 47 years (OR 2.59, 95% CI 1.0 to 7.0; P = 0.06).
16000320	2005	Hum. Mol. Genet.	0964-6906	TITLE	0	0	5795	LONGTERM|DICTIONARY	ptprj	Ptprj	65#70	NaN	Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	4	186	LONGTERM|DICTIONARY	at2	AT2	73#76	NaN	However, the interaction between taurine, angiotensin II type2 receptor (AT2) and cardiomyopathy related to angiotensin II is still unknown.
16025228	2005	Cardiovasc Drugs Ther	0920-3206	OBJECTIVE	1	5	186	LONGTERM|DICTIONARY	at2	AT2	49#52	NaN	This study investigates the roles of taurine and AT2 in rats with streptozotocin (STZ)-induced diabetic cardiomyopathy.
16053028	2005	Sarcoidosis Vasc Diffuse Lung Dis	1124-0490	BACKGROUND AND AIM	1	1	3119	LONGTERM|DICTIONARY	dqb1	DQB1	81#85	NaN	Sarcoidosis has been reported to be associated with the HLA genes, in particular DQB1.
16075239	2006	Eur Arch Otorhinolaryngol	0937-4477	ALL_TEXT_1/3	1	2	537	LONGTERM|DICTIONARY	cf2	CF2	318#321	NaN	Forty-four patients affected by nasal polyps were admitted to the Department of Otolaryngology, Lublin University School of Medicine, Lublin, Poland, and screened for the most-commonly identified CFTR mutations [DeltaF508, G542X, N1303 K, 1717-1 (G to A), W1282X, G551D, R553X and DeltaI507] by applying the INNO-LIPA CF2 test strips.
16094257	2005	Psychiatr. Genet.	0955-8829	TITLE	0	0	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	24#31	NaN	Association analysis of CHMP1.5 genetic variation and bipolar disorder.
16094257	2005	Psychiatr. Genet.	0955-8829	OBJECTIVES	1	2	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	143#150	NaN	We hypothesized that the linkage in this region might be due to a gene in close physical proximity to G-olf, and we examined variations in the CHMP1.5 gene within intron 5 of G-olf for association with bipolar disorder.
16094257	2005	Psychiatr. Genet.	0955-8829	CONCLUSIONS	4	7	57132	LONGTERM|DICTIONARY	chmp1.5	CHMP1.5	17#24	NaN	Variation in the CHMP1.5 gene does not appear to be associated with bipolar disorder.
16150646	2006	Clin. Immunol.	1521-6616	TITLE	0	0	2212	LONGTERM|DICTIONARY	fcgamma-receptor iia	Fcgamma-receptor IIA	0#20	NaN	Fcgamma-receptor IIA genotype and invasive pneumococcal infection.
16167465	2005	Neuropsychopharmacol Hung	1419-8711	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	78#99	NaN	Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	3	1230	LONGTERM|DICTIONARY	ccr1	CCR1	46#50	NaN	However, in pattern II lesions, the number of CCR1 cells is decreased, while the number of CCR5 expressing cells is increased in late active versus early active regions.
16182378	2006	J. Neuroimmunol.	0165-5728	ALL_TEXT_1/3	1	4	1234	LONGTERM|DICTIONARY	ccr5	CCR5	22#26	NaN	In contrast, CCR1 and CCR5 cells were equal in all regions of pattern III lesions.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	2353	LONGTERM|DICTIONARY	c-fos	c-fos	269#274	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
16259952	2006	Biochem. Biophys. Res. Commun.	0006-291X	ALL_TEXT_1/3	1	1	4609	LONGTERM|DICTIONARY	c-myc	c-myc	259#264	NaN	We evaluated the effects of d-myo-inositol 1,4,5-tris-phosphate on cardiac hypertrophy. d-myo-inositol 1,4,5-tris-phosphate augmented cardiac hypertrophy as evidenced by its effects on DNA synthesis, protein synthesis, and expression of immediate-early genes c-myc and c-fos, beta-myosin heavy chain, and alpha-actin.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3586	LONGTERM|DICTIONARY	il-10a	IL-10A	4#10	NaN	The IL-10A/A genotype is a predictable factor of microinflammatory state and high AS incidence rate in ESRD patients.
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	213	LONGTERM|DICTIONARY	alb	Alb	69#72	NaN	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	213	LONGTERM|DICTIONARY	alb	Alb	190#193	NaN	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	3	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	38#47	NaN	Compared with the control group, CRP, TNF-alpha, CH50, C3, IL-10 and Alb of ESRD group were in the normal range, but still significantly higher than those of the control group, while IL-10, Alb were significant lower (P < 0.05).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	213	LONGTERM|DICTIONARY	alb	Alb	186#189	NaN	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16313808	2007	Zhonghua Yi Xue Za Zhi	0376-2491	RESULTS	3	5	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	15#24	NaN	Levels of CRP, TNF-alpha, CH50 and C3 of ESRD patients with IL-10A/A genotype were significantly higher than those of ESRD patients with G/G and G/A genotype (P < 0.05), while IL-10 and Alb were significantly lower (P < 0.01).
16322490	2006	Stroke	1524-4628	RESULTS	3	7	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	TNF-alpha-238G>A was associated with increased risk of new ICH after diagnosis (chi2; P=0.003).
16322490	2006	Stroke	1524-4628	RESULTS	3	8	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	120#129	NaN	After adjusting for age, race/ethnicity, and clinical presentation, the risk of new ICH was increased for patients with TNF-alpha-238 AG genotype (hazard ratio, 4.01; P=0.015).
16322490	2006	Stroke	1524-4628	CONCLUSIONS	4	10	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	2#11	NaN	A TNF-alpha SNP was associated with increased risk of new ICH in the natural course of BAVMs.
16352452	2006	Mol. Genet. Metab.	1096-7192	TITLE	0	0	3073	LONGTERM|DICTIONARY	hexa	HexA	39#43	NaN	Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	113#117	NaN	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_1/3	1	1	3073	LONGTERM|DICTIONARY	hexa	HexA	187#191	NaN	A DNA-proven Tay-Sachs disease (TSD) carrier and his brother were found to have serum percent Hexosaminidase A (%HexA) enzymatic activities in the non-carrier range, while the leukocyte %HexA profiles clearly identified them as TSD heterozygotes.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3073	LONGTERM|DICTIONARY	hexa	HexA	48#52	NaN	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	4	3073	LONGTERM|DICTIONARY	hexa	HexA	286#290	NaN	To determine if these HEXB polymorphisms reduce HexA and HexB enzymatic activities, 69 DNA samples from subjects previously screened enzymatically in both serum and leukocytes for TSD carrier status were selected for either high, mid-range or low serum Total Hex (defined as the sum of HexA and HexB) activities and were tested for the HEXB mutations.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	5	3073	LONGTERM|DICTIONARY	hexa	HexA	92#96	NaN	Further, three additional TSD carriers ascertained by the atypical pattern of normal serum %HexA but carrier leukocyte %HexA, were found to have the [delTG (+) 619A>G] genotype.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_2/3	2	5	3073	LONGTERM|DICTIONARY	hexa	HexA	120#124	NaN	Further, three additional TSD carriers ascertained by the atypical pattern of normal serum %HexA but carrier leukocyte %HexA, were found to have the [delTG (+) 619A>G] genotype.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	3073	LONGTERM|DICTIONARY	hexa	HexA	166#170	NaN	Given the high frequency of the [delTG (+) 619A>G] haplotype in the Ashkenazi Jewish population (approximately 10%), up to 10% of TSD carriers may have normal serum %HexA values with low total Hex.
16352452	2006	Mol. Genet. Metab.	1096-7192	ALL_TEXT_3/3	3	7	3074	LONGTERM|DICTIONARY	hex	Hex	193#196	NaN	Given the high frequency of the [delTG (+) 619A>G] haplotype in the Ashkenazi Jewish population (approximately 10%), up to 10% of TSD carriers may have normal serum %HexA values with low total Hex.
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	4	84639	LONGTERM|DICTIONARY	il1f10	IL1F10	52#58	NaN	Association of alleles and genotypes of the markers IL1F10.3, IL1RN.4, and IL1RN.VNTR was observed with AS (p<0.05).
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	5	3557	LONGTERM|DICTIONARY	il1rn	IL1RN	56#61	NaN	Haplotypes of pairs of these markers and of the markers IL1RN.6/1 and IL1RN.6/2 were also significantly associated with AS.
16361275	2006	Ann. Rheum. Dis.	0003-4967	RESULTS	3	5	3557	LONGTERM|DICTIONARY	il1rn	IL1RN	70#75	NaN	Haplotypes of pairs of these markers and of the markers IL1RN.6/1 and IL1RN.6/2 were also significantly associated with AS.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_2/3	2	3	3106	LONGTERM|DICTIONARY	hlab27	HLAB27	220#226	NaN	We investigated whether this dimorphism (MICA-129met [methionine] and MICA-129val [valine]) is associated with susceptibility to ankylosing spondylitis (AS) in a cohort of Algerian patients stratified according to their HLAB27 status and the age of onset of the disease.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	71#78	NaN	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
16386647	2006	Hum. Immunol.	0198-8859	ALL_TEXT_3/3	3	5	3106	LONGTERM|DICTIONARY	hla-b27	HLA-B27	358#365	NaN	Statistical analysis revealed: (1) a weaker association between AS and HLA-B27 in Algerians than in that reported for European patients (63% versus 80-90%), suggesting a possible influence of other genetic/environmental determinants in the studied population and (2) an association between MICA-129 met/met genotype and juvenile AS (p = 0.02) independent of HLA-B27 status.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	13#21	NaN	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	180#188	NaN	To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_2/3	2	7	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	54#62	NaN	Results showed a significantly higher amount of serum TNFalpha in the entire SLE population compared with controls.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	11	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	215#223	NaN	In addition, evaluation of SLE patients administered antimalarial drugs for three or more years who did not require any other specific SLE treatment indicates that patients with the combined genotype low IL-10/high TNFalpha are the best responders to antimalarial therapy, developing mild disease with a good course under this treatment.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	75#83	NaN	In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
16507146	2006	Arthritis Res. Ther.	1478-6362	ALL_TEXT_3/3	3	12	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	151#159	NaN	In conclusion, we proposed that an antimalarial-mediated downregulation of TNFalpha levels in SLE patients is influenced by polymorphisms at IL-10 and TNFalpha promoters.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	RATIONALE	1	1	4790	LONGTERM|DICTIONARY	nuclear factor (nf)-kappab	nuclear factor (NF)-kappaB	106#132	NaN	The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVES	2	3	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	109#118	NaN	To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappaB and affecting outcomes from sepsis.
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	MEASUREMENTS AND MAIN RESULTS	3	6	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	77#86	NaN	The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappaB in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p=0.0009).
16528020	2006	Am. J. Respir. Crit. Care Med.	1073-449X	CONCLUSIONS	4	8	4790	LONGTERM|DICTIONARY	nf-kappab	NF-kappaB	167#176	NaN	These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappaB, more severe organ dysfunction, and higher mortality.
16625233	2006	J Hum Hypertens	0950-9240	TITLE	0	0	5468	LONGTERM|DICTIONARY	peroxisome proliferator-activated receptor-gamma2	peroxisome proliferator-activated receptor-gamma2	48#97	NaN	Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
16645213	2006	J Mol Diagn	1525-1578	ALL_TEXT_3/3	3	10	4869	LONGTERM|DICTIONARY	npm1	NPM1	39#43	NaN	Our results suggest that DHPLC detects NPM1mutations as well as direct sequencing and immunohistochemistry, providing a helpful approach in the diagnosis of NPMc+ AML.
16702373	2006	Cancer Epidemiol. Biomarkers Prev.	1055-9965	TITLE	0	0	4683	LONGTERM|DICTIONARY	nijmegen breakage syndrome 1	Nijmegen breakage syndrome 1	12#40	NaN	Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	1	5928	LONGTERM|DICTIONARY	msi	MSI	56#59	NaN	Gastric carcinoma (GC) with microsatellite instability (MSI) exhibits clinicopathological characteristics distinct from microsatellite-stable (MSS) GC.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	3	5928	LONGTERM|DICTIONARY	msi	MSI	76#79	NaN	The relationship between Hp-induced inflammation and the mutator pathway of MSI remains unclear.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	BACKGROUND AND AIM	1	5	5928	LONGTERM|DICTIONARY	msi	MSI	97#100	NaN	The objective of this study was to elucidate the relationship between cytokine polymorphisms and MSI phenotypes.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	METHODS	2	7	5928	LONGTERM|DICTIONARY	msi	MSI	16#19	NaN	The presence of MSI and mutations in exons 5 to 8 of the p53 gene were examined in GC cases.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi	MSI	26#29	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16824064	2006	J. Gastroenterol. Hepatol.	0815-9319	RESULTS	3	9	5928	LONGTERM|DICTIONARY	msi-l	MSI-L	41#46	NaN	High and low frequency of MSI (MSI-H and MSI-L) and MSS were detected in 16 (8.8%), 14 (7.7%) and 151 (83.4%) GC cases, respectively.
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6043	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6044	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
16882462	2007	Ann Epidemiol	1047-2797	RESULTS	3	6	6925	LONGTERM|DICTIONARY	e2/2, e2/3	E2/2, E2/3	66#76	NaN	The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
16909243	2006	Pediatr. Nephrol.	0931-041X	TITLE	0	0	7490	LONGTERM|DICTIONARY	wt1	WT1	0#3	NaN	WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	1	7490	LONGTERM|DICTIONARY	wt1	WT1	0#3	NaN	WT1 mutations have been considered a rare cause of nephrotic syndrome but recent reports challenge this assumption.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	3	7490	LONGTERM|DICTIONARY	wt1	WT1	16#19	NaN	We screened for WT1 mutations in 200 patients with nephrotic syndrome: 114 with steroid resistance (SRNS) and 86 with steroid dependence (SDNS) for whom other inherited forms of nephrotic syndrome (NPHS2, CD2AP) had been previously excluded.
16909243	2006	Pediatr. Nephrol.	0931-041X	ALL_TEXT_1/3	1	4	7490	LONGTERM|DICTIONARY	wt1	WT1	94#97	NaN	Three girls out of 32 of the group with steroid resistance under 18 years presented classical WT1 splice mutations (IVS9+5G>A, IVS9+4C>T) of Frasier syndrome.
16911713	2006	Am. J. Reprod. Immunol.	1046-7408	ALL_TEXT_3/3	3	5	6690	LONGTERM|DICTIONARY	psti	PstI	14#18	NaN	Genotypes for PstI polymorphisms did not differ significantly among control and endometriosis (P = 0.058).
16930377	2006	Eur. J. Neurol.	1468-1331	ALL_TEXT_2/3	2	4	7018	LONGTERM|DICTIONARY	transferrin	transferrin	98#109	NaN	Although most patients with RLS have normal serum ferritin levels, concentrations of ferritin and transferrin in the cerebrospinal fluid are reduced, suggesting iron deficiency within the central nervous system.
16945136	2006	BMC Cancer	1471-2407	BACKGROUND	1	6	6648	LONGTERM|DICTIONARY	manganese superoxide dismutase	manganese superoxide dismutase	21#51	NaN	Polymorphisms in the manganese superoxide dismutase (MnSOD) and glutathione peroxidase (GPX-1) genes have been proposed as low penetrance alleles, and have not been clearly associated with breast cancer.
16956834	2006	Haematologica	1592-8721	TITLE	0	0	1906	LONGTERM|DICTIONARY	et-1	ET-1	0#4	NaN	ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nuclear factor of kappa b	nuclear factor of kappa B	82#107	NaN	The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	2	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	109#117	NaN	The signal transduction target upon interleukin 1 beta (IL1beta) stimulation, the nuclear factor of kappa B (NFkappaB) activation, supports cancer development, signal transduction in which is mediated by FS-7 cell-associated cell surface antigen (FAS) signaling.
17006606	2007	J. Hum. Genet.	1434-5161	ALL_TEXT_1/3	1	3	4790	LONGTERM|DICTIONARY	nfkappab	NFkappaB	84#92	NaN	Based on recent papers describing the prognostic roles of the polymorphisms and the NFkappaB functions on cancer development, we sought to determine if Japanese gastric cancer patients were affected by the IL1B -31/-511 and FAS-670 polymorphisms.
17040410	2006	Neurogastroenterol. Motil.	1350-1925	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	Serotonin transporter gene polymorphism and irritable bowel syndrome.
17095747	2007	Am. J. Respir. Crit. Care Med.	1073-449X	OBJECTIVE	2	5	5027	LONGTERM|DICTIONARY	p2x(7)	P2X(7)	143#149	NaN	The association of these polymorphisms with clinical TB was subsequently investigated in two separate case-control cohorts and the function of P2X(7) was assessed in subjects from one cohort.
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	8	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	Reprimo methylation occurred in 0 of 19 NE samples, 6 (13%) of 45 ESCC, 9 (36%) of 25 BE, 7 (64%) of 11 HGD, and 47 (63%) of 75 EAC.
17121882	2007	Clin. Cancer Res.	1078-0432	CONCLUSIONS	4	11	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	Reprimo methylation occurs significantly more frequently in BE, HGD, and EAC than in NE or ESCC, suggesting that this epigenetic alteration is a specialized columnar, cell-specific early event with potential as a biomarker for the early detection of esophageal neoplasia.
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	6	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	150#157	NaN	In Barrett's esophagus (BE; P=0.001), high-grade dysplasia (HGD; P=0.001), and esophageal adenocarcinoma (EAC; P=0.00003), the level and frequency of Reprimo methylation were significantly higher than in normal esophagus (NE).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	9	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	12#19	NaN	Analysis of Reprimo methylation in EAC versus NE revealed an area under the receiver-operator characteristic curve of 0.812 (P<0.00001; 95% confidence interval, 0.73-0.90).
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	10	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	51#58	NaN	In vitro 5AzaC treatment of OE33 EAC cells reduced Reprimo methylation and increased Reprimo expression.
17121882	2007	Clin. Cancer Res.	1078-0432	RESULTS	3	10	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	85#92	NaN	In vitro 5AzaC treatment of OE33 EAC cells reduced Reprimo methylation and increased Reprimo expression.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	56475	LONGTERM|DICTIONARY	reprimo	Reprimo	0#7	NaN	Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17121882	2007	Clin. Cancer Res.	1078-0432	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	54#57	NaN	Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer.
17131847	2007	Ann Acad Med Stetin	1427-440X	PURPOSE	1	1	2244	LONGTERM|DICTIONARY	fibrinogen	fibrinogen	40#50	NaN	1.The assessment in haemostasis system, fibrinogen, tissue plasminogen activator (t-PA) and its inhibitor type-1, von Willebrand factor and beta-thromboglobulin (beta-TG) levels and the changes in renin-angiotensin system (RAS), by determined angiotensin converting enzyme I (ACE) activity, in patients with essential hypertension (in relation to left ventricular hypertrophy) in comparison with normotension subjects.2.
17151092	2007	Carcinogenesis	0143-3334	ALL_TEXT_3/3	3	9	3853	LONGTERM|DICTIONARY	pc-3	PC-3	47#51	NaN	Moreover, we found that PCa cell lines DU 145, PC-3, LNCaP and LAPC-4 retained the ability to up-regulate MKP5 following curcumin, resveratrol and [6]-gingerol exposure, suggesting utility of these phytochemicals in PCa treatment.
17197814	2007	AIDS	0269-9370	TITLE	0	0	474272	LONGTERM|DICTIONARY	bw4	Bw4	6#9	NaN	HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples.
17197814	2007	AIDS	0269-9370	OBJECTIVE	2	3	474272	LONGTERM|DICTIONARY	bw4	Bw4	57#60	NaN	To investigate if the presence of HLA-B alleles with the Bw4 epitope in HIV-1-infected men decreased the risk of transmission to their female sex partners.
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474272	LONGTERM|DICTIONARY	bw4	Bw4	116#119	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474272	LONGTERM|DICTIONARY	bw4	Bw4	141#144	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474272	LONGTERM|DICTIONARY	bw4	Bw4	145#148	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474275	LONGTERM|DICTIONARY	bw6	Bw6	91#94	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474275	LONGTERM|DICTIONARY	bw6	Bw6	95#98	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	9	474275	LONGTERM|DICTIONARY	bw6	Bw6	120#123	NaN	HIV-1 infection in the women was associated with the HLA-B genotype of their male partner [Bw6/Bw6, 22/118 (18.6%); Bw4/Bw6, 18/154 (11.7%); Bw4/Bw4, 4/53 (7.6%)].
17197814	2007	AIDS	0269-9370	RESULTS	4	10	474272	LONGTERM|DICTIONARY	bw4	Bw4	63#66	NaN	Compared with men who were homozygous for Bw6, men who carried Bw4 were about half as likely to have transmitted HIV-1 to their female partner (OR, 0.52; 95% CI, 0.27-0.98; P = 0.04).
17197814	2007	AIDS	0269-9370	RESULTS	4	10	474275	LONGTERM|DICTIONARY	bw6	Bw6	42#45	NaN	Compared with men who were homozygous for Bw6, men who carried Bw4 were about half as likely to have transmitted HIV-1 to their female partner (OR, 0.52; 95% CI, 0.27-0.98; P = 0.04).
17197814	2007	AIDS	0269-9370	CONCLUSION	5	12	474272	LONGTERM|DICTIONARY	bw4	Bw4	20#23	NaN	The presence of HLA-Bw4 in HIV-1-infected men was associated with a decreased risk of male-to-female HIV-1 transmission, which suggests that these alleles reduce infectivity for HIV-1.
17347480	2007	Circ. Res.	1524-4571	TITLE	0	0	7442	LONGTERM|DICTIONARY	transient receptor potential vanilloid type-1	transient receptor potential vanilloid type-1	14#59	NaN	Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	7	55599	LONGTERM|DICTIONARY	anti-u1-ribonucleoprotein	anti-U1-ribonucleoprotein	166#191	NaN	The microsatellite IFN-gamma CA(14) allele was associated with risk for IIMs overall (OR 3.3, 95% CI 1.4 to 7.8), the strongest association being observed within the anti-U1-ribonucleoprotein (RNP) group (OR 6.0, 95% CI 1.5 to 23.1), and persisting after adjustment for known myositis human leucocyte antigen (HLA) class II associations.
17405833	2007	Ann. Rheum. Dis.	0003-4967	RESULTS	3	6	391109	LONGTERM|DICTIONARY	odds ratio (or) 1.6	odds ratio (OR) 1.6	99#118	NaN	In the IFN-gamma gene, a weak allelic association was observed in PM versus controls at rs1861493 (odds ratio (OR) 1.6, 95% confidence interval (CI) 1.03 to 2.4).
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_3/3	3	6	3497	LONGTERM|DICTIONARY	ige	IgE	116#119	NaN	In conclusion, our results suggest an ambivalent influence of a genetic determinant of pro-inflammatory pathways on IgE-mediated hypersensitivity to betalactams.
17471286	2008	Pharmacogenomics J.	1473-1150	TITLE	0	0	3497	LONGTERM|DICTIONARY	ige	IgE	69#72	NaN	Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population.
17471286	2008	Pharmacogenomics J.	1473-1150	ALL_TEXT_2/3	2	4	3497	LONGTERM|DICTIONARY	ige	IgE	124#127	NaN	TNFA GG genotype was a significant independent predictor of the primary risk of betalactam allergy, concurrently with total IgE level, with an age- and sex-adjusted odds ratio estimated at 2.45 (95% confidence interval: 1.18-5.08, P=0.0163).
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	5	282706	LONGTERM|DICTIONARY	g30	G30	75#78	NaN	In this study, we performed association and epistasis analyses of the DAOA/G30 and DAO loci in a sample of 373 cases with DSM-IV schizophrenia/schizoaffective disorder and 812 controls from the Republic of Ireland.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	TITLE	0	0	282706	LONGTERM|DICTIONARY	g30	G30	51#54	NaN	Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_1/3	1	3	282706	LONGTERM|DICTIONARY	g30	G30	91#94	NaN	(2002); PNAS 99: 13675-13680, identifying the novel schizophrenia susceptibility gene DAOA/G30 and a number of independent studies have since reported evidence of association between the DAOA and DAO genes and schizophrenia.
17492767	2007	Am. J. Med. Genet. B Neuropsychiatr. Genet.	1552-4841	ALL_TEXT_2/3	2	6	282706	LONGTERM|DICTIONARY	g30	G30	133#136	NaN	Corrected for the number of tests performed, we found evidence for association between markers at both genes and schizophrenia: DAOA/G30 (P = 0.005, OR = 1.34 (1.09, 1.65)) and DAO (P = 0.003, OR = 1.43 (1.12, 1.84).
17714919	2008	J. Dermatol. Sci.	0923-1811	METHODS	3	4	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	106#115	NaN	We investigated the polymorphisms of IL-2 -330, IL-4 -590, IL-4 receptor +1902, IL-10 -1082 and -819, and IFN-gamma intron 1 in 114 psoriasis patients and 281 healthy normal controls in Korean.
17785557	2007	Clin. Cancer Res.	1078-0432	EXPERIMENTAL DESIGN	2	4	7157	LONGTERM|DICTIONARY	p53	p53	30#33	NaN	We genotyped CXCL12 G801A and p53Arg72Pro in 167 PC patients and 167 age-matched healthy subjects.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	99#106	NaN	Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	3	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	195#202	NaN	Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	274#281	NaN	We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	294#301	NaN	We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_2/3	2	4	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	322#329	NaN	We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	67#74	NaN	We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17922187	2008	Breast Cancer Res. Treat.	0167-6806	ALL_TEXT_3/3	3	7	2099	LONGTERM|DICTIONARY	eralpha	ERalpha	193#200	NaN	We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
17961231	2008	BMC Neurol	1471-2377	BACKGROUND	1	1	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	Neuroserpin, primarily localized to CNS neurons, inhibits the adverse effects of tissue-type plasminogen activator (tPA) on the neurovascular unit and has neuroprotective effects in animal models of ischemic stroke.
17961231	2008	BMC Neurol	1471-2377	BACKGROUND	1	2	5274	LONGTERM|DICTIONARY	neuroserpin	neuroserpin	41#52	NaN	We sought to evaluate the association of neuroserpin polymorphisms with risk for ischemic stroke among young women.
17961231	2008	BMC Neurol	1471-2377	CONCLUSION	4	8	5274	LONGTERM|DICTIONARY	neuroserpin	neuroserpin	44#55	NaN	This study provides the first evidence that neuroserpin is associated with early-onset ischemic stroke among Caucasian women.
17961231	2008	BMC Neurol	1471-2377	TITLE	0	0	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	Neuroserpin polymorphisms and stroke risk in a biracial population: the stroke prevention in young women study.
17961231	2008	BMC Neurol	1471-2377	METHODS	2	4	5274	LONGTERM|DICTIONARY	neuroserpin	Neuroserpin	0#11	NaN	Neuroserpin single nucleotide polymorphisms (SNPs) chosen through HapMap were genotyped in the study population and assessed for association with stroke.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hepatic lipase	hepatic lipase	124#138	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3990	LONGTERM|DICTIONARY	hl	HL	140#142	NaN	To investigate the single nucleotide polymorphism (SNP), the distribution of their haplotypes and linkage disequilibrium of hepatic lipase (HL) gene promoter 250G/A, 514C/T, 710T/C and 763A/G in cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3990	LONGTERM|DICTIONARY	hl	HL	83#85	NaN	There are significant haplotypes and linkage disequilibrium among the four SNPs of HL gene in the cerebral infarction patients of Shanghai.
18001531	2008	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	3	3990	LONGTERM|DICTIONARY	hl	HL	4#6	NaN	The HL gene polymorphism was analyzed by polymerase chain reaction- restriction fragment length polymorphism.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	preproneuropeptide y	preproneuropeptide Y	51#71	NaN	The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_1/3	1	1	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	73#82	NaN	The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_2/3	2	2	27087	LONGTERM|DICTIONARY	leu7	Leu7	84#88	NaN	The current study evaluated the impact of obesity on the disease risk linked to the Leu7Pro polymorphism of preproNPY in 393 elderly subjects.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_2/3	2	2	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	108#117	NaN	The current study evaluated the impact of obesity on the disease risk linked to the Leu7Pro polymorphism of preproNPY in 393 elderly subjects.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_3/3	3	5	27087	LONGTERM|DICTIONARY	leu7	Leu7	110#114	NaN	The results indicate that obesity may be a pivotal factor in multiplying the disease risk associated with the Leu7Pro polymorphism in preproNPY.
18043699	2009	Eur J Clin Nutr	1476-5640	ALL_TEXT_3/3	3	5	4852	LONGTERM|DICTIONARY	prepronpy	preproNPY	134#143	NaN	The results indicate that obesity may be a pivotal factor in multiplying the disease risk associated with the Leu7Pro polymorphism in preproNPY.
18064451	2008	Immunogenetics	0093-7711	ALL_TEXT_1/3	1	3	51497	LONGTERM|DICTIONARY	th1	Th1	265#268	NaN	Our aim was to assess the involvement on T1D and RA of IL4 polymorphisms considered individually and in combination with other polymorphisms in 5q31-33, specifically in the OCTN locus, where the L503F polymorphism has been associated with Crohn's disease and other Th1 diseases.
18074111	2008	Mol. Cell. Biochem.	0300-8177	TITLE	0	0	4524	LONGTERM|DICTIONARY	methylene tetrahydrofolate reductase	methylene tetrahydrofolate reductase	54#90	NaN	Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
18077176	2008	Neurobiol. Dis.	1095-953X	ALL_TEXT_2/3	2	6	581	LONGTERM|DICTIONARY	bax	Bax	252#255	NaN	The current investigation focused on detection of PtdSer on the outer leaflet of the bilayer in synaptosomes from brain of subjects with AD and amnestic mild cognitive impairment (MCI), as well as expression levels of apoptosis-related proteins Bcl-2, Bax, and caspase-3.
18083240	2008	J. Neuroimmunol.	0165-5728	ALL_TEXT_2/3	2	2	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	46#55	NaN	In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects.
18162506	2008	Diabetes	1939-327X	OBJECTIVE	1	1	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	Insulin gene (INS) mutations have recently been described as a cause of permanent neonatal diabetes (PND).
18162506	2008	Diabetes	1939-327X	TITLE	0	0	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
18162506	2008	Diabetes	1939-327X	CONCLUSIONS	4	12	3630	LONGTERM|DICTIONARY	insulin	Insulin	0#7	NaN	Insulin gene mutation screening is recommended for all diabetic patients diagnosed before 1 year of age.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	51#83	NaN	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	85#94	NaN	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	127#136	NaN	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_1/3	1	2	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	226#235	NaN	To clarify whether the +869T/C polymorphism in the transforming growth factor-beta1 (TGF-beta1) gene, which is associated with TGF-beta1 expression, is involved in the intractability of GD and severity of HD, we genotyped the TGF-beta1 +869T/C polymorphism by polymerase chain reaction-restriction fragment length polymorphism method in genomic DNA samples from 33 patients with HD who developed hypothyroidism before they were 50 years old (severe HD) and 30 untreated, euthyroid patients with HD who were older than 50 years (mild HD).
18190611	2008	Clin. Exp. Immunol.	1365-2249	TITLE	0	0	7040	LONGTERM|DICTIONARY	transforming growth factor-beta1	transforming growth factor-beta1	32#64	NaN	The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.
18190611	2008	Clin. Exp. Immunol.	1365-2249	ALL_TEXT_3/3	3	6	7040	LONGTERM|DICTIONARY	tgf-beta1	TGF-beta1	47#56	NaN	In conclusion, the +869T/C polymorphism in the TGF-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.
18455351	2008	Int. J. Dev. Neurosci.	0736-5748	ALL_TEXT_3/3	3	7	759	LONGTERM|DICTIONARY	ca1	CA1	50#53	NaN	Rosiglitazone also prevented neuronal loss in the CA1 area after SE observed by Nissl-staining.
18508830	2009	Eur. Respir. J.	1399-3003	TITLE	0	0	23564	LONGTERM|DICTIONARY	g-6a	G-6A	21#25	NaN	Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	36#40	NaN	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_1/3	1	3	23564	LONGTERM|DICTIONARY	g-6a	G-6A	201#205	NaN	In order to investigate whether the G-6A polymorphism of the AGT gene is associated with IPF development, severity and progression, the present study utilised a case-control study design and genotyped G-6A in 219 patients with IPF and 224 control subjects.
18508830	2009	Eur. Respir. J.	1399-3003	ALL_TEXT_3/3	3	8	23564	LONGTERM|DICTIONARY	g-6a	G-6A	0#4	NaN	G-6A polymorphism of the angiotensinogen gene is associated with idiopathic pulmonary fibrosis progression but not with disease predisposition.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	47#56	NaN	Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	67#76	NaN	Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	TITLE	0	0	3459	LONGTERM|DICTIONARY	ifnr1	IFNR1	78#83	NaN	Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	OBJECTIVE	1	2	3458	LONGTERM|DICTIONARY	interferon (ifn)-gamma	interferon (IFN)-gamma	36#58	NaN	We studied the polymorphisms in the interferon (IFN)-gamma (gamma) and IFN-gamma receptor 1 (IFNR1) gene with the aim of clarifying the relationships among these polymorphisms, penicillin allergy and anti-penicillin antibodies.
18548239	2008	Eur. J. Clin. Pharmacol.	1432-1041	RESULTS	3	6	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	59#68	NaN	There was no significant difference in the whole-allele of IFN-gamma distribution between patients with a penicillin allergy and control subjects.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	1	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	5#14	NaN	Anti-TNF-alpha therapies are widely used in rheumatoid arthritis (RA) patients.
18565259	2008	Clin. Exp. Rheumatol.	0392-856X	OBJECTIVE	1	3	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	219#228	NaN	The aim of this study is to determine whether two functional single-nucleotide polymorphisms, V212F in the FCGR3A, and M196R in the TNFRSF1B genes correlate with rheumatoid arthritis susceptibility and response to anti-TNF-alpha therapy.
18568133	2008	J Gastrointestin Liver Dis	1841-8724	BACKGROUND AND AIMS	1	1	3938	LONGTERM|DICTIONARY	lactase	Lactase	0#7	NaN	Lactase non-persistence causes gastrointestinal symptoms after milk ingestion.
18688140	2009	Neurol India	0028-3886	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	Serotonin transporter	0#21	NaN	Serotonin transporter gene polymorphisms in patients with chronic tension-type headache: a preliminary study.
18698679	2008	World J. Gastroenterol.	1007-9327	CONCLUSION	4	7	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	TNF-alpha is a key cytokine known to play a role in inflammatory response, and the locus for the gene is found in the IBD3 region on chromosome 6p21, known to be associated with an increased risk for IBD.
18930330	2009	J. Hepatol.	0168-8278	BACKGROUND/AIMS	1	2	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	101#109	NaN	We investigated the impact of sequence diversity in candidate genes involved in immunity (CTLA-4 and TNFalpha), in bile formation (10 hepatobiliary transporter genes) and in the adaptative response to cholestasis (three nuclear receptor genes) on the susceptibility and severity of PBC.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	5	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	22#30	NaN	Ht SNPs of CTLA-4 and TNFalpha genes were significantly associated with susceptibility to PBC.
18930330	2009	J. Hepatol.	0168-8278	CONCLUSIONS	4	9	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	49#57	NaN	They also demonstrate that allelic variations in TNFalpha and SLC4A2/AE2 have a significant impact on the evolutive profile of PBC under UDCA therapy.
18930330	2009	J. Hepatol.	0168-8278	RESULTS	3	6	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	116#124	NaN	The progression rate of liver disease under ursodeoxycholic acid (UDCA) therapy was significantly linked to SNPs of TNFalpha and SLC4A2/anion exchanger 2 (AE2) genes.
1894189	1991	Haemostasis	0301-0147	ALL_TEXT_1/3	1	1	2147	LONGTERM|DICTIONARY	thrombin	thrombin	217#225	NaN	Various reactions of disseminated intravascular coagulation (DIC) were experimentally induced by infusion of thrombokinase in rats, by administration of endotoxin in rabbits and pigs and by infusion of adrenaline and thrombin in dogs.
18997459	2009	Ann. Nutr. Metab.	1421-9697	TITLE	0	0	7124	LONGTERM|DICTIONARY	tnfalpha	TNFalpha	14#22	NaN	Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
19018715	2009	Pharmacogenomics	1744-8042	ALL_TEXT_1/3	1	1	4914	LONGTERM|DICTIONARY	trk	Trk	75#78	NaN	The neuroplasticity hypothesis of bipolar disorder indicates that the BDNF/Trk signaling pathway is associated with the pathogenesis of this illness and treatment with mood stabilizers, such as lithium.
19058785	2009	Biol. Psychiatry	1873-2402	RESULTS	3	7	146	LONGTERM|DICTIONARY	alpha1	alpha1	74#80	NaN	Significant nominal association with BD was observed for six single SNPs (alpha1: rs11805078; alpha2: rs2070704, rs1016732, rs2854248, and rs2295623; alpha3: rs919390) in the three genes of Na+, K+-ATPase alpha isoforms.
19058873	2009	Lung Cancer	1872-8332	TITLE	0	0	840	LONGTERM|DICTIONARY	caspase7	Caspase7	21#29	NaN	Polymorphisms in the Caspase7 gene and the risk of lung cancer.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3552	LONGTERM|DICTIONARY	il-1alpha	IL-1alpha	213#222	NaN	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	164#181	NaN	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	il-1beta	IL-1beta	183#191	NaN	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_1/3	1	1	3553	LONGTERM|DICTIONARY	interleukin 1beta	interleukin 1beta	194#211	NaN	The objective of this study is to replicate previously published results regarding the involvement of several susceptibility genes in temporal lobe epilepsy (TLE): interleukin 1beta (IL-1beta), interleukin 1beta (IL-1alpha), interleukin 1RA (IL-1RA), apolipoprotein E (ApoE) and prodynorphin (PDYN).
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3552	LONGTERM|DICTIONARY	il-1alpha	IL-1alpha	47#56	NaN	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19066720	2009	Neurol. Sci.	1590-1874	ALL_TEXT_3/3	3	3	3553	LONGTERM|DICTIONARY	il-1beta	IL-1beta	131#139	NaN	We were thus able to confirm the role of ApoE, IL-1alpha and IL-1RA genes in TLE disease, but failed to confirm the involvement of IL-1beta and PDYN.
19094875	2009	Med Clin (Barc)	0025-7753	BACKGROUND AND OBJECTIVE	1	1	1312	LONGTERM|DICTIONARY	cathecol-o-methyl transferase	Cathecol-O-methyl transferase	0#29	NaN	Cathecol-O-methyl transferase (COMT) is one of the most plausible susceptibility genes of schizophrenia risk.
19141695	2009	Am. J. Clin. Nutr.	1938-3207	RESULTS	4	11	9370	LONGTERM|DICTIONARY	adiponectin	adiponectin	169#180	NaN	Cytokeratin-18 fragments increased significantly postprandially in both groups but more consistently in patients with NASH; their increase was predicted by postprandial adiponectin and FFA responses.
19141698	2009	J. Nutr.	1541-6100	ALL_TEXT_3/3	3	9	9933	LONGTERM|DICTIONARY	pufa	PUFA	23#27	NaN	In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
19164214	2009	J. Clin. Oncol.	1527-7755	TITLE	0	0	21977	LONGTERM|DICTIONARY	mtor	mTOR	40#44	NaN	Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	759	LONGTERM|DICTIONARY	ca1	CA1	173#176	NaN	After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19220408	2009	Epilepsia	1528-1167	RESULTS	3	4	761	LONGTERM|DICTIONARY	ca3	CA3	103#106	NaN	After status epilepticus (SE), TASK-2 immunoreactivity was increased in dentate granule cell layer and CA3 pyramidal cell layer, whereas its immunoreactivity was reduced in CA1 pyramidal cell layer.
19237575	2009	Proc. Natl. Acad. Sci. U.S.A.	1091-6490	ALL_TEXT_3/3	3	6	920	LONGTERM|DICTIONARY	cd4	CD4	268#271	NaN	Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
19362357	2009	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	51497	LONGTERM|DICTIONARY	t(h)1	T(H)1	166#171	NaN	The T cell-specific T-box transcription factor (TBX21) plays a crucial role in the regulation of the immune system because this factor induces the differentiation of T(H)1 and blocks T(H)2 commitment together with the homeobox transcription factor HLX1.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	0#22	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	PURPOSE	1	1	6247	LONGTERM|DICTIONARY	xlrs	XLRS	24#28	NaN	X-linked retinoschisis (XLRS) is a recessively inherited disorder that causes macular degeneration and resultant visual defect in young males.
19390641	2009	Mol. Vis.	1090-0535	TITLE	0	0	6247	LONGTERM|DICTIONARY	x-linked retinoschisis	X-linked retinoschisis	37#59	NaN	Molecular genetic characteristics of X-linked retinoschisis in Koreans.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	13	6247	LONGTERM|DICTIONARY	xlrs	XLRS	141#145	NaN	A missense mutation was the predominant type, and common or founder mutations were not observed in the Korean patients in this study who had XLRS.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	15	6247	LONGTERM|DICTIONARY	xlrs	XLRS	38#42	NaN	The genetic characteristics of Korean XLRS will be helpful for understanding the worldwide spectrum of RS1 mutation.
19390641	2009	Mol. Vis.	1090-0535	CONCLUSIONS	4	15	6247	LONGTERM|DICTIONARY	rs1	RS1	103#106	NaN	The genetic characteristics of Korean XLRS will be helpful for understanding the worldwide spectrum of RS1 mutation.
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_3/3	3	5	7157	LONGTERM|DICTIONARY	tp53	TP53	13#17	NaN	However, the TP53Arg72Pro genotype disappeared as a susceptibility factor both in the multivariate regression analysis and in a univariate regression analysis adjusted for gender, age, and smoking, suggesting that it was connected with one of these factors in the predisposition to bladder cancer.
19523860	2011	Urol. Oncol.	1873-2496	ALL_TEXT_3/3	3	7	7157	LONGTERM|DICTIONARY	tp53	TP53	32#36	NaN	We concluded that the effect of TP53Arg72Pro, described in some studies as an important risk factor, may not be an independent, but an age-related factor of susceptibility to bladder cancer.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hypoxia-inducible factor-1	Hypoxia-inducible factor-1	0#26	NaN	Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	1	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	28#33	NaN	Hypoxia-inducible factor-1 (HIF-1), an important genetic component of angiogenesis, becomes stable as a response to tumor hypoxia and facilitates tumor survival.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	TITLE	0	0	3091	LONGTERM|DICTIONARY	hypoxia-inducible factor-1alpha	hypoxia-inducible factor-1alpha	26#57	NaN	Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_1/3	1	3	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	67#72	NaN	In this study, we have investigated the relationship between seven HIF-1alphapolymorphisms [C > T substitution in intron 8 (rs10873142), T418I (rs41508050) in exon 10, P564P (rs41492849), L580L (rs34005929), P582S (rs11549465), A588T (rs11549467) in exon 12 and dinucleotide GT repeats in intron 13 (rs10645014)] among lung cancer patients in the Turkish population.
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_2/3	2	6	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	143#148	NaN	There was no significant difference between the lung cancer cases and controls in terms of the distribution of genotyping frequencies of seven HIF-1alphapolymorphisms (P > 0.05).
19546348	2009	Exp. Biol. Med. (Maywood)	1535-3699	ALL_TEXT_3/3	3	9	3091	LONGTERM|DICTIONARY	hif-1	HIF-1	46#51	NaN	These findings show that polymorphisms in the HIF-1alphagene do not confer susceptibility to lung cancer.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_3/3	3	6	7137	LONGTERM|DICTIONARY	ctni	cTnI	73#77	NaN	In drug development studies in BALB/c mice with novel kinase inhibitors, cTnI concentration was a reliable stand-alone biomarker of cardiac injury and was used in combination with measurements of in vivo target inhibition to demonstrate an off-target contribution to cardiotoxicity.
19549929	2009	Toxicol Pathol	1533-1601	ALL_TEXT_3/3	3	7	7137	LONGTERM|DICTIONARY	ctni	cTnI	74#78	NaN	Additional attributes, including low cost and rapid turnaround time, made cTnI concentration in serum invaluable for detecting cardiotoxicity, exploring structure-activity relationships, and prioritizing development of compounds with improved safety profiles early in drug discovery.
19563289	2009	J. Periodontol.	0022-3492	TITLE	0	0	3552	LONGTERM|DICTIONARY	interleukin-1	interleukin-1	26#39	NaN	The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction.
19753311	2009	Mol. Vis.	1090-0535	PURPOSE	1	2	1134	LONGTERM|DICTIONARY	machr 1	mAChR 1	62#69	NaN	Among all of the muscarinic acetylcholine receptors (mAChRs), mAChR 1 (M1) was the most effective in preventing myopic eye change.
1976809	1990	J. Rheumatol.	0315-162X	ALL_TEXT_3/3	3	5	720	LONGTERM|DICTIONARY	c4a	C4A	52#55	NaN	Our results showed that the frequency of phenotypic C4A deficiency was 44.1% in Japanese patients with SLE and this value was comparable with that (43.2%) in Caucasian patients.
1982251	1991	Dis. Markers	0278-0240	ALL_TEXT_1/3	1	1	3630	LONGTERM|DICTIONARY	insulin	insulin	122#129	NaN	Polymorphism of the genes encoding the alpha, beta, and gamma chains of the human T-cell receptor (TCRA, TCRB, and TCRG), insulin gene (INS), and three closely linked polymorphic genes on chromosome 11q23, Thy-1 (THY1), T3-D (CD3D), and c-ets proto oncogene (ETS1) were investigated among 56 unrelated patients with insulin-dependent diabetes mellitus (IDDM) and 48 healthy controls.
20100586	2011	Biol. Blood Marrow Transplant.	1523-6536	ALL_TEXT_2/3	2	8	7124	LONGTERM|DICTIONARY	tnf-alpha	TNF-alpha	0#9	NaN	TNF-alpha genotypes were not correlated with the overall incidence of aGVHD.
20236202	2011	J Eur Acad Dermatol Venereol	1468-3083	BACKGROUND	1	2	412	LONGTERM|DICTIONARY	steroid sulphatase	steroid sulphatase	34#52	NaN	RXLI is caused by a deficiency in steroid sulphatase (STS), whose gene has been located on the X chromosome (locus Xp22.3).
20237592	2010	Can. J. Physiol. Pharmacol.	1205-7541	ALL_TEXT_1/3	1	3	29265	LONGTERM|DICTIONARY	chymase	chymase	182#189	NaN	After 8 weeks of intravenous administration of Ucn in spontaneously hypertensive rats (SHR), serum and tissue sACE, angiotensin II (Ang II), nitric oxide (NO), Ang-(1-7), and tissue chymase activities were evaluated.
20467232	2010	Tohoku J. Exp. Med.	1349-3329	TITLE	0	0	217	LONGTERM|DICTIONARY	aldehyde dehydrogenase-2	aldehyde dehydrogenase-2	20#44	NaN	The polymorphism in aldehyde dehydrogenase-2 gene is associated with elevated plasma levels of high-sensitivity C-reactive protein in the early phase of myocardial infarction.
20558149	2010	Brain Res.	1872-6240	TITLE	0	0	1378	LONGTERM|DICTIONARY	complement receptor 1	Complement receptor 1	0#21	NaN	Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
20558149	2010	Brain Res.	1872-6240	ALL_TEXT_1/3	1	1	351	LONGTERM|DICTIONARY	abeta	Abeta	26#31	NaN	The amyloid beta-protein (Abeta)-induced complement system activation plays an important role in Alzheimer's disease (AD).
20570322	2010	Gynecol. Oncol.	1095-6859	CONCLUSIONS	4	14	672	LONGTERM|DICTIONARY	brca	BRCA	27#31	NaN	The highest frequencies of BRCA mutations were seen in women with fallopian tube cancer diagnosed under age 60, in Jewish women, in women with a family history of breast or ovarian cancer, and in women with a personal history of breast cancer.
20610570	2010	Endocrinology	1945-7170	ALL_TEXT_2/3	2	5	3569	LONGTERM|DICTIONARY	il6	Il6	0#3	NaN	Il6 null mutant mice were also refractory to low doses of lipopolysaccharide sufficient to induce preterm delivery in wild-type mice.
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	1	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	330#338	NaN	In an attempt to evaluate the association between allele 8 (A8) of D19S884 in the fibrillin-3 gene and circulating transforming growth factor (TGF) β and inhibin levels in women with polycystic ovary syndrome (PCOS), we studied 120 similarly aged women from families with PCOS and compared 40 women with PCOS who did not have A8 (A8- PCOS) with 40 women with PCOS who had A8 (A8+ PCOS) and 40 normally menstruating women who did not have either PCOS or A8 (A8- Non-PCOS).
20630504	2011	Fertil. Steril.	1556-5653	ALL_TEXT	1	2	28886	LONGTERM|DICTIONARY	a8- pcos	A8- PCOS	0#8	NaN	A8- PCOS is associated with higher levels of TGF-β1 compared with A8+ PCOS or A8- Non-PCOS, similar levels of TGF-β2 compared with A8+ PCOS but lower levels of TGF-β2 compared with A8- Non-PCOS, and lower levels of inhibin B and aldosterone compared with A8+ PCOS.
20638924	2010	Cancer Epidemiol	1877-783X	PURPOSE	1	1	7157	LONGTERM|DICTIONARY	p53	p53	65#68	NaN	To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy.
20644276	2010	Neurol India	0028-3886	ALL_TEXT_3/3	3	8	348	LONGTERM|DICTIONARY	apo-e	Apo-E	41#46	NaN	Our results suggest that the presence of Apo-E4 allele might influence seropositive status in patients with MG and seems an associated susceptible factor in female patients.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3845	LONGTERM|DICTIONARY	k-ras	K-ras	17#22	NaN	[Significance of K-ras detection in colorectal cancer].
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	OBJECTIVE	1	1	3845	LONGTERM|DICTIONARY	k-ras	K-ras	36#41	NaN	To determine the mutation status of K-ras gene in colorectal cancer and analyze the associations between its mutation status and clinicopathological characteristics in colorectal cancer so as to select the patients likely to benefit from a targeted therapy.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	METHODS	2	5	3845	LONGTERM|DICTIONARY	k-ras	K-ras	30#35	NaN	Then the associations between K-ras mutation status and clinicopathological characteristics in colorectal cancer were analyzed.
20646601	2010	Zhonghua Yi Xue Za Zhi	0376-2491	CONCLUSION	4	9	3845	LONGTERM|DICTIONARY	k-ras	K-ras	13#18	NaN	Detection of K-ras gene status in colorectal cancer will help to select the patients likely to benefit from the monoclonal antibody therapy of targeting epidermal growth factor receptor.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	1	3497	LONGTERM|DICTIONARY	ige	IgE	153#156	NaN	Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
20816194	2010	J. Allergy Clin. Immunol.	1097-6825	BACKGROUND	1	2	3497	LONGTERM|DICTIONARY	ige	IgE	231#234	NaN	The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczema and increased serum IgE levels, such as other primary immunodeficiencies and atopic dermatitis.
20842733	2011	Genes Chromosomes Cancer	1098-2264	ALL_TEXT_3/3	3	8	4524	LONGTERM|DICTIONARY	mthfr	MTHFR	48#53	NaN	We observed that interactions between MTHFR677, MTHFR1298, and SHMT polymorphisms may have a significant impact on genetic instability in lung cancer patients.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	p130	p130	146#150	NaN	Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	TITLE	0	0	5934	LONGTERM|DICTIONARY	rb2	RB2	151#154	NaN	Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
20857490	2011	Int. J. Cancer	1097-0215	ALL_TEXT_3/3	3	10	9149	LONGTERM|DICTIONARY	mirk	Mirk	56#60	NaN	In TOV21G cells, but not in normal diploid fibroblasts, Mirk depletion led to increased apoptosis and loss of viability.
21094227	2011	Toxicol. Lett.	1879-3169	ALL_TEXT_3/3	3	12	9464	LONGTERM|DICTIONARY	th2	Th2	142#145	NaN	In conclusion, to the best of our knowledge, this is the first report to demonstrate that dicloxacillin-induced liver injury is mediated by a Th2-type immune reaction and exacerbated by DK-PGD(2).
21297633	2011	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	3	347051	LONGTERM|DICTIONARY	p < 5	P < 5	39#44	NaN	We identified 29 additional risk loci (P < 5 × 10(-8)), increasing the number of ulcerative colitis-associated loci to 47.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_3/3	3	9	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	67#76	NaN	The present study suggests that the variant genotypes of G6544A of IFN-gamma might be associated with focal form of brucellosis and play as a genetic risk factor in brucellosis.
21313874	2011	Pak. J. Biol. Sci.	1028-8880	ALL_TEXT_1/3	1	2	3458	LONGTERM|DICTIONARY	ifn-gamma	IFN-gamma	0#9	NaN	IFN-gamma plays a key role in the defense mechanism against brucella infection.
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	4	164045	LONGTERM|DICTIONARY	helicase	helicase	124#132	NaN	The current study was conducted to elucidate the effects of Hg(2+) on the structure and activity of BLM642-1290 recombinant helicase, and to further explore the molecular mechanisms of mercury toxicity to the DNA helicase.
21440839	2011	Biomed. Environ. Sci.	0895-3988	OBJECTIVE	1	4	164045	LONGTERM|DICTIONARY	helicase	helicase	213#221	NaN	The current study was conducted to elucidate the effects of Hg(2+) on the structure and activity of BLM642-1290 recombinant helicase, and to further explore the molecular mechanisms of mercury toxicity to the DNA helicase.
21497595	2011	Eur. J. Pharmacol.	1879-0712	TITLE	0	0	3553	LONGTERM|DICTIONARY	il-1b	IL-1b	90#95	NaN	Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneys.
21497595	2011	Eur. J. Pharmacol.	1879-0712	ALL_TEXT_3/3	3	11	3553	LONGTERM|DICTIONARY	il-1b	IL-1b	233#238	NaN	In conclusion, erythropoietin promotes inflammatory cell apoptosis, drives inflammatory and apoptotic cells into tubular lumens, eventually leads to inflammation clearance, renoprotection and tissue remodelling through caspase-3 and IL-1β in isolated haemoperfused kidneys.
21966456	2012	PLoS ONE	1932-6203	METHODOLOGY/PRINCIPAL FINDINGS	2	7	5733	LONGTERM|DICTIONARY	ep3	EP3	0#3	NaN	EP3 was expressed in the conjunctival epithelium of patients with chemical eye burns and Mooren's ulcer and in normal human conjunctival epithelium.
22119709	2012	Toxicol. Appl. Pharmacol.	1096-0333	ALL_TEXT_2/3	2	6	920	LONGTERM|DICTIONARY	cd4	CD4	43#46	NaN	After JWH-133 treatment, the percentage of CD4(+) T cells, neutrophils, mast cells, natural killer (NK1.1) cells, and activated T cells declined in the intestinal lamina propria (LP) and mesenteric lymph nodes (MLN) of mice with chronic colitis.
22322133	2013	Blood Coagul. Fibrinolysis	1473-5733	TITLE	0	0	2160	LONGTERM|DICTIONARY	f11	F11	26#29	NaN	Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency.
22570617	2012	PLoS Genet.	1553-7404	ALL_TEXT_3/3	3	9	7040	LONGTERM|DICTIONARY	tgf-beta	TGF-beta	64#72	NaN	These results suggest that neuro-protective therapies targeting TGF-beta signaling could be effective for multiple forms of glaucoma.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	2033	LONGTERM|DICTIONARY	p300	p300	48#52	NaN	We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
23698071	2013	J. Invest. Dermatol.	1523-1747	ALL_TEXT_2/3	2	3	2033	LONGTERM|DICTIONARY	p300	p300	130#134	NaN	We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression.
2480601	1990	Proc. Natl. Acad. Sci. U.S.A.	0027-8424	TITLE	0	0	5354	LONGTERM|DICTIONARY	proteolipid protein	proteolipid protein	47#66	NaN	Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant.
24997986	2015	Nat. Genet.	1546-1718	TITLE	0	0	1956	LONGTERM|DICTIONARY	erbb	ErbB	104#108	NaN	Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
24997986	2015	Nat. Genet.	1546-1718	ALL_TEXT_3/3	3	7	1956	LONGTERM|DICTIONARY	erbb	ErbB	110#114	NaN	These findings provide insight into the somatic mutational landscape in GBC and highlight the key role of the ErbB signaling pathway in GBC pathogenesis.
26095815	2016	Placenta	1532-3102	DISCUSSION	4	12	23526	LONGTERM|DICTIONARY	ha-1	HA-1	10#14	NaN	Increased HA-1 expression, combined with increased preeclamptic syncytiotrophoblast deportation, provides a novel potential mechanism for exposure of the maternal immune system to increased fetal antigenic load during preeclampsia.
26141506	2015	Chem. Biol. Interact.	1872-7786	ALL_TEXT_3/3	3	7	7124	LONGTERM|DICTIONARY	tnf-a	TNF-a	108#113	NaN	CT administration produced a significantly reduction (p<0.05) in the mechanical hyperalgesia induced by CG, TNF-α, PGE2 and DA when compared with control group.
6889048	1983	Pediatrics	0031-4005	ALL_TEXT_3/3	3	5	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	14#26	NaN	Deficiency of antithrombin is known to be associated with an increased risk of thrombosis.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	TITLE	0	0	3126	LONGTERM|DICTIONARY	dr4	DR4	28#31	NaN	[The molecular basis of HLA DR4 alleles associated with rheumatoid arthritis in a Chinese population].
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_1/3	1	2	3126	LONGTERM|DICTIONARY	dr4	DR4	28#31	NaN	The results showed that the DR4 was significantly associated with RA(RR = 3.1, chi 2 = 13.8, P < 0.005).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_2/3	2	5	3126	LONGTERM|DICTIONARY	dr4	DR4	72#75	NaN	The DRB1 *0405 (Dw15) was the most common allele, accounting for 48% of DR4 positive normal individuals and also is a principal subtype associated with RA susceptibility (RR = 3.1, P < 0.005).
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	10	3126	LONGTERM|DICTIONARY	dr4	DR4	14#17	NaN	The different DR4 subtype structures and frequencies may account for the different associations of DR4 with RA in various ethnic groups.
7987717	1995	Zhonghua Yi Xue Za Zhi	0376-2491	ALL_TEXT_3/3	3	10	3126	LONGTERM|DICTIONARY	dr4	DR4	99#102	NaN	The different DR4 subtype structures and frequencies may account for the different associations of DR4 with RA in various ethnic groups.
8930979	1997	Neuroreport	0959-4965	TITLE	0	0	5663	LONGTERM|DICTIONARY	ps-1	PS-1	22#26	NaN	Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
8942447	1997	Am J Psychiatry	0002-953X	CONCLUSIONS	4	9	3126	LONGTERM|DICTIONARY	dr4	DR4	77#80	NaN	Alternatively, it may be that maternal B lymphocytes that do not express the DR4 antigen encoded by DRB1*04 respond to influenza virus by producing antibodies that perturb neurodevelopment, thus underpinning a proportion of schizophrenia cases.
9047388	1997	Oncogene	0950-9232	TITLE	0	0	7157	LONGTERM|DICTIONARY	p53	p53	84#87	NaN	Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
9047388	1997	Oncogene	0950-9232	ALL_TEXT_2/3	2	6	7157	LONGTERM|DICTIONARY	p53	p53	55#58	NaN	Seven tumors (of 29, 24%) had an alteration of p16 and p53; five (of 33, 15%) had alterations of p16 and PRAD-1; three (of 29, 10%) had alterations of all three genes.
9070496	1997	Cancer	0008-543X	BACKGROUND	1	3	355	LONGTERM|DICTIONARY	fas antigen	Fas antigen	0#11	NaN	Fas antigen (Fas) and Fas ligand participate in cytotoxicity mediated by T lymphocytes and natural killer cells.
9070496	1997	Cancer	0008-543X	BACKGROUND	1	3	356	LONGTERM|DICTIONARY	fas ligand	Fas ligand	22#32	NaN	Fas antigen (Fas) and Fas ligand participate in cytotoxicity mediated by T lymphocytes and natural killer cells.
9149321	1997	Psychiatr. Genet.	0955-8829	ALL_TEXT_3/3	3	9	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	66#87	NaN	The findings support the hypothesis that allelic variation in the serotonin transporter gene may contribute to susceptibility for both major depression and bipolar disorder.
9149321	1997	Psychiatr. Genet.	0955-8829	ALL_TEXT_1/3	1	1	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	120#141	NaN	We have recently reported an association between a polymorphism of a variable number tandem repeat (VNTR) region of the serotonin transporter gene and susceptibility to major depressive disorder.
9149321	1997	Psychiatr. Genet.	0955-8829	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	52#73	NaN	Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder.
9361298	1997	Neurobiol. Dis.	0969-9961	TITLE	0	0	2705	LONGTERM|DICTIONARY	connexin32	Connexin32	0#10	NaN	Connexin32 and X-linked Charcot-Marie-Tooth disease.
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	TITLE	0	0	348	LONGTERM|DICTIONARY	apoe	ApoE	0#4	NaN	ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	alipoprotein e	alipoprotein E	147#161	NaN	We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
9481718	1998	Nephrol. Dial. Transplant.	0931-0509	METHODS	2	4	348	LONGTERM|DICTIONARY	apoe	apoE	163#167	NaN	We studied the prevalence of nephropathy (N+ = urinary albumin excretion rate (UAE) > 20 mg/d) in 134 Caucasian NIDDM patients ranked according to alipoprotein E (apoE) genotype (same distribution in 132 controls).
9545398	1998	Am. J. Hum. Genet.	0002-9297	TITLE	0	0	695	LONGTERM|DICTIONARY	btk	btk	13#16	NaN	Mutations in btk in patients with presumed X-linked agammaglobulinemia.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	1	695	LONGTERM|DICTIONARY	btk	Btk	119#122	NaN	In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	2	695	LONGTERM|DICTIONARY	btk	Btk	56#59	NaN	Most laboratories have been able to detect mutations in Btk in 80%-90% of males with presumed XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_1/3	1	3	695	LONGTERM|DICTIONARY	btk	Btk	45#48	NaN	The remaining patients may have mutations in Btk that are difficult to identify, or they may have defects that are phenotypically similar to XLA but genotypically different.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	6	695	LONGTERM|DICTIONARY	btk	Btk	158#161	NaN	Excluding the patients in whom the marked decrease in B cell numbers characteristic of XLA could not be confirmed by immunofluorescence studies, mutations in Btk were identified in 43 of 46 patients with presumed sporadic XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	7	695	LONGTERM|DICTIONARY	btk	Btk	188#191	NaN	Two of the three remaining patients had defects in other genes required for normal B cell development, and the third patient was unlikely to have XLA, on the basis of results of extensive Btk analysis.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	8	695	LONGTERM|DICTIONARY	btk	Btk	53#56	NaN	Our techniques were unable to identify a mutation in Btk in one male with both a family history and laboratory findings suggestive of XLA.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	12	695	LONGTERM|DICTIONARY	btk	Btk	81#84	NaN	These studies indicate that 90%-95% of males with presumed XLA have mutations in Btk.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_2/3	2	5	695	LONGTERM|DICTIONARY	btk	Btk	13#16	NaN	Mutations in Btk were identified in 38 of 40 families with more than one affected family member and in 56 of 61 families with sporadic disease.
9545398	1998	Am. J. Hum. Genet.	0002-9297	ALL_TEXT_3/3	3	9	695	LONGTERM|DICTIONARY	btk	Btk	96#99	NaN	DNA samples from 41 of 49 of the mothers of males with sporadic disease and proven mutations in Btk were positive for the mutation found in their son.
9550468	1998	Arthritis Rheum.	0004-3591	OBJECTIVE	1	1	356	LONGTERM|DICTIONARY	fas-l	Fas-L	91#96	NaN	To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
9550468	1998	Arthritis Rheum.	0004-3591	RESULTS	3	4	356	LONGTERM|DICTIONARY	fas-l	Fas-L	11#16	NaN	The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE.
9620294	1998	J. Invest. Dermatol.	0022-202X	TITLE	0	0	5727	LONGTERM|DICTIONARY	patched	PATCHED	41#48	NaN	Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	PATCHED	13#20	NaN	Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
9620294	1998	J. Invest. Dermatol.	0022-202X	ALL_TEXT_1/3	1	1	5727	LONGTERM|DICTIONARY	patched	patched	64#71	NaN	Mutations in PATCHED (PTC), the human homolog of the Drosophila patched gene, have been identified in most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell carcinomas.
9759613	1998	Thromb. Haemost.	0340-6245	TITLE	0	0	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	23#35	NaN	The molecular basis of antithrombin deficiency in Belgian and Dutch families.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	antithrombin	antithrombin	34#46	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_1/3	1	1	462	LONGTERM|DICTIONARY	at	AT	48#50	NaN	The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_2/3	2	4	462	LONGTERM|DICTIONARY	at	AT	19#21	NaN	DNA studies of the AT gene were performed, using polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis, followed by direct sequencing of the seven exons and intron-exon junction regions.
9759613	1998	Thromb. Haemost.	0340-6245	ALL_TEXT_3/3	3	7	462	LONGTERM|DICTIONARY	at	AT	82#84	NaN	In these cases, Southern blot and polymorphism analysis of different parts of the AT gene proved useful for diagnosis.
9845763	1999	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1003-9406	TITLE	0	0	6532	LONGTERM|DICTIONARY	serotonin transporter	serotonin transporter	41#62	NaN	[Association of VNTR region of the human serotonin transporter gene with bipolar disorder among the Han Chinese].
9858366	1999	Neuroreport	0959-4965	TITLE	0	0	3782	LONGTERM|DICTIONARY	hskca3	hSKCa3	29#35	NaN	Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family-based study.
9858366	1999	Neuroreport	0959-4965	ALL_TEXT_3/3	3	5	3782	LONGTERM|DICTIONARY	hskca3	hSKCa3	66#72	NaN	Further studies using family-based designs should clarify whether hSKCa3 is a susceptibility factor to schizophrenia or co-segregates with a major disease gene in tight linkage.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_1/3	1	2	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	28#37	NaN	Despite surface expression, GPIbalpha failed to support ristocetin-induced platelet agglutination and to bind two conformation-dependent monoclonal antibodies, suggesting a qualitative defect.
9886312	1999	Br. J. Haematol.	0007-1048	ALL_TEXT_3/3	3	5	2811	LONGTERM|DICTIONARY	gpibalpha	GPIbalpha	207#216	NaN	Infusion of 1-desamino-8-D-arginine vasopressin normalized bleeding time in the two severely affected patients, although it did not modify ristocetin-induced platelet agglutination or membrane expression of GPIbalpha, GPIX, GPIIb-IIIa and GMP-140.
